<SEC-DOCUMENT>0001601485-25-000124.txt : 20251113
<SEC-HEADER>0001601485-25-000124.hdr.sgml : 20251113
<ACCEPTANCE-DATETIME>20251113160850
ACCESSION NUMBER:		0001601485-25-000124
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		83
CONFORMED PERIOD OF REPORT:	20250930
FILED AS OF DATE:		20251113
DATE AS OF CHANGE:		20251113

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elicio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001601485
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				113430072
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39990
		FILM NUMBER:		251478485

	BUSINESS ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		(857) 209-0050

	MAIL ADDRESS:	
		STREET 1:		451 D STREET, 5TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Angion Biomedica Corp.
		DATE OF NAME CHANGE:	20140228
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>angn-20250930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:46abd97b-e878-4f3c-a24b-01e71dba1284,g:89379ce6-47e2-4598-9348-41e57d269da1,d:48b4e94dc81c43c39c91c977a31d007f-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:angn="http://www.angn.com/20250930" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>angn-20250930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-26">2025</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-27">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-28">12-31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-29">0001601485</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">False</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-99" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="f-439">0.1</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="angn-20250930.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="agreement"><xbrli:measure>angn:agreement</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>angn:entity</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-11-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:PurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:AngionCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024RegistrationStatementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2021PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:Inducement2024PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-03-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-02-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-30</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-01</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-31</xbrli:startDate><xbrli:endDate>2025-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-06-01</xbrli:startDate><xbrli:endDate>2025-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">angn:GKCCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyAndJayVenkatesanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-07-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001601485</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i48b4e94dc81c43c39c91c977a31d007f_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">_____________________________________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September 30, 2025</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.262%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from &#160;&#160;&#160;to </span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-39990</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Elicio Therapeutics, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;padding-left:9pt;padding-right:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:10pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:34.426%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.106%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">11-3430072</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">451 D Street, 5th Floor</ix:nonNumeric>                       <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Boston</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">Massachusetts</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">02210</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">857</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">209-0050</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:33.256%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.737%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.01</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">ELTX</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">Nasdaq</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.451%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-22">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9746;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding as of November&#160;10, 2025 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">17,489,516</ix:nonFraction>.</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:88.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.573%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TABLE OF CONTENTS</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_19">PART I FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_22">Item 1. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_25">Condensed Consolidated Balance Sheets (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_31">Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_31">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_34">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_40">Condensed Consolidated Statements of Cash Flows (unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_40">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:31.5pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_43">Notes to Unaudited Interim Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_43">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_100">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_100">23</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_124">Item 3. Quantitative and Qualitative Disclosures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_124">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_127">Item 4. Controls and Procedures </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_127">31</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_130">PART II OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_133">Item 1. Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_133">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_136">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_136">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_139">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_139">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_142">Item 3. Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_142">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_145">Item 4.  Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_145">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_148">Item 5. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_148">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_151">Item 6. Exhibits </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_151">35</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_154">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_154">36</a></span></div></td></tr></table></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q, including the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements concerning our business strategy and plans, future operating results and financial position, as well as our objectives and expectations for our future operations, are forward-looking statements. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;positioned,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our financial condition, including our ability to obtain the funding necessary to advance the development of ELI-002 7P and any other current or future product candidates, our ability to continue as a going concern and our cash runway;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability of our clinical trials to demonstrate safety and efficacy of our product candidates, and other positive results; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to utilize our platform to develop a pipeline of product candidates to address unmet needs in cancer; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timing, progress and results of clinical trials for ELI-002 7P, and other current or future product candidates we may develop, including statements regarding the timing of initiation and completion of studies or trials and related preparatory work, the period during which the results of the studies or trials will become available, and the timing, progress and results of our research and development programs; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timing, scope and likelihood of regulatory filings and approvals, including timing of Investigational New Drug applications and U.S. Food and Drug Administration (&#8220;FDA&#8221;) approval of ELI-002 7P and any current or future product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the timing, scope or likelihood of foreign regulatory filings and approvals; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to develop and advance our current product candidates and programs into, and successfully complete, clinical studies; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our manufacturing, commercialization, and marketing capabilities and strategy; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the need to hire additional personnel and our ability to attract and retain such personnel; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the size of the market opportunity for our product candidates, including estimates of the number of patients who suffer from the diseases we are targeting; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expectations regarding the approval and use of our product candidates in combination with other drugs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expectations regarding potential for accelerated approval or other expedited regulatory designation; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our competitive position and the success of competing therapies that are or may become available; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our anticipated research and development activities and projected expenditures; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">existing regulations and regulatory developments in the United States, Europe and other jurisdictions; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the extent to which global economic and political developments, including the ongoing conflict between Ukraine and Russia, the conflicts in the Middle East, including the conflict between Israel and Palestine, geopolitical tensions with China, and other geopolitical events, as well as the macroeconomic conditions, including tariffs, inflation, volatility in interest rates, potential for economic slowdown or recession and potential governmental shutdowns, will affect our business operations, clinical trials, or financial condition;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our expectations regarding other macroeconomic trends; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our intellectual property position, including the scope of protection we are able to establish and maintain for intellectual property rights covering ELI-002 7P, other current or future product candidates we may develop, including the extensions of existing patent terms where available, the validity of intellectual property rights held by third parties, and our ability not to infringe, misappropriate or otherwise violate any third-party intellectual property rights; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our continued reliance on third parties to conduct additional clinical trials of our product candidates, and for the manufacture of our product candidates for clinical trials; </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to have manufactured sufficient supplies of drug product for clinical testing and commercialization; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our ability to obtain, and negotiate favorable terms of, any collaboration, licensing or other arrangements that may be necessary or desirable to develop, manufacture or commercialize our product candidates; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our estimates regarding expenses, future revenue, capital requirements and needs for additional financing; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our projected financial performance; </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">our anticipated use of proceeds from potential financing activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the period over which we estimate our existing cash and cash equivalents will be sufficient to fund our planned operating expenses and capital expenditure requirements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the potential impact of anticipated funding pressures and the expected effect from U.S. export controls and tariffs; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the impact of laws and regulations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We discuss these risks in greater detail under the sections titled &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December 31, 2024 (the &#8220;Form 10-K&#8221;) filed with the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) on March 31, 2025, our Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed with the SEC on May 13, 2025, and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 filed with the SEC on August 7, 2025, as updated and/or supplemented in subsequent filings with the SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, forward-looking statements represent our management&#8217;s beliefs and are based on assumptions as of the date they were made. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be read to indicate that we have conducted an exhaustive inquiry into or review of all relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely on these statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q also contains estimates, projections and other information concerning our industry, our business and the markets for certain drugs, including data regarding the estimated size of those markets, their projected growth rates and the incidence of certain medical conditions. Information that is based on estimates, forecasts, projections or similar methodologies is inherently subject to uncertainties, and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market and other data from reports, research surveys, studies and similar data prepared by third parties, industry, medical and general publications, government data and similar sources. In some cases, we do not expressly refer to the sources from which this data is derived. In that regard, when we refer to one or more sources of this type of data in any paragraph, you should assume that other data of this type appearing in the same paragraph is derived from the same sources, unless otherwise expressly stated or the context otherwise requires.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In this Quarterly Report on Form 10-Q, unless the context indicates otherwise, the terms &#8220;Company,&#8221; &#8220;Elicio,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Elicio Therapeutics, Inc. and our wholly-owned subsidiaries. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Trademarks</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report on Form 10-Q includes trademarks, service marks and trade names owned by us or other companies. All trademarks, service marks and trade names included in this Quarterly Report on Form 10-Q are the property of their respective owners. We do not intend our use or display of other companies&#8217; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I FINANCIAL INFORMATION</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_22"></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_25"></div><div style="margin-top:10pt;text-align:center;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets </span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">20,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-32">17,618</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Restricted cash, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="f-33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-34">1,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-35">854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">21,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">20,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-39">328</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-40">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease, right-of-use assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-41">5,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-42">5,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Restricted cash, noncurrent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-43">702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="f-44">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-45">770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="3" id="f-46">600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-47">28,284</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-48">28,178</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Liabilities and stockholders&#8217; equity (deficit)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accounts payable</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="f-49">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">1,038</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">5,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Deferred research obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:fixed-zero" scale="3" id="f-53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-54">1,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease liability, current</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-55">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-56">901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt;text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Total current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">6,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">11,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-59">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:WarrantLiability" format="ixt:num-dot-decimal" scale="3" id="f-60">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">4,356</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">5,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Long-term debt, net of debt discount and debt issuance costs</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">9,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">20,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-65">24,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-66">39,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Commitments and contingencies - Note 9</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-67"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-68"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Stockholders' equity (deficit):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-69"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-70">0.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-71"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-72">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-73">17,273,107</ix:nonFraction> shares and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-74">11,043,837</ix:nonFraction> shares issued at September&#160;30, 2025 and December&#160;31, 2024, respectively; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-75">17,258,652</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-76">11,029,382</ix:nonFraction> outstanding as of September&#160;30, 2025 and December&#160;31, 2024, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-77">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-78">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-79"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-80">14,455</ix:nonFraction></ix:nonFraction> shares outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-81">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonValue" scale="3" id="f-82">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-83">229,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-84">183,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-85">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-86">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-87">225,954</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-88">194,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Total stockholders' equity (deficit)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-89">3,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-90">11,312</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total liabilities and stockholders' equity (deficit)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-91">28,284</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-92">28,178</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Research and development</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-93">5,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-94">7,208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-95">19,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-96">22,947</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">General and administrative</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-97">3,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-98">3,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-99">9,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-100">8,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-101">8,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-102">10,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-103">28,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-104">31,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-105">8,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-106">10,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-107">28,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-108">31,510</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Other (expense) income</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-109">1,811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-110">5,617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-111">3,177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-112">3,279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Loss on issuance of pre-funded warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-114">2,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-116">3,502</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Gain on sale of equipment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="f-117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="f-118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="3" id="f-119">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="f-120">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Foreign exchange transaction (loss) gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-122">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" format="ixt:fixed-zero" scale="3" id="f-123">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="3" id="f-124">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Grant income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="angn:GrantRevenueNonoperating" format="ixt:fixed-zero" scale="3" id="f-125">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="angn:GrantRevenueNonoperating" format="ixt:fixed-zero" scale="3" id="f-126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GrantRevenueNonoperating" scale="3" id="f-127">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:GrantRevenueNonoperating" format="ixt:fixed-zero" scale="3" id="f-128">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Interest income</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-129">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-130">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-131">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="f-132">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-133">426</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-134">137</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-135">796</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestExpenseNonoperating" scale="3" id="f-136">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Total other (expense), net</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-137">2,038</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-138">8,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-139">2,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-140">6,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-141">10,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-142">18,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-143">31,853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-144">37,894</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Other comprehensive income (loss):</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:30.6pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-145">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-146">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-147">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-148">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive loss</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-149">10,044</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-150">18,802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-151">31,709</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-152">37,899</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Net loss per common share, basic and diluted</span></div></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-153"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-154">0.60</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-155"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-156">1.39</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-157"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-158">2.09</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-159"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-160">3.23</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Weighted average common shares and pre-funded warrants outstanding, basic and diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-161"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-162">16,692,476</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-163"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-164">13,582,345</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-165"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-166">15,247,864</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-167"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-168">11,720,527</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_34"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.229%"><tr><td style="width:1.0%"/><td style="width:34.743%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.277%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.429%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.432%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:20pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Common Stock</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Treasury Stock</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Paid-in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Capital</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated Other <br/>Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Deficit</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Stockholders'</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Equity (Deficit)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of December 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-169">11,043,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-170">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-9" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-171">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-172">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-173">183,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-174">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-175">194,101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-176">11,312</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-177">106,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-178">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-179">834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-180">835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-181">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-182">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-183">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of senior note payable into common stock, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-184">0.3</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-185">3,500,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-186">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-187">20,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-188">20,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock and warrants from the January 2025 Offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-189">0.8</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-190">1,261,830</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="f-191">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-192">9,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" format="ixt:num-dot-decimal" scale="3" id="f-193">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon the exercise of common warrants</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-194">68,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-195">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-196">715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-197">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-198">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-199">517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-200">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-201">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">11,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">11,209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of March 31, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-204">15,983,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-205">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-23" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-206">14,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-207">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-208">214,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-209">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-210">205,310</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-211">8,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-212">12,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-213">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-214">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common warrants associated with June 2025 Promissory Note</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-215">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-216">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-217">0.1</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-218">281,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-219">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-220">2,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-221">2,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-222">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-223">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-224">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-225">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-226">10,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-227">10,561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of June 30, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-228">16,277,387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-229">163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-34" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-230">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-231">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-232">217,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-233">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-234">215,871</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-235">1,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-236">17,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-237">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-238">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon the exercise of common warrants</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-239">190,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-240">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-241">2,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-242">2,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-243">0.3</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-42" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-244">787,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-245">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-246">8,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-247">8,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-248">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-249">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-250">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-251">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-252">10,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-253">10,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of September 30, 2025</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-254">17,273,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-255">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-47" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-256">14,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-257">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-258">229,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-259">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-260">225,954</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-261">3,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.333%"><tr><td style="width:1.0%"/><td style="width:34.811%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.268%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.421%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.428%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Common Stock</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Treasury Stock</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Additional</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Paid-in</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Capital</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated Other <br/>Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Accumulated </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Deficit</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Stockholders'</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Equity (Deficit)</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Shares</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Amount</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of December 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-262">9,603,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-263">96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-52" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-264">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-265">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">153,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-267">197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-268">142,203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-269">11,373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-270">0.1</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-271">615,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-272">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-273">5,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-274">5,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon settlement of restricted stock</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="f-275">903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-276">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-277">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-278">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-279">324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-280">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-281">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-282">11,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-283">11,827</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of March 31, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-62" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-284">10,219,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-285">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-63" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-286">14,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-287">150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-288">159,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-289">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-290">154,030</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-291">4,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-292">3,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-293">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-294">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon settlement of restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-68" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="f-295">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-296">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-297">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-71" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-298">34,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-299">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-300">302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="f-301">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-302">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-303">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-304">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-305">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-306">7,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-307">7,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of June 30, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-308">10,258,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-309">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-77" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-310">14,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-311">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-312">159,892</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-313">238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-314">161,259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-315">1,652</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-316">5,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-317">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-318">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon net settlement of restricted stock units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-82" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="f-319">348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-320">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="f-321">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from at-the-market offering</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-84" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-322">9,803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-323">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-324">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from the Public Offering, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="6" id="f-325">0.5</ix:nonFraction> million</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-88" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-326">510,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-327">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-328">1,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-329">1,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-330">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-331">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-332">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-333">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-334">18,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-335">18,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Balance as of September 30, 2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-93" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-336">10,784,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-337">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-94" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-338">14,455</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-339">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-340">161,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-341">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-342">180,097</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-343">18,986</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="margin-top:12pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_40"></div><hr style="page-break-after:always"/><div style="min-height:9pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(in thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.731%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash flows from operating activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net loss</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-344">31,853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-345">37,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Adjustments to reconcile net loss to net cash used in operating activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-346">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-347">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Amortization of right-of-use assets, operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-348">687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="f-349">637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:InterestExpenseNoncash" scale="3" id="f-350">603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:InterestExpenseNoncash" scale="3" id="f-351">82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Amortization of debt discount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-352">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="3" id="f-353">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Costs expensed upon the issuance of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:CostsExpensedUponTheIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:CostsExpensedUponTheIssuanceOfWarrants" scale="3" id="f-355">549</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-356">3,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-357">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-358">1,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="f-359">988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Loss on issuance of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-360">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="angn:GainLossOnIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-361">3,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:8pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Gain on disposal of property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="f-362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="f-363">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Changes in operating assets and liabilities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Prepaid expenses and other current assets</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-364">1,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="f-365">580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Other long-term prepaid assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="f-366">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" format="ixt:num-dot-decimal" scale="3" id="f-367">2,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accounts payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-368">717</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-369">2,385</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accrued expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="angn:IncreaseDecreaseInAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-370">3,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:IncreaseDecreaseInAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="f-371">1,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Deferred research obligation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-372">1,169</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="f-373">613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-374">669</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-375">702</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net cash used in operating activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-376">30,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-377">28,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash flows from investing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-378">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-379">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from sale of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:fixed-zero" scale="3" id="f-380">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="f-381">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net cash used in investing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:fixed-zero" scale="3" id="f-382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-383">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash flows from financing activities</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from issuance of related party convertible note</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:fixed-zero" scale="3" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-385">19,727</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="3" id="f-386">9,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="3" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock and common warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:fixed-zero" scale="3" id="f-388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-389">22,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from the exercise of common warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-390">1,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="f-391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-392">11,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-393">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from the June 2025 Promissory Note, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-394">9,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="3" id="f-395">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Payment of warrant issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:PaymentOfWarrantIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-396">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:PaymentOfWarrantIssuanceCosts" scale="3" id="f-397">549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:17pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Proceeds from the exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-398">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-399">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net cash provided by financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-400">31,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-401">42,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Effect of foreign currency on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-402">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-403">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:17pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Net increase in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-404">1,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-405">13,726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cash, cash equivalents and restricted cash at the beginning of the period</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-406">19,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-407">14,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Cash, cash equivalents, and restricted cash at the end of the period</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-408">21,313</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-409">28,027</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Components of cash and cash equivalents, and restricted cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-410">20,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-411">26,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="f-412">702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-413">2,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-414">21,313</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-415">28,027</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Supplemental disclosure of noncash investing and financing activities:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Fair value of pre-funded warrants at issuance date</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:FairValueOfPreFundedWarrants" format="ixt:fixed-zero" scale="3" id="f-416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:FairValueOfPreFundedWarrants" format="ixt:num-dot-decimal" scale="3" id="f-417">13,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Fair value of common stock warrants upon settlement</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:FairValueOfCommonStockWarrantsUponSettlement" format="ixt:num-dot-decimal" scale="3" id="f-418">2,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:FairValueOfCommonStockWarrantsUponSettlement" format="ixt:fixed-zero" scale="3" id="f-419">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Fair value of common warrants issued with January 2025 Offering</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:WarrantIssuedStockIssuance" format="ixt:num-dot-decimal" scale="3" id="f-420">9,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:WarrantIssuedStockIssuance" format="ixt:fixed-zero" scale="3" id="f-421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Fair value of common warrants issued with June 2025 Promissory Note</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:WarrantIssuedDebtIssuance" scale="3" id="f-422">641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:WarrantIssuedDebtIssuance" format="ixt:fixed-zero" scale="3" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Fair value of common warrants at issuance date</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:WarrantExercisedFairValue" format="ixt:fixed-zero" scale="3" id="f-424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:WarrantExercisedFairValue" format="ixt:num-dot-decimal" scale="3" id="f-425">6,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Conversion of related-party senior note payable and interest into equity</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:SettlementOfPromissoryNotesPayable" format="ixt:num-dot-decimal" scale="3" id="f-426">20,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:SettlementOfPromissoryNotesPayable" format="ixt:fixed-zero" scale="3" id="f-427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Accretion of convertible notes discount from issuance costs</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:AccretionOfConvertibleNotesDiscountFromIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:AccretionOfConvertibleNotesDiscountFromIssuanceCosts" scale="3" id="f-429">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Vesting of restricted common stock</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="angn:VestingOfRestrictedCommonStock" format="ixt:fixed-zero" scale="3" id="f-430">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="angn:VestingOfRestrictedCommonStock" scale="3" id="f-431">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.</span></div><div style="height:9pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELICIO THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements</span></div><div style="text-align:center"><span><br/></span></div></div><div><span><br/></span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_46"></div><div style="margin-bottom:6pt;margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 1&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-432" continuedAt="f-432-1" escape="true">Description of the Business and Financial Condition</ix:nonNumeric></span></div><ix:continuation id="f-432-1"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of September&#160;30, 2025, the Company had an accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="f-433">226.0</ix:nonFraction> million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September&#160;30, 2025, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-434">20.6</ix:nonFraction> million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it might have to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-435" continuedAt="f-435-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-435-1" continuedAt="f-435-2"><ix:nonNumeric contextRef="c-1" name="angn:GrantRevenuePolicyTextBlock" id="f-436" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Grant Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Not-for-Profit Entities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and that the grants are not within the scope of ASC 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant. Employees also track hours worked by using the project code.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please refer to Note 2 &#8211; &#8220;Summary of Significant Accounting Policies" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's significant accounting policies.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-437" continuedAt="f-437-1" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-435-2"><ix:continuation id="f-437-1"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-438" continuedAt="f-438-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2023-09&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#8217;s consolidated financial statements, once adopted. The Company is currently evaluating the effect that adoption of ASU 2023-09 will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><ix:continuation id="f-438-1" continuedAt="f-438-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span></ix:continuation><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-438-2">(&#8220;ASU 2024-04&#8221;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is currently evaluating the effect that adoption of ASU 2024-04 will have on its consolidated financial statements</ix:continuation>.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_55"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 3&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-440" continuedAt="f-440-1" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-440-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-441" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-442">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-443">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-445">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-446">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-447">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-448">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-449">6,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-450">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-451">3,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="angn:WarrantsFairValueDisclosure" scale="3" id="f-452">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-453">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-454">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-455">3,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-456">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-457">3,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-458">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-459">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-461">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-462">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-463">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-465">12,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-467">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="angn:WarrantsFairValueDisclosure" scale="3" id="f-468">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="angn:WarrantsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-469">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-471">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-472">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-473">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at September&#160;30, 2025 and December&#160;31, 2024 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the warrants assumed in the merger (the &#8220;Merger&#8221;) with Angion Biomedica Corp. (&#8220;Angion&#8221; and the warrants, the &#8220;Angion Warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="f-474" continuedAt="f-474-1" escape="true">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-474-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:72.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.694%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.695%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the nine months ended, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the year ended,</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-475">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-476">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-477">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="f-478">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-479">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="f-480">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-481" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion Warrant liability was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"/><td style="width:59.646%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.407%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.038%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.409%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-113" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-482">76.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-114" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="f-483">76.00</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-115" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-484">2.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-116" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="f-485">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-117" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-486"><ix:nonFraction unitRef="number" contextRef="c-117" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-487">80.3</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-118" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-488">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-119" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-489"><ix:nonFraction unitRef="number" contextRef="c-119" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-490">3.8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="f-491">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-121" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="f-492">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-122" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" format="ixt:fixed-zero" scale="-2" id="f-493">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;Public Offering&#8221;), consisting of (i) <ix:nonFraction unitRef="shares" contextRef="c-123" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-494">500,000</ix:nonFraction> shares of the Company&#8217;s common stock (the &#8220;July 2024 Shares&#8221;), (ii) pre-funded warrants exercisable for <ix:nonFraction unitRef="shares" contextRef="c-124" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-495">1,800,000</ix:nonFraction> shares of common stock (the &#8220;July 2024 Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-125" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-496">2,300,000</ix:nonFraction> shares of common stock (the &#8220;July 2024 Common Warrants&#8221;). Each July 2024 Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-497">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. As of the current reporting period end, the outstanding July 2024 Pre-Funded Warrants are equity classified. The Company identified the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Refer to Note 6 and 8 for further discussion. Each July 2024 Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-498">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. At the Company&#8217;s annual stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval for GKCC, LLC (&#8220;GKCC&#8221;), together with its affiliates, to exceed the <ix:nonFraction unitRef="number" contextRef="c-3" decimals="INF" name="angn:SaleOfStockBeneficialOwnershipLimitationPercentage" scale="-2" id="f-499">19.99</ix:nonFraction>% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) (&#8220;Stockholder Approval&#8221;). As a result of obtaining Stockholder Approval, certain July 2024 Common Warrants are equity classified while the remainder of the outstanding July 2024 Common Warrants are liability classified and are subsequently remeasured at each reporting period end. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three and nine months ended September 30, 2025, the Company recognized a change in fair value of $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-500">1.8</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-501">3.2</ix:nonFraction> million, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_61"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 4&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-502" continuedAt="f-502-1" escape="true">Balance Sheet Components</ix:nonNumeric></span></div><ix:continuation id="f-502-1" continuedAt="f-502-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="f-503" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:PrepaidResearchAndDevelopmentExpenses" scale="3" id="f-504">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:PrepaidResearchAndDevelopmentExpenses" format="ixt:num-dot-decimal" scale="3" id="f-505">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:AdvancedProfessionalFees" scale="3" id="f-506">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AdvancedProfessionalFees" scale="3" id="f-507">243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-508">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidInsurance" scale="3" id="f-509">347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-510">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:OtherPrepaidExpensesAndOtherAssetsCurrent" scale="3" id="f-511">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="f-512">854</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-513">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-502-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment, Net</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-514" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-515">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-516">1,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-517">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-518">242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-519">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-520">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-521">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-522">2,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-523">1,707</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-524">1,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-525">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-526">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for the three and nine months ended September 30, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-527">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-528">0.2</ix:nonFraction> million, respectively. For the three and nine months ended September 30, 2024, depreciation expense was <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Depreciation" format="ixt:fixed-zero" scale="0" id="f-529">immaterial</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-530">0.2</ix:nonFraction> million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-531">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:PrepaidExpenseOtherNoncurrent" scale="6" id="f-532">0.6</ix:nonFraction> million for September&#160;30, 2025 and December&#160;31, 2024, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-533" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="f-534">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-535">1,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-536">1,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-537">2,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-538">2,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AccruedResearchAndDevelopmentCurrent" format="ixt:num-dot-decimal" scale="3" id="f-539">4,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-540">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="angn:AccruedOtherOperatingLiabilitiesCurrent" scale="3" id="f-541">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-542">5,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-543">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_64"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5 &#8212; <ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" id="f-544" continuedAt="f-544-1" escape="true">Research Grants</ix:nonNumeric></span></div><ix:continuation id="f-544-1" continuedAt="f-544-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-545">2.8</ix:nonFraction> million award, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-546">2.3</ix:nonFraction> million was received in September 2022 and the remaining $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-547">0.5</ix:nonFraction> million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-548">0.5</ix:nonFraction> million payment was applied as a credit to the second grant agreement described below. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-549">3.1</ix:nonFraction> million, with such amount received net of the $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="angn:ResearchAndDevelopmentArrangementCredit" scale="6" id="f-550">0.5</ix:nonFraction> million credit described above.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three and nine months ended September 30, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company incurred </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="f-551">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-552">2.2</ix:nonFraction> million in research and development expenses related to this project, respectively. As of September&#160;30, 2024, the grant funds available for the second grant agreement were</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrantReceived" scale="6" id="f-553">0</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the deferred research obligation was </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-554">0</ix:nonFraction>, as the second grant agreement activities were completed in the third quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="angn:ResearchAndDevelopmentArrangementGrant" scale="6" id="f-555">1.5</ix:nonFraction> million. For each of the three and nine months ended September 30, 2024, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-556"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-557">0.2</ix:nonFraction></ix:nonFraction> million in research and development expenses related to this project, all of which was reimbursed from available grant funds. For the three and nine months ended September 30, 2025, the Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="0" id="f-558">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-559">0.8</ix:nonFraction> million in research and development expenses related to this project, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" scale="0" id="f-560">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" scale="6" id="f-561">0.8</ix:nonFraction> million was reimbursed from available grant funds, respectively. The third grant agreement activities were completed in the second quarter of 2025.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-544-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The award money for the <ix:nonFraction unitRef="agreement" contextRef="c-3" decimals="INF" name="angn:NumberOfResearchGrantAgreements" format="ixt-sec:numwordsen" scale="0" id="f-562">three</ix:nonFraction> grant agreements was recorded as contra-expense to offset the research and development costs incurred. Following completion of the third grant agreement with GI Research Foundation, during 2025, the remaining $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="angn:GrantRevenueNonoperating" scale="6" id="f-563">0.4</ix:nonFraction> million of the grant funds were recognized as grant income, as there were no further conditions to be met.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_67"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-564" continuedAt="f-564-1" escape="true">Common Stock and Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="f-564-1" continuedAt="f-564-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-565">300,000,000</ix:nonFraction> shares of common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-566">0.01</ix:nonFraction> per share, and <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-567">10,000,000</ix:nonFraction> shares of preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-568">0.01</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a registration statement on Form S-3 (the &#8220;Prior Shelf Registration St</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">atement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-569">100</ix:nonFraction>&#160;million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" scale="6" id="f-570">21</ix:nonFraction> million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#8220;2022 ATM Program"). During the nine months ended September 30, 2024, the Company issued and sold a total of <ix:nonFraction unitRef="shares" contextRef="c-148" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-571">650,179</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-149" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-572">8.42</ix:nonFraction> per share under the 2022 ATM Program for aggregate net sale proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-573">5.4</ix:nonFraction> million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-574">200</ix:nonFraction>&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services LLC, as agent, to provide for the issuance and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-6" name="angn:SaleOfStockAggregateInitialOfferingPrice" format="ixt:num-dot-decimal" scale="6" id="f-575">40</ix:nonFraction>&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221;). During the nine months ended September 30, 2025, the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="c-152" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-576">1,176,449</ix:nonFraction> shares of common stock at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-153" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-577">9.68</ix:nonFraction> per share under the 2024 ATM Program for aggregate net sale proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-578">11.4</ix:nonFraction> million after deducting sales commissions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, providing for the issuance and sale by the Company to GKCC of pre-funded warrants (the &#8220;March 2024 Pre-Funded Warrants&#8221;) (the &#8220;March 2024 Offering&#8221;). Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-154" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-579">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds to the Company from the March 2024 Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-580">6.0</ix:nonFraction> million. Refer to Note 8 for additional information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offerings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the Public Offering, which resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-581">10.9</ix:nonFraction>&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Public Offering consisted of the July 2024 Shares or in lieu thereof, the July 2024 Pre-Funded Warrants, and accompanying July 2024 Common Warrants. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-156" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-582">5.00</ix:nonFraction> per July Share and accompanying July 2024 Common Warrant, and each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-157" decimals="2" name="us-gaap:SharesIssuedPricePerShare" scale="0" id="f-583">4.99</ix:nonFraction> per July 2024 Pre-Funded Warrant and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">accompanying July 2024 Common Warrant, which represented the combined purchase price per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant less the $<ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-584">0.01</ix:nonFraction> per share exercise price for each such July 2024 Pre-Funded Warrant. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-564-2"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The July 2024 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-585">5.00</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-125" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-586">five years</ix:nonNumeric> from the issuance date. Refer to Note 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the &#8220;January 2025 Offering&#8221;): (i) an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-158" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-587">1,261,830</ix:nonFraction> shares of the Company&#8217;s common stock (the &#8220;January 2025 Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-159" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-588">1,261,830</ix:nonFraction> shares of common stock (the &#8220;January 2025 Common Warrants&#8221;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-589">7.925</ix:nonFraction>. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-160" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-590">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-161" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-591">five years</ix:nonNumeric> from the initial exercise date. The January 2025 Offering resulted in net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-592">9.2</ix:nonFraction>&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into a note purchase agreement (the &#8220;June 2025 Promissory Note Financing&#8221;) with GKCC pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#8220;June 2025 Promissory Note&#8221;) in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-593">10.0</ix:nonFraction>&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-594">103,225</ix:nonFraction> shares of the Company&#8217;s common stock (the &#8220;June 2025 Warrant&#8221;). The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-163" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-595">7.75</ix:nonFraction> per share, is immediately exercisable, and expires <ix:nonNumeric contextRef="c-163" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-596">five years</ix:nonNumeric> from the date of issuance. Refer to Note 11 for further detail.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_70"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 7&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-597" continuedAt="f-597-1" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-597-1" continuedAt="f-597-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September&#160;30, 2025, there was an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-598">806,700</ix:nonFraction> shares of common stock available for issuance under the Company&#8217;s equity incentive plans, including <ix:nonFraction unitRef="shares" contextRef="c-164" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-599">462,097</ix:nonFraction> shares available for future grants under the Company&#8217;s 2021 Incentive Award Plan, <ix:nonFraction unitRef="shares" contextRef="c-165" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-600">177,295</ix:nonFraction> shares available for future grants under the Company&#8217;s 2022 Equity Incentive Plan, as amended, and <ix:nonFraction unitRef="shares" contextRef="c-166" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" format="ixt:num-dot-decimal" scale="0" id="f-601">167,308</ix:nonFraction> shares available for future grants issuance under the Company&#8217;s 2024 Inducement Incentive Award Plan. Refer to Note 8 &#8211; &#8220;Stock-Based Compensation" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-602" escape="true"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-603">1,890,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-604">15.69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-167" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-605">6.78</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="f-606">920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-607">656,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-608">7.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-609">31,918</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-610">4.56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-611">51,106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-612">6.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-613">2,464,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-614">13.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-615">6.96</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-616">10,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-617">1,345,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-618">19.92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-619">5.36</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-620">5,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-621">656,099</ix:nonFraction> stock options were granted during the nine months ended September 30, 2025. The weighted average grant date fair value per share for the stock option grants during the nine months ended September 30, 2025 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-622">7.40</ix:nonFraction>. As of September&#160;30, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="f-623">5.1</ix:nonFraction> million, which the Company expects to recognize over a weighted-average period of approximately <ix:nonNumeric contextRef="c-1" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-624">2.7</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-597-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-625" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-626">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-627">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-628">755</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-629">414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-630">434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-631">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-632">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-633">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-634">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-635">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-636">1,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-637">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-638" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:35.649%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.277%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-639">3.7</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-640">3.4</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-641">3.6</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-642">3.7</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-643">4.3</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="f-644">3.4</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="f-645">4.2</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-646">0.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-647">0.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-648">0.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-649">0.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years (for employees)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-176" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-650">6.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-180" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-651">5.8</ix:nonNumeric> - <ix:nonNumeric contextRef="c-181" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-652">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-182" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-653">5.5</ix:nonNumeric> - <ix:nonNumeric contextRef="c-183" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-654">6.1</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-184" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-655">5.0</ix:nonNumeric> - <ix:nonNumeric contextRef="c-185" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-656">6.1</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-176" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-657">110.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-658">104.6</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-659">104.8</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-660">106.9</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-661">110.4</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-662">79.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-663">104.8</ix:nonFraction>%</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the condensed consolidated financial statements for the period ended September&#160;30, 2024.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period was determined by Angion&#8217;s board of directors. No offering periods or purchasing periods were active as of September&#160;30, 2025. As of September&#160;30, 2025, <ix:nonFraction unitRef="shares" contextRef="c-186" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="0" id="f-664">275,309</ix:nonFraction> shares remained available for purchase under the ESPP and <ix:nonFraction unitRef="shares" contextRef="c-186" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:fixed-zero" scale="0" id="f-665">no</ix:nonFraction> offerings have been authorized.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_76"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 8&#8212;<ix:nonNumeric contextRef="c-1" name="angn:WarrantsAndRightsOutstandingTextBlock" id="f-666" continuedAt="f-666-1" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="f-666-1" continuedAt="f-666-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with FASB ASC Topic 815, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 815&#8221;), certain of the Company&#8217;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-187" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-667">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the March 2024 Pre-Funded Warrants were liability-classified, with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-5" name="angn:WarrantExercisedFairValue" format="ixt:num-dot-decimal" scale="6" id="f-668">6.6</ix:nonFraction>&#160;million, as determined by the Black-Scholes option pricing model as of the grant date. The Company recorded the $<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="6" id="f-669"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-5" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="6" id="f-670">0.6</ix:nonFraction></ix:nonFraction> million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024 and nine months ended September 30, 2024. As of September 30, 2025, the March 2024 Pre-Funded Warrants were classified as equity due to the receipt of Stockholder Approval in November 2024, as discussed in Note 3.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 3 and 6, in July 2024, the Company closed its Public Offering consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-126" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-671">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-672">5.00</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the July 2024 Pre-Funded Warrants and July 2024 Common Warrants were liability-classified, with a fair value of $<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-5" name="angn:WarrantExercisedFairValue" scale="6" id="f-673">6.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-5" name="angn:WarrantExercisedFairValue" scale="6" id="f-674">6.5</ix:nonFraction> million, respectively, measured using the Black-Scholes option pricing model as of the grant date. The Company recorded the $<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-5" sign="-" name="angn:GainLossOnIssuanceOfWarrants" scale="6" id="f-675">2.9</ix:nonFraction> million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As of September&#160;30, 2025, certain July 2024 Pre-Funded Warrants are classified as equity, following Stockholder Approval in November 2024. For the three and nine months ended September 30, 2025, the Company recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-676">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="6" id="f-677">3.2</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in fair value remeasurement, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following receipt of Stockholder Approval in November 2024, the Company remeasured the March 2024 Pre-Funded Warrants and the July 2024 Pre-Funded Warrants, held by GKCC, at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. As a result of obtaining Stockholder Approval, the March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants held by GKCC and its affiliates met the equity classification requirements under ASC 815. During the quarter ended December 31, 2024, the Company reclassified the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. The Company will re-assess the equity classification for the remaining March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants at each reporting period end. During the nine months ended September 30, 2025, there were no changes to the equity classification.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in January 2025, the Company closed the January 2025 Offering pursuant to which the Company agreed to issue and sell: (i) the January 2025 Shares and (ii) the January 2025 Common Warrants. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-194" decimals="3" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-678">7.925</ix:nonFraction>. The January 2025 Common Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-194" decimals="1" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-679">7.80</ix:nonFraction> per share, are immediately exercisable and will expire <ix:nonNumeric contextRef="c-195" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-680">five years</ix:nonNumeric> from the initial exercise date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-681">9.7</ix:nonFraction> million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-682">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-163" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-683">7.75</ix:nonFraction> per share, is immediately exercisable and expires <ix:nonNumeric contextRef="c-163" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-684">five years</ix:nonNumeric> from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-685">0.6</ix:nonFraction> million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="f-686" escape="true"><ix:continuation id="f-666-2"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables summarize information regarding the warrants outstanding and warrant activity at September&#160;30, 2025:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"/><td style="width:25.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.296%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.610%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.870%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Warrants Outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-198" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-687">144,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-199" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-688">53.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-200" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-689">3.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Angion Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-201" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-690">3,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-202" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-691">76.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-203" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-692">2.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-204" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-693">1,032,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-205" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-694">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-206" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-695">1,600,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-207" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-696">0.01</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-208" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-697">2,041,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-698">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-210" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-699">3.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2025 Common Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-211" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-700">1,261,830</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-212" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-701">7.80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-213" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-702">4.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-214" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-703">103,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-215" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-704">7.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-216" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-705">4.7</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Warrants Outstanding at September 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-706">6,188,021</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-217" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-707">4.69</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" format="ixt-sec:duryear" id="f-708">4.0</ix:nonNumeric></span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of September 30, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:20.936%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.137%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.279%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.151%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.645%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.679%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.685%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Warrants</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted <br/>Average <br/>Exercise <br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-709">5,081,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-710">3.85</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-4" name="angn:ClassOfWarrantOrRightWeightedAverageLife" format="ixt-sec:duryear" id="f-711">4.5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-712">1,365,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" scale="0" id="f-713">7.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightExercisedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-714">258,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" scale="0" id="f-715">5.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at September&#160;30, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-716">6,188,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-717">4.69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-3" name="angn:ClassOfWarrantOrRightWeightedAverageLife" format="ixt-sec:duryear" id="f-718">4.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_79"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 9&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-719" continuedAt="f-719-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-719-1" continuedAt="f-719-2"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-719-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property from a university, which agreement has been amended from time to time to license additional intellectual property and to adjust fees and milestone and diligence requirements. The Company is required to pay certain contractual maintenance and milestone payments related to clinical trials and product sales and royalties on product sales over the term of the contract, with royalty payments commencing in the calendar year of commercialization. Royalty rates range from <ix:nonFraction unitRef="number" contextRef="c-218" decimals="4" name="angn:RoyaltyRatePercent" scale="-2" id="f-720">0.25</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="angn:RoyaltyRatePercent" scale="-2" id="f-721">2.00</ix:nonFraction>%, depending on whether commercial sales relate to a licensed product or an identified product, and the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions. During the nine months ended September 30, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="f-722">0.4</ix:nonFraction>&#160;million. <ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:fixed-zero" scale="0" id="f-723">No</ix:nonFraction> such expenses were recorded in the nine months ended September 30, 2025. <ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:fixed-zero" scale="0" id="f-724">No</ix:nonFraction> commercialization royalties have been achieved to date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is required to pay a total of up to $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="angn:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" format="ixt:num-dot-decimal" scale="6" id="f-725">20.9</ix:nonFraction>&#160;million upon achievement of certain late-stage developmental and commercial milestones. The developmental milestone payments will be recorded when each milestone is achieved, and the commercial milestone payments and royalties will be recorded when the sales occur.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Future minimum annual maintenance payments are $<ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="angn:CollaborativeArrangementFutureMinimumMaintenancePayments" format="ixt:num-dot-decimal" scale="6" id="f-726">0.1</ix:nonFraction>&#160;million for the year ended December&#160;31, 2025 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_82"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 10&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-727" continuedAt="f-727-1" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="f-727-1" continuedAt="f-727-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="6" id="f-728">11.1</ix:nonFraction>&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a right-of-use (&#8220;ROU&#8221;) lease asset of $<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="f-729">8.0</ix:nonFraction>&#160;million with a corresponding lease liability of $<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="f-730">8.0</ix:nonFraction>&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:ProceedsFromSecuredLinesOfCredit" format="ixt:num-dot-decimal" scale="6" id="f-731">0.7</ix:nonFraction>&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of September&#160;30, 2025 and December&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately <ix:nonFraction unitRef="sqft" contextRef="c-228" decimals="0" name="us-gaap:AreaOfRealEstateProperty" format="ixt:num-dot-decimal" scale="0" id="f-732">6,157</ix:nonFraction> square feet for approximately $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="angn:LesseeOperatingLeaseAnnualRentExpense" format="ixt:num-dot-decimal" scale="6" id="f-733">0.2</ix:nonFraction>&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for all leases for the three and nine months ended September 30, 2025 was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-734">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-735">1.0</ix:nonFraction> million, respectively. Lease expense for all leases for the three and nine months ended September 30, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-736">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseExpense" scale="6" id="f-737">1.1</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" id="f-738" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-739">1,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-740">1,096</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-741">4.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="c-98" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-742">5.3</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-743">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="number" contextRef="c-98" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-744">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-745" escape="true"><ix:continuation id="f-727-2"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.673%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2025 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="f-746">338</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-747">1,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-748">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-749">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-750">1,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="angn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" scale="3" id="f-751">253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-752">6,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-753">1,041</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-754">5,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-755">981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-756">4,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i48b4e94dc81c43c39c91c977a31d007f_85"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11 - <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-757" continuedAt="f-757-1" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="f-757-1" continuedAt="f-757-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, pursuant to which the Company issued a <ix:nonFraction unitRef="number" contextRef="c-230" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-758">3</ix:nonFraction>% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-759">20.0</ix:nonFraction> million (the &#8220;Convertible Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to <ix:nonFraction unitRef="number" contextRef="c-230" decimals="2" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-760">3</ix:nonFraction>% per annum, with an initial interest payment date of June 30, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-761">19.7</ix:nonFraction> million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the nine months ended September 30, 2025, the Company recorded an immaterial amount in other expense related to the accretion of the discount of Convertible Note debt issuance costs. During the nine months ended September 30, 2025, the Company recorded accrued interest expense of $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-762">0.1</ix:nonFraction> million related to the interest due on the Convertible Note but not yet payable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued <ix:nonFraction unitRef="shares" contextRef="c-233" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-763">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-764">20.0</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="f-765">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-766">10.0</ix:nonFraction>&#160;million to GKCC, an entity controlled by a member of the board of directors of the Company. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus <ix:nonFraction unitRef="number" contextRef="c-236" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-767">5.00</ix:nonFraction>%, provided that the maximum interest rate shall not exceed <ix:nonFraction unitRef="number" contextRef="c-237" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-768">12.5</ix:nonFraction>% per annum, with an initial interest payment date of July 1, 2026. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-757-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-769">103,225</ix:nonFraction> shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-163" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-770">7.75</ix:nonFraction> per share, is immediately exercisable and expires <ix:nonNumeric contextRef="c-163" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="f-771">five years</ix:nonNumeric> from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of <ix:nonFraction unitRef="number" contextRef="c-238" decimals="4" name="angn:ClassOfWarrantOrRightOwnershipPercentMaximum" scale="-2" id="f-772">49.99</ix:nonFraction>% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrants, as determined by the Black-Scholes option pricing model, was $<ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="f-773">0.6</ix:nonFraction> million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-774">9.9</ix:nonFraction> million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of September 30, the net carrying value of the June 2025 Promissory Note was $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="f-775">9.7</ix:nonFraction> million and the debt discount for the June 2025 Promissory Note was $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="6" id="f-776">0.3</ix:nonFraction> million. Accretion of the discount on the June 2025 Promissory Note was $<ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="f-777">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:AmortizationOfDebtDiscountPremium" scale="6" id="f-778">0.5</ix:nonFraction> million for the three and nine months ended September 30, 2025, respectively.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_88"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 12&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-779" continuedAt="f-779-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-779-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company did <ix:nonFraction unitRef="usd" contextRef="c-6" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-780"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-781"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-782"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="INF" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="0" id="f-783">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t record a provision or benefit for income taxes during the three and nine months ended September&#160;30, 2025 or 2024. As of September&#160;30, 2025 and December&#160;31, 2024, the Company continues to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 4, 2025, H.R. 1 (the &#8220;Act&#8221;), formerly known as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The Company is currently evaluating the full impact of the Act on its financial position, results of operations, and cash flows. However, the Company does not expect the Act to have a material effect on its financial statements. The impact to the Company&#8217;s income tax expense and effective tax rate for the three and nine months ended September 30, 2025 associated with this legislation is not material.</span></div></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_91"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 13&#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-784" continuedAt="f-784-1" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="f-784-1" continuedAt="f-784-2"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock and preferred stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock and preferred stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-785" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three and nine months ended September&#160;30, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-786">10,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-787">18,838</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-788">31,853</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-789">37,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average of common shares and pre-funded warrants outstanding, basic and diluted</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-790"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-791">16,692,476</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-792"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-793">13,582,345</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-794"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-795">15,247,864</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-796"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-797">11,720,527</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-798"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-799">0.60</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-800"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-801">1.39</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-802"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-803">2.09</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-804"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-805">3.23</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><ix:continuation id="f-784-2"><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-806" continuedAt="f-806-1" escape="true">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</ix:nonNumeric></span></div><ix:continuation id="f-806-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"/><td style="width:72.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.904%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.397%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.906%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-241" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-807">2,464,007</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-242" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-808">819,302</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-243" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-809">3,555,319</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-244" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-810">2,448,769</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-811">6,019,326</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-812">3,268,071</ix:nonFraction></span></td></tr></table></div></ix:continuation></ix:continuation><div id="i48b4e94dc81c43c39c91c977a31d007f_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 14 &#8212;<ix:nonNumeric contextRef="c-1" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="f-813" continuedAt="f-813-1" escape="true">Related Party Transactions</ix:nonNumeric></span><ix:continuation id="f-813-1" continuedAt="f-813-2"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span></ix:continuation></div><ix:continuation id="f-813-2"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-154" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-814">0.01</ix:nonFraction> per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the March 2024 Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="f-815">6.0</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Jay Venkatesan, a member of the Company&#8217;s board of directors, and trusts affiliated with Jay Venkatesan, purchased <ix:nonFraction unitRef="shares" contextRef="c-245" decimals="0" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-816">1,600,000</ix:nonFraction> July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants and <ix:nonFraction unitRef="shares" contextRef="c-246" decimals="0" name="angn:ClassOfWarrantOrRightIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-817">200,000</ix:nonFraction> July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants, respectively, with such July 2024 Pre-Funded Warrants and July 2024 Common Warrants subject to the terms and conditions of the July 2024 Pre-Funded Warrants and July 2024 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the Public Offering were approximately $<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="f-818">10.9</ix:nonFraction> million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-819">20.0</ix:nonFraction> million. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-820">19.7</ix:nonFraction> million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued <ix:nonFraction unitRef="shares" contextRef="c-233" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-821">3,500,573</ix:nonFraction> shares of its common stock to GKCC in exchange for the principal balance of $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-822">20.0</ix:nonFraction> million plus $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-5" name="angn:AccruedInterestPremiumForConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="6" id="f-823">0.3</ix:nonFraction>&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-824">10.0</ix:nonFraction> million. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="f-825">9.9</ix:nonFraction> million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-163" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-826">103,225</ix:nonFraction> shares of the Company&#8217;s common stock.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span></div><div style="margin-top:10pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Unaudited Interim Condensed Consolidated Financial Statements (Continued)</span></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Note 15 - <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-827" continuedAt="f-827-1" escape="true">Segment Reporting</ix:nonNumeric></span></div><ix:continuation id="f-827-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has <ix:nonFraction unitRef="entity" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-828">one</ix:nonFraction> reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;), its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Other segment items include interest income, interest expense, grant income, and change in the fair value of liability-classified warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. All long-lived assets are located in the United States. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-829" continuedAt="f-829-1" escape="true">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</ix:nonNumeric></span></div><ix:continuation id="f-829-1"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:44.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-830">1,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-831">3,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-832">8,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-833">9,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-834">2,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-835">1,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-836">6,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-837">6,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-838">456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="f-839">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-840">1,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-841">3,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-842">1,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-843">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-844">3,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-845">4,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:RecoveryOfDirectCosts" format="ixt:fixed-zero" scale="3" id="f-846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" scale="3" id="f-847">544</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" scale="3" id="f-848">754</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" sign="-" name="us-gaap:RecoveryOfDirectCosts" scale="3" id="f-849">888</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-850">1,333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="f-851">846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-852">3,782</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-853">2,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-854">1,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-855">2,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-856">5,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:OtherGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-857">5,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-858">2,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-859">8,496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-860">2,984</ix:nonFraction></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-861">6,387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-862">10,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-863">18,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-864">31,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-865">37,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:71.848%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.121%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-866">28,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-867">28,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_100"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">You should read the following discussion and analysis of our financial condition and results of operations together with our condensed</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">consolidated financial statements and the related notes appearing elsewhere in this Quarterly Report on Form 10-Q and in our audited financial statements and accompanying notes for the years ended December 31, 2024 and 2023 included in the Form 10-K. In addition to the historical financial information, this discussion contains forward-looking statements that involve risks, assumptions and uncertainties, such as statements of our plans, objectives, expectations, intentions, forecasts and projections. Our actual results and the timing of selected events could differ materially from those discussed in these forward-looking statements as a result of several factors, including those set forth under the sections titled &#8220;Risk Factors&#8221; in this Quarterly Report on Form 10-Q, the Quarterly Reports for the quarters ended March 31, 2025 and June 30, 2025, and the Form 10-K, which you should read carefully to gain an understanding of the important factors that could cause actual results to differ materially from our forward-looking statements. Please also see the section titled </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Forward-Looking Statements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">at the beginning of this report.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_103"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Our proprietary Amphiphile (&#8220;AMP&#8221;) technology is designed to generate robust anti-tumor T lymphocytes (&#8220;T cell&#8221;) responses by preferentially targeting lymph nodes.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Recent advances have identified T cell responses as a key component of effective cancer immunotherapy and we believe our AMP technology can generate a robust T cell response that can potentially provide meaningful clinical benefit. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We believe the therapeutic utility of currently approved and development stage cancer immunotherapies are limited in many cases due to their inability to sufficiently localize to lymph nodes and adequately engage with the critical immune cells responsible for stimulating adaptive immunity.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our AMP technology is specifically intended to localize payloads to lymph nodes leading to the generation of a robust T cell response that we believe is critical to generate an anticancer immune response.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our lead programs focus on our cancer immunotherapy product candidates, which target biologically validated driver tumor mutations using common and well characterized neoantigens.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This strategy results in an &#8220;off-the-shelf&#8221; therapeutic option allowing patients to receive treatment without delayed manufacturing timelines and increased costs associated with personalized immunotherapy approaches.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our clinical pipeline includes the lymph node targeted therapeutic cancer immunotherapy ELI-002 7P, currently being evaluated in a Phase 2 study, designed to stimulate an immune response against mutant KRAS (&#8220;mKRAS&#8221;) pancreatic ductal adenocarcinoma (&#8220;PDAC&#8221;), the most common form of pancreatic cancer. The ELI-002 7P formulation is designed to provide immune response coverage against seven KRAS mutations in 88% of PDAC patients and 25% of all solid tumors, thereby increasing the potential patient population for ELI-002 7P. In August 2025, we announced that following the Independent Data Monitoring Committee&#8217;s (&#8220;IDMC&#8221;) pre-specified interim review of unblinded safety and efficacy data in our Phase 2 AMPLIFY-7P study in mKRAS-driven PDAC, the IDMC recommended that the trial continue to the final analysis without modifications. In addition, the IDMC confirmed the favorable safety profile of ELI-002 7P to date. We anticipate the final disease-free survival analysis to occur in the first half of 2026. ELI-002 2P (2-peptide formulation) has been studied previously in the Phase 1 (AMPLIFY-201) trial in patients with high relapse risk mKRAS-driven solid tumors, following surgery and chemotherapy. Our preclinical pipeline includes the lymph node targeted therapeutic immunotherapies ELI-007, currently being evaluated in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers, and ELI-008, currently being evaluated in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe that each of our immunotherapy product candidates, if approved, has the potential to reduce the risk of recurrence of tumors carrying specific oncogenic driver mutations.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations to date have been financed primarily by aggregate net proceeds of $214.8 million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, promissory notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion. Since inception, we have had significant annual operating losses. Our net loss was $10.1 million and $31.9 million for the three and nine months ended September 30, 2025, respectively, and $18.8 million and $37.9 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">for the three and nine months ended September 30, 2024, respectively. As of September&#160;30, 2025, we had an accumulated deficit of $226.0&#160;million and $20.6&#160;million in cash and cash equivalents.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway. As of the filing date of this Quarterly Report on Form 10-Q, we believe that our cash on hand will enable us to fund our operations through the second quarter of 2026 based on our current financial operating plan. This period could be shortened or lengthened if there are any significant increases or decreases in planned or actual spending on development programs or more rapid progress of development programs than anticipated. There is no assurance that financing will be available when needed to allow us to continue as a going concern. Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. We plan to address this condition through the sale of common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If we are unable to obtain additional capital when and as needed to continue as a going concern, we might have to further reduce or scale back our operations and/or liquidate our assets, and the values we receive for our assets in liquidation or dissolution could be significantly lower than the values reflected in our financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. Our condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our accounts payable and accrued expenses. We expect to continue to incur net losses for the foreseeable future, and we expect our research and development expenses, general and administrative expenses, and capital expenditures will continue to increase. In particular, we expect our expenses to increase as we continue our development of, and seek regulatory approvals for, our product candidates, as well as hire additional personnel, pay fees to outside consultants, attorneys and accountants, and incur other increased costs associated with being a public company. In addition, if and when we seek and obtain regulatory approval to commercialize any product candidate, we will also incur increased expenses in connection with commercialization and marketing of any such product. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depending on the timing of our clinical trials and our expenditures on other research and development activities. We anticipate that our expenses will increase significantly in connection with our ongoing activities, as we:</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; advance our lead product candidate, ELI-002 7P, to late stage clinical trials;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; advance our preclinical programs to clinical trials; </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; expand our pipeline of product candidates;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; seek regulatory approval for our investigational medicines;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; maintain, expand, protect and defend our intellectual property portfolio;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; acquire or in-license technology;</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; expand our clinical, scientific, management and administrative teams; and</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226; operate as a public company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of the filing date of this Quarterly Report on Form 10-Q, we believe that our cash on hand will enable us to fund our operations through the second quarter of 2026 based on our current plan. We have based this estimate on assumptions that may prove to be wrong, and we could exhaust our available capital resources sooner than we expect. To finance our operations beyond that point we will need to raise additional capital, which cannot be assured. Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have not had any products approved for sale. We do not expect to generate any product sales unless and until we successfully complete development and obtain regulatory approval for one or more of our product candidates. If we obtain regulatory approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution. As a result, until such time, if ever, that we can generate substantial product revenue, we expect to finance our cash needs through equity offerings, debt financings or other capital sources, including collaborations, licenses or similar arrangements. However, we may be unable to raise additional funds or enter into such other arrangements when needed or on favorable terms, if at all. Any failure to raise capital as and when needed could have a negative impact on our financial condition and on our ability to pursue our business plans and strategies, including our research and development activities. If we are unable to raise capital, we will need to delay, reduce or terminate planned activities to reduce costs.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_106"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Components of Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following discussion summarizes the key factors our management believes are necessary for an understanding of our financial statements.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operating expenses since inception have consisted primarily of research and development expenses and general and administrative costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses consist primarily of costs incurred for the development of our product candidates and our drug discovery efforts, which include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">personnel costs, which include salaries, benefits, and equity-based compensation expense;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">expenses incurred under agreements with consultants and contract organizations that conduct research and development activities on our behalf;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to sponsored research service agreements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">costs related to production of preclinical and clinical materials, including fees paid to contract manufacturers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory and vendor expenses related to the execution of preclinical studies and planned clinical trials; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">laboratory supplies and equipment used for internal research and development activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expense all research and development costs in the periods in which they are incurred. Costs for certain research and development activities are recognized based on an evaluation of the progress to completion of specific tasks using information and data provided to us by our vendors and service providers.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our research and development expenses are not currently tracked on a program-by-program basis. We use our personnel and infrastructure resources across multiple research and development programs directed toward identifying and developing product candidates. Substantially all our research and development costs are incurred on the development of ELI-002 7P and our preclinical candidates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We expect our research and development expenses to increase substantially for the foreseeable future as we continue to invest in research and development activities related to developing our product candidates, including investments in conducting clinical trials, manufacturing and otherwise advancing our programs. The process of conducting the clinical research necessary to obtain regulatory approval is costly and time-consuming, and the successful development of our product candidates is highly uncertain. At this time, we cannot reasonably estimate the nature, timing and costs of the efforts that will be needed to complete the development of, or the period, if any, in which material net cash inflows may commence from ELI-002 7P or any of our preclinical candidates. This is due to the numerous risks and uncertainties associated with developing drugs, including the uncertainty of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the scope, rate of progress and expense of our research and development activities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">clinical trials and early-stage results;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the terms and timing of regulatory approvals; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">the ability to market, commercialize and achieve market acceptance for ELI-002 7P, or any of our preclinical candidates that we or our future collaboration partners may develop in the future. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Any of these variables with respect to the development of ELI-002 7P, or any other of our preclinical candidates that we may develop could result in a significant change in the costs and timing associated with the development of such candidates. For example, if the FDA or other regulatory authority were to require us to conduct preclinical and clinical studies beyond those which we currently anticipate will be required for the completion of clinical development or if we experience significant delays in enrollment in any clinical trials, we could be required to expend significant additional financial resources and time on the completion of our clinical development programs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our general and administrative expenses consist primarily of personnel costs, including equity-based compensation, and other expenses for outside professional services, including marketing, legal, audit and accounting, facility-related costs not otherwise included in research and development expenses, and recruiting. We expect our general and administrative expenses to increase over the next several years to support our continued research and development activities, manufacturing activities, increased costs of expanding our operations and operating as a public company. These increases will likely include increases related to the hiring of additional personnel and legal, regulatory and other fees and services associated with maintaining compliance with the Nasdaq Marketplace Rules or the Nasdaq Listing Rules and SEC requirements, accounting and audit fees, director and officer insurance costs and investor relations costs associated with being a public company.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other (Expense) Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three and nine months ended September 30, 2025 and 2024, other income and expense consisted primarily of interest income, foreign exchange transaction gains and losses, gain on sale of equipment, interest expense, gains and losses related to the re-measurement of our warrant liabilities, and a loss on issuance of the July 2024 Pre-Funded Warrants. </span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_109"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Results of Operations</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Comparison of the Three Months Ended September 30, 2025 and 2024</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes our results of operations for the periods indicated (in thousands, except percentages):</span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.315%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">% Change</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="3" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7,208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,169)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></div></td><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,006&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,136&#160;</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:30pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,045&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,344&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,299)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Loss from operations</span></div></td><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(8,045)</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10,344)</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#bfe4ff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:20pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total other (expense), net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,038)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(8,494)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#bfe4ff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net loss</span></div></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(10,083)</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(18,838)</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,755&#160;</span></td><td style="background-color:#bfe4ff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bfe4ff;padding:0 1pt"/><td colspan="2" style="background-color:#bfe4ff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#bfe4ff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Research and development expenses were $5.0&#160;million for the three months ended September 30, 2025, compared to $7.2&#160;million for the three months ended September 30, 2024. The decrease of $2.2&#160;million was primarily due to less clinical trial costs as patients progressed through the Phase 2 study of ELI-002 7P.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">General and administrative expenses were $3.0 million for the three months ended September 30, 2025, compared to $3.1 million for the three months ended September 30, 2024. The decrease of $0.1&#160;million was primarily due to lower professional fees incurred in connection with general corporate matters.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Other (Expense) Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other (expense) income for the three months ended September 30, 2025 was $(2.0)&#160;million compared to $(8.5)&#160;million for the three months ended September 30, 2024. The decrease of $6.5&#160;million was primarily due to the change in fair value associated with the outstanding liability-classified common warrants, and the initial loss recognized from the Public Offering, including losses from the July 2024 Pre-Funded Warrants and July 2024 Common Warrants.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_112"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Nine Months Ended September 30, 2025 and 2024</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations for the periods indicated (in thousands, except percentages):</span></div><div style="margin-top:6pt;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">$ Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">% Change</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Operating expenses:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19,823&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">22,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,124)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total operating expenses</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">28,872&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31,510&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,638)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Loss from operations</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(28,872)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(31,510)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other (expense), net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(6,384)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Net loss</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(31,853)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(37,894)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,041&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Research and development expenses were $19.8&#160;million for the nine months ended September 30, 2025, compared to $22.9&#160;million for the nine months ended September 30, 2024. The decrease of $3.1&#160;million was primarily due to lower costs as patients progressed through the Phase 2 study of ELI-002 7P.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:107%">General and administrative expenses were $9.0&#160;million for the nine months ended September 30, 2025, compared to $8.6&#160;million for the nine months ended September 30, 2024. The increase of $0.5&#160;million was primarily due to the external costs associated with the January 2025 Offering and June 2025 Promissory Note Financing.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other (Expense) Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income for the nine months ended September 30, 2025 was $(3.0)&#160;million compared to $(6.4)&#160;million for the nine months ended September 30, 2024. The decrease of $3.4&#160;million was primarily due to the change in fair value associated with the outstanding liability-classified common warrants, and the losses recognized from the March 2024 Offering and the Public Offering.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_115"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Liquidity and Capital Resources</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Sources and Uses of Liquidity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our operations through September&#160;30, 2025 have been financed primarily by aggregate net proceeds of $214.8 million from the issuance of common stock, pre-funded warrants, convertible preferred stock, convertible notes, promissory notes, the exercise of stock options and common warrants, the private placement of our securities, at-the-market offerings, and proceeds from the Merger with Angion. Since inception, we have had significant operating losses. Our net loss was $31.9 million and $37.9 million for the nine months ended September 30, 2025 and 2024, respectively. As of September&#160;30, 2025, we had an accumulated deficit of $226.0&#160;million and $20.6&#160;million in cash and cash equivalents. Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, and to a lesser extent, general and administrative expenditures. Cash used to fund operating expenses is impacted by the timing of when we pay these expenses, as reflected in the change in our outstanding accounts payable and accrued expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about our ability to continue as a going concern. We expect to incur substantial expenditures in the foreseeable future for the development of our product candidates and will require additional financing to continue this development. The unaudited condensed consolidated financial statements appearing elsewhere in this Quarterly Report on Form 10-Q have been prepared on a basis that assumes that we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The unaudited condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. We plan to address this condition through the sale of common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. However, there is no assurance that we will be successful in raising additional capital or that such additional funds will be available on acceptable terms, if at all. Should we be unable to raise this amount of capital our operating plans will be limited to the amount of capital that we can access. We may also consider steps to reduce our operating expenses. There can be no assurances that we will be successful in any of the foregoing.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Summary Statement of Cash Flows</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table sets forth a summary of our net cash flow activity for the nine months ended September 30, 2025 and 2024 (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net cash provided by (used in)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating activities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(30,155)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(28,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Investing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">31,832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">42,094&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effect of foreign currency on cash</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">144&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net increase in cash</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,821&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13,726&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Operating Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the nine months ended September 30, 2025, net cash (used in) operating activities was $(30.2)&#160;million, which consisted of a net loss of $31.9 million, changes in our assets and liabilities of $4.9&#160;million, and non-cash charges of $6.6 million. The non-cash charges were related to $3.2&#160;million of change in the fair value of warrant liabilities,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$1.9&#160;million of stock-based compensation, $0.7&#160;million amortization of the ROU asset, $0.2 million depreciation and $0.6 million of non-cash interest expense.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the nine months ended September 30, 2024, net cash (used in) operating activities was $(28.3)&#160;million, which consisted of a net loss of $37.9&#160;million and changes in our assets and liabilities of $0.3&#160;million and non-cash charges of $9.3&#160;million. The non-cash charges were primarily related to $3.3 million of change in the fair value of warrant liabilities, $3.5 million loss on the issuance of the March 2024 Pre-Funded Warrants in the March 2024 Offering, $1.0 million of stock-based compensation, $0.6 million amortization of the ROU asset, $0.5 million related to issuance costs for the July 2024 Pre-Funded Warrants and July 2024 Common Warrants, $0.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">of non-cash interest expense, and $0.2&#160;million of depreciation.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Investing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the nine months ended September 30, 2025 and 2024, net cash provided by or used in investing activities was immaterial. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Financing Activities</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the nine months ended September 30, 2025, net cash provided by financing activities was $31.8&#160;million as a result of the issuance of $11.4&#160;million of our common stock under our at-the-market offering program with JonesTrading Institutional Services LLC, as sales agent, $9.1&#160;million from the January 2025 Offering, $9.9&#160;million from the June 2025 Promissory Note Financing, $1.3 million from the exercise of common warrants and $0.1 million from the exercise of stock options. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the nine months ended September 30, 2024, net cash provided by financing activities was $42.1&#160;million, primarily as a result of the issuance of the convertible note for $19.7 million, $10.9 million from the Public Offering, $6.0 million from the issuance of the March 2024 Pre-Funded Warrants in the March 2024 Offering, and the issuance of $5.4 million of our common stock under our at-the-market offering program with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Future Cash Needs and Funding Requirements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on our current operating plan, as of the filing date of this Quarterly Report on Form 10-Q, we believe our cash and cash equivalents will be sufficient to fund our planned operations through the second quarter of 2026. However, we have based our projections of operating capital requirements on assumptions that may prove to be incorrect and we may use all our available capital resources sooner than we expect. We are unable to estimate the exact amount of our operating capital requirements. The amount and timing of our future funding requirements will depend on many factors, including, but not limited to:</span></div><div style="margin-top:8pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the scope, progress, results and costs of researching and developing product candidates, and conducting preclinical studies and clinical trials;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the outcome of any future clinical trials, for any existing or future product candidates;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">whether we are able to take advantage of any FDA expedited development and approval programs for any of our product candidates;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the outcome, costs and timing of seeking and obtaining and maintaining FDA and any foreign regulatory approvals;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs associated with any delays we may encounter as a result of evolving regulatory requirements or adverse results with respect to any of our product candidates;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the number and characteristics of product candidates we pursue, including product candidates in preclinical development;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the ability of our product candidates to progress through clinical development successfully;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">our need to expand our research and development activities, including to conduct additional clinical trials;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">market acceptance of our product candidates, including physician adoption, market access, pricing and reimbursement;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs of acquiring, licensing or investing in businesses, products, product candidates and technologies;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">our ability to maintain, expand and defend the scope of our intellectual property portfolio, including the amount and timing of any payments potentially required to make, or that we may receive, in connection with the licensing, filing, prosecution, defense and enforcement of any patents or other intellectual property rights;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">our need and ability to hire additional personnel, including management, clinical development, medical and commercial personnel;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the effect of competing technological, market developments and government policy;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs associated with being a public company, including our need to implement additional internal systems and infrastructure, including financial and reporting systems;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the costs associated with securing and establishing commercialization and manufacturing capabilities, as well as those associated with packaging, warehousing and distribution;</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the economic and other terms, timing of and success of our existing licensing arrangements and any collaboration, licensing or other arrangements into which we may enter in the future and timing and amount of payments thereunder; and</span></div><div style="margin-top:2pt;padding-left:63pt;text-align:justify;text-indent:-28.8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:25.26pt">the timing, receipt and amount of sales and general commercial success of any future approved products, if any.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Until such time as we can generate significant revenue from sales of product candidates, if ever, we expect to finance our operations through the sale of common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions. Adequate funding may not be available to us on acceptable terms, or at all. To the extent we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our stockholders will be or could be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through additional collaborations, or other similar arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or grant licenses on terms that may not be favorable to and/or may reduce the value of our common stock. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or commercialization efforts or grant rights to develop and market our product candidates even if we would otherwise prefer to develop and market such product candidates ourselves.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_118"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Critical Accounting Policies and Significant Judgments and Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our critical accounting policies are described under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Critical Accounting Policies and Significant Judgments and Estimates&#8221; in the Form 10-K. There have been no material changes in our critical accounting policies and estimates in the preparation of our condensed consolidated financial statements during the nine months ended September 30, 2025 compared to those disclosed in the Form 10-K. </span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_121"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company and an emerging growth company, as defined under the Jumpstart Our Business Startup (&#8220;JOBS&#8221;) Act. Under the JOBS Act, emerging growth companies can delay the adoption of new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. Other exemptions and reduced reporting requirements under the JOBS Act for emerging growth companies include presentation of only two years of audited financial statements in a registration statement for an initial public offering, an exemption from the requirement to provide an auditor's report on internal controls over financial reporting pursuant to Sarbanes-Oxley Act of 2002, as amended (&#8220;Sarbanes-Oxley&#8221;), an exemption from any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation, and less extensive disclosure about our executive compensation arrangements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have elected to use the extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date that (i) we are no longer an emerging growth company or (ii) we affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our condensed consolidated financial statements may not be comparable to companies that comply with new or revised accounting standards as of public company effective dates.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We will remain an emerging growth company until the earliest of (i) December 31, 2026, (ii) the last day of our first fiscal year in which we have total annual gross revenue of $1.235 billion or more, (iii) the date on which we are deemed to be a &#8220;large accelerated filer,&#8221; as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), which means the market value of equity securities that is held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter and (iv) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Even after we no longer qualify as an emerging growth company, we may still qualify as a &#8220;smaller reporting company&#8221; and/or &#8220;non-accelerated filer&#8221; which may allow us to take advantage of many of the same exemptions from disclosure requirements including not being required to comply for a period of time with the auditor attestation requirements of Section 404 of Sarbanes-Oxley, and reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_124"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 3. Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_127"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 4. Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Definition and Limitations of Disclosure Controls</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures are also designed to ensure that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management evaluates these controls and procedures on an ongoing basis. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our management, with the participation of our President and Chief Executive Officer, our principal executive officer, and our Chief Strategy and Financial Officer, our principal accounting and financial officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of September&#160;30, 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Based on the evaluation of our disclosure controls and procedures, our President and Chief Executive Officer and our Chief Strategy and Financial Officer concluded that our disclosure controls and procedures were effective as of September&#160;30, 2025.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Changes in Internal Control Over Financial Reporting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f)) under the Exchange Act) that occurred during the quarter ended September&#160;30, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_130"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II OTHER INFORMATION</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_133"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 1. Legal Proceedings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, we may be subject to various legal proceedings, claims and administrative proceedings that arise in the ordinary course of our business activities or otherwise. Although the results of the litigation and claims cannot be predicted with certainty, as of the date of this report, we do not believe we are party to any claim, proceeding or litigation the outcome of which, if determined adversely to us, would individually or in the aggregate be reasonably expected to have a material adverse effect on our business. The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to us, including any costs associated with the indemnification of directors and officers.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_136"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 1A. Risk Factors</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors, described in the sections titled &#8220;Risk Factors&#8221; in the Form 10-K and our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025, as well as the other information in this Quarterly Report on Form 10-Q, before deciding whether to invest in shares of our common stock. There have been no material changes in our risk factors from those described in the Form 10-K, other than as described in our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 and June 30, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None.</span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_142"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_145"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">None. </span></div><div id="i48b4e94dc81c43c39c91c977a31d007f_148"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 5. Other Information</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the fiscal quarter ended September&#160;30, 2025, none of our directors or executive officers <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-868"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-869">adopted</ix:nonNumeric></ix:nonNumeric>, modified or <ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-870"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-871">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any &#8220;non-Rule 10b5-1 trading arrangement.&#8221;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_151"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="-sec-extract:summary;margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.    Exhibits </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.650%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:57.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.127%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit <br/>Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Exhibit <br/>Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Filed Herewith</span></td><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Date</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit311.htm">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit312.htm">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1&#x5E;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit321.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2&#x5E;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="elicio10-qxexhibit322.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Instance Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">X</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________________________</span></div><div style="margin-top:3pt;text-indent:-9pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:112%">&#x5E;          The certification that accompanies this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, is not deemed &#8220;filed&#8221; by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="margin-top:6pt;padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i48b4e94dc81c43c39c91c977a31d007f_154"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="#i48b4e94dc81c43c39c91c977a31d007f_13">Table of Contents</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div></div><div style="margin-top:12pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">ELICIO THERAPEUTICS, INC.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ ROBERT CONNELLY</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">November&#160;13, 2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Robert Connelly</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">President and Chief Executive Officer </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Executive Officer)</span></div></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="margin-top:10pt;padding-left:72pt;text-align:right;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.124%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ PREETAM SHAH</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">November&#160;13, 2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Preetam Shah</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Chief Strategy and Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>elicio10-qxexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit311</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit311001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit311001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Exhibit 31.1  CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION  302 OF THE SARBANES-OXLEY ACT OF 2002  I, Robert Connelly, certify that:  1. I have reviewed this Quarterly Report on Form 10-Q of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of  the circumstances under which such statements were made, not misleading with respect to the  period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to  me by others within those entities, particularly during the period in which this report is being  prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of  financial statements for external purposes in accordance with generally accepted accounting  principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such  evaluation; and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board  of directors (or persons performing the equivalent functions):  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio10-qxexhibit311002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit311002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which are reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly     Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)    Date: November 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>elicio10-qxexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit312</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit312001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit312001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">     Exhibit 31.2  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION  302 OF THE SARBANES-OXLEY ACT OF 2002  I, Preetam Shah, certify that:  1. I have reviewed this Quarterly Report on Form 10-Q of Elicio Therapeutics, Inc.;  2. Based on my knowledge, this report does not contain any untrue statement of a  material fact or omit to state a material fact necessary to make the statements made, in light of  the circumstances under which such statements were made, not misleading with respect to the  period covered by this report;  3. Based on my knowledge, the financial statements, and other financial information  included in this report, fairly present in all material respects the financial condition, results of  operations and cash flows of the registrant as of, and for, the periods presented in this report;  4. I am responsible for establishing and maintaining disclosure controls and  procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over  financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant  and have:  a. Designed such disclosure controls and procedures, or caused such  disclosure controls and procedures to be designed under my supervision, to ensure that material  information relating to the registrant, including its consolidated subsidiaries, is made known to  me by others within those entities, particularly during the period in which this report is being  prepared;  b. Designed such internal control over financial reporting, or caused such  internal control over financial reporting to be designed under my supervision, to provide  reasonable assurance regarding the reliability of financial reporting and the preparation of  financial statements for external purposes in accordance with generally accepted accounting  principles;  c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and  procedures and presented in this report our conclusions about the effectiveness of the disclosure  controls and procedures, as of the end of the period covered by this report based on such  evaluation; and  d. Disclosed in this report any change in the registrant&#8217;s internal control over  financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s  fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably  likely to materially affect, the registrant&#8217;s internal control over financial reporting; and  5. I have disclosed, based on my most recent evaluation of internal control over  financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board  of directors (or persons performing the equivalent functions):  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- elicio10-qxexhibit312002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit312002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    a. All significant deficiencies and material weaknesses in the design or  operation of internal control over financial reporting which are reasonably likely to adversely  affect the registrant&#8217;s ability to record, process, summarize and report financial information; and  b. Any fraud, whether or not material, that involves management or other  employees who have a significant role in the registrant&#8217;s internal control over financial reporting.  ELICIO THERAPEUTICS, INC.  By:  /s/ Preetam Shah    Preetam Shah  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)    Date: November 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>elicio10-qxexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit321</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit321001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit321001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Exhibit 32.1  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer&#8217;s knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Quarterly Report on Form 10-Q of the Company for the period ended  September 30, 2025 (the &#8220;Quarterly Report&#8221;), as filed with the Securities and Exchange  Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities  Exchange Act of 1934, and  2. The information contained in this Quarterly Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.    ELICIO THERAPEUTICS, INC.  By:  /s/ Robert Connelly   Robert Connelly  President and Chief Executive Officer  (Principal Executive Officer)  Date:  November 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>elicio10-qxexhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>elicio10-qxexhibit322</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- elicio10-qxexhibit322001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="elicio10-qxexhibit322001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">    Exhibit 32.2  CERTIFICATIONS PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  (18 U.S.C. SECTION 1350)  The undersigned officer of Elicio Therapeutics, Inc. (the &#8220;Company&#8221;) certifies to such  officer&#8217;s knowledge, pursuant to 18 U.S.C. &sect; 1350, as adopted pursuant to &sect; 906 of the Sarbanes- Oxley Act of 2002, that:  1. The Quarterly Report on Form 10-Q of the Company for the period ended  September 30, 2025 (the &#8220;Quarterly Report&#8221;), as filed with the Securities and Exchange  Commission, fully complies with the requirements of Section 13(a) or 15(d) of the Securities  Exchange Act of 1934, and  2. The information contained in this Quarterly Report fairly presents, in all material  respects, the financial condition and results of operations of the Company.    ELICIO THERAPEUTICS, INC.  By: /s/ Preetam Shah    Preetam Shah  Chief Strategy and Financial Officer  (Principal Financial Officer and Principal  Accounting Officer)  Date:  November 13, 2025    </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>angn-20250930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:46abd97b-e878-4f3c-a24b-01e71dba1284,g:89379ce6-47e2-4598-9348-41e57d269da1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:angn="http://www.angn.com/20250930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.angn.com/20250930">
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="angn-20250930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.angn.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficit" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit">
        <link:definition>9952154 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical">
        <link:definition>9952155 - Statement - Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialCondition" roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition">
        <link:definition>9952157 - Disclosure - Description of the Business and Financial Condition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952158 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.angn.com/role/FairValueMeasurements">
        <link:definition>9952159 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponents" roleURI="http://www.angn.com/role/BalanceSheetComponents">
        <link:definition>9952160 - Disclosure - Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrants" roleURI="http://www.angn.com/role/ResearchGrants">
        <link:definition>9952161 - Disclosure - Research Grants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandStockholdersEquity" roleURI="http://www.angn.com/role/CommonStockandStockholdersEquity">
        <link:definition>9952162 - Disclosure - Common Stock and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.angn.com/role/StockBasedCompensation">
        <link:definition>9952163 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://www.angn.com/role/Warrants">
        <link:definition>9952164 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.angn.com/role/CommitmentsandContingencies">
        <link:definition>9952165 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.angn.com/role/Leases">
        <link:definition>9952166 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.angn.com/role/Debt">
        <link:definition>9952167 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.angn.com/role/IncomeTaxes">
        <link:definition>9952168 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.angn.com/role/NetLossPerShare">
        <link:definition>9952169 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://www.angn.com/role/RelatedPartyTransactions">
        <link:definition>9952170 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReporting" roleURI="http://www.angn.com/role/SegmentReporting">
        <link:definition>9952171 - Disclosure - Segment Reporting</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.angn.com/role/FairValueMeasurementsTables">
        <link:definition>9955512 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsTables" roleURI="http://www.angn.com/role/BalanceSheetComponentsTables">
        <link:definition>9955513 - Disclosure - Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.angn.com/role/StockBasedCompensationTables">
        <link:definition>9955514 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://www.angn.com/role/WarrantsTables">
        <link:definition>9955515 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.angn.com/role/LeasesTables">
        <link:definition>9955516 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.angn.com/role/NetLossPerShareTables">
        <link:definition>9955517 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingTables" roleURI="http://www.angn.com/role/SegmentReportingTables">
        <link:definition>9955518 - Disclosure - Segment Reporting (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DescriptionoftheBusinessandFinancialConditionDetails" roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails">
        <link:definition>9955519 - Disclosure - Description of the Business and Financial Condition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>9955520 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails">
        <link:definition>9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails">
        <link:definition>9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails">
        <link:definition>9955523 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955524 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails">
        <link:definition>9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsNarrativeDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails">
        <link:definition>9955527 - Disclosure - Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetComponentsScheduleofAccruedExpensesDetails" roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails">
        <link:definition>9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ResearchGrantsDetails" roleURI="http://www.angn.com/role/ResearchGrantsDetails">
        <link:definition>9955529 - Disclosure - Research Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockandStockholdersEquityDetails" roleURI="http://www.angn.com/role/CommonStockandStockholdersEquityDetails">
        <link:definition>9955530 - Disclosure - Common Stock and Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationNarrativeDetails" roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails">
        <link:definition>9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofShareOptionActivityDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails">
        <link:definition>9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails">
        <link:definition>9955533 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails">
        <link:definition>9955534 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsNarrativeDetails" roleURI="http://www.angn.com/role/WarrantsNarrativeDetails">
        <link:definition>9955535 - Disclosure - Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsScheduleofOutstandingWarrantsDetails" roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails">
        <link:definition>9955536 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsScheduleofWarrantsActivityDetails" roleURI="http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails">
        <link:definition>9955537 - Disclosure - Warrants - Schedule of Warrants Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails">
        <link:definition>9955538 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.angn.com/role/LeasesNarrativeDetails">
        <link:definition>9955539 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" roleURI="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails">
        <link:definition>9955540 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtDetails" roleURI="http://www.angn.com/role/DebtDetails">
        <link:definition>9955542 - Disclosure - Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.angn.com/role/IncomeTaxesDetails">
        <link:definition>9955543 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" roleURI="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails">
        <link:definition>9955544 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails">
        <link:definition>9955545 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails">
        <link:definition>9955546 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentReportingDetails" roleURI="http://www.angn.com/role/SegmentReportingDetails">
        <link:definition>9955547 - Disclosure - Segment Reporting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="angn_WarrantLiability" abstract="false" name="WarrantLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_GainLossOnIssuanceOfWarrants" abstract="false" name="GainLossOnIssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_GrantRevenueNonoperating" abstract="false" name="GrantRevenueNonoperating" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_PurchaseAgreementMember" abstract="true" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPublicOfferingMember" abstract="true" name="JulyPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ConversionOfConvertibleDebtMember" abstract="true" name="ConversionOfConvertibleDebtMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ConversionOfConvertiblePreferredStockMember" abstract="true" name="ConversionOfConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_InterestExpenseNoncash" abstract="false" name="InterestExpenseNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_CostsExpensedUponTheIssuanceOfWarrants" abstract="false" name="CostsExpensedUponTheIssuanceOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_IncreaseDecreaseInAccruedExpenses" abstract="false" name="IncreaseDecreaseInAccruedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" abstract="false" name="ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_PaymentOfWarrantIssuanceCosts" abstract="false" name="PaymentOfWarrantIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_FairValueOfPreFundedWarrants" abstract="false" name="FairValueOfPreFundedWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_FairValueOfCommonStockWarrantsUponSettlement" abstract="false" name="FairValueOfCommonStockWarrantsUponSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantIssuedStockIssuance" abstract="false" name="WarrantIssuedStockIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantIssuedDebtIssuance" abstract="false" name="WarrantIssuedDebtIssuance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantExercisedFairValue" abstract="false" name="WarrantExercisedFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_SettlementOfPromissoryNotesPayable" abstract="false" name="SettlementOfPromissoryNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts" abstract="false" name="AccretionOfConvertibleNotesDiscountFromIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_VestingOfRestrictedCommonStock" abstract="false" name="VestingOfRestrictedCommonStock" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantsAndRightsOutstandingAbstract" abstract="true" name="WarrantsAndRightsOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_WarrantsAndRightsOutstandingTextBlock" abstract="false" name="WarrantsAndRightsOutstandingTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="angn_GrantRevenuePolicyTextBlock" abstract="false" name="GrantRevenuePolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" abstract="false" name="ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="angn_AngionCommonStockMember" abstract="true" name="AngionCommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_WarrantsFairValueDisclosure" abstract="false" name="WarrantsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_WarrantLiabilityMember" abstract="true" name="WarrantLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_MeasurementInputStrikePriceMember" abstract="true" name="MeasurementInputStrikePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_PreFundedWarrantMember" abstract="true" name="PreFundedWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" abstract="true" name="JulyPreFundedWarrantsAndJulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyPreFundedWarrantsMember" abstract="true" name="JulyPreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JulyCommonWarrantsMember" abstract="true" name="JulyCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SaleOfStockBeneficialOwnershipLimitationPercentage" abstract="false" name="SaleOfStockBeneficialOwnershipLimitationPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="angn_PrepaidResearchAndDevelopmentExpenses" abstract="false" name="PrepaidResearchAndDevelopmentExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AdvancedProfessionalFees" abstract="false" name="AdvancedProfessionalFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_OtherPrepaidExpensesAndOtherAssetsCurrent" abstract="false" name="OtherPrepaidExpensesAndOtherAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedResearchAndDevelopmentCurrent" abstract="false" name="AccruedResearchAndDevelopmentCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_AccruedOtherOperatingLiabilitiesCurrent" abstract="false" name="AccruedOtherOperatingLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" abstract="true" name="ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementGrant" abstract="false" name="ResearchAndDevelopmentArrangementGrant" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementGrantReceived" abstract="false" name="ResearchAndDevelopmentArrangementGrantReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementCredit" abstract="false" name="ResearchAndDevelopmentArrangementCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" abstract="false" name="ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_NumberOfResearchGrantAgreements" abstract="false" name="NumberOfResearchGrantAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="angn_JulySharesAndJulyCommonWarrantMember" abstract="true" name="JulySharesAndJulyCommonWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_RegistrationStatementMember" abstract="true" name="RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreement2022Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_A2024RegistrationStatementMember" abstract="true" name="A2024RegistrationStatementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_MarchSubscriptionAgreementMember" abstract="true" name="MarchSubscriptionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreementMember" abstract="true" name="AtTheMarketEquityOfferingSalesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AtTheMarketEquityOfferingSalesAgreement2024Member" abstract="true" name="AtTheMarketEquityOfferingSalesAgreement2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JanuaryPublicOfferingMember" abstract="true" name="JanuaryPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JanuaryCommonWarrantsMember" abstract="true" name="JanuaryCommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SeniorSecuredConvertiblePromissoryNoteMember" abstract="true" name="SeniorSecuredConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_SaleOfStockAggregateInitialOfferingPrice" abstract="false" name="SaleOfStockAggregateInitialOfferingPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_The2021PlanMember" abstract="true" name="The2021PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_The2022PlanMember" abstract="true" name="The2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_Inducement2024PlanMember" abstract="true" name="Inducement2024PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_March2024PreFundedWarrantsMember" abstract="true" name="March2024PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_January2025CommonWarrantsMember" abstract="true" name="January2025CommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_June2025WarrantsMember" abstract="true" name="June2025WarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ElicioWarrantsMember" abstract="true" name="ElicioWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AngionWarrantsMember" abstract="true" name="AngionWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_June2025CommonWarrantsMember" abstract="true" name="June2025CommonWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" abstract="false" name="ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightRollForward" abstract="true" name="ClassOfWarrantOrRightRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightIssuedInPeriod" abstract="false" name="ClassOfWarrantOrRightIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightExercisedInPeriod" abstract="false" name="ClassOfWarrantOrRightExercisedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" abstract="true" name="ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" abstract="false" name="ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" abstract="true" name="ClassOfWarrantOrRightWeightedAverageLifeRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightWeightedAverageLife" abstract="false" name="ClassOfWarrantOrRightWeightedAverageLife" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="angn_CommitmentsAndContingenciesDisclosureTable" abstract="true" name="CommitmentsAndContingenciesDisclosureTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="angn_UniversityMember" abstract="true" name="UniversityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_CommitmentsAndContingenciesDisclosureLineItems" abstract="true" name="CommitmentsAndContingenciesDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="angn_RoyaltyRatePercent" abstract="false" name="RoyaltyRatePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" abstract="false" name="CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_CollaborativeArrangementFutureMinimumMaintenancePayments" abstract="false" name="CollaborativeArrangementFutureMinimumMaintenancePayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_BostonMassachusettsMember" abstract="true" name="BostonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_NewtonMassachusettsMember" abstract="true" name="NewtonMassachusettsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_LesseeOperatingLeaseAnnualRentExpense" abstract="false" name="LesseeOperatingLeaseAnnualRentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_GKCCMember" abstract="true" name="GKCCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_AccruedInterestPremiumForConvertiblePreferredStock" abstract="false" name="AccruedInterestPremiumForConvertiblePreferredStock" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="angn_ClassOfWarrantOrRightOwnershipPercentMaximum" abstract="false" name="ClassOfWarrantOrRightOwnershipPercentMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="angn_PurchaseOfWarrantsMember" abstract="true" name="PurchaseOfWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_YekaterinaChudnovskyMember" abstract="true" name="YekaterinaChudnovskyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" abstract="true" name="JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_YekaterinaChudnovskyAndJayVenkatesanMember" abstract="true" name="YekaterinaChudnovskyAndJayVenkatesanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ClinicalTrailMember" abstract="true" name="ClinicalTrailMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_EmployeeRelatedReasearchAndDevelopmentMember" abstract="true" name="EmployeeRelatedReasearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_TranslationalMedicineAndCMCMember" abstract="true" name="TranslationalMedicineAndCMCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="angn_ReportableSegmentMember" abstract="true" name="ReportableSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>angn-20250930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:46abd97b-e878-4f3c-a24b-01e71dba1284,g:89379ce6-47e2-4598-9348-41e57d269da1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0c7e57a7-332b-47ad-96c9-ee3bd6705713" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_d9f11ea2-ce30-4706-88de-29a3e99983d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0c7e57a7-332b-47ad-96c9-ee3bd6705713" xlink:to="loc_us-gaap_TreasuryStockCommonValue_d9f11ea2-ce30-4706-88de-29a3e99983d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6a4a132b-5560-4012-8e91-b77d51d86a43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0c7e57a7-332b-47ad-96c9-ee3bd6705713" xlink:to="loc_us-gaap_CommonStockValue_6a4a132b-5560-4012-8e91-b77d51d86a43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_76225f1f-c901-4960-a385-2b17350690c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0c7e57a7-332b-47ad-96c9-ee3bd6705713" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_76225f1f-c901-4960-a385-2b17350690c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_47438eca-5ec2-47bb-ad92-6140367baa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0c7e57a7-332b-47ad-96c9-ee3bd6705713" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_47438eca-5ec2-47bb-ad92-6140367baa2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b13bbe11-e81f-4374-8c12-5173683fbe11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0c7e57a7-332b-47ad-96c9-ee3bd6705713" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b13bbe11-e81f-4374-8c12-5173683fbe11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b4920488-ac09-4906-885a-db78f67a06bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5cd029bd-d73c-4999-b93b-04d22519ba68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4920488-ac09-4906-885a-db78f67a06bd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5cd029bd-d73c-4999-b93b-04d22519ba68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_052561e0-fd4a-4648-b3ef-6d92040d239f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4920488-ac09-4906-885a-db78f67a06bd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_052561e0-fd4a-4648-b3ef-6d92040d239f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_45e96328-2efc-46d3-ad28-c70fe6bdf689" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4920488-ac09-4906-885a-db78f67a06bd" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_45e96328-2efc-46d3-ad28-c70fe6bdf689" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4925dc01-4f3b-4dab-8965-ef4fe5dc4ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b4920488-ac09-4906-885a-db78f67a06bd" xlink:to="loc_us-gaap_AccountsPayableCurrent_4925dc01-4f3b-4dab-8965-ef4fe5dc4ebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bbe1cd5f-ac27-43ad-a808-0863b356b8cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4c80109c-283f-46a5-b6e8-baaebeb62c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbe1cd5f-ac27-43ad-a808-0863b356b8cf" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4c80109c-283f-46a5-b6e8-baaebeb62c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f4ddde97-0ffc-4ddd-898a-8d0c3f966553" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbe1cd5f-ac27-43ad-a808-0863b356b8cf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f4ddde97-0ffc-4ddd-898a-8d0c3f966553" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_e7a8a177-ca11-481a-99db-b78cb5659da4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_bbe1cd5f-ac27-43ad-a808-0863b356b8cf" xlink:to="loc_us-gaap_RestrictedCashCurrent_e7a8a177-ca11-481a-99db-b78cb5659da4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6a8f5946-f6ba-4a7a-a307-c29c60217a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_674c0b97-788a-40f2-83f9-c61eec4a72ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a8f5946-f6ba-4a7a-a307-c29c60217a8f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_674c0b97-788a-40f2-83f9-c61eec4a72ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_85df13d0-e916-416c-a410-f4a3f33be03c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a8f5946-f6ba-4a7a-a307-c29c60217a8f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_85df13d0-e916-416c-a410-f4a3f33be03c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3c7a885f-3772-4e4c-831d-90907d0eae07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a8f5946-f6ba-4a7a-a307-c29c60217a8f" xlink:to="loc_us-gaap_AssetsCurrent_3c7a885f-3772-4e4c-831d-90907d0eae07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_cf2afedd-ee2b-4c54-b5fe-3a0ba48d713f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a8f5946-f6ba-4a7a-a307-c29c60217a8f" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_cf2afedd-ee2b-4c54-b5fe-3a0ba48d713f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_1d9d7797-06e2-4980-a082-ac43b7890eff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6a8f5946-f6ba-4a7a-a307-c29c60217a8f" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_1d9d7797-06e2-4980-a082-ac43b7890eff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc233116-a1b6-4b32-8ea5-f8081b11292f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_14471a8a-8487-4613-9482-014f6be122ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc233116-a1b6-4b32-8ea5-f8081b11292f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_14471a8a-8487-4613-9482-014f6be122ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f063379e-73d6-4f96-ad50-7f3abc2e01e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc233116-a1b6-4b32-8ea5-f8081b11292f" xlink:to="loc_us-gaap_StockholdersEquity_f063379e-73d6-4f96-ad50-7f3abc2e01e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_617e35f0-397d-47f6-b337-8bb21daeafd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_fc233116-a1b6-4b32-8ea5-f8081b11292f" xlink:to="loc_us-gaap_Liabilities_617e35f0-397d-47f6-b337-8bb21daeafd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_95f9a2a5-51a7-4e05-9a48-055f17328942" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a6b5344c-fa86-402b-8927-ace8d6027d07" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_95f9a2a5-51a7-4e05-9a48-055f17328942" xlink:to="loc_us-gaap_LiabilitiesCurrent_a6b5344c-fa86-402b-8927-ace8d6027d07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability_008b2810-70d3-4390-ada9-ecf7da0a88dc" xlink:href="angn-20250930.xsd#angn_WarrantLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_95f9a2a5-51a7-4e05-9a48-055f17328942" xlink:to="loc_angn_WarrantLiability_008b2810-70d3-4390-ada9-ecf7da0a88dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1ac18484-5ca1-4395-a7aa-53a8abf4a0be" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_95f9a2a5-51a7-4e05-9a48-055f17328942" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1ac18484-5ca1-4395-a7aa-53a8abf4a0be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6729a3c5-3c86-481f-af27-7926d9a64b0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_95f9a2a5-51a7-4e05-9a48-055f17328942" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6729a3c5-3c86-481f-af27-7926d9a64b0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5b23bc7b-c868-4d87-8315-e780bae7fd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_2b2048fa-ed25-4b70-8328-7f1d0444dc29" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5b23bc7b-c868-4d87-8315-e780bae7fd9a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_2b2048fa-ed25-4b70-8328-7f1d0444dc29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_60fe8028-11bc-444b-a8ea-27ebcf42e3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_5b23bc7b-c868-4d87-8315-e780bae7fd9a" xlink:to="loc_us-gaap_OperatingIncomeLoss_60fe8028-11bc-444b-a8ea-27ebcf42e3c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_b88133cd-1cc9-425b-8c85-e21697a3be3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ba84141f-cdc6-4b81-9862-a56556e58f0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_b88133cd-1cc9-425b-8c85-e21697a3be3c" xlink:to="loc_us-gaap_CostsAndExpenses_ba84141f-cdc6-4b81-9862-a56556e58f0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_80de2e27-4082-4e70-835f-64cb47ac60f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d86c4969-3aa4-4f18-967a-96fe81d53cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_80de2e27-4082-4e70-835f-64cb47ac60f9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d86c4969-3aa4-4f18-967a-96fe81d53cbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_388f968e-ee8a-4dd3-8145-403d0580137b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_80de2e27-4082-4e70-835f-64cb47ac60f9" xlink:to="loc_us-gaap_NetIncomeLoss_388f968e-ee8a-4dd3-8145-403d0580137b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_80fdaca2-03fc-4cdf-99c7-36c83f7b6b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_80fdaca2-03fc-4cdf-99c7-36c83f7b6b8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_a6e523b2-2232-4ca0-b641-6ce5649e6a10" xlink:href="angn-20250930.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_a6e523b2-2232-4ca0-b641-6ce5649e6a10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaa862fa-4d6e-48d7-9f36-259b8d402513" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaa862fa-4d6e-48d7-9f36-259b8d402513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_60decd60-3eed-44c3-bee3-dddb4d7fd953" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_60decd60-3eed-44c3-bee3-dddb4d7fd953" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_37e0b7dc-5e57-4c96-8c91-c83fcfe97d29" xlink:href="angn-20250930.xsd#angn_GrantRevenueNonoperating"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:to="loc_angn_GrantRevenueNonoperating_37e0b7dc-5e57-4c96-8c91-c83fcfe97d29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_428855dc-63c9-4299-9339-979a567009a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:to="loc_us-gaap_InvestmentIncomeInterest_428855dc-63c9-4299-9339-979a567009a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_73c534d9-f387-4703-8e0c-ef5ea341a962" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_c4ee5be2-536f-4943-989e-e37fe08a8e10" xlink:to="loc_us-gaap_InterestExpenseNonoperating_73c534d9-f387-4703-8e0c-ef5ea341a962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7dac8091-482b-4018-b151-c622ee7cbe48" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_5bce5b7c-c943-4645-b2e8-45a4d493439e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7dac8091-482b-4018-b151-c622ee7cbe48" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_5bce5b7c-c943-4645-b2e8-45a4d493439e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6282abbc-cb75-481b-b7d6-4b41b7bd840d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_7dac8091-482b-4018-b151-c622ee7cbe48" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6282abbc-cb75-481b-b7d6-4b41b7bd840d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_2dfd4ded-79ab-48e2-b22d-401dedfbcdf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_2dfd4ded-79ab-48e2-b22d-401dedfbcdf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_a15e605d-7c56-4477-a7e4-84a9fc65421f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_a15e605d-7c56-4477-a7e4-84a9fc65421f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_77384690-715b-480d-a048-fe062d627801" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_77384690-715b-480d-a048-fe062d627801" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_aed06c0e-af21-46c9-8542-913a1358ee1a" xlink:href="angn-20250930.xsd#angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_aed06c0e-af21-46c9-8542-913a1358ee1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_a4c6625e-3954-4ae3-b9d6-1fd2e9cffbcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_a4c6625e-3954-4ae3-b9d6-1fd2e9cffbcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PaymentOfWarrantIssuanceCosts_d0b97201-09b4-46d3-9d97-1b6e5fcad2db" xlink:href="angn-20250930.xsd#angn_PaymentOfWarrantIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_angn_PaymentOfWarrantIssuanceCosts_d0b97201-09b4-46d3-9d97-1b6e5fcad2db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_ba4992c7-aff8-4d08-902d-fac7544f2c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_ba4992c7-aff8-4d08-902d-fac7544f2c8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_92eb3925-b31a-47b0-996d-67c73be262f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cd711019-5bbb-4b24-bf56-4512cfbe8d57" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_92eb3925-b31a-47b0-996d-67c73be262f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_59a9cfd4-3745-4489-a5d1-ba110fb806b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_NetIncomeLoss_59a9cfd4-3745-4489-a5d1-ba110fb806b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_50668408-1aad-4eb6-ac0a-1a7acb573434" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_Depreciation_50668408-1aad-4eb6-ac0a-1a7acb573434" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_466fd80b-1812-4610-98c3-6e7396b60949" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_466fd80b-1812-4610-98c3-6e7396b60949" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash_f8580b7d-f7c5-42a1-8ccc-36183189443e" xlink:href="angn-20250930.xsd#angn_InterestExpenseNoncash"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_angn_InterestExpenseNoncash_f8580b7d-f7c5-42a1-8ccc-36183189443e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_fe41d6dc-129e-4dcf-b7f3-6a4982473da3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_fe41d6dc-129e-4dcf-b7f3-6a4982473da3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_592b3b95-ae8d-493b-90be-953beebd4fb2" xlink:href="angn-20250930.xsd#angn_CostsExpensedUponTheIssuanceOfWarrants"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_592b3b95-ae8d-493b-90be-953beebd4fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_47b5b655-c432-448e-b777-62c22c62bb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_47b5b655-c432-448e-b777-62c22c62bb8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4c172649-2fb0-4b96-bc05-9856f83c89c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_ShareBasedCompensation_4c172649-2fb0-4b96-bc05-9856f83c89c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_bae219f1-bd7b-4263-a1e9-ce8dcc67514c" xlink:href="angn-20250930.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_bae219f1-bd7b-4263-a1e9-ce8dcc67514c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_dc55c6d6-80ae-4438-91d8-29a6868459d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_dc55c6d6-80ae-4438-91d8-29a6868459d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9070ca45-0f65-4b99-9f1c-e0e0d9165299" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_9070ca45-0f65-4b99-9f1c-e0e0d9165299" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_eb36cbe0-ffb8-4098-827a-42f6de564f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_eb36cbe0-ffb8-4098-827a-42f6de564f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bbaa2e48-05cf-4d7e-8a1c-27048d028301" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bbaa2e48-05cf-4d7e-8a1c-27048d028301" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_IncreaseDecreaseInAccruedExpenses_3e417e64-369b-4a61-9fab-7e56e140e5b5" xlink:href="angn-20250930.xsd#angn_IncreaseDecreaseInAccruedExpenses"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_angn_IncreaseDecreaseInAccruedExpenses_3e417e64-369b-4a61-9fab-7e56e140e5b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_eca0ba0e-c5d8-49cb-bd36-842e11733149" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_eca0ba0e-c5d8-49cb-bd36-842e11733149" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_27c26b02-de45-4064-8097-7afd4450c487" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d45e2d80-a7e2-4a22-865b-1b71d5f015aa" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_27c26b02-de45-4064-8097-7afd4450c487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11ace45d-1583-4a9e-ab48-f559f1128d32" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e3d340dc-ca26-4011-a54c-6e807ff58639" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11ace45d-1583-4a9e-ab48-f559f1128d32" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e3d340dc-ca26-4011-a54c-6e807ff58639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_f30446b0-6566-400e-831a-e9e7560a310f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_11ace45d-1583-4a9e-ab48-f559f1128d32" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_f30446b0-6566-400e-831a-e9e7560a310f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_189d7773-fa13-491a-9e0b-599c01277506" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2bd6e81a-ead9-4fa3-8c78-6c3b40fa36f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_189d7773-fa13-491a-9e0b-599c01277506" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2bd6e81a-ead9-4fa3-8c78-6c3b40fa36f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d4e165c9-188b-4bf2-9104-1cff7ee0f1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_189d7773-fa13-491a-9e0b-599c01277506" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d4e165c9-188b-4bf2-9104-1cff7ee0f1c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d65a2d44-cf27-447a-8111-63fafa4cab74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_53cd10b0-8b38-4323-89a7-c7b2fcfc31cf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d65a2d44-cf27-447a-8111-63fafa4cab74" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_53cd10b0-8b38-4323-89a7-c7b2fcfc31cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aec3446d-3d86-43f8-a962-eb0016d25f5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d65a2d44-cf27-447a-8111-63fafa4cab74" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aec3446d-3d86-43f8-a962-eb0016d25f5f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8f87582a-4f8d-4271-8472-80f8157638c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d65a2d44-cf27-447a-8111-63fafa4cab74" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8f87582a-4f8d-4271-8472-80f8157638c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4df56a19-54d2-469f-be6a-562cc545055a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d65a2d44-cf27-447a-8111-63fafa4cab74" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4df56a19-54d2-469f-be6a-562cc545055a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_406ca6d0-cbd2-409d-9503-9e9fc3f4abfc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_e9b4faf4-42e3-4f3f-a195-fbdd7999f713" xlink:href="angn-20250930.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_406ca6d0-cbd2-409d-9503-9e9fc3f4abfc" xlink:to="loc_angn_WarrantsFairValueDisclosure_e9b4faf4-42e3-4f3f-a195-fbdd7999f713" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_78ab2405-bbec-4aac-9621-70849bd661ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a83e2944-93da-443f-b89e-9f87cfd1cc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_78ab2405-bbec-4aac-9621-70849bd661ee" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a83e2944-93da-443f-b89e-9f87cfd1cc5a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_49b6db75-ab7a-499d-8981-c1d9f338307f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_b60406f3-ccb7-416f-8a96-2aeae2f9aedd" xlink:href="angn-20250930.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_49b6db75-ab7a-499d-8981-c1d9f338307f" xlink:to="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_b60406f3-ccb7-416f-8a96-2aeae2f9aedd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses_4909c0d9-a607-4793-8360-cde0a00a0e20" xlink:href="angn-20250930.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_49b6db75-ab7a-499d-8981-c1d9f338307f" xlink:to="loc_angn_PrepaidResearchAndDevelopmentExpenses_4909c0d9-a607-4793-8360-cde0a00a0e20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees_b1ed8a9a-d3d7-4139-8ee8-0d269f073d4d" xlink:href="angn-20250930.xsd#angn_AdvancedProfessionalFees"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_49b6db75-ab7a-499d-8981-c1d9f338307f" xlink:to="loc_angn_AdvancedProfessionalFees_b1ed8a9a-d3d7-4139-8ee8-0d269f073d4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_224ee255-0f55-4d17-ada1-f29795f22d9f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_49b6db75-ab7a-499d-8981-c1d9f338307f" xlink:to="loc_us-gaap_PrepaidInsurance_224ee255-0f55-4d17-ada1-f29795f22d9f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3499b063-8208-4249-b1ad-638edb3590c3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f687412f-9a0c-4bc3-912c-d35372c4cfb1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_3499b063-8208-4249-b1ad-638edb3590c3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f687412f-9a0c-4bc3-912c-d35372c4cfb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_acc7d43e-48f0-46a6-837c-9035035f6a24" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_3499b063-8208-4249-b1ad-638edb3590c3" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_acc7d43e-48f0-46a6-837c-9035035f6a24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a9f08c15-d01f-4769-90d4-7f75a0fdc678" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent_df1a9269-71b6-4d2f-af0e-c6176398f032" xlink:href="angn-20250930.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a9f08c15-d01f-4769-90d4-7f75a0fdc678" xlink:to="loc_angn_AccruedResearchAndDevelopmentCurrent_df1a9269-71b6-4d2f-af0e-c6176398f032" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_563778a8-f87f-4972-8096-e614672b4720" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a9f08c15-d01f-4769-90d4-7f75a0fdc678" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_563778a8-f87f-4972-8096-e614672b4720" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_91ddefb6-ed54-43a8-a008-6c9f94173cae" xlink:href="angn-20250930.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a9f08c15-d01f-4769-90d4-7f75a0fdc678" xlink:to="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_91ddefb6-ed54-43a8-a008-6c9f94173cae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9d76459d-ce56-434a-9b47-4476ac3b550a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a9f08c15-d01f-4769-90d4-7f75a0fdc678" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_9d76459d-ce56-434a-9b47-4476ac3b550a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9a34ac6-c3dc-419b-b128-dc234a7f4aac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4e62baa3-f0b9-4235-898c-c84398ff6cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9a34ac6-c3dc-419b-b128-dc234a7f4aac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4e62baa3-f0b9-4235-898c-c84398ff6cd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0b7bf6a7-138d-4364-a5e8-fd5251879ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_d9a34ac6-c3dc-419b-b128-dc234a7f4aac" xlink:to="loc_us-gaap_OperatingLeaseLiability_0b7bf6a7-138d-4364-a5e8-fd5251879ef6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9497f47f-a21f-4485-a785-c87bb0f2036e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_603bf4c5-eb96-4782-82fb-fe90ff3f0f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_9497f47f-a21f-4485-a785-c87bb0f2036e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_603bf4c5-eb96-4782-82fb-fe90ff3f0f9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8384a714-67b8-4291-b52d-29a39324dfb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_9497f47f-a21f-4485-a785-c87bb0f2036e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8384a714-67b8-4291-b52d-29a39324dfb5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="angn-20250930.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2fbe9b-f0f8-4812-9375-ae0c8d18a07d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2365cdd0-9078-4776-b0b8-7d3f4ca5cf1e" xlink:href="angn-20250930.xsd#angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2fbe9b-f0f8-4812-9375-ae0c8d18a07d" xlink:to="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_2365cdd0-9078-4776-b0b8-7d3f4ca5cf1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_226c23b6-ae8e-48f4-a3e8-fef231d77f68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2fbe9b-f0f8-4812-9375-ae0c8d18a07d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_226c23b6-ae8e-48f4-a3e8-fef231d77f68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48139e0e-752a-4dd0-95ac-e5ef5a5d4825" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2fbe9b-f0f8-4812-9375-ae0c8d18a07d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_48139e0e-752a-4dd0-95ac-e5ef5a5d4825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_62979afa-034f-480a-936b-959ac51468cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2fbe9b-f0f8-4812-9375-ae0c8d18a07d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_62979afa-034f-480a-936b-959ac51468cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_838d55f2-a635-4f3f-985c-181f7baa8233" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2fbe9b-f0f8-4812-9375-ae0c8d18a07d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_838d55f2-a635-4f3f-985c-181f7baa8233" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_595a3514-c826-4438-94bb-a97afb4f169f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1e2fbe9b-f0f8-4812-9375-ae0c8d18a07d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_595a3514-c826-4438-94bb-a97afb4f169f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>angn-20250930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:46abd97b-e878-4f3c-a24b-01e71dba1284,g:89379ce6-47e2-4598-9348-41e57d269da1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8b015ff-ab94-4778-8232-50d79dab5ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f8b015ff-ab94-4778-8232-50d79dab5ba7" xlink:to="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aab91a98-4d2f-485d-969a-e5eb277011ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aab91a98-4d2f-485d-969a-e5eb277011ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_aab91a98-4d2f-485d-969a-e5eb277011ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aab91a98-4d2f-485d-969a-e5eb277011ac" xlink:to="loc_us-gaap_EquityComponentDomain_aab91a98-4d2f-485d-969a-e5eb277011ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aab91a98-4d2f-485d-969a-e5eb277011ac" xlink:to="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_05820d9f-679f-4058-8f07-fd2c33b7e13c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_CommonStockMember_05820d9f-679f-4058-8f07-fd2c33b7e13c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_4efec284-315d-4b9a-9b78-f1b9e3c6ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_TreasuryStockCommonMember_4efec284-315d-4b9a-9b78-f1b9e3c6ab0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8ed12d7e-ffe9-4615-bdeb-fd49f3a626cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8ed12d7e-ffe9-4615-bdeb-fd49f3a626cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_768172fc-60f1-4950-8aeb-8df9cfd6179b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_768172fc-60f1-4950-8aeb-8df9cfd6179b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_02503f0b-3fa3-4c51-b101-4148d1b6e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_RetainedEarningsMember_02503f0b-3fa3-4c51-b101-4148d1b6e24a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_21415059-541a-4d6e-9485-75d9e72d0b57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_21415059-541a-4d6e-9485-75d9e72d0b57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_21415059-541a-4d6e-9485-75d9e72d0b57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_21415059-541a-4d6e-9485-75d9e72d0b57" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_21415059-541a-4d6e-9485-75d9e72d0b57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_21415059-541a-4d6e-9485-75d9e72d0b57" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_7b4a7f65-99af-4a61-8970-f6bf4e02c70d" xlink:href="angn-20250930.xsd#angn_PurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:to="loc_angn_PurchaseAgreementMember_7b4a7f65-99af-4a61-8970-f6bf4e02c70d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_8dab43b0-cebe-4768-8ae0-d356c6a508f8" xlink:href="angn-20250930.xsd#angn_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:to="loc_angn_AtTheMarketOfferingMember_8dab43b0-cebe-4768-8ae0-d356c6a508f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_aeaa6196-2982-494c-8246-fb4f0944a93a" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:to="loc_angn_JulyPublicOfferingMember_aeaa6196-2982-494c-8246-fb4f0944a93a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_56f16606-a73a-45ab-8aaf-1b0f32002bab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_56f16606-a73a-45ab-8aaf-1b0f32002bab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_56f16606-a73a-45ab-8aaf-1b0f32002bab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_56f16606-a73a-45ab-8aaf-1b0f32002bab" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_56f16606-a73a-45ab-8aaf-1b0f32002bab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_56f16606-a73a-45ab-8aaf-1b0f32002bab" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember_4f44cd7c-a8d5-431a-901e-ae87c3c23173" xlink:href="angn-20250930.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:to="loc_angn_ConversionOfConvertibleDebtMember_4f44cd7c-a8d5-431a-901e-ae87c3c23173" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertiblePreferredStockMember_ff27be51-b709-4b08-9391-b6562da45458" xlink:href="angn-20250930.xsd#angn_ConversionOfConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:to="loc_angn_ConversionOfConvertiblePreferredStockMember_ff27be51-b709-4b08-9391-b6562da45458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f8b015ff-ab94-4778-8232-50d79dab5ba7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_496ddac9-bac7-4c7e-845b-0b5dad9ab474" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_496ddac9-bac7-4c7e-845b-0b5dad9ab474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_90b568de-b236-4baf-9242-af71a477065d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockholdersEquity_90b568de-b236-4baf-9242-af71a477065d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_91ea51cb-c5e6-4940-8be6-23782f22077f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_TreasuryStockCommonShares_91ea51cb-c5e6-4940-8be6-23782f22077f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_909bf502-7747-4010-afdf-5a97474c1276" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_909bf502-7747-4010-afdf-5a97474c1276" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_678fbc2d-f747-46a2-9df3-16de755e27fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_678fbc2d-f747-46a2-9df3-16de755e27fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_48218c7d-88f4-43e5-b074-7f52c7c56001" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_48218c7d-88f4-43e5-b074-7f52c7c56001" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_08862026-4876-4301-834f-424b99e14aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_08862026-4876-4301-834f-424b99e14aa2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_32bef22c-5d56-4800-8ce5-34323be1efce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_32bef22c-5d56-4800-8ce5-34323be1efce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c65ed7c9-2e6f-4fa6-a840-aa589c435ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c65ed7c9-2e6f-4fa6-a840-aa589c435ddd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cbb1db9b-7ca0-44f0-be67-35e88eddb6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cbb1db9b-7ca0-44f0-be67-35e88eddb6ea" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_92032334-f546-4f85-a883-6076ec6b4e26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_92032334-f546-4f85-a883-6076ec6b4e26" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_d676ac31-926d-4a65-885c-895db81b39eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_d676ac31-926d-4a65-885c-895db81b39eb" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d4742290-212e-4652-bc31-54cfb18b516e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d4742290-212e-4652-bc31-54cfb18b516e" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_78419311-cdea-47f8-b765-e295367928f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_78419311-cdea-47f8-b765-e295367928f7" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_31017073-77cc-4f8b-be9c-fb334a366171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_31017073-77cc-4f8b-be9c-fb334a366171" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_beb963c3-befe-48d6-8360-3de90b78ddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_beb963c3-befe-48d6-8360-3de90b78ddd2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c913dc44-e0bf-4782-98d5-7009a62fab18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_NetIncomeLoss_c913dc44-e0bf-4782-98d5-7009a62fab18" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d9484ff0-d31b-44c1-a7ac-3d037d364a68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_557d495a-40ad-4b91-874c-1a191e2e46bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_5024a75d-7abb-4899-8d0f-971bf0f9a27b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_504da65d-db06-4dc0-8427-a587f8a5bf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:to="loc_us-gaap_StatementTable_504da65d-db06-4dc0-8427-a587f8a5bf0e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_103c570f-19ab-48f2-a84d-74aa42088984" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_504da65d-db06-4dc0-8427-a587f8a5bf0e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_103c570f-19ab-48f2-a84d-74aa42088984" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_103c570f-19ab-48f2-a84d-74aa42088984_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_103c570f-19ab-48f2-a84d-74aa42088984" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_103c570f-19ab-48f2-a84d-74aa42088984_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_103c570f-19ab-48f2-a84d-74aa42088984" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_fc6b36ee-f05e-406c-88a5-1ecec3cf5827" xlink:href="angn-20250930.xsd#angn_PurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:to="loc_angn_PurchaseAgreementMember_fc6b36ee-f05e-406c-88a5-1ecec3cf5827" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_42a0948b-9aad-4e91-b946-3d4f82160129" xlink:href="angn-20250930.xsd#angn_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:to="loc_angn_AtTheMarketOfferingMember_42a0948b-9aad-4e91-b946-3d4f82160129" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_1f618e01-dac0-43d0-b600-25c70c39bfe1" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:to="loc_angn_JulyPublicOfferingMember_1f618e01-dac0-43d0-b600-25c70c39bfe1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9567dffb-b8e7-43ac-a4ef-fa728605a4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9567dffb-b8e7-43ac-a4ef-fa728605a4c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2ce611df-6849-4748-844e-326c24a41f72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2ce611df-6849-4748-844e-326c24a41f72" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_edfbb3dd-0a61-4883-ad11-e9aa4931fc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_68ec5852-bcef-4ca2-9550-deaa7715300b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_edfbb3dd-0a61-4883-ad11-e9aa4931fc9b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_68ec5852-bcef-4ca2-9550-deaa7715300b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1edb4940-51dc-4421-87f1-bb824aee2b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68ec5852-bcef-4ca2-9550-deaa7715300b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1edb4940-51dc-4421-87f1-bb824aee2b2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1edb4940-51dc-4421-87f1-bb824aee2b2b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1edb4940-51dc-4421-87f1-bb824aee2b2b" xlink:to="loc_us-gaap_ClassOfStockDomain_1edb4940-51dc-4421-87f1-bb824aee2b2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cac25e69-44ae-4f56-9eed-76870dcdd7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1edb4940-51dc-4421-87f1-bb824aee2b2b" xlink:to="loc_us-gaap_ClassOfStockDomain_cac25e69-44ae-4f56-9eed-76870dcdd7a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionCommonStockMember_0947b68f-8b1c-46c9-b300-1fc6de98df1c" xlink:href="angn-20250930.xsd#angn_AngionCommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cac25e69-44ae-4f56-9eed-76870dcdd7a9" xlink:to="loc_angn_AngionCommonStockMember_0947b68f-8b1c-46c9-b300-1fc6de98df1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8ba82126-3929-4cd1-a960-6ea4d716e94d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_edfbb3dd-0a61-4883-ad11-e9aa4931fc9b" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8ba82126-3929-4cd1-a960-6ea4d716e94d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78ab57e5-8e13-4614-baf7-49b801786320" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78ab57e5-8e13-4614-baf7-49b801786320" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_78ab57e5-8e13-4614-baf7-49b801786320_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78ab57e5-8e13-4614-baf7-49b801786320" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_78ab57e5-8e13-4614-baf7-49b801786320_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78ab57e5-8e13-4614-baf7-49b801786320" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_024d6d64-e9d1-4616-a8fc-27ec0310ff5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_024d6d64-e9d1-4616-a8fc-27ec0310ff5d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f7e940fd-2c07-404c-b126-02d5488539b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f7e940fd-2c07-404c-b126-02d5488539b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_96c7b549-8447-4640-8d68-0e98bbf134f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_96c7b549-8447-4640-8d68-0e98bbf134f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a582fa1b-99fc-4952-b287-e7ad9b30eff7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a582fa1b-99fc-4952-b287-e7ad9b30eff7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_a582fa1b-99fc-4952-b287-e7ad9b30eff7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a582fa1b-99fc-4952-b287-e7ad9b30eff7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_a582fa1b-99fc-4952-b287-e7ad9b30eff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9fa4fdc6-c4f0-4a5e-af20-1429649b2b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a582fa1b-99fc-4952-b287-e7ad9b30eff7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9fa4fdc6-c4f0-4a5e-af20-1429649b2b2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e6d320-5f0a-4b4d-bd07-92b490cf2d45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9fa4fdc6-c4f0-4a5e-af20-1429649b2b2a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e6d320-5f0a-4b4d-bd07-92b490cf2d45" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e34244c1-a743-410d-913d-4106379b9ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e34244c1-a743-410d-913d-4106379b9ed0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e002de6a-1220-4d3d-99cb-3ebfdc3f0133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e002de6a-1220-4d3d-99cb-3ebfdc3f0133" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_592b624c-6152-4076-a824-b8339f1daea4" xlink:href="angn-20250930.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:to="loc_angn_WarrantsFairValueDisclosure_592b624c-6152-4076-a824-b8339f1daea4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_fa378023-3625-4a6a-a5ce-bee90b41a62d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_fa378023-3625-4a6a-a5ce-bee90b41a62d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_aa652e4e-2c7e-4c40-8448-80478906fc20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0745b6f6-52cd-46c2-91a0-c6819a0d1311" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_aa652e4e-2c7e-4c40-8448-80478906fc20" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0745b6f6-52cd-46c2-91a0-c6819a0d1311" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ca603584-2972-405f-bd98-5deabfd6514c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0745b6f6-52cd-46c2-91a0-c6819a0d1311" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ca603584-2972-405f-bd98-5deabfd6514c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca603584-2972-405f-bd98-5deabfd6514c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ca603584-2972-405f-bd98-5deabfd6514c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_ca603584-2972-405f-bd98-5deabfd6514c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe9e8b2d-737f-4c27-ae36-d2cc98520d37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ca603584-2972-405f-bd98-5deabfd6514c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe9e8b2d-737f-4c27-ae36-d2cc98520d37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember_f279b309-1bde-4e70-a3b6-639b14bb96d0" xlink:href="angn-20250930.xsd#angn_WarrantLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe9e8b2d-737f-4c27-ae36-d2cc98520d37" xlink:to="loc_angn_WarrantLiabilityMember_f279b309-1bde-4e70-a3b6-639b14bb96d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_aa652e4e-2c7e-4c40-8448-80478906fc20" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c2dcd02b-edd2-4df7-b861-6fe894a7d8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c2dcd02b-edd2-4df7-b861-6fe894a7d8ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d61c5a34-0ede-43a1-87f6-3df7872e2a42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d61c5a34-0ede-43a1-87f6-3df7872e2a42" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5eb3f08a-8377-4e11-9ae2-1fc60735452e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59d24a2c-0233-40dd-9114-b201ac0b8329" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59d24a2c-0233-40dd-9114-b201ac0b8329" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_59d24a2c-0233-40dd-9114-b201ac0b8329_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59d24a2c-0233-40dd-9114-b201ac0b8329" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_59d24a2c-0233-40dd-9114-b201ac0b8329_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b494e37c-d2ac-4ee2-97db-de8b164e907d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59d24a2c-0233-40dd-9114-b201ac0b8329" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b494e37c-d2ac-4ee2-97db-de8b164e907d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d3a33d58-29bc-49f9-9f3e-f7adb084b48c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b494e37c-d2ac-4ee2-97db-de8b164e907d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d3a33d58-29bc-49f9-9f3e-f7adb084b48c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_897c374c-1cb7-42f3-a6f8-7a32d0681025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_897c374c-1cb7-42f3-a6f8-7a32d0681025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_897c374c-1cb7-42f3-a6f8-7a32d0681025_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_897c374c-1cb7-42f3-a6f8-7a32d0681025" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_897c374c-1cb7-42f3-a6f8-7a32d0681025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_897c374c-1cb7-42f3-a6f8-7a32d0681025" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember_1e4cef72-d713-404d-840a-e4d56bc492f0" xlink:href="angn-20250930.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_angn_MeasurementInputStrikePriceMember_1e4cef72-d713-404d-840a-e4d56bc492f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_d22a7901-0f2e-48b9-9445-5ed614760025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_d22a7901-0f2e-48b9-9445-5ed614760025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_5d81e902-670d-4ca3-8eff-39f694d72b57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_5d81e902-670d-4ca3-8eff-39f694d72b57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_baaf91e2-a2e1-4774-924f-b1c95e768284" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_baaf91e2-a2e1-4774-924f-b1c95e768284" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_9716a7f8-0329-4462-8d26-719f275cb411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_9716a7f8-0329-4462-8d26-719f275cb411" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ad83c3f3-8f5c-4e39-a54e-4b8fecc8279a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ad83c3f3-8f5c-4e39-a54e-4b8fecc8279a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_468ea617-05f6-41ab-9578-4c512fc9f413" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_468ea617-05f6-41ab-9578-4c512fc9f413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_468ea617-05f6-41ab-9578-4c512fc9f413_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_468ea617-05f6-41ab-9578-4c512fc9f413" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_468ea617-05f6-41ab-9578-4c512fc9f413_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b18b31-3b3d-4cdb-9890-877f283d9f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_468ea617-05f6-41ab-9578-4c512fc9f413" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b18b31-3b3d-4cdb-9890-877f283d9f1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_e06a4324-1418-4696-9ca0-4639fffc87f2" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b18b31-3b3d-4cdb-9890-877f283d9f1c" xlink:to="loc_angn_JulyPublicOfferingMember_e06a4324-1418-4696-9ca0-4639fffc87f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1d4ac19a-a72b-49d1-b188-aad740533cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1d4ac19a-a72b-49d1-b188-aad740533cdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1d4ac19a-a72b-49d1-b188-aad740533cdb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1d4ac19a-a72b-49d1-b188-aad740533cdb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1d4ac19a-a72b-49d1-b188-aad740533cdb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1d4ac19a-a72b-49d1-b188-aad740533cdb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_df302f58-5adc-43fc-bc63-0e62e1e06d7d" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:to="loc_angn_PreFundedWarrantMember_df302f58-5adc-43fc-bc63-0e62e1e06d7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_92da9773-47d8-40be-985c-657ca931c5ab" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:to="loc_angn_JulyPreFundedWarrantsMember_92da9773-47d8-40be-985c-657ca931c5ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_2d514d34-a481-41ef-8ab8-112785cf8827" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:to="loc_angn_JulyCommonWarrantsMember_2d514d34-a481-41ef-8ab8-112785cf8827" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6ac2291e-2149-4d05-921c-fef913a95a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6ac2291e-2149-4d05-921c-fef913a95a9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d4bb7d2a-53c0-4ce7-b4f1-cdd105bf7578" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d4bb7d2a-53c0-4ce7-b4f1-cdd105bf7578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16daa01d-0447-4477-ac78-08d1576cc1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16daa01d-0447-4477-ac78-08d1576cc1c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_1f807a7d-62cf-41b3-a7b7-2656e59ee228" xlink:href="angn-20250930.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_1f807a7d-62cf-41b3-a7b7-2656e59ee228" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_df0bb4b6-5bf2-4496-906c-007657a11ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_df0bb4b6-5bf2-4496-906c-007657a11ed4" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b800651b-600a-4a7e-ae37-9156fd384551" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b800651b-600a-4a7e-ae37-9156fd384551" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b92e87e9-1775-46b5-93de-c65ac0c1ff1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b800651b-600a-4a7e-ae37-9156fd384551" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b92e87e9-1775-46b5-93de-c65ac0c1ff1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b92e87e9-1775-46b5-93de-c65ac0c1ff1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b92e87e9-1775-46b5-93de-c65ac0c1ff1d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_b92e87e9-1775-46b5-93de-c65ac0c1ff1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b92e87e9-1775-46b5-93de-c65ac0c1ff1d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d967d5dd-4224-4525-ba13-140356a38135" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:to="loc_us-gaap_EquipmentMember_d967d5dd-4224-4525-ba13-140356a38135" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b3c41869-93ee-4ae2-908e-3653a6e3eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b3c41869-93ee-4ae2-908e-3653a6e3eafa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_462fdfe3-f1da-41db-a337-ef883a143471" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_462fdfe3-f1da-41db-a337-ef883a143471" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dd3c5f36-ef2a-45a7-aefe-7ebfcc9ab354" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dd3c5f36-ef2a-45a7-aefe-7ebfcc9ab354" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_43627c43-342d-44a9-b6da-dbc3c6b4480c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_43627c43-342d-44a9-b6da-dbc3c6b4480c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0cecc047-455e-4dd0-b25a-c62029163a55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0cecc047-455e-4dd0-b25a-c62029163a55" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrantsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#ResearchGrantsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/ResearchGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9fa2c593-5376-439d-b7a9-616ee0170e00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9fa2c593-5376-439d-b7a9-616ee0170e00" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_fbb00332-b535-4e81-86ca-7ce12ac241a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9fa2c593-5376-439d-b7a9-616ee0170e00" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_fbb00332-b535-4e81-86ca-7ce12ac241a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_fbb00332-b535-4e81-86ca-7ce12ac241a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_fbb00332-b535-4e81-86ca-7ce12ac241a5" xlink:to="loc_us-gaap_ProjectMember_fbb00332-b535-4e81-86ca-7ce12ac241a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_fbb00332-b535-4e81-86ca-7ce12ac241a5" xlink:to="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_f4e216a3-6057-4ba2-aea7-9d7bcabc4063" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_f4e216a3-6057-4ba2-aea7-9d7bcabc4063" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_e019094a-042a-412a-85dc-4d0b6fbbda27" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_e019094a-042a-412a-85dc-4d0b6fbbda27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_0a9b9a27-9f7d-472e-80ce-bd8b9c989581" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_0a9b9a27-9f7d-472e-80ce-bd8b9c989581" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant_630f7963-7acc-4c27-b267-767f9d4bcb46" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrant_630f7963-7acc-4c27-b267-767f9d4bcb46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_54ec582b-5132-4225-8e58-0dc45d3ff10c" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_54ec582b-5132-4225-8e58-0dc45d3ff10c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit_2188201e-2ddd-4193-905d-c6dbed001781" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementCredit_2188201e-2ddd-4193-905d-c6dbed001781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1f466bd0-598a-4a27-b2c2-ceab64038007" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1f466bd0-598a-4a27-b2c2-ceab64038007" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_35dc6221-f888-483f-9100-75b365d4dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_35dc6221-f888-483f-9100-75b365d4dfeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_dc607904-5592-4585-99fd-9642d3c58bec" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_dc607904-5592-4585-99fd-9642d3c58bec" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements_4755ec05-0037-4c7d-a29b-770af72f652d" xlink:href="angn-20250930.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_NumberOfResearchGrantAgreements_4755ec05-0037-4c7d-a29b-770af72f652d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_5ec7e089-0b27-4c33-bb06-46502f17cb3d" xlink:href="angn-20250930.xsd#angn_GrantRevenueNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_GrantRevenueNonoperating_5ec7e089-0b27-4c33-bb06-46502f17cb3d" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#CommonStockandStockholdersEquityDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1eb0b759-2acc-4417-931c-ceea9decee78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1eb0b759-2acc-4417-931c-ceea9decee78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1eb0b759-2acc-4417-931c-ceea9decee78_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1eb0b759-2acc-4417-931c-ceea9decee78" xlink:to="loc_us-gaap_EquityComponentDomain_1eb0b759-2acc-4417-931c-ceea9decee78_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0e3496b9-7114-4e16-8ef6-00d3d5df4c13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1eb0b759-2acc-4417-931c-ceea9decee78" xlink:to="loc_us-gaap_EquityComponentDomain_0e3496b9-7114-4e16-8ef6-00d3d5df4c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c442977a-b67a-4769-acd5-26946ef71b60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0e3496b9-7114-4e16-8ef6-00d3d5df4c13" xlink:to="loc_us-gaap_CommonStockMember_c442977a-b67a-4769-acd5-26946ef71b60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d2055b4a-4ee6-4578-a27c-892f145019a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d2055b4a-4ee6-4578-a27c-892f145019a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d2055b4a-4ee6-4578-a27c-892f145019a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2055b4a-4ee6-4578-a27c-892f145019a3" xlink:to="loc_us-gaap_ClassOfStockDomain_d2055b4a-4ee6-4578-a27c-892f145019a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e59ed3a4-39bf-408d-b502-53fdc88c914c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2055b4a-4ee6-4578-a27c-892f145019a3" xlink:to="loc_us-gaap_ClassOfStockDomain_e59ed3a4-39bf-408d-b502-53fdc88c914c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_f99df2bc-a44b-406f-8223-c1e3ad96c4cb" xlink:href="angn-20250930.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e59ed3a4-39bf-408d-b502-53fdc88c914c" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_f99df2bc-a44b-406f-8223-c1e3ad96c4cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_286dc73a-3c67-4608-9e9b-6cc0016dfb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_286dc73a-3c67-4608-9e9b-6cc0016dfb6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_286dc73a-3c67-4608-9e9b-6cc0016dfb6d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_286dc73a-3c67-4608-9e9b-6cc0016dfb6d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_286dc73a-3c67-4608-9e9b-6cc0016dfb6d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_286dc73a-3c67-4608-9e9b-6cc0016dfb6d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember_2290a852-994a-4f87-8833-94e37dde3a75" xlink:href="angn-20250930.xsd#angn_RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_RegistrationStatementMember_2290a852-994a-4f87-8833-94e37dde3a75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_f17e6c6f-1e22-42a8-9380-853a915c8591" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_f17e6c6f-1e22-42a8-9380-853a915c8591" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember_4a8b7e45-1d45-454d-a3b7-5d1da850e1fb" xlink:href="angn-20250930.xsd#angn_A2024RegistrationStatementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_A2024RegistrationStatementMember_4a8b7e45-1d45-454d-a3b7-5d1da850e1fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_e44711da-b9e6-4081-bd29-23127255177e" xlink:href="angn-20250930.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_MarchSubscriptionAgreementMember_e44711da-b9e6-4081-bd29-23127255177e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_041e1d5d-efad-4869-b399-e4045ea0f8c0" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_JulyPublicOfferingMember_041e1d5d-efad-4869-b399-e4045ea0f8c0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_cd017dfa-4373-4d5b-a9dc-aa021a73fbf3" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_cd017dfa-4373-4d5b-a9dc-aa021a73fbf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_3a422db3-5595-4ce7-86c8-9ce94c8037cb" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_3a422db3-5595-4ce7-86c8-9ce94c8037cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_a8e4f4cf-ea36-434b-8500-5a5369a4d4eb" xlink:href="angn-20250930.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_JanuaryPublicOfferingMember_a8e4f4cf-ea36-434b-8500-5a5369a4d4eb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1322ba95-7da4-4b21-a566-68eccd37a429" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1322ba95-7da4-4b21-a566-68eccd37a429" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1322ba95-7da4-4b21-a566-68eccd37a429_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1322ba95-7da4-4b21-a566-68eccd37a429" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1322ba95-7da4-4b21-a566-68eccd37a429_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1322ba95-7da4-4b21-a566-68eccd37a429" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_1b42502e-5a76-48d8-8c79-4b1495ecf30b" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_PreFundedWarrantMember_1b42502e-5a76-48d8-8c79-4b1495ecf30b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_77b49025-544c-4c81-a9b0-e8ef60432eed" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JulyCommonWarrantsMember_77b49025-544c-4c81-a9b0-e8ef60432eed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_5c4acbe7-e7e5-4682-ad7f-ed96890b0bef" xlink:href="angn-20250930.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JanuaryCommonWarrantsMember_5c4acbe7-e7e5-4682-ad7f-ed96890b0bef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_f735c0ba-7885-4dc1-88c2-1312ee156356" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JulyPreFundedWarrantsMember_f735c0ba-7885-4dc1-88c2-1312ee156356" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_8f3b1b8c-5e4b-49e1-b605-67dba6cb94f5" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_8f3b1b8c-5e4b-49e1-b605-67dba6cb94f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_45b3cc07-3846-4533-a93a-08c0ba74789d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_DebtInstrumentAxis_45b3cc07-3846-4533-a93a-08c0ba74789d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_45b3cc07-3846-4533-a93a-08c0ba74789d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_45b3cc07-3846-4533-a93a-08c0ba74789d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_45b3cc07-3846-4533-a93a-08c0ba74789d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_59510b1f-edc2-455f-8767-bb3071856a03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_45b3cc07-3846-4533-a93a-08c0ba74789d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_59510b1f-edc2-455f-8767-bb3071856a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b33a7281-7c35-4496-948e-1a96b5a05ba4" xlink:href="angn-20250930.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59510b1f-edc2-455f-8767-bb3071856a03" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b33a7281-7c35-4496-948e-1a96b5a05ba4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2f983fc8-4a50-42bf-b14a-73e4b46f0e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2f983fc8-4a50-42bf-b14a-73e4b46f0e8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8ea1300a-f3e3-45cb-8657-489c7ff98b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8ea1300a-f3e3-45cb-8657-489c7ff98b43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f5d34d07-c889-466e-ac44-64ce800d483a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f5d34d07-c889-466e-ac44-64ce800d483a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5a2e996b-ba94-4ddc-b01e-7ec9759e31a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5a2e996b-ba94-4ddc-b01e-7ec9759e31a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice_7053e0a8-faee-418b-9afe-658252b46821" xlink:href="angn-20250930.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_angn_SaleOfStockAggregateInitialOfferingPrice_7053e0a8-faee-418b-9afe-658252b46821" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4f554c3-98b3-4462-8fcc-6af7dc19b9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4f554c3-98b3-4462-8fcc-6af7dc19b9b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8a1a0838-c220-4f63-8d0f-b9091a5ea094" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8a1a0838-c220-4f63-8d0f-b9091a5ea094" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e77f0683-8d0b-4918-a35d-37447898724e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e77f0683-8d0b-4918-a35d-37447898724e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d376d75-3403-4f14-b379-d0a6e9706769" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d376d75-3403-4f14-b379-d0a6e9706769" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_650471e3-8aeb-4a93-a5b4-8afcb1340025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_650471e3-8aeb-4a93-a5b4-8afcb1340025" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_653f1a8a-632c-4780-8f63-cd14b1ad793e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_653f1a8a-632c-4780-8f63-cd14b1ad793e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b004b99d-56f5-4859-bf92-eb2d29314820" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b004b99d-56f5-4859-bf92-eb2d29314820" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3f2ed128-0451-42c7-973e-88b03b1d14a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3f2ed128-0451-42c7-973e-88b03b1d14a5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5e582670-4709-437c-bb00-1cfb53fbf4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_108d363f-a5ef-438f-8e19-176b6e464387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_108d363f-a5ef-438f-8e19-176b6e464387" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9a1fe527-b422-4c7c-af54-e4321f874948" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9a1fe527-b422-4c7c-af54-e4321f874948" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_7291d093-67f2-4820-b6bb-544404ce4f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_7291d093-67f2-4820-b6bb-544404ce4f6c" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_290cddaa-e717-4736-acb7-d81f42bb3f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:to="loc_us-gaap_PlanNameAxis_290cddaa-e717-4736-acb7-d81f42bb3f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_290cddaa-e717-4736-acb7-d81f42bb3f8e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_290cddaa-e717-4736-acb7-d81f42bb3f8e" xlink:to="loc_us-gaap_PlanNameDomain_290cddaa-e717-4736-acb7-d81f42bb3f8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_290cddaa-e717-4736-acb7-d81f42bb3f8e" xlink:to="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2021PlanMember_caf052cd-e6ef-4f09-8e3d-aac2fe5d6673" xlink:href="angn-20250930.xsd#angn_The2021PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:to="loc_angn_The2021PlanMember_caf052cd-e6ef-4f09-8e3d-aac2fe5d6673" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2022PlanMember_5ee94cec-921e-4488-926e-c938fa48b63c" xlink:href="angn-20250930.xsd#angn_The2022PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:to="loc_angn_The2022PlanMember_5ee94cec-921e-4488-926e-c938fa48b63c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_Inducement2024PlanMember_bf11cabd-b4f8-4546-b993-3ff1d4725d6d" xlink:href="angn-20250930.xsd#angn_Inducement2024PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:to="loc_angn_Inducement2024PlanMember_bf11cabd-b4f8-4546-b993-3ff1d4725d6d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c5019569-2c1f-496c-8230-f9aa8ac002ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:to="loc_us-gaap_AwardTypeAxis_c5019569-2c1f-496c-8230-f9aa8ac002ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5019569-2c1f-496c-8230-f9aa8ac002ac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c5019569-2c1f-496c-8230-f9aa8ac002ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c5019569-2c1f-496c-8230-f9aa8ac002ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22ce0c48-a928-40d6-bfb0-6c164f444be0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c5019569-2c1f-496c-8230-f9aa8ac002ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22ce0c48-a928-40d6-bfb0-6c164f444be0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b8c413b4-5d01-4f58-96e3-fc4501999477" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22ce0c48-a928-40d6-bfb0-6c164f444be0" xlink:to="loc_us-gaap_EmployeeStockMember_b8c413b4-5d01-4f58-96e3-fc4501999477" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ed8a46df-787a-4c5b-ad89-49674bb36879" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ed8a46df-787a-4c5b-ad89-49674bb36879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_6ce3a2b8-7d77-4310-a720-9b108ace5b82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_6ce3a2b8-7d77-4310-a720-9b108ace5b82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_56d075b7-85fa-4ff2-968b-fdcdcbf60e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_56d075b7-85fa-4ff2-968b-fdcdcbf60e8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5cda87d3-dfba-45af-a817-9fa4db4026a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5cda87d3-dfba-45af-a817-9fa4db4026a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d26669e3-8db4-4b38-a7d6-64803e065548" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d26669e3-8db4-4b38-a7d6-64803e065548" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9740bde9-f9dc-4984-98a2-81117ac28dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9740bde9-f9dc-4984-98a2-81117ac28dc4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3c42b2b4-0b57-4e01-baff-266793fd1c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3c42b2b4-0b57-4e01-baff-266793fd1c5f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_59c8602a-d9c8-4c49-b069-24218b145a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_eeff083b-3fcb-4815-bec7-257a3ec8a37a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_59c8602a-d9c8-4c49-b069-24218b145a5c" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_eeff083b-3fcb-4815-bec7-257a3ec8a37a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3d6c6c47-a589-4532-8ece-f71228fd93d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_eeff083b-3fcb-4815-bec7-257a3ec8a37a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3d6c6c47-a589-4532-8ece-f71228fd93d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3d6c6c47-a589-4532-8ece-f71228fd93d7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3d6c6c47-a589-4532-8ece-f71228fd93d7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3d6c6c47-a589-4532-8ece-f71228fd93d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3d6c6c47-a589-4532-8ece-f71228fd93d7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_293593d8-d409-4b18-bd37-eb2b7a678956" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_293593d8-d409-4b18-bd37-eb2b7a678956" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5ea4154d-607f-4c30-adeb-a174149e5e47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5ea4154d-607f-4c30-adeb-a174149e5e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_10fd4b0d-5d18-4c45-b16d-1df2338557a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_59c8602a-d9c8-4c49-b069-24218b145a5c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_10fd4b0d-5d18-4c45-b16d-1df2338557a9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:to="loc_us-gaap_AwardTypeAxis_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20a76052-2c75-41b8-bffb-e8943b4564da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20a76052-2c75-41b8-bffb-e8943b4564da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_300710cf-480c-4679-a2e2-e4b34722242b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20a76052-2c75-41b8-bffb-e8943b4564da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_300710cf-480c-4679-a2e2-e4b34722242b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_51f53ec9-0d8a-43a1-9119-bc17dde4b55e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:to="loc_srt_RangeAxis_51f53ec9-0d8a-43a1-9119-bc17dde4b55e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_51f53ec9-0d8a-43a1-9119-bc17dde4b55e_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_51f53ec9-0d8a-43a1-9119-bc17dde4b55e" xlink:to="loc_srt_RangeMember_51f53ec9-0d8a-43a1-9119-bc17dde4b55e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_51f53ec9-0d8a-43a1-9119-bc17dde4b55e" xlink:to="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c6ad2fa5-99b9-4751-9d9b-cb57324edb2e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:to="loc_srt_MinimumMember_c6ad2fa5-99b9-4751-9d9b-cb57324edb2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ece9003a-c798-4dda-97d9-4b1d25143ac4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:to="loc_srt_MaximumMember_ece9003a-c798-4dda-97d9-4b1d25143ac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dfbd3911-f9bb-4fec-9094-67d0a6630662" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dfbd3911-f9bb-4fec-9094-67d0a6630662" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_eeef0a22-cd00-4e27-a7bc-3096cef8f019" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_eeef0a22-cd00-4e27-a7bc-3096cef8f019" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_543634e8-4913-44b4-9b6e-b37fd1216c84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_543634e8-4913-44b4-9b6e-b37fd1216c84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60352115-34f3-4418-8576-199a70d3894f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60352115-34f3-4418-8576-199a70d3894f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_da4f4f14-e10d-4818-845c-08fadf50ec75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_da4f4f14-e10d-4818-845c-08fadf50ec75" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_cb21f663-8f89-4002-8586-c1ae42e4eafd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_cb21f663-8f89-4002-8586-c1ae42e4eafd" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#WarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_198b3efe-5abe-4a20-ab21-5367ec1c3037" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_198b3efe-5abe-4a20-ab21-5367ec1c3037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_198b3efe-5abe-4a20-ab21-5367ec1c3037_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_198b3efe-5abe-4a20-ab21-5367ec1c3037" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_198b3efe-5abe-4a20-ab21-5367ec1c3037_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_198b3efe-5abe-4a20-ab21-5367ec1c3037" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_403a8cf9-268d-40e4-bcbb-d009bec351c5" xlink:href="angn-20250930.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_March2024PreFundedWarrantsMember_403a8cf9-268d-40e4-bcbb-d009bec351c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_4d9e9ef3-0eba-43a9-8e9b-7505948a9c7b" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_PreFundedWarrantMember_4d9e9ef3-0eba-43a9-8e9b-7505948a9c7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_f9b72fef-c59a-443a-b553-5b1e7532f003" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_JulyCommonWarrantsMember_f9b72fef-c59a-443a-b553-5b1e7532f003" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_54dae0ba-0bfc-4843-ac10-9ce9bd0e4610" xlink:href="angn-20250930.xsd#angn_January2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_January2025CommonWarrantsMember_54dae0ba-0bfc-4843-ac10-9ce9bd0e4610" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_3b75afb0-3517-4e90-8818-1bb058f767ad" xlink:href="angn-20250930.xsd#angn_June2025WarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_June2025WarrantsMember_3b75afb0-3517-4e90-8818-1bb058f767ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_c1742dbb-1933-4719-821a-933b80161142" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_c1742dbb-1933-4719-821a-933b80161142" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f3265864-3dd8-4d9b-a911-8d0784d1f68e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f3265864-3dd8-4d9b-a911-8d0784d1f68e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f3265864-3dd8-4d9b-a911-8d0784d1f68e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f3265864-3dd8-4d9b-a911-8d0784d1f68e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f3265864-3dd8-4d9b-a911-8d0784d1f68e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f3265864-3dd8-4d9b-a911-8d0784d1f68e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_932fc1c3-d010-4564-a6b4-e4fd7eca214b" xlink:href="angn-20250930.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:to="loc_angn_MarchSubscriptionAgreementMember_932fc1c3-d010-4564-a6b4-e4fd7eca214b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_37cbf718-41e8-47a2-999c-236502b5b015" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:to="loc_angn_JulyPublicOfferingMember_37cbf718-41e8-47a2-999c-236502b5b015" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6778dee7-f3e9-47d6-ae96-37b5bc92f547" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6778dee7-f3e9-47d6-ae96-37b5bc92f547" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6778dee7-f3e9-47d6-ae96-37b5bc92f547_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6778dee7-f3e9-47d6-ae96-37b5bc92f547" xlink:to="loc_us-gaap_EquityComponentDomain_6778dee7-f3e9-47d6-ae96-37b5bc92f547_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_46594617-c84a-48bc-ac93-a81fb8458456" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6778dee7-f3e9-47d6-ae96-37b5bc92f547" xlink:to="loc_us-gaap_EquityComponentDomain_46594617-c84a-48bc-ac93-a81fb8458456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f2b97592-e1cd-4cac-9ca3-cd51c78c7f70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_46594617-c84a-48bc-ac93-a81fb8458456" xlink:to="loc_us-gaap_CommonStockMember_f2b97592-e1cd-4cac-9ca3-cd51c78c7f70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d872d5d-1ca8-4af8-91e1-5f105c010611" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d872d5d-1ca8-4af8-91e1-5f105c010611" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantExercisedFairValue_23039124-f053-4598-9a29-b92b66b27350" xlink:href="angn-20250930.xsd#angn_WarrantExercisedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_angn_WarrantExercisedFairValue_23039124-f053-4598-9a29-b92b66b27350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_85cc6867-dd9b-45a2-bcb0-c25166f448ea" xlink:href="angn-20250930.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_85cc6867-dd9b-45a2-bcb0-c25166f448ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_d042e365-9e22-4664-b634-af27aef3ddca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_d042e365-9e22-4664-b634-af27aef3ddca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0450426f-10e3-432d-9912-f09b079938b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0450426f-10e3-432d-9912-f09b079938b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_9405aa88-e501-4584-b4c2-aa3552abda3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_9405aa88-e501-4584-b4c2-aa3552abda3c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_8a7f40aa-8cee-4498-8226-f525040fb035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_8a7f40aa-8cee-4498-8226-f525040fb035" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30164a45-b096-4cdb-ac88-55354e23dc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30164a45-b096-4cdb-ac88-55354e23dc0c" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#WarrantsScheduleofOutstandingWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ElicioWarrantsMember_ccd00a62-2080-4ae3-a5b5-fc87951d3b26" xlink:href="angn-20250930.xsd#angn_ElicioWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_ElicioWarrantsMember_ccd00a62-2080-4ae3-a5b5-fc87951d3b26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionWarrantsMember_860c69e8-0715-437b-bb92-400866daa5ff" xlink:href="angn-20250930.xsd#angn_AngionWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_AngionWarrantsMember_860c69e8-0715-437b-bb92-400866daa5ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_2b90abf4-ced4-43c8-866c-49fe085be487" xlink:href="angn-20250930.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_March2024PreFundedWarrantsMember_2b90abf4-ced4-43c8-866c-49fe085be487" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_de885de2-6530-4d0c-8e36-409ffdac637c" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_PreFundedWarrantMember_de885de2-6530-4d0c-8e36-409ffdac637c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_2c7e6f7f-ec67-4a87-b6d9-4265c92a7489" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_JulyCommonWarrantsMember_2c7e6f7f-ec67-4a87-b6d9-4265c92a7489" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_50f2c4d4-fa7a-42b6-a05a-e9c5fa66dc7b" xlink:href="angn-20250930.xsd#angn_January2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_January2025CommonWarrantsMember_50f2c4d4-fa7a-42b6-a05a-e9c5fa66dc7b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025CommonWarrantsMember_ccdfa9e2-559b-4b54-8bd3-53355eaa0a1e" xlink:href="angn-20250930.xsd#angn_June2025CommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_June2025CommonWarrantsMember_ccdfa9e2-559b-4b54-8bd3-53355eaa0a1e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5744d56b-3690-4d95-95d4-a51db7061f48" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:to="loc_srt_RangeAxis_5744d56b-3690-4d95-95d4-a51db7061f48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5744d56b-3690-4d95-95d4-a51db7061f48_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5744d56b-3690-4d95-95d4-a51db7061f48" xlink:to="loc_srt_RangeMember_5744d56b-3690-4d95-95d4-a51db7061f48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9adf55e8-a547-4ec7-9032-b44a64065308" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5744d56b-3690-4d95-95d4-a51db7061f48" xlink:to="loc_srt_RangeMember_9adf55e8-a547-4ec7-9032-b44a64065308" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_9dac5ec8-0f2f-4e2f-9391-8676b70768fc" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9adf55e8-a547-4ec7-9032-b44a64065308" xlink:to="loc_srt_WeightedAverageMember_9dac5ec8-0f2f-4e2f-9391-8676b70768fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_168eeda4-8cde-45ed-8d0e-ccdbc2c54c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_168eeda4-8cde-45ed-8d0e-ccdbc2c54c7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3308c1-3f81-4806-9e6c-8b05f54e3e03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3308c1-3f81-4806-9e6c-8b05f54e3e03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_853669a1-020c-43ce-8824-35ecf2dc1b01" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_853669a1-020c-43ce-8824-35ecf2dc1b01" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:href="angn-20250930.xsd#angn_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:href="angn-20250930.xsd#angn_CommitmentsAndContingenciesDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6a83c3e7-78e4-46aa-aeef-f63090f7147b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_srt_StatementScenarioAxis_6a83c3e7-78e4-46aa-aeef-f63090f7147b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_6a83c3e7-78e4-46aa-aeef-f63090f7147b_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_6a83c3e7-78e4-46aa-aeef-f63090f7147b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_6a83c3e7-78e4-46aa-aeef-f63090f7147b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9faa7f70-965c-46b2-bdbc-f2b8d4cf3e5e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_6a83c3e7-78e4-46aa-aeef-f63090f7147b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9faa7f70-965c-46b2-bdbc-f2b8d4cf3e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_aaf5d6cc-d358-431e-acf4-4bf4d8f383d7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9faa7f70-965c-46b2-bdbc-f2b8d4cf3e5e" xlink:to="loc_srt_ScenarioForecastMember_aaf5d6cc-d358-431e-acf4-4bf4d8f383d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1d773fd8-f73a-4429-aa97-ec4a16cea3c5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_srt_RangeAxis_1d773fd8-f73a-4429-aa97-ec4a16cea3c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1d773fd8-f73a-4429-aa97-ec4a16cea3c5_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1d773fd8-f73a-4429-aa97-ec4a16cea3c5" xlink:to="loc_srt_RangeMember_1d773fd8-f73a-4429-aa97-ec4a16cea3c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1d773fd8-f73a-4429-aa97-ec4a16cea3c5" xlink:to="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_caf57e38-d44e-458f-bb17-83aeee37ffe6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:to="loc_srt_MinimumMember_caf57e38-d44e-458f-bb17-83aeee37ffe6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cabdaf64-9b69-4723-ac2c-db8483055e58" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:to="loc_srt_MaximumMember_cabdaf64-9b69-4723-ac2c-db8483055e58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_943756a7-ab20-4ca1-84a2-8721d13968f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_943756a7-ab20-4ca1-84a2-8721d13968f0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_943756a7-ab20-4ca1-84a2-8721d13968f0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_943756a7-ab20-4ca1-84a2-8721d13968f0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_943756a7-ab20-4ca1-84a2-8721d13968f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b1f65444-7b80-4166-8e41-b36e6e8bfe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_943756a7-ab20-4ca1-84a2-8721d13968f0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b1f65444-7b80-4166-8e41-b36e6e8bfe9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_df3c72c7-2174-4ca7-9b96-43fe6d86f245" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b1f65444-7b80-4166-8e41-b36e6e8bfe9b" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_df3c72c7-2174-4ca7-9b96-43fe6d86f245" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_srt_CounterpartyNameAxis_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3acdc650-4e67-45d2-92a5-4186c75e7619" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3acdc650-4e67-45d2-92a5-4186c75e7619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_UniversityMember_537eaa49-a77a-41ba-97fe-80c642927c75" xlink:href="angn-20250930.xsd#angn_UniversityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3acdc650-4e67-45d2-92a5-4186c75e7619" xlink:to="loc_angn_UniversityMember_537eaa49-a77a-41ba-97fe-80c642927c75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RoyaltyRatePercent_32c84b34-61ef-443a-884d-d609ab582846" xlink:href="angn-20250930.xsd#angn_RoyaltyRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_angn_RoyaltyRatePercent_32c84b34-61ef-443a-884d-d609ab582846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d0a01646-8c2e-4bbe-856a-fa94ba8d8ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d0a01646-8c2e-4bbe-856a-fa94ba8d8ed9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_4da6f507-9234-4083-9294-9d95ba38f1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_us-gaap_RoyaltyExpense_4da6f507-9234-4083-9294-9d95ba38f1e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_b62d35f2-b2f3-4a9f-9422-63e14a40efbe" xlink:href="angn-20250930.xsd#angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_b62d35f2-b2f3-4a9f-9422-63e14a40efbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_742e3f4f-7502-44ae-8dad-93b8755d8167" xlink:href="angn-20250930.xsd#angn_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_742e3f4f-7502-44ae-8dad-93b8755d8167" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_127cee1d-d982-4018-8c5b-10f1defa2911" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_127cee1d-d982-4018-8c5b-10f1defa2911" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_127cee1d-d982-4018-8c5b-10f1defa2911" xlink:to="loc_srt_StatementGeographicalAxis_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615" xlink:to="loc_srt_SegmentGeographicalDomain_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615" xlink:to="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember_fb091d13-f9ba-47fc-a225-1225817343a4" xlink:href="angn-20250930.xsd#angn_BostonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:to="loc_angn_BostonMassachusettsMember_fb091d13-f9ba-47fc-a225-1225817343a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember_8ba1bb67-85e7-41f3-b5ca-0d21c59512cd" xlink:href="angn-20250930.xsd#angn_NewtonMassachusettsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:to="loc_angn_NewtonMassachusettsMember_8ba1bb67-85e7-41f3-b5ca-0d21c59512cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_148c6655-366f-4804-b015-24052c63adf9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_OperatingLeaseExpense_148c6655-366f-4804-b015-24052c63adf9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b0ced0d1-755f-401a-aaf5-b0143dc0a523" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b0ced0d1-755f-401a-aaf5-b0143dc0a523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9cd43aa2-a3ec-4207-adc8-e6e4c1a961a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9cd43aa2-a3ec-4207-adc8-e6e4c1a961a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_26f5bc11-5644-4d40-a094-3af5ab2a0df3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_26f5bc11-5644-4d40-a094-3af5ab2a0df3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_0226ecbc-a0f4-4fc2-9b6c-47e28a675a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_0226ecbc-a0f4-4fc2-9b6c-47e28a675a0e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense_7298031c-67d8-4d12-8ac8-2095e4b50d68" xlink:href="angn-20250930.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_angn_LesseeOperatingLeaseAnnualRentExpense_7298031c-67d8-4d12-8ac8-2095e4b50d68" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#DebtDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0cf6da7e-1788-41c7-b496-31b5919ae18b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_DebtInstrumentAxis_0cf6da7e-1788-41c7-b496-31b5919ae18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0cf6da7e-1788-41c7-b496-31b5919ae18b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cf6da7e-1788-41c7-b496-31b5919ae18b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0cf6da7e-1788-41c7-b496-31b5919ae18b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a3f7135f-586c-4bc6-b520-5e6a22d4b9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cf6da7e-1788-41c7-b496-31b5919ae18b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a3f7135f-586c-4bc6-b520-5e6a22d4b9a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_923c27ba-9daf-4dc4-a377-df667630c597" xlink:href="angn-20250930.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a3f7135f-586c-4bc6-b520-5e6a22d4b9a1" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_923c27ba-9daf-4dc4-a377-df667630c597" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b37cc501-7e29-48be-828a-03694ba5967f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b37cc501-7e29-48be-828a-03694ba5967f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0a4fa1b4-2e26-4e68-b53f-01baeac254f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b37cc501-7e29-48be-828a-03694ba5967f" xlink:to="loc_us-gaap_ConvertibleDebtMember_0a4fa1b4-2e26-4e68-b53f-01baeac254f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_98155476-2d2e-4011-a0ed-30b1a0e2760d" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:to="loc_angn_PreFundedWarrantMember_98155476-2d2e-4011-a0ed-30b1a0e2760d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_cb86f63a-b2ff-4c67-9080-52395e3b5b45" xlink:href="angn-20250930.xsd#angn_June2025WarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:to="loc_angn_June2025WarrantsMember_cb86f63a-b2ff-4c67-9080-52395e3b5b45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e818e43c-f551-4804-9c68-715be11f0556" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e818e43c-f551-4804-9c68-715be11f0556" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e818e43c-f551-4804-9c68-715be11f0556_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e818e43c-f551-4804-9c68-715be11f0556" xlink:to="loc_us-gaap_EquityComponentDomain_e818e43c-f551-4804-9c68-715be11f0556_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d3e9a2d4-ef9d-4df4-96bb-795f3eb5a09e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e818e43c-f551-4804-9c68-715be11f0556" xlink:to="loc_us-gaap_EquityComponentDomain_d3e9a2d4-ef9d-4df4-96bb-795f3eb5a09e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5d6526e0-10c4-44ad-b4ae-80efeb60ac30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d3e9a2d4-ef9d-4df4-96bb-795f3eb5a09e" xlink:to="loc_us-gaap_CommonStockMember_5d6526e0-10c4-44ad-b4ae-80efeb60ac30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_cd118232-3455-413b-a970-da705935b3eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_dei_LegalEntityAxis_cd118232-3455-413b-a970-da705935b3eb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_cd118232-3455-413b-a970-da705935b3eb_default" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_cd118232-3455-413b-a970-da705935b3eb" xlink:to="loc_dei_EntityDomain_cd118232-3455-413b-a970-da705935b3eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_249d1d42-4eb9-4662-8c87-b15ff086827b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_cd118232-3455-413b-a970-da705935b3eb" xlink:to="loc_dei_EntityDomain_249d1d42-4eb9-4662-8c87-b15ff086827b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GKCCMember_a59a7a39-0f1d-4839-aa1e-2063403ad73c" xlink:href="angn-20250930.xsd#angn_GKCCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_249d1d42-4eb9-4662-8c87-b15ff086827b" xlink:to="loc_angn_GKCCMember_a59a7a39-0f1d-4839-aa1e-2063403ad73c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cb1e3840-44fa-4c6f-acee-e57064fedb6e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_srt_RangeAxis_cb1e3840-44fa-4c6f-acee-e57064fedb6e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cb1e3840-44fa-4c6f-acee-e57064fedb6e_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cb1e3840-44fa-4c6f-acee-e57064fedb6e" xlink:to="loc_srt_RangeMember_cb1e3840-44fa-4c6f-acee-e57064fedb6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_22e2c50b-eab8-42e4-a1c7-9c0ab442c99a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cb1e3840-44fa-4c6f-acee-e57064fedb6e" xlink:to="loc_srt_RangeMember_22e2c50b-eab8-42e4-a1c7-9c0ab442c99a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c206e70d-bdac-49df-b0c3-b07084749c20" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_22e2c50b-eab8-42e4-a1c7-9c0ab442c99a" xlink:to="loc_srt_MaximumMember_c206e70d-bdac-49df-b0c3-b07084749c20" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de07daa6-5615-4d7f-bba4-70694e7a8a96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de07daa6-5615-4d7f-bba4-70694e7a8a96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d0f34667-f314-4189-bb08-8b816e817414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d0f34667-f314-4189-bb08-8b816e817414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3981edbc-c673-416c-b880-b6937b02e56c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3981edbc-c673-416c-b880-b6937b02e56c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_a7217f6b-ede2-4821-ae63-8dbe018cab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_InterestExpenseDebt_a7217f6b-ede2-4821-ae63-8dbe018cab4e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6b72172d-f82c-4ed7-826c-bf4a3224cc03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6b72172d-f82c-4ed7-826c-bf4a3224cc03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_b5cb0d87-0be0-4f7e-ab3b-31e22b8875e9" xlink:href="angn-20250930.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_b5cb0d87-0be0-4f7e-ab3b-31e22b8875e9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f1c9ffe-7771-45a7-b58b-4c31d58080d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f1c9ffe-7771-45a7-b58b-4c31d58080d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4e0f976d-2c1f-4829-b092-f4bfa52b2e98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4e0f976d-2c1f-4829-b092-f4bfa52b2e98" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_04b648ab-29c6-4964-b3f7-5ff7e552ce0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_04b648ab-29c6-4964-b3f7-5ff7e552ce0f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_071d587b-9216-49e5-a1eb-0bdf00f6b9a9" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_071d587b-9216-49e5-a1eb-0bdf00f6b9a9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_af045791-4f44-4055-9c01-e0206bfb3790" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_af045791-4f44-4055-9c01-e0206bfb3790" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3db4f1bd-f1da-4daf-b087-55e2696e6d64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3db4f1bd-f1da-4daf-b087-55e2696e6d64" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fa6954c1-9396-494e-a465-daaf02d4a660" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fa6954c1-9396-494e-a465-daaf02d4a660" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_708c5a6e-f56a-48af-920a-bd25e30db1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_708c5a6e-f56a-48af-920a-bd25e30db1c9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_d625d82b-a348-41eb-bc7b-eeb7dcf40bef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_d625d82b-a348-41eb-bc7b-eeb7dcf40bef" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_eee140f9-511e-4024-a741-98fb74fe3066" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_271b6040-b4bd-4490-9e8f-04f9953da203" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_eee140f9-511e-4024-a741-98fb74fe3066" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_271b6040-b4bd-4490-9e8f-04f9953da203" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3e14adb-5567-4585-85d0-e75af51c1c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_271b6040-b4bd-4490-9e8f-04f9953da203" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3e14adb-5567-4585-85d0-e75af51c1c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a3e14adb-5567-4585-85d0-e75af51c1c6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3e14adb-5567-4585-85d0-e75af51c1c6e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a3e14adb-5567-4585-85d0-e75af51c1c6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3e14adb-5567-4585-85d0-e75af51c1c6e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f2372c56-6287-48c2-8dec-13caebfe4766" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f2372c56-6287-48c2-8dec-13caebfe4766" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0bf80361-1062-465d-946f-93b74d44f896" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:to="loc_us-gaap_WarrantMember_0bf80361-1062-465d-946f-93b74d44f896" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a7fc67c4-a282-44cd-91c9-b397e9a94a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_eee140f9-511e-4024-a741-98fb74fe3066" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a7fc67c4-a282-44cd-91c9-b397e9a94a4f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f842496d-cdde-40a0-8beb-eb45980b99ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f842496d-cdde-40a0-8beb-eb45980b99ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f842496d-cdde-40a0-8beb-eb45980b99ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f842496d-cdde-40a0-8beb-eb45980b99ec" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f842496d-cdde-40a0-8beb-eb45980b99ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c8680854-2ccd-45a1-b2c4-a569ec9a3142" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f842496d-cdde-40a0-8beb-eb45980b99ec" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c8680854-2ccd-45a1-b2c4-a569ec9a3142" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember_f4c22c52-1fc9-49c5-b1de-bbe7f479a789" xlink:href="angn-20250930.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c8680854-2ccd-45a1-b2c4-a569ec9a3142" xlink:to="loc_angn_PurchaseOfWarrantsMember_f4c22c52-1fc9-49c5-b1de-bbe7f479a789" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_87eb4fc3-7d20-415d-b140-bf270cb05723" xlink:href="angn-20250930.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:to="loc_angn_MarchSubscriptionAgreementMember_87eb4fc3-7d20-415d-b140-bf270cb05723" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_9b3f4c06-f0e0-41d4-9f94-5be86412c748" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:to="loc_angn_JulyPublicOfferingMember_9b3f4c06-f0e0-41d4-9f94-5be86412c748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_77a8ef82-28b4-4354-9192-056e15468ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_77a8ef82-28b4-4354-9192-056e15468ebd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_77a8ef82-28b4-4354-9192-056e15468ebd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_77a8ef82-28b4-4354-9192-056e15468ebd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_77a8ef82-28b4-4354-9192-056e15468ebd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_77a8ef82-28b4-4354-9192-056e15468ebd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_e8b93baa-8403-4e62-a11f-7e61cf0f775f" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:to="loc_angn_PreFundedWarrantMember_e8b93baa-8403-4e62-a11f-7e61cf0f775f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_6ec1752a-63a4-44e5-8be6-290769f27f92" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_6ec1752a-63a4-44e5-8be6-290769f27f92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_84c8c326-b3d1-4464-92e5-297978ae5862" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_srt_CounterpartyNameAxis_84c8c326-b3d1-4464-92e5-297978ae5862" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_84c8c326-b3d1-4464-92e5-297978ae5862_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_84c8c326-b3d1-4464-92e5-297978ae5862" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_84c8c326-b3d1-4464-92e5-297978ae5862_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_84c8c326-b3d1-4464-92e5-297978ae5862" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember_9acf35a0-6bfe-4430-b873-a44fb348a7b0" xlink:href="angn-20250930.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:to="loc_angn_YekaterinaChudnovskyMember_9acf35a0-6bfe-4430-b873-a44fb348a7b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_08899bea-4b1b-4af8-a5c4-7850009480c2" xlink:href="angn-20250930.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:to="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_08899bea-4b1b-4af8-a5c4-7850009480c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_14cb1fac-cf6c-455a-8482-84eacf269bd5" xlink:href="angn-20250930.xsd#angn_YekaterinaChudnovskyAndJayVenkatesanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:to="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_14cb1fac-cf6c-455a-8482-84eacf269bd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9c25646b-653a-411b-96f2-c83396b67bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_DebtInstrumentAxis_9c25646b-653a-411b-96f2-c83396b67bf3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9c25646b-653a-411b-96f2-c83396b67bf3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c25646b-653a-411b-96f2-c83396b67bf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9c25646b-653a-411b-96f2-c83396b67bf3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_71f14367-4e48-483d-80c9-96ee83893527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c25646b-653a-411b-96f2-c83396b67bf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_71f14367-4e48-483d-80c9-96ee83893527" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b69948e5-0034-41b6-86e1-04e1189bb445" xlink:href="angn-20250930.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_71f14367-4e48-483d-80c9-96ee83893527" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b69948e5-0034-41b6-86e1-04e1189bb445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8afa0553-ef40-422f-882d-c2d15cda8cda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8afa0553-ef40-422f-882d-c2d15cda8cda" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8afa0553-ef40-422f-882d-c2d15cda8cda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8afa0553-ef40-422f-882d-c2d15cda8cda" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8afa0553-ef40-422f-882d-c2d15cda8cda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_675225bd-ac0e-42c4-adde-e13f78902652" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8afa0553-ef40-422f-882d-c2d15cda8cda" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_675225bd-ac0e-42c4-adde-e13f78902652" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_8605fd1a-80f1-4c9c-81c0-1ba969f5a3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_675225bd-ac0e-42c4-adde-e13f78902652" xlink:to="loc_us-gaap_ConvertibleDebtMember_8605fd1a-80f1-4c9c-81c0-1ba969f5a3d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0f083102-ac57-4cb1-8630-c75aafdae5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0f083102-ac57-4cb1-8630-c75aafdae5d0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0f083102-ac57-4cb1-8630-c75aafdae5d0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0f083102-ac57-4cb1-8630-c75aafdae5d0" xlink:to="loc_us-gaap_EquityComponentDomain_0f083102-ac57-4cb1-8630-c75aafdae5d0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e53ee06c-b38e-4957-8786-e6c20ab94bff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0f083102-ac57-4cb1-8630-c75aafdae5d0" xlink:to="loc_us-gaap_EquityComponentDomain_e53ee06c-b38e-4957-8786-e6c20ab94bff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bec63328-0006-47ae-9c68-cc8eacf5aca5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e53ee06c-b38e-4957-8786-e6c20ab94bff" xlink:to="loc_us-gaap_CommonStockMember_bec63328-0006-47ae-9c68-cc8eacf5aca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a356a609-ddd1-4b55-ba74-2b49aa683904" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a356a609-ddd1-4b55-ba74-2b49aa683904" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c4796c31-cb18-4f1c-be79-721a3eefae57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c4796c31-cb18-4f1c-be79-721a3eefae57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_62566691-035f-4d7e-9386-962ca9a09941" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_62566691-035f-4d7e-9386-962ca9a09941" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_dd35ee44-b208-4ce1-a9f4-a39def822218" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_dd35ee44-b208-4ce1-a9f4-a39def822218" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e22d5f3c-66c0-478d-9e1a-b547eb95540a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e22d5f3c-66c0-478d-9e1a-b547eb95540a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_449fc304-9258-470e-89bd-d0f7e0128a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_449fc304-9258-470e-89bd-d0f7e0128a0e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9f07f3d0-856f-4498-bb4f-14f63e3ce632" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9f07f3d0-856f-4498-bb4f-14f63e3ce632" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_1668a2fd-7643-4e39-bc4a-8cecc9d0e302" xlink:href="angn-20250930.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_1668a2fd-7643-4e39-bc4a-8cecc9d0e302" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_92134f6c-807e-4a49-b854-3b8d56f8d40e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_92134f6c-807e-4a49-b854-3b8d56f8d40e" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#SegmentReportingDetails"/>
  <link:definitionLink xlink:role="http://www.angn.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2ddfb9f0-9b09-4168-b10e-5661e7b829a3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:to="loc_srt_ProductOrServiceAxis_2ddfb9f0-9b09-4168-b10e-5661e7b829a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2ddfb9f0-9b09-4168-b10e-5661e7b829a3_default" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_2ddfb9f0-9b09-4168-b10e-5661e7b829a3" xlink:to="loc_srt_ProductsAndServicesDomain_2ddfb9f0-9b09-4168-b10e-5661e7b829a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_2ddfb9f0-9b09-4168-b10e-5661e7b829a3" xlink:to="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember_7046ff49-bc19-4e96-be0d-1601db35613c" xlink:href="angn-20250930.xsd#angn_ClinicalTrailMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_ClinicalTrailMember_7046ff49-bc19-4e96-be0d-1601db35613c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_b2ff9232-d211-4fa1-8b3a-d263a627f975" xlink:href="angn-20250930.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_b2ff9232-d211-4fa1-8b3a-d263a627f975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember_2cea45ba-cb7a-4a83-b646-ab805f792bf1" xlink:href="angn-20250930.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_TranslationalMedicineAndCMCMember_2cea45ba-cb7a-4a83-b646-ab805f792bf1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember_5ed977d6-bc2f-42d0-bba3-5a39eb9b2871" xlink:href="angn-20250930.xsd#angn_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_OtherMember_5ed977d6-bc2f-42d0-bba3-5a39eb9b2871" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b6d1d472-96ed-4b4f-93ce-fb9a3257b764" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b6d1d472-96ed-4b4f-93ce-fb9a3257b764" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6d1d472-96ed-4b4f-93ce-fb9a3257b764_default" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6d1d472-96ed-4b4f-93ce-fb9a3257b764" xlink:to="loc_us-gaap_SegmentDomain_b6d1d472-96ed-4b4f-93ce-fb9a3257b764_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42c460c3-b305-4b8d-8e99-4b565826ddf1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6d1d472-96ed-4b4f-93ce-fb9a3257b764" xlink:to="loc_us-gaap_SegmentDomain_42c460c3-b305-4b8d-8e99-4b565826ddf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember_c7299d85-8f38-4dd6-9c24-81dc023dec58" xlink:href="angn-20250930.xsd#angn_ReportableSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_42c460c3-b305-4b8d-8e99-4b565826ddf1" xlink:to="loc_angn_ReportableSegmentMember_c7299d85-8f38-4dd6-9c24-81dc023dec58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_147ecb33-5313-4123-a4a7-51ea0822da58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_147ecb33-5313-4123-a4a7-51ea0822da58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_8fd5f686-b98c-4d56-b877-0a7c24fc8171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_8fd5f686-b98c-4d56-b877-0a7c24fc8171" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_36f860ad-40ca-4b6a-ab56-b9f13d2100fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_36f860ad-40ca-4b6a-ab56-b9f13d2100fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_d310fb4a-f85b-46ae-9712-cffccc4e599e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_d310fb4a-f85b-46ae-9712-cffccc4e599e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_908e6cc5-82ed-414f-9c0a-451c9d48c7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_908e6cc5-82ed-414f-9c0a-451c9d48c7cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2620aff5-421a-4bd4-892c-9e21a634a005" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_NetIncomeLoss_2620aff5-421a-4bd4-892c-9e21a634a005" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4b29bb34-8ec6-4c4a-8dd4-81fdc0e83a98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_Assets_4b29bb34-8ec6-4c4a-8dd4-81fdc0e83a98" xlink:type="arc" order="6"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>angn-20250930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:46abd97b-e878-4f3c-a24b-01e71dba1284,g:89379ce6-47e2-4598-9348-41e57d269da1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_109a9aa4-7f18-410d-a2cc-d4a7a639db3e_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_709b7f9f-cb34-4886-8d07-6702b84b1b74_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant award</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrant_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementGrant" xlink:to="lab_angn_ResearchAndDevelopmentArrangementGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3a6ae979-9ef8-4cd9-aac9-7cc741a91185_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_b10689fa-bdf7-4533-9bc5-8972874e92e5_terseLabel_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other prepaid expenses and other current assets</link:label>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_label_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:label id="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_documentation_en-US" xlink:label="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Prepaid Expenses And Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:href="angn-20250930.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:to="lab_angn_OtherPrepaidExpensesAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_c198d408-0a27-4a40-9b5b-3add5544df32_terseLabel_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_label_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPreFundedWarrantsMember" xlink:to="lab_angn_JulyPreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_4a016544-a313-4342-ae09-5b428eab1751_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, current</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_8d61d942-0db7-42b2-89be-428537f9eb89_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_aea872c4-c098-4a05-80c0-fd8cce488e9c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025 (remaining three months)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_June2025WarrantsMember_75ef1b1e-3476-4e4f-9332-8798f4c347ac_terseLabel_en-US" xlink:label="lab_angn_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">June 2025 Warrants</link:label>
    <link:label id="lab_angn_June2025WarrantsMember_label_en-US" xlink:label="lab_angn_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">June 2025 Warrants [Member]</link:label>
    <link:label id="lab_angn_June2025WarrantsMember_documentation_en-US" xlink:label="lab_angn_June2025WarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">June 2025 Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember" xlink:href="angn-20250930.xsd#angn_June2025WarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_June2025WarrantsMember" xlink:to="lab_angn_June2025WarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_66d35c1e-4f25-4cf2-914e-cb7e063ac7fe_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_bf199090-9d0e-418d-bf95-70d93a9d97e2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_706c6e24-68bf-49c3-b249-0fd952af28ae_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightRollForward" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_a92f9571-4b56-431b-b547-9f86dc9d7c36_periodStartLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_79e8e61d-7cca-4694-9f3f-3bb60fae7f37_periodEndLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Weighted Average Life</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLife_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant Or Right, Weighted Average Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_652998cb-5801-4617-ac2c-4d0dbcb817bb_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Issued Accounting Standards Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_d282c8f0-f10e-45d3-b277-ef20780672e7_terseLabel_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of research grant agreements</link:label>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_label_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:label id="lab_angn_NumberOfResearchGrantAgreements_documentation_en-US" xlink:label="lab_angn_NumberOfResearchGrantAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Research Grant Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements" xlink:href="angn-20250930.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_NumberOfResearchGrantAgreements" xlink:to="lab_angn_NumberOfResearchGrantAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_7a742b18-62e5-4814-9680-09a4dfe5f149_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_3956abed-fca3-4aad-a81c-68794ed6ec65_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_c97e613e-9942-4b96-bd81-9b9bc9898892_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_346b9ff9-46d6-473f-9aef-ce5ff173db46_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_987ce24d-2eb2-4beb-b3c9-40245978d576_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_16d5de2e-ab1c-4dff-9737-b52c1a5e1940_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_22d4ad4c-063b-43d7-afd5-69892532adc1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_350d6036-495a-4551-8111-9c8741ded579_terseLabel_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase of Warrants</link:label>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_label_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants [Member]</link:label>
    <link:label id="lab_angn_PurchaseOfWarrantsMember_documentation_en-US" xlink:label="lab_angn_PurchaseOfWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember" xlink:href="angn-20250930.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PurchaseOfWarrantsMember" xlink:to="lab_angn_PurchaseOfWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_8cd96874-3bc2-4766-b147-59a451daa248_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_ecc9561d-21bc-42cd-8f6a-f05d3b8f373c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureLineItems_a4cf75d9-d123-4735-a550-ba46d3ab35de_terseLabel_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureLineItems_label_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Line Items]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureLineItems_documentation_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:href="angn-20250930.xsd#angn_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:to="lab_angn_CommitmentsAndContingenciesDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_a7069ce1-f6f3-477a-83de-c15e6f0c5f68_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock, Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_42fd66b4-c719-4245-904d-207e8d22ad23_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_4142cedb-04fd-49e3-b53a-d83908dc6ca1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon settlement of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_ead7d8c9-d0ef-4468-8228-c0b2872d9014_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Area of office space (in square feet)</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_48d6bc5b-865e-4fbd-97a2-b39d9e0f7f8c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a409fc36-8d14-497a-ac93-a11ce7579148_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0b49cea2-430b-44e4-a5ff-b4936b56e398_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_120cc65f-cd96-4b13-ba0a-e5f80ffbea17_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_ac65a21c-a38e-4df9-959b-38043a2d96c0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Professional fees and other general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_OtherGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_OtherGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_35b17f17-41f8-43f9-9968-c370331d1c51_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_d6cc0965-cd16-429a-a876-7d3fbf44cd6b_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_12fe079f-dc1f-4a67-b048-2fa31c373868_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders' equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_eea25793-51e4-4e93-b886-92231dd71c5e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_919a9586-bf50-4c1c-9816-5be4e605d196_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_83359f12-7c9a-4e38-80fb-8e1e004c1a1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_d12ec75a-353f-485e-9039-61f22d21344c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AdvancedProfessionalFees_157be7af-5f3e-46cd-bd62-abf1ab765ea4_terseLabel_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advanced professional fees</link:label>
    <link:label id="lab_angn_AdvancedProfessionalFees_label_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:label id="lab_angn_AdvancedProfessionalFees_documentation_en-US" xlink:label="lab_angn_AdvancedProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Advanced Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees" xlink:href="angn-20250930.xsd#angn_AdvancedProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AdvancedProfessionalFees" xlink:to="lab_angn_AdvancedProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_d7ad6d41-189b-4d91-9244-919681767806_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_1807b230-ea9c-4065-ad25-de006874362a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_f23688d3-89f9-42c4-bed2-162971d9fccc_terseLabel_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Share And July Common Warrant</link:label>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_label_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant [Member]</link:label>
    <link:label id="lab_angn_JulySharesAndJulyCommonWarrantMember_documentation_en-US" xlink:label="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Shares And July Common Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember" xlink:href="angn-20250930.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulySharesAndJulyCommonWarrantMember" xlink:to="lab_angn_JulySharesAndJulyCommonWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_df0ae419-35e0-4c8a-b490-9d173e4bb125_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grants</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research, Development, and Computer Software Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_d7d61783-fdd5-41d8-a603-ac9e75463aa6_terseLabel_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock and warrants from the January Offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_label_en-US" xlink:label="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:to="lab_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_768d232e-6444-43b1-8504-b63daa11c5b9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ecef7f73-6d74-4c22-8637-1a3ab4c8af9a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_d337d3ac-398b-4185-a172-69f4ee160f01_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_2cbbcbd2-023a-4172-bf08-962935fb6a32_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_aaf84c25-5e1a-424e-b205-9ebf10c7efc3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_f0c160c3-0460-47ca-8b33-1453e3bacd0c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value measurements, recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_8e61f7aa-ad7c-454d-b0aa-ef256f1267af_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Stock Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2f01eda1-ad36-4a98-b235-2af00a6fe27e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f0e4ca93-e155-470c-b8b6-b767bc9364c3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_457a89af-ff7b-4e2a-953b-f0beb33c90c1_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_e48914fd-be87-43bf-bd38-e95e6702a61f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_96a7300f-22b5-49f4-bff9-b0fcb137618d_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_54f0f9eb-e2f0-4753-86a8-975a6aab6382_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_09d68bd4-0019-49f6-8bd8-235d65b340c0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_62af8dc7-735f-48ad-a469-63ece2bdd23e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa70c848-4aac-4795-9963-0330ec95991c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_a5f2abc2-286c-417d-a869-518cc3b12312_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_c0cc544e-4fc0-4562-8a85-d1cdd98480fd_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_733ea832-ad4e-4fed-8ab2-bac4e9c46d64_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingAbstract_label_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding [Abstract]</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingAbstract_documentation_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract" xlink:to="lab_angn_WarrantsAndRightsOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_9c582691-8c21-4422-9c4c-cd79ae1f7270_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3bbfbc0b-85a6-4118-aa17-c0a286a9c4ab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_a49526b8-8c07-444d-af86-e404e410d8fa_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f54d56f7-9df6-4b66-bb42-e698a3386ff9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_8c67ac6d-495a-420a-badc-5a1a4970d121_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Sept. 2022</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_e9656ce3-a11d-4020-82ad-4d2482bc59a2_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of property and equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_70070b13-c6d4-4b08-b088-ad5b20c44e14_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders' equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3afc3811-0ed6-423c-8047-fed4912fe8c0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_1ab12966-312d-4a62-85f3-6a84f5e970bd_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant award received</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant Received</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementGrantReceived_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Grant Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:to="lab_angn_ResearchAndDevelopmentArrangementGrantReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_b4de8e46-aeb4-4be9-878d-c784d059f277_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_0cf7e231-8ce2-415e-a1cb-a51a604c35cf_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_4b10cda0-117b-40ab-b179-8544aa0266e2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c5557fb1-b49f-4335-b8f1-5403369803f9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_bbf0be55-51cc-477e-8b84-377272c9d9bd_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: operating lease liability, current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_e7a9c426-bc1e-4797-b428-32e708cde89a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_af1ec65d-a9d4-4be9-9371-d5ef18b108e5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_2283027e-4665-4ee8-ba38-1e99aa1aff99_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyCommonWarrantsMember_e5136651-25dc-4ae1-ba31-0c12812ae61a_terseLabel_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_6dece716-6891-419a-bb78-686071cce023_verboseLabel_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Common Warrants</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyCommonWarrantsMember" xlink:to="lab_angn_JulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_6cd72f30-323e-47a5-9b40-22551d60338a_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_d5981de2-bcd1-4e75-a9d4-df8f99e80eff_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_29d7c4e9-71b4-41bb-b58b-a185e097a9a8_terseLabel_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_label_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:label id="lab_angn_AccruedOtherOperatingLiabilitiesCurrent_documentation_en-US" xlink:label="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Other Operating Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:href="angn-20250930.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:to="lab_angn_AccruedOtherOperatingLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_3f8b6106-04ab-4645-85f7-fbe22b353797_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_ccdecebf-74b9-4df9-9f08-adf4fcfb1815_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_b12d9b82-2972-456a-b0c9-c0967087bfbd_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total segment assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2dcfac7f-1a4f-4916-8c25-a142d876d052_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4b1399d8-2754-4043-9a7b-1dc8f9a9c743_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PurchaseAgreementMember_ae4501d7-dde6-44e7-976f-05e08c0b54f1_terseLabel_en-US" xlink:label="lab_angn_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Agreement</link:label>
    <link:label id="lab_angn_PurchaseAgreementMember_label_en-US" xlink:label="lab_angn_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Agreement [Member]</link:label>
    <link:label id="lab_angn_PurchaseAgreementMember_documentation_en-US" xlink:label="lab_angn_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember" xlink:href="angn-20250930.xsd#angn_PurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PurchaseAgreementMember" xlink:to="lab_angn_PurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_de65dd11-a80a-41b3-a18a-833fb134838c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SettlementOfPromissoryNotesPayable_e9783c7c-b6c9-44a9-8340-1e0ab3faf78b_terseLabel_en-US" xlink:label="lab_angn_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of related-party senior note payable and interest into equity</link:label>
    <link:label id="lab_angn_SettlementOfPromissoryNotesPayable_label_en-US" xlink:label="lab_angn_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Settlement Of Promissory Notes Payable</link:label>
    <link:label id="lab_angn_SettlementOfPromissoryNotesPayable_documentation_en-US" xlink:label="lab_angn_SettlementOfPromissoryNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Settlement Of Promissory Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SettlementOfPromissoryNotesPayable" xlink:href="angn-20250930.xsd#angn_SettlementOfPromissoryNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SettlementOfPromissoryNotesPayable" xlink:to="lab_angn_SettlementOfPromissoryNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f3f57b63-6157-4c40-860b-ec604ba29c5c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_ba75026a-92da-4909-8efe-cf0e2f3b3442_terseLabel_en-US" xlink:label="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_label_en-US" xlink:label="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee&#8203; Operating &#8203;Lease&#8203; Liability&#8203; Payments&#8203; Due&#8203; After&#8203; Year&#8203; Four</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_documentation_en-US" xlink:label="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee&#8203; Operating &#8203;Lease&#8203; Liability&#8203; Payments&#8203; Due&#8203; After&#8203; Year&#8203; Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:href="angn-20250930.xsd#angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:to="lab_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b2fac5d-9f8b-4d58-9b39-64ad8b0ac097_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_f285c4c7-2ccd-48c7-993c-8edad3956930_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac82d3ee-8724-402f-abb7-07950f97bd79_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of foreign currency on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_NewtonMassachusettsMember_8629120f-d645-4735-9406-801b34c23a61_terseLabel_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Newton, Massachusettes</link:label>
    <link:label id="lab_angn_NewtonMassachusettsMember_label_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Newton, Massachusetts [Member]</link:label>
    <link:label id="lab_angn_NewtonMassachusettsMember_documentation_en-US" xlink:label="lab_angn_NewtonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Newton, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember" xlink:href="angn-20250930.xsd#angn_NewtonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_NewtonMassachusettsMember" xlink:to="lab_angn_NewtonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3372f819-37ee-40b7-802e-8f8d7d4fa59b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_de0b6ce7-0190-4ea1-a99f-2456ea7e5d1c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_4e24d2d4-0fd8-456a-bdde-db05d82958cf_terseLabel_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average strike price</link:label>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_label_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price [Member]</link:label>
    <link:label id="lab_angn_MeasurementInputStrikePriceMember_documentation_en-US" xlink:label="lab_angn_MeasurementInputStrikePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Strike Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember" xlink:href="angn-20250930.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_MeasurementInputStrikePriceMember" xlink:to="lab_angn_MeasurementInputStrikePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_596c96a4-4f07-476e-ac1c-92c76d887c9c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_f654894f-497c-4974-b951-e1be24a9f4fd_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GrantRevenuePolicyTextBlock_0367ca8f-7a52-4f3a-a1bc-c2c9c49a5289_terseLabel_en-US" xlink:label="lab_angn_GrantRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant Income</link:label>
    <link:label id="lab_angn_GrantRevenuePolicyTextBlock_label_en-US" xlink:label="lab_angn_GrantRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant Revenue [Policy Text Block]</link:label>
    <link:label id="lab_angn_GrantRevenuePolicyTextBlock_documentation_en-US" xlink:label="lab_angn_GrantRevenuePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grant Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenuePolicyTextBlock" xlink:href="angn-20250930.xsd#angn_GrantRevenuePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GrantRevenuePolicyTextBlock" xlink:to="lab_angn_GrantRevenuePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_65bdae19-a607-46fe-843e-25a579172b82_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_029aec52-1f52-48c1-9bd0-58054f27ac91_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_737d424e-028b-4163-ada8-89bb9f1521ec_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_2ae2d512-81ad-4237-8114-6f4f415da507_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Sept. 2023</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) Sept. 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_d84ce078-0a01-41ba-a727-7802f66b0c3c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_771b0b43-07f4-48fa-a10a-c1473fe6559b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_259cd5d2-369f-449b-b4fa-e55a38f267d3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of equipment</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6faa8c39-1893-4a91-ac12-b169d9b13d4c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_153340ef-1280-4c2e-ba12-bdb3ce7b6db7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_64022940-23d4-440f-9500-75cbc08f9e22_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_79ef4efe-c14d-4124-aece-7d6a82e7f912_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_0fc5419d-4f80-40bd-82ba-393629fca082_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_c54e25bc-6491-4620-85ba-b010d85f8f7e_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on fair value of warrants</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_1f847e6b-0840-4233-9e71-698bc5b57889_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_8d25fc0d-ea62-4cdb-bda2-be7d045506ad_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d9dd26f2-8e2b-4417-85ab-81d0418952f4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of related party convertible note</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_b7d820da-81fd-4f13-9716-1553e2d264d3_verboseLabel_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of pre-funded warrants at issuance date</link:label>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_label_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_FairValueOfPreFundedWarrants_documentation_en-US" xlink:label="lab_angn_FairValueOfPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value of Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfPreFundedWarrants" xlink:href="angn-20250930.xsd#angn_FairValueOfPreFundedWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_FairValueOfPreFundedWarrants" xlink:to="lab_angn_FairValueOfPreFundedWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_e4bffca9-0f80-4cea-b6c8-e7a6f10a7e0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bdee225d-fbb3-4d89-8925-2474061c740e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5b86ca34-36a0-4a4d-bd74-7a53a90539a9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_59feffc6-7266-4246-9b6e-99540b9fc669_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4bf94cf7-f472-4a70-af20-f5b8b4e3c75c_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_419f6f03-7971-49af-b871-9c1e3c33cb44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_57ebce4b-540a-403b-8f4a-125aab4d2a60_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_82771594-84fb-424e-b535-f77e3a47b802_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash at the beginning of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7e9057b1-283c-4ff5-9fab-1490eeda0f46_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash at the end of the period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5447faa0-9cb1-4fd9-a565-a35471bae489_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_06f33137-4876-4f4a-a554-bd0d092da542_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax provision (benefit)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_77f544bb-2f1c-47cf-ae81-89577a5819a7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_a79499c1-0e4d-4132-9dc3-acc8617a2725_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued (in shares)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightIssuedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_e3414e38-f8cc-49fd-81eb-0a85181d21b5_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_5fbe5413-d28c-43b3-9adf-026b13d79ab5_terseLabel_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs</link:label>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_label_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs</link:label>
    <link:label id="lab_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_documentation_en-US" xlink:label="lab_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:href="angn-20250930.xsd#angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:to="lab_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_329dccc7-43d0-4286-91a2-203214a83350_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (per share)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_fface000-909f-4f6b-8523-e9556fdd2141_terseLabel_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_label_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]</link:label>
    <link:label id="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_documentation_en-US" xlink:label="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:href="angn-20250930.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:to="lab_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1a957d3e-14dc-42af-b566-c730c3893f03_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial expenses</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_c9f42968-841a-4982-bce4-74670a0cbb57_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_16363368-0cdc-44a5-8e6e-d168274755f8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_RegistrationStatementMember_6467cc31-d2b5-46ec-b286-06c2427d31e0_terseLabel_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Registration Statement</link:label>
    <link:label id="lab_angn_RegistrationStatementMember_label_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Registration Statement [Member]</link:label>
    <link:label id="lab_angn_RegistrationStatementMember_documentation_en-US" xlink:label="lab_angn_RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember" xlink:href="angn-20250930.xsd#angn_RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_RegistrationStatementMember" xlink:to="lab_angn_RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_4e36e817-6436-4cb1-8c57-0d24026fdc7e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PreFundedWarrantMember_012e62fc-f5ee-4af8-8578-c246ce509bb1_terseLabel_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_2f8fb14f-fc2d-4cda-b4d5-f324bf9daa44_verboseLabel_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_label_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant [Member]</link:label>
    <link:label id="lab_angn_PreFundedWarrantMember_documentation_en-US" xlink:label="lab_angn_PreFundedWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PreFundedWarrantMember" xlink:to="lab_angn_PreFundedWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_fa7c3c34-d120-46fb-aaee-e96291deeb58_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other (expense) income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Income and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract" xlink:to="lab_us-gaap_OtherIncomeAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_b03703c6-ecfe-426d-9233-88635478e94b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets, operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GrantRevenueNonoperating_b0e56db6-94f2-43a4-95e0-c71f89ae7238_terseLabel_en-US" xlink:label="lab_angn_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant income</link:label>
    <link:label id="lab_angn_GrantRevenueNonoperating_label_en-US" xlink:label="lab_angn_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grant Revenue, Nonoperating</link:label>
    <link:label id="lab_angn_GrantRevenueNonoperating_documentation_en-US" xlink:label="lab_angn_GrantRevenueNonoperating" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Grant Revenue, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating" xlink:href="angn-20250930.xsd#angn_GrantRevenueNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GrantRevenueNonoperating" xlink:to="lab_angn_GrantRevenueNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_54914445-d1be-42b0-9d87-8b82ebb79ff3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_0d355fcb-5e44-4d98-a0cd-92e8e2612fd1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c0f81122-8650-4138-b3d7-1ac9eb308bfc_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ff2a3046-5503-4b83-b458-6ebd161f8905_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_9db58ced-0d41-40f8-9419-6cde351049c7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_dc86d16d-8c98-474d-b89d-364efd7d1d20_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Credit</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementCredit_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementCredit" xlink:to="lab_angn_ResearchAndDevelopmentArrangementCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_dd41c4c4-57e2-4c62-ae95-6365d3cba05e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_c605323c-e5c7-4739-a19c-98fe0816b9ac_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_182185e7-bbf8-4311-b903-2d79d4fa4030_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee related general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_RoyaltyRatePercent_b0b93262-086a-4213-8c3a-d9057c28afce_terseLabel_en-US" xlink:label="lab_angn_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty rates (as a percent)</link:label>
    <link:label id="lab_angn_RoyaltyRatePercent_label_en-US" xlink:label="lab_angn_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Rate, Percent</link:label>
    <link:label id="lab_angn_RoyaltyRatePercent_documentation_en-US" xlink:label="lab_angn_RoyaltyRatePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RoyaltyRatePercent" xlink:href="angn-20250930.xsd#angn_RoyaltyRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_RoyaltyRatePercent" xlink:to="lab_angn_RoyaltyRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_42d665a5-5eb9-43cf-889d-f74c1f91a703_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_934e6979-80b3-4696-9a4e-c2c8d893ffc3_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_3944e2a6-4ccd-4c7a-8042-677273e91059_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f677817c-012d-4134-bc84-bfa0c3f582a4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_54382787-c805-4bcc-ad1c-bd682a2a302f_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_FairValueOfCommonStockWarrantsUponSettlement_8eed3123-ea6c-43dc-9608-1bb01bd990d9_terseLabel_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common stock warrants upon settlement</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrantsUponSettlement_label_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants Upon Settlement</link:label>
    <link:label id="lab_angn_FairValueOfCommonStockWarrantsUponSettlement_documentation_en-US" xlink:label="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Stock Warrants Upon Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:href="angn-20250930.xsd#angn_FairValueOfCommonStockWarrantsUponSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:to="lab_angn_FairValueOfCommonStockWarrantsUponSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_b4e1bf12-c7a6-470a-8f69-e25a5582b16f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_cace1d8c-7f80-44b9-8f83-1a33234bf683_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a91f36d7-b128-42c3-8e25-415bb065c000_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_8c585954-3448-4175-816b-61a0867d95ff_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_d617e21c-f9b4-4e5b-af54-393443b1dcda_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_24350f85-f91c-485c-aacb-01cb8ca37b03_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_6feb8691-1f31-4f6a-9bf1-99d29e736db2_terseLabel_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_label_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky [Member]</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyMember_documentation_en-US" xlink:label="lab_angn_YekaterinaChudnovskyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember" xlink:href="angn-20250930.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_YekaterinaChudnovskyMember" xlink:to="lab_angn_YekaterinaChudnovskyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_c471ce0d-f345-4340-bf0c-17382ac10ee6_terseLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of pre-funded warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_3be41750-3de9-4a8d-83ea-c057c4327a8b_negatedTerseLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_eafb505b-0941-48f3-b283-bc60abba187f_negatedLabel_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on issuance of warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_label_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Issuance Of Warrants</link:label>
    <link:label id="lab_angn_GainLossOnIssuanceOfWarrants_documentation_en-US" xlink:label="lab_angn_GainLossOnIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Issuance Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants" xlink:href="angn-20250930.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GainLossOnIssuanceOfWarrants" xlink:to="lab_angn_GainLossOnIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_6e3f2309-529f-47aa-afb2-7656220d71c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_57cf01ae-5e4e-4746-8792-a07e8e757015_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_7d36b89e-91b7-4d32-ac02-781e78331444_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_f7ce40b5-989d-4188-8ad4-7f2c64f4dd11_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantIssuedStockIssuance_1992ef13-14f4-4dc7-abdb-2416df667f38_terseLabel_en-US" xlink:label="lab_angn_WarrantIssuedStockIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants issued with January 2025 Offering</link:label>
    <link:label id="lab_angn_WarrantIssuedStockIssuance_label_en-US" xlink:label="lab_angn_WarrantIssuedStockIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Issued, Stock Issuance</link:label>
    <link:label id="lab_angn_WarrantIssuedStockIssuance_documentation_en-US" xlink:label="lab_angn_WarrantIssuedStockIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Of Common Warrants Issued With January 2025 Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedStockIssuance" xlink:href="angn-20250930.xsd#angn_WarrantIssuedStockIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantIssuedStockIssuance" xlink:to="lab_angn_WarrantIssuedStockIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_9f4aabf4-3a59-4acd-b7e4-9679d2771343_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, contractual term (in years)</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_8f58fa70-23ef-4ea8-a596-37ab87246245_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantExercisedFairValue_375f33ed-a072-42c7-a437-671d70e10cda_terseLabel_en-US" xlink:label="lab_angn_WarrantExercisedFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants at issuance date</link:label>
    <link:label id="lab_angn_WarrantExercisedFairValue_label_en-US" xlink:label="lab_angn_WarrantExercisedFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Exercised, Fair Value</link:label>
    <link:label id="lab_angn_WarrantExercisedFairValue_documentation_en-US" xlink:label="lab_angn_WarrantExercisedFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Exercised, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantExercisedFairValue" xlink:href="angn-20250930.xsd#angn_WarrantExercisedFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantExercisedFairValue" xlink:to="lab_angn_WarrantExercisedFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_57a2d816-1dbd-4606-9278-ad053ad71e77_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dc21f69e-4eb1-47ce-8c4c-9d2f2669a381_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ed225146-fc47-47e2-be42-fae62c49c211_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_d22a7f71-95f0-4253-adaa-c4d3a4176dd1_terseLabel_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reimbursement from grant funds</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_label_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Reimbursement from Grant Funds</link:label>
    <link:label id="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_documentation_en-US" xlink:label="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research And Development Arrangement, Reimbursement from Grant Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:to="lab_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0f9178bf-73c8-493f-a900-e730c6ba43a4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_1b9501aa-2007-42f6-a93f-52d91f61de87_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_d6ebbe8e-fa18-4c9f-b14e-e0e022facf58_terseLabel_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Quantitative Information Regarding Operating Leases</link:label>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases [Table Text Block]</link:label>
    <link:label id="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_documentation_en-US" xlink:label="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule Of Quantitative Information On Operating Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:href="angn-20250930.xsd#angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:to="lab_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_8c2e72ac-7c9e-4cd6-9171-bd2082339b39_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_629c607c-77c2-4be6-a1f5-4a82ebc87ba1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_495a36a7-d46f-4fe6-b706-64b74011aa7a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_59583a97-087a-4054-90b2-53f495c2f49b_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProjectMember_ff0d424a-3470-4d87-9353-c5ee60d2c451_terseLabel_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:label id="lab_us-gaap_ProjectMember_label_en-US" xlink:label="lab_us-gaap_ProjectMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProjectMember" xlink:to="lab_us-gaap_ProjectMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_f94bfd44-8c1f-40a0-b721-dcba1d02272e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseOtherNoncurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense Other, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="lab_us-gaap_PrepaidExpenseOtherNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f61b6396-c9e8-4f0e-83e2-644e0bfe133b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_16215d11-0e94-472a-a00c-53ed8c3b938a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_8b0f0223-e460-49ae-b467-c4c3011945da_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_e4424d71-09ed-48c7-a483-9e72d292c7f0_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_fd15fca9-2cf6-421d-a3b8-ed603dfe3942_terseLabel_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee related research and development expenses</link:label>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_label_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development [Member]</link:label>
    <link:label id="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Related Reasearch and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:href="angn-20250930.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:to="lab_angn_EmployeeRelatedReasearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e77ba775-4e7f-4559-92ce-e6ac8b5930b3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7c9b03b0-b943-4028-9038-5eebc1d3d571_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d627407-d065-4b2d-9b34-46d5e0d70c7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_7d0df3fa-1163-4f42-a397-5ddb5d0ffc02_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_InterestExpenseNoncash_07a6a54a-d741-4c7c-8ea3-200b87e962f6_terseLabel_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_angn_InterestExpenseNoncash_label_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:label id="lab_angn_InterestExpenseNoncash_documentation_en-US" xlink:label="lab_angn_InterestExpenseNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash" xlink:href="angn-20250930.xsd#angn_InterestExpenseNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_InterestExpenseNoncash" xlink:to="lab_angn_InterestExpenseNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0a7f3a13-0725-4e14-bd9c-26ef64a4d3f8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6058c4fa-37bc-4f7f-88d9-62d1caab74a4_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Black-Scholes Option-Pricing Model Following Assumptions</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3b2df553-597b-42a1-ad5c-7120b545325f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_9f03e698-bc2d-49c1-ba17-a239d08fb966_terseLabel_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_label_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding [Text Block]</link:label>
    <link:label id="lab_angn_WarrantsAndRightsOutstandingTextBlock_documentation_en-US" xlink:label="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingTextBlock" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsAndRightsOutstandingTextBlock" xlink:to="lab_angn_WarrantsAndRightsOutstandingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_59cd3859-1ebb-4828-af58-9157fa56ff8e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_eec62a71-6cdc-4da4-a570-4b02ead78df8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_94db893d-4201-409a-bbd8-7f7759612c8b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_00be9708-910d-4169-b7b0-d87daef269fc_terseLabel_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JanuaryCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JanuaryCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember" xlink:href="angn-20250930.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JanuaryCommonWarrantsMember" xlink:to="lab_angn_JanuaryCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_f88bd4d4-efad-4087-a132-f5134efdd6ba_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_d24cd02e-00ef-4884-b6b0-225839f657cd_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Volatility (annual)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2e702738-e380-45e6-a4e9-d7aaa5fb7e98_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_60be3375-e165-4e0b-87c2-768a72aca295_terseLabel_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and grant reimbursements</link:label>
    <link:label id="lab_us-gaap_RecoveryOfDirectCosts_label_en-US" xlink:label="lab_us-gaap_RecoveryOfDirectCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Direct Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecoveryOfDirectCosts" xlink:to="lab_us-gaap_RecoveryOfDirectCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_b3d50447-4c61-473e-b175-7e25f2883a76_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c892478e-1849-4285-8ff0-25dc18c65055_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_efe9eef4-14dc-4eff-9439-77daf785a9a6_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_55e528c7-719d-4402-a75a-cfe8eeef67ad_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CostsExpensedUponTheIssuanceOfWarrants_94c7974a-4a8d-40c2-b92f-b99c77fc8cfe_terseLabel_en-US" xlink:label="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs Expensed Upon The Issuance Of Warrants</link:label>
    <link:label id="lab_angn_CostsExpensedUponTheIssuanceOfWarrants_label_en-US" xlink:label="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs Expensed Upon The Issuance Of Warrants</link:label>
    <link:label id="lab_angn_CostsExpensedUponTheIssuanceOfWarrants_documentation_en-US" xlink:label="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Costs Expensed Upon The Issuance Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:href="angn-20250930.xsd#angn_CostsExpensedUponTheIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:to="lab_angn_CostsExpensedUponTheIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_5a19538f-2ccf-403d-8a09-83aa83b5772b_negatedTerseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercised In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightExercisedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Exercised In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightExercisedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightExercisedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_4cf4672f-3d29-4a1d-b01b-ac41086e71bc_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance, beginning of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_772eeb0f-0d8f-4044-b948-decab6b4beab_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance, end of the period</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AngionWarrantsMember_66f587c2-7e74-44f9-9e2c-a66fe44575b0_terseLabel_en-US" xlink:label="lab_angn_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Angion Warrants</link:label>
    <link:label id="lab_angn_AngionWarrantsMember_label_en-US" xlink:label="lab_angn_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Angion Warrants [Member]</link:label>
    <link:label id="lab_angn_AngionWarrantsMember_documentation_en-US" xlink:label="lab_angn_AngionWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Angion Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionWarrantsMember" xlink:href="angn-20250930.xsd#angn_AngionWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AngionWarrantsMember" xlink:to="lab_angn_AngionWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_615d4851-a8d6-4066-916a-53b5dcf7f5e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_a8134f85-ff4a-4f20-9dde-b882d1923338_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_The2022PlanMember_773b1e7d-f5fd-4976-9f4e-fa6682951170_terseLabel_en-US" xlink:label="lab_angn_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2022 Plan</link:label>
    <link:label id="lab_angn_The2022PlanMember_label_en-US" xlink:label="lab_angn_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2022 Plan [Member]</link:label>
    <link:label id="lab_angn_The2022PlanMember_documentation_en-US" xlink:label="lab_angn_The2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2022 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2022PlanMember" xlink:href="angn-20250930.xsd#angn_The2022PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_The2022PlanMember" xlink:to="lab_angn_The2022PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_47cc8821-5ee1-4ee4-8e1f-4fb28faa4d58_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred research obligation</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_1d215eeb-163b-413f-b8cb-d0a8a1eb87c4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_376b7dd9-c005-4142-9b3e-f85685c6c3ef_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of equity-classified broker warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_93cb8689-b365-4de4-9025-f72ae236dc35_netLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ae2f4d35-1dda-49f3-be9b-eb9819144d42_periodStartLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a96ec5ce-11a8-487f-855f-ce2aabdce446_periodEndLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3fe12142-bc35-4162-80c7-684b4cb58c1f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fedb3727-2243-441c-a095-59a9514b530a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_26c84896-228a-4be5-841c-daa1d05295f7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8d2b2b17-1f34-4a84-96d4-1eada5d4f259_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a932e926-3b6d-44c8-85be-ce0a1a3eea44_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43795193-0d1c-4b7b-8ac7-dfb8b4745611_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_aa2786d1-b87b-40ab-8933-23de152b9605_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_8880ca47-917f-4eb3-b819-fe2484e2dd83_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_5998c5a2-d820-4c96-8d8d-520ed1f782f0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, net of debt discount and debt issuance costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_12f88364-1ac7-4d61-b285-eb02eedcd371_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net carrying value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_d8c710ab-8a80-4a7f-a7a6-b642a35142f7_terseLabel_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_label_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note [Member]</link:label>
    <link:label id="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember_documentation_en-US" xlink:label="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Convertible Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:href="angn-20250930.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:to="lab_angn_SeniorSecuredConvertiblePromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_18b1a9db-e942-48f7-8046-ce9249bbc5f5_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_8cec344f-0719-4d08-85af-68fd5353e173_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_626311c2-90d0-485d-bd0b-7d8453ff7598_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_9c5c2411-7363-43c4-a651-ccf432009491_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Exercise Price [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Rollforward</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentAbstract_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract" xlink:to="lab_us-gaap_ResearchAndDevelopmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember_7602dee8-097a-4ba3-b408-8134dbd97f93_terseLabel_en-US" xlink:label="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky And Jay Venkatesan</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember_label_en-US" xlink:label="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky And Jay Venkatesan [Member]</link:label>
    <link:label id="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember_documentation_en-US" xlink:label="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Yekaterina Chudnovsky And Jay Venkatesan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:href="angn-20250930.xsd#angn_YekaterinaChudnovskyAndJayVenkatesanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:to="lab_angn_YekaterinaChudnovskyAndJayVenkatesanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_932a6307-571e-42fa-81e7-fc8c6540d71c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_6ac1875c-65cc-4792-9029-c32d25e13947_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_98018224-5d33-423b-b75d-a543935924e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_9a1b4de8-e880-4f16-af93-2c3132fce13b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_9cac7757-b233-4bb2-8ce8-f7c502348fda_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f3854449-3501-42e0-830e-27d028207a5f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable into common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_44a12378-cc28-4b92-9833-2173410362cd_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty expense</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantLiability_8f516871-0bed-468e-a9d8-330faf855519_terseLabel_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_angn_WarrantLiability_label_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_angn_WarrantLiability_documentation_en-US" xlink:label="lab_angn_WarrantLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability" xlink:href="angn-20250930.xsd#angn_WarrantLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantLiability" xlink:to="lab_angn_WarrantLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_17f2b392-7569-4713-a141-f4c41c7d9436_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_dc8576e4-2b58-41e5-8fa6-2b8f27e1bd24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other long-term prepaid assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_88accd15-e9bf-494f-ad5b-5556771acd9c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the exercise of common warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_Inducement2024PlanMember_3b64ccf2-8ab8-481d-94ad-8ce39a1224da_terseLabel_en-US" xlink:label="lab_angn_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan</link:label>
    <link:label id="lab_angn_Inducement2024PlanMember_label_en-US" xlink:label="lab_angn_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan [Member]</link:label>
    <link:label id="lab_angn_Inducement2024PlanMember_documentation_en-US" xlink:label="lab_angn_Inducement2024PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inducement 2024 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_Inducement2024PlanMember" xlink:href="angn-20250930.xsd#angn_Inducement2024PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_Inducement2024PlanMember" xlink:to="lab_angn_Inducement2024PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPublicOfferingMember_825c8d79-e6a3-4cda-8af3-f7b515c6b58a_terseLabel_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Public Offering</link:label>
    <link:label id="lab_angn_JulyPublicOfferingMember_93262546-59fc-4904-b848-1c69a7a91c41_verboseLabel_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">July 2024 Public Offering</link:label>
    <link:label id="lab_angn_JulyPublicOfferingMember_label_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Public Offering [Member]</link:label>
    <link:label id="lab_angn_JulyPublicOfferingMember_documentation_en-US" xlink:label="lab_angn_JulyPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPublicOfferingMember" xlink:to="lab_angn_JulyPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_f1eda4ca-07c1-44f0-8473-185799e853a8_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_29a918ac-67cc-400c-a580-eba09f5a9963_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_807eceec-d1c9-4765-98e0-75f4c166632b_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_a8fe5e1e-d359-4efc-8aea-a9c4a432b16d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_45c70a95-d5dd-458a-9946-3fe1bbfacdd5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_feece452-ae8e-4d37-b061-9fc0f7cf286b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_ff922ae3-b43f-4714-adfe-17e110354102_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_2896108d-9961-40e4-8f7b-c7414dd3b407_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for future grants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantLiabilityMember_6aff91c5-d5e3-47a1-802d-aee672590dbf_terseLabel_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:label id="lab_angn_WarrantLiabilityMember_label_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Liability [Member]</link:label>
    <link:label id="lab_angn_WarrantLiabilityMember_documentation_en-US" xlink:label="lab_angn_WarrantLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember" xlink:href="angn-20250930.xsd#angn_WarrantLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantLiabilityMember" xlink:to="lab_angn_WarrantLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantIssuedDebtIssuance_83fb06e1-a91c-420b-ba73-3c44a9317147_terseLabel_en-US" xlink:label="lab_angn_WarrantIssuedDebtIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of common warrants issued with June 2025 Promissory Note</link:label>
    <link:label id="lab_angn_WarrantIssuedDebtIssuance_label_en-US" xlink:label="lab_angn_WarrantIssuedDebtIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Issued, Debt Issuance</link:label>
    <link:label id="lab_angn_WarrantIssuedDebtIssuance_documentation_en-US" xlink:label="lab_angn_WarrantIssuedDebtIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Issued, Debt Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedDebtIssuance" xlink:href="angn-20250930.xsd#angn_WarrantIssuedDebtIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantIssuedDebtIssuance" xlink:to="lab_angn_WarrantIssuedDebtIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_8ebf08dd-2b4b-4d87-983b-883f0ddc8c5e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_90caec6c-94b3-4868-9a17-991120e779d9_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock split, conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d8d85c04-b985-472a-a134-6cda3578e663_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_235145c5-8710-4872-9dc3-7ca5645dcc47_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from secured lines of credit</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSecuredLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Secured Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromSecuredLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_b32de40c-a84e-4725-98a2-dfe7bc4710b7_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4b5f2cf2-3d07-4039-9f6e-8959e2ee62cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options outstanding, total intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_d8a91872-4318-46f8-ab3b-16252df81f7c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_a4b0e660-005f-4814-9039-fda9b73469a6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_A2024RegistrationStatementMember_c8ee1ab2-90a4-4742-9bef-f08da97d0bf8_terseLabel_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:label id="lab_angn_A2024RegistrationStatementMember_label_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Registration Statement [Member]</link:label>
    <link:label id="lab_angn_A2024RegistrationStatementMember_documentation_en-US" xlink:label="lab_angn_A2024RegistrationStatementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember" xlink:href="angn-20250930.xsd#angn_A2024RegistrationStatementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_A2024RegistrationStatementMember" xlink:to="lab_angn_A2024RegistrationStatementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_e4d3698e-be32-4da4-9f6f-4fd541fbd588_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81e50a16-6994-4089-b85b-9018135585fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_27725c03-39a1-4409-af8d-78196d437550_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_78501416-4ba3-4877-a3e5-ff8585180a82_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ReportableSegmentMember_1b527479-61ba-43a6-b99d-e58e904b92c0_terseLabel_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:label id="lab_angn_ReportableSegmentMember_label_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reportable Segment [Member]</link:label>
    <link:label id="lab_angn_ReportableSegmentMember_documentation_en-US" xlink:label="lab_angn_ReportableSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Reportable Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember" xlink:href="angn-20250930.xsd#angn_ReportableSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ReportableSegmentMember" xlink:to="lab_angn_ReportableSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_1ab6cef7-2b55-4cd8-bc22-313fc75ea0b7_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_09147d11-1c1c-40c1-bd30-c402375421fb_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_0d82a1f3-5073-4fc2-9ae6-b4c1059f8fe2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_78cdcf9e-b124-4cf1-87e7-f14031b8171b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureTable_9946b87e-bec8-4d61-8493-2838c7d6566d_terseLabel_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureTable_label_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Table]</link:label>
    <link:label id="lab_angn_CommitmentsAndContingenciesDisclosureTable_documentation_en-US" xlink:label="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureTable" xlink:href="angn-20250930.xsd#angn_CommitmentsAndContingenciesDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable" xlink:to="lab_angn_CommitmentsAndContingenciesDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9819bd24-832a-4a55-a2b8-6066e0ccd104_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_b12eecae-ad7f-4a38-a5a2-68cdd50ca238_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_0782e2bc-a1f8-4e06-8854-f069079f705c_terseLabel_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chemistry, manufacturing and controls expenses</link:label>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_label_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC [Member]</link:label>
    <link:label id="lab_angn_TranslationalMedicineAndCMCMember_documentation_en-US" xlink:label="lab_angn_TranslationalMedicineAndCMCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Translational Medicine and CMC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember" xlink:href="angn-20250930.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_TranslationalMedicineAndCMCMember" xlink:to="lab_angn_TranslationalMedicineAndCMCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0a14b108-2614-43b5-90a3-58a86ec95ba0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_f9f8b9e1-78c3-4c67-a928-818c049e912f_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_VestingOfRestrictedCommonStock_d364c87d-be6f-4d38-9753-cb350f648502_terseLabel_en-US" xlink:label="lab_angn_VestingOfRestrictedCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting of restricted common stock</link:label>
    <link:label id="lab_angn_VestingOfRestrictedCommonStock_label_en-US" xlink:label="lab_angn_VestingOfRestrictedCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting of Restricted Common Stock</link:label>
    <link:label id="lab_angn_VestingOfRestrictedCommonStock_documentation_en-US" xlink:label="lab_angn_VestingOfRestrictedCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting of Restricted Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_VestingOfRestrictedCommonStock" xlink:href="angn-20250930.xsd#angn_VestingOfRestrictedCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_VestingOfRestrictedCommonStock" xlink:to="lab_angn_VestingOfRestrictedCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4f16ebdc-8f60-4885-a07d-1aea387d2fc1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable into common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f3bc99e7-530a-4d4a-937b-0d27d4f080d0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d4b2e5eb-130b-4948-984c-1b8f3288f4c2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_0004e8ba-350e-4fa8-8eaf-9fe17c452e02_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Life (years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Life [Roll Forward]</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_2180542e-9bd3-45ed-bbec-76e3ad949f36_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a3b5f5c7-c8ce-41bc-8412-4329ef2b8c2b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_5294e9cf-2698-4a40-a820-031f65c91f97_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_UniversityMember_84e97ed3-1a30-4d3e-9de1-e53d7cb427e4_terseLabel_en-US" xlink:label="lab_angn_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">University</link:label>
    <link:label id="lab_angn_UniversityMember_label_en-US" xlink:label="lab_angn_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">University [Member]</link:label>
    <link:label id="lab_angn_UniversityMember_documentation_en-US" xlink:label="lab_angn_UniversityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">University</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_UniversityMember" xlink:href="angn-20250930.xsd#angn_UniversityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_UniversityMember" xlink:to="lab_angn_UniversityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_014d2ee8-58ff-46d2-80bc-19d7ee901fec_terseLabel_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March Subscription Agreement</link:label>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_label_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March Subscription Agreement [Member]</link:label>
    <link:label id="lab_angn_MarchSubscriptionAgreementMember_documentation_en-US" xlink:label="lab_angn_MarchSubscriptionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March Subscription Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember" xlink:href="angn-20250930.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_MarchSubscriptionAgreementMember" xlink:to="lab_angn_MarchSubscriptionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_81bdaa6f-8d58-4ae1-84e4-381ba563b0d3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_23b06379-bb43-4a65-b140-2106bdc17fc5_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_a4886a9a-d915-4018-a402-939e342d3b7e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_db929811-4d27-4138-a90f-470f2d47c424_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_822a2578-7033-42db-8e98-dfe17cd1eed6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_dca5ca03-55fb-4242-9930-a704bbb0c2ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_7f36bb72-6a38-45cf-bf8e-4042adbb43c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_ee8d6317-b3be-4831-b49f-614d09f4214b_terseLabel_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate initial offering price</link:label>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_label_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:label id="lab_angn_SaleOfStockAggregateInitialOfferingPrice_documentation_en-US" xlink:label="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Initial Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:href="angn-20250930.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:to="lab_angn_SaleOfStockAggregateInitialOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_4b0a5bfc-7351-44ea-860c-73b354283498_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.01 par value per share; 300,000,000 shares authorized; 17,273,107 shares and 11,043,837 shares issued at September&#160;30, 2025 and December&#160;31, 2024, respectively; 17,258,652 and 11,029,382 outstanding as of September&#160;30, 2025 and December&#160;31, 2024, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_bfaef94b-e4a4-47b8-9c5a-50b14fa83885_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_caee8b22-e6cd-43e7-866e-eb8afe998163_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_The2021PlanMember_e50f7b47-e35f-41f5-bdea-927f659765ff_terseLabel_en-US" xlink:label="lab_angn_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The 2021 Plan</link:label>
    <link:label id="lab_angn_The2021PlanMember_label_en-US" xlink:label="lab_angn_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The 2021 Plan [Member]</link:label>
    <link:label id="lab_angn_The2021PlanMember_documentation_en-US" xlink:label="lab_angn_The2021PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The 2021 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2021PlanMember" xlink:href="angn-20250930.xsd#angn_The2021PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_The2021PlanMember" xlink:to="lab_angn_The2021PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_f1431270-eb50-4760-b74e-fb0e90981133_terseLabel_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid research and development contract services</link:label>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_label_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:label id="lab_angn_PrepaidResearchAndDevelopmentExpenses_documentation_en-US" xlink:label="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Research And Development Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses" xlink:href="angn-20250930.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PrepaidResearchAndDevelopmentExpenses" xlink:to="lab_angn_PrepaidResearchAndDevelopmentExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_99932ace-9d1b-4f0a-b16f-d106869c0c8d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f60a629d-02c5-4122-905d-12bb0dac0c0a_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average of common shares and pre-funded warrants outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_0692a786-cdae-4e68-8027-b6602f611d21_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies - Note 9</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_4d06f53a-7350-4c40-988a-f2a46e56b305_terseLabel_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research Grant Agreement with GIRF Aug. 2024</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_label_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024 [Member]</link:label>
    <link:label id="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_documentation_en-US" xlink:label="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research Grant Agreement With The Gastro-Intestinal Research Foundation (&#8220;GIRF&#8221;) August 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:to="lab_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c7f6e54f-e5af-4476-be7e-04f5e60f3a33_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_186cd0fb-0c5a-4044-8c0d-52d94d64cd97_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AngionCommonStockMember_3d77b1e3-98c9-4135-ac31-2acaefe26889_terseLabel_en-US" xlink:label="lab_angn_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Angion Common Stock</link:label>
    <link:label id="lab_angn_AngionCommonStockMember_label_en-US" xlink:label="lab_angn_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Angion Common Stock [Member]</link:label>
    <link:label id="lab_angn_AngionCommonStockMember_documentation_en-US" xlink:label="lab_angn_AngionCommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Angion Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionCommonStockMember" xlink:href="angn-20250930.xsd#angn_AngionCommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AngionCommonStockMember" xlink:to="lab_angn_AngionCommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_ef17fde9-ecfa-4c5d-b4d2-ceb736f698f2_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_7c2541bf-20e3-492a-8f5e-a0630894b910_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_5e37366a-1288-49b2-8893-1fd007917d83_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Project [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:to="lab_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_80855464-960a-4f2b-8f23-0de4eaf51353_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b60ffaf2-3ecc-4732-9d00-d715fd73a698_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e4c4d8ae-9cf6-4a3e-9221-af32c00ae6c0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_a6d789c1-7434-4fa2-9064-1ed5774895a4_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_7b3b43fa-acbb-4f28-ab76-76c1e9811b21_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable, weighted average remaining contractual life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5ddba476-00f8-42d8-a624-2fcb9413a421_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_a7ac0c94-9233-41b1-8622-d66c7f5546f8_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_5879e243-599c-497e-ab38-915e32bebeb4_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other expense related to accretion of discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketOfferingMember_fe4e59a7-203c-4030-8179-5b814d8caf88_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:label id="lab_angn_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_angn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-the-Market Offering [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_angn_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-the-Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember" xlink:href="angn-20250930.xsd#angn_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketOfferingMember" xlink:to="lab_angn_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_a8256c61-f7a5-4ded-ad75-11e6dd75bc4e_terseLabel_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_label_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants [Member]</link:label>
    <link:label id="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July Pre-Funded Warrants and July Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:to="lab_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_bb7d0b58-0407-4c6f-ab62-0e95c110eee5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_fcec141b-2a23-4b88-831b-7e65821d6761_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_f1dab83d-3e23-4057-a5da-9b7a4d4ac81d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_7cc5136f-923a-485c-b014-d2ea05a1263c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_fd12511c-e8fb-4942-9a70-07ce81878c70_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_6eab76bb-b6ca-4db7-9d02-ff0994a18309_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_ff28f017-2931-484a-afc2-6bb6f0b09758_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_3aebdac0-dc90-4f92-97be-4641de2b653d_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_641ace81-e219-4735-a7cd-d5523f49ecbe_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8fa68901-a34d-4e0c-8a68-cefb17317a76_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_2592c714-cb75-4cd2-95d4-680e8fcd1655_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_42440e63-c796-4934-94d9-2eeb850d545f_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of cash and cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_e313092c-c66f-409d-9bf9-4a53e0cae4c3_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Remaining Contractual Life (years)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_8f7a3dd7-4da2-48d5-a4e0-fd0bfd46e236_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_January2025CommonWarrantsMember_6301e29e-1906-4596-ba4c-6a381e1ef0ad_terseLabel_en-US" xlink:label="lab_angn_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants</link:label>
    <link:label id="lab_angn_January2025CommonWarrantsMember_label_en-US" xlink:label="lab_angn_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants [Member]</link:label>
    <link:label id="lab_angn_January2025CommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_January2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January 2025 Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember" xlink:href="angn-20250930.xsd#angn_January2025CommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_January2025CommonWarrantsMember" xlink:to="lab_angn_January2025CommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_PaymentOfWarrantIssuanceCosts_e5074323-bfaa-4a8e-ac5c-82b18258be9b_negatedTerseLabel_en-US" xlink:label="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of warrant issuance costs</link:label>
    <link:label id="lab_angn_PaymentOfWarrantIssuanceCosts_label_en-US" xlink:label="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment Of Warrant Issuance Costs</link:label>
    <link:label id="lab_angn_PaymentOfWarrantIssuanceCosts_documentation_en-US" xlink:label="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payment Of Warrant Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PaymentOfWarrantIssuanceCosts" xlink:href="angn-20250930.xsd#angn_PaymentOfWarrantIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_PaymentOfWarrantIssuanceCosts" xlink:to="lab_angn_PaymentOfWarrantIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_ee868415-f90b-4987-96a2-62e991de9d87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_2b8ecc69-19e1-495b-9d95-f4f580109448_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from the June 2025 Promissory Note, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ConversionOfConvertiblePreferredStockMember_c82ec27a-562f-4167-affe-1ae21f4f9b34_terseLabel_en-US" xlink:label="lab_angn_ConversionOfConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Preferred Stock</link:label>
    <link:label id="lab_angn_ConversionOfConvertiblePreferredStockMember_label_en-US" xlink:label="lab_angn_ConversionOfConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_angn_ConversionOfConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_angn_ConversionOfConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertiblePreferredStockMember" xlink:href="angn-20250930.xsd#angn_ConversionOfConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ConversionOfConvertiblePreferredStockMember" xlink:to="lab_angn_ConversionOfConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d9295b95-cc1b-4453-8b4d-0cb042dc9af4_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_4495d737-ea31-4624-8862-28b18335945e_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued (in dollars per share)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:to="lab_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_eca30e12-a005-4818-b785-918c9d569a77_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option Activity, Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3515a0d0-73a6-4e3d-b2ae-6d3f4cb9411e_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_14284531-57e0-4683-91ac-1e258b316d08_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_b1090bb8-3644-4bd9-b5df-5c49b22f14bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9e017320-02b2-4698-8fef-74bac0b0a000_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_ce82c8e0-1244-4fea-95f2-46999a686e88_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_81aef0ff-ac2d-4813-9ddb-264f781986b2_terseLabel_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_label_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:label id="lab_angn_WarrantsFairValueDisclosure_documentation_en-US" xlink:label="lab_angn_WarrantsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure" xlink:href="angn-20250930.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_WarrantsFairValueDisclosure" xlink:to="lab_angn_WarrantsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_2311f99e-87da-4159-8477-08672ad717c7_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign exchange transaction (loss) gain</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d4c17f91-c333-4f33-ab96-f183d20c7af0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_47254261-d893-42d8-b2f6-1394a0b881c6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss per common share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_af2b5e50-ed5e-4517-be67-9b8dfd977852_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_a500c579-090c-4217-bd61-9da7770402e4_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_38271f7b-fc93-4a4c-9a57-6dde467ea2f7_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_f38ac0a6-9598-469a-9f66-dda77ebba6b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidInsurance_527eaa78-2ff1-45ff-a128-1ea5f0d7805b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid insurance</link:label>
    <link:label id="lab_us-gaap_PrepaidInsurance_label_en-US" xlink:label="lab_us-gaap_PrepaidInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidInsurance" xlink:to="lab_us-gaap_PrepaidInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_4e5db3c6-7797-4560-9d80-11658765c19c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ElicioWarrantsMember_19b08882-a551-4cf7-aa2e-0b29c7643ab4_terseLabel_en-US" xlink:label="lab_angn_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elicio Warrants</link:label>
    <link:label id="lab_angn_ElicioWarrantsMember_label_en-US" xlink:label="lab_angn_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Elicio Warrants [Member]</link:label>
    <link:label id="lab_angn_ElicioWarrantsMember_documentation_en-US" xlink:label="lab_angn_ElicioWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Elicio Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ElicioWarrantsMember" xlink:href="angn-20250930.xsd#angn_ElicioWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ElicioWarrantsMember" xlink:to="lab_angn_ElicioWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_51a19507-b658-439d-8699-fb816b53aac4_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares sold in offering (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_GKCCMember_804f56f0-399a-4463-abf8-a8d4bd06a535_terseLabel_en-US" xlink:label="lab_angn_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GKCC</link:label>
    <link:label id="lab_angn_GKCCMember_label_en-US" xlink:label="lab_angn_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">GKCC [Member]</link:label>
    <link:label id="lab_angn_GKCCMember_documentation_en-US" xlink:label="lab_angn_GKCCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">GKCC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GKCCMember" xlink:href="angn-20250930.xsd#angn_GKCCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_GKCCMember" xlink:to="lab_angn_GKCCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_03cc1fc3-42e0-49e3-afb7-6c31f7073b8a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_6ca610bd-d367-4d83-a3b2-5304469c9d04_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_b4f9a7b6-f99f-4484-acf8-93ebd445d515_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_09536a97-645a-4469-ae5f-97b23c90b769_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_March2024PreFundedWarrantsMember_bb3a671d-fb47-4d1d-b59c-405a6ca3eff7_terseLabel_en-US" xlink:label="lab_angn_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants</link:label>
    <link:label id="lab_angn_March2024PreFundedWarrantsMember_label_en-US" xlink:label="lab_angn_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_angn_March2024PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_angn_March2024PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">March 2024 Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember" xlink:href="angn-20250930.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_March2024PreFundedWarrantsMember" xlink:to="lab_angn_March2024PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_09220199-0942-49c4-9f28-92e47b38989b_terseLabel_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, beneficial ownership limitation, percentage</link:label>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_label_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:label id="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_documentation_en-US" xlink:label="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale Of Stock, Beneficial Ownership Limitation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:href="angn-20250930.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:to="lab_angn_SaleOfStockBeneficialOwnershipLimitationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f1a429dc-5657-4724-89f2-abf5bf3e2de1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_118701dd-7524-4f00-a564-c4c093f21733_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred research obligation</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_bacebf62-ae59-45e5-bcdd-c10bc09fd696_terseLabel_en-US" xlink:label="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate sales milestone payments per product</link:label>
    <link:label id="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_label_en-US" xlink:label="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:label id="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_documentation_en-US" xlink:label="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:href="angn-20250930.xsd#angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:to="lab_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0c12bca4-1a21-4ca4-924d-d7501151ac26_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less present value discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ba1d706f-718a-4f1a-92c6-4d00f688bf9e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_0290de6b-be1a-4f0b-8eb8-80c1bece1164_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0094d72c-a8c7-4d18-b000-1abd86860daa_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_383a82b1-ec50-4f3c-8eb4-ef6689aaeaff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_19d6d09a-54d1-44dd-bd64-7bf9258f3583_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_36f5c9d5-cb10-4b7d-8772-1ea2818b5968_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_0d038b28-e496-47eb-9b9d-bd7887737605_terseLabel_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">January 2025 Public Offering</link:label>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_label_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">January Public Offering [Member]</link:label>
    <link:label id="lab_angn_JanuaryPublicOfferingMember_documentation_en-US" xlink:label="lab_angn_JanuaryPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">January Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember" xlink:href="angn-20250930.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_JanuaryPublicOfferingMember" xlink:to="lab_angn_JanuaryPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClinicalTrailMember_414b2c9a-2632-4213-9c85-9aeccb283092_terseLabel_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Clinical trial expenses</link:label>
    <link:label id="lab_angn_ClinicalTrailMember_label_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Clinical Trail [Member]</link:label>
    <link:label id="lab_angn_ClinicalTrailMember_documentation_en-US" xlink:label="lab_angn_ClinicalTrailMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Clinical Trail</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember" xlink:href="angn-20250930.xsd#angn_ClinicalTrailMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClinicalTrailMember" xlink:to="lab_angn_ClinicalTrailMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e0cf9ae6-8144-4930-8381-90da45533a13_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_898abcce-2e25-4025-9dbb-04e786c4ef46_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_5d219249-1bfd-40c7-8cff-7378ed4759de_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts_cb175f1d-93d4-4056-b26b-da4d78bcd1f1_terseLabel_en-US" xlink:label="lab_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accretion of convertible notes discount from issuance costs</link:label>
    <link:label id="lab_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts_label_en-US" xlink:label="lab_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accretion Of Convertible Notes Discount From Issuance Costs</link:label>
    <link:label id="lab_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts_documentation_en-US" xlink:label="lab_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accretion Of Convertible Notes Discount From Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts" xlink:href="angn-20250930.xsd#angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts" xlink:to="lab_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_f35ce27b-6854-47d5-afab-2137ead7d6df_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1ae3ba7f-1672-49d6-8e6a-82b420658486_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_ff11a07b-05fc-4edb-bf07-c8aeadc54442_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_4f2e2d2a-ef32-47d8-96eb-1817ea78c71b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_3f0ae958-418b-4bea-9433-07558673f159_terseLabel_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share of shares issued (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharesIssuedPricePerShare_label_en-US" xlink:label="lab_us-gaap_SharesIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssuedPricePerShare" xlink:to="lab_us-gaap_SharesIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_95ba3a05-3ada-4be5-978b-45f72c479c86_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_IncreaseDecreaseInAccruedExpenses_4883871e-328c-4289-8e33-6e2967023856_terseLabel_en-US" xlink:label="lab_angn_IncreaseDecreaseInAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_angn_IncreaseDecreaseInAccruedExpenses_label_en-US" xlink:label="lab_angn_IncreaseDecreaseInAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Expenses</link:label>
    <link:label id="lab_angn_IncreaseDecreaseInAccruedExpenses_documentation_en-US" xlink:label="lab_angn_IncreaseDecreaseInAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_IncreaseDecreaseInAccruedExpenses" xlink:href="angn-20250930.xsd#angn_IncreaseDecreaseInAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_IncreaseDecreaseInAccruedExpenses" xlink:to="lab_angn_IncreaseDecreaseInAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_2a269488-277d-45a6-85f1-a8604d03cac8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_ef3d4431-a740-4879-8dbe-d2fab5ccba3b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_c954b093-a365-4f00-8708-c95fdd97987c_terseLabel_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ownership maximum (as a percent)</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_label_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Ownership Percent Maximum</link:label>
    <link:label id="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_documentation_en-US" xlink:label="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Ownership Percent Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:to="lab_angn_ClassOfWarrantOrRightOwnershipPercentMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7c53be08-6b2f-45bf-98a9-acbf1fa32e1d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b6a74311-6813-4e11-a0e7-5598a1c6dbf6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8c723235-8517-4751-8061-0ca870a101af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on disposal of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_e2354d9e-b1a4-4f57-946a-e661f02da821_terseLabel_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued research and development</link:label>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_label_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:label id="lab_angn_AccruedResearchAndDevelopmentCurrent_documentation_en-US" xlink:label="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Research And Development, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent" xlink:href="angn-20250930.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedResearchAndDevelopmentCurrent" xlink:to="lab_angn_AccruedResearchAndDevelopmentCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_d23906a0-1eb6-4cf1-a5c4-7186fdda2895_terseLabel_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_label_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:label id="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock_documentation_en-US" xlink:label="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Interest Premium For Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:href="angn-20250930.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:to="lab_angn_AccruedInterestPremiumForConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a5e19689-10ca-48b7-9b0c-d70bda8ce2d5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_dd350c99-204b-40cd-b0e6-bb4f87fc8bd4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_fa926604-93f0-4ba4-874e-76d1023b8076_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_June2025CommonWarrantsMember_9496d638-e12b-4579-9ea2-364f92d83451_terseLabel_en-US" xlink:label="lab_angn_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants</link:label>
    <link:label id="lab_angn_June2025CommonWarrantsMember_label_en-US" xlink:label="lab_angn_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants [Member]</link:label>
    <link:label id="lab_angn_June2025CommonWarrantsMember_documentation_en-US" xlink:label="lab_angn_June2025CommonWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">June 2025 Common Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025CommonWarrantsMember" xlink:href="angn-20250930.xsd#angn_June2025CommonWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_June2025CommonWarrantsMember" xlink:to="lab_angn_June2025CommonWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4fb87588-6a58-461a-bb2f-9b25063c946a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term in years (for employees)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_42afd099-aca2-42eb-9b27-dc5685a81845_terseLabel_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, payment per year</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_label_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Rent Expense</link:label>
    <link:label id="lab_angn_LesseeOperatingLeaseAnnualRentExpense_documentation_en-US" xlink:label="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Annual Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:href="angn-20250930.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:to="lab_angn_LesseeOperatingLeaseAnnualRentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_811dfe13-e49f-43cb-8c10-8abdb250ba45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_2dcc30b7-89e2-43a4-a4a0-9c8306d556e3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4bf3e5ec-b156-4854-ae50-6a9915d93d5c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_cc4b485d-c5d4-4631-8cf1-3ba8a7a219f9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_OtherMember_283a66eb-d9f2-4a74-8d6e-34dc1eda3dc6_terseLabel_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other research and development expenses</link:label>
    <link:label id="lab_angn_OtherMember_label_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_angn_OtherMember_documentation_en-US" xlink:label="lab_angn_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember" xlink:href="angn-20250930.xsd#angn_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_OtherMember" xlink:to="lab_angn_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_4eb22d21-0670-4a28-b94d-3611a55b3350_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common warrants associated with June 2025 Promissory Note</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_e6664cc8-f6b1-40d9-8248-7492aaaaf22d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_320d32a0-91bf-486a-8c89-98541aa79a93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_cddcc057-4df8-4e57-a40c-6e2325a9641c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Description of the Business and Financial Condition</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a6890893-babe-41cc-aeae-236baa151f20_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_47cba96d-e41f-4ffa-9f2f-1c4caebc7d85_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_27e50d74-b153-4a4e-a51f-24c4c75c1bc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_d0265863-2c8a-4d51-ad30-9f905bdb4734_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_c0d7168a-b366-4e68-903c-3371177e98ce_verboseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_40b0d1a4-afee-4388-afe2-e6c397420ad4_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_b359b82f-74ae-49e2-bb63-258f69884361_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares authorized for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_86f91aac-b3a5-47db-8052-1edad1dcfb61_terseLabel_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Convertible Debt</link:label>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_label_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt [Member]</link:label>
    <link:label id="lab_angn_ConversionOfConvertibleDebtMember_documentation_en-US" xlink:label="lab_angn_ConversionOfConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Conversion Of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember" xlink:href="angn-20250930.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_ConversionOfConvertibleDebtMember" xlink:to="lab_angn_ConversionOfConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_eb55a9b4-5536-4f28-bec5-bca6c12c0191_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost, 14,455 shares outstanding</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_e9c932cb-f2d0-486a-8a4a-ca213f5fb320_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c29f5b51-1138-4518-b89f-7051c642d841_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_fff68dec-38a6-412d-8de5-7df24f61be5c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average discount rate&#8212;operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_15bbb3d3-312b-4a55-acc1-33170eb4c6b1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_6a53761c-b60d-4f05-baec-3b6eb06fe27f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Outstanding Warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5223a1b0-2b72-43a0-8320-baa5f0d8da0c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_54c5f41b-1dcb-4046-96af-0c97463826b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon the exercise of common warrants</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3bfd09b4-1966-41da-b404-6e5f37ef52c9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares and pre-funded warrants outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_766d268c-8b18-4b4e-bd4a-ded643bd8444_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted average of common shares and pre-funded warrants outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_fb92b6da-c288-4256-90b1-bd908bc54b09_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_87bf0db7-e733-404e-952e-94fbdf5e23db_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_3fbff04a-e254-4003-9446-a85942e251de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Net Loss Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_5e4629d0-0156-4e48-ad5d-4e15a06dbda1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2f8ac625-4ba9-4fc3-8177-b475fa36e30f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_4476e422-7f80-4bf2-9b71-9a8e12b82a4c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_2627eaf5-2652-4447-ae0f-8132d18a0a6d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_7876f3e3-893b-4779-8350-4e9199ee8e0e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of senior note payable</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_dab7b6db-172d-4f85-9da3-2151e9e2bbeb_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_3d5be6e6-322e-4e0e-811a-d4097c8663cd_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_ed118256-fcb8-46e4-b36a-9866a6c80acd_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock and warrants from the January Offering</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_daa974eb-e0ea-4621-ae81-c662e05060c9_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022 [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreement2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_1bed15ad-67dc-48ab-9da3-a77d325a6cd0_terseLabel_en-US" xlink:label="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Future minimum annual maintenance payments</link:label>
    <link:label id="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_label_en-US" xlink:label="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Future Minimum Maintenance Payments</link:label>
    <link:label id="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_documentation_en-US" xlink:label="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Future Minimum Maintenance Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:href="angn-20250930.xsd#angn_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:to="lab_angn_CollaborativeArrangementFutureMinimumMaintenancePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8ec0530a-d932-4c6e-a360-3ac98bb9c530_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_dfe9c544-fd9f-483c-b903-47773f30f2c4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ac5ff7dc-a942-4a55-9639-4b6c4028f5b9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_a738d603-e9d3-4aba-a40b-2f860ad42193_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_aee3a65b-0249-4b1d-aac9-47b7040735f8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_51b4f544-e697-4376-a066-45bcf464e02a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average remaining lease term&#8212;operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1e7d5d70-f0cd-4091-83be-32898750cc4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_29b366dd-7845-45f1-80f1-d5b47ca1eabe_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_0e356f98-c64b-4ca2-a710-cf6fce503f79_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_115d660b-a7fd-4ab9-9bc6-e00b4f5c72f6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock and common warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_eeed9e0d-7f8a-4848-bc4e-bf7dc707efd5_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_9e2bcd34-549c-4a98-864f-83afe5f73370_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (unvested) (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_89d14185-7027-474c-87aa-c365207896fb_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_5ab00681-71fe-4000-a316-bc7a860f4df2_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_BostonMassachusettsMember_6b4cdf8b-dbc5-46ca-89be-906514feebd4_terseLabel_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:label id="lab_angn_BostonMassachusettsMember_label_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts [Member]</link:label>
    <link:label id="lab_angn_BostonMassachusettsMember_documentation_en-US" xlink:label="lab_angn_BostonMassachusettsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Boston, Massachusetts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember" xlink:href="angn-20250930.xsd#angn_BostonMassachusettsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_BostonMassachusettsMember" xlink:to="lab_angn_BostonMassachusettsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_1e85acf1-75c1-494c-a57d-aaa1d9dcabeb_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024 [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreement2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_f9777d8b-4c23-44c5-8eae-96b72a8ff2fc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_8221ced7-2554-4412-9bbc-f9386b2f9016_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_60e2ed1f-69bd-4c06-99c2-1f70dcc76bf0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_fa178b74-f85f-4d5c-ac11-0efc69c4c1ed_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_45e5f2e3-9e91-479f-8ef4-b712a112b876_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_622e3f14-cf36-4b4f-94c5-bcabc6aa4686_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_e9b83fff-01cc-4c6b-b1f8-9ae7dbf59c40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_49b082df-94da-4c7d-858d-ca2abdaf33b8_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f3aaeba7-2b51-484e-a97e-fe78168cb9b5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_a699c95f-1521-4930-a22b-acb9f6cd6b90_terseLabel_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_label_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement [Member]</link:label>
    <link:label id="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember_documentation_en-US" xlink:label="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At-The-Market Equity Offering Sales Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:to="lab_angn_AtTheMarketEquityOfferingSalesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_88329138-cd8b-4972-8bd6-eacf22203999_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_13f9cc4b-4f9f-4127-b597-e07acb110703_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>angn-20250930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:46abd97b-e878-4f3c-a24b-01e71dba1284,g:89379ce6-47e2-4598-9348-41e57d269da1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.angn.com/role/Cover" xlink:type="simple" xlink:href="angn-20250930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_25d13f0a-aa21-44bf-9fed-83e685f9176e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_DocumentType_25d13f0a-aa21-44bf-9fed-83e685f9176e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_801e5f4f-eaa5-4dd1-865d-d6211991cba3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_DocumentQuarterlyReport_801e5f4f-eaa5-4dd1-865d-d6211991cba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0a226d44-4d35-48fa-a94d-2c29167ab10e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_DocumentPeriodEndDate_0a226d44-4d35-48fa-a94d-2c29167ab10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_85845067-c5c1-4b16-b73e-b0f59902da60" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_DocumentTransitionReport_85845067-c5c1-4b16-b73e-b0f59902da60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_31076dbd-a9fa-4687-b9de-1baf9e70da94" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityFileNumber_31076dbd-a9fa-4687-b9de-1baf9e70da94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_37b63dea-f7a6-4fe3-9204-6945317ad1ff" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityRegistrantName_37b63dea-f7a6-4fe3-9204-6945317ad1ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2f965661-7832-4d4e-803a-62f66d749938" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2f965661-7832-4d4e-803a-62f66d749938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_227cd445-9f18-4368-bd20-61d374961a2e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityTaxIdentificationNumber_227cd445-9f18-4368-bd20-61d374961a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_340303ad-8b99-4991-95ea-60ada7347d8b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityAddressAddressLine1_340303ad-8b99-4991-95ea-60ada7347d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_38d178b7-e1d5-475b-8ecb-4dd3758cc9eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityAddressCityOrTown_38d178b7-e1d5-475b-8ecb-4dd3758cc9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b8a974b8-bdd3-4301-b4df-dab650584072" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityAddressStateOrProvince_b8a974b8-bdd3-4301-b4df-dab650584072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_8debef93-bc3f-4c99-819a-a81bf0eac9ec" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityAddressPostalZipCode_8debef93-bc3f-4c99-819a-a81bf0eac9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_ed723f43-c436-4774-a071-7341e3804346" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_CityAreaCode_ed723f43-c436-4774-a071-7341e3804346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_b2258238-9f44-4a41-b24f-ea08c4651e10" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_LocalPhoneNumber_b2258238-9f44-4a41-b24f-ea08c4651e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_95b07ea6-c918-43e6-b6fe-5dc3f5297116" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_Security12bTitle_95b07ea6-c918-43e6-b6fe-5dc3f5297116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_fde54603-af81-493b-b68a-01a690c8d7f2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_TradingSymbol_fde54603-af81-493b-b68a-01a690c8d7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c3faa5d8-3332-4284-bbce-7c8abb0939bc" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_SecurityExchangeName_c3faa5d8-3332-4284-bbce-7c8abb0939bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_a39e62eb-34df-44e5-b843-b0175ea7deae" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityCurrentReportingStatus_a39e62eb-34df-44e5-b843-b0175ea7deae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1b4a30ce-2213-44ad-9e5f-5e2c3a9bc561" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityInteractiveDataCurrent_1b4a30ce-2213-44ad-9e5f-5e2c3a9bc561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_e5949d2f-a534-4fce-aea8-ce2953abfb4d" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityFilerCategory_e5949d2f-a534-4fce-aea8-ce2953abfb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_341babd9-3189-4e4f-a5cb-b15b5efac029" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntitySmallBusiness_341babd9-3189-4e4f-a5cb-b15b5efac029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a636a7ae-9ad2-480d-aed4-38ccdc90d7e7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityEmergingGrowthCompany_a636a7ae-9ad2-480d-aed4-38ccdc90d7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_3a8d37b0-1418-4fd8-935a-5abf41f8e5c9" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityExTransitionPeriod_3a8d37b0-1418-4fd8-935a-5abf41f8e5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_2bbdd8b0-2d2c-45ca-9e39-67dcb7bfcb02" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityShellCompany_2bbdd8b0-2d2c-45ca-9e39-67dcb7bfcb02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_56027ac6-14e5-44fd-a1fe-cf2bbaed37e7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_56027ac6-14e5-44fd-a1fe-cf2bbaed37e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_ac2b0134-f88e-44d1-81d9-e1331727360c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_DocumentFiscalYearFocus_ac2b0134-f88e-44d1-81d9-e1331727360c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_42c7cb95-bc1b-482b-8e3a-4e7a2656d75e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_DocumentFiscalPeriodFocus_42c7cb95-bc1b-482b-8e3a-4e7a2656d75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_fa9515f0-6ac8-4c47-a573-3a8d5c4a1fc7" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_CurrentFiscalYearEndDate_fa9515f0-6ac8-4c47-a573-3a8d5c4a1fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5409fbe9-211d-4b79-8622-6d1663fe80e4" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_EntityCentralIndexKey_5409fbe9-211d-4b79-8622-6d1663fe80e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e239f205-860a-4147-ba95-8dfe6da05363" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d895e1d3-207a-408e-82ea-1c73bf42cf85" xlink:to="loc_dei_AmendmentFlag_e239f205-860a-4147-ba95-8dfe6da05363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_58ed6827-75a5-44a2-bd0b-894439089ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58ed6827-75a5-44a2-bd0b-894439089ab3" xlink:to="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_674a4fc9-0bd0-4a55-b319-2e026245822c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:to="loc_us-gaap_AssetsCurrentAbstract_674a4fc9-0bd0-4a55-b319-2e026245822c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4bac1a19-91b7-46d6-b93b-2aa8b33d03b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_674a4fc9-0bd0-4a55-b319-2e026245822c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4bac1a19-91b7-46d6-b93b-2aa8b33d03b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_ce0e8f16-2d52-48b6-bd4a-ac92930c4315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_674a4fc9-0bd0-4a55-b319-2e026245822c" xlink:to="loc_us-gaap_RestrictedCashCurrent_ce0e8f16-2d52-48b6-bd4a-ac92930c4315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_48c31e02-0656-46f5-a472-8800d0c9fee7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_674a4fc9-0bd0-4a55-b319-2e026245822c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_48c31e02-0656-46f5-a472-8800d0c9fee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4133bec7-3f24-4992-ab81-23454640494a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_674a4fc9-0bd0-4a55-b319-2e026245822c" xlink:to="loc_us-gaap_AssetsCurrent_4133bec7-3f24-4992-ab81-23454640494a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_b2b39c90-9993-4add-9f9b-025f4ef52131" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_b2b39c90-9993-4add-9f9b-025f4ef52131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_28ffb95b-35bd-49e5-a74a-6e29dab0f463" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_28ffb95b-35bd-49e5-a74a-6e29dab0f463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_ae76913d-cccc-482f-bda7-57b33e3ea029" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_ae76913d-cccc-482f-bda7-57b33e3ea029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_44fcff7e-2092-4f08-8a7b-065087e3c42c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_44fcff7e-2092-4f08-8a7b-065087e3c42c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_71cb699b-dab1-474a-a1fb-62ae1fc9e592" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_eba37787-78e7-4961-beda-89dc858ed58b" xlink:to="loc_us-gaap_Assets_71cb699b-dab1-474a-a1fb-62ae1fc9e592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_58ed6827-75a5-44a2-bd0b-894439089ab3" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_bf53bfe9-0a26-4939-8538-e1809394f695" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_bf53bfe9-0a26-4939-8538-e1809394f695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7aaf3258-9914-4fca-ab31-924e03f99a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bf53bfe9-0a26-4939-8538-e1809394f695" xlink:to="loc_us-gaap_AccountsPayableCurrent_7aaf3258-9914-4fca-ab31-924e03f99a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c95c5c58-5f7a-4e1a-807f-4ba114edc390" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bf53bfe9-0a26-4939-8538-e1809394f695" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c95c5c58-5f7a-4e1a-807f-4ba114edc390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9f47b96b-f3de-40e3-bc9c-eeec5ee62b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bf53bfe9-0a26-4939-8538-e1809394f695" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_9f47b96b-f3de-40e3-bc9c-eeec5ee62b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8858dcae-98a8-4dc8-b803-27c5c5210623" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bf53bfe9-0a26-4939-8538-e1809394f695" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8858dcae-98a8-4dc8-b803-27c5c5210623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0150806b-2ab9-4fc5-a95b-4b550fbc0097" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_bf53bfe9-0a26-4939-8538-e1809394f695" xlink:to="loc_us-gaap_LiabilitiesCurrent_0150806b-2ab9-4fc5-a95b-4b550fbc0097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiability_d2757708-c64a-4deb-a77e-4f634d5e63b6" xlink:href="angn-20250930.xsd#angn_WarrantLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_angn_WarrantLiability_d2757708-c64a-4deb-a77e-4f634d5e63b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7fe33e80-293a-4276-94f9-a46f69e5f922" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7fe33e80-293a-4276-94f9-a46f69e5f922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5e26bd7e-2368-44f8-a966-a1cf20bd92b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5e26bd7e-2368-44f8-a966-a1cf20bd92b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_be28d53a-262d-4e41-85ef-67ff13138df1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_us-gaap_Liabilities_be28d53a-262d-4e41-85ef-67ff13138df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_133630ea-3eee-45d6-b543-92684874c62d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_us-gaap_CommitmentsAndContingencies_133630ea-3eee-45d6-b543-92684874c62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_080a863c-c15c-4525-8429-b53f46b84bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:to="loc_us-gaap_CommonStockValue_080a863c-c15c-4525-8429-b53f46b84bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_5db53a96-06d5-4517-9b55-4428996e3760" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:to="loc_us-gaap_TreasuryStockCommonValue_5db53a96-06d5-4517-9b55-4428996e3760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_63e683c6-b19a-402a-9301-b70de4970afa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:to="loc_us-gaap_AdditionalPaidInCapital_63e683c6-b19a-402a-9301-b70de4970afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c7eabb73-3d98-48a4-bc94-7224c94a1419" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c7eabb73-3d98-48a4-bc94-7224c94a1419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8166df7d-aab5-4df3-8a85-7ce8e5f83523" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_8166df7d-aab5-4df3-8a85-7ce8e5f83523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2be05ebf-36a3-4ee1-8458-c4e4d772635a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_41228f22-1422-4cd2-9925-e88c44fb3a58" xlink:to="loc_us-gaap_StockholdersEquity_2be05ebf-36a3-4ee1-8458-c4e4d772635a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cf5a4d6-00e1-45b8-9908-6917f58b15f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b39c0f73-93f7-4188-aca8-03cca9acb917" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_0cf5a4d6-00e1-45b8-9908-6917f58b15f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4ad7d3dd-ceb3-4c59-b759-bd11bde008c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_176b4394-b07e-4a0f-b1bf-ad885bbdd93a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ad7d3dd-ceb3-4c59-b759-bd11bde008c8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_176b4394-b07e-4a0f-b1bf-ad885bbdd93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_d4dc7d87-ca78-43c1-99fc-91990b82a1d3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ad7d3dd-ceb3-4c59-b759-bd11bde008c8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_d4dc7d87-ca78-43c1-99fc-91990b82a1d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4c588af4-a722-4fd6-a716-2a2fb1b37c81" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ad7d3dd-ceb3-4c59-b759-bd11bde008c8" xlink:to="loc_us-gaap_CommonStockSharesIssued_4c588af4-a722-4fd6-a716-2a2fb1b37c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_dab0962b-d00b-4fc6-bdd0-021ca454322a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ad7d3dd-ceb3-4c59-b759-bd11bde008c8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_dab0962b-d00b-4fc6-bdd0-021ca454322a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_8d25e850-7a4f-4306-b549-cc6380580353" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4ad7d3dd-ceb3-4c59-b759-bd11bde008c8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_8d25e850-7a4f-4306-b549-cc6380580353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_3365f269-09e5-4b58-90c6-b59f9f950ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_3365f269-09e5-4b58-90c6-b59f9f950ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_50cd0344-97e9-4c44-9089-02018ad56bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_3365f269-09e5-4b58-90c6-b59f9f950ff1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_50cd0344-97e9-4c44-9089-02018ad56bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_014c76ca-e46b-42ad-837d-aeea1e40bc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_3365f269-09e5-4b58-90c6-b59f9f950ff1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_014c76ca-e46b-42ad-837d-aeea1e40bc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_372a86cc-e023-43a6-ae67-8a74a74855b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_3365f269-09e5-4b58-90c6-b59f9f950ff1" xlink:to="loc_us-gaap_CostsAndExpenses_372a86cc-e023-43a6-ae67-8a74a74855b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_a4809833-1dd3-4ed0-aed4-64673c37005e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_OperatingIncomeLoss_a4809833-1dd3-4ed0-aed4-64673c37005e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherIncomeAndExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_01bda940-f524-4e82-8a30-caacef7679bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_01bda940-f524-4e82-8a30-caacef7679bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_f84c4e8e-fe48-4e69-ad50-3c3cb29552b6" xlink:href="angn-20250930.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_f84c4e8e-fe48-4e69-ad50-3c3cb29552b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_426aed54-3c6c-45fe-b951-5545fa340c42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_426aed54-3c6c-45fe-b951-5545fa340c42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d680a1a2-c9cf-4d49-a7c8-275c089046a6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_d680a1a2-c9cf-4d49-a7c8-275c089046a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_88a7ff56-ec95-41d2-9875-6465b9a3568d" xlink:href="angn-20250930.xsd#angn_GrantRevenueNonoperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_angn_GrantRevenueNonoperating_88a7ff56-ec95-41d2-9875-6465b9a3568d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_a79316fc-ca71-4738-b118-a7c6a2acf759" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_us-gaap_InvestmentIncomeInterest_a79316fc-ca71-4738-b118-a7c6a2acf759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_4b8e832f-8738-4b87-9a5c-e6928f7a12de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_us-gaap_InterestExpenseNonoperating_4b8e832f-8738-4b87-9a5c-e6928f7a12de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_99e5cf83-7226-49ad-baa2-080578e79e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherIncomeAndExpensesAbstract_745cc91c-407f-4db6-99e6-759d4f5d9dc7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_99e5cf83-7226-49ad-baa2-080578e79e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_13fde303-5305-49f9-afbb-b8ccd5f2edea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_NetIncomeLoss_13fde303-5305-49f9-afbb-b8ccd5f2edea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_3b23198d-2997-453a-9aea-92f6877dcd56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_3b23198d-2997-453a-9aea-92f6877dcd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_729c529a-a510-4c60-9076-6f45bcc6eb6f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract_3b23198d-2997-453a-9aea-92f6877dcd56" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_729c529a-a510-4c60-9076-6f45bcc6eb6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_583d0f84-166d-4158-9bc6-4bff762a5cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_583d0f84-166d-4158-9bc6-4bff762a5cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_21125325-29e7-424f-90cb-35b227d72516" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_EarningsPerShareBasic_21125325-29e7-424f-90cb-35b227d72516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9901a1c2-e702-402f-822a-a9d3877efb2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9901a1c2-e702-402f-822a-a9d3877efb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_731ff956-9db1-4c97-8867-ab7f44827b13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_731ff956-9db1-4c97-8867-ab7f44827b13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cf04019-c848-46fc-8eda-49ef78494d34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_5a284539-67db-4e43-b0a8-4c682fceab73" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2cf04019-c848-46fc-8eda-49ef78494d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficit"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_b2cc667d-b96d-42e3-b373-e1d80313799c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_b2cc667d-b96d-42e3-b373-e1d80313799c" xlink:to="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_aab91a98-4d2f-485d-969a-e5eb277011ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_aab91a98-4d2f-485d-969a-e5eb277011ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_aab91a98-4d2f-485d-969a-e5eb277011ac" xlink:to="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_05820d9f-679f-4058-8f07-fd2c33b7e13c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_CommonStockMember_05820d9f-679f-4058-8f07-fd2c33b7e13c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_4efec284-315d-4b9a-9b78-f1b9e3c6ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_TreasuryStockCommonMember_4efec284-315d-4b9a-9b78-f1b9e3c6ab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8ed12d7e-ffe9-4615-bdeb-fd49f3a626cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8ed12d7e-ffe9-4615-bdeb-fd49f3a626cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_768172fc-60f1-4950-8aeb-8df9cfd6179b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_768172fc-60f1-4950-8aeb-8df9cfd6179b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_02503f0b-3fa3-4c51-b101-4148d1b6e24a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_7546f0f4-1cc8-49f6-b227-da55cf8c983a" xlink:to="loc_us-gaap_RetainedEarningsMember_02503f0b-3fa3-4c51-b101-4148d1b6e24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_21415059-541a-4d6e-9485-75d9e72d0b57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_21415059-541a-4d6e-9485-75d9e72d0b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_21415059-541a-4d6e-9485-75d9e72d0b57" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_7b4a7f65-99af-4a61-8970-f6bf4e02c70d" xlink:href="angn-20250930.xsd#angn_PurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:to="loc_angn_PurchaseAgreementMember_7b4a7f65-99af-4a61-8970-f6bf4e02c70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_8dab43b0-cebe-4768-8ae0-d356c6a508f8" xlink:href="angn-20250930.xsd#angn_AtTheMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:to="loc_angn_AtTheMarketOfferingMember_8dab43b0-cebe-4768-8ae0-d356c6a508f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_aeaa6196-2982-494c-8246-fb4f0944a93a" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_7f98cf1e-cf51-483a-a27e-336873227636" xlink:to="loc_angn_JulyPublicOfferingMember_aeaa6196-2982-494c-8246-fb4f0944a93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_56f16606-a73a-45ab-8aaf-1b0f32002bab" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_56f16606-a73a-45ab-8aaf-1b0f32002bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_56f16606-a73a-45ab-8aaf-1b0f32002bab" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertibleDebtMember_4f44cd7c-a8d5-431a-901e-ae87c3c23173" xlink:href="angn-20250930.xsd#angn_ConversionOfConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:to="loc_angn_ConversionOfConvertibleDebtMember_4f44cd7c-a8d5-431a-901e-ae87c3c23173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ConversionOfConvertiblePreferredStockMember_ff27be51-b709-4b08-9391-b6562da45458" xlink:href="angn-20250930.xsd#angn_ConversionOfConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_4d94b1d4-f7e5-44ae-91c9-f893f2e7ba04" xlink:to="loc_angn_ConversionOfConvertiblePreferredStockMember_ff27be51-b709-4b08-9391-b6562da45458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f8b015ff-ab94-4778-8232-50d79dab5ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8a34c24a-9928-4bc1-bdb5-97d4364a8196" xlink:to="loc_us-gaap_StatementLineItems_f8b015ff-ab94-4778-8232-50d79dab5ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f8b015ff-ab94-4778-8232-50d79dab5ba7" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_496ddac9-bac7-4c7e-845b-0b5dad9ab474" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_496ddac9-bac7-4c7e-845b-0b5dad9ab474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_90b568de-b236-4baf-9242-af71a477065d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockholdersEquity_90b568de-b236-4baf-9242-af71a477065d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_91ea51cb-c5e6-4940-8be6-23782f22077f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_TreasuryStockCommonShares_91ea51cb-c5e6-4940-8be6-23782f22077f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_909bf502-7747-4010-afdf-5a97474c1276" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_909bf502-7747-4010-afdf-5a97474c1276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_678fbc2d-f747-46a2-9df3-16de755e27fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_678fbc2d-f747-46a2-9df3-16de755e27fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_48218c7d-88f4-43e5-b074-7f52c7c56001" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_48218c7d-88f4-43e5-b074-7f52c7c56001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_08862026-4876-4301-834f-424b99e14aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_08862026-4876-4301-834f-424b99e14aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_32bef22c-5d56-4800-8ce5-34323be1efce" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_32bef22c-5d56-4800-8ce5-34323be1efce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c65ed7c9-2e6f-4fa6-a840-aa589c435ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c65ed7c9-2e6f-4fa6-a840-aa589c435ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cbb1db9b-7ca0-44f0-be67-35e88eddb6ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_cbb1db9b-7ca0-44f0-be67-35e88eddb6ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_92032334-f546-4f85-a883-6076ec6b4e26" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants_92032334-f546-4f85-a883-6076ec6b4e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_d676ac31-926d-4a65-885c-895db81b39eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_d676ac31-926d-4a65-885c-895db81b39eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d4742290-212e-4652-bc31-54cfb18b516e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_d4742290-212e-4652-bc31-54cfb18b516e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_78419311-cdea-47f8-b765-e295367928f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_78419311-cdea-47f8-b765-e295367928f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_31017073-77cc-4f8b-be9c-fb334a366171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_31017073-77cc-4f8b-be9c-fb334a366171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_beb963c3-befe-48d6-8360-3de90b78ddd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_beb963c3-befe-48d6-8360-3de90b78ddd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c913dc44-e0bf-4782-98d5-7009a62fab18" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_NetIncomeLoss_c913dc44-e0bf-4782-98d5-7009a62fab18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d9484ff0-d31b-44c1-a7ac-3d037d364a68" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d9484ff0-d31b-44c1-a7ac-3d037d364a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_557d495a-40ad-4b91-874c-1a191e2e46bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_StockholdersEquity_557d495a-40ad-4b91-874c-1a191e2e46bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_5024a75d-7abb-4899-8d0f-971bf0f9a27b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8b901712-063c-4fa4-8ab6-275acf105111" xlink:to="loc_us-gaap_TreasuryStockCommonShares_5024a75d-7abb-4899-8d0f-971bf0f9a27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4bd22fa0-d539-44e1-94df-ecc2a8441749" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_504da65d-db06-4dc0-8427-a587f8a5bf0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4bd22fa0-d539-44e1-94df-ecc2a8441749" xlink:to="loc_us-gaap_StatementTable_504da65d-db06-4dc0-8427-a587f8a5bf0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_103c570f-19ab-48f2-a84d-74aa42088984" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_504da65d-db06-4dc0-8427-a587f8a5bf0e" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_103c570f-19ab-48f2-a84d-74aa42088984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_103c570f-19ab-48f2-a84d-74aa42088984" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseAgreementMember_fc6b36ee-f05e-406c-88a5-1ecec3cf5827" xlink:href="angn-20250930.xsd#angn_PurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:to="loc_angn_PurchaseAgreementMember_fc6b36ee-f05e-406c-88a5-1ecec3cf5827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketOfferingMember_42a0948b-9aad-4e91-b946-3d4f82160129" xlink:href="angn-20250930.xsd#angn_AtTheMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:to="loc_angn_AtTheMarketOfferingMember_42a0948b-9aad-4e91-b946-3d4f82160129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_1f618e01-dac0-43d0-b600-25c70c39bfe1" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_324573ba-e6f5-4b9d-8f35-f8b7e22cfdc9" xlink:to="loc_angn_JulyPublicOfferingMember_1f618e01-dac0-43d0-b600-25c70c39bfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_504da65d-db06-4dc0-8427-a587f8a5bf0e" xlink:to="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_9567dffb-b8e7-43ac-a4ef-fa728605a4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_9567dffb-b8e7-43ac-a4ef-fa728605a4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2ce611df-6849-4748-844e-326c24a41f72" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_92eadf10-0c5c-4c9e-ad4e-ff38b0ba78c8" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2ce611df-6849-4748-844e-326c24a41f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="angn-20250930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf0b7bb1-82c0-4e98-8d5f-4300dca24418" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf0b7bb1-82c0-4e98-8d5f-4300dca24418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_09975390-0ee2-4319-b086-ab3ce9ddcb5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf0b7bb1-82c0-4e98-8d5f-4300dca24418" xlink:to="loc_us-gaap_NetIncomeLoss_09975390-0ee2-4319-b086-ab3ce9ddcb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf0b7bb1-82c0-4e98-8d5f-4300dca24418" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d14fb348-13f8-4c80-b9ca-0a1a6bb43c53" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_us-gaap_Depreciation_d14fb348-13f8-4c80-b9ca-0a1a6bb43c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c967b79d-a5cb-4f02-999e-d3948b1c2c98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c967b79d-a5cb-4f02-999e-d3948b1c2c98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_InterestExpenseNoncash_b555f389-db6b-4498-b367-2c0a46794240" xlink:href="angn-20250930.xsd#angn_InterestExpenseNoncash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_angn_InterestExpenseNoncash_b555f389-db6b-4498-b367-2c0a46794240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_f05ae827-2767-426f-a9d1-d76d0301e490" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_f05ae827-2767-426f-a9d1-d76d0301e490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_ed6408c4-738a-4393-93d1-90d5f72b1edc" xlink:href="angn-20250930.xsd#angn_CostsExpensedUponTheIssuanceOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_angn_CostsExpensedUponTheIssuanceOfWarrants_ed6408c4-738a-4393-93d1-90d5f72b1edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_3912f0e1-f61a-4a31-bce3-6204059e96da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_3912f0e1-f61a-4a31-bce3-6204059e96da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_fced4bbf-d81c-4c84-a10a-47d38fe19d50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_us-gaap_ShareBasedCompensation_fced4bbf-d81c-4c84-a10a-47d38fe19d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_07d5e8d0-f02b-430d-b8ca-c8055241defd" xlink:href="angn-20250930.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_07d5e8d0-f02b-430d-b8ca-c8055241defd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5a8a800b-0b4b-4c3d-a62a-1ef9330fc0de" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_5a8a800b-0b4b-4c3d-a62a-1ef9330fc0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e55b35c7-abae-4b57-bb0f-723bf69b9d7b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f5d80fea-2a76-4b90-a24e-f3c14e0fb775" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f5d80fea-2a76-4b90-a24e-f3c14e0fb775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2517dcd5-8565-44a0-aaa5-58da8700faaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2517dcd5-8565-44a0-aaa5-58da8700faaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_448912df-2af1-4056-b207-4b2df2a9750a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_448912df-2af1-4056-b207-4b2df2a9750a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_IncreaseDecreaseInAccruedExpenses_4bc133b4-fedf-4bdc-a642-7ded4cb37f46" xlink:href="angn-20250930.xsd#angn_IncreaseDecreaseInAccruedExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:to="loc_angn_IncreaseDecreaseInAccruedExpenses_4bc133b4-fedf-4bdc-a642-7ded4cb37f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f20d8b4f-644b-4fed-8593-55b6ebc82685" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f20d8b4f-644b-4fed-8593-55b6ebc82685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5d6b29a2-f017-4834-98ed-37b690deefcc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_017837f1-0e12-426d-b4a4-224599b864eb" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5d6b29a2-f017-4834-98ed-37b690deefcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_49e84cc4-aa9f-4556-8492-dc11ab40dac1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_bf0b7bb1-82c0-4e98-8d5f-4300dca24418" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_49e84cc4-aa9f-4556-8492-dc11ab40dac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d3383cdf-3345-4481-910c-26d75703dbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d3383cdf-3345-4481-910c-26d75703dbc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5ad03e92-09f4-4f0a-b93e-2795a1ad6f97" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d3383cdf-3345-4481-910c-26d75703dbc0" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5ad03e92-09f4-4f0a-b93e-2795a1ad6f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d19f9836-6f23-4759-a275-bf82bea325b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d3383cdf-3345-4481-910c-26d75703dbc0" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_d19f9836-6f23-4759-a275-bf82bea325b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b2fb503-1873-42e6-8de1-ad06e6a1ef56" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d3383cdf-3345-4481-910c-26d75703dbc0" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b2fb503-1873-42e6-8de1-ad06e6a1ef56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_602c720c-67ae-427b-a2b4-89d58af73817" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_602c720c-67ae-427b-a2b4-89d58af73817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_870a9144-3ea1-4a1b-9eb8-33759a362be3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_870a9144-3ea1-4a1b-9eb8-33759a362be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_c090a5bf-8ef7-4219-ac88-1d1f998429e8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_c090a5bf-8ef7-4219-ac88-1d1f998429e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_1612a18a-eebc-4a2f-801c-2321e6b617f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_1612a18a-eebc-4a2f-801c-2321e6b617f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_c721cd9d-b77a-4cf8-ae14-0c610282680d" xlink:href="angn-20250930.xsd#angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts_c721cd9d-b77a-4cf8-ae14-0c610282680d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_9a7f810a-541d-4b2c-935c-cdb0c74da129" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_9a7f810a-541d-4b2c-935c-cdb0c74da129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PaymentOfWarrantIssuanceCosts_7617e69e-1dc1-45d1-8195-55ba64d1d529" xlink:href="angn-20250930.xsd#angn_PaymentOfWarrantIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_angn_PaymentOfWarrantIssuanceCosts_7617e69e-1dc1-45d1-8195-55ba64d1d529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_3a9ede8b-2b23-4874-af1f-38592872b70d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_3a9ede8b-2b23-4874-af1f-38592872b70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac1fcaad-9b7c-40bd-bc4f-48f1b92f8c66" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9b80bb19-695e-48bc-bbc9-6bcf87195c2d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ac1fcaad-9b7c-40bd-bc4f-48f1b92f8c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_68ed6bbb-2418-499d-9bb8-fe9e650bc493" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_68ed6bbb-2418-499d-9bb8-fe9e650bc493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf80e089-34ca-43f2-9f2b-c362802e5189" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_bf80e089-34ca-43f2-9f2b-c362802e5189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d83abc9c-0ade-4dd8-bba4-c3bdb0b83709" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d83abc9c-0ade-4dd8-bba4-c3bdb0b83709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_51157230-5374-4580-9b33-ce878b5e50eb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_51157230-5374-4580-9b33-ce878b5e50eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6b29da88-1fe0-478c-b1b4-1dca5fda6be5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6b29da88-1fe0-478c-b1b4-1dca5fda6be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29fb81bc-a65f-46e4-9694-9396f5955317" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6b29da88-1fe0-478c-b1b4-1dca5fda6be5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_29fb81bc-a65f-46e4-9694-9396f5955317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_5557a710-abd0-4f31-91b3-fddc0bda602f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6b29da88-1fe0-478c-b1b4-1dca5fda6be5" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_5557a710-abd0-4f31-91b3-fddc0bda602f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c98c5bc4-6cc6-4be2-b973-e98ef05e1b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6b29da88-1fe0-478c-b1b4-1dca5fda6be5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c98c5bc4-6cc6-4be2-b973-e98ef05e1b1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_d2bdd6a0-b134-414a-b1f1-d3259ae54745" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfPreFundedWarrants_3b9d000f-e8cd-4d33-bf69-79da5924d90e" xlink:href="angn-20250930.xsd#angn_FairValueOfPreFundedWarrants"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_FairValueOfPreFundedWarrants_3b9d000f-e8cd-4d33-bf69-79da5924d90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_FairValueOfCommonStockWarrantsUponSettlement_e53337a4-4bb7-493b-8419-6fe92d218fa7" xlink:href="angn-20250930.xsd#angn_FairValueOfCommonStockWarrantsUponSettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_FairValueOfCommonStockWarrantsUponSettlement_e53337a4-4bb7-493b-8419-6fe92d218fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedStockIssuance_d8b60a26-a66d-4d8a-9c38-71a506475822" xlink:href="angn-20250930.xsd#angn_WarrantIssuedStockIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_WarrantIssuedStockIssuance_d8b60a26-a66d-4d8a-9c38-71a506475822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantIssuedDebtIssuance_0d530412-0fa3-4481-b0af-1d1d1c2c29fa" xlink:href="angn-20250930.xsd#angn_WarrantIssuedDebtIssuance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_WarrantIssuedDebtIssuance_0d530412-0fa3-4481-b0af-1d1d1c2c29fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantExercisedFairValue_31ee3b41-defb-4d85-a72b-19b56027bcd6" xlink:href="angn-20250930.xsd#angn_WarrantExercisedFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_WarrantExercisedFairValue_31ee3b41-defb-4d85-a72b-19b56027bcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SettlementOfPromissoryNotesPayable_7e282515-b839-4d65-a373-6ab5accd10a9" xlink:href="angn-20250930.xsd#angn_SettlementOfPromissoryNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_SettlementOfPromissoryNotesPayable_7e282515-b839-4d65-a373-6ab5accd10a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts_f0e2f0d1-add4-4c09-b415-513a722c7b6f" xlink:href="angn-20250930.xsd#angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts_f0e2f0d1-add4-4c09-b415-513a722c7b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_VestingOfRestrictedCommonStock_fd1bcb90-f6e5-4708-80ea-aee8fe86871a" xlink:href="angn-20250930.xsd#angn_VestingOfRestrictedCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_39e9514b-de41-48c4-bba4-185f25a5a108" xlink:to="loc_angn_VestingOfRestrictedCommonStock_fd1bcb90-f6e5-4708-80ea-aee8fe86871a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="simple" xlink:href="angn-20250930.xsd#DescriptionoftheBusinessandFinancialCondition"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6b0148ac-837a-46df-a056-000850360a67" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7aea47c4-645f-48e3-803d-3db31de940ea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6b0148ac-837a-46df-a056-000850360a67" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7aea47c4-645f-48e3-803d-3db31de940ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="angn-20250930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c163e6ac-d935-4fbe-af56-0cc75133daaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6ab04b27-b048-4091-ad33-9d2f2c63aee9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c163e6ac-d935-4fbe-af56-0cc75133daaf" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6ab04b27-b048-4091-ad33-9d2f2c63aee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_36ee7d2b-a085-4a80-a6a1-c61729ac16d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_c885280e-6058-4c95-a1a3-05a5c45b1503" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_36ee7d2b-a085-4a80-a6a1-c61729ac16d1" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_c885280e-6058-4c95-a1a3-05a5c45b1503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponents" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_97e055d1-637c-4dd2-8397-ab691994fb86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_883742d0-2348-49c8-acfb-0cc0475fd9db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_97e055d1-637c-4dd2-8397-ab691994fb86" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_883742d0-2348-49c8-acfb-0cc0475fd9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrants" xlink:type="simple" xlink:href="angn-20250930.xsd#ResearchGrants"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ResearchGrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_7e12bc01-0667-4cfe-a055-ee47498c45d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_20f466a8-a773-440b-89d4-60c32ce70098" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_7e12bc01-0667-4cfe-a055-ee47498c45d2" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock_20f466a8-a773-440b-89d4-60c32ce70098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommonStockandStockholdersEquity" xlink:type="simple" xlink:href="angn-20250930.xsd#CommonStockandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommonStockandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_673ffa9f-0d64-40f6-88ec-7e0b0f5a9315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_575f77d2-44ab-41b8-81a2-24c802913598" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_673ffa9f-0d64-40f6-88ec-7e0b0f5a9315" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_575f77d2-44ab-41b8-81a2-24c802913598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c170fddb-6a83-41be-9a65-b9db07cae42f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_57f571dc-7b46-4e82-9a8f-7827c7a58991" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c170fddb-6a83-41be-9a65-b9db07cae42f" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_57f571dc-7b46-4e82-9a8f-7827c7a58991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Warrants" xlink:type="simple" xlink:href="angn-20250930.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_da959e16-7a69-4d56-9f96-d56b3dd5e81a" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingTextBlock_7dbb3aaa-4ff8-4e25-802b-0ef7ae01f0b7" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_da959e16-7a69-4d56-9f96-d56b3dd5e81a" xlink:to="loc_angn_WarrantsAndRightsOutstandingTextBlock_7dbb3aaa-4ff8-4e25-802b-0ef7ae01f0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="angn-20250930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc99bd6b-c1fe-4303-b262-778efc505caf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_97d15b8b-29ab-44b4-93db-fe4783fa9fdc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_bc99bd6b-c1fe-4303-b262-778efc505caf" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_97d15b8b-29ab-44b4-93db-fe4783fa9fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Leases" xlink:type="simple" xlink:href="angn-20250930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b5d959d9-072c-4a4a-99b2-2de09ab84d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_be774be8-e28a-47c4-b846-c65694c3b0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b5d959d9-072c-4a4a-99b2-2de09ab84d9a" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_be774be8-e28a-47c4-b846-c65694c3b0bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/Debt" xlink:type="simple" xlink:href="angn-20250930.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_dafb946a-9de4-42d8-8579-f4109f9335bc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_67135ddb-d400-41c3-adbd-a73152da9dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_dafb946a-9de4-42d8-8579-f4109f9335bc" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_67135ddb-d400-41c3-adbd-a73152da9dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxes" xlink:type="simple" xlink:href="angn-20250930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7c757d56-385f-4c29-8caa-c4443b0cf235" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_45c2236c-e623-4c3f-8286-7002144c48da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7c757d56-385f-4c29-8caa-c4443b0cf235" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_45c2236c-e623-4c3f-8286-7002144c48da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShare" xlink:type="simple" xlink:href="angn-20250930.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_43b01e8d-6da0-46d0-b83b-86f1ddae60fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_fd880d9d-352d-4c33-a5ba-8aebab45b902" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_43b01e8d-6da0-46d0-b83b-86f1ddae60fd" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_fd880d9d-352d-4c33-a5ba-8aebab45b902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="angn-20250930.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_09d594f7-b682-4378-9527-e8dd544c8862" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ffd162b8-b331-470e-b122-76bf71c47347" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_09d594f7-b682-4378-9527-e8dd544c8862" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_ffd162b8-b331-470e-b122-76bf71c47347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReporting" xlink:type="simple" xlink:href="angn-20250930.xsd#SegmentReporting"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReporting" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bbb1b1b0-97bd-46f8-9401-5f241581515b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_bc52dba2-067d-4e62-b8b9-dace8130992c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bbb1b1b0-97bd-46f8-9401-5f241581515b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_bc52dba2-067d-4e62-b8b9-dace8130992c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="angn-20250930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_fe9ce312-fe1a-444a-aa37-9b2a5997142d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenuePolicyTextBlock_aaa14476-63aa-41d0-b54c-232d8ee23b85" xlink:href="angn-20250930.xsd#angn_GrantRevenuePolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe9ce312-fe1a-444a-aa37-9b2a5997142d" xlink:to="loc_angn_GrantRevenuePolicyTextBlock_aaa14476-63aa-41d0-b54c-232d8ee23b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3cd16059-bb5a-48bf-b516-08b03b722673" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe9ce312-fe1a-444a-aa37-9b2a5997142d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3cd16059-bb5a-48bf-b516-08b03b722673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9fd8c876-ec84-41be-ae27-ea61fe06a035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_fe9ce312-fe1a-444a-aa37-9b2a5997142d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_9fd8c876-ec84-41be-ae27-ea61fe06a035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fd5fa643-c410-4931-b46a-27235b751ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0df08fbd-0cf7-479e-8c8e-c6a1fbbed9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fd5fa643-c410-4931-b46a-27235b751ce8" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_0df08fbd-0cf7-479e-8c8e-c6a1fbbed9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d2c7a037-1d69-46ae-9ce3-94a218aaea7a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fd5fa643-c410-4931-b46a-27235b751ce8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d2c7a037-1d69-46ae-9ce3-94a218aaea7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_bf5f3499-d8c6-4635-bc52-fef4204230e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fd5fa643-c410-4931-b46a-27235b751ce8" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_bf5f3499-d8c6-4635-bc52-fef4204230e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsTables" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_199edfc7-6c69-4ad0-8afe-e8c79aa97d52" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_9b949353-68f7-4a58-85f5-56e0f9f06532" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_199edfc7-6c69-4ad0-8afe-e8c79aa97d52" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_9b949353-68f7-4a58-85f5-56e0f9f06532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_27c2f8bd-976b-4ffb-a073-1d5e34a6cafc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_199edfc7-6c69-4ad0-8afe-e8c79aa97d52" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_27c2f8bd-976b-4ffb-a073-1d5e34a6cafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1704e2ca-6927-40c6-8995-9d27c30197c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_199edfc7-6c69-4ad0-8afe-e8c79aa97d52" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_1704e2ca-6927-40c6-8995-9d27c30197c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f009c3af-81fa-4d16-8dd3-bfdb2adf23ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_018fe313-8bff-48e6-a52d-cda88564710c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f009c3af-81fa-4d16-8dd3-bfdb2adf23ec" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_018fe313-8bff-48e6-a52d-cda88564710c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_43b9a505-8e95-41d2-9927-9cbb170c1d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f009c3af-81fa-4d16-8dd3-bfdb2adf23ec" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_43b9a505-8e95-41d2-9927-9cbb170c1d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6cc5f166-d6c6-4ba4-8efe-fb235da1d6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f009c3af-81fa-4d16-8dd3-bfdb2adf23ec" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6cc5f166-d6c6-4ba4-8efe-fb235da1d6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsTables" xlink:type="simple" xlink:href="angn-20250930.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_1c569e2c-364a-431d-aaf1-8bf426c3b470" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_0db7c742-e27e-4f95-a5e7-d9430b10f962" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_1c569e2c-364a-431d-aaf1-8bf426c3b470" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_0db7c742-e27e-4f95-a5e7-d9430b10f962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesTables" xlink:type="simple" xlink:href="angn-20250930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_779ae007-0988-4f6d-bb47-4ac3ff0fa5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_e8b5e031-1c23-43c9-af29-2e396c04a95e" xlink:href="angn-20250930.xsd#angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_779ae007-0988-4f6d-bb47-4ac3ff0fa5ca" xlink:to="loc_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock_e8b5e031-1c23-43c9-af29-2e396c04a95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_58563eff-6c80-4996-a536-e0db6d6c2d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_779ae007-0988-4f6d-bb47-4ac3ff0fa5ca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_58563eff-6c80-4996-a536-e0db6d6c2d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="angn-20250930.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_57687b40-cb9e-4c5d-a7d6-20ec7434fe4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d0ca29c6-dcf9-4f07-bb50-74197f9f9c04" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_57687b40-cb9e-4c5d-a7d6-20ec7434fe4f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d0ca29c6-dcf9-4f07-bb50-74197f9f9c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f62e51be-e865-4054-a3f2-0693ac2090b2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_57687b40-cb9e-4c5d-a7d6-20ec7434fe4f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_f62e51be-e865-4054-a3f2-0693ac2090b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingTables" xlink:type="simple" xlink:href="angn-20250930.xsd#SegmentReportingTables"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReportingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bee2afd5-bb52-4e1d-a522-1c89fdd0d3d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_40ddc051-b7df-4798-aa0a-f8e34c9c74f3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bee2afd5-bb52-4e1d-a522-1c89fdd0d3d7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_40ddc051-b7df-4798-aa0a-f8e34c9c74f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#DescriptionoftheBusinessandFinancialConditionDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_96163b3e-82a9-451e-af16-c1c10c6ca745" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_956cf7db-6967-47f2-8018-cbd461b265a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_96163b3e-82a9-451e-af16-c1c10c6ca745" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_956cf7db-6967-47f2-8018-cbd461b265a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6757f1a-dd72-44b8-919b-cc66038a970b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_96163b3e-82a9-451e-af16-c1c10c6ca745" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e6757f1a-dd72-44b8-919b-cc66038a970b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_15662f3e-fb5c-49c2-be31-61cd1d43c42f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_68ec5852-bcef-4ca2-9550-deaa7715300b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_15662f3e-fb5c-49c2-be31-61cd1d43c42f" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_68ec5852-bcef-4ca2-9550-deaa7715300b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1edb4940-51dc-4421-87f1-bb824aee2b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68ec5852-bcef-4ca2-9550-deaa7715300b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1edb4940-51dc-4421-87f1-bb824aee2b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cac25e69-44ae-4f56-9eed-76870dcdd7a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1edb4940-51dc-4421-87f1-bb824aee2b2b" xlink:to="loc_us-gaap_ClassOfStockDomain_cac25e69-44ae-4f56-9eed-76870dcdd7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionCommonStockMember_0947b68f-8b1c-46c9-b300-1fc6de98df1c" xlink:href="angn-20250930.xsd#angn_AngionCommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cac25e69-44ae-4f56-9eed-76870dcdd7a9" xlink:to="loc_angn_AngionCommonStockMember_0947b68f-8b1c-46c9-b300-1fc6de98df1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_edfbb3dd-0a61-4883-ad11-e9aa4931fc9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_68ec5852-bcef-4ca2-9550-deaa7715300b" xlink:to="loc_us-gaap_ClassOfStockLineItems_edfbb3dd-0a61-4883-ad11-e9aa4931fc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8ba82126-3929-4cd1-a960-6ea4d716e94d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_edfbb3dd-0a61-4883-ad11-e9aa4931fc9b" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_8ba82126-3929-4cd1-a960-6ea4d716e94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d1f29cbc-b935-4cfc-9110-8f7ec456392e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d1f29cbc-b935-4cfc-9110-8f7ec456392e" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78ab57e5-8e13-4614-baf7-49b801786320" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78ab57e5-8e13-4614-baf7-49b801786320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_78ab57e5-8e13-4614-baf7-49b801786320" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_024d6d64-e9d1-4616-a8fc-27ec0310ff5d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_024d6d64-e9d1-4616-a8fc-27ec0310ff5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f7e940fd-2c07-404c-b126-02d5488539b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f7e940fd-2c07-404c-b126-02d5488539b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_96c7b549-8447-4640-8d68-0e98bbf134f5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b99fdd80-56ab-48b2-8f3d-3030e20ed191" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_96c7b549-8447-4640-8d68-0e98bbf134f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a582fa1b-99fc-4952-b287-e7ad9b30eff7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a582fa1b-99fc-4952-b287-e7ad9b30eff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_9fa4fdc6-c4f0-4a5e-af20-1429649b2b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_a582fa1b-99fc-4952-b287-e7ad9b30eff7" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_9fa4fdc6-c4f0-4a5e-af20-1429649b2b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e6d320-5f0a-4b4d-bd07-92b490cf2d45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_9fa4fdc6-c4f0-4a5e-af20-1429649b2b2a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_b2e6d320-5f0a-4b4d-bd07-92b490cf2d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_c6e2fa6c-a3e9-44cf-86f4-be35aa4d8465" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e34244c1-a743-410d-913d-4106379b9ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e34244c1-a743-410d-913d-4106379b9ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e002de6a-1220-4d3d-99cb-3ebfdc3f0133" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_2d459746-e83c-48c5-91f4-d66aa2095668" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_e002de6a-1220-4d3d-99cb-3ebfdc3f0133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_07481b49-279d-4030-9f67-080b74741ac6" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsFairValueDisclosure_592b624c-6152-4076-a824-b8339f1daea4" xlink:href="angn-20250930.xsd#angn_WarrantsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:to="loc_angn_WarrantsFairValueDisclosure_592b624c-6152-4076-a824-b8339f1daea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_fa378023-3625-4a6a-a5ce-bee90b41a62d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_03be6359-f81f-472f-8ca9-0b9b19563b35" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_fa378023-3625-4a6a-a5ce-bee90b41a62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2c38f688-6fc8-430b-95a6-15cac2fc211f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0745b6f6-52cd-46c2-91a0-c6819a0d1311" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2c38f688-6fc8-430b-95a6-15cac2fc211f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0745b6f6-52cd-46c2-91a0-c6819a0d1311" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_ca603584-2972-405f-bd98-5deabfd6514c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0745b6f6-52cd-46c2-91a0-c6819a0d1311" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_ca603584-2972-405f-bd98-5deabfd6514c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe9e8b2d-737f-4c27-ae36-d2cc98520d37" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_ca603584-2972-405f-bd98-5deabfd6514c" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe9e8b2d-737f-4c27-ae36-d2cc98520d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantLiabilityMember_f279b309-1bde-4e70-a3b6-639b14bb96d0" xlink:href="angn-20250930.xsd#angn_WarrantLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_fe9e8b2d-737f-4c27-ae36-d2cc98520d37" xlink:to="loc_angn_WarrantLiabilityMember_f279b309-1bde-4e70-a3b6-639b14bb96d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_aa652e4e-2c7e-4c40-8448-80478906fc20" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable_0745b6f6-52cd-46c2-91a0-c6819a0d1311" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_aa652e4e-2c7e-4c40-8448-80478906fc20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_aa652e4e-2c7e-4c40-8448-80478906fc20" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c2dcd02b-edd2-4df7-b861-6fe894a7d8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_c2dcd02b-edd2-4df7-b861-6fe894a7d8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d61c5a34-0ede-43a1-87f6-3df7872e2a42" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_d61c5a34-0ede-43a1-87f6-3df7872e2a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5eb3f08a-8377-4e11-9ae2-1fc60735452e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_6c842b51-437d-45f0-8572-8f7e3d7f83a9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5eb3f08a-8377-4e11-9ae2-1fc60735452e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f1067cbb-f8c3-476f-9225-eba444ddf6f4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f1067cbb-f8c3-476f-9225-eba444ddf6f4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59d24a2c-0233-40dd-9114-b201ac0b8329" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59d24a2c-0233-40dd-9114-b201ac0b8329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b494e37c-d2ac-4ee2-97db-de8b164e907d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59d24a2c-0233-40dd-9114-b201ac0b8329" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b494e37c-d2ac-4ee2-97db-de8b164e907d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d3a33d58-29bc-49f9-9f3e-f7adb084b48c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b494e37c-d2ac-4ee2-97db-de8b164e907d" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d3a33d58-29bc-49f9-9f3e-f7adb084b48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_897c374c-1cb7-42f3-a6f8-7a32d0681025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_897c374c-1cb7-42f3-a6f8-7a32d0681025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_897c374c-1cb7-42f3-a6f8-7a32d0681025" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MeasurementInputStrikePriceMember_1e4cef72-d713-404d-840a-e4d56bc492f0" xlink:href="angn-20250930.xsd#angn_MeasurementInputStrikePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_angn_MeasurementInputStrikePriceMember_1e4cef72-d713-404d-840a-e4d56bc492f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_d22a7901-0f2e-48b9-9445-5ed614760025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_d22a7901-0f2e-48b9-9445-5ed614760025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_5d81e902-670d-4ca3-8eff-39f694d72b57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_5d81e902-670d-4ca3-8eff-39f694d72b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_baaf91e2-a2e1-4774-924f-b1c95e768284" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_21b0c5d2-6727-4df4-a57f-f952fd847fd2" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_baaf91e2-a2e1-4774-924f-b1c95e768284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_5894e7d1-fead-483a-afdd-bf06412b2150" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_9716a7f8-0329-4462-8d26-719f275cb411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_9716a7f8-0329-4462-8d26-719f275cb411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ad83c3f3-8f5c-4e39-a54e-4b8fecc8279a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_a7b7dae9-65ff-4a6f-9a92-5ce159d6c5ff" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_ad83c3f3-8f5c-4e39-a54e-4b8fecc8279a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1d597061-899a-4df7-b0f0-5bc183cde440" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1d597061-899a-4df7-b0f0-5bc183cde440" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_468ea617-05f6-41ab-9578-4c512fc9f413" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_468ea617-05f6-41ab-9578-4c512fc9f413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b18b31-3b3d-4cdb-9890-877f283d9f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_468ea617-05f6-41ab-9578-4c512fc9f413" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b18b31-3b3d-4cdb-9890-877f283d9f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_e06a4324-1418-4696-9ca0-4639fffc87f2" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b18b31-3b3d-4cdb-9890-877f283d9f1c" xlink:to="loc_angn_JulyPublicOfferingMember_e06a4324-1418-4696-9ca0-4639fffc87f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1d4ac19a-a72b-49d1-b188-aad740533cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1d4ac19a-a72b-49d1-b188-aad740533cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1d4ac19a-a72b-49d1-b188-aad740533cdb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_df302f58-5adc-43fc-bc63-0e62e1e06d7d" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:to="loc_angn_PreFundedWarrantMember_df302f58-5adc-43fc-bc63-0e62e1e06d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1fb03bfc-a97f-4e2d-ab5b-415005269197" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_92da9773-47d8-40be-985c-657ca931c5ab" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:to="loc_angn_JulyPreFundedWarrantsMember_92da9773-47d8-40be-985c-657ca931c5ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_2d514d34-a481-41ef-8ab8-112785cf8827" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_9dba8e0e-70c8-411d-9da8-2329f6155828" xlink:to="loc_angn_JulyCommonWarrantsMember_2d514d34-a481-41ef-8ab8-112785cf8827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_33195c79-fdae-46c2-b96b-66ca64002b98" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6ac2291e-2149-4d05-921c-fef913a95a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_6ac2291e-2149-4d05-921c-fef913a95a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d4bb7d2a-53c0-4ce7-b4f1-cdd105bf7578" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_d4bb7d2a-53c0-4ce7-b4f1-cdd105bf7578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16daa01d-0447-4477-ac78-08d1576cc1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_16daa01d-0447-4477-ac78-08d1576cc1c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_1f807a7d-62cf-41b3-a7b7-2656e59ee228" xlink:href="angn-20250930.xsd#angn_SaleOfStockBeneficialOwnershipLimitationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_angn_SaleOfStockBeneficialOwnershipLimitationPercentage_1f807a7d-62cf-41b3-a7b7-2656e59ee228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_df0bb4b6-5bf2-4496-906c-007657a11ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_835c398e-6968-4a69-8509-fce8fb5f0d39" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_df0bb4b6-5bf2-4496-906c-007657a11ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52331301-e90b-4ce3-8386-d66a60a96ed3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PrepaidResearchAndDevelopmentExpenses_d095bdae-cdc3-4818-9c1b-8c4bad49e13d" xlink:href="angn-20250930.xsd#angn_PrepaidResearchAndDevelopmentExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52331301-e90b-4ce3-8386-d66a60a96ed3" xlink:to="loc_angn_PrepaidResearchAndDevelopmentExpenses_d095bdae-cdc3-4818-9c1b-8c4bad49e13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AdvancedProfessionalFees_2bd23283-befa-4e57-8ded-8ad58a59686d" xlink:href="angn-20250930.xsd#angn_AdvancedProfessionalFees"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52331301-e90b-4ce3-8386-d66a60a96ed3" xlink:to="loc_angn_AdvancedProfessionalFees_2bd23283-befa-4e57-8ded-8ad58a59686d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_b1cb11ef-a921-4545-a93e-7934ea082315" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52331301-e90b-4ce3-8386-d66a60a96ed3" xlink:to="loc_us-gaap_PrepaidInsurance_b1cb11ef-a921-4545-a93e-7934ea082315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_5eeaf0f0-c3e7-437c-9304-ac22d521d8ed" xlink:href="angn-20250930.xsd#angn_OtherPrepaidExpensesAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52331301-e90b-4ce3-8386-d66a60a96ed3" xlink:to="loc_angn_OtherPrepaidExpensesAndOtherAssetsCurrent_5eeaf0f0-c3e7-437c-9304-ac22d521d8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_48e6d455-fd03-4e34-8a29-e728cb6c0780" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_52331301-e90b-4ce3-8386-d66a60a96ed3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_48e6d455-fd03-4e34-8a29-e728cb6c0780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cfc0272a-4bdb-4004-921e-2bdd18275af8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b800651b-600a-4a7e-ae37-9156fd384551" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cfc0272a-4bdb-4004-921e-2bdd18275af8" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b800651b-600a-4a7e-ae37-9156fd384551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b92e87e9-1775-46b5-93de-c65ac0c1ff1d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b800651b-600a-4a7e-ae37-9156fd384551" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b92e87e9-1775-46b5-93de-c65ac0c1ff1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_b92e87e9-1775-46b5-93de-c65ac0c1ff1d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_d967d5dd-4224-4525-ba13-140356a38135" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:to="loc_us-gaap_EquipmentMember_d967d5dd-4224-4525-ba13-140356a38135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b3c41869-93ee-4ae2-908e-3653a6e3eafa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b3c41869-93ee-4ae2-908e-3653a6e3eafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_462fdfe3-f1da-41db-a337-ef883a143471" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_11b7e4bf-66dc-4500-b250-a916e03a93e7" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_462fdfe3-f1da-41db-a337-ef883a143471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b800651b-600a-4a7e-ae37-9156fd384551" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_dd3c5f36-ef2a-45a7-aefe-7ebfcc9ab354" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_dd3c5f36-ef2a-45a7-aefe-7ebfcc9ab354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_43627c43-342d-44a9-b6da-dbc3c6b4480c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_43627c43-342d-44a9-b6da-dbc3c6b4480c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0cecc047-455e-4dd0-b25a-c62029163a55" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_eaeb6d96-b810-4683-b593-c7a612233d7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0cecc047-455e-4dd0-b25a-c62029163a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d54a1aff-d42b-4f06-81b8-34bb66565fe4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_64b0f484-2be6-43db-a361-099650dc6054" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d54a1aff-d42b-4f06-81b8-34bb66565fe4" xlink:to="loc_us-gaap_Depreciation_64b0f484-2be6-43db-a361-099650dc6054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseOtherNoncurrent_0e93ab2b-a926-41f4-95d3-57947f1e76b9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d54a1aff-d42b-4f06-81b8-34bb66565fe4" xlink:to="loc_us-gaap_PrepaidExpenseOtherNoncurrent_0e93ab2b-a926-41f4-95d3-57947f1e76b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#BalanceSheetComponentsScheduleofAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7547f44c-f5b8-4ce2-966a-366513864272" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_88759eb4-52fe-44b0-8b4b-9b9892695903" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7547f44c-f5b8-4ce2-966a-366513864272" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_88759eb4-52fe-44b0-8b4b-9b9892695903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0bfa0eb7-0dad-4489-b293-971b55385202" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7547f44c-f5b8-4ce2-966a-366513864272" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_0bfa0eb7-0dad-4489-b293-971b55385202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedResearchAndDevelopmentCurrent_d7750e79-2b73-46a4-86a6-65a315717e3b" xlink:href="angn-20250930.xsd#angn_AccruedResearchAndDevelopmentCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7547f44c-f5b8-4ce2-966a-366513864272" xlink:to="loc_angn_AccruedResearchAndDevelopmentCurrent_d7750e79-2b73-46a4-86a6-65a315717e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_b8fce52f-e88a-4e79-809d-f117b58e6433" xlink:href="angn-20250930.xsd#angn_AccruedOtherOperatingLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7547f44c-f5b8-4ce2-966a-366513864272" xlink:to="loc_angn_AccruedOtherOperatingLiabilitiesCurrent_b8fce52f-e88a-4e79-809d-f117b58e6433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c51e3412-28d8-43e8-bf55-a99d5b68a0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7547f44c-f5b8-4ce2-966a-366513864272" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c51e3412-28d8-43e8-bf55-a99d5b68a0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/ResearchGrantsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#ResearchGrantsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/ResearchGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentAbstract_b6b56a53-0e41-46b4-96c1-c6f7f9d1795b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9fa2c593-5376-439d-b7a9-616ee0170e00" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentAbstract_b6b56a53-0e41-46b4-96c1-c6f7f9d1795b" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9fa2c593-5376-439d-b7a9-616ee0170e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_fbb00332-b535-4e81-86ca-7ce12ac241a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9fa2c593-5376-439d-b7a9-616ee0170e00" xlink:to="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_fbb00332-b535-4e81-86ca-7ce12ac241a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProjectMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis_fbb00332-b535-4e81-86ca-7ce12ac241a5" xlink:to="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_f4e216a3-6057-4ba2-aea7-9d7bcabc4063" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member_f4e216a3-6057-4ba2-aea7-9d7bcabc4063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_e019094a-042a-412a-85dc-4d0b6fbbda27" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member_e019094a-042a-412a-85dc-4d0b6fbbda27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_0a9b9a27-9f7d-472e-80ce-bd8b9c989581" xlink:href="angn-20250930.xsd#angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProjectMember_460144dc-1d52-418b-851b-f3fb3055761c" xlink:to="loc_angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member_0a9b9a27-9f7d-472e-80ce-bd8b9c989581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_9fa2c593-5376-439d-b7a9-616ee0170e00" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrant_630f7963-7acc-4c27-b267-767f9d4bcb46" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrant_630f7963-7acc-4c27-b267-767f9d4bcb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_54ec582b-5132-4225-8e58-0dc45d3ff10c" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementGrantReceived"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementGrantReceived_54ec582b-5132-4225-8e58-0dc45d3ff10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementCredit_2188201e-2ddd-4193-905d-c6dbed001781" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementCredit_2188201e-2ddd-4193-905d-c6dbed001781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_1f466bd0-598a-4a27-b2c2-ceab64038007" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_1f466bd0-598a-4a27-b2c2-ceab64038007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_35dc6221-f888-483f-9100-75b365d4dfeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_35dc6221-f888-483f-9100-75b365d4dfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_dc607904-5592-4585-99fd-9642d3c58bec" xlink:href="angn-20250930.xsd#angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds_dc607904-5592-4585-99fd-9642d3c58bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NumberOfResearchGrantAgreements_4755ec05-0037-4c7d-a29b-770af72f652d" xlink:href="angn-20250930.xsd#angn_NumberOfResearchGrantAgreements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_NumberOfResearchGrantAgreements_4755ec05-0037-4c7d-a29b-770af72f652d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GrantRevenueNonoperating_5ec7e089-0b27-4c33-bb06-46502f17cb3d" xlink:href="angn-20250930.xsd#angn_GrantRevenueNonoperating"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_86036931-f506-4a32-bddf-3c0c02c632ef" xlink:to="loc_angn_GrantRevenueNonoperating_5ec7e089-0b27-4c33-bb06-46502f17cb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#CommonStockandStockholdersEquityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommonStockandStockholdersEquityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dda965a1-b42f-43e1-a331-fd6e007b6d70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dda965a1-b42f-43e1-a331-fd6e007b6d70" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1eb0b759-2acc-4417-931c-ceea9decee78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1eb0b759-2acc-4417-931c-ceea9decee78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0e3496b9-7114-4e16-8ef6-00d3d5df4c13" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1eb0b759-2acc-4417-931c-ceea9decee78" xlink:to="loc_us-gaap_EquityComponentDomain_0e3496b9-7114-4e16-8ef6-00d3d5df4c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c442977a-b67a-4769-acd5-26946ef71b60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0e3496b9-7114-4e16-8ef6-00d3d5df4c13" xlink:to="loc_us-gaap_CommonStockMember_c442977a-b67a-4769-acd5-26946ef71b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_d2055b4a-4ee6-4578-a27c-892f145019a3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_d2055b4a-4ee6-4578-a27c-892f145019a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e59ed3a4-39bf-408d-b502-53fdc88c914c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_d2055b4a-4ee6-4578-a27c-892f145019a3" xlink:to="loc_us-gaap_ClassOfStockDomain_e59ed3a4-39bf-408d-b502-53fdc88c914c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulySharesAndJulyCommonWarrantMember_f99df2bc-a44b-406f-8223-c1e3ad96c4cb" xlink:href="angn-20250930.xsd#angn_JulySharesAndJulyCommonWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e59ed3a4-39bf-408d-b502-53fdc88c914c" xlink:to="loc_angn_JulySharesAndJulyCommonWarrantMember_f99df2bc-a44b-406f-8223-c1e3ad96c4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_286dc73a-3c67-4608-9e9b-6cc0016dfb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_286dc73a-3c67-4608-9e9b-6cc0016dfb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_286dc73a-3c67-4608-9e9b-6cc0016dfb6d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RegistrationStatementMember_2290a852-994a-4f87-8833-94e37dde3a75" xlink:href="angn-20250930.xsd#angn_RegistrationStatementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_RegistrationStatementMember_2290a852-994a-4f87-8833-94e37dde3a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_f17e6c6f-1e22-42a8-9380-853a915c8591" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2022Member_f17e6c6f-1e22-42a8-9380-853a915c8591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_A2024RegistrationStatementMember_4a8b7e45-1d45-454d-a3b7-5d1da850e1fb" xlink:href="angn-20250930.xsd#angn_A2024RegistrationStatementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_A2024RegistrationStatementMember_4a8b7e45-1d45-454d-a3b7-5d1da850e1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_e44711da-b9e6-4081-bd29-23127255177e" xlink:href="angn-20250930.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_MarchSubscriptionAgreementMember_e44711da-b9e6-4081-bd29-23127255177e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_041e1d5d-efad-4869-b399-e4045ea0f8c0" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_JulyPublicOfferingMember_041e1d5d-efad-4869-b399-e4045ea0f8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_cd017dfa-4373-4d5b-a9dc-aa021a73fbf3" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreementMember_cd017dfa-4373-4d5b-a9dc-aa021a73fbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_3a422db3-5595-4ce7-86c8-9ce94c8037cb" xlink:href="angn-20250930.xsd#angn_AtTheMarketEquityOfferingSalesAgreement2024Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_AtTheMarketEquityOfferingSalesAgreement2024Member_3a422db3-5595-4ce7-86c8-9ce94c8037cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryPublicOfferingMember_a8e4f4cf-ea36-434b-8500-5a5369a4d4eb" xlink:href="angn-20250930.xsd#angn_JanuaryPublicOfferingMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2b480a4a-277b-449d-b1da-3d05cd2a458d" xlink:to="loc_angn_JanuaryPublicOfferingMember_a8e4f4cf-ea36-434b-8500-5a5369a4d4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1322ba95-7da4-4b21-a566-68eccd37a429" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1322ba95-7da4-4b21-a566-68eccd37a429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1322ba95-7da4-4b21-a566-68eccd37a429" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_1b42502e-5a76-48d8-8c79-4b1495ecf30b" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_PreFundedWarrantMember_1b42502e-5a76-48d8-8c79-4b1495ecf30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_77b49025-544c-4c81-a9b0-e8ef60432eed" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JulyCommonWarrantsMember_77b49025-544c-4c81-a9b0-e8ef60432eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JanuaryCommonWarrantsMember_5c4acbe7-e7e5-4682-ad7f-ed96890b0bef" xlink:href="angn-20250930.xsd#angn_JanuaryCommonWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JanuaryCommonWarrantsMember_5c4acbe7-e7e5-4682-ad7f-ed96890b0bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsMember_f735c0ba-7885-4dc1-88c2-1312ee156356" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JulyPreFundedWarrantsMember_f735c0ba-7885-4dc1-88c2-1312ee156356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_8f3b1b8c-5e4b-49e1-b605-67dba6cb94f5" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7238aeea-ee6c-448d-8d87-188e4f0ce482" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_8f3b1b8c-5e4b-49e1-b605-67dba6cb94f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_45b3cc07-3846-4533-a93a-08c0ba74789d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_DebtInstrumentAxis_45b3cc07-3846-4533-a93a-08c0ba74789d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_59510b1f-edc2-455f-8767-bb3071856a03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_45b3cc07-3846-4533-a93a-08c0ba74789d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_59510b1f-edc2-455f-8767-bb3071856a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b33a7281-7c35-4496-948e-1a96b5a05ba4" xlink:href="angn-20250930.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_59510b1f-edc2-455f-8767-bb3071856a03" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b33a7281-7c35-4496-948e-1a96b5a05ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_50ba4bca-3ec0-481a-b6ad-e603b62f132f" xlink:to="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_2f983fc8-4a50-42bf-b14a-73e4b46f0e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_2f983fc8-4a50-42bf-b14a-73e4b46f0e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8ea1300a-f3e3-45cb-8657-489c7ff98b43" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8ea1300a-f3e3-45cb-8657-489c7ff98b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f5d34d07-c889-466e-ac44-64ce800d483a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f5d34d07-c889-466e-ac44-64ce800d483a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5a2e996b-ba94-4ddc-b01e-7ec9759e31a7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_5a2e996b-ba94-4ddc-b01e-7ec9759e31a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SaleOfStockAggregateInitialOfferingPrice_7053e0a8-faee-418b-9afe-658252b46821" xlink:href="angn-20250930.xsd#angn_SaleOfStockAggregateInitialOfferingPrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_angn_SaleOfStockAggregateInitialOfferingPrice_7053e0a8-faee-418b-9afe-658252b46821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4f554c3-98b3-4462-8fcc-6af7dc19b9b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e4f554c3-98b3-4462-8fcc-6af7dc19b9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8a1a0838-c220-4f63-8d0f-b9091a5ea094" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8a1a0838-c220-4f63-8d0f-b9091a5ea094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e77f0683-8d0b-4918-a35d-37447898724e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e77f0683-8d0b-4918-a35d-37447898724e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d376d75-3403-4f14-b379-d0a6e9706769" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d376d75-3403-4f14-b379-d0a6e9706769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssuedPricePerShare_650471e3-8aeb-4a93-a5b4-8afcb1340025" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SharesIssuedPricePerShare_650471e3-8aeb-4a93-a5b4-8afcb1340025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_653f1a8a-632c-4780-8f63-cd14b1ad793e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_653f1a8a-632c-4780-8f63-cd14b1ad793e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b004b99d-56f5-4859-bf92-eb2d29314820" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_b004b99d-56f5-4859-bf92-eb2d29314820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3f2ed128-0451-42c7-973e-88b03b1d14a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3f2ed128-0451-42c7-973e-88b03b1d14a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_5e582670-4709-437c-bb00-1cfb53fbf4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_5e582670-4709-437c-bb00-1cfb53fbf4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_108d363f-a5ef-438f-8e19-176b6e464387" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_108d363f-a5ef-438f-8e19-176b6e464387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9a1fe527-b422-4c7c-af54-e4321f874948" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9a1fe527-b422-4c7c-af54-e4321f874948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_7291d093-67f2-4820-b6bb-544404ce4f6c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_02189c82-fa5a-46b8-93a0-3e94b70ab8ee" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_7291d093-67f2-4820-b6bb-544404ce4f6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3d2284cd-f133-4918-9f3f-795e07768f82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3d2284cd-f133-4918-9f3f-795e07768f82" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_290cddaa-e717-4736-acb7-d81f42bb3f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:to="loc_us-gaap_PlanNameAxis_290cddaa-e717-4736-acb7-d81f42bb3f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_290cddaa-e717-4736-acb7-d81f42bb3f8e" xlink:to="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2021PlanMember_caf052cd-e6ef-4f09-8e3d-aac2fe5d6673" xlink:href="angn-20250930.xsd#angn_The2021PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:to="loc_angn_The2021PlanMember_caf052cd-e6ef-4f09-8e3d-aac2fe5d6673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_The2022PlanMember_5ee94cec-921e-4488-926e-c938fa48b63c" xlink:href="angn-20250930.xsd#angn_The2022PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:to="loc_angn_The2022PlanMember_5ee94cec-921e-4488-926e-c938fa48b63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_Inducement2024PlanMember_bf11cabd-b4f8-4546-b993-3ff1d4725d6d" xlink:href="angn-20250930.xsd#angn_Inducement2024PlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_dd55f88f-334d-4947-975e-f2480b4c0cb5" xlink:to="loc_angn_Inducement2024PlanMember_bf11cabd-b4f8-4546-b993-3ff1d4725d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c5019569-2c1f-496c-8230-f9aa8ac002ac" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:to="loc_us-gaap_AwardTypeAxis_c5019569-2c1f-496c-8230-f9aa8ac002ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22ce0c48-a928-40d6-bfb0-6c164f444be0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c5019569-2c1f-496c-8230-f9aa8ac002ac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22ce0c48-a928-40d6-bfb0-6c164f444be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_b8c413b4-5d01-4f58-96e3-fc4501999477" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22ce0c48-a928-40d6-bfb0-6c164f444be0" xlink:to="loc_us-gaap_EmployeeStockMember_b8c413b4-5d01-4f58-96e3-fc4501999477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_147c038d-15a8-4182-938f-66295b0922d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ed8a46df-787a-4c5b-ad89-49674bb36879" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_ed8a46df-787a-4c5b-ad89-49674bb36879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_6ce3a2b8-7d77-4310-a720-9b108ace5b82" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_6ce3a2b8-7d77-4310-a720-9b108ace5b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_56d075b7-85fa-4ff2-968b-fdcdcbf60e8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_56d075b7-85fa-4ff2-968b-fdcdcbf60e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5cda87d3-dfba-45af-a817-9fa4db4026a8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5cda87d3-dfba-45af-a817-9fa4db4026a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d26669e3-8db4-4b38-a7d6-64803e065548" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_d26669e3-8db4-4b38-a7d6-64803e065548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9740bde9-f9dc-4984-98a2-81117ac28dc4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9740bde9-f9dc-4984-98a2-81117ac28dc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3c42b2b4-0b57-4e01-baff-266793fd1c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8d31f764-62ab-4780-acc3-f9fc13b8f2db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_3c42b2b4-0b57-4e01-baff-266793fd1c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationScheduleofShareOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a99b62c7-a2ff-4c7f-974a-4ff48f92a1fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de00b2d5-d8b8-4331-a4c5-ead35544a6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a99b62c7-a2ff-4c7f-974a-4ff48f92a1fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de00b2d5-d8b8-4331-a4c5-ead35544a6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3dba80a5-85d7-43b3-b534-9f5939ca8e77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de00b2d5-d8b8-4331-a4c5-ead35544a6e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3dba80a5-85d7-43b3-b534-9f5939ca8e77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6e08da94-64d0-43fc-9a07-0cc0134d035f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de00b2d5-d8b8-4331-a4c5-ead35544a6e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_6e08da94-64d0-43fc-9a07-0cc0134d035f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d744a33a-9862-45b7-b051-f2659dadfc6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de00b2d5-d8b8-4331-a4c5-ead35544a6e0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d744a33a-9862-45b7-b051-f2659dadfc6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6cc98025-16f5-4320-a4a0-0510b4efcac4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de00b2d5-d8b8-4331-a4c5-ead35544a6e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6cc98025-16f5-4320-a4a0-0510b4efcac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_929d3e41-2c78-4c9e-8825-5156f20a4e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_de00b2d5-d8b8-4331-a4c5-ead35544a6e0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_929d3e41-2c78-4c9e-8825-5156f20a4e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b4851321-b864-49e0-894c-a0f3bbd504ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a99b62c7-a2ff-4c7f-974a-4ff48f92a1fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b4851321-b864-49e0-894c-a0f3bbd504ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_959289ab-f0eb-47c1-af5e-cafe5a933371" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a99b62c7-a2ff-4c7f-974a-4ff48f92a1fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_959289ab-f0eb-47c1-af5e-cafe5a933371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3315ccc2-2581-4892-aef5-94be6aa6170e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_959289ab-f0eb-47c1-af5e-cafe5a933371" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3315ccc2-2581-4892-aef5-94be6aa6170e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a64f308e-d7de-4e2a-aa49-08c17e12ab96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_959289ab-f0eb-47c1-af5e-cafe5a933371" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a64f308e-d7de-4e2a-aa49-08c17e12ab96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6db5f972-7337-4a81-aa46-cd786a04e8c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_959289ab-f0eb-47c1-af5e-cafe5a933371" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_6db5f972-7337-4a81-aa46-cd786a04e8c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_24306dd1-b0a2-4923-aaf0-8b81a9bb73d6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_959289ab-f0eb-47c1-af5e-cafe5a933371" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_24306dd1-b0a2-4923-aaf0-8b81a9bb73d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bd0dcc4c-a66e-4d03-911a-bdf709153948" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_959289ab-f0eb-47c1-af5e-cafe5a933371" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bd0dcc4c-a66e-4d03-911a-bdf709153948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a2bfacd3-8f90-43eb-a475-885b6f9d1f92" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a99b62c7-a2ff-4c7f-974a-4ff48f92a1fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a2bfacd3-8f90-43eb-a475-885b6f9d1f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_657d0a6a-2411-428f-8fc3-97db398a8d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a99b62c7-a2ff-4c7f-974a-4ff48f92a1fc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_657d0a6a-2411-428f-8fc3-97db398a8d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0d7e281a-3e40-4d76-9dff-585ce6f1abdf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_657d0a6a-2411-428f-8fc3-97db398a8d1f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_0d7e281a-3e40-4d76-9dff-585ce6f1abdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_967ef450-bd9f-4d3b-9402-0e0dd3636a6a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_657d0a6a-2411-428f-8fc3-97db398a8d1f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_967ef450-bd9f-4d3b-9402-0e0dd3636a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aac1a4a5-d722-4b5e-b20a-36d494615876" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_657d0a6a-2411-428f-8fc3-97db398a8d1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_aac1a4a5-d722-4b5e-b20a-36d494615876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5ca4cf75-8b7f-438c-a24a-e4d726dd1aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_657d0a6a-2411-428f-8fc3-97db398a8d1f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_5ca4cf75-8b7f-438c-a24a-e4d726dd1aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a729945-3dae-4231-a2a1-723f9456b7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_eeff083b-3fcb-4815-bec7-257a3ec8a37a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a729945-3dae-4231-a2a1-723f9456b7dc" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_eeff083b-3fcb-4815-bec7-257a3ec8a37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3d6c6c47-a589-4532-8ece-f71228fd93d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_eeff083b-3fcb-4815-bec7-257a3ec8a37a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3d6c6c47-a589-4532-8ece-f71228fd93d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3d6c6c47-a589-4532-8ece-f71228fd93d7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_293593d8-d409-4b18-bd37-eb2b7a678956" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_293593d8-d409-4b18-bd37-eb2b7a678956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5ea4154d-607f-4c30-adeb-a174149e5e47" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_809cb904-0701-458c-8c2e-186409c315c6" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_5ea4154d-607f-4c30-adeb-a174149e5e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_59c8602a-d9c8-4c49-b069-24218b145a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_eeff083b-3fcb-4815-bec7-257a3ec8a37a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_59c8602a-d9c8-4c49-b069-24218b145a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_10fd4b0d-5d18-4c45-b16d-1df2338557a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_59c8602a-d9c8-4c49-b069-24218b145a5c" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_10fd4b0d-5d18-4c45-b16d-1df2338557a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ec80333-b94f-4545-9164-2ef9ec47356c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1ec80333-b94f-4545-9164-2ef9ec47356c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:to="loc_us-gaap_AwardTypeAxis_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20a76052-2c75-41b8-bffb-e8943b4564da" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1ee4b3d3-8dcc-4be3-ae8b-bfe32932e03b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20a76052-2c75-41b8-bffb-e8943b4564da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_300710cf-480c-4679-a2e2-e4b34722242b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_20a76052-2c75-41b8-bffb-e8943b4564da" xlink:to="loc_us-gaap_EmployeeStockOptionMember_300710cf-480c-4679-a2e2-e4b34722242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_51f53ec9-0d8a-43a1-9119-bc17dde4b55e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:to="loc_srt_RangeAxis_51f53ec9-0d8a-43a1-9119-bc17dde4b55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_51f53ec9-0d8a-43a1-9119-bc17dde4b55e" xlink:to="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c6ad2fa5-99b9-4751-9d9b-cb57324edb2e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:to="loc_srt_MinimumMember_c6ad2fa5-99b9-4751-9d9b-cb57324edb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ece9003a-c798-4dda-97d9-4b1d25143ac4" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_57af5a3e-abf7-4f11-8991-053d4bfb6e01" xlink:to="loc_srt_MaximumMember_ece9003a-c798-4dda-97d9-4b1d25143ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5db7df45-3f6d-4600-9d60-b68af478c664" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dfbd3911-f9bb-4fec-9094-67d0a6630662" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_dfbd3911-f9bb-4fec-9094-67d0a6630662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_eeef0a22-cd00-4e27-a7bc-3096cef8f019" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_eeef0a22-cd00-4e27-a7bc-3096cef8f019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_543634e8-4913-44b4-9b6e-b37fd1216c84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_543634e8-4913-44b4-9b6e-b37fd1216c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60352115-34f3-4418-8576-199a70d3894f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_60352115-34f3-4418-8576-199a70d3894f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_da4f4f14-e10d-4818-845c-08fadf50ec75" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_da4f4f14-e10d-4818-845c-08fadf50ec75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_cb21f663-8f89-4002-8586-c1ae42e4eafd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5eaab9a7-4486-49e7-aa29-a61fe86e9828" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_cb21f663-8f89-4002-8586-c1ae42e4eafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#WarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_97b148d9-9246-4eed-bb92-9ec33212ed62" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_97b148d9-9246-4eed-bb92-9ec33212ed62" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_198b3efe-5abe-4a20-ab21-5367ec1c3037" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_198b3efe-5abe-4a20-ab21-5367ec1c3037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_198b3efe-5abe-4a20-ab21-5367ec1c3037" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_403a8cf9-268d-40e4-bcbb-d009bec351c5" xlink:href="angn-20250930.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_March2024PreFundedWarrantsMember_403a8cf9-268d-40e4-bcbb-d009bec351c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_4d9e9ef3-0eba-43a9-8e9b-7505948a9c7b" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_PreFundedWarrantMember_4d9e9ef3-0eba-43a9-8e9b-7505948a9c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_f9b72fef-c59a-443a-b553-5b1e7532f003" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_JulyCommonWarrantsMember_f9b72fef-c59a-443a-b553-5b1e7532f003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_54dae0ba-0bfc-4843-ac10-9ce9bd0e4610" xlink:href="angn-20250930.xsd#angn_January2025CommonWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_January2025CommonWarrantsMember_54dae0ba-0bfc-4843-ac10-9ce9bd0e4610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_3b75afb0-3517-4e90-8818-1bb058f767ad" xlink:href="angn-20250930.xsd#angn_June2025WarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_June2025WarrantsMember_3b75afb0-3517-4e90-8818-1bb058f767ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_c1742dbb-1933-4719-821a-933b80161142" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_b25617ca-42c6-486f-87dc-2fcedf17d655" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_c1742dbb-1933-4719-821a-933b80161142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f3265864-3dd8-4d9b-a911-8d0784d1f68e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f3265864-3dd8-4d9b-a911-8d0784d1f68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f3265864-3dd8-4d9b-a911-8d0784d1f68e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_932fc1c3-d010-4564-a6b4-e4fd7eca214b" xlink:href="angn-20250930.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:to="loc_angn_MarchSubscriptionAgreementMember_932fc1c3-d010-4564-a6b4-e4fd7eca214b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_37cbf718-41e8-47a2-999c-236502b5b015" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6b167ab2-5a5b-4cba-95d0-ae28d5c66b1e" xlink:to="loc_angn_JulyPublicOfferingMember_37cbf718-41e8-47a2-999c-236502b5b015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6778dee7-f3e9-47d6-ae96-37b5bc92f547" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6778dee7-f3e9-47d6-ae96-37b5bc92f547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_46594617-c84a-48bc-ac93-a81fb8458456" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6778dee7-f3e9-47d6-ae96-37b5bc92f547" xlink:to="loc_us-gaap_EquityComponentDomain_46594617-c84a-48bc-ac93-a81fb8458456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f2b97592-e1cd-4cac-9ca3-cd51c78c7f70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_46594617-c84a-48bc-ac93-a81fb8458456" xlink:to="loc_us-gaap_CommonStockMember_f2b97592-e1cd-4cac-9ca3-cd51c78c7f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_77642354-90a6-498e-a1c7-5f7b14acb75d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d872d5d-1ca8-4af8-91e1-5f105c010611" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2d872d5d-1ca8-4af8-91e1-5f105c010611" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantExercisedFairValue_23039124-f053-4598-9a29-b92b66b27350" xlink:href="angn-20250930.xsd#angn_WarrantExercisedFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_angn_WarrantExercisedFairValue_23039124-f053-4598-9a29-b92b66b27350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GainLossOnIssuanceOfWarrants_85cc6867-dd9b-45a2-bcb0-c25166f448ea" xlink:href="angn-20250930.xsd#angn_GainLossOnIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_angn_GainLossOnIssuanceOfWarrants_85cc6867-dd9b-45a2-bcb0-c25166f448ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_d042e365-9e22-4664-b634-af27aef3ddca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_d042e365-9e22-4664-b634-af27aef3ddca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_0450426f-10e3-432d-9912-f09b079938b6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_0450426f-10e3-432d-9912-f09b079938b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_9405aa88-e501-4584-b4c2-aa3552abda3c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_9405aa88-e501-4584-b4c2-aa3552abda3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_8a7f40aa-8cee-4498-8226-f525040fb035" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_8a7f40aa-8cee-4498-8226-f525040fb035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30164a45-b096-4cdb-ac88-55354e23dc0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_3586736c-b72b-41a1-bfb7-ce3f6675af87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30164a45-b096-4cdb-ac88-55354e23dc0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#WarrantsScheduleofOutstandingWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_5744f629-42ad-49ee-9e27-21a92215a358" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_5744f629-42ad-49ee-9e27-21a92215a358" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ab6dab1f-36ab-4ecb-9e2f-164d6b1bb4a5" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ElicioWarrantsMember_ccd00a62-2080-4ae3-a5b5-fc87951d3b26" xlink:href="angn-20250930.xsd#angn_ElicioWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_ElicioWarrantsMember_ccd00a62-2080-4ae3-a5b5-fc87951d3b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AngionWarrantsMember_860c69e8-0715-437b-bb92-400866daa5ff" xlink:href="angn-20250930.xsd#angn_AngionWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_AngionWarrantsMember_860c69e8-0715-437b-bb92-400866daa5ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_March2024PreFundedWarrantsMember_2b90abf4-ced4-43c8-866c-49fe085be487" xlink:href="angn-20250930.xsd#angn_March2024PreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_March2024PreFundedWarrantsMember_2b90abf4-ced4-43c8-866c-49fe085be487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_de885de2-6530-4d0c-8e36-409ffdac637c" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_PreFundedWarrantMember_de885de2-6530-4d0c-8e36-409ffdac637c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyCommonWarrantsMember_2c7e6f7f-ec67-4a87-b6d9-4265c92a7489" xlink:href="angn-20250930.xsd#angn_JulyCommonWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_JulyCommonWarrantsMember_2c7e6f7f-ec67-4a87-b6d9-4265c92a7489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_January2025CommonWarrantsMember_50f2c4d4-fa7a-42b6-a05a-e9c5fa66dc7b" xlink:href="angn-20250930.xsd#angn_January2025CommonWarrantsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_January2025CommonWarrantsMember_50f2c4d4-fa7a-42b6-a05a-e9c5fa66dc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025CommonWarrantsMember_ccdfa9e2-559b-4b54-8bd3-53355eaa0a1e" xlink:href="angn-20250930.xsd#angn_June2025CommonWarrantsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_622a378f-89ce-453b-a471-199723d86a17" xlink:to="loc_angn_June2025CommonWarrantsMember_ccdfa9e2-559b-4b54-8bd3-53355eaa0a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5744d56b-3690-4d95-95d4-a51db7061f48" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:to="loc_srt_RangeAxis_5744d56b-3690-4d95-95d4-a51db7061f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9adf55e8-a547-4ec7-9032-b44a64065308" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5744d56b-3690-4d95-95d4-a51db7061f48" xlink:to="loc_srt_RangeMember_9adf55e8-a547-4ec7-9032-b44a64065308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_9dac5ec8-0f2f-4e2f-9391-8676b70768fc" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9adf55e8-a547-4ec7-9032-b44a64065308" xlink:to="loc_srt_WeightedAverageMember_9dac5ec8-0f2f-4e2f-9391-8676b70768fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_17e1c432-a991-44cb-bf04-3b2babe1a745" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_168eeda4-8cde-45ed-8d0e-ccdbc2c54c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_168eeda4-8cde-45ed-8d0e-ccdbc2c54c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3308c1-3f81-4806-9e6c-8b05f54e3e03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7c3308c1-3f81-4806-9e6c-8b05f54e3e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_853669a1-020c-43ce-8824-35ecf2dc1b01" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_5842daf3-b467-4c49-aa93-3cb921594003" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms_853669a1-020c-43ce-8824-35ecf2dc1b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#WarrantsScheduleofWarrantsActivityDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_angn_WarrantsAndRightsOutstandingAbstract_25c4ef49-e0b3-416d-94fa-16f9e8c100e6" xlink:href="angn-20250930.xsd#angn_WarrantsAndRightsOutstandingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightRollForward_f1be5715-1a94-431a-8265-69bb08e20d4e" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_25c4ef49-e0b3-416d-94fa-16f9e8c100e6" xlink:to="loc_angn_ClassOfWarrantOrRightRollForward_f1be5715-1a94-431a-8265-69bb08e20d4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_907b2334-41ca-4317-a239-ce8c57bf5951" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_f1be5715-1a94-431a-8265-69bb08e20d4e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_907b2334-41ca-4317-a239-ce8c57bf5951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_49fd6612-b3a6-497c-8522-23187c081bbe" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_f1be5715-1a94-431a-8265-69bb08e20d4e" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_49fd6612-b3a6-497c-8522-23187c081bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightExercisedInPeriod_7bcd8c0c-bba8-416c-87ef-ceb21176a26d" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightExercisedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_f1be5715-1a94-431a-8265-69bb08e20d4e" xlink:to="loc_angn_ClassOfWarrantOrRightExercisedInPeriod_7bcd8c0c-bba8-416c-87ef-ceb21176a26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5e9ba03a-7835-47a2-90ca-2a2b1fbe2ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightRollForward_f1be5715-1a94-431a-8265-69bb08e20d4e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_5e9ba03a-7835-47a2-90ca-2a2b1fbe2ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_a3842718-a4c6-42ba-9f6d-1c40fe0d0aa8" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_25c4ef49-e0b3-416d-94fa-16f9e8c100e6" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_a3842718-a4c6-42ba-9f6d-1c40fe0d0aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_757d8643-1a0b-4ab7-8c6c-b591604f040d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_a3842718-a4c6-42ba-9f6d-1c40fe0d0aa8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_757d8643-1a0b-4ab7-8c6c-b591604f040d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_9b5d30f0-c8dd-418d-956e-654d89fa7d28" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_a3842718-a4c6-42ba-9f6d-1c40fe0d0aa8" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod_9b5d30f0-c8dd-418d-956e-654d89fa7d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_99f73a15-86e1-4e7b-ae3c-044b79d9d1e1" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_a3842718-a4c6-42ba-9f6d-1c40fe0d0aa8" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod_99f73a15-86e1-4e7b-ae3c-044b79d9d1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_75fcd517-1d3c-4ae5-8db0-2b983c14b70d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward_a3842718-a4c6-42ba-9f6d-1c40fe0d0aa8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_75fcd517-1d3c-4ae5-8db0-2b983c14b70d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_428f1195-397f-4551-8cee-f9e7f30b7be7" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_WarrantsAndRightsOutstandingAbstract_25c4ef49-e0b3-416d-94fa-16f9e8c100e6" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_428f1195-397f-4551-8cee-f9e7f30b7be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_09ea941a-1634-4575-869f-531fb5c1e9b9" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_428f1195-397f-4551-8cee-f9e7f30b7be7" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_09ea941a-1634-4575-869f-531fb5c1e9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_36453e05-7265-4f03-9603-6853daa73d9d" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightWeightedAverageLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward_428f1195-397f-4551-8cee-f9e7f30b7be7" xlink:to="loc_angn_ClassOfWarrantOrRightWeightedAverageLife_36453e05-7265-4f03-9603-6853daa73d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8a3d1815-f7e2-4cd1-ab5f-5b2567b45b50" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:href="angn-20250930.xsd#angn_CommitmentsAndContingenciesDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8a3d1815-f7e2-4cd1-ab5f-5b2567b45b50" xlink:to="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_6a83c3e7-78e4-46aa-aeef-f63090f7147b" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_srt_StatementScenarioAxis_6a83c3e7-78e4-46aa-aeef-f63090f7147b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_9faa7f70-965c-46b2-bdbc-f2b8d4cf3e5e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_6a83c3e7-78e4-46aa-aeef-f63090f7147b" xlink:to="loc_srt_ScenarioUnspecifiedDomain_9faa7f70-965c-46b2-bdbc-f2b8d4cf3e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_aaf5d6cc-d358-431e-acf4-4bf4d8f383d7" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_9faa7f70-965c-46b2-bdbc-f2b8d4cf3e5e" xlink:to="loc_srt_ScenarioForecastMember_aaf5d6cc-d358-431e-acf4-4bf4d8f383d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1d773fd8-f73a-4429-aa97-ec4a16cea3c5" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_srt_RangeAxis_1d773fd8-f73a-4429-aa97-ec4a16cea3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1d773fd8-f73a-4429-aa97-ec4a16cea3c5" xlink:to="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_caf57e38-d44e-458f-bb17-83aeee37ffe6" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:to="loc_srt_MinimumMember_caf57e38-d44e-458f-bb17-83aeee37ffe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_cabdaf64-9b69-4723-ac2c-db8483055e58" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_161777bf-e871-4d67-b8e3-106724ae2f13" xlink:to="loc_srt_MaximumMember_cabdaf64-9b69-4723-ac2c-db8483055e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_943756a7-ab20-4ca1-84a2-8721d13968f0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_us-gaap_TypeOfArrangementAxis_943756a7-ab20-4ca1-84a2-8721d13968f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b1f65444-7b80-4166-8e41-b36e6e8bfe9b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_943756a7-ab20-4ca1-84a2-8721d13968f0" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b1f65444-7b80-4166-8e41-b36e6e8bfe9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_df3c72c7-2174-4ca7-9b96-43fe6d86f245" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_b1f65444-7b80-4166-8e41-b36e6e8bfe9b" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_df3c72c7-2174-4ca7-9b96-43fe6d86f245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_srt_CounterpartyNameAxis_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3acdc650-4e67-45d2-92a5-4186c75e7619" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d33ca6ea-ce0c-4a3d-94f7-5f09bcf62f69" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3acdc650-4e67-45d2-92a5-4186c75e7619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_UniversityMember_537eaa49-a77a-41ba-97fe-80c642927c75" xlink:href="angn-20250930.xsd#angn_UniversityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3acdc650-4e67-45d2-92a5-4186c75e7619" xlink:to="loc_angn_UniversityMember_537eaa49-a77a-41ba-97fe-80c642927c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:href="angn-20250930.xsd#angn_CommitmentsAndContingenciesDisclosureLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureTable_cf7f15ee-b4e3-4ed3-abeb-ac5e0a6d50d6" xlink:to="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_RoyaltyRatePercent_32c84b34-61ef-443a-884d-d609ab582846" xlink:href="angn-20250930.xsd#angn_RoyaltyRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_angn_RoyaltyRatePercent_32c84b34-61ef-443a-884d-d609ab582846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d0a01646-8c2e-4bbe-856a-fa94ba8d8ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d0a01646-8c2e-4bbe-856a-fa94ba8d8ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_4da6f507-9234-4083-9294-9d95ba38f1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_us-gaap_RoyaltyExpense_4da6f507-9234-4083-9294-9d95ba38f1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_b62d35f2-b2f3-4a9f-9422-63e14a40efbe" xlink:href="angn-20250930.xsd#angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct_b62d35f2-b2f3-4a9f-9422-63e14a40efbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_742e3f4f-7502-44ae-8dad-93b8755d8167" xlink:href="angn-20250930.xsd#angn_CollaborativeArrangementFutureMinimumMaintenancePayments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_angn_CommitmentsAndContingenciesDisclosureLineItems_2b1aeded-a99b-4521-b489-f87ffdda2b00" xlink:to="loc_angn_CollaborativeArrangementFutureMinimumMaintenancePayments_742e3f4f-7502-44ae-8dad-93b8755d8167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5b299e50-382b-4d3d-a72a-934821c131d7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_127cee1d-d982-4018-8c5b-10f1defa2911" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5b299e50-382b-4d3d-a72a-934821c131d7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_127cee1d-d982-4018-8c5b-10f1defa2911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_127cee1d-d982-4018-8c5b-10f1defa2911" xlink:to="loc_srt_StatementGeographicalAxis_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fa1604f8-3b6e-4bcf-8ecf-c216c15a8615" xlink:to="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_BostonMassachusettsMember_fb091d13-f9ba-47fc-a225-1225817343a4" xlink:href="angn-20250930.xsd#angn_BostonMassachusettsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:to="loc_angn_BostonMassachusettsMember_fb091d13-f9ba-47fc-a225-1225817343a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_NewtonMassachusettsMember_8ba1bb67-85e7-41f3-b5ca-0d21c59512cd" xlink:href="angn-20250930.xsd#angn_NewtonMassachusettsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_00ab1ab7-03b9-4433-83cb-ae24257a3f50" xlink:to="loc_angn_NewtonMassachusettsMember_8ba1bb67-85e7-41f3-b5ca-0d21c59512cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_127cee1d-d982-4018-8c5b-10f1defa2911" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_148c6655-366f-4804-b015-24052c63adf9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_OperatingLeaseExpense_148c6655-366f-4804-b015-24052c63adf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_b0ced0d1-755f-401a-aaf5-b0143dc0a523" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_b0ced0d1-755f-401a-aaf5-b0143dc0a523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9cd43aa2-a3ec-4207-adc8-e6e4c1a961a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9cd43aa2-a3ec-4207-adc8-e6e4c1a961a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_26f5bc11-5644-4d40-a094-3af5ab2a0df3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSecuredLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_ProceedsFromSecuredLinesOfCredit_26f5bc11-5644-4d40-a094-3af5ab2a0df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_0226ecbc-a0f4-4fc2-9b6c-47e28a675a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_0226ecbc-a0f4-4fc2-9b6c-47e28a675a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseAnnualRentExpense_7298031c-67d8-4d12-8ac8-2095e4b50d68" xlink:href="angn-20250930.xsd#angn_LesseeOperatingLeaseAnnualRentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_85881c4b-b7cd-4a05-9e5c-21541c51f24d" xlink:to="loc_angn_LesseeOperatingLeaseAnnualRentExpense_7298031c-67d8-4d12-8ac8-2095e4b50d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f26483ca-f16b-4fd4-85b1-04de57472d74" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ff84cbfe-171d-4836-9d19-24d8081fc267" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f26483ca-f16b-4fd4-85b1-04de57472d74" xlink:to="loc_us-gaap_OperatingLeasePayments_ff84cbfe-171d-4836-9d19-24d8081fc267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1239e0c3-9e35-4f5b-867b-501ce8fd7cf9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f26483ca-f16b-4fd4-85b1-04de57472d74" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_1239e0c3-9e35-4f5b-867b-501ce8fd7cf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2dde2059-b8cd-4d11-be21-ddc0b565e6d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f26483ca-f16b-4fd4-85b1-04de57472d74" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2dde2059-b8cd-4d11-be21-ddc0b565e6d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a0e9d02a-1e17-40b2-b349-caef466f2f78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a0e9d02a-1e17-40b2-b349-caef466f2f78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_94a5d5d5-fbb9-4c29-961e-4cb62697860f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_94a5d5d5-fbb9-4c29-961e-4cb62697860f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_80f9ef25-14d2-4046-922e-03df74c1ef15" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_80f9ef25-14d2-4046-922e-03df74c1ef15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_39ada971-a250-4027-84b5-91dd867ea9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_39ada971-a250-4027-84b5-91dd867ea9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7a871e98-4a95-483c-b76b-a19c354c5852" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7a871e98-4a95-483c-b76b-a19c354c5852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_d39f4c8b-aee8-4057-a450-fe9be777d103" xlink:href="angn-20250930.xsd#angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour_d39f4c8b-aee8-4057-a450-fe9be777d103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e48ebb23-68c5-4041-8d3a-bb791ea99595" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e48ebb23-68c5-4041-8d3a-bb791ea99595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1247baab-9b2c-4904-b2e7-3c45fc84948c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_1247baab-9b2c-4904-b2e7-3c45fc84948c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ae58bea4-06dc-422e-99f6-13def005d18a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_OperatingLeaseLiability_ae58bea4-06dc-422e-99f6-13def005d18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b08ab7e5-adcc-4b4a-8bc4-9203730700ee" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b08ab7e5-adcc-4b4a-8bc4-9203730700ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5b8123a8-d1c5-40e3-8848-b8394c59b4fe" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_70a1d38d-0064-4330-97db-03bbb0d4f822" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5b8123a8-d1c5-40e3-8848-b8394c59b4fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/DebtDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#DebtDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/DebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ce92981d-339b-4390-9263-5c82edf2eb0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ce92981d-339b-4390-9263-5c82edf2eb0c" xlink:to="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0cf6da7e-1788-41c7-b496-31b5919ae18b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_DebtInstrumentAxis_0cf6da7e-1788-41c7-b496-31b5919ae18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a3f7135f-586c-4bc6-b520-5e6a22d4b9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0cf6da7e-1788-41c7-b496-31b5919ae18b" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a3f7135f-586c-4bc6-b520-5e6a22d4b9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_923c27ba-9daf-4dc4-a377-df667630c597" xlink:href="angn-20250930.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a3f7135f-586c-4bc6-b520-5e6a22d4b9a1" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_923c27ba-9daf-4dc4-a377-df667630c597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b37cc501-7e29-48be-828a-03694ba5967f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3a2b906e-0bb4-499a-9eb8-67f82fe9ba41" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b37cc501-7e29-48be-828a-03694ba5967f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_0a4fa1b4-2e26-4e68-b53f-01baeac254f1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b37cc501-7e29-48be-828a-03694ba5967f" xlink:to="loc_us-gaap_ConvertibleDebtMember_0a4fa1b4-2e26-4e68-b53f-01baeac254f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ed4a1968-fa5c-4b9f-9fa2-b9361ef34dc3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_98155476-2d2e-4011-a0ed-30b1a0e2760d" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:to="loc_angn_PreFundedWarrantMember_98155476-2d2e-4011-a0ed-30b1a0e2760d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_June2025WarrantsMember_cb86f63a-b2ff-4c67-9080-52395e3b5b45" xlink:href="angn-20250930.xsd#angn_June2025WarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3457e999-fb87-48d7-be9d-daccc095d786" xlink:to="loc_angn_June2025WarrantsMember_cb86f63a-b2ff-4c67-9080-52395e3b5b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_e818e43c-f551-4804-9c68-715be11f0556" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_e818e43c-f551-4804-9c68-715be11f0556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d3e9a2d4-ef9d-4df4-96bb-795f3eb5a09e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_e818e43c-f551-4804-9c68-715be11f0556" xlink:to="loc_us-gaap_EquityComponentDomain_d3e9a2d4-ef9d-4df4-96bb-795f3eb5a09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5d6526e0-10c4-44ad-b4ae-80efeb60ac30" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d3e9a2d4-ef9d-4df4-96bb-795f3eb5a09e" xlink:to="loc_us-gaap_CommonStockMember_5d6526e0-10c4-44ad-b4ae-80efeb60ac30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_cd118232-3455-413b-a970-da705935b3eb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_dei_LegalEntityAxis_cd118232-3455-413b-a970-da705935b3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_249d1d42-4eb9-4662-8c87-b15ff086827b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_cd118232-3455-413b-a970-da705935b3eb" xlink:to="loc_dei_EntityDomain_249d1d42-4eb9-4662-8c87-b15ff086827b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_GKCCMember_a59a7a39-0f1d-4839-aa1e-2063403ad73c" xlink:href="angn-20250930.xsd#angn_GKCCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_249d1d42-4eb9-4662-8c87-b15ff086827b" xlink:to="loc_angn_GKCCMember_a59a7a39-0f1d-4839-aa1e-2063403ad73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cb1e3840-44fa-4c6f-acee-e57064fedb6e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_srt_RangeAxis_cb1e3840-44fa-4c6f-acee-e57064fedb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_22e2c50b-eab8-42e4-a1c7-9c0ab442c99a" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cb1e3840-44fa-4c6f-acee-e57064fedb6e" xlink:to="loc_srt_RangeMember_22e2c50b-eab8-42e4-a1c7-9c0ab442c99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c206e70d-bdac-49df-b0c3-b07084749c20" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_22e2c50b-eab8-42e4-a1c7-9c0ab442c99a" xlink:to="loc_srt_MaximumMember_c206e70d-bdac-49df-b0c3-b07084749c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_362b1885-7e75-4cd7-abd4-6eb7e60f17d8" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de07daa6-5615-4d7f-bba4-70694e7a8a96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de07daa6-5615-4d7f-bba4-70694e7a8a96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_d0f34667-f314-4189-bb08-8b816e817414" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_d0f34667-f314-4189-bb08-8b816e817414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_3981edbc-c673-416c-b880-b6937b02e56c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_3981edbc-c673-416c-b880-b6937b02e56c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_a7217f6b-ede2-4821-ae63-8dbe018cab4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_InterestExpenseDebt_a7217f6b-ede2-4821-ae63-8dbe018cab4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6b72172d-f82c-4ed7-826c-bf4a3224cc03" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_6b72172d-f82c-4ed7-826c-bf4a3224cc03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_b5cb0d87-0be0-4f7e-ab3b-31e22b8875e9" xlink:href="angn-20250930.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_b5cb0d87-0be0-4f7e-ab3b-31e22b8875e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f1c9ffe-7771-45a7-b58b-4c31d58080d1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_9f1c9ffe-7771-45a7-b58b-4c31d58080d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4e0f976d-2c1f-4829-b092-f4bfa52b2e98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_4e0f976d-2c1f-4829-b092-f4bfa52b2e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_04b648ab-29c6-4964-b3f7-5ff7e552ce0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_04b648ab-29c6-4964-b3f7-5ff7e552ce0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_071d587b-9216-49e5-a1eb-0bdf00f6b9a9" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightOwnershipPercentMaximum"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_angn_ClassOfWarrantOrRightOwnershipPercentMaximum_071d587b-9216-49e5-a1eb-0bdf00f6b9a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_af045791-4f44-4055-9c01-e0206bfb3790" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_af045791-4f44-4055-9c01-e0206bfb3790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3db4f1bd-f1da-4daf-b087-55e2696e6d64" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_3db4f1bd-f1da-4daf-b087-55e2696e6d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fa6954c1-9396-494e-a465-daaf02d4a660" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fa6954c1-9396-494e-a465-daaf02d4a660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_708c5a6e-f56a-48af-920a-bd25e30db1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_708c5a6e-f56a-48af-920a-bd25e30db1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_d625d82b-a348-41eb-bc7b-eeb7dcf40bef" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ac68732e-f3dc-43ec-9068-017826dba78a" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_d625d82b-a348-41eb-bc7b-eeb7dcf40bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ee67780b-951e-4a1f-89d3-3489fb88bd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4041cab8-a39f-49ae-92b8-f921caddecc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ee67780b-951e-4a1f-89d3-3489fb88bd5e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4041cab8-a39f-49ae-92b8-f921caddecc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0f4abb88-5006-48c2-b63e-b76d313aa60e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_80ffbbe5-57b7-45e8-9f45-6c8a7680de28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f4abb88-5006-48c2-b63e-b76d313aa60e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_80ffbbe5-57b7-45e8-9f45-6c8a7680de28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6cca81a4-fa88-4e60-8de1-13483c60b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_80ffbbe5-57b7-45e8-9f45-6c8a7680de28" xlink:to="loc_us-gaap_NetIncomeLoss_6cca81a4-fa88-4e60-8de1-13483c60b7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c05adb-e581-44a5-a8ba-f3257bb53276" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f4abb88-5006-48c2-b63e-b76d313aa60e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c05adb-e581-44a5-a8ba-f3257bb53276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2860f2be-fd91-4b2e-956f-1fdc9af993a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c05adb-e581-44a5-a8ba-f3257bb53276" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2860f2be-fd91-4b2e-956f-1fdc9af993a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9c264dbd-dd5a-45f4-b269-926f3a1afca8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c05adb-e581-44a5-a8ba-f3257bb53276" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9c264dbd-dd5a-45f4-b269-926f3a1afca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b4128e88-d436-45e3-a5fa-495bf954d7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f4abb88-5006-48c2-b63e-b76d313aa60e" xlink:to="loc_us-gaap_EarningsPerShareBasic_b4128e88-d436-45e3-a5fa-495bf954d7b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_fa4ac2fe-893c-45ba-8b66-e6b8d2f1793f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0f4abb88-5006-48c2-b63e-b76d313aa60e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_fa4ac2fe-893c-45ba-8b66-e6b8d2f1793f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c227a694-3040-4b04-ba58-b0a70176a0f8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_271b6040-b4bd-4490-9e8f-04f9953da203" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c227a694-3040-4b04-ba58-b0a70176a0f8" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_271b6040-b4bd-4490-9e8f-04f9953da203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3e14adb-5567-4585-85d0-e75af51c1c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_271b6040-b4bd-4490-9e8f-04f9953da203" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3e14adb-5567-4585-85d0-e75af51c1c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_a3e14adb-5567-4585-85d0-e75af51c1c6e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f2372c56-6287-48c2-8dec-13caebfe4766" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f2372c56-6287-48c2-8dec-13caebfe4766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0bf80361-1062-465d-946f-93b74d44f896" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_779df234-df70-48a4-a51b-c369d79c684f" xlink:to="loc_us-gaap_WarrantMember_0bf80361-1062-465d-946f-93b74d44f896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_eee140f9-511e-4024-a741-98fb74fe3066" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_271b6040-b4bd-4490-9e8f-04f9953da203" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_eee140f9-511e-4024-a741-98fb74fe3066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a7fc67c4-a282-44cd-91c9-b397e9a94a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_eee140f9-511e-4024-a741-98fb74fe3066" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_a7fc67c4-a282-44cd-91c9-b397e9a94a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_016db153-c5db-49c2-8155-26256a1a8532" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_016db153-c5db-49c2-8155-26256a1a8532" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f842496d-cdde-40a0-8beb-eb45980b99ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f842496d-cdde-40a0-8beb-eb45980b99ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c8680854-2ccd-45a1-b2c4-a569ec9a3142" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f842496d-cdde-40a0-8beb-eb45980b99ec" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c8680854-2ccd-45a1-b2c4-a569ec9a3142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PurchaseOfWarrantsMember_f4c22c52-1fc9-49c5-b1de-bbe7f479a789" xlink:href="angn-20250930.xsd#angn_PurchaseOfWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_c8680854-2ccd-45a1-b2c4-a569ec9a3142" xlink:to="loc_angn_PurchaseOfWarrantsMember_f4c22c52-1fc9-49c5-b1de-bbe7f479a789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_afc5efd6-5c20-4cea-bb5b-17d6841ecbfa" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_MarchSubscriptionAgreementMember_87eb4fc3-7d20-415d-b140-bf270cb05723" xlink:href="angn-20250930.xsd#angn_MarchSubscriptionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:to="loc_angn_MarchSubscriptionAgreementMember_87eb4fc3-7d20-415d-b140-bf270cb05723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPublicOfferingMember_9b3f4c06-f0e0-41d4-9f94-5be86412c748" xlink:href="angn-20250930.xsd#angn_JulyPublicOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a169bcf7-0355-464f-a96d-f04942bd777b" xlink:to="loc_angn_JulyPublicOfferingMember_9b3f4c06-f0e0-41d4-9f94-5be86412c748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_77a8ef82-28b4-4354-9192-056e15468ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_77a8ef82-28b4-4354-9192-056e15468ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_77a8ef82-28b4-4354-9192-056e15468ebd" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_PreFundedWarrantMember_e8b93baa-8403-4e62-a11f-7e61cf0f775f" xlink:href="angn-20250930.xsd#angn_PreFundedWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:to="loc_angn_PreFundedWarrantMember_e8b93baa-8403-4e62-a11f-7e61cf0f775f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_6ec1752a-63a4-44e5-8be6-290769f27f92" xlink:href="angn-20250930.xsd#angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_a7d636e5-8cae-499b-a490-b613fd321d46" xlink:to="loc_angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember_6ec1752a-63a4-44e5-8be6-290769f27f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_84c8c326-b3d1-4464-92e5-297978ae5862" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_srt_CounterpartyNameAxis_84c8c326-b3d1-4464-92e5-297978ae5862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_84c8c326-b3d1-4464-92e5-297978ae5862" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyMember_9acf35a0-6bfe-4430-b873-a44fb348a7b0" xlink:href="angn-20250930.xsd#angn_YekaterinaChudnovskyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:to="loc_angn_YekaterinaChudnovskyMember_9acf35a0-6bfe-4430-b873-a44fb348a7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_08899bea-4b1b-4af8-a5c4-7850009480c2" xlink:href="angn-20250930.xsd#angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:to="loc_angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember_08899bea-4b1b-4af8-a5c4-7850009480c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_14cb1fac-cf6c-455a-8482-84eacf269bd5" xlink:href="angn-20250930.xsd#angn_YekaterinaChudnovskyAndJayVenkatesanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_772c616f-be41-4eed-9cb4-b191ab9f708e" xlink:to="loc_angn_YekaterinaChudnovskyAndJayVenkatesanMember_14cb1fac-cf6c-455a-8482-84eacf269bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9c25646b-653a-411b-96f2-c83396b67bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_DebtInstrumentAxis_9c25646b-653a-411b-96f2-c83396b67bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_71f14367-4e48-483d-80c9-96ee83893527" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9c25646b-653a-411b-96f2-c83396b67bf3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_71f14367-4e48-483d-80c9-96ee83893527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b69948e5-0034-41b6-86e1-04e1189bb445" xlink:href="angn-20250930.xsd#angn_SeniorSecuredConvertiblePromissoryNoteMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_71f14367-4e48-483d-80c9-96ee83893527" xlink:to="loc_angn_SeniorSecuredConvertiblePromissoryNoteMember_b69948e5-0034-41b6-86e1-04e1189bb445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8afa0553-ef40-422f-882d-c2d15cda8cda" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8afa0553-ef40-422f-882d-c2d15cda8cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_675225bd-ac0e-42c4-adde-e13f78902652" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8afa0553-ef40-422f-882d-c2d15cda8cda" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_675225bd-ac0e-42c4-adde-e13f78902652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_8605fd1a-80f1-4c9c-81c0-1ba969f5a3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_675225bd-ac0e-42c4-adde-e13f78902652" xlink:to="loc_us-gaap_ConvertibleDebtMember_8605fd1a-80f1-4c9c-81c0-1ba969f5a3d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0f083102-ac57-4cb1-8630-c75aafdae5d0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0f083102-ac57-4cb1-8630-c75aafdae5d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e53ee06c-b38e-4957-8786-e6c20ab94bff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0f083102-ac57-4cb1-8630-c75aafdae5d0" xlink:to="loc_us-gaap_EquityComponentDomain_e53ee06c-b38e-4957-8786-e6c20ab94bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bec63328-0006-47ae-9c68-cc8eacf5aca5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e53ee06c-b38e-4957-8786-e6c20ab94bff" xlink:to="loc_us-gaap_CommonStockMember_bec63328-0006-47ae-9c68-cc8eacf5aca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_ec11d4b6-464e-4f9d-b4b2-e88fedf2537b" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a356a609-ddd1-4b55-ba74-2b49aa683904" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_a356a609-ddd1-4b55-ba74-2b49aa683904" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c4796c31-cb18-4f1c-be79-721a3eefae57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c4796c31-cb18-4f1c-be79-721a3eefae57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_62566691-035f-4d7e-9386-962ca9a09941" xlink:href="angn-20250930.xsd#angn_ClassOfWarrantOrRightIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_angn_ClassOfWarrantOrRightIssuedInPeriod_62566691-035f-4d7e-9386-962ca9a09941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_dd35ee44-b208-4ce1-a9f4-a39def822218" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_dd35ee44-b208-4ce1-a9f4-a39def822218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e22d5f3c-66c0-478d-9e1a-b547eb95540a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e22d5f3c-66c0-478d-9e1a-b547eb95540a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_449fc304-9258-470e-89bd-d0f7e0128a0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_449fc304-9258-470e-89bd-d0f7e0128a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9f07f3d0-856f-4498-bb4f-14f63e3ce632" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9f07f3d0-856f-4498-bb4f-14f63e3ce632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_1668a2fd-7643-4e39-bc4a-8cecc9d0e302" xlink:href="angn-20250930.xsd#angn_AccruedInterestPremiumForConvertiblePreferredStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_angn_AccruedInterestPremiumForConvertiblePreferredStock_1668a2fd-7643-4e39-bc4a-8cecc9d0e302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_92134f6c-807e-4a49-b854-3b8d56f8d40e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_5aec34da-ecfb-400c-85d2-b8ed409ac174" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_92134f6c-807e-4a49-b854-3b8d56f8d40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.angn.com/role/SegmentReportingDetails" xlink:type="simple" xlink:href="angn-20250930.xsd#SegmentReportingDetails"/>
  <link:presentationLink xlink:role="http://www.angn.com/role/SegmentReportingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_45b253ba-23ae-47d1-aaa0-840f2404b14a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_196dca13-785b-46d1-bf10-b91b8c03042e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_45b253ba-23ae-47d1-aaa0-840f2404b14a" xlink:to="loc_us-gaap_NumberOfReportableSegments_196dca13-785b-46d1-bf10-b91b8c03042e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_45b253ba-23ae-47d1-aaa0-840f2404b14a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_2ddfb9f0-9b09-4168-b10e-5661e7b829a3" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:to="loc_srt_ProductOrServiceAxis_2ddfb9f0-9b09-4168-b10e-5661e7b829a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_2ddfb9f0-9b09-4168-b10e-5661e7b829a3" xlink:to="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ClinicalTrailMember_7046ff49-bc19-4e96-be0d-1601db35613c" xlink:href="angn-20250930.xsd#angn_ClinicalTrailMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_ClinicalTrailMember_7046ff49-bc19-4e96-be0d-1601db35613c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_b2ff9232-d211-4fa1-8b3a-d263a627f975" xlink:href="angn-20250930.xsd#angn_EmployeeRelatedReasearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_EmployeeRelatedReasearchAndDevelopmentMember_b2ff9232-d211-4fa1-8b3a-d263a627f975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_TranslationalMedicineAndCMCMember_2cea45ba-cb7a-4a83-b646-ab805f792bf1" xlink:href="angn-20250930.xsd#angn_TranslationalMedicineAndCMCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_TranslationalMedicineAndCMCMember_2cea45ba-cb7a-4a83-b646-ab805f792bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_OtherMember_5ed977d6-bc2f-42d0-bba3-5a39eb9b2871" xlink:href="angn-20250930.xsd#angn_OtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_3f99f2b3-c0df-4d5b-8ca6-ec5680b319d1" xlink:to="loc_angn_OtherMember_5ed977d6-bc2f-42d0-bba3-5a39eb9b2871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b6d1d472-96ed-4b4f-93ce-fb9a3257b764" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b6d1d472-96ed-4b4f-93ce-fb9a3257b764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_42c460c3-b305-4b8d-8e99-4b565826ddf1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b6d1d472-96ed-4b4f-93ce-fb9a3257b764" xlink:to="loc_us-gaap_SegmentDomain_42c460c3-b305-4b8d-8e99-4b565826ddf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_angn_ReportableSegmentMember_c7299d85-8f38-4dd6-9c24-81dc023dec58" xlink:href="angn-20250930.xsd#angn_ReportableSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_42c460c3-b305-4b8d-8e99-4b565826ddf1" xlink:to="loc_angn_ReportableSegmentMember_c7299d85-8f38-4dd6-9c24-81dc023dec58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f26d0c35-9f3f-4533-b903-278651da0c44" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_147ecb33-5313-4123-a4a7-51ea0822da58" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_147ecb33-5313-4123-a4a7-51ea0822da58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_8fd5f686-b98c-4d56-b877-0a7c24fc8171" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_8fd5f686-b98c-4d56-b877-0a7c24fc8171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_36f860ad-40ca-4b6a-ab56-b9f13d2100fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_36f860ad-40ca-4b6a-ab56-b9f13d2100fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherGeneralAndAdministrativeExpense_d310fb4a-f85b-46ae-9712-cffccc4e599e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_OtherGeneralAndAdministrativeExpense_d310fb4a-f85b-46ae-9712-cffccc4e599e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_908e6cc5-82ed-414f-9c0a-451c9d48c7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_908e6cc5-82ed-414f-9c0a-451c9d48c7cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2620aff5-421a-4bd4-892c-9e21a634a005" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_NetIncomeLoss_2620aff5-421a-4bd4-892c-9e21a634a005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4b29bb34-8ec6-4c4a-8dd4-81fdc0e83a98" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_cbf21044-1f9b-4c55-8f45-a5f67e545f10" xlink:to="loc_us-gaap_Assets_4b29bb34-8ec6-4c4a-8dd4-81fdc0e83a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>elicio10-qxexhibit311001.jpg
<TEXT>
begin 644 elicio10-qxexhibit311001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$N(DD42+N59HVB8?56&5_$5X1K%A>_\ "#_"^[%C=-%IEW%]L"0.SP89,[E
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M:UH@UC3+O[78G.)(8V8\'!&P#=GVQFK.F:G::QIT-_8N\EM,H>-VB:/<IY!
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MD.S9L*]=^<\YS^E3ZMX 2;Q>GBS0]0.E:SL\N=C#YL-PN,8=,J>@'((Z#N*
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M8'LY3+'.D&^0$C! .X8'0_516L-'U9K[2KJ;5[>1K*-TE_T,@SE@ 3_K/E/
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MU"GE22&+S(KB/&-LB9!/'0@@\#T& #S_ ..TTVF^)/!.IZ>2NI1W,BQE/O,
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M9B[$XW9 Z5E?\*^;2_%EWXC\,ZFNFW-\/],MIK?S[><YSNVAE*MG)R#W/J:
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MYI/$GC7P_P"$].@OM7U!(H;C_4; 9&EXSE0N<C!'/3D>M>,VTLLZ?&V2XR9
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M+\_[N5[U[C0!3N=4LK._LK&XN$2YO6=;>,]9"J[FQ]!5MF"J68@*!DDG@"O
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M:[1LE2%(#8X)&<4M% 'EDWP?O[F^NKF;QYKG^F2F6YBC/EI(3P05#8Q@ ?0
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M@\1:1<^()]"AOHWU."%9Y+< Y"'&&SC!ZCH>XKC_ (T7-M#X#\N>=(S)>VV
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7'_%.*.3X9>("Z*Q6T8KN&<'CD5V%87C+1KKQ%X3U#1K1X8Y+R(Q&2
M4G" ]\ <_3B@#5L/^0=:_P#7)/Y"K%9%W!K8\,_9]-ELH-66-%1Y@TD(((SD
M#!Y4'Z$]ZUAG:-V,XYQ0 M%%% !1110 5P-B/^+[:M_V H?_ $::[ZN3M?#N
MIP_$:\\2N]H;:XLDL_)#MO4*V[=G;@GKQ^M %7XMY'PYOB!DBXM,#U_TF.K-
MEX@UJ+QQ+H&IP6+I+I[7]LUKN#+M<(8V+'#'YAA@%^E6O&^@WGB;PS+I-G+!
M$\LL3F28G"A)%?H!SG;C\:JWWAO5+[QBFM">WMX_[*DT\B-V,B%V#>8IV@<$
M<#\>.E %"S\9ZJNO^']/U&.P$FJF6.XM(03)8R*A=59PQ5C@8(PI[U:T_P 5
M7Z7WBBQU?[+'<:0%EA\F)OWT+*2CX+<DD%=H[C&>:R[#P-XBMHO"JR:CI0.@
MRL!Y=N_[Y&C9"[?-RYSG' SDY/2NAU?PDFI^+]*UU9S%]EC:*ZB _P"/A PD
MC!_W9%#4 5)O$FIB^&C P1ZG!91W-W*EC-<Q*[E@J*J'('R-DEO3 Y.-?PMJ
MNH:SX?M[S5=,DTZ^)99K=U(P02,C/.TCD9]:Q]>\-:X/%,?B3PSJ%G!=O;BU
MN[:^C9H9T#%E;Y3D,,G_ #UZ73+>ZMK%$OKH7-VQ+2R*NU=Q[*N3A1T R>G)
M)R: .4L?$'BG5/%.L:9:VVD1P:5>P1S/*TA9X70.VW'\>#W 'UZBM_PG&KWE
MA9:SI.G/>V-Q<!39QV$_F^06*^8LWW"<8;;C'.,\9K;T#0M0TSQ/XAU.Y>V:
M#598Y42-F+1[$"8.1@Y SVQ[UD:%X2\3^'BVBV>M61\-"5FAW0O]KAC8EC$K
M [<<D!CDC/ Z8 -"T\2WL/C#6M%U=K."&ULUO;25(V!EA)(=FRQ^X1@@=<YX
MJO?>(];T]?"GVJULMVK7J03C8RM#N1F  R?F 7!.>O:K_B7PDGB#5]&U!9S
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M'VMI;RO$FIZC!8SR(<%8G)+<]LA<?0UV-WHUA>:%+HTEM&+"2 V_DA0%5,8
M [8[?2J_B;P[9>*M!N-(OMZQ2X*R1G#QN#E74^H(KD==U[Q/I7V;0]2AA@M;
MM/(?Q-%EHXLC&YXL?NV/8EMH)!Z9  ,?P'XSUE?!G@X7!BN1>:@^F2R2JQ<J
MN\JX;/H@'(/K77Q^)M6;6O%NFPV,-Y-I$$$MG'$3&T[2([!&+$@<J!GBH-0\
M$"+P[X>LO#4EO VB74=U;"YRT<N P8,5YRV\G([U3N_ NNW\OBN676;:"37;
M2&$-!"P,31J1UW?=.X@]21Z=* +ND^++^Y\7#09I-/NS)IK7BS6JLBQRJX1H
MR=S!AEAR#QCI67IWB?QEK?A:ZUB%-&LX($O$=BDDD@>)F"L@R 1\N#D^_M6E
M9^&/$$7BC3=<GNM*4VVG/8R6UO"ZH 65AL)/'*]<<#L:L^&O"U[I?A"^T&^G
M@;[0]P5F@R<"9F8Y! Z%OQ]J ,O0O$E]8>#?"4%Q,EQ?ZK:QF*06LDFQ%A#L
MSJK%I&Z#C;][/&*BU3QOXDTKPOXBOYM)B\[2GC-O<S6\L$-W&Y RJ-\P92<$
M9Q[\T]O NN_\(SH$,.KV<&MZ!M6RG2%C$R!-A60$Y.Y>I'3M5S6_#/B3Q%X,
MU+3-2U#3_P"T+]4C/D(ZV\"JV[Y0<LS'N21V].0#-\9MK;V6D-K"6"(?$E@;
M5;4N65"XR'+<%@<\C@^U="=?U&U^(46A7RVJ6%Y://8S*C!Y'0C?&26QD [N
MG(]*/%.@ZGX@T[2(HFM(9K._@O9=SL58Q-G:ORYY]3T]#6;XYBTWQ)]BT6WU
M2*+7X+Z%XUMIE,UN#_K"1U"^47Z@ _+ZB@#I/#U_=ZIIS7MSY/E2RN;8Q(5W
M0AB$8Y)SN #?0BN'UO5DT/XU3ZC):75S%#X6+R):H&<*+@DG!(STKTJ"&.VM
MXX(4"11J$1%Z*H& !7+_ /".ZF?B6?$Y>T^R_P!G?V=Y&YM^WS-^_.W&>VW]
M: ,?X=VW]F:-KWBJ>2&+3]6G?4X;:!]ZP1;2<G'&\]P.F*M6WB[7;B;1+N#3
M&NK'4G030QV,Z/:(XRKF5OD=1QNP!ZBK&E>#KG1;O5;"UFMY/#&H[F^PON5[
M5G!$@C(R-ASG;QC/'O'X9\-^+-%CMM(N]<LKC1+(J()$A9;MXU/R1L<[0!@
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M^M)?ZEXE\!Z/8Z:MDNJ:=&%MUU<;BUI&.%::%1E]HQEE(!QSCOT_A'1+#0M
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M4 %%%% !1110 445A:[/XE:9;;P];Z>K+'YDEQJ.\QY)("*$Y)X))SQQP<\
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M##(L8,Q#_NU;'."<<9]: +%%1PSQ7,2RP2I+&WW71@P/T(J2@ HHHH ****
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M,+D@<X' JW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %1SW$-M$9)YHXHP0-TC!1D]
M.34E<+\6X()?!&^6-&>.^M-CD<IF= <'J.">E '7C5-/)N0+ZU)M?]?^^7]U
M_O<_+^-/6^LVLOMJW4!M-N[SQ(-F/7=TQ7!SZ+I2?&6Q@73[587T*5WB$2A&
M99DVDKT)&3C-<_I]SING^';FTN( T0\:2V]C%YOE0Q2"7>F\CH@P3MQR<#WH
M ]3N-?TFUTB?5I-1MOL$"DR3K*&48ZC([^W6BQUS3[[1(=66YACM9(UD9WE7
M$>0#ACG (R*\M>>*5?BS;M=VES(UFL@\@!59OLAW%5R>A&"<GD5;N-7LK+_A
M7[2ZBEII+6K))<Q>68X[HPQF/>6!4':7P3ZT >GKJ-B]FMXMY;M:MTG$JE#S
MC[V<=:HZA>M<1VYTS5["'9?)%<&3$@<9^:(8(PYR ._M7F?BW1M!M? FORZ;
M?O?I-JEK<22EHS'%,TT8?RR@ 4E2-V/6MWQUH>D:5'X9>QTVSM6;Q+9.6AA5
M"6)P3P.X4?E0!WEQJ=A:W$=O<7UM#/)C9')*JLV?0$Y-8.JZUJ-E\0/#VDQO
M!_9^H17+2+Y9\P-&JD?-G&/F].W6N"\<7VGW.B_$);1X+=T9([LW+[Y9Y5C7
M:(U)&Q0 ,'G)W8 QFNEU"YBNOB'X!ECF257M+[YU8$$^7'GGZ@T =KJ>HV^D
MZ9<7]TZI%!&SG+ 9P,X&>YQ7,>'M<U/4K33=?GU;2QI%U:++=V[85K61@&15
M?//7!W<\9'7 V_%2HWA'6?,52HL9C\PX&$/-<+;7.FVO@WX<P20Q_:[A;=[6
M223RX4E6WY>3'WL G"]VQR.M 'I=M=6]Y;K/:W$4\+=)(G#*?Q'%5TUG2Y+>
MXN$U*T>&V&9Y%G4K$/\ :(/'XUXY+J1M?"GCKR;J.YC77TFNA:\;[8^3YQ50
M3\I&0>3P3S7H0_X1;5-4?4]+EM[N_DTMH=UK+O06X.Y=R@X'S'C(SUQT. #<
MT'7K#Q'I46HZ?,LD,HW#!&0,G&1VR.<&K5WJ-EIX0WMY;VP<X4S2JFX^V3S7
M*?"F6U?X;:&L#Q-(MHGFA""0>1SCZ'\JKZ'*MU\2?&5CJR(\IBMOLT<P!#6A
M0YV@]5WEMWN>: .WEN8(!&99XXQ(P5"[@;B>@'J:+:ZM[R!9[6>*>%L[9(G#
M*<'!P1[UXE;Z>LGA/P5'?1K-;CQ2;>S>7EFL_P!]L7)Y*D <=",=J]HL-.LM
M*M!:Z?:0VMN&9A%"@102<DX'N: "34K&*\2SDO;=+I_NP-*H=OHN<FGS7MI;
M.4GNH8F6,RD/(%(0=6Y[#(Y]Z\FL##J?P0\0_P!J@?VS!)>/>%O]8EXLC-&?
M7=_JPOM@"M'3].6Y^)VA_P!L6D,E_)X6WW@D0'?,)8@2P[D'/7T]J /0SJVF
MB.WD.H6@CN3M@;SEQ*?13GYOPJ*Z>Z77+$)J%K%:&.3S;5TS+,<#:5.> .<\
M&O()M)TU?A1X]D%G;[[74[Y+=M@S"JR@JJ'^$ G( QUKK[^.$_%+P9<;$\^;
M3;SS),#<X"QXR>_4_F: .JT7Q+I6OS7L>G7<4YM)V@8HX.XJ%)(]@6QGU!HU
M'Q-I6EZS8:5=7<4=W>;RB,X&U54DL<]!D #U)]C7-?#AK5+CQ5 IA6Y'B"\(
MC& ^S*=NN.11XL:T@^)W@N:Z,,<7DZ@&>7 '$<9&2?QH [.XU*QM)XX+F]MX
M9I?]7')*JL_T!/-6:\TT#[+JFF^/[/Q (_M U"X%T)L96WV#R6YZ*$&5/L37
M3?#XZBWP^T(ZL7-Z;1#(9/O8_AW>^W&<]Z -LZE8"\^QF]MA=<#R3*N_GI\N
M<U1TKQ/I.M7VH6EC>0RR6,WDR;7!RP56./4#=@GU!KA5EOM"U6T=UM=;\-WN
MN-Y$R_+=6%S)*P(/9U#EE]0,]JJQ7NC:9I/Q*.I(6B&H3!X('"3-&T,8PO<
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MM>>QNTU2=KF F%)"HDS"\99"Q^0(%P3TP.U 'JUQJ-C9EA<WMO 44,PEE5<
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MFI_\)<X\426S0!;=;.&.1<%'X:?&>V\!/^V7O5?XCB!;KP?+.(P@U^ ,[XP
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MQVKV]O*D4<=X;I]TD\BQ H(U)&Q0,8/.3NP!C-.\3W6JW/B+PW<>'98KB_\
M[#N&7#@F0!HMZJW(#D!@"<X- 'JT6H64\<DD-W;R)$,R,D@(3ZD'BBSOK/4(
M3-974%S$#M+PR!QGTR*\TUS7M'/@7PYJ.DLUIH/]J0B_V("UNN&SYH8'D2["
MVX')YYSFNE\.6.B+XIU+5-+UJ34;J\MX_M7E21-"-O",?+4#>1G'J : -?4O
M$VE:5J^GZ7=W<4=W>E]B,X&U54L6.>@X ]R?K6/HGB>=M?\ $UIK5[916^G7
M<,%O)@0J0\8?!W,<GGU[=*I>+C:P_$OP3-=&%(ME^'>7 7_5+C)/XUB/INGW
M^H_%*2[M8+AD5=C2*&V?Z(#D9Z'('(]!Z4 >HW5Y:V5N;B[N8;>$=9)7"*/Q
M/%/AFBN(4F@E26)QE71@RL/4$=:\ET_6$MKSP+_:^IO8V5SX=06]T^S8;DB/
M<"74@$IT/7DCO7<>"=,TK2M+O(-&OIKRS>]DE\QV1D5VP66,H NP'/ Z'<*
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MU@MYYM*OE(B0+YA'EE0V.O//-8GAK_A'_$7A3PXU[X@N4U6PN8Y#:(84N%O
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M[*T5KFQ5+]87NP&>6-8\H2<#*]"O'3%>F7.D:;>10Q76G6D\<!S$DL*L(_\
M=!''X4^73[*>=)YK.WDF3&R1XE++]"1Q0!XWKT<47@[XIV\"HL4>I1N(T& I
M*PEC@=.0:[/Q +G4=:T_4?">LV']JP6DNRUN/GM[R$LN\!E.00RKR/H:Z]-+
MTZ(2B.PM4$P*R[85&\'J&XY'UILVC:7<1113Z;9RQQ#;&CP*P0>@!' H S?!
M.H1ZKX-TR\AL/L"/$0+;=D1[6*X![KQP?3%<9JNEM#XH\0>$$A/V+Q7$+N%P
MF4A<82Y;ZX",/]HBO4418T5$4*JC 4#  ]*0QQF592BF1055R.0#C(!]#@?D
M* .!\#76I:WIR37L)2_T2WDTP[QPUTIVN_/4;4CP?]MA7/>&9O#WB#PIH-IJ
M>O7:ZOI]U&QTX-"ERMXC$-\NS><L6))/0DD\&O7TCCBW>6BIN8LVT8R3U)]Z
MKIIE@E^U^EC;+>.-K7 B42$>A;&: ///#^D6-QXA\>M!86<M[;WZ/:;HE;RI
M1 I5ES]T[NX[CVK/\,3>&_$/ASPO%=:]='5=.GA9=.5HDN([I/E<%=@<KG<6
M)/(R2:]4M].LK29YK:SMX97X9XXE4M]2!S21Z980WTE]%8VR7D@P]PL2B1A[
MMC)H P/B3'%)\-O$7G(C!;"9EW '#!3@CWS7+ZAIVF_VY\,Q]DMMLHF#?(/G
M!MBW/K\V#SWKTRXMH+N(Q7,$<T9Y*2(&'Y&H#I&F$Q9TZT/E#$?[A?D&<\<<
M<T >5ZG<:5I<WQ06]L_.TU9K'?:PR&(%I(D&25^Z"Q!8^@/7I4L^ISCXA:T]
MCJ=G=:G+X6/V;[)@*TZR.411DEB.#U)Y[#BO3QI.G S$:?:@S*5E(A7]X#U#
M<<CZT^'3K*V>-X+.WB:)/+C*1*I1,YVC X&>U 'C]YJFAW/PK\$O#=6OF0:E
MIYD#N-\<JN/.+9Y!R6))]<]ZTOM^CW>M^,M$\3Z]_9WVJ;<J2O"B3VC1*$*.
MZ$G&&^Z>#R.<UZ0-$TD3R3C2[(2R.)'D%NFYF'1B<<GWJ6YTRPO9X9[JQMIY
MH3F*26)6:,_[)(X_"@#,T;4=(L8=+T"*_/VO[$CP6]TX^T/$HP&8=<\<_0^A
MK"^+<,$G@I6F1"5O[3:S#D9G0'![<9KJ+C1K:ZURTU25(C-:*?*81 ."0RG+
M]2,,V%Z9)//&+=U96EZBI=VT-PJG($L8< _C0!Y[J5L;'XHW<.B0Q07;^$YC
M#'$H4&19@(^!Z$UC79BU/X#:-_9I_P")S ]JEMC_ %J7RRJK^X;/F$^Q)->L
M+IE@EPMPME;+.H 601*&  P #C/2DCTO3XKY[Z.PM4O'^]<+"HD;ZMC- '':
M/<6]O\7_ !/%/+%'-/9V/E(S -)@2YVCJ?PI?BC!;RZ?X?,\<;8UZR4%P. 9
M.1GW%=J;6W-TMT8(C<*NP3%!O"^F>N/:FW5C9WH47=K!<!#E?-C#[?IF@#AH
MM-TX?&RYB%G;;?[ BD\ORUQN$[KNQTSMXSZ<5Q\B6W_"CI?EBVVVN%8>G[L?
M;APOIP?RKV;^R]/\\S?8+7S2-I?R5W$8QC./3BF?V+I7E>5_9EEY>[=L\A<9
M]<8ZT <)XP2_L]3U[5M(N;*^ACLD36-&O?E\R%59@T;CE259QSP2#WJU>W:7
MGQ)\"W 1HO/TV\D$4G#+N2(X(]?\*[*71M+GE2673;.22, ([P*2N.F#CC&!
M4DFGV4URMS+:6[W"8VRM&"RXZ8.,T >1:5-H>N>%;K1?$>O75MJMOJ$C7%@C
M0I.UP)BR-%E-[$_+@@GKCI3?&^I:=<Z'\08;62WLY4D6.YCF??/=2JB895)P
MB  8P#G!/%>O-IE@VH+J#6-L;U1M%P8E\P#TW8S1)IEA--+-+8VSRS)Y<KM$
MI9T_NL<<CV- '!6.N6I^*RF_NX?L\VBQ_P!ES.X\MSO/G;6Z%B0N>^%%<?=/
MILGPD\8K UJZ0>(Y&B"%3Y:FZCVE?0$=/:O;+G2M.O88H;NPM9XH2#&DL*LJ
M$=, CC\*1M)TYX6B;3[5HF<R%#"I!<]6QCJ?6@#C+JQL9_CC;^=;02,?#[R$
M,@.6$Z@$^IQFN6C6%?A-K")>06L-IXAE\I)&VQ,%NP5B8]%4G'/09R>,UZ[_
M &5IPE$OV"U\P+M#^2N0,8QG'3'%8OB+PY/<Z9%#H,>FVS+<I--;SP8ANE7/
MR/MY R0<X/*CC% &1H46G:Y\1+GQ-#=::[#3DM4MX;B*>7<'8M*2A(7A@HYR
M1G..E:?Q"TF?4_"4\UDN=2TUTU"R.,GS8CN 'U *_C46C^%G35;74KW1]"TV
M>U9FC_LQ,NY92IW.43Y<,?EP<G!SQSUU 'D;:S?Q>);+Q=IULPM/%%O_ &?!
M&8^5E5<V\C^N3YG/]W%;7BK3K/2]7^']O"B#R-2$".P&XJ(7ZGW."?<UWHMH
M%CBC6&,)#CRE"C"8&!M';CCBF7&GV5W(DES:6\SI]UI(PQ7Z$CB@#S[3+JU@
M\2?$:VDFB2=Y$9(V8!BOV0'('IP>:P[6VL[7P-\+;J&&&.X?4[-6E50&;=$X
M8$]3G 'X"O7)-.LII9)9;.WDDE0)(S1*2ZCD G'(]JB.C:68TC.FV91#E%\A
M<*?88XH I>,8XI?!6N+,B.GV"<X< CB-N>:\]O;>RTCX2^%]8MK5(8@FG-J=
MS;0JTAMQM9BQ(.X!R#@Y'6O69[>&YA:&XACEB;JDBAE/X&FQ6=K!;&VAMH8X
M""#$B *<]>!Q0!YO?V7A75VU?4;?Q5-//>Z>EM<WL$D+Q0*9%\MI B@;LGO_
M  ANU07=SJCZ9XRT?Q+96-QJ,6A&9=2M5^2XB"RB/<A^XX;>?SQTKTF#2--M
M;1[2WTZTAMG.7ACA548^I4#!K.UG04D\*ZKI6C6=E;27MM)" !Y2 NA7<=JG
MIGTH \]N-&T]_"_PXO-'MX$U8W=DR30 >8Z;,S[B.2NT$MGTIMK<:%J^G>)/
M#_BK7IK*[&ISM<6;-$CR@R;HFBRA=OE"!=I)X ':O1?"^@Q:+HMC#+96,6H0
MVT<$TULH/F%5 )W;03G&>:TI=,T^>^COI;&VDNXAB.=XE,B?1L9% 'GECJVE
M6?C7Q7I7BFYCMA=6MN+=M0E""6U\K:RAB0.'+YP>I)[4Y7TK2_B#X2$&+33A
MHEQ%:BX8@E0T>T98Y)Q@@'FO0;O3;"_DBDO+*VN'A.Z)IHE<H?521Q^%22VM
MO<212301220MNB9T!*'U4GH?I0!SOQ(4M\-O$8 R?[/F/_CIKFY-5A/B_P "
M3-/%)I#VLL,<J,#&MV8UV@GIN*[@/J17I;*KHR.H96&"I&0159],L)+ 6#V-
MLUF!C[.8E,>/]W&* .2\,VTD/Q*\7O:<:9(+8N%^Y]JV'?CMNV[2WN1FH_%-
MQ;6?Q0\'3W<L4,/V>_4O(P49V1\9/>NVM[:"S@6"V@C@A7[L<2!5'T I)K6W
MN6B:>"*5HFWQET#%&]1GH?>@#RM[.QNHOBO+/!!+(AD 9U!*C[*IXSTY'YCV
MI+76H[#5_!TFKZM)IUA=>'(TMKP^7Y?VCY2ZEG5@"5"\\=,=Z].&CZ8!(!IU
MG^]_UG[A?GYSSQSS2RZ3IL]D+*;3[22T!R('A4H#Z[2,4 8_@G3](T[1KB+0
M[N:ZL7NY)5F=U9&9L%O+*@#9NST&,[JZ2FQQQPQ+%$BI&@"JBC 4#L!3J "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ JO=W]GIZ(]Y=06ZNX1#-($#,3@ 9ZD^E6*X/
MXMK;?\(A;270C\I-3M"S/T5?.7=SVXH ZW3]<TG59IX=.U.SNY;=MLR03JYC
M/^T >*(]<TF;4?[/BU.T>\^;]PLRE_E^]QG/'?TK@M?TDCXAVL_A>**&\30[
MM;DVP"C! %N#CC)?)'LOM5'PQ=^%_$6D^%H9M7NI=5TV2'R],!C2:"9!M?<H
M0-L'S9R<$>] 'HR^)=":=(%UG3S+)*T*(+E"6=0"R@9Z@$$CMD5%HMXBZ--=
M76OVNI1)-*QO4"1QHH8_(2IQ\HX)SVYKE?A[8Z7<W_BZ0VUI++%XBN"K%%8H
M-B8(].K?F:Y*TN3:^ ])NT(.DVOBQY-0V<JD(G<AFQ_"&*'\J /9+'5=/U/S
M?L%];W)B(600R!BA/0$#I^-<IXV\6_V<FG1:1K%HMTVJ6]M/ -DCLC2*KJ 3
MP1GGC(SVK-\217MQX_\ MWAMP]VOA^Z%P\)R&8_\>X)'&2^2/8&N<N]<T*X^
M$_@]([RU6>TO[ 3Q.X$D4J.!*6!Y!SN))]<]Z /;*H6VMZ5>7AL[;4K2:Y +
M&*.96; ."< ]CP?2L[QH+VX\":T-)+-=O8R>08CEF)4_=QW(Z8K"T'6O"7B2
M#P]/I;6T^K6=LRVD,;?/99CVOO4'Y5X"_,,$XQU% '7/KFDQWZV+ZG:+=L_E
MB$S*'+8SMQGKCG'6GIJ^FR:DVFIJ%HU^@W-:K,IE4>I3.?TKR:VDAOO@'>Z;
M=Y_MN!I8I8&/[\7WG%EXZ[V8J0>^:Z'Q.+SPQJ'ASQ<\+W$\42Z9JB0C+2I)
MC:1])<?]]T =P-7TTP3SC4+0PV[[)I!,I6-O1CG@\C@U"GB'1I-.EU!=6LC9
MQ,4DG\]=B,.H8YP#[&N(\6F7PU9>%;N_N)8;&+4&EU2Y@4-Y<LJ/B0@@C:)'
M/4<<=\5F^)(/#DW@KQQJNDZBVI/=V:&YNO,1X6D52$"E0%W@8SCGD9ZT >EQ
M:]H\ZW31:I9.+0@7)6=3Y)/3?S\N?>I+'5=/U."2>QOK>YBC8I(\4@8(PZ@X
MZ'V->?>*C9:%HWA75X$%KI27<#7]S9Q*2$\EEC=OE.Y59@>0<<8YQ67XJ72Y
M/"_BC6?#6H7.K2W*VW]IW$$BO&\2N RC8 -WE[MV.0IYZB@#JKWQ89OB#X:T
MW2M7M+BPO5N3<PP[')V1;D.[D@$YZ8SCOS5SXBZKJ6A^#Y]2TNY6">*:!26B
M#Y5Y40CG@<,>QKG]6US0K_XC^ ;JPU"QEC*7BJ\<B\*T(V ^F3P >]:OQ;"G
MX:ZEO V"6V+9Z!1<1DD^V* .DMO$.BWDUW#;:M8S268)N5CN$8P@=2V#QCWI
M\6N:1/ITFHPZK8R6,>=]REPAB7'7+ X%<=?:=8R_$[PM=:%%;JUO;7)O7M0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%4M3UC3-%MUN-4U"ULH6;:KW,RQ@GT!)ZT 7:*C@G
MANH(Y[>5)89%#))&P96!Z$$=14E !1110 4444 %%%94OB;0+>X>WFUS38YX
M_OQO=QAE^H)R* -6BH;:ZM[VW6>UN(IX6^[)$X93]".*FH **** "BH;JZM[
M&UDNKN>*"WB&YY97"JH]23P*2SO+?4+*&\M)EFMIT$D4B'(=3R"* )Z*** "
MBBB@ HHHH ***I1:OIT^J3:9#>P27T*"26!'!=%)P"P'3\: +M%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K)UR&WBM)[]]&;5)XX618$1&=E/)4!R!SQGUP.N!6M63J$GB&/4XO[
M.M=,GL#'B07%Q)%*KYZ@A&!&,<<'WH POA7)IY^'UA#I[3;(&ECFBF38\,N\
ML\97MM+8'MBNSKFH-$U31?#E^FB26+ZU=W+WC272L(#+(X+\+\P 7@?09[UT
M@SM&[&>^* %HHHH **** "O-H+Q[+XVZ^\=A<W9;2;;(MPF1\QZ[F%>DUQ<>
M@^(+3X@:GXC@ATR6"[M8[987NY$90ASN)$1'.>GZT 8/@2]QXE\=ZA;6LEM(
MTB2)H##9.K)&<N5^Z#(<<J2.>36]IOB^^?Q3I>BZ@ED9;^SDG>.W8[[.5 I:
M)^3NX;KQTZ567P-JESJ7B37+K4X;;6-5L38VQM VRU3'!W'!9L@'.!C'%,T[
MPEXBAU?PM?3-HT":1;36LL-OYA!5P@W*2!DG;T(&,]6H O\ AOQ?/XDFAEM9
M+%HO.DCO+3E;FRVAMN\$\Y*@'@=>,]:I/X]U":SL]7TW2Y+[3KBX"&WAM)FF
M$)8KYH<#8?[VW'3^*I(?!U_=Z_HNLZA!IUMJ=@Q^TW]E(V^\385V,NQ1@D@G
M).,8'7B/P]X8\7>'5.A6VI::_AU)&,$[J_VR&(L3Y8'W21D@,3QUQVH M:EK
MM]K=AXFBTB.U-KI@EM)&N Q,\HCW.JX(V !@-Q#9.>,#F]\.O^2;^&_^P=#_
M .@"LF/PKX@TC4/$4.D2Z=-I6MRR7)%T[I);3R+AR JD.IP#C*X_GT/A#2;S
M0?"6F:3?2023V=ND):#.TA1@=>?Y4 9#^*]3OM*UC6-%M;6:STR:6(0RE@]U
MY7^L*L.$Y#!<ALX[9J ^.;V_U7P_;Z-8VLMKK=C)=PS7$S*4*A20P XQN[9R
M1CCK2V/A76M#M]<TO3)+*33-2FEG@DGD99+1I1\XVA2'4'D?,OH?6GV_@VYT
MS7_"\NG_ &8Z;HEC+:8EE82R;PHW8"D9^3/7G/:@#3\'Z_=Z]9ZBFH6\,-[I
MU_+8S^0Q,;LF"&7/(!##@U5U#Q%K$?CE?#EE8V3"337O([B:9N")%3Y@!T^8
M\#.>.1S4WA+0]1T2XUU[XVI74=2DOH_(D9BH95&TY4=-O7WI)]#U)OB+#XAC
M^R&SCTU['8TK"0EI%?=C;C'RXQGOGVH YQ_'WB)?".HZY_96G#^QKJ6WU",S
MO^],3[6\KC@8Y!;OQCN>AG\27MKXVTO2IX;=-,U.W>2VN?FWF50"8B,X!VDL
M#WP1CO6(_@K6Y/!7BC1&?3Q/K%[<7,<@F<K&LK;B#\F21^OM5GQG;PZAX:M-
M)^WVUOXCMYK:2R6"4/)%.& 5@IP2N-V21]W<>U '3:)J%UJ7VZ:581:I=/#;
M,@(+JAVLQR?[P8#']W/?CC=1U:#1_C#>N[ W$^A00VT(P6FE,\FU0,C/3U
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MBX$C.58G9D,A?(X(SSQ27G@+Q%<^&?%FD&[TMCK=^;N.3]XFS=Y>[(P>GEX
MYZYSQB@#H(_$NJ6GC.'1M7M+.&UO+.6ZMY()69H_+*[EDR #PP.1].>M,LO$
MFN:G8:3K.G:7#<:9J%PJF -MFBMV) F+$[3V)0#.#U.*DO\ 0-3U'QGI.L2)
M9"TM;2>VGB\]RS>;MSM^3&!M[XSGM6?X7\->+/#UO%H+:CITF@VS_N+D!_M9
MBW9$9'W1Z;L].@ST +EOXEOFUWQ=:+H\4L^D0P20I;OF2[+H[!22!@\ 8YQD
M]:32?%EW/XOAT"]^PRR36#79:U)S!(K*K1."3DC=UXZ=*J7WA#7+K4/&4\%[
M;6G]N6T,-M+%*YDA,:,N6^4?>W=CQ[T:?X7\0P^)M%U>;^QH(K+3WLI;:V\S
M:H)4@H2!G.WN!MS_ !4 2_#8 6GB4#I_PD5__P"C*M:QXL>T\3MH,$UC;7AM
M%N+9;[(%XQ9AY:," "-HSU/S=.*G\&Z%J&@PZLE^;4F]U.>^0P2,VT2MNVG*
MCIZ]ZK>*_#=WXD2]L;FPTN^TZ: "W-S(R2VTW(+J0A]5Z$'@^M %2;4]>D^*
M&F:>);:*T;1Y+EH&1OO>9&K9.>2.0/3)ZYI+[QMJ6FWE@;VTM($O-56P%B[?
MZ2L3.46?(.,$@'&WH>M3Q^%-6L?$6@:E:7UO<BRTO^S+I[O=O<90^8N.K$IT
M)'7K6(? OB@Z1#8M=Z3+):ZTFIK=2&3S+K;*7'FG'RD XXW< #C% &G8:WJL
M7Q \6B_NK?\ LO3+6VDV!&RD965\CG[WJ?8>E.M_&>K2W6BS)I,EQ8:FZHZ0
MVLPDLPXRKNY&UEZ!B,8SP2*L?\(IJ#>*M<NY9K233-;LHK>Z7#"52B.A"#I@
MA^I/'H:B\+Z)XSTF&UT?4-2TR;2;+:L5S$KBZEC3[B,#\J] "1G(XZG- %"7
MQQXC;0_$NIP:7IJC0KV>&5'G<^;'$JL=I"CYB"3D@#H,=ZTH_%FJIXAT"&ZL
M;1--UU7^SE)6::)EC\P;^-IR >!T/<U43PAK8\-^,=,8Z?YNNW-Q-"PG?;$)
M4"8;Y.2,9XZ^U6KCPSK$UWX/F L1_8F3.#._[PF(Q_+\GH<\X]/>@"K>^/-0
M.GR:MI&F27]G%=-#]DBM9FFFC60QM(C@;,Y!(7G@=0>!9?Q-XBN_$VNZ+ING
M:<'T^"":*:XF?#"0,?F 4'/R@8[<\G@&MI7AGQ;X?N;O2],U'3#X>GN))HI)
ME?[3:"1BS(@'RM@DX)/?)!Z5IV>A:K9^,M>UD+9O!J%M!#"AG<.IB# %OD[[
MNV<8[T <]>^+M7UK2O NHZ:8+2+5[Q%GA<,QW!';;D$?+E/J>.G.=J;Q==/X
M@U'1+633TU*Q\O;9W&Y7NU9%9GC.1P,D8P>5Y(S67:>!=<LO"7A6PCFT]K_0
M;T3_ #._E3)AP>=N0</Z'I5OQ/X/U+Q3!=6M]#ICMYB/8:DKND]GA5W%0%/\
M08@;^<@'IF@#NZR-=U&^L/L:V=O&4FE*SW<Q_=6L84L789!/0 #(Y/6JUK>Z
MU_PFEW83?89='6U#PO%N\^*0;1B7^'YLL1CLM0>*]$U;4]0T.]TR6T==/N6E
MFL[QF6*;*[0V5!^93R..OTH P;CXBW\7@37M<@LK*XN-(OWLW*RLL4P!0"1>
M">0X.W/KS6S#XEU2V\:1:+J]I9PVUW9RW5M)!*S-'Y94,LF0!T8'(^G/6N?O
M/ 7B*Y\,>*]'-WI;'6M0-Y')^\39N,9.1@]/+P!SUSGC%=!J'A[4M2\9Z7J\
MJ6:VEO9SVL\7GN7;S=N2OR8XV^V<]J .3\<ZUJ'B/X4W.L016R:5<SPF*-PW
MG>4+A LF[.,D@';C@'KD8KU*\NX;"RGO+A]D$$;2R-Z*HR3^0KS23P)XK7P#
M<>"XKK2I;&.1/L=[*\@E\M95D"N@7&1CJ#V QW'HUW9+J6DSV%\ R7,#0S"/
M@$,I#8_,T <A=^-M0T_PSIWBR[L[?^Q+LQ-+$I;SK:&4@)(6SAOO+E0!C/!.
M.9=&U'6KKXG>)+*>XMFL+2"TV1!&RJN)6XYQN)ZGV'I56+P9K%SX-MO!VJ36
M4NEP-%&UY'(WFRV\;AE3RRN%8A54G<>.:U8=!U:P\=:KK5H]E)9ZC;P(\<K,
MLBO$&  P",'=U[>AH XGP5XBU;P]\.?"]P+*T?29;S['*6D;SOWD[J'4 ;0
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M#VVIV\5M)O4[TQ 7W YQ_#C&* /2*HW6LZ;8ZC9Z?<WD4=Y>$K;P$_/)@$G
M], \UR]QXZ?2;KQA_:D436V@) \;0J5:7S4+!3DD9SA<^^:SO$']LGQIX#?4
MS9%7O)6*6Z,IB?R'^7)8[Q[X7ITYX /1Z9--%;0O-/(D<2#<SN<!1ZDUP=YX
MXU:73YM5T337OH(;IH5LDL9VDN$20QNRRCY <AB!@\#DYX&NFO7^LZQJMAHW
MV6)=,5$EDNXV;S)G7?L ##: ",DYY/3CD W=-U.RUC3XK_3[A+BTF!,<J=&
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M_P ?_C/_ +&";_T7%6O>ZU<R^)QX?TTP1W*6?VR>>X0R*BEBB*%#*220QZC
M'?- &_17'KXHUB*/0M,U#3H+/7]5FFB$9?S(HTB!9I>#D@J%PN0<L,GBF?\
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MM= _M:W3P[-J<4ID?4H6*13(RJ(^JXW9+ L1P.^>-"3Q'J]GKOA;3[R&R/\
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M3(HHX(DBB18XT4*B(,!0.@ ["GT %%%% !1110 4444 %%%% !1110 4444
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M YCQ-X0U'Q19WNGZ@NF3Q2LC6EZ=RS61"J&9%P<G<K,/F'7!S7:HNQ%7<6P
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M5='L_P"SY/-C8PW5OQP<<J01D8SS0!/\/A=+XA\:B]:)[@:HH9H5*JW[E,$
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M/2"\TU[M)KA79HV5D'(!&X?-TXSZBJ.K> ]8OQXKM8=7M%L]= ?=+;LTT;!
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M)4D#80AF;!#+C.>]7;37/$(\2:=:RV7VO3KM'%Q-'836_P!C<#*Y+GYU;D=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]IJ%E?AS9W=O<!#AC#('VGWP>*IZ7<3Q:<TFJ:E97#B=U$T V(!O(5>2?F'
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M6W&C:>()FWRQ_94VNWJ1C!/N:+OP]HM_!;P7FD6%Q#;',$<MNC+%_N@CC\*
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MK;/)]Q9IE0MVX!/->9>'UM/#GC*U66-D\-:K-)+H!=ALMYW'S #'RB09,?/
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M5W10#(#:Y.3WR<'GO65'J-G=?"_Q];ZM+ NLK-?&[BG8!]_/DX!YQ@(%^G%
M'K&CW,EYH>GW4Q!EFMHY'(&,L5!/\ZJV%X8%U2>_UJRN+>*Y;:R;8Q:IM7]V
MYR?F&<Y..HI?#$T5QX4TB2*1)(S9Q ,I!!^0 UY;=VUH/A[\4HA#"(XM5N61
M HPC>5%@@=CG- 'KL6JZ=/=26L-_:R7,2"22%)E+HI_B(!R![U0T+Q5I'B)K
MS^S;R&86LS1$K(#NVXRP']W)QGH<5R-Q9V5CX]^'QM((8#-:7BN8U ,@\E&Y
M_O<\\]ZYYKT6W@#QHEL^9X?$-S)<PPX,OV87*&3Y3VV$]1C!H ]=M-7TV_\
M-^QZC:7/D_ZWR9E?9_O8/'XU&-=TAMVW5;$[8O..+A.(\XW]?NYXSTKD+.#P
MMK>NQZO::ZVKW;Z>\+1HT+1_9^O[U408PV,!N<]N#CE+'1M(/[.;ZB=/M&O/
M['E'VEHE,F<GC=UZ@?3 H ]?AU33[F\:S@O[66Z1!(T*3*SA3T8J#G'(YI!J
MVFF_^P#4+0WF2/L_G+YF0,GY<YZ5P$EG9V/C/X<-:00P--;W:NT:@&0?9PW)
M_BYYY[US=SJ^F7.B^&;NQN+6SL?^$ICE6UDEW7"_OW\R25F/RYR3C' 89)H
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M[:&7;]WS(PV/IF@#C/$PA7XJ^!6/EB5A?C/&2/)%<J;33F\'?%9_(MBZ7EX
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M9OV\/0_9@C?-YF)=N/?)7\Q5?PU=^%O$=IX5D76KF?4]/*?9].1HDEMW"A9
MRJ@8( #G/! [G%>F+96J7!N%MH5F.29!& QS[]:2*QLX+F6YAM8(YY?]9*D8
M#/\ 4CDT >::1/>Z+JFA+!<6VN>&[[4)!9,1MN["9UD+ XX=0#(#GD9/I7J=
M58=-L;>X:X@LK:*=AAI$B56(],@9JRRJZE6 92,$$9!% '$?#66-K+Q,RR*5
M'B&^)(/ &_-4?%T6GZU+HVO^&]8\[68[R&.U-K>&2.:,NHE4H&*[0F68X_AY
MKOX+.UM2QM[:&$MU,:!<_E3;73K&R=WM+*WMV?[[11*A;ZX'- 'F7B[5-.>^
M\=V,<EO87:Z4J7+3-NEO<PN46)2<!0&P2 223TP#6YH\WB6^\)^'YO#5_HAM
M?[.@64WD4DK&0( <%' XZ?4&NT>SMI)_/>WA:;84\QD!;:>HSZ>U21QQPQ+%
M$BI&@PJJ, #T H X?XGN8_!UE]H>,2?VE9;B.%)\Y"<9[=:ZK5-3TBR$$&JW
M=I"MVQCB6Y=0)#C.!G@\5:GM+:ZV_:+>*;;]WS$#8^F:;/86=U;K;W%I!- F
M"L<D895QTP",4 >6ZCH:6?ASXB?\(X NCW5D'AB@/[KSPC^?Y8'&"NP''&<C
MMBNJO9H3\&YY491"V@,5.>,&WXKKA&@B\H(HCQMVXXQZ8K*TK0XM,T_^RRL<
M^G1'_18Y%R8DR<(<\$+T!ZXP.V2 9FBRP_\ "I]/D=E,(T2,L<\8$ S3?AC%
M/#\,O#R7((D^QH0#UVGE?_'2*UM3T2+4--?2XUCM[&XR+I8EVLZ'J@QTW#@G
MKCIR<C41$BC6.-0B* JJHP !T H \1U76M+N=!MI[2XMK"WC\41RM9-)NF1A
M<_O)92Q)7)R<   $<GI76:1;Z9=_%7Q:[PVLJG3[-LLJGAEDW'\1C-=V=/LB
M92;.W)E8/)F(?.PZ$\<D4'3K%I'D-G;EWSN8Q+EL]<G'- 'C'A355L;#X8SZ
ME,J:1]GNHQ-(W[M+GE8]QZ [=P&?4UV'@Z\L)OB9XZ6TN+=_,>S<")P=V(<,
M1CKSU/K7;-IM@]JUJUE;-;N<M$8E*,?4C&*EAM;>VW>1!%%NQN\M N<# SCT
M  H Q/'3*OP^\1EB /[,N1DG_IDU-T;4K#3? &DWVH74$%FEA;AYI6 0910,
MGIU(%;TUO#<Q^7/%'*F<[74,,_0TS[':_9FMOLT/V=@0T7EC:?J.E '&0:5I
MI^)%GJWAPVZA[.9=4-H1Y4@.TQ;MO&_.2.Y -<)-JUE<? +7;'4KB%==CDG^
MW6\S 2FX\\MDJ>2<8P?0>U>X6]M!:0K#;01PQ+T2- JC\!44FF:?-.\\MC;/
M-(H5Y&B4LP]"<9(X% &%._BF[G@N-"OM".E/&A4SPR22,,<D,KA?IQ6?\0)$
M35O!89U4G7H\ G'_ "RD']1^==OT&!4$]C:7+A[BUAE8# ,D88@?C0!3U74=
M$@EAT_5KFR1KM6\J"Z90)0N-V W!ZBO*?$>B_P!G?"WQU%HN?[$DNHY[&-#E
M1&#$TVS_ &-P?&..#CCFO8;FPL[U46ZM()UC.4$L88*?49Z4^>WANK66VGB6
M2"5#&\;#(92,$$>F* .3^)LL1^%6O2*RB-K([3G@YQBG>,Y83\)-9D9E,;:1
M)M(/!)C^7]<5MZ=HZ6FF1:;<^7=VUL ENTR[F" 84-GJ0.-W>F:EH4.I00V#
MI%'IBR+++ BX\XJVY5/8+D GUQCIG(!P_C6WNU^#^B6;AO[2+Z;$@_B\[?'^
MO!KT\D $DX ZDUF7FDC4=5M+F[*M!8OYMO".\N"-[?0%@![YZXQHR1I+&T<B
M*Z,,%6&0?PH \5MIIC^S[:S6H,UO%?N]ZD7S%K<7CM(,#MMQGVSVKK]<6+4O
MB%X-O-)EBF;R[EKF2(AE:T,8QNQU4N5QGN?K7;P6=K;!A!;0Q!OO>6@7/UQ3
M+;3K&S21+6SMX$DY=8HE4/\ 7 YH X;X6V&F2:1?7:6MJ]Q#K%Z$F"*6CS(P
MX/4?*>W8U8\=W$%GXI\$W5U-'!;QZC*'EE8*JY@<#)/ KM(+2VM=WV>WBAW?
M>\M N?KBG300W"A9HDD56# .H(!'0\]Z //-/CL+WXB>/7F2"4"PLP#( <*8
MI-W7H.F:YO3-7&F>%_AI?WU]-::0+::&:[0*RPS%0L1;<K # D7..,GI7L1T
MZQ+NYLK<L^=Y,2Y;/7/'-*;"S-J]J;2#[._WHO+&QOJ,8- '/>#K71(Y]7O-
M#OY;^.\N!-<7/F*T3S8^;85 7.,9QQG'<&L633],OOC9>P7=K:W ;P_&6BE1
M6#'SWR2IZG&/P-=_#!#;0I#!$D42#"I&H55'L!TI@LK07'V@6L/GYSYGEC=G
MZ]: /*8[W1+BZ\7^'/%>MR:<\U_*S6TAC07%NP7RC&60LQV@ !3D;1BM"[U*
MP\,^/K"XGOX%23P^EN;;4KI(9(P),JVYSABW(8#D;<\\"O19K&SN+F*XFM8)
M)XO]7*\8+)]">17+ZOH&N3>(KB_MUT74K.>.-%MM3C8&WVYSL8!@0223D ^_
M H XO5](T_1?@3';Q7FGWICNX'-S:NKQ[FND8A6'4*#MSZ#MTK;\7B]M-5US
M5M%OK.Y,-BBZMHU\,)/ %8AD<<J<,X]":ZS1O#5GI]M.)[.P,ES+YTD<%L$A
M5MH7Y5Y[*,D\D^G &E)I6G321R26%J[Q8\MFA4E,=,<<4 <)#J5J?BOIEU=8
MLTO?#*B*&X(#%VG4^7SU;GI53P=;Z-#X>\7ZE-I\%S]CU?4G_=H#(%&?E0]5
M)4D#!'7WKTR2W@FD226&-W3(1F4$KG@X/;--@L[6UW?9[:&+=][RT"Y^N* /
M(=.U73I/$GPXFBO[%+06US%':P2;EMD:!0D3.269^@YQDCI4$UKIY^&GQ-E$
M-N675KT!@HR,%2H!]CT]Z]CCT^RB5%CL[=%C8L@6)0%)ZD<<$TT:7IX0J+&U
MVD@D>2N#^E '"PW]O;_%G2IKJYC07/AD1Q,[@>:YG0[5]2?05Z+4*V=JIB*V
MT(,.?*(0?)GKM]/PJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"[O+:PMFN+RXC@A4@%Y
M&"C). .>Y/%3UR'Q!U*RTS3](DO8(6#ZK L5Q<,PBM).2LKX(R!@\$@$D9(H
M W4\0Z,]C/?#5+06MNQ2:5IE58F'9L_=/L:;:^(]$OM1_LZUU6SFO3&)?(CF
M4OL(SG&<]"#^->53:A9-;_%B)M1CNFEL4DCD;:/,'V3&Y0 !C. ".O')SDZS
MRV$&J?"LPO;QC9*!L*CAK4Y_-L?C0!TGC[Q/%HOA;5WL=7M[75;:W:2,':Y#
M8RJD'@$]@>O:NCTZ66YT:TE=_P!]);HQ?'\14'./K7CXUFR7X3^,M(U>YABU
M]);TW5O.P$DDC,61U4\L-NW!'&%]J]:T"XAN/#>FSPRI)$UK&0ZMD?='>@#E
MO!_C*%M.DB\1:Y:B_?5+FUMQ,R1-(J2%% 48],?6NKU#7=*TI]E_J%O;,$\P
MB20 JF<;CZ+GN>*\;NI;'_A2OB^9'M_,;69VW@C)/VH%3GZ=*Z+Q/K.FRZUX
MLL8YK>QNCHZ!Y2=\NH*8Y"JQ*<KM7)!(!)W=L9H ]#EUO2H+VVLI=2M$NKH;
MH(6F4/*/51G+?A4AU2P$]Q";VW$ML@DG0R &)3_$P[#@\FO-9T-S\)/"WB32
MB)[[P_:VUVNPYWJD2K/'GW3<#[KBKGBI[O\ X0*3Q D-P5N+^VU"ZBC7]X+1
M9$(7![A%5B.F=WO0!W5EKFEZDTZV>H6\SV^#,J2#,8/()'8'UJ:PU"SU2QBO
M;"YBN;649CFB8,K#.."/<&N/\/W'A75_$C:[I>JS:I=K8&&>X\P&.*'<&"N
M  V<D \\&NHT&[TF^T2UN=#,!TQU/D?9TV)C)!P,#'.>U &C1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !39(HYHS'*BNAZJPR#3J* (S!"Q8F)"6QG*CG'2D^S0<?N8^.GRCB
MI:* (7M+:60R26\3R%=A9D!)7TSZ5*0",$#'3%+10!%]FM\8\B+'IL%+Y$.]
M7\I-RKM!VC('I]*DHH :(T6+RPBB,#;M XQZ8IV!C&./2BB@".&W@MD*00QQ
M(3DJBA03Z\4Z.-(HUCC1411@*HP!^%.HH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M;)(D4;22.J(HR68X %8J>,_"TF=GB31VP<'%]'P?3[U &Y138Y$EC62-U=&&
M593D$>H-.H ***IZ9JECK-BM[IURES;,S*LB="58J1^!!% %RBBB@ HHH) !
M). .IH **I:9J^G:S%-+IMY%=1PS-!(\3;E#@ E<]\9%7: "BBB@ HJEJNKZ
M?HEA)?:G>0VEK']Z65L#Z>Y]JN*P=0RG*D9!H 6BBJ/]L:<=9_L<7L)U'RC.
M;8-EP@(&XCL.1UH O453T[5+'5H))K"Y2XCCE>%V3H'4X9?P-7* "BHKFY@L
M[:2YNIHX8(UW/)(P55'J2:CL+^UU2PAOK*99[6==\<J]&7U% %FBBB@ HHHH
M **** "BBB@ HHHH **** "BJ-QK&G6NJ6FF3WD*7UWN\BW+?/(%!8D#T !Y
MJ]0 4444 %%%17%S!9V\EQ<S1PP1KN>21@JJ/4D]* ):*K:?J%IJMA#?6,ZS
MVLR[HY4Z,/459H **** "BBB@ HHJC?ZQIVERVL5]>PP27<RP6Z.WS2NQP H
MZF@"]1110 4444 %%%% !1110 4444 %%%% !1110 44R66.")Y99%CC0%F=
MS@*/4FJ^F:G9:SI\=_IUS'<VDN[9+&<JV"5./Q!H MT444 %%%4=4UG3M$ME
MN-3O8;6)F"*TC8W,3@ #J3]* +U%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7!^)
M?&NJ>'H+^^GM[*&"UNXXHK.4DSW<)9%:56#?*,N< J?N\GFN\KS75? 7B*^T
MSQ/IL>H::8=5O1>17$R.9@ Z,L38X"KMP",\=A0!Z5167;IK@UA&N)K!M,^R
M .L:.)?M&[DC)(V;?QS6I0 4444 %%%% !7G_P *(HY?"FJQ21J\;:O>*R,,
M@C?T(KOI"XC8QJK/CY0S8!/N<''Y5Q'A7P]XG\,:1=V,9TB1[B[FNEF:20A#
M(V<;-HW8_P!X4 <WH6M1^!?$7CK2(D>32-.>VN+.V4G$4DX'[I>N%+L, #CG
MBNK@\3ZW#KK6ESI<MY9/:23I=6]A/!Y<B#/E-YF0=PZ,".>,5!_PK:WD\,:W
MI]SJ,LVIZS()[K4M@5O-4AHRJ@\*I PN?7FKNE6'C5[22/6]4TSS8H72W>QC
M=3+(5(623=P,==JC&>>P% #/"WBFZ\30PW=G=:7=VTEJSRQP[HY+6?*[8GRS
M'N_.T?=Z<UGV7CR=?AK!XBGL+=+J>[:U2"(D1*YN&B!)ZXXR3W]LU=L_"=TO
MBRV\236VG6E_%:R0W'V*1L7SMMP9,H-H!!/\1Y'/'.!>Z1<^&OAC!X9O[S2U
MN;V_\B%YPS02^9,TS*^<%?EW#(.>!CG% '1Q^(-<7QS-X:>WT^?;8"^6Y#/%
ME2Q3:5^?G<.N>A]JP;/Q_P"()O"^B^)+C3]-2PN[U;6XB1W,@#3&(,AZ#!QP
M<YYZ=*O:$VOZ3KL4%Y9^'YWOE*F:RNYGG 1&92YD#'RP?EZ\%QQS5>/P)K4?
MP[TWPUYU@9[2]6Y,_F.%8+,9<8VY!YQ^OM0!IZMXMU SZS#HENLLNEGRRCV4
M\WVB78'*!H^$X91DYY/0 9,UKXJO-7U&PTJRM!87\NGKJ%VM]&S&U4G:L90%
M26+;NXP%SW%5)O#?BC2_%%]JOAN^TQ;752DEY:7Z2,(I54+OC*8)R ,@XSC\
MGW?A76K/Q59^(M&OK:XNOL0LK^*_+(MPH;<'#*#M8$GC&,<<4 0_##S_ ++X
MH^U",7'_  D-WYGE9V[ODSC/.*LZOXON(/$E]H5G-86^H0VZ2VD%\K WS,"<
M1MN4#! '<YSZ5;\'>']2T#^V3J%S:3?;]2EOD%NC#;OQP<GVZ?J:J>*_"M[X
MGM]2T^ZM],N;.<#['/.S":R?8 67"G/(W !E]"<'@ O1:[?2>.[[PZRVXCCT
MY+V&8(V06=DVL-W.-N>,5DZ/XZNM3T'1'-M;KJNKWD]K$@SY2")I-\AYR0%C
MSC/)(&1U%F;PUK-GXOMM9TN[M)%;3$TZY^V[R^$<L)%V_>/)R"1]:Q8/AUK=
MKX6TN"WU6SCUK2+^6\LI_+8Q,)&8M')W((<@D =* '^.[G6Y?AUXRMM8LX42
MWA MKN X2Y0X).PLQ4J>#D\]JU[3Q#K%IXMTK1M2MK(6FIVDLMLT#,9(FB"D
MAR>#D-V P?7K3-:\.^)/$/@S5=-U&[TX:AJ$2PA8-ZV\"@Y)&069CW/'8=N;
M-UH&JW7BOPYJY^QI%I<$T4T8E8ES*J@E?E[;<\]<]J -'Q-KPT#3[>1(A-=W
MEU%96D3-M#RR' R>P')/L#7+J-33XT6@O7M)F&@SF)X4:(']]'D,"6QSWSWZ
M<5O^-/#4WB;1[>*SNEM-0LKN.^LYG7<JRQDXW#N#DC\:S[;0?$DWC2R\1:A)
MI49@T^2SDM[<R/N+.K9#$#NH[<>] %&W\>SP>#KC6;VUMK4Q:L]C*\:L\4"B
M7897Q@D=STR2.E:DGBJYL](6YD:POFO;^*RTR:T8B*X\P+AF.6P ?,S@GA..
MM5M%\-Z_HVBSVJ/ILLLNIS7CQN[F.6*4L6C;Y<@_,,'!Z=.U9TWPQ9M)U..Q
MG@TFYFU&+4K"&VR\%I-&H (! SN.2<  9& <<@'2"XU[SM7LM4M+=[)+3S+>
M^MQL60D$,AC+,01C.<X(-<SX.UYM.\"^!M(M5C;4-5M]D)ER4C2-"[N0,$X&
M !D9)'(KI;&S\3SV%TVM7&FM=O T,,%EYBP@GJ[,V23TQQP,]<U@VW@/4K30
M?"ODW5HNM>'"1"^6,,\;+M=&XRNX=P#C'>@"W<>-;W2;SQ!IFHV4=QJ&FV']
MHVYM595NH>1]TEBI##!Y/J/2I(?%-[=>']2UC3[_ $G4K.WL6N89[>-@#(H8
MM&Z[R5X [YY/''-AO#NJ2ZIJ7B#S;2WUJ:S2SM55FDBA16+_ #,0"VYCSP.
M![U3M_ H?5]8U!X+33/[3TUK*>"Q<NDCL3F9LJHW ' X[G)H E;Q=?"W\&7(
M@M_+UXQK,F&S$6A,F5.>G&,$5%IOB7Q-JNO:I:166E16NEZBL%S))-(6:$H&
M)3 Y< YY ';WJC;^#O%#V?A2"ZO=)0:!.A!B61O-C6,QACG'S$$<=.O)Z5O>
M'= O],UCQ#<WOV5[?5;D7"+$[%D^0)M.5&>%SF@#(3QQJUU;:7JVGZ7+>:=>
MSJK6T=C/YL<#'B7S<;&P,$KCOC<<9KJ_$6MP>'/#][J]RC/';1[MB]78G"J/
MJ2!^-<MX<\+^+/#T::''J]A)X=A<^1*8W^V)%G/E9SM]MW4#H.F.F\3Z#!XG
M\-7^BW$C1QW<6SS%&2C9RK8[X(!_"@"D-1\06&IQ_P!J6MG)I36KS3W5OE/L
MCKSM8,Q+@C.& '3I6+=>-]3L_"%KXRDM;9M&E*22VJJWGQ6[L%63?G:S %25
MVCJ1GC)T=&TGQ1/:BS\4WVG3VR0M"19*X:YRI7=*6X'!/R@=3G/&*S(/!&JG
MP:O@R]N;271T98Q>!F$[6ZN&$93;M#8&W=NZ<XS0!;?Q'XBO/%NKZ%IEKI:_
M9;6&X@N)Y'8,'W?> QUV]!TY.3TK#O?%NL:YX>\#ZI8R062ZKJ4<-S"R,_S#
M><9##Y-T?3J>.>N>HM-"U*S\;ZMKB"S:WN[2*WBB\U@R^7N()^7'.[MTQWK!
MM? >LVG@SPWI<=U8&_T/41>*[%S%,N9,@\94XD]^GOP 7KCQ%XJF\5ZCX?TV
MRTAIK2U@N5FN)) CAV(8$ 9!.TX'..Y-2MXJU74-)UC5]%@LY+33)Y8E@F#;
M[OROOE7!PF2&"Y5LX!.,\6].T'5+;QU?:[<26;V]U916I$;,'!C+'=@C&"6/
M&>/4U1LO"FL:)%KFFZ5/9/IFJ32SQ/.S"2S>4?. H4B1<\@97T]Z *%]J]MK
M_BOX::O:!A!=F[E0-U4&U8X/N.GX5I:?XON-6UR[L+2:P2XL[\V\^G3*RW A
M#8\U26 8$8887&#U)'*/X,GL]0\'_P!EM;BQ\/+(A69V#RAXC'V4C/.[W/I4
M>I>#[[6]1LKC4(]/6XL=1^TP:E ["X$(D+"+&T=5PA^8COB@#J-;O+VPT6ZN
MM-L3?7D:9AM@X7>V<=3T'?\ "N>TSQ7>W?BC4-!633KZ2&P6\@N;;='&27*%
M&Y?H1U!]L9K4\8Z+=^(O"E]I=C=K:W$X7;(X)4X8,5;'.U@"I]B:R+3PYXAB
M\8CQ!+-I(#:4+%K6)9%52KEU"MZ<]<>V.] &3I_C[7[CP_X:\07%AIR:?JMW
M%:31([F53(Y0.IZ  XX.<^HZ#=GUW4-9GU^UT86BPZ7FWD>X1F\^;9N9!@C8
M "HW'=R3QQSCP^!=9@\!^'O#PFL&FTJ]AN6E,CA9%CDW@ ;<@G./;'>KT'A?
M7M(\0:U<Z1<:>VG:RWGSPW1??;SE=K,FT?.#UP=OUH L_"W_ ))AX=_Z\U_K
M68WBOQA?2>(HM)TK23)HUR8]LTTA\Y0BOM7 'S'/4X X'/)'1>"M$O/#?A#3
MM'OIX)IK2+R]\"D+C\>3]>/I7+>'!J[^(_'<6FK98DU$*))Y&4Q/Y*#=M"G>
M.G&5Z=>> "9/'^J:J_A7^Q=/LRFOVT\BFYE;]S)&F2#@= 3U&2<=LYK5L=>U
MK4]2NM%B&G0:GIMK"^H2E7EB\Z4$JB#*G&!DL3W P:J6_@BYTO4O"']FO;FQ
MT"":)A,["2;S4"EN%(!R-WOG'%77\.ZCIOC2]\0Z.UK*FI01QWMK<R-'EXQA
M)%=5;^$X((]\T 4=-\?OJMEI]M%9I!K=UJ$VFR0.Q:."6%2TK9&"RA1D#@G<
M!D<FKESXDU?0[#5)M;T^)O(N(8+&>WR%O#*55?DRS)AFP>OJ >E9=W\.[N/2
M[2XTK488?$-MJ<NJBXDC/DR2RD^8C <A"I"^N%%:.I>%]8\2^%[VRUS4;>#4
M)S&\#6"MY5J\;;T8;CECNZGCC  &,D C3Q?J&GZI>)J]E(^DP6#WG]HPV$UN
ML93):-EDSDX&00>>F*PO%-[K&I:?X*U&[2SCM;O7+&86Z*WF0[B2H+DX;@X.
M%'/3-=#;Z#XEUK1[S3O%U]IS0S6KVVW3$=?,WKM,CENX'10,9.?3&0WA#Q=<
M:)H.E75]I#+HU];SQ7($A>>.'.W<N %;&,X)SZCN :D?BK4WA\8*8[3SM!;]
MTVQMLH\H2?,-V0><<'W]JJR^,]<F?P?%8V%@7\0V33EI9' B<0"3& /N@M[D
MXQQUIUWX2UY=2\4?8+O3A9:]$"[3!_,AD$/ED #@J< YSQZ&BT\(:U;7/@N1
MI["0>'K=X)<%U,H:(1?+P<8 SSU]!0!*_BC6FDN--6*T35K&VC>[,=I<7,+3
M."PC79@J, '<<_>Z'!J$^/IA'H*:C#'X>GU.WD=CJD3;4F1@OE=5P3DL"2.
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M,%:.=!EHI%8,K#Z$"LZQT'7M2TVXLO%NHV5U#+;/;&.PB:,2!AM9W+$_-C.
M  ,D\\8ZNB@#AX/!NIS^'-/\,ZM>6MQI=E)$?.0,);B*)@T:,IX7[JY()R!T
M&<B>+POJD5_XMN?.LS_;JJ(UW-^YVQ>5SQ\W'/;T]Z[&B@#A(_!6JV]EX/\
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MQSUS61<?#JZL[/2+K0M3C@US3;B>X^T3Q$Q7+3G,JNH.0IXQ@D@ =^:]!HH
MX[5_"6K>(/#PCO\ 6(XM;BN8[RVN;6(B&VEC^Z%1B21RV23D[O0 !MQX5UKQ
M+X:U'3/%>I6KM=0>0BZ=$R1QG(82$,26;<JGL  0.IKLZ* .#;POXKO[GP[/
MJ6J:69-'N#(9(X)"9QL*9(+#!(/0<9Y]JCOO ^MO;^+-.LM1L8]-UYY9\R1,
M98Y)(PC+G.-OR@YP3C(QW'<7U[!IUA<7UTY2WMXVEE8*6PJC).!R>!VI]K<Q
M7MI#=0,6AGC62-B",JPR#@\C@]Z .3@\+:K%XB\.ZE)=6<B:59/9R (R&7>%
M!8#G;C8.,G//3LR_\+^(;/Q;=ZYX9U2R@74EC6^M;^%I$+(-JR)M(.=N!C(!
MQ^7:44 <QJ&@ZC=0FSN/L.KZ?+:B*>#4,KNEW,3(, @?>^Z!Q@8(Q6EX:T;_
M (1[PUIVD?:'N?L<"Q>:XP6P/3L/0=A6K10!P+?#N>[T7Q'HEYJ,7V#4KV6]
MMGBB(EAD=Q("23@[6'08R.XK670-3U34-&NM?ELV.DL9D%KN(GF*E1(V0-H
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M.];5MH.CV=XUY:Z38P739S-%;HKG/7Y@,UH4 ><0_#W6+#P[X<33M5MK?7-
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MAC R"68$G<QP/0#L.34.L^'[W4O%F@ZS!=01QZ49B8GC+&7S4V'D$8P.>AH
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M.,;UMQ+OF=-X#9887!7IR<GD8YS[WQMJ&G1:'_PDD9\/+>6SF>Y,0ECCN0P
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M1@_-G)S]*IW>L:_I.HV>E7MS;W-UJ<\KP/:6I!@@C12PVLWS-N8 $]B20>E
M':45YKJ_BCQCHGA76+VXM($DLKR&.UN+B''VJ&214Y57^1U+<GH>.*MW/B;7
MO#'C"TL_$$UE=:7J5O<31/:P-&UL\*>8R'+'<-H//!)[#I0!W]%>=WOB_6['
MP)9^.&:"2S<17%QIXC^[;R, -KYSO4,"2>#@\"K$FK^*M2\::QHFF7VF6\-K
M;VUS#++:LYVN6RI&_DD+][CITYR #O,C)YZ52O\ 5;73I[*&X,N^\G$$.R)G
M&_!/) ^48!Y/%<EX!DU.?6?%CWNH_:4BUB2':8@O2*+&#G@ <8_'.:TO%.M:
MCI&L^&X;5[?[+J&H"UN%>,E\%&;*MG ^[Z&@#J*K:A?VVEZ?/?7;LEO ADD9
M49RJCJ<*"?TKC'\7SOXNN=$EU"+3;^.]B6VL[J'"7=L2FYT<_><@O@ \$ 8/
M6NG\3_\ (IZS_P!>,_\ Z+:@"YIU_;ZIIEKJ%HQ>VNH4FB8@@E& (.#TX-6:
M\GTO6O$GAGP?X.U22:PN-#G@LK2:T2!EEA1T55D$F[YCDC(P!SCGK6S>>)O$
M6I6VJW7AVV:62QO)+:"V, 9+@Q-M<.Y8%<D-C&,<9SF@#LGU6U36HM)8R?:Y
M(&N% B8IL! /S8P#DCC.:NUR(U[6'\?6>CNMO!:W.CO>")HB9(I0Z+AF#88#
M<>F/K7,+XR\5KX'_ .$IFN=.\NTU V\]JELW[]/M/DG#%ODP#P.>G).<  ]5
MHKE+O6K^[\9WGAZUG2Q%MIRWB3/&&,K,Q7H>-BXYQR2>HQS-X#UK4O$?A"RU
MC5%MTFNP76.")HPJYP/O,V<XR#QP1Q0!TM%%% !1110 4444 %%%% !1110
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M$T31NRC'48)'YUQ2> M3_P"$;T#2)->MV&C7<%Q$_P!@(#K#]Q2/,ZGN<^F
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M@L,=.: .4OO $&K:;K27]XXU'59HYWN[==GD-$ (=@R>%QW.22W3/%BP\/\
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M1VRQ))48 [ GKGC=GM+>Z4+<6\4P7D"1 V/SJ1$2)%2-51%&%51@ 4 <5;>
M[B/PTGA6YU1+C0(Y%*HT!$[0JX<1,^[&,@#=MR5XP#S6K9>'+JT\:ZCKYOX7
MBO;>* VPMB"@CW;3OWG/WCGY:Z*B@#G=#\-W.B:[K-VFHK)8ZE=&[^S>1ATD
M*JIR^>5^4$# /O2^)/#MSKM_HMS#?Q6RZ9>"[V/;F3S&"LN,[UP,,?6NAHH
MY'6?!]UK\$ECJ5];361O1=0N;8^?;@.'V(^[';&[ P"1@UTNH6::CIMU8R,R
MI<PO"S+U 8$$C\ZLT4 <?8^#;H:5HVD:IJ$%SIVD-$T*0VYC:8Q#$?F$L1@8
M!('4@=!P85\%:QIVO:A<Z%XD-CIFI3FYNK1[59625OOM$Q/REO<$ ]C7;44
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MOM0OWODGCL$D9&=@2H3.#D#&3@#.>*[*R^TBPM_MA0W7E+YQ3[N_ W8]LYH
MGHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ IDD,4N/,C1\=-R@XI]% " !0   !P .U+110 C*
MKJ590RGJ",@TV.*.($1HJ \X48I]% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRH))4=.3^M &W1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8XK*T@\WRK6&/S?]9LC W_7UK'\1Z'>:AI\$>CW%M:30W*7#1S0;X;@+GY)
M"#C)!R.ZB@#GM N='U[Q[=>(8]7T:63^S4M%L[:\2=\*Y9I&QC&,[1[9SC.*
MXNS-A#\#?#\Z&W20:S"^\8!W"[/.?4+^E>EZ=X;N)+^VOM7M=&BEMBS1KI]N
M02S*4.YVY(PQ^7'7'/%=%]CM=NW[-#C.<>6* /,9]5TFV\6^+='\4ZQ)IL=^
MR20>8R+%<VK0JFU693T(88!ZDXYS3].O+'PY\0])M[V22STAM 6#29+]MH5A
M)ET);HY4)P>< #VKTR2TMIC$9;>)S$<QED!V'V]*6>V@ND"7$$<R@[@LB!@#
MZ\T <-\+[JSF'BM+2:%Q_P )!=2!8V!^1MN& '8\X/>L_P 8-=6&I^(=6T;4
M;2X$-LBZQHE^/EGC$>0T; [E)5BH[$BO3$BCB!$:*@8ECM&,D]3]:BDLK6:9
M)I;:%Y4.5=HP64^H/:@#@EU>SL?BV;S4I4L%O/#L)B6Y8(2PF<E!GJPW#@<U
MQ^BZS#IOA+P?J4\F[2+'7+O^T<#/D,[S")Y!U !8'GV]J]PDMX)I(Y)88W>(
MYC9E!*'V/:C[/!Y!@\F/R2"#'M&TCTQTH \R\;7?AV[^'_C34M$:WE-W;QBY
MO87W1SR#Y54-G!8#&<>H[U=O6LH/B3X%6V,$8>PO$ C(&5V1E1QVSG'XUWPM
M+98%@6WB$*?=C"#:/H*!:6P96%O$"OW3L''TH Y'XM&(?"W7_-*_\>XV[O7<
M,8]ZH7YL9_BSX59C;R,=*N64G!R<Q[2/UQ^->@211S+MEC5USG##(IGV2V#!
MOL\61T.P<4 >+7\D/_"M/'RPNACA\3,V$((1?/A)/'0=3^=='K'B.PLOB-:W
MM]K+6>C7VEB*RU"-D,)E65C(N]E(&1L.> =HYZ5Z.MK;JKJL$05QA@$&&'H:
M2:TMKB 03V\4L0QB-T#*,=.#0!Y-JUCX=L=-\&PZ:^_39/$R21O<,")59)"S
M+G'R%CQQ@]1P1G=U:TTR#XN>%($@M(P+.]<1JBKAB4(./7.X_G7>O;02;?,@
MC?:,#<@.!0UM \@D:&,N.C%1G\Z /'X]3TNP\->+_M5O!<VW_"6%0K2%8H6+
MQ%9'*G(16&X^N,=ZV?#.IVA^)_B8MJT%VUQI]JZRIM5)-OF;BF.JKTSDXZ$U
MZ-]CM=CI]FAV.,,NP88>_K2_9H.?W,?*A/NC[HZ#Z>U ''_".1)/A;H6QU;$
M+ X.<'>W%8ECK>AV>N>-=!\83PP2WMX946Z)475JT:JBH>K8VD87G)XYS7IL
M<4<*E8HT0$YPJ@4V2UMYIHY98(GECYC=D!*?0]J .!BN%TOXIZ5]KB-GIMQH
M(M].$QPL<H<,\63T?8%^H6N2\16Z0>"_'TZM&-(N-9MWLLD;6?S(O.9/8MN'
M']TU[7<6T%W$8KB&.:,\E)$##\C2M;P/&L;0QE%^ZI4$#Z"@#AIC9V_QGT>.
MW,$>[0YT"QX&5$J%1@=NN/QKAYKVP;]GS4;)[B$W5M=N)HBPW1$WQ(##^$D<
M_2O<!:VZN'$$08=&"#(I#:V[!@8(B&;<<H.3Z_6@#@_%HMM'\3^#=1CA@@T(
M7LOVN2- L8E>'RX'<CC )(#'IQ3HHQ_PL[Q#J-G(@TW^Q8TO9%8;&N0S%<GI
MN$?7T##UKO&@B:$PM$AB(VE"HVD>F*2.UMXK<6\<$20C@1J@"_ETH Y/X5.C
M_"_P_L96Q:A3@YP03D5G>';RWMO%?C>P\020QS2W"W"_:2 LMF8PJXSP57#
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M)SVKV&*TMH(#!#;Q1PDY,:( I_ 4&TMC'Y9MX3'NW;=@QGUQZT >06-]:?\
M"!_%* 7RS2?:KZ0,V S*T"!6P !ACG''/.,UZAX8=)/">CNC*RFRAP0<@_(*
MT#;P-OW0QG>=S94?,?4^M/2-(T"1HJJ.BJ,"@#S3PC:6MV/'C645K)J*:U<M
M;/A2R/Y2A&![?,6Y^M4/"]YX8\0:)X9LKO4[R36-,FAVZ7E4F@N(QM8E0H;8
M/F)).".O->L1V\$))BAC0G@E5 IJVL$<[W$=O$+AQAI H#-[$]: /*-,MM!E
MT'XDQ:A%:%O[4O X95WA2B[,=_O9VX[].:F\'M?:'XOT:U\2.8GF\-006CS'
M $B',L>3_']TGU"CTKK/"WAB?2;O5Y]2AL97O-2EOX'CR[1;PHVY91TV]1US
MTKIKBVM[N+RKF"*:/.=LB!AGZ&@#Q37;:.W^''CB4M&NDW&NI)89(VE?.B\Q
MD_V2P;IQP:Z_QXFFZ7)X2NXUM;2T&OPR2S*%1,>5(H9CTZ8&3[5WKV\,B*CP
MQLB_=4J"!]*&@A:(1-$AC&,(5&!CIQ0!PL=Q9R?&TNDL1$GAH-U W#[1GG\.
M:XB(V$7P&AGC-ND@U@.'7:#N%]P<^NS]/:O<&M;=G+M!$7/5B@R:;]CM=NW[
M-#C.<>6* //M:UK3_#_Q.N+NXU+3Q]KT>.-H;ZY$"KB1MA5B"&#?-D#D8!YS
MBM#PE=^'_!?@71+.?7K":*1_L\=W#(&CFF8D[0PSP.F3V SBK-_X?UT:_=WE
MG)H]Y97*QJMMJ,#9M@BXPC+D%2<G! Y)YJY;^$;4:;+:7"VN+FY%S<I;VXC1
MFVJN$7G:"% )Y)R>1G@ G\91:A/X*UJ+2M_V][*58 GWBVT\+[^GO7#:G/::
M[X%\%C0WC_M".\L_LJ1D;X"@Q*"!R JA@WTKU6H8[2VAGDGBMXDFD^_(J ,W
MU/>@#@_"EMIEU\1?'.Z&UFDCO+1T!56*D0KR/3# \^HJU\2[Q],L]!U*9';2
M[35X9=0VJ3LB 8!V ZA7*GZ@5VB6\$;EXX8T8]650#3V570HZAE88((R"* /
M./$VK^#Y?#GB76[.SAUB.:WACOYK>9O+E^8+&K.I_AW9;;R .>HJ'2-3MKCX
MP,W]KVM\]SX?"));A1&["<G;'@G( R>K$<Y/IZ3':V\-O]GB@B2#!'EJ@"X/
M7CI2I;PQE3'#&A1=BE5 VKZ#VH \-M-8TV/X2^#K)[V 75GJ]I]IAWC=!MN#
MNWC^#'OBNA\075SI%_K>LZ+?6NJ:<UW%_:FB7 'F>9MC57@8'.XJ(R >#CCG
MBO3EL[569EMH0S/YC$1C);^\??WH:RM6N%N&MH3.OW93&-P^AZT >7RZGI,'
MB?Q?H?BS5Y=-%]*)(ED*)'<VK0J@"LRDDC## /4\<YJ?3+VR\._$6PM]0DDL
M],;0(X-)DOWVXVOET+-T<@)D'G"BO2Y;6WGDC>:"*1XSF-G0$H?49Z43VUO=
M*JW$$4RJ=P$B!@#Z\]Z .&^%MU9S6WB=+2:%U7Q!>.%C8<*S J<#L>U9OBZ2
MZTW4O$>K:-J%I=)%%&NL:'?# F01C#1,/F4E#@=B0>]>G)''$"(T5 26(48R
M3R3]:BDLK66=)Y+:%YD.5D:,%E/J#VH X./5K/3_ (N75SJ4R6(O-"MS"MPP
M4NPE?*CU89' YKD-)U6.Q^&?A#4'8R:9I^NR/J2H,F%3--L9U'("LR-C_=KV
MZ2W@EECEDAC>2,DQNR@E/H>U @A6#R%B018V^6%&W'IB@#SKQ5?>&[_P=XTU
M319+>>6YTTI=7T$FZ.1@C!$W9P6 /0<C(SU%1S-96_BGX8^08(PUO<J-A R#
M; ]O5OUKT=+2VCMUMTMX5A7I&$ 4?ATH^R6P*G[/%E?N_(.* )J*** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K&\4W<%IX?N&FUV/1-V M\^P[#D'@-P20",>];-
M<-\8)8H_A9K0E=%WI&JACC)\Q3@>_% '2WGB/1=-N7M;W5K.&XCB\YXY)E#*
MF0-Q'89( ]<\5FZOXZT/3/#,>NQWD5U:SN([=H6W"1RVW&1T /7/3'KQ6)>W
M>G3?&C17-Q:N1HLY1MZGDR(1CW(W8]LUR%Q<VS_#3Q6T,T;0P>*FE;RV!"1_
M:HSNXZ+C)S0!Z_<:]I5K:1W4U]$L,JEHR#DL!U( Y('<]JCE\3:%#!:32:Q8
MK%>#-NYG7$HZY7GD<=>U<+JWB+3=.^(:ZAJNIS6NC:EID<=CJ$3E82Z2.74L
M!CD,&!Z$ <]*HZO!X=TS3_ ]OIV(=,/B%9H1=.?G0K(2X#<A"Q!';D'N* ._
MA\;>%YXDEBU_3G1XVE!%POW%.">O SQ]:MP>(M&N='&K0ZG;/IY.T7"R#:6S
MMV_7/&.N>*Y'5SIT/Q@\,0_Z+&4L+PJGRC:S%""!ZGYOKS7+6^N:78:;K3RK
M9S1GQJWESRMF*S)VE9V"D?*"#W )/)H ]/O-9@U#P_JL^D:BHN+6*0%T +PR
M*NX!E8<'IP1T--\%7]SJG@?0[^]E,MU<644LLA &YBH)/'%<)H^IV2Z]\1MV
MIBX$EM!,L\@"^8GV8C>, #;G !Z'CDYR>O\ AO+'-\-O#ICD5PMA"C;3G#!0
M"#[B@#7O_$.D:7*8K[4((&&W?O; 3<<*6/103T)QFI+_ %C3],VB\NXXF92Z
MKU8J.K8'.!D9/09KSG3-<T2RO?%WAKQ=M6YN]3EG2":-F-[!)M\KRP!ER H7
M Y&!6EIEZNC?%'55U?9907VFVO\ 9IF8*BI&&\R(-TR&;.!VYH ["7Q#HT%M
M9W$NJV:PWK*EJ_G+B=F( "<_-U'2H+?Q9H%W;7UQ:ZM:SQ6 S<F)]_ECMP.N
M<'&.O:O)[FWBL?"-N+IHDTV[\:K<6$<I 7[*9AR ?X#\S>F&ST-=;]HMI/B]
MK,$$T322^'HUV(P)9A))QCN<$?@10!O:1X[T'4]$LM3DU"VM5O&"11S2@,68
MX5<=VZ<"M"W\3Z'=V'VZVU2UFMC,8!)%(&#2#J@QR3WP.W->1_VGI4_P;\'6
MTEU;-Y&HV,=PCL,(5D^=6SW ZCL",\$5V>OS1Z1\2O#>I7'EQ:+-;W$(G&!'
M'<R;2&8] 65< GKS0!NZYK27/@C6-4T/4D\RVM9G2>':^R2-2=I# @'(P01F
MKOAFZFOO"FCW=S(9)Y[&&61R/O,R D_F:X"[1$D^)VJP3(ND7-@$20,/+DN%
M@8.5/0GE5)'4\=17;^"I8YO N@/%(KK_ &=;C*G(R(U!% %J]\0Z/IT[0WFH
MV\+J5#[VP(RWW=QZ+GMG&:DEUK3(-4ATR6^@2_F7=%;E_G<>H'<5YWHM[:6W
MA[QMHOB&2.._-Y=R2Q3$!KB.4?NV0'E@1A1CT HOM+U31/AQX5U^X21]8\-Q
MQ33IU=H"H6:,^X0_FE 'H_\ :VGA[M#>0J;, W&YP/*!&?FSTXYJM%XFT2:*
M[D75+55LP#<^9($\D'H6#8P#V)X-<=XNCO;7P-%J[07#,VIV^IZC%"/WHA#J
M=N/5$6,?\ S4+7?A+5+?6]>TG4);^X_L::WGO'F;RXXR,K&V<#<220.HP<XR
M* .XTWQ'HNL736VG:G:W4ZPI.T<4@9A&PRK8]""/S'K6'XL\5Q:9KNB:(+Y;
M4W\TGVF8$;XHUC9AC((!9@HSCIGOR)?APEDWP^\/36JP%AIT,;O&!G(4%E)'
M?<3D>N:S?&%]:6_Q'\"K-<PQLL]V2'<# ,! S]2<4 7O#\SV&J:A%J7C:+5?
ML\.XV[I%&;:/<2KR%?XL$ DX!QG%:D/C#PY<7-G;PZW8R37G_'NBS F7DCCZ
MX./7'%<Y:7UE'\9]:WW5NN-%@W[I ,8D<G/T!!/M7$:?<Z?!\%/!C":VC==8
MMG)W*"&%P=Q/N%Z^U 'L-[XCT?39W@O-1@A=-OF;VXCW<+O/1<]LXS2WOB/1
M=.NFM;W5;."X6(S-%),H94&/F([#D?7->4^-=9T^[TSX@64,D5A<HHWVR+NG
MOL1IB4YSB/& -H&-N2PS6^=0TR\^*/A29;FWD!T:<QLS#.24P1GU&[![C.*
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MJY"C)PKJQ/X $_A63<^(='U+XK>&;JRU"WGMFT^[43QOF,L3&=H;IGCD=N]
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MHH **** "BBB@ HHHH *0@'J,TM4=4UG3=%@2;4KV&UCD<1H9&QO8G  '<T
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MC,L ,@/F(%+%ACM@$YZ5'_PE.BW&GP7-OJ0>.[A:6![=#(Y0<%PH4D 'J2,
M]: -DHA !52 <C(Z&EVKS\HY.3QU->;^'/$!U#X;6E[J_BE[2>?4)$CO@4WS
M!;A@J*,8.5 ' Z&NPO?%F@:==SVEUJMM'<P1B26+=EE4G X'.?;K0!LX&,8X
MI  .@ K/BU[2IM%368[^!M.D4,EP&^5LG  ]\\8ZYXZTRU\2:->:BVG0ZA"+
M]>MI(?+F'&?]6V&QCG..E &AY:H9)(HT\UAR>FX]LG%<[X/\.7.@6U['>FUF
MDGOI[M)(@<IYK%BO([>O?T%6/$OBNR\,G3DN0[27]W';1A48@9/S,2!Q@9..
MI/XU@'Q2NE_$/4TU+6&71QI4%S#'*H 1G=P=H"ACPN><GK0!W4D4<RA98U=0
M<X89YIQ /4 U076],DTJ'4X[R*2RG ,,J'<),] H'))]!S3M,UC3]9ADET^Y
M6812&*50"K1N.JLIP5/L10!=*@XR <<BC:OH/RK&U/Q=X?T:YEMM1U:UMYXH
M3/)&S_,J9 R0/<CZTZ[\5:)8P)/<:A&L+1I*90K,B(WW6=@"$4]BV!0!K[5_
MNC\JY)] \16VKW\UGJ6EW-G>S^=LU"S9Y(/E"[5*N R@#@$#ZTV[U*]3XH:/
M9Q:@[:;=Z;<3& !=A92@# @9/#=R16AH^JZ:(-:OAXB2^M(;IS+([KY=GA5)
MC#  8 YY)ZT :.D:7'I%B8$*LSR-+*R1A%9V.20HX ]!^9)R:O8&[=@9/&:R
M8M:L-7%U96%^\5Y'$'*^64E16^ZX61>1QUP17*^ O'VFW?AG0+;6==@?7+V+
M)21@&=RQP#C@$C&!QVP* .^6*-'9UC57?[S 8)^M/K"M[FVNO%&I6]OK[RSI
M;(LEA&486IRWS]#\Q]#GITKE]!UV2Y^$[W^N^)'L)GFN(FU-M@==L[JN!C&<
M+C 'TH ]"2*.(L8XU0L<MM&,GU-!BC,HD**9 ,!L<@?6N?O?%]AI_B>P\/R-
M*]Q<0/,TGEL0JC '08));MTQSC(K0L/$&EZI%=RV-VLZ6CE)RBL?+8=5/'WA
MZ=: -.F+#$K%EB0$MN)"CKTS]:CLKVWU&RAO+242V\RAXY #AE/0C/:J$_B;
M1K6Y^SSW\:,)1 7(/EK(>B%\;0W3Y2<\T :;11NZNR*73[K$9(^E#PQ2,K/&
MC%3E25!P?45R'BKQ.ECXFT/0?M,MO'>M,UU+$C;U1(]RA3@]6(Y'( [9K<TR
M&XT312NJ:K+J'E,S"YDA"OL)^4,%ZD @9QSUQ0!JX&<X&:XS3_#7B2QA_L^3
M5-(O+,.["YNM/9K@AF+'=\X5FY/./P[5SUIKLGB3PE'XCF\97&@?/-]I C4Q
M+$7=8U7<.& 53N&2>?48[R?Q-HFFR06EYJ]NMPT'FA9' =D 'S$#IG(^I/%
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M^U:M]KVF:<8UN+H;Y(S,B1HTC&,8R^%!.T9'S=.14,_BK0;:WLKB;5[-(;X
MVSF48E!&<CVQWZ"@#6VC.<#-->*.1E9XU9D.5)&2I]JQ8O&7A^XLX;NWU))X
MIE=X_)1I&*H<.VU06 !X)(P*KZQXWTG2K?1YTF^TQZK<1Q6\D(+H5;DMD ]
M#@=2?QP =*1D8/2DP,8P,>E8<%_977B_RH-=+S"PW-I:[<*I<'SFXW!N0N">
MAZ5.WB;1DNTMFOXU>28P(Q!\MI?^>8?&TOD8VYSGM0!J/'')&8W160]589!_
M"E5%7.U0,\G ZUBWOB_P]IUQ<V]UJULD]LH::,-N9,YP"!DYX/'7BM.QOK74
M[&&]LIX[BUG0/'+&<JP/<4 2I%'%GRT5-QR=HQD^M/K,U#Q!I6E.Z7EV(VC0
M22@(S^4AZ,^T'8O!Y; X/I6+XV\6)HFAV<UG<+YE_<P0Q3(N\".1U#.I (.%
M)(]\=: .MHK&T&SN+<W<YUBXO[&Y99+6.XCP\ Q\PW<%@3R,CCWK9H ****
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M^479CUR<X]\XKV4 #H ,TM 'E[Z[8MK]G9F1;.6;08_+OHHO,FO!D_N8S@C
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M[1P,8W$<SKU5)"-C$8/ )Z&N0UH_;/B@T=C<(LT_ABXMX9E;@2M(I0;O7'S
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M86UJW[Y5EB_TF1@IW;@,@Y P!U/- '>W5Y?1_%FQL!?S_89])FF-M\NQ761
M&'&2<$]<U0\,>*4TO1_$5[XCU69[>SUVYM5N9T+;$4J%!V+@#\ ,GWIUQ>V\
MWQ@T:=7Q&VC3KEU*X9I$*@YZ$@$X/-0>"[*RUS1_&>EW0$EO>:U>AE[M&^ '
M'L>Q]J .WFU:SMY;**5Y%DO6VVZF%\L<;L'CY> 3SCH?2GZAJ5GI5K]IO9UB
MB+K&I()+,QPJJ!RQ). !R:XSP"FK7;D:VA\[05?2XY3TN'!&Z;\4$0SUR7]:
MT/B#J2Z7I.G3R6D<L9U*!7N9(3*+(9)\_:.ZXP#T!8?0@&Y8Z]IFHQW;V]T/
M]#;9<K*C1-"<9^=7 *\<Y(Z5%9>)=(O]02QM[H_:9(O.CCDB>/S8_P"\A8 .
M/=<UY7>6]WJ@^)5CI?VZZN[R"TFMVFA96N$6(;OX0/FP5 P,YX&*[33?$FC^
M,UBDTBS<ZK';2(9I;5D;3RR8*EV7@[L#:IYP3T% &]_PE.B_;H+0WH$EQ,8(
M7,;B*209RBR8V%N", YR".U&H^*=&TJ1TO;SREC=8Y9?*=HXF;& \@!5"<C[
MQ'4>M<1X(U[2[GP[HGAG4-)D?7]*:.-[*>T8F"2,X\_>5V@8RP;/? Y(JA;7
M>BVMYK_ACQ=:ZH]W<ZA/-;P1FX:._AD<NFP(=N>0#G&,=>#@ [_4?&WAO2KB
MYM[S5H4FME5I8U#.R@YQPH))X)P.< FJ>J>/M(L['1KNTD>]@U:Z2""6WB=T
MP3\Q)4=0 WR]<CIP<85E=Z=I'Q;OEO7@L@-!M43SI/E3#OE=YZ]![G'M7/+I
MTFB^'=&OI;>6#3CXQ:_B3RF_<6K>8$)7&5!X/_ A0!ZG?^)=*TR(R7<\B*L0
MFDVV\CF*,]&<*I*#@\MCH?0U-/KFFV]M:SFZ61+O!MO(4RM,,;LHJ EACG('
M2O.KK5=,TCQMKL?BA-2AL-86&:PGC^T!)5\I4:)ECZ,"#P1GGZ9?YMMX0\;>
M'[ZXLIM.\-MH\EC;>9N=;25I0X$A.2A90HY[C&>* -WX?:O<:O<>)S+J$][#
M;ZLT-NTZ[61!&AV[<#;@D\8!SUYKHM2\0:9I,WDW=PPF$)G:.*%Y66,'!<A
M2%SW/%<M\/+J*?6O&)B64)+JYF1FA9593$@R"0!U!_G47B'4XE\<W.G2PR6;
MR:4/*NH+8O->_,W[E6"G"KU('/S9R .0#L7US34T^UOA=I);W87[.T0,AFR,
MC8J@ECC)P!T!]*BMO$NCW6F3ZA%?1_9H)3#,S@JT<@."C*0&#9(&TC/(XYKR
M?0]5.B:+\/M>NH+HZ/8V<]E>R"!S]FD<+ARN,D?*5R.G(]JW_%%W!-HUCXCT
M'29'TVUUN'4+PPVQ1[M I#RA, M@E3D]=N>@!(!W5EXBTJ_>\CANPLED ;F.
M=&A>$$9#,K@$ CG/2FVOB;2+R]BLXKIA<31F6%)(7C\Y!U:,L ''?Y<\5Q7B
MF:U\;^"?$4WA&T,]U<6B(]ZMNT37 5PWD@LH+_*&'H-P'?B;6+NV\97/@V31
M'#7-MJ4=Y.%&&M851O,20?P$DA=IQD_2@#K/^$KT3^R[W4OMI^R6,K074GDO
M^Y=<;@PVY&,C/%)=^+M!L;N.UN-2B2XD@^T)$ 2S)QR !U.1@=3G@5YE?W\-
MCX7^)>B3K,-2GO;NXBMQ$Q+Q/&FUP<8V\'G_ !%;MO=6\GQ#\(RD[0FB3(3(
MA0HQ\O .0,$@-@'K0!O:O\0-'L?"#^(;*1[VW,GDQ^5$Y_>%MN'&,I@GG./3
MJ15JYU33;GQ%H<8UFYMKF03-#I^TI]J&PY,BLN0%P2,X_&O-KS]_\.?'(@5I
M"/$C7(6-228OM$3;P!U7 8Y''!KJ]=U&UO/B'X#NX9,PYO3O92N T6U2<] Q
MZ9Z]J -N?X@>%;>.>236(=EO,8)F1'<1N,9S@' ^8?-TYZUKW>KV-BUNDT^9
M+G)ACB1I'D &255020!C)QCD>M>8":W;PI\4U#(7N+JZ,0[R@P*J[?[V6! Q
MWJ:_UBQT._\ !6MR77EL-)>!_-CD:%DVQY7<BL5<-CJ,8!!P<9 /1=(U_2M>
MCD?2[Z*Z$>!($/*'G@@\@\'@^E:5<=\.9='?1[XZ5JT.HR37TUW=&)2HCDE;
M=M"MR% X&>N":[&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBL[6->TSP_;
MQ3ZI=K;1RRK$C,"<LQP!P/?KTH T:*Y_3?&WA[5[R[M+/4-]Q:)YLL;Q.C;/
M[ZA@-R^ZY'(]15-/'WA;5+21+?6'"2VDLXGBAD7;&IVLP;;@,"0<=>AQ@T =
M917,6GBGP_I.B:&DVM2S17T""TN;H,TEP-N0S';U(&><5?TSQ3HVKV][/:W>
MU+%BMT+B-X&AXW997 (&.<D8H V**QK7Q5I%WJ L4N)([EH#<)'/!)$9(AU9
M=RC</I67IGB?P[I?AYM0;7[FZL9+V2-;F[WLWF%\>6/E!V@G:., =Z .MHK!
MTOQAH.O:E<Z7IVH[KV%-[1F)D8ITWIO4!ESW&1TK&\!ZQ(GA6_N]7U":;R-4
MNH!-.Q=B!*411CJ>@  Y)P!0!V]%8L'BO1I_MZ_:VADT]!)=1W$+Q/&A&0VU
MP"0>Q%30^(=/F:[7=/$UI"+B99K:2,K&=V& 91G[K=,]* -2BJFF:E::QIEM
MJ-C(9;6YC$D3E2NY3T." 15N@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *Y[5_#MUJ7BO0]:COH84TKSL0- 6,GFIL/S;AC Z<
M5T-% !1110!7OH);FPG@AD2.22,HKNA8+D8S@$9_.L[PGH<OAOPQ8Z-+=)=?
M8XQ$LJQ&/<HZ9&3S^-;-% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7.ZQH&J7.NPZOI&MBRG2W-NT-Q;">%E+;
ML@;E*MG&2#S@>E=%10!F:9IDUI-+=WUV+N_F18WE6(1*%4DA57)P,LQY)//7
MH!IT44 %%%% !1110 5FZY9ZG?:=Y.DZM_9=UYBM]H^SK/\ *#RNUN.?6M*B
M@"GI6G)I6GQVJ2/*06>263&Z1V)9G..,EB3QQSQ5RBB@ HHHH **** .>MO#
MMU!XYO/$37T+1W-JEK]F$!!549F!W[N3ECVKH:** "BBB@ HHHH **** "BB
MB@ HHHH **** "N<U70-6FU\:QI&N+9RFW%O)!<VHN(BH8ME0&4J>><'G ]*
MZ.B@#.TS3);.2:ZO+H75].J)+,(A&NU<[5503@ LQY)/S'GIC1HHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ KAOBPZ1^$+=Y%+(NIV990I8D><N1@=?I7<U
M@>+/#LWB;38+*.^2T6*YBN2S0>86,;!E'WA@9'- &'=);ZM\2](URQD1K/3+
M"X%Y=K]QM^T)'NZ$CYV([<9QD51\#LMO\$?)E1HI8K6Z22)T*N&9I, J1G)R
M,>N17I"!@BAR"V.2!@$_2EH \CMW5?#_ ,+8W5P]K-$;A2AS#M@927X^7#$#
MG%,U^PO=6O\ XEVNF1M)<W,-@UNN"!<>4N9%4]&Z;2!ZXKU^B@#DM"\5:3XH
MNK:[M=,G6ZMXF^T37=HT1LP1\R;V49)(&0IQ@$GH,^>W;K'\']2$L;C;XA\P
MQM&=Q1KQ64A<9((Z>M>WU@^+O#LOBC1ETZ.]2T7SXYF<P^824<. /F&.5&:
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MD'F'.^3HF0.3_P#JYR #T:BO/-)\<ZAJ?A?PLYA']IZR\L<C0(#M$(?>R*Q
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M)50=""5P>GZUS.D>+O$H\!KXRU*\LI;9(9D-E';%3)+YQCC;?NX&< C'3U-
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MCTZ_%[;R"U*SC#%E3?O/RC(!XY  ]ZZRLIO$%BGB:/P^?.^WR6[7(S$0FQ2
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M<H8T!.,')Y))R><8 M0^';RXU/3]2UG4(+NYTZ.06ODVQB42.NUI&!=LG'
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MFW#G"+CC\ZK0^!6M+#5-'LM4,.AZE)(\EJ8-TD0D_P!8L4FX!5.3P5.,G!H
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MV6UN)8[99(KF,'(W1L< C)P<UT^FV7]GV,=N9Y;AQEI)I<;I&)R6., 9)Z
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MI>1X1=T<C2LG!QR,+GG-3:QX8N=7AU2R;48AIFHQB-[:6U\PQ?*%)C;< #@
M\@@$ XZYBG\&R1Z_8ZKI.K26#06"Z=*AA67S(5;<N"WW6!SS@]>E '++XO\
M$DG@?1-2BO;?[9<:Z-/F:2W&'0W#1CIP.%&<#/IBMN34=>LM:M_#<VH3W]W+
M!-?/=6EO!%(L0=51 LC;."QRV">!QSD1Q?#B6#P[9:/'KCE+34QJ2/);!CO$
MAD"_>'&XG.22?:M3Q-X1EUR\T_5+#5I=*UFP#+%=PQ!U9&QN1D8X93C.">*
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M4%4(7>&7>,$L<X.1Z;L.J7GB#Q=KFDVM_+86^D)"A:%$9Y99%+Y.]2-JC:
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MG:ZLS)SV.,9Z],=P7_#:*ZW^)I;C4[NZV:Y=0[9MA!VE &)"@YP , [<= *
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M62% 'GG*KD#NV  /R%>9?#C1/^$@^%NE6%YJ*RZ9YC//:+& Y*S,PC9\\*2
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M$ED=4)37Y))+AO(&8RZ!&V<]-H&,YIDO@5ENM'U&QUB6SU73;06/VE(59;B
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MV9N(V()#_+QRHY7&.V*9'X'L''B".]N)KRWUUM]U#(% 4[0HVD $8 'KR :
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MEZI<BVO+B42P^24CN(Q$Q#JS*-XSCE21R/:NNUZYMK30;V6\U$Z;#Y+*UVK
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MR+'- ^]D-TCYY'S?*"3UQWZT >M:9XHT?5]3N-.LKOS+N!!(\;1.F4)P'4L
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M*L_&3M8KCH,\]NE &_16$/%^BG3-2U'[1+]FTR5X;QOLTFZ%E 9LKMS@ @Y
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M]I<+NCD (R,XZ'D$$$8/I0!<(R",D9]*Y/2O"VN:1;II\/BJ1]-CR$$EDAN
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M:_OY[6UFMFB01R3F%# '<[4!VH"QR< 5V,_B32X18[9VN'OXC-:QV\;2-+&
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M\YXY/%:<.I2KJ^A6=SIU_:VSZ(@6Y@L7$\TN0#;L^W=&HQN_AR2#D <^ET4
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M.XL,\'ZUS]YI-W9?"OQKFVN VL7UW<V5J(F,FR0@(-@&03M+8QP#SCFO6Z*
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M"^MI/L][K-TVR6)D$L+HB[AD<@X/(KOJSM<T^]U/36MK#59M+N"ZL+F&-78
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M7T2PW1@1IXX^0C[1N ]0#D5Y%>6U[+\*_%MFFF:D;JYUN::&#[%+OD1KE7#
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M]JT'ESW<: AV\OKGD8!Y.WZ5>FC&M_$'1]?LX[A;'3+&X$\SV[H9&DVA8PI
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M\N6-E)!#+V/%>;^,GU'5+;QMIDFDZFL_D_Z#%9VKB.Z3RQ^]>51AVZC:3T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 8<'AQE\12ZM=:M>W:
M!_,MK.4KY5LQ7:2H R3@D#)XW'OS6Y110 4444 %%%% !1110 4444 %%%%
M!39%+QLH9D+ @,O4>XIU% &)X>\/-HD<CW.IWFJ7LH5'NKLC?L4DJH    W$
M^I)Y/3&W110 4444 %%%% !4<\(N('B9G56&"48J<>Q'(_"I** &0PQ6T$<$
M,:QQ1J$1%& J@8  ]*?110 4444 %%%% %+6-+M];T>[TNZ:58+J)HI#$^U@
M",<&LFT\-7ZJ(=3\27VI6BX'D2PPIO Z!V1 6'KR,]\C(KHZ* "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0LI/)) "D8 ]:JZ7JNI:;H'PR@M+E8[2_A@M[F+R@2X^S%A\QZ<J.GYUM2>
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ML_\ K2$,?S?-_=/;'//M0!SMQXSU3PM:^.%U&Z_M0Z&+:2UEEB6-F,Z_*KA
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MXHM?#\JW*WEU"98G\D^4V-Q*[^F["L<>@K7JJ;&-KB"YD+S30(5C+G@$C!;
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ML;=QEE3'SAER,$]2#GTKK_$UQ=VGAJ_GL;RTLKI(B8[F\.(HC_>;@]!['G%
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MT;2RN1G"@9/U^E ' >+[:+2_[$L+C5M6LX5>6YEU@0B</-MVA91L*Y8,2,@
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M'6M0,&MRB6XW",E6PH8@[>IVCV X %:T_A=KGQ!H^L2ZC(9M,BDB1!$H602
M!]W?.%'3&*Z&B@#@9?A?"=!U#P];Z[?V^A7;ETLE2,^1EPY5'*YVYY [>_.>
M[AC:*%(WE>5E&#(X&YO<X 'Y 4-+&DB1LZAY,A%)Y; R<4_H,F@#B9?AQ _A
M?4/#JZS?+IUW.TJIMC)A#2>:54[><MW;/' Q6O-X9-QXGL-=FOW::TMWMA$(
ME".KXW9[Y.T=*98>+8=2O;!+;3;][&_$AMM06-6A;9G[V#E 0/E+ 9KHJ .,
MT;X>IHESY-KKNI?V&LIFCTEBIB1L[MN[&[9GG;G![YYSN^)M M_%'A^ZT>YE
MEACGVGS82 R,K!E(SZ%16M10!S%EX/:V\31:_<:U?7=X+/[',)%C5)5W;AD*
MHVX)Z#'OGG.5'\,HX](L])_X2#4?L%A>)=642K&#!M<N%SM^;D]6SQVKN6EC
M65(F=1(X)52>2!UQ^8_.JMC?R7EQ>Q/8W5L+:;RE>90%G& =Z8)RO./PH P7
M\%>3X@O=5TW6;RP_M%%%]!&D;I,RC <;E.QL=2.OI5:'X>Q0>'M!T=-8NS#H
MUU'=P.Z1EF=,[0< ?+\QXZ^]=I10!A1>&4@\77/B"&_N8VNX8X[FV4+Y<ICS
ML))&X8W'@$9H\4^%K7Q38P0RW$]I<VLRW%I=V[ 202#H1GJ/4'K6[5.34H(-
M3AL)@T<DX)@9ONRD#+*#_> YP>HR1G!P 8DG@JWU'P_>Z7KFH7>J27JJ)KN7
M:CC:<IL" *FT\C ZDYS5BU\-R?;K*^U+4I-0NK"-TM7>)4"%AAG8#[SD#&>!
M@G &:WZ* .,;X?1/X4U7P\^JW)MM3N)+B:3RTWJ7;<P7C&"?;BM&Z\+O=Z[H
M^KR:E)Y^EQR1Q*(EVOYBA6+=^@'0BNBHH XT_#^)O"VKZ VJW!M]5N9+B:3R
MTWJ9&W.%XQ@GV.*T+CPNUUKFB:M+J4OG:2DB1J(E"R>8H5BWX =,8KHJ* .3
MC\"VW]E>(M.N+^XF@UV62:X^55,;NH4E,#IA1@'/2GW/@PW4.B,^MWXOM)D+
MQ7@6/<P9-C*5V[0"O'3WY-=310!QUQX"QX@N=5TK7]3TH7VTWUO;%&2<@8W#
M<#L8CJPYJ36/ D5YJEGJND:K>:+J%M;BT\VUVL)(1T1U<$''8G]>*ZVB@"II
MM@FFV,=JDLLVW):69MSR,3DLQ]22>G'I@5@#P4EO+JR:?J5Q9V.K.TMW:HBM
MAV&':-CRA8=>OJ,5U5% '-ZEX/@O6T);:Z>RM]%D62U@B12N54H V><;21@8
M^M=%MW1[7YR,'MFG44 <0GPXBC\+VOA]=;OC9VEQ'/!O2,L@C?>B_=Y&>I/)
MXK6D\*1W'BB77+J[:8S:>=.EMC&HC>(L6/OG)/?IQ70T4 <?X?\  9T"2*!=
M?U.ZTFV;?:Z=.5*1$'*@L!N8+V!.!@>E:_BKP]'XJ\/7.C374MM!<X$CQ*"V
M 0<#/ Y K9HH YWQ'X2A\2Z9:0W-]<07UG*)[:_ML))%(!C<.V".HZ&L3Q)I
M<VC>";V.[U'5]2N+UXH+K4(HP9(8MW+"-%QL4%B5 .=QSUR.]HH \Y\-RW\F
MJ6W]D^+[C6;0N?M,,VEI'&B8/S&147#9Q@<D^F,D;=AX,?3;&>WM=9NDDEU%
M]2$WEIE9')++C&"AR1CK@GFNKHH Y:Z\#6.H:=K]O>SNT^NA1=S0J(\;5"IM
M7G&,9YR22?H'/X0EEU70]2GUJZFN=)$FQGCC_>F1=K;@  !@ #&,>YKIZ* .
M4O\ P/%>ZSJ]]'JU];1:O;+!>VT6S;)M4HI!*DK\I/0C-,M/ PM)O#<HU>ZE
M;08GBM_,C3]X&0(0V .B@ 8QZG)KKJ* ./N/A_;7ECXDM+K4+B2+7G$D^U54
MQN  "G'0;1P<]*Z>PMI;2RCAGO);R51\\\H4,Y]<* !] *LT4 <S=>$/M\;V
ME]J,MQIS7WVX0/$NY&$GF!%?J$W>V<9&<5N:E80ZKI=WIUSN\BZA>"3:<':R
ME3@^N#5JB@#FK'PB((M+@O\ 49K^VTHJUG$\:IAE7:C/M'S,HZ=!WP3@B,>"
MTMI]6&G:G<6=EJSM+=VR(K 2,,.\;'[A8=>OJ,5U-% '+/X(MHM;L=2TR_NM
M-^S6*Z<8;<(5>!3N5?F!VD'N.:H6WPWBM-$T?2HM:O?(TF^%];ET0D,"Q53Q
MROSM[G/7ICN** .;U?PB-0\06FOV.I7&FZK!";=YH45UFA)SL=6!!YY![5-X
M:\,)X:_M+9J%U=_;[R2\D\\(-KOC.-JCT'MZ 5O44 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !7,>--=N-'@T>UM9/)FU74X; 3[03$KY+, >-V%(&<C)Z'%=/65XA
M\/V7B72_L-[YBA9%FBFA;;)#(IRKH>Q!H Y][W4-'^(5EH+7UQ<Z;J]E-)$9
M2&DMI8\9(;'*D,.#G!Z<<55^&-F\0\1RM>W,H77;V,I(5VDAQ\QP =WXX]JZ
M:S\/B'4AJ=Y>S7NH+;FWCGD1%\I"03M50!DD DG/0=!Q3/#OAJ+PV+Y8;^[N
M5O;J2\D%QLXD<@L1M4<<=* *&JZM/=>/;#PO#<26T36,FH7$D9 >10X144_P
MC)))'/ Y'-<A8M?Z1HWQ.GM=3G6\L[J2:*Y*HSY6W5E!!7!Z 9QG\:[K7_"<
M&M:G8:K#>W6G:I8[EAN[;:24;[R,K AE/H1Q5&/P#;+9:_;/J^I2#7<_:V8Q
M9Y0(2OR8!('T] * ,>_O];N-4\"6EOK=Q:QZM:3?:MD<;$LMN&W@E3\V2>N1
MG!QQ4L<^M7NJ:GX<BU&]FDTFU@0W4<D<4DDLBEO,;Y>1T  XX;.>,;9\&0F\
M\/W7]J7WF:'&T=MQ%APR;#O^3GY1CC%,UOP/!JNO1ZY9ZKJ.D:D(A!+-8NH\
MZ,'(5U8$''8X_I0!EZ=JFO7.L:+X8UNZCM[\Z;+>7TUDP_?,D@C55;'RY!+-
M@ Y&!@9K+\5:=K%M:>&;;4M=FN9/^$EAB22'"$PL69/,&,,ZX'.,=\$\UTVK
M^ ['4H],DMKZ^T_4--W?9[^WD!E^;[X<L"'W'DY[D^IJ6^\%6M]H]K92:C?B
MXMKQ+];_ 'JTQG7HYW*5/'&-N,8&.* *5G>W6O>+=>T+^T;NVM]%AMHE:%E6
M2621"YD8X[#  QC.<@\8YB3Q7XBN_">G2?VB;?4K;Q(FCW4L<*;+D"7:6*D<
M9&,A2._X=Q)X2B36QK-AJ-W9W[VZVUS(NQQ<HOW2X8$;AV88].1Q4%YX%T^Y
MT:PTR*[O+6*SO%OA)$4+RSAR^]RRG)+$DXQ^7% &-KEUJWA%K1M1O=9U30SY
M[75[;1IY]NQ*F,N$49C4;^0.IY&,"NN\.727OAVPN(]174DDA!%X !YW^U@
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M6W7B%;ZZ:>Y@6W>!MGE;%)*X^7=D$GOWK,^)_P WPVUV)06EEMFCC11EG8]
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M: .&U;7]6L'@O8=5FNY/[?CM96MU'V1('EV>3\P&YP#RRY(;()[5I7EX-/\
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M&VN"4$L+(P9""% ."!U%2VO@T6_B#^W'UO4IM1-C]B>1_*PZ[BV=H3 (.,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>elicio10-qxexhibit311002.jpg
<TEXT>
begin 644 elicio10-qxexhibit311002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$MR%)2WF63?AR/NA@>I[C% &W-XU\/0:$=:DU "P63R7?RGW))G;L9<;E;)
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M.OR[A\C '!'()XQ]*71?%D%_X7TO5;J*:*>]AB*P+ ^Z21HPY$8(RPQDY'&
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MQJ5C(@6)(P<9(49.3CJ2?;&3G$^'%Q<SZ9K2W-U<7)AUN\A1YY"[!%?"C)[
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M_:8H;.5V0,"=V OW0!DMTY'/(K27Q/I$NF6.H6]T+B'4,"T$*EFG."<*HYX
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M"T8G4)'PI8 $-L9?QK:U:1O&G_")"RM;J"YL]3AOKL30/&;58U;>C%@.22%
M'7KT&:]"HH \GV3MX0^)D LKWS;V\NVM4-I)F8/"JJ4&WY@6!'%>B^'B6\,Z
M8"LD;"TC4JZ%64A0""#R#FM.B@#R33;>\MOA-J?@F]L+I]<CCN+2)/)8K<&1
MV*2J^-NWY@22>,'.*U[^VFTWQCX MWCNKA=-M;F*YN8[>1T4F!%4LP&!N(->
MB44 9VO-M\/:B=KN3;2 *B%F)*D  #DFO-;>.X3PU\,HFL;X265Q$;I?LDF8
M L+(2XV_+\Q YKUNB@#SA;>YN?%'Q%2*TN?]-L(([9V@=4F98)%8*Q&#@D#K
M6.[W<7A;P+J_]C:G<VFC6XM=1M%MY(YES"J%U0X9@C+U'!R<=S7K]% 'D_BJ
M*RU'X<^(KC0_#][$VH>0JDVDGGW;+("24(+;0O0GW[8)W_'DANAX2DMK>ZF1
M-<M[E_+MI&,<2JX+, ,J!D=:[FB@#S'4YKZW\6>-[RRT>6^>31X$MXIK5S%<
M.@DW)R,/PP^4'GI46E3/)\0?#NII;:S/!)I<T$EQ<6<D:K(6C.W9@",  ]
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MBJ)[BYDMX[*TE6)I'D"$^9NV+SC..@%<Y!X>U#0=$\!:?+97,DMIJS7=TMM
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MVU 1Y@63=MP6ZXW?+NQMSWK?EE6*%I6#%5&X[%+$CV R3^%>46-CJ,?PDO/
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MD0WYC_<.Y. -W4 D8#$!3V-6-5\46&DF[#I<7!LH?/N_L\>_[/'@G<W([ G
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ME_BP,G'?&*X[26E3XEV6K)IVO26<VB20-=7=L^XR>:C'*G[G /R@*#_"#GD
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M.<W::D#]CC@7+S8&6P#C&,'). .AJ(>,]'&E:G?R/<1KI9*WL#0,98"!GYE
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M,;2,SLA  "@GJ: &/XNT;2?['T]WO6DOK;?:#R))&D54!^]@[FQC@9.33?\
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M@2I7!(8'!Z'J.:\^NI=8L)?&UU8Z/>RFXU.UDC+6#,3"%C5Y(U9<.RX) YY
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MU>WU9KT6\=PGV.Y>UD\Z(IN9<9*Y^\O/!%0ZCXAM-/U!-/$=Q=7S0-<_9[=
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MPM,\.?V;XEU;6A>O+)J@B$T3( J^6I5=O?H><YS6[10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 06]G#:M
M*T2G?,^^1V))8XQR3[  #H*GHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ@'(8,<G/7J:H:GJ5]I'Q AMK[5IH]%U.PF,'RQ@6]Q%AF^;;G'EY(R3RI_
M [6L?2?$5MK&K:MIL5O<13Z7(D<WG* &+KN!7!/&,=<=:XWPIKVL:QH,6E7>
MHW<>OQZF8+F5XXUD6%?WNXIMP T15>G#-UJJUMJ$OB;XCS6.KW&GO;_9Y5:!
M$+,ZVH(W%@?EXY  )]: /5**\^TSQ5?:]=^$]+:=K9]1T?\ M.\FA #.<* B
M9!V@LS$XYP!C%:7A;5M0/BGQ%X;U"=KL::T,MM=.H#M%*I(5\  E2",XY% &
MO/XCMK?Q59^'W@N/M-W!)/'+M'E[4QD9SG/([5L5P/B:">Y^*GAF&"[>U=M/
MO09HU5G4?N_N[@0#[D'Z55TS6]8;PMK,$^N)'-IVNMIXO[B,&5X Z' 55PTI
M5RJX7DXXH ](HK@=$OM8U76?%VAIJ%[:BUCMGL)KA(S-"948\\$%<J#AN<$@
MX['AC7=1U_0-#M7OIXM72>2/5&"IN4P'$H(VX&YC&!@ @/GM0!WU%>=2:EXE
M\2VFL7.@S307=IJ$MK:#?$(!Y3[2)%(+'=@D^@(QTR>\26<Z8LLGDQW'D[FR
MV8U?'//=0>_I0!9HKS33-?U:+Q'X0@;4Y[Z'5$N$O9BBBWF=(MX:#(#!01@'
M&"".O6NN\7W6JV7AZ2XTBVFN9TEC,D5O@RM#O'F>6#P6VYQ_C0!IZC>-I^FW
M-XMK<730QEQ!;KNDDQV49&34\,AF@CE,;QEU#;'&&7(Z'WKSB?Q0UW\//$^K
MZ%X@NFFLT:2-;B%1/9LJ#,3JR^H)R<GGKQ6IJNN7MO<^$+>:X:VT[4587MX"
M%^<1!HTW'A=[9YX)VX'6@#MJ*\HN=:\21>!O&6JQZY<E=.N)8]-N/)A(DB3'
MS9V?-R67=WV\5MQWFL:9XZ\.6T^L37EMK-I<&:"2-%2)XT1E,>!D?>(Y)H Z
MZQU$WCWHDLKJT6UG:'?<(%$H !WIR<KSUXZ&N?F\>Q+%;SVN@:U?6MW&9+2>
MT@619@"/1LKP=PW 9 /?BLW2;S4]5T3QM;WNJ7#M9:C<6\$RI&K+&L2$+]W'
M<]L\UB)<ZIH/P L-4T[5[F*X2SM&3<D;!%9D4J/DZ88\]>G- 'K=%<G)J%SK
M7C74M BO9K*#3[.&4F#:))9)2V#D@_*H4<#J6Y]*K3R:Y90>'['5=<ADN6\Y
M;Q;&,B>\<#Y/+&/E SES\H''(!H [6BO)1XG\1R^#--N5U22&\7Q(-,D>2&-
MC+%YY0!P!C., [2,\\]ZZ'3YM5@\<ZQX<N-:O+JVDTN.]BFD6-98'9W1@I50
M,< C(.* .WCECE7=&ZNH)7*G(R#@C\""*=7$?"1)O^%;Z1<37<\[3Q%L2E2%
M.]LX( )SU.2:KZ@=?U+XBZCH-KXBN+"T&EQ7<9C@B9HW,K+@97D?+SG)]Q0!
MW]8^I^(K;2M;TG2YH+AI=3D:.&1%&Q2JECN).>@[ US-AJ.J^*M-\1WUGJL]
ME-87L]G9)&J%080/FD!!W;FSD=@1C!YK,_MU_$TGPQUF6(12W=S*[H.@;R'!
MQ[9!Q[4 >HT5YU)J7B7Q+::Q<:#--!=V>H2VMH-\0A'E/M(D4@L=V"3Z C'3
M)[Z'SY]/C,I$-P\0WF(A@C$<[21@X/3(H ATK4&U.P6Z>QNK(EW7R;I L@VL
M1D@$\'&1[$5=KR5?$GB)_A9IFK+K#C47U?[-+,84(E0W;1X(QP-H'W<5TVE7
M6J6'Q+NM"N=5GU"TFTI;]?M"(#%)YI0A=BCY2,<'/3K0!V4DL<2[I'5%R%RQ
MP,DX _$D"LF/Q%;2>+9?#GV>X6[CL_MGF,H$;(7V<'.2<Y[=JYWXG1326?AW
MRKRXMPVNV<;"%@ V9!@G(.<$ C/&>H-5+NPN;GXO_9(=4N;9O^$:4/<QJAF8
M?:#T)4J"?7;],=: /1:*\QT?Q?J]QX;\/6DT[S:A?ZE<V,ET@1'9(3(<C/RA
MF"*.G<XYQ74^&H?$5MJ>J0ZM(9=-9D>P,TB-.@Q\ZN5 ! /0]<'F@#I:*X;Q
M)/K4WQ TK1;'6Y[&TOK"Y=Q'%&Q1DV ,I*]?F[Y'T/-5S>:[JEYK6BV=]>&X
MTB.&V2YA:&,R3M"'\V16!R"6 V@8X/X 'H-5-4OFTW3+B]2SN;QH4W"WM4#2
M2>R@D9-<=/K.N6VH>%=.UZ:*Q2\@F%]<V[@(]P@&V,.?NY^9NQ)&!T.<2;6O
M$T7PT\5:S_;=P9+.YFCTZX\B'$L$;860?)SNR1G_ &<B@#U5&WQJVUER =K=
M1[&AY8XV17=5:1MJ G!8X)P/7@$_A7">*?$5WHE[93ZBVI6^@R60WZA8QA_L
M]P3]Z48)V[<8XQDG(/&*.HI/>^-O #)KMQ*MQ8W3-/;,GER,L2?O%!4CYMQY
M/8\8H ]+HKS_ $8Z_J_B[Q!;/XDN8K72M2A\N-8(OWD9C5VC8[>G.,C!]SQ5
M"/Q!K%M?^&)3JLE\;[4WM+V6)%^QR B0A8L@,=NT?,,@X.2: /3Z:TL:,BNZ
MJTAVH">6."<#UX!/X5YE/=^(;R7QVB^)+N!='??:&*&+(_<"0*Q*G*Y/0 $^
MM-^T7NM^+?A[?R:C=0/?Z3-<2)"5"*_E1L2 5(YWD<YXZ8H [F#Q)9W'BFZ\
M/>3=QWEO")]\D)6*5?ESL?HV-Z@_6MBLG6K:ZBT_4K_28EEUG[(Z6OF-D!L9
M50#P 6 SZX&>@QS_ (,\1P:UJEQ M_J$=U!;@76DZE&$F@DS]\?*-RGIP2!Q
M@#- '4ZEJ#:=';LMC=7?G7"0$6R!C&&.-[9(PH[FKM<EX[U'4-+CT"6PO7MQ
M/K5I:SHJ*1+&[@,"2"1^!'>L\MK>J?$#7]$7Q!=VEE#96\\/D11;XV<OD!BI
MX^7N"?<4 =W)+'$H:1U0%@H+'&23@#\20*=7CTFI:EXC\*?#G4KO4;B.ZN=6
M2&<P;55R!*-Y&TC=\@/IR>*Z2YU#6M;U'Q!IFEW-W%+I9CMH)8GB4F4Q*_F2
M!AR"6Q@#& ?7@ [VBO.+NZ\5S>(_#.D7.L_8)[_3KDWHM(XW5)8P@W(67U8\
M'('ZU):Q^(+GQKJ7AR;Q3>BWM]+MI1/'!"LOF,65B#M(&2N3P3Z$4 >AUD^)
M?$%OX7T"ZUB[@N)K>V7<ZVZAFQTSR0*XS0_$6JZOX0\*7EYJJQ/=/-'=I!'_
M *3>%-ZJ(P 0.5#,> !W K*U75K_ %7X+^,UU&222:RN[JS5Y0HD*)( H?;\
MI8 X)'7% 'KB,'C5QT8 TZHH#BUC)[(/Y5Q&AW6N^*O#.F>);#61:RW%QYSV
M\BJ8!;AV4Q8QG=M'WLYW9Z#@ '>45Q&G7VI>+I?$QM-4GTYM-OY-/M%B5"%>
M-%)D<,#NRS'CI@>O-8-AXMUWQ$G@*ZAOVT\:Q]JBO(DB1E+11O\ ,NX$CE20
M,D=,@XY /5&8*I9B H&23T%(CK(BNC!D895@<@BO)=9O=5;P;\1-(NM8N[C^
MR3^XNCL65HWA5]C%5 (R2. "1Q6OJ4NLV-_X)TVRUZZCAU'S(YR\43' @+ C
MY.H[=1G&0>X!Z+6/XF\16WA;19-5O(+B:"-E5A H)&Y@H)R1QDBN=TRYU&[\
M477A6?6KIUTJPBDFNE5$EN9)"V">" %4#IU)YS7,^(-;U#5/A3XKLM4<37>D
MZHEBUR%"^>JSQ%7(' 8AAD#B@#V"BHKF=;:UEN'!*Q(7('7 &:\UF\0ZX_PO
M3QW;ZBXNU3[8UD0IMVBWX,6,9X7^+.<CTXH ]/HKAY=;O=-\>Z6][J$PT'6+
M%V@BE5 L%PH#D%MH."F<9/4&F7.M:I:6NA6QGN'N==O)&4MY:O!"$>18UR
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MB]U_X2>%=3U&027DVK68E<*%W%;G;G X!.WM7J]PCR6\B1S-"[*0LB@$J?4
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ME'&-K*0!V!XR"*V=*T6'2Y[VZ\QY[V^=9+FXD !?:NU0 . H P!]>I)-:=%
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M:A/>R,=/_L[S^!A%9"8FW!E53\I(&<=LGO=,TW59_P"R+_4M4NEN+:&1)[9
MJ1W!;A6D49PP !P#@$G'%;]% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOFC:6*"/9+&96"':RMCY-OTI?%/Q#OO"'PVT&\5S?Z[J\$7DM.J@!BBL[$*
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MHYI8H98X85\L+&C @;,$Y)ZYJMX#^(>NVOB>7PAX[N +ZY"R6%Z$5!(&'"C
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M,\9!!V]<9S@@BNKH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"G?Z;#J1@6Y9V
MABD64PC&UV4AE+<9.& .,]0,YJY110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_6I>K(S1^X;/EA?; %:=GI\>I?$[3H/$-K!=70\*0M-%<('4S><=QVG@G)-
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXP_Z#6B?^"J7_P"2*Z&B@#GOLGC#_H-:)_X*I?\ Y(H^R>,/^@UHG_@JE_\
MDBNAHH Y[[)XP_Z#6B?^"J7_ .2*/LGC#_H-:)_X*I?_ )(KH:* .>^R>,/^
M@UHG_@JE_P#DBC[)XP_Z#6B?^"J7_P"2*Z&B@"GIL>HQVQ74[FUN)]Q(>VMV
MA7;Q@;6=SGKSG\*N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>WD\#"*W=#Y5[= HO\&9W(!';@BNX>"&39OB1MARFY0=I]1Z4]$5%"HH51T
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8_UDBG*ECZ X;'J!Z8.A10 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 5RGQ)OKW2O .K:EIUY+:WEK%YD<D>#SN'4$$$5U=<9\5V!^&FMP+E
MIIH-D4:C+.VX< #DT %YI_B.+PPFI:/X@NI=0CMQ.+>\BBDBN#MR4.U%9<]
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M&?AV(Z=NU6 C44:2T*Y82J%+$@@>@/7OQUKD-9U"W\.?$74;CQ!'J2:7J=M
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"M9V45DD@C+,\K
MF261SEI&P!D_@ ..   .E6:** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>elicio10-qxexhibit312001.jpg
<TEXT>
begin 644 elicio10-qxexhibit312001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ME_/"[FQ@9)'7UKG8-#U!/"'Q/UAK6X2#7+ISI\!B;?*HD<APF,X;>,<=CVH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6JA!?$BU>>"2%)R#C",Z@,<\<'K6[J&HV>DV37E_<)!;HRJTCG !9@H_4@4
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MNE#6\#Z=<!Y0>A53'D]#TH ZFBL[2-<T_78KB33Y7<6\Q@F62%XF20 $J5<
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M%]D\P%@P;YCO&1E1TQ6N-"UF?7;+4+W7(7@M"[I:6]EY2/(R% S$R,3@,>*
M/(-%\1-X5^*?Q%U?^S+F_BM]S2);E<HOF#YCD]/7&<#FNL^!ND>7HVJ^)?MD
M$O\ ;ESYWV> DK;[6;Y3D#YLN?P ZYK<\/\ P[DT3QCK/B&358KK^U]PN+9K
M3:H!;. =Y^G.:=X.^'?_  A&M:C-I>KN=)O7,ATV2'(B/8J^[C'3IR,9Z T
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MY6H6\3PR%1Q.C*0-WN.Q]./3'0T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 -=TCC9W8
M*B@EF8X  [FN4TCXE>%-<\0'0['4B]\03&KPNBRX&3L) !XY]QTS752Q1SQ/
M%*BR1N-K(PR&'H17C_BNZN]/^.?AB_UK18CI\A-EI]S;S;CYCG 9_E'(W?=Z
M#)()Q0!Z)JGC/0]'N[FVN[I]]I&DMV8XF=;9&.%,A ^7/YXYZ<TGB3QKX?\
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MS%27X));"XY/<U+KV@RZQ<:;<P:G/83V$S31O$JMO)4KM8'@K@G(_4=:VJ*
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M%>G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MPB((\8..H;=Q_M'UI&AT6P\<?#ZP@40VT-G>K!!=OF15*ILR&Y!(S@'GMVH
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MC%4Y[F&3X7^/X(YY)Y(M?>=RZ8?9Y\+;V  QD GH.AXXH ]D77=*>XLK=;^
MS7P<VL>_F;9][:.^.]:%8O\ ;OA^YU+24%S;37=ZLK:<X3<9%4?O"C8P!COG
MD>M;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %(0#U I:* *8TV(ZM_:+G=,L1AC
M&  BD@M[DDJ.O3'&.<VR >HI:* #'&*  .@HHH 8D4<;,R1JK.<L0,%C[T"*
M,2F41KYA&"^.2/3-/HH 3:,DX&3U/K2+&BA0J* HP,#I3J* $VCT%&!Z"EHH
M 0@'&0..E,B@AAW>5$D>XY;8H&3[U)10 FT>@I"BEE8J,KT..E.HH 0(H& H
M '8"H[B'SK>2)6"%QC=M#8_ \?G4M% %>RLX=/L8;.W4K#"@103DX'J>YJ8Q
M1F42E%,@& V.0/K3J* &/%')M\R-7VG*[AG!]13L#.<"EHH 3:-V[ SC&:-H
M]!2T4 8VNV.N7AM4T;5;?3XMS"Z,EMYKLI'!3D ,.>N1T],'2LK2'3[&WL[=
M=L$$:Q1KG.% P*GHH 0J&QD X.>:,#T%+10 THC  JI .1D=Z78N&&T?-UXZ
MTM% #=B;E.U<K]TXZ?2G444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1110 4444 %%%% !15.XU6QM=3L]-GN%2\O0YMXB#F0( 6QVX!%7* "BBB@
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MQBHM4\;^)-*\+^(K^;28O.TIXS;W,UO+!#=QN0,JC?,&4G!&<>_-/;P+KO\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !01D8-%% #(H8H$V0QI&F<[44 4^BB
M@ HHHH **** "JT>G645]+?1V=NEY,H66X6)1(X'0%L9(^M6:* "BBB@ I"
MP((!!X(-+10!3L=)TW3#*;#3[6T,K;I#!"J;SZG Y-7*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *9'#%"6\J)$WG<VU0,GU-/HH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "F2PQSQ-%-&LD;C#(XR"/0BGT4 5
M;#3;'2[?[/I]E;VD&<^7;Q+&N?H!BK5%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_>=V"@?4F@"2BFQR)+&LD;JZ,,JRG((]C22S1V\+S32+'%&I9W<X"@=23V%
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MWD1G2>)E3EB'!"_6@"6BF"6-HO-$B&/&=X/&/K3/M=N(UD-Q%L8X#;Q@GZT
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MQVH TZ*ABN[:>62*&XBDDB.)$1P2A]P.E(;VU#(IN80TC%$'F#+,.H'J1Z4
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M,T'AF'Q:(=^T-'# 5)9<'CRUFVC'3J*]<N="TF\M[>"XTVTDBMCF!#"N(O\
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M"0ZMIMK?1HVY%N(E<*?49'%27&E:?=Z<-/N+&VEL@H46[Q*8P!T 7&!CMZ4
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M38A'-]H0):H-LO\ ?''#>]7(]*T^+49M1CL;9+Z90DMRL2B1U'0%L9(X'Y4
M<-I6G^&M5U7P_K-CK<<S""2&"VMHXE$T3)\R2JHR57'0]#[FN+DTG3H_@7J-
M\EI"MW;:C)]GN OSP[;W V-U48)X&.I]:]DL/#6AZ5-<3:?H]A:R7((F:&W5
M#(/0X'(]J3_A&/#_ -A:Q_L+3/LC/O:W^R1^66]2N,9]Z .4FTVRTCXNZ&--
MM8;4W.EW8F\I0OF[6C(W8^\<DG)YKF_#\6E>)O!UA-JFO&VU:TO?-N(XTC6Z
M2\$ARO(W$L> .X(%>J_V'I/VR&\_LNR^U0+MBG^SIOC'HK8R!]*C'AS1%UDZ
MP-)L1J1ZW8@7S?3.[&<XXS0!YTF@Z1=Z]\3$N-.MI4C6)D5XP51FM<EE'0,3
MSD<U!IZVL]Y\*+B_6!_,TFX\V2< [L6\9&XGKCD\^]>G?\(_HH>Z<:1I^Z[&
M+EOLR9F'^WQ\WXTA\.Z(UM;6QT?3S!:OYEO%]F3;"WJHQA3[B@#*^(ESJ%I\
M/-<N-)+B\2T8HT?WE'\3#W"Y/X5SFOV]H+?P%J7AM(XYVU"WB@:  %[5T)E4
MXZKM&3Z8KTHC(P>E9UCH.D:9,9K'3+2VD.?FAA52,G) P.,GDXH Y+0;&R'Q
M<\6$6MN&CM;%T(C&58B3)'H3ZUH^-;BR6\\.VMQ&9;N?40;-'EV0^8J,<R'!
MR #D+U+;>G6M^'1-)M]0DU"'3+**]D^_<);JLC?5@,FG:EI.G:S;+;ZG86U[
M K!Q'<1+(H8=#@CK0!QGPVF0:EXOMA<V\I&LNX$ VH<QQ[BJY.!D\\GFN_JI
M::5I]A<3W%G8VUO-/M\V2*)5:3:,+D@<X' JW0 4444 %%%% !1110 4444
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M=Q3FTG:!BC@[BH4DCV!;&?4&C4?$VE:7K-AI5U=Q1W=YO*(S@;5522QST&0
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MZ?<\[B',:Q(2-@&>O.3G [T >C7_ (FTK3=;LM(N;N)+R[#.L;.!M51G<<]
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M3:X.Y@JL2/4#=C/J#7E]A?V"ZC\-KBVN+*VL09_(@$N^2*)H&_ULA/))QD8
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M,EF(P3]C'4GWH ]-DU.PANEM9;ZV2X;&V)I5#G/3 SGFK+NL:,[L%51DL3@
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ME<6 OX;RWDLRI<7"2@QE1U.X'&* &Q:7I\$LDD-C:QR2QB*1DA4%T P%) Y
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MOYM1MGAN9TMX2DRD2.S!3@YQ@9R3V H UK.PL].B:*RM(+:-F+LD,80%CU)
M[^]17VCZ9J;QOJ&G6EVT6=C3PJY7/7&1Q3)]=TBUABFN-5L88IEW1O)<(H=?
M4$GD<U/-J%E;O"DUW;QM,"8@\@!DP,G;D\X )X["@!EUI&FWWE?:]/M+CR?]
M5YT*OL_W<CC\*N  # & *JV6I6&I6INK&]MKJW!(,L$JN@(ZC(..*;9:KIVI
M-(MC?VMTT>-X@F5]N>F<'B@!KZ+I4NH?VA)IEF]Z,'[0T"F3CI\V,\4Y])TZ
M6^^W2:?:O=XV^>T*F3'INQFDBU?3)[]K"+4;22\3):W293(,=<KG-*-7TTWW
MV(:A:&[W%?(\Y=^0,D;<YSB@"$>'M%%O);C1]/$$K!Y(Q;)M=O4C&":D&B:4
ML\$ZZ99":  0R"W7=&!T"G''X5-=WUG81K)>74%LC':&FD" GTR:/M]G]M-G
M]K@^U!=Y@\P;POKMZX]Z "&PL[>ZGNH+2"*XGQYTJ1A7DQTW$<G\:+JPL[YH
M6N[2"X,+^9$98P_EM_>7(X/N*KC7M',D$8U:Q+W#F.%?M"9E8'!"C/)!XP*?
MJ.I6>G0_Z5J%I9M("(VN9 H)^A(SCZT )=:+I5[=I=W>F6<]R@PLTL"LZC.<
M D9ZU>KD_ OB*?5? MOK.M7=N)#).)9L".,!9G0>P& *WDUO2I-.;44U.S:Q
M0D-<B=3&I'7+9Q0 D.B:3;W9NX=,LH[DL7,R0*'W'J<@9R?6I&TK3FGN)VL+
M4S7*>7/(85W2KC&UCCYA[&GVU_9WDD\=K=P3O _ES+%(&,;?W6QT/L:A.LZ6
M)+B,ZE9A[89G7SUS$,X^89^7GUH +;1-)LVMVM=,LH&ME98#% JF(-]X+@<
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MTNRDGGC\J:1[="TB=-K$C)'L:I:IXLT?1]:L-)O+V"*ZO-S*KR!=B*I.YL]
M2 !ZD\=#5^YU?3+*ZCM;K4;2"XE($<4LRJ[D], G)H ;>:'I.HVD-K>Z797-
MM#CRH9K='2/' V@C _"I;G3;&]M4M;JRMY[=""L4L2LBD=" 1@8[4VYU?3;)
MI5NM1M(&A3S)!+,JE$SC<<G@9(&:C.NZ0IM =5L0;S_CV!N$_?\ ^YS\WX4
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M0!5FT'1[G3ETZ?2K&6Q4Y6V>W0Q@^H4C%7+>WAM+>.WMX8X88QM2.-0JJ/0
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MDX&!(L2AAQCKC/2@#S;2]2\/3'QKH'BZ>WAGDU.4R07$GEM-;$+Y&SD$@*
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M*TZ]ABAN["UGBA(,:2PJRH1TP"./PI&TG3GA:)M/M6B9S(4,*D%SU;&.I]:
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M$BI&@"JBC 4#L!3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ![@D<9+Y(]@:YR[US0KCX3^#TCO+59[2_L!/$[@212HX$I8'D'.XDGUSWH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7->-]"
MO_$6D6]E8&V5H[R&Y=KAV48C</@84]<8]O>NEHH KV=G;V<.R"U@MMWS.D*@
M+N[] ,_7%*EE:QW,ES';0I/(,/*L8#,/<]34]% $$=E:PAA%;0IO&&VQ@9'H
M:6.TMH4=([>)$<8950 -]?6IJ* (;:TMK*+RK6WA@CSG9$@49]<"F#3K$3/,
M+.W$KL'=_*7+,.A)QR1ZU9HH *AAL[:VDED@MH8GE.Z1D0*7/J2.M344 0&Q
MM#>?;#:P?:@,>=Y8WX]-W6I719!AU##(.",\@Y!_.G44 -DC2:-HY45T8896
M&01Z$5"MA9I;+;+:0"W7E8A&-H^@Z58HH C%O (# (8Q"008]HVX/48Z4D%M
M;VL @MX(X81TCC0*H_ 5+10!6@T^RM2IM[.WA*DE?+B5<$]<8'? S]*L,H92
MK %2,$'H:6B@"M'916=K)%IT%O;,02H6,!-V."0,9K*\/Z9J\,DFH>(+JTN=
M3>-81]CC9(HXP2<+N))))R3QT48XK>HH *KM86;+M:T@*[BV#&,;CU/U-6**
M *_V"SW;OLD&[&,^6,XQC'3TXI#IUBT+0FSMS$QRR&)=I^HQ5FB@".""&VA6
M&")(HE&%2-0JCZ 4W[);"?SQ;Q>=G/F;!N_.IJ* ()+.UFN([B6VA>>+_5R,
M@+)]#U%<U+X8N;OX@S:W>6^GSZ<^GK9"&1B[Y60N'VE,?Q8QG\:ZRB@!ABC:
M(Q-&IC*[2A'&/3'I445C9P6QMH;2".W/6)(P%_(<58HH BCMH(8VCBAC1&ZJ
MJ  _A5*^T6TOULXI(HE@M95E1%C&0RD,N#_",@9QUZ=,@Z5% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*. 3C+<X!.,\'I72>$_"7_",W.K,)Q)!<7+/9Q#I;PL2^P>GSN_X;?2L/_A
MM2N] \1Z?<W=O:W&H:LVJV5S;NSF"3*,@(*C."@R?<T 7X_&=Y8:G?1:Q92'
M3+>P:]&I0V<T4:[?O1,'_BQR"#SZ"L3Q5>:OJ-OX'O[N&TBMKK7;.984W>9!
MD,5!8G#<$YP!@^O6MZ/0_$NOZ)?:;XMNM-CBGM7M@NF!SO+#'F,7Q@CLH&.>
M3TQDOX5\8W>D>'M-O)]&)T6_M[A;E9)";B.($#*[1M;&,\G)[CN :FH>+[[?
MXH;3;>W*>'HPTJ3[MUPWE^8P4@_(-O )#9/8"B+QG<75MH\2VT5O?:E9&_\
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M=@&.S(9"V1P1D U-)X$UJZTGQGI]S>V 777,T+QHX*.45<,#T4%.V2<YXZ4
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MJ&GSK/:3KOBE7.&'XU:KSV#X@-'X/\,:M>_9-.35SMEN7C9K>V.UBH(##&2
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M@]P14E,BBC@B2*)%CC10J(@P% Z #L*?0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M<[XYT&[\3^$+[1;.2&*6["KYDQ.$ 8-G !STQVZUT5% '+RZ'JDWCJQ\0'[&
M(K>P>T>$2L6)=E8L#MZ KBL%_A[JD^AWT!O[:VU$:V^M6%Q%N=8I220C@@9&
M"1GOGIQ@^C44 <S#IWB6[T:_76+K3FOI[=H(H;0.D";A@L2V68_AP!@=2:R'
M\&:Q%X8\*VUK<6/]I^'I8V0R%_)G58S&02!E20<]#C%=[10!Y[<_#V_UB3Q:
MFKZA:^1K\-NO^CQ,&A>)<*1D] W;G..HSBIF\->+=1O?#=SJ=]I ET>X:1Y(
MDD8S@QE-Q!Q@D'ITSW[5WE% '!Z=X4\4Z%?WMCI&KV"^'[NX>X43PNUS:;R6
M=8L':1DD@MTST/>U%X8UK1O%VIZGHEU9-8ZML:Z@O ^Z*55V[T*_>R.JDCGO
M72V.K6.I7%[!:3B26RF\BX7:1L? ;'(YX(Z5=H YSP+H%[X7\(6.C7UQ!/+;
M!AO@4A<%BV.>O7KQ]*K1^'M4A\6Z]K"-9M%J-I%;Q1F1@R&,-@M\O?<>G3'>
MNLHH \]C\$:Q%X/\+Z()K$RZ+?073REWVRB(D@ ;>"<^^,=Z[;5+'^U-&O;!
MG\O[5;O"6 SMW*1GWZU<HH X#_A#]??0?"NGS7.FN^AW<$Y*;U$B0H4"]#R0
M<D]NF#UK4@\/ZI!XLU_65-FT>I6L4$49D8%#&& ).WON/3ICO75T4 <5HWAC
M6='\*:/HCC3+V"TA>WNX)RWEW*'&T_=."/0@CKZ\:O@_PV/"VB/IZLNQ[F6=
M(8R3' KL2(T)Y*KZ\9Y.!TK0TW6]-U>:\BT^Z2X>SE\F?:#A'QG&2,'@]JT*
M .:TC0M0L/&NO:S,UJ;74U@541V+Q^4I4$Y&#G=GV]ZQ](\)^*- FGTG3M8L
M1X<EF>6,R1.;NV5V+,D9!V]2<,<XSG!Z5WM% 'GFD-J:_%#QS_9T=G)E;$,+
MB5DVMY)P>%.1UR./K4T?P]DTJ'P[<Z/=QG4]&:4LUP"L=V)B3*&QDKDG(/./
M0UT&H/X:\)I<:Y>0V5@9"!-=+  \AZ $J-S5NT <7J'@^]U*V\274KVJ:IK5
ME]@4!V,=O$%8?>VY8Y8L>!V';)EUCPKJ&K?#RWT'S[:&_MUM]DGS-$S0LK#/
M .#L_#/>NMDD2*-I)'5(T!9F8X"@=237/?\ ">>&O[4@TQM2\N]N&18(9()$
M:7?]TKE1N4_WAQ[T -%SXCB\5Z=;23:=-I\ELQNXXHW$D3_,0X).-F=B@'DY
M)['%SQ9I=UKGA74M)LVA26]MWM]\Q(5 P()X!SUZ5LT4 <7>>&==EE\+W5O<
MV FT=6CE@FWO#+F,()!@ AEP<9_O'FLV7P%K<GA#Q1H;7]A(VL7TUS'+Y;IY
M8D8,Q(YYXP /S->C44 <I-H&JS^,M&UMC9+%8VDEM+&)&+-YFW)4[>VT<'K[
M5(^C7<'Q F\3RS6B6 TP6;*TA#*%<R%R<8QSC&??/:NGILD:2QM'(BNC JRL
M,@@]010!P^EZ;IFK_$BY\0Z5?)<V2VL1F^SR!X9+K#*CAAD%EB8@^SK77ZI_
MR"+W_K@__H)J'.E>'-/BABAAL[;=LB@MH<;F.3A$09)X)P!V)IMAJ.D>*=)>
M6U>*]LI&:*1'C.-P.&5T89!'<$4 <'X2T._\2?"[PUIE[]E32_+@GE='8R2H
MC!UCVE<+R%!.X\ \#/'5:+H6H:?XQ\0:Q.UJ;;5?(V(CL7C\I-G.1@YZ^WO5
MUKS0?"_V'35^S:>+N80VMO#%M#N>P51@?6MB@#@M$\)^*/#[2:-8ZQ8_\(V9
M7>(O$_VNW1F+&-"#M[G#')&>G:I_$/@^^\2A[>^73R([Q9[+459A<VJ!PVU1
MMY/!&=P'(X..>VHH X9/#'BC1O$.I3>'M4TY=*U2X-U-#?0N[V\K !VCVD!L
MXSAB!G];\?A[48/'::ZLL$MM'I0TX++*WFN0^_>QVXY/&/Q]JZJB@#SM? >K
MCP>=+^U62WL6KC5('^<QD^=YNQN 1U(R*[^ 7"VJ"=HWN-OS% 54M[=2!4M4
MM*U:QUJQ%YITXGMR[Q[PI7YE8JPP0#P010!PT_@/69_ ^N: ;BP6;4M2>]6;
M>Y6,-*)2I&WDC;C\<]N=^?0]2N/'6FZ^?LB06ME):O$)&+$N58D';CC;^/M7
M3T4 <WXPT+4=;ATQM-N;=);&^2Z,-T&,4X4$;6QSP2".O(%9,/A'7(W\7-)>
MZ?+_ &[& @6-T\MS$(R3R?E&.G)/J*[JB@#AKCPCJ\N@>$-/62R\S0;BWFD8
MR/B;R8R@ ^7C(.?;WKK-7MI[W1KRUM_+$T\#Q*9&(4%AC)P">,U=HH X-_!V
MKGPUX1TM9;'S-!NK>=W,CXF$*E0!\O&<Y[XQWJQ>^$]5O/$'B&^2\@M8]5TP
M6,4D3L9(&4/A^@[OT!&,=:[2B@#@=/\ !_B"'5/"U[/=Z3&-&MY;9X;>%\,C
MJJY7)'S'9Z #/>F-\/=0GT37=(EU."*"ZU&34;"XAC;S896D$BELG'RD8XZ@
M]J]!HH Y2PT_Q?/I]PNNWVERS_9VAACLUDCC=F&/,D)R<XZ*!CD^V(;7PMJ4
M'PL;PFTMH;K[ ]@)PS;-K*5WXQG.#T]NM;NK^(]*T)&;4+DQA(_-DV1/)Y:9
MQO8(#M7/<X'!]*T89HKF".>&19(I%#HZG(92,@@^F* .+7PKKT&I>';ZVN]/
M+:;IYL989U=XU)VCSH\8^;"XP<<'&>]9W_" ZV/AS<^%C?6#O)>&>.;:ZA4\
M_P [GKDD\8& /4UZ110!&#-Y&2B>=MSLWG;N],XSCWQ^%<;I'@B9/A]?>%-7
MFA9+DSXFMB3CS'9\X('*EOQQ7;5GR:WIL6MPZ,]T@U&:-I4@P22J]3TP.O>@
M#"\/Z7XQ@6*WU[5]/G@M4*Q26D3K+<'! ,I)P,9SA1R<<\8->S\(7DOB71]>
MU%-/AU&PB=+BZLF;=?;DVX<%1@ _-R6Y QBNS=UC1G=@J*,LS'  ]361:>(=
M$UJ]ETJ&X$LY@$Y@EA=/,A)P'7< '3W&10!Y_P""-%U#Q+\(;#19FM8],N9)
M!+.KL93$+ABR!=N,G!&[=P#G&:Z.^\,>(M.\676M^%K_ $Z.+4(XTO;34(W9
M-T:[5D0H0<[<#' ./RZS3],L-)M_L^G65O9P9SY=O$L:Y]< 8JU0!Q&K>$]=
M36=-\0:'JMLVL6]LUI="_1O)NHF;>?N\KAB2 ,]AVYGUGPQK6J6.CS'4;5]5
ML-22_8R1LL#85E,:@$E0 W')R1D]:["L_4=;TW2;BSM[Z[2&:]F6"W0@DR.>
M@&!_.@#F/$WA#4?%%G>Z?J"Z9/%*R-:7IW+-9$*H9D7!R=RLP^8=<'-=JB[$
M5=Q;  RW4_6G44 >;1^ ==B^'UOX5^VZ<ZVMS')#-AURB3>:-W7YCP,#@8SS
MFMR\\+WFH^-'U:Z^R_8)M'?2YH%D8OAW#,P.W'MC\?:NMHH XGPQX>\7:-':
MZ1>ZS87&BV14031PNMW)&OW(W.=H' !(R2!COFNB\1V%SJOAS4=-M#$LUW;2
M6X>4D*N]2N> <XSTK4HH XC4_">KW_@+2O#ZR627%DUKNE+N480%3D#;D;BO
M3M[UH)H>IKX_F\1G[(87TQ;$0^:VX%7:3=G;C&6Q^OM6UI.K6.N:='J&G3B>
MUD+*L@4KDJQ4\$ ]015V@#SBW\":]:>'-)LHKS3VN-.U1[_RY-YAN%=W;:PQ
MD%2^0>>0#3[GP-KT]CXOMFO].<:_@JPC=/+8QJA)Y/ V\#G.>HZ5VFJZWINB
M+;MJ-TD N)E@AR"2[L<   >I%:% '(W'AS5;C7_"NHEK-4T:.5)D\QB9#)&$
M^7Y>,8SSUZ<=:HZ!X2\2^'?,T6SU:Q_X1OSGDA+1O]KAC9BQB4@[>I.&ZC/3
MICO** .,O?">J7GB'Q%?1WD-K'JFF"QBDB9O-@90V'Z =7Z \8ZU3T_P?X@A
MU/PM>3W>DQC1H);9X;>%]K(ZJN5R1\QV^@ SWKOZ* .:\*:%?Z)=Z[)>/;.F
MI:@]ZGDLQ*;E5=IR!G[O7WZ54\0>&M:;Q7:^)O#=[9PWZVQL[FWOE8PSQ;MP
MY7D,"3_GKV%% '':KX3U.^.BZJNHPMK^EW#SK(Z%8)!(-LD6,DJI7 !Y(QDY
M)-32>&KV[O\ 5M9N?LJZI>:<-.@B21C'#%EB<OM!8EFR?E'0#WKJZ* ."_X0
MW5QX>\(::);$OH-S!,[F1\3")"@ ^7C(;/?&.]-7P;KVFMXCL=)O-/;2=:>:
MXVW0?S+::5</C;PRD_3'OW[^B@#A4\':Q'9^#(#<V,A\/E3(WSIYH$1C  P>
MQSGU["M+3] U32_%VO:I!<6DEEJ;13")PPD61(Q'MW#@*< YP3VQWK8AUO3;
MC6I]'AND>_@B$LL(!RBDX!)QCKVS3]2U:QTB.WDOIQ"MQ.EM$=I.Z1SA5X!Z
MGOTH X>S^'FHVO@_0+$7MJFL:#=&YM;A0QBDRS%D<8! 8-@XST!]JVW\.WUY
MJ]UKMXMHFH'3S86T$<K-'&K'<S%RH))./X1@#OFNJHH \_7P5K">%/"FCB:Q
M,FAWD%R\A=\3"+. !MX)S[XQWKH-)N];D\3ZO;WKV4NF1A&M6MU8-&3D%')X
M+<9XZ9'J*V[BXAM+>2XN)%CAC4L[MT J'3-3L]9TV#4=/G$]I.NZ*0 @,,XS
M@\T 8NO:%J&H^*O#VJVK6HATJ29W25V#2>9&4(& <8!S[^U4=7\-^(+;Q;)X
MA\+W]A')>0I!?6FH(YCDV9V.I3D, 2,=*Z:+5K&;6+C28YP;ZWB2:6+:?E1B
M0ISC'.#WJ[0!S-[HNJW-O#:W8T[5[22%UO8+T%%DD+;@R?*^U1R #GC'.1DX
MJ> ]2TO2O"JZ5>VTM[H,LK*MWO\ +=)0P9 1EAM# +[ 9KT"B@#A8?!^MQQ^
M,/-O;"5]>3"81T$;&$1DGKP.<#G.!S3I?"&KC3_!YM[FR2^\/X1O,#M'*OD^
M42,8(..<?AFNXHH X?Q!X.O_ !)$UKJ T]]EVLUGJ2EEN;50P8A1MY/!'W@.
M1P<<]/KVC6_B'0;[2+LL(+R%HF9>JY'!'N#S^%:-% '&1^%M7U#3M%TO79[.
M2VTJ>*<SP%B]V8A^[W*0 G."V"V<8XS5RRT+4K;Q[J6O2-:&TO+:*V$:NV]!
M&6(;[N#G<>.WK73T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>*-?.A6]@
MD*(]YJ-[%8VPDSM#N3\S8Y( !.!UQCC.:W:P/%WAK_A)M-MXXKG[+?65U'>V
M=QMW".5#QD9&5()!'O0!0;Q#JVG>+X_#M\+.=[ZT>XL+J.-HUWI]^-UW-V((
M(/MCO7+K\0/%<7@?3?&MQ9Z4VD,5-[;1B3S@C2;"Z'.!@X^4@^N><#LX="NK
MKQ!;Z]K#6PN;.U>WMX;<L40N07<LP!)(4 #' SR<\<7X%T*]\2_"#1-(NY+9
M=*E >9TW>;)&LI;R]O09(P6STSQGF@#H=2\5ZI<2ZU'H,:M+I;^2D;V,TXN9
M1&KE=R$!!\P7G)SSTZU[GQ1XIN=>TK2K&QL;*;4-*>\V7P<M;RKM!5MI&0"V
M./K[58N/"OB'3O%%_JGAK6+.WM=497O+6]MVE5) H7S(]K#D@#()QQ^5P^&M
M07QEI6LK>12P65D]HXFR99MY4LY(X!RO3&/IV ,GQ'XL\1>'].U.ZN5TN&2Q
MMHY88=K2&](4&9E ?<B Y4$CC&33SJ&KW?Q9T^"&^ACL7T)[I;=X"V TT0;)
M#C+' PW0#L<DTW5O NL7[^*X(=6M5L]>0<RV[--$P38$#;L;.,].,GUS5^+P
MKJT'B/1]974K0S6^G'3[L&W;#H75\Q_-P<KCG/KCM0!33QY<:?I/C#4=7@@*
M:'=F")+?(\T;$*@DD\EG S^E7-1\0ZQX=U'0O[6^Q7%EJMRMDYMXF1K>=P2G
M)8[U)!!X!'7VJ!? ;WMCXKL-6GA>UU^<S_N,[H#M4#KP<;%.>.>U6D\-:IJ*
MZ)%K]U:SQZ1.MRKP*P:YE12J.P/W,9+$ G)QR ,$ PI_&'BLZ-XKU""/1T&@
M7DR%7CD;SXXT5ROWAM."?FY],#K6GJGC@6NJ:;9O=VFE1:A8+<VUS?1,\4LK
M'_5;@RA2!@G)YW#&.[!X,U3^P_%VG&ZL\Z_/-*K@-^X\Q A!'\6 ,YXJW<>&
M]3N=+33+M-+O[!M/CM9+:Y#;5E3</-4X/4%>.#\HPPH Z>Q>XDT^V>[5%N6B
M4S*ARH? W >V<UP\_C/6+"_TA+Z.Q1[[5?L$VGQ@O);(Q81NTJL5W$*K8(&0
MW'3-=?H.DC0O#VGZ2+AYQ9VZ0>:_5]HQGV^E</#\/=?AT72M-_MNP9=*U5=0
M@E:U<O-AV8F4[^6^<],9]: +<WB3Q3<ZOXLL+$:3%_8JQ21231R/Y@:(R;2
MPY/3=GC'0YXLZ?XSN-=_X1VSL(X8+W5-._M*=I5+K!$-H( !&XEVP.> "3GI
M4UOX8U2#5_%-\;BT?^VXXD13N'E%(_+!/'.1SQCT]ZR[7P%J^E1^'+W3=1M%
MU71[/^SY/-C8PW5OQP<<J01D8SS0!/\ #X72^(?&HO6B>X&J*&:%2JM^Y3!
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MFK>+;K1]8L='U*^T[3KBXLA*EW<6[_9YI]Q!C4[QMQ@'DDG<.G>Q)X%@;6=
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M;>8V,JL5W$*"00,AN,8-68_&%Q=^*+O18;JQM;ZVO8XQI]W$RR3VV5W2QN6
M8E2Q  /3!'>LVW^'WB"'1=%TTZU8,-(U1;Z&4VCEIL%R3)\_+?.>F,]S6KK/
M@^]\0*MMJ4EE(D-\MU:WZJPN;=!('V+QC) V[L@ 'H<4 ;GBG7X?"WAF_P!:
MGC,B6L>X1@XWL2%5<]LL0,^]9&H>(-8\.ZOH<>K_ &.XLM5N!9,]O$T;6\[
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M8!ZL<NS$\9X'&.77</B+1]"\/V6G75D;BV>&"XC,3-]IC4!3M_N<?,3V]?4
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M7=N&",@YSGT[/UGP=JNKZ;I]R^L1KXAL+P7L-R(3Y ;&TQ[,Y$97CKG//?%
M%32$OH_C/JBW\T$S_P!AP^6\,9CROG/U!)YSGOTQ6UXQUV_T&/1Y+..V=+O5
M+>SF\X,2$D?!*X(Y^M0:9X=UJ/QM)XCU&^L#YNGI9O;V\+\%79LABWOZ<^@Q
MFK/B_0+SQ!;Z9%:300FSU"&^8R@G=Y3;@HQZ^O;T- &;+KGB6\\9ZSX?T_\
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MDL3C#(ZAE8>X-165A9Z=!Y%C:06L.<^7!&$7/K@"K%% !1110 4444 %%%%
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M ]!CJ?6NL\81ZC:W^N:MIWV+5K 621:QI%T=D@B568-$_;*LQP1C(..:[?\
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MG/K7=2^']%F29)=(L)%GD\V97MD(D?\ O-D<GW-2#1M+%Y'=C3;,7,2A8YA
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M2+>MWI.V3 R,[,X/X?I6S::9IMS\9->6:SMI?^)5;.5>,$;B\@+$>N.,^AH
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MGZ9\2;W3M4U-=(LY],@73B5A6!XP7\U 70J#DKP,9 '7 H ](1TEC62-E=&
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M-'Y<>_(Q(N<\BJOPKGMO^$=N[598OM,>I7OF1!AO4>>W4=1U%5O'L27'Q$\
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M+KMK=V\4BD0($7[$ O*NP/.2"WS8Q5FTU?3]4$R:;J-I<2QJ"WE2+)LR/E)
M/0_K0!/:V-I8Q&*SM8+>,G)2&,("?7 J*TTC3-/\[[%IUI;>><R^3"J>8?\
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MD!01[ ]<YG76=+>^%BNHVC799D$ F7>6 )("YSD '/I5Q]VQMF-^/EW=,^]
M%6'2M.MKV6^M]/M(KR4?O)TA59'_ -Y@,FJ^FZ0+74+W5+@K)?WFU79?NQQI
MG9&OL,L<]RQ/' &9X)UO4=<L=5?4S 9[35+BS'D(57;&0HX))]3UJAJ%]XNT
MGQ!HLLD]C=V.I7HM9;"*W*O;J59MXDW'=M"G)( ] ,\ '77EC9ZA$(KVU@N8
MPP8)-&' (Z'![U')I&F3"42Z=:.)F#R[H%.]@, GCD@<9--OM;TK3)!'?ZE:
M6KE=P6>94.,XSR>F>,U=!! (.0>A% %0:1I@FBF&G6@EB $;B!=R =,''%1R
MZ%H\US+<RZ58R3S "65K="S@$$;CC)Y Z^E8_CK6]3T#2;2\TXVV'OK>WE\Y
M"QVR2!3MP0 >>^:L^,?$EOX7\/27TUS!;R2.L$#SYV"1S@%L<D#EB!SA30!O
M      #H!55=+T];PWBV-J+HG)G$*[_^^L9K#\,WVIMI-QJNLZ[I&H6)C\R&
M?3XBD:HH)<EBS9_I@TD7BE8?"$WBG4'2"TE@-Q:V\C!#Y>TL@)/5W&#CMD #
M@D@&X^D:;)J"Z@^G6C7J@ 7+0J9!C_:QFI;NRM=0MFMKVVAN8'^]%-&'5OJ#
MQ7"66O:W+H=MXLM=:M=1L$L1<:CIB1H3&^U798G7D%5+?*Y). .^1WEI=07U
MG!=VT@D@GC66-QT96&0?R- $=KIMC8DFSLK:W)4*3#$J9 X X'058=%D1D=0
MR,,,K#((]#5(ZWI*WXL&U.S%V7\L0&==Y;&=N,YSCG'6F7?B'1;#[1]KU>QM
M_LVWS_-N$7R]V=N[)XS@XSUQ0!9M=-L; .+.RM[</]\0Q*F[ZX'-,L=)TW3/
M,_L_3[2T\PY?[/"L>X^^ ,T^74;&"R6]EO+=+1@I6=I $8-TPW0YR,>M<QX3
M\0W6L^+/%-HVH6]Y8V,EL+1H%4* \99AD$Y.>.3V[4 ;=UI&==@UFT94NUB^
MSS*WW9H<Y /H5.2#[L.^19FTK3KB^BOI]/M9;N+_ %=P\*M(GT8C(JEXLU"^
MTGPIJFI:=Y'VFSM9+A1.I93L4MC (]/6DM=<CM_!=OKNIR*B+8)=7#@8'W S
M8'\A0!--I'VW7;;4;LJR6(;[)$O(#L,-(W^UC*@=@6ZYX++2/+UFYUBZ*O>S
M1K FW[L,*DD(/7)))/?CT%<YX+UK6O$DPU-M>T.\TL@EK:QB8RPL>0C,6[?0
M9Q3_ (C>*_[ \)ZI+IFKV5OJ]O&&2.0J[YXX"D]<<\@].E '6W=E:W]N;>\M
MH;F$D$QS1AU..G!XJ)](TV3S=^GVC>:%63="IWA>%!XYQV]*M1DM$C'J5!-<
MSXJUO4]'U?PY#:&V^R:AJ*VD^]"9,%6;Y3G ^[Z'K0!M?V-I>83_ &;9YA&(
MCY"_N^<_+QQSZ47&B:3=W375SIEE-<.AC:62W1G*$8*DD9QCC%8_C?Q1#X8T
MB)S?6EG=7DPM[>6[R8D8\EF YP #^.!QFC2=3OM.\,W>L^(M8TV]MHXS<)<:
M?$5C\H+G(RQW$\]/:@#I$C2*-8XT5$4855& !Z 52&AZ0(Y(QI5CLD(+K]G3
M#'U(QS6#JOBJ70/ MSXBU(PQW+VYGM[-W"@,5RD6>K-TSCWP,51.N:EI5J/$
MCZ[;:MX>$<8NXUC3?;L2 SH\> 57<"5;)P#S0!UPT?2Q)#(--L]\(Q$WD+E/
M]TXX_"IH[*UAFFFBMH4EG(,SK& 9,?WCW_&LK5-9;1=4TYKAU?3=1F6U5\#,
M,S [.>ZMC'J"1V/&Q<7$%I \]S-'#"@R\DC!54>I)X% %6VT72K.":"UTRR@
MAG.98XH%59#_ +0 Y_&E&CZ8MH;0:=:"V9MQA$"["?7;C&:X_P ,^(;[Q9#;
M:U9:]:0P)<S?:]-98W"VZNZ(<CYU<A0V2=IR>,5U]EK.EZB\B6.HVERT0#.L
M,RN5!Z$X/ ]Z %_L;2P\+_V;9[H1B(^0N8^_R\<?A2?V-I?[W_B6V?[Z02R?
MN%^=P<ACQR0>_6F0:_HUS=16MOJUC+<3%Q%%'<(S/M^]@ \XYSZ54USQ9I'A
M_4--L;^[ABGOY2B*\@7:H4DNQ/0<8]R10!I)IMC'>->)96ZW3=9Q$H<_\"QF
MI+JTMKZV>VN[>*X@<8>*9 ZM]0>#7'V'BPVOC#Q1;:WJ]E#I=DMFUJ\I2%%\
MU78C<3\Q.!W[<"NNFO[.WLQ>37<$=L0")GD 0@],'ISVH 6&RM;:S%I!;0Q6
MRKM$*1A4 ]-HXQ45II.FV$,D-GI]I;12\2)#"J*_U '-26.H6>IVJW-A=P74
M#$@2PR!U)'49%5KS7]&TYY4O=6L;9XE#2+-<(A0$X!.3P"3B@!?["T?R/(_L
MJQ\G=N\O[.FW/KC'6IFTVQ>2.1[*V9XXS$C&)250C!4'' ]JBN]<TFPGCAO-
M3L[>63&Q)9U4MGI@$]^U2WNIV&G!3>WMO;!@2OG2!<@=3SZ=_2@!;33[+3U9
M;*TM[96.6$,80$^^!3+;2=-LKF2YM-/M()Y<^9+%"JL^>N2!DUGZQJ=O<:*\
MMAXCL=/)DC O&,<J#Y@2N"0"6&1U[YJ_?:QIFF,%O]1M;4E=V)YE3CUY/3WH
M DATVQM[I[J&RMX[B3[\J1*';ZD#)I]U9VU];M;WEO#<0/\ >BF0.K?4'BL>
M7QAHT/BJ/P\]];K>/;F<AI0 OS*JISU9MQ('7 ]Q5V+Q!HT]U%;0ZM8R3RNR
M1Q)<(6=E&6  /)'?TH MVMI;64"P6EO%;PK]V.) BC\!Q3TBCC:1DC56D;<Y
M48+' &3ZG  ^@%4[77-)OKHVUIJ=G/.%+&.*=6; ."< ] >*AD\3:#%L\S6]
M.3?,8%W72#=(,90<_>Y''N* ++Z5ITFHKJ+Z?:M?(,+<F%3(!Z!L9IT>F6$-
MVUW%8VR7+YW3+$H<YZY;&:S)O%VCP>+(O#DE[ M\\!F(:0+M.Y%5.>K-N) Z
MX7W%;M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7*?$QU3X9^(BS!0;&09)[D8%=744]O!<
MH$N(8Y4!R%D4,,_C0!Y[XP:W.D> 9B8R3K5AL?CH5;H?2GZ;9Z=-\4?&_G06
MSD65GNW*IP"DF[\QC-=T=,L&14-C;%%SM4Q+@9ZXXI?[-L2S,;*WW/G<?*7+
M9]>* /(_#&L6%KX9^',=P]O#>/;7!M]0NY"(K<*NUQC< S$$  GCD^QRYY["
M;X6^(H&N(9WA\3D@MM#!6NTP<#&W(R>W>O;_ .S;'RTC^Q6VQ'\Q5\I<*W]X
M#'7WI7T^RD#![.W8,Y=@T2G+'J3QU]Z . U6$VOQ2DATA(H+M_"MPL"Q@+EQ
M*OE\#T[5'X.U;PGK7A;PK9S&*76-/:(+9;R+B&Y0;9'9 0<9W,2>#UZUZ(MA
M9I*LJVD"R+@*XC (P,#!QZ4L=C:0W4EU%:P)<2\22K& [_4]30!Y/?7>EZ<G
MQ2>]LA=V2W%L);:*0Q[MT2+R5Y4;CDD>AK2T?4[:7XR*S:O97;SZ $5K; C+
M"?.Q.26P,GJ3UZ"O1%T^R0R%;.W7S 5?$2C<#U!XY%*EC9QA0EK H1#&H$8&
MU#U4>WM0!R'PJ=)/!\I1E8?VE>=#G_ENY_K52:PTR^^-US!=VMK.'\.H6BE1
M6#'SW!)4]3C]#7>06EO:AA;V\4(;J(T"Y_*D^Q6GVC[1]EA\_.?,\L;L_7K0
M!Y4E[HDU[XP\.>*]:?36FOI&-M(8D%Q;,JB(H60L2% &%.1@8J_9:=I2_%RS
MM9[9& \+Q&)+Q5,A(E89;/5]O4_6O19K&SN+B*XGM8)9XN8Y'C#,GT)Y%<U<
M>%[F]^(;ZY>6VGSZ:VFK9>3*Q=\B0N'VE-O?&,_C0!YU;0R:)IUM<H-GA5/&
M3RKC_5I;_=1O3RA+D@]. :[*^MDG^*SW5J8VM3H3KJ1&"C?/F+=VW?>(SV![
M5WIAB,'D&-#%MV^65&W'ICTJ&'3K*WM3:P6=O%;MR8DB54/X 8H \ETS3['_
M (9PEO(+2W-V=%F1ITC!DQDE@6ZXR!Q[>U:VN7FGWDOP[N;:>WF_XF4<8E1@
M?^6#9 /U(_&O1XK6W@B:*&WBCC;[R(@ /U J,Z;8LD:&RMBL8P@,2X4>@XXH
M X'3[/3I?B)\0?-@MF*VEH#N53@&%]WY\9K T^^M['P/\,M5N-1MX_LKD>5<
MS"..0&)U/SGY591G&>_'&:]>.G6)=V-E;EGSO/E+EL^O'-<]X@\.ZC/>6-QH
MPTHV]N)!)IU]"?)D9L?O 5'#@ @9!X8T 5? UKI\FJ>(=9M;_3KF34KL3>79
M3I-Y"[ H#,O\3%2Q'3/KUJ'4EDC^-FAR2Y\B31[F.'/3S ZEL>^W%;&@^'C8
M7SZE<VFF6MVT1A\O3H=B;203N8@%SD#' QSZFM#5M(34S:3H_DWME+YUM/MS
ML;!4@CNK*2"/0]B 0 >>^+=4TYM2\<6,<EO87:Z2B7#S-NEO<Q2%%B0G 4;B
M"0"26[8S45D]Y=:9H6I>%]:LCJUMX?@%Q87F&@NH<'(W Y5E96!(Z9 .*]1^
MR02R+<36T!N?+V%]H8@'JH8C.*CETG39TC2;3[218@!&'A4A .@&1Q0!2\)W
MT>I>$=(O(;-K**6TC9+9CGREVC"Y[C'0^E>3/JUG/\"O$=AJEQ NO)+<_;X)
MF E-P9BP.T\GC;@_[/M7N72JLFF:?-.\\MC;23.NQY&B4LR^A.,D4 >;MK]A
M9^/)/[5UO^S["_TFW_L^ZW1>1(JE_,3>ZL <L#C(SQGM46OVND:/\-=!M=*G
ME.F)K5J;>2Y?)=?M&[(/'R]2/;GI7I]U8V=[&L=W:P7$:G<JRQAP#Z@&EGL[
M6Y"B>VAEV_=\R,-CZ9H XSQ,(5^*O@5CY8E87XSQDCR17*FTTYO!WQ6?R+8N
MEY> ':N5Q"A4#T^;]:];.GV19&-G;EHP A\I<J!TQQQ31I>GA646-L W4>2O
M/Z4 >:#7(=,\6:))K&KR:;87GA^!+2\)C\HRAB9%+.K $@H>V=H]JKN=(\-Z
MCX*-G<RMX3_M"[<W5PP,/GLG[I@< !-QDVG &<D<8->J2Z;8SVJVLUE;26ZG
M(B>)2@/K@C%236MO<6QMIX(I8",&)T#*1Z8/% '"^%[W3YOBUXQ%K<VSM-;V
M+#RW4[RJN&(QUQP#Z5/\0!"NM^"9&V"7^W(U#'&<>7)Q],X_2NS@L[:US]GM
MX8<@*?+0+D#@#CTI)[.UN65KBVAE9>ADC#8_.@#SFSL].E\9_$OS(+9MMO;
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M0QH;B!B#"T9*%F.T* %)(VC':NGM_"=]>^5%J^E^&K>.-T<S6%NQD;:01MW
M>7TZY8CMZCKY;&SGN8KF6U@DN(O]7*\8+)]#U% %5KVTT3PX+R\DDAM;2U#R
M-<,"ZJJ_Q'NW'XFN$UGPEKFN> KW??V$=U=-_:B@6K>9'.,.BB7S<?* L8;;
M]T=*])F@AN(_+GB25,YVNH8?D:06T M_LXAC$.,>7M&W'TZ4 >7:SXP37OAI
MX<\2K^\LH]1M9=8CC&[RT1CY@91V#A3CN,5LZO<^&]7TGQ3J6AR07M]/HTL=
MQ=6LOF)M$;;$.#C=R>.N!SVKMHK&T@1TBM8(TD&'5(P P]_6EMK.VLH!!:V\
M,$()/EQ(%7\A0!B>!;VUO? ^B&UN(YA'8P1N8V#!6$:Y4X[CTKB]3TP:]\7]
M?TZ#4[BQNG\/QK'/:SLCQOYAY.TC(Y&0>Q_&O488(K:(101)%&O1$4*!^ J)
M=/LEF\Y;.W$N=V\1+NSZYQ0!Q/@/4+8^&[SPS)96^GZYIJO#>640 \QB.)E[
MLKC!S[_2N.MM9TS_ (5I\.X/MUOYMMJUD9T\P9AVLP;?_=Q[XKVIK2V:X%PU
MO$9ATD*#</QZU&FFV$;,R65LK-)YI*Q*"7_O=/O<GGK0!Y]>O<R^._&\>F29
MOV\/0_9@C?-YF)=N/?)7\Q5?PU=^%O$=IX5D76KF?4]/*?9].1HDEMW"A9 R
MJ@8( #G/! [G%>F+96J7!N%MH5F.29!& QS[]:2*QLX+F6YAM8(YY?\ 62I&
M S_4CDT >::1/>Z+JFA+!<6VN>&[[4)!9,1MN["9UD+ XX=0#(#GD9/I7J=5
M8=-L;>X:X@LK:*=AAI$B56(],@9JRRJZE6 92,$$9!% '$?#66-K+Q,RR*5'
MB&^)(/ &_-4?%T6GZU+HVO\ AO6/.UF.\ACM3:WADCFC+J)5*!BNT)EF./X>
M:[^"SM;4L;>VAA+=3&@7/Y4VUTZQLG=[2RM[=G^^T42H6^N!S0!YEXNU33GO
MO'=C');V%VNE*ERTS;I;W,+E%B4G 4!L$@$DD], UN:/-XEOO"?A^;PU?Z(;
M7^SH%E-Y%)*QD" '!1P..GU!KM'L[:2?SWMX6FV%/,9 6VGJ,^GM4D<<<,2Q
M1(J1H,*JC  ] * .'^)[F/P=9?:'C$G]I66XCA2?.0G&>W6NJU34](LA!!JM
MW:0K=L8XEN74"0XS@9X/%6I[2VNMOVBWBFV_=\Q V/IFFSV%G=6ZV]Q:030)
M@K')&&5<=, C% 'ENHZ&EGX<^(G_  C@"Z/=60>&* _NO/"/Y_E@<8*[ <<9
MR.V*ZJ]FA/P;GE1E$+: Q4YXP;?BNN$:"+R@BB/&W;CC'IBLK2M#BTS3_P"R
MRL<^G1'_ $6.1<F),G"'/!"] >N,#MD@&9HLL/\ PJ?3Y'93"-$C+'/&! ,T
MWX8Q3P_#+P\ER")/L:$ ]=IY7_QTBM;4]$BU#37TN-8[>QN,BZ6)=K.AZH,=
M-PX)ZXZ<G(U$1(HUCC4(B@*JJ,  = * /$=5UK2[G0;:>TN+:PMX_%$<K632
M;ID87/[R64L25R<G   !')Z5UFD6^F7?Q5\6N\-K*IT^S;+*IX99-Q_$8S7=
MG3[(F4FSMR96#R9B'SL.A/')%!TZQ:1Y#9VY=\[F,2Y;/7)QS0!XQX4U5;&P
M^&,^I3*FD?9[J,32-^[2YY6/<>@.W<!GU-=AX.O+";XF>.EM+BW?S'LW B<'
M=B'#$8Z\]3ZUVS:;8/:M:M96S6[G+1&)2C'U(QBI8;6WMMWD011;L;O+0+G
MP,X]  * ,3QTRK\/O$98@#^S+D9)_P"F34W1M2L--\ :3?:A=006:6%N'FE8
M!!E% R>G4@5O36\-S'Y<\4<J9SM=0PS]#3/L=K]F:V^S0_9V!#1>6-I^HZ4
M<9!I6FGXD6>K>'#;J'LYEU0VA'E2 [3%NV\;\Y([D UPDVK65Q\ M=L=2N(5
MUV.2?[=;S,!*;CSRV2IY)QC!]![5[A;VT%I"L-M!'#$O1(T"J/P%12:9I\T[
MSRV-L\TBA7D:)2S#T)QDC@4 84[^*;N>"XT*^T(Z4\:%3/#))(PQR0RN%^G%
M9_Q D1-6\%AG52=>CP"<?\LI!_4?G7;]!@5!/8VERX>XM896 P#)&&('XT 4
M]5U'1()8=/U:YLD:[5O*@NF4"4+C=@-P>HKRGQ'HO]G?"WQU%HN?[$DNHY[&
M-#E1&#$TVS_8W!\8XX...:]AN;"SO51;JT@G6,Y02QA@I]1GI3Y[>&ZM9;:>
M)9()4,;QL,AE(P01Z8H Y/XFRQ'X5:](K*(VLCM.>#G&*=XSEA/PDUF1F4QM
MI$FT@\$F/Y?UQ6WIVCI::9%IMSY=W;6P"6[3+N8(!A0V>I XW=Z9J6A0ZE!#
M8.D4>F+(LLL"+CSBK;E4]@N0"?7&.F<@'#^-;>[7X/Z)9N&_M(OIL2#^+SM\
M?Z\&O3R0 23@#J369>:2-1U6TN;LJT%B_FV\([RX(WM] 6 'OGKC&C)&DL;1
MR(KHPP589!_"@#Q6VFF/[/MK-:@S6\5^[WJ1?,6MQ>.T@P.VW&?;/:NOUQ8M
M2^(7@V\TF6*9O+N6N9(B&5K0QC&['52Y7&>Y^M=O!9VML&$%M#$&^]Y:!<_7
M%,MM.L;-)$M;.W@23EUBB50_UP.: .&^%MAIDFD7UVEK:O<0ZQ>A)@BEH\R,
M.#U'RGMV-6/'=Q!9^*?!-U=31P6\>HRAY96"JN8' R3P*[2"TMK7=]GMXH=W
MWO+0+GZXITT$-PH6:))%5@P#J" 1T//>@#SS3X["]^(GCUYD@E L+, R '"F
M*3=UZ#IFN;TS5QIGA?X:7]]?36FD"VFAFNT"LL,Q4+$6W*P P)%SCC)Z5[$=
M.L2[N;*W+/G>3$N6SUSQS2FPLS:O:FT@^SO]Z+RQL;ZC&#0!SW@ZUT2.?5[S
M0[^6_CO+@37%SYBM$\V/FV%0%SC&<<9QW!K%DT_3+[XV7L%W:VMP&\/QEHI4
M5@Q\]\DJ>IQC\#7?PP0VT*0P1)%$@PJ1J%51[ =*8+*T%Q]H%K#Y^<^9Y8W9
M^O6@#RF.]T2XNO%_ASQ7K<FG/-?RLUM(8T%Q;L%\HQED+,=H  4Y&T8K0N]2
ML/#/CZPN)[^!4D\/I;FVU*Z2&2,"3*MN<X8MR& Y&W// KT6:QL[BYBN)K6"
M2>+_ %<KQ@LGT)Y%<OJ^@:Y-XBN+^W71=2LYXXT6VU.-@;?;G.Q@&!!)).0#
M[\"@#B]7TC3]%^!,=O%>:?>F.[@<W-JZO'N:Z1B%8=0H.W/H.W2MOQ>+VTU7
M7-6T6^L[DPV*+JVC7PPD\ 5B&1QRIPSCT)KK-&\-6>GVTXGL[ R7,OG21P6P
M2%6VA?E7GLHR3R3Z< :4FE:=-)'))86KO%CRV:%24QTQQQ0!PD.I6I^*^F75
MUBS2]\,J(H;@@,7:=3Y?/5N>E5/!UOHT/A[Q?J4VGP7/V/5]2?\ =H#(%&?E
M0]5)4D#!'7WKTR2W@FD226&-W3(1F4$KG@X/;--@L[6UW?9[:&+=][RT"Y^N
M* /(=.U73I/$GPXFBO[%+06US%':P2;EMD:!0D3.269^@YQDCI4$UKIY^&GQ
M-E$-N675KT!@HR,%2H!]CT]Z]CCT^RB5%CL[=%C8L@6)0%)ZD<<$TT:7IX0J
M+&UVD@D>2N#^E '"PW]O;_%G2IKJYC07/AD1Q,[@>:YG0[5]2?05Z+4*V=JI
MB*VT(,.?*(0?)GKM]/PJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+7TEO3=6\[ 222,Q9'53RPV[<$<87VKUK0+B&X\-Z;/#*DD36L9#JV1]T=Z
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MFR2)%&TDCJB*,EF. !6*GC/PM)G9XDT=L'!Q?1\'T^]0!N44V.1)8UDC=71A
ME64Y!'J#3J "BBJ>F:I8ZS8K>Z=<I<VS,RK(G0E6*D?@010!<HHHH ***"0
M23@#J: "BJ6F:OIVLQ32Z;>174<,S02/$VY0X )7/?&15V@ HHHH **I:KJ^
MGZ)827VIWD-I:Q_>EE; ^GN?:KBL'4,IRI&0: %HHJC_ &QIQUG^QQ>PG4?*
M,YM@V7" @;B.PY'6@"]15/3M4L=6@DFL+E+B..5X79.@=3AE_ U<H **BN;F
M"SMI+FZFCA@C7<\DC!54>I)J.PO[75+"&^LIEGM9UWQRKT9?44 6:*** "BB
MB@ HHHH **** "BBB@ HHHH **HW&L:=:ZI::9/>0I?7>[R+<M\\@4%B0/0
M'FKU !1110 445%<7,%G;R7%S-'#!&NYY)&"JH]23TH EHJMI^H6FJV$-]8S
MK/:S+NCE3HP]15F@ HHHH **** "BBJ-_K&G:7+:Q7U[#!)=S+!;H[?-*['
M"CJ: +U%%% !1110 4444 %%%% !1110 4444 %%%% !13)98X(GEED6.- 6
M9W. H]2:KZ9J=EK.GQW^G7,=S:2[MDL9RK8)4X_$&@"W1110 4451U36=.T2
MV6XU.]AM8F8(K2-C<Q.  .I/TH O4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<'
MXE\:ZIX>@O[Z>WLH8+6[CBBLY23/=PED5I58-\HRYP"I^[R>:[RO-=5\!>(K
M[3/$^FQZAIIAU6]%Y%<3(YF #HRQ-C@*NW (SQV% 'I5%9=NFN#6$:XFL&TS
M[( ZQHXE^T;N2,DC9M_'-:E !1110 4444 %>?\ PHBCE\*:K%)&KQMJ]XK(
MPR"-_0BN^D+B-C&JL^/E#-@$^YP<?E7$>%?#WB?PQI%W8QG2)'N+N:Z69I)"
M$,C9QLVC=C_>% '-Z%K4?@7Q%XZTB)'DTC3GMKBSME)Q%).!^Z7KA2[#  XY
MXKJX/$^MPZZUI<Z7+>63VDDZ75O83P>7(@SY3>9D'<.C CGC%0?\*VMY/#&M
MZ?<ZC+-J>LR">ZU+8%;S5(:,JH/"J0,+GUYJ[I5AXU>TDCUO5-,\V*%TMWL8
MW4RR%2%DDW<#'7:HQGGL!0 SPMXINO$T,-W9W6EW=M):L\L<.Z.2UGRNV)\L
MQ[OSM'W>G-9]EX\G7X:P>(I["W2ZGNVM4@B)$2N;AH@2>N.,D]_;-7;/PG=+
MXLMO$DUMIUI?Q6LD-Q]BD;%\[;<&3*#: 03_ !'D<\<X%[I%SX:^&,'AF_O-
M+6YO;_R(7G#-!+YDS3,KYP5^7<,@YX&.<4 =''X@UQ?',WAI[?3Y]M@+Y;D,
M\65+%-I7Y^=PZYZ'VK!L_'_B";POHOB2XT_34L+N]6UN(D=S( TQB#(>@P<<
M'.>>G2KVA-K^DZ[%!>6?A^=[Y2IFLKN9YP$1F4N9 Q\L'Y>O!<<<U7C\":U'
M\.]-\->=8&>TO5N3/YCA6"S&7&-N0><?K[4 :>K>+=0,^LPZ);K++I9\LH]E
M/-]HEV!R@:/A.&49.>3T &3-:^*KS5]1L-*LK06%_+IZZA=K?1LQM5)VK&4!
M4EBV[N,!<]Q52;PWXHTOQ1?:KX;OM,6UU4I)>6E^DC"*55"[XRF"<@#(.,X_
M)]WX5UJS\56?B+1KZVN+K[$+*_BORR+<*&W!PR@[6!)XQC''% $/PP\_[+XH
M^U",7'_"0W?F>5G;N^3.,\XJSJ_B^X@\27VA6<UA;ZA#;I+:07RL#?,P)Q&V
MY0,$ =SG/I5OP=X?U+0/[9.H7-I-]OU*6^06Z,-N_'!R?;I^IJIXK\*WOB>W
MU+3[JWTRYLYP/L<\[,)K)]@!9<*<\C< &7T)P> "]%KM])X[OO#K+;B./3DO
M89@C9!9V3:PW<XVYXQ63H_CJZU/0=$<VUNNJZO>3VL2#/E((FDWR'G) 6/.,
M\D@9'469O#6LV?B^VUG2[NTD5M,33KG[;O+X1RPD7;]X\G()'UK%@^'6MVOA
M;2X+?5;./6M(OY;RRG\MC$PD9BT<G<@AR"0!TH ?X[N=;E^'7C*VUBSA1+>$
M"VNX#A+E#@D["S%2IX.3SVK7M/$.L6GBW2M&U*VLA::G:2RVS0,QDB:(*2')
MX.0W8#!]>M,UKP[XD\0^#-5TW4;O3AJ&H1+"%@WK;P*#DD9!9F/<\=AVYLW6
M@:K=>*_#FKG[&D6EP3131B5B7,JJ"5^7MMSSUSVH T?$VO#0-/MY$B$UW>74
M5E:1,VT/+(<#)[ <D^P-<NHU-/C1:"]>TF8:#.8GA1H@?WT>0P);'/?/?IQ6
M_P"-/#4WB;1[>*SNEM-0LKN.^LYG7<JRQDXW#N#DC\:S[;0?$DWC2R\1:A)I
M49@T^2SDM[<R/N+.K9#$#NH[<>] %&W\>SP>#KC6;VUMK4Q:L]C*\:L\4"B7
M897Q@D=STR2.E:DGBJYL](6YD:POFO;^*RTR:T8B*X\P+AF.6P ?,S@GA..M
M5M%\-Z_HVBSVJ/ILLLNIS7CQN[F.6*4L6C;Y<@_,,'!Z=.U9TWPQ9M)U..QG
M@TFYFU&+4K"&VR\%I-&H (! SN.2<  9& <<@'2"XU[SM7LM4M+=[)+3S+>^
MMQL60D$,AC+,01C.<X(-<SX.UYM.\"^!M(M5C;4-5M]D)ER4C2-"[N0,$X&
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M]35&R\*:QHD6N:;I4]D^F:I-+/$\[,)+-Y1\X"A2)%SR!E?3WH H7VKVVO\
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M:31([F53(Y0.IZ  XX.<^HZ#=GUW4-9GU^UT86BPZ7FWD>X1F\^;9N9!@C8
M"HW'=R3QQSCP^!=9@\!^'O#PFL&FTJ]AN6E,CA9%CDW@ ;<@G./;'>KT'A?7
MM(\0:U<Z1<:>VG:RWGSPW1??;SE=K,FT?.#UP=OUH L_"W_DF'AW_KS7^M9C
M>*_&%])XBBTG2M),FC7)CVS32'SE"*^U< ?,<]3@#@<\D=%X*T2\\-^$-.T>
M^G@FFM(O+WP*0N/QY/UX^E<MX<&KOXC\=Q::MEB340HDGD93$_DH-VT*=XZ<
M97IUYX )D\?ZIJK^%?[%T^S*:_;3R*;F5OW,D:9(.!T!/49)QVSFM6QU[6M3
MU*ZT6(:=!J>FVL+ZA*5>6+SI02J(,J<8&2Q/<#!JI;^"+G2]2\(?V:]N;'0(
M)HF$SL))O-0*6X4@'(W>^<<5=?P[J.F^-+WQ#H[6LJ:E!''>VMS(T>7C&$D5
MU5OX3@@CWS0!1TWQ^^JV6GVT5FD&MW6H3:;) [%HX)85+2MD8+*%&0."=P&1
MR:N7/B35]#L-4FUO3XF\BXA@L9[?(6\,I55^3+,F&;!Z^H!Z5EW?P[NX]+M+
MC2M1AA\0VVIRZJ+B2,^3)+*3YB,!R$*D+ZX45HZEX7UCQ+X7O;+7-1MX-0G,
M;P-8*WE6KQMO1AN.6.[J>.,  8R0"-/%^H:?JEXFKV4CZ3!8/>?VC#836ZQE
M,EHV63.3@9!!YZ8K"\4WNL:EI_@K4;M+..UN]<L9A;HK>9#N)*@N3AN#@X4<
M],UT-OH/B76M'O-.\77VG-#-:O;;=,1U\S>NTR.6[@=% QDY],9#>$/%UQHF
M@Z5=7VD,NC7UO/%<@2%YXX<[=RX 5L8S@G/J.X!J1^*M3>'Q@ICM/.T%OW3;
M&VRCRA)\PW9!YQP??VJK+XSUR9_!\5C86!?Q#9-.6ED<")Q ),8 ^Z"WN3C'
M'6G7?A+7EU+Q1]@N].%EKT0+M,'\R&00^60 ."IP#G/'H:+3PAK5M<^"Y&GL
M)!X>MW@EP74RAHA%\O!Q@#//7T% $K^*-::2XTU8K1-6L;:-[LQVEQ<PM,X+
M"-=F"HP =QS][H<&H3X^F$>@IJ,,?AZ?4[>1V.J1-M29&"^5U7!.2P)(X XY
MXL:IX;\1V?BZ?7_"]]IZ_;XHXKZTU%7*,4R%D4ISN .,=/Z7+_0]3O+>.SO8
M].UFRD@9;N"]+1AI2Q;<F%?:!D@#J!CGCD W=,ENYM,MI;^...[:,&9(CE W
M?:>XJGXGU^#PQX=N]7GC,JP* L:G!D=F"JN>V6(&>U<]I^GZ[X3M/"VAV%U9
MW=K$6BO$F#F9D)R#&>RH">6[!1U-;WBSP[#XK\,7NBSRM"+A1ME49,;J0RM[
MX8#B@#-O/$6J:#KNCV>KQV<UKJSFWCFME9/(GV[E1LEMRM@@,,<CI5;PYXC\
M3Z_J-V/L.EPV-AJL]C='S9#(RH!@IQ@G)&<XSGH,9-HZ#JVL76B3:^;'_B4R
M_:0+61F^T3A"JL=RC8!N)P-W..>.9O"&A:AH1UD7K6K+?ZE-?H8'8[/,Q\AR
MHZ8Z]\]!0!:UK6Y+'5-*TBT6,WVI/)Y;2@E(TC7<[D @MU4 9&2W451;5O%%
MMI>HF?1H)+R"[6&VDCD"Q3Q,5_?%2Q*A022I/\/7T3QAX:U#5[G2=6T2\@M=
M8TF5WMS<J6BD1QM='QR 0!R/3\15UKPWXDUWPV8KK4;$:F;F&<P(K_9&2-L^
M4V?F96YR<<\#&!0!#:^-+V=_%-M')I]S+HUK'=0W4*-Y4ZLCMM*[C@@H1D,1
MS[8J8^,+[^S_  7>BWMMFOM"D\>&S$9(3)E3GH,8P13;;PEK$GB#7KZ_O+$6
M^LV$=M+'!&^Z-E5UPN3@C#YR>N.@K/M_!GBAM.\*V=S>Z2@T"XB9#&LC>;&D
M;1@G.,-@CCIU.3TH T],\7W&L:U=6-I-8+/:7[VUQITJLMRD2L5\T$MA@1AA
MA<8;J2.:M_XWU5[*\U'1-.:^AM;IX!9K93O)<JDFQV251L4Y#8&&X')!.!+J
M'@^^UK4]/NM0CT]+FPU'[3#J4#L+CR0Y98B-HZJ0I^8CJ<5'8^%_%>A:I?VV
MBZKIPT*^N7N<7,3M/:-(<N(\?*PR21NZ9Z'G(!JQ^(+[6-;U'3=&6WA_LZ*(
MSR7D;-NED7<L84,-N%QDG."<8X-9_P (MW_"K](W*%;,^0#T/GR5)'X8UK1O
M&.H:OH=S926>JI%]K@O2^Z.2-=HD0J#NR.JG&3WJ_P"!- OO#'A.UTB_N+>>
M6!I"'@5@N&=G[]?O>@H H'Q?<77B6_T:TFL(;VSN8XQ872L)KB$A"TJ-N QA
MFP #]WDC/$]KXCU&XUCQ9II2U#Z.D+P2[&P_F1E\,-W;&.#[^U4_$?@^^\3"
M2WO8]/\ DNUFLM25V%S:(&#84;>3P1]X#D<<<RW'AG6X?%6N7^FW-@+/6K>)
M)_/#^9"\:% 5 X8$'N1@]CT( :9XSN=6TOPPL,$$>IZY;-<?-EHX$107;&06
MY90!D=>O%8OCVZUF?X;ZRFLV$4,UOJ-O'!)"PV7,8N(BL@4DE,YQ@D].M3)X
M!UVRT'PN^GZE8IKWA]&BC9XW^SSQ,H5D?^+L.0/P[UI>(/#7B'Q#X1GT^[O+
M ZA<SPR.4WK!"L;JX5!@EB2O)..OH * +>G^(-77QR_A[5;>R"36!OK:2U9B
M5"N$9'W?>/S Y 'TKJJYAM#U*3X@6OB%OLBV\6G/9/$)6+Y9U<L/EQP5QCOU
MXZ5T] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#! ^4@\=^P /1[JZ@LK62YN95B@B4L[N<!146G:C::OIT&H6,PFM;A \4@!
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M,=36[::]K4'CR/0M5CL&M[RR>[MVME<-$4=5*,6.&X8'< OTH ZRBBN%CO\
M5E^*^IP3:C;C3K72XIQ$UN?D1G;=@[_O?)RV#Q@8XH [JBO/[CQMJ\?@F/QK
M%;VKZ62)GL=C><+<OMW"3=C?C#8VXZC/&3VEUJ=M::--JKL3:PV[7+,!R4"[
ML_E0!<HKAK7Q5K\]WHL\6G&ZL=0*BXCCL9XVLPPRK^:WRNHZ$@#U%9=QXV\5
M+X=\1ZQ';Z0J:%J$\$D;+(3/''MR =PVG!)R<^F!C) /3:*XO6/&AM-?@TH7
M=EIK7-BES9S:A$QCN9&+ QA@RA2N%SU)WC'3FU#K^J#QQ::#<1VJQW&DM>DJ
MC;XY5=%*YW8*_,?3ZT =517F]UX\UR#P;J.K):V$ES9:TVFLNUU5U$RQ!@-Q
MP3G/7%:T_B#7--OK;2M2^P?;KZ2:6"2SMIIUCMXPGWD'S,^YP."!CGV(!V5-
M=UC1G=@J*"68G  ]:P/"FKZOJ<5]'K&GM;RVMP8XIQ \*74?575'^9?0@D_6
MLB"ZUF7XOWMD;^ V,.EQ3)";<_*KR,& ._[QV#YL$8P,>H!U6DZQI^N6(O=,
MN5N;8NT8D4$ LIP>ON#5ZO'=!U[6O#7@"76+6.Q?3;;6)TN(I5<RR*]V4)4@
M@*1N[AL^U=?XJ\2ZQHO]K31"QMK>SL_M%K]H4RO?.%9G555P5"@ $X/WL]!0
M!V=%>=ZCK&L:CXK\"O97<%K:ZG:SW1@D@,@#B%3\Q#KNXD('3!YYXQUOBG4K
MO1O"VJ:I91PR3V=M)<*LV=IV*6(..>U &O17G[>*_$T%UX8>2#2I+?78]BQ*
M)%>&3RO,#%LD,O!R-H(Z9/6K5AXF\0E_%6FRV5G?ZMHPB:W%MF&.X$J;E!#L
M=I&#GF@#MJ*XO2O%&H7OBVX\/B[T^Y)TS[;#>6\#!$</L92-Y#@$@Y##N*Q?
M"7BG4[+X=:5J.HW$=W=ZI>O;P8MG+"1YI2S,%8EP K$*H7H![@ ].JIJ>I6>
MCZ;<:C?S""TMT+RR$$[5]<#FN0;Q1XCMH_$ ETY)8K&R-Y9WSVDUM%*5!+1L
MCDG<,=0<$>F*J7/BGQ;:_#^Y\536^BF$Z9#=P0@2;@S*"^[G!'(( /'0DXR0
M#T..198UD0Y1P&4^H-4M3UO3=&^S?VA=I;FZF6" -DF21B % 'N16/JFLZK#
M<6B1&RL[26S,IO+A3)OG.-L*1AU8G&6XSTQUKD]:UZ3Q1\.?"6M30+#+=:S8
ML\:$D*PGVG&>V10!ZG1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ML(PJXW'D]2<_05H?\(U?:=XKO]=T>ZMU_M.*-;VVN$8J9$&%D4@\''!'?U%
M'/#X@:Q>:+H%W:6EE%=76L?V3?03;B$E&[<48'@?+W!X/M6_X<UK5YO%.N:#
MJ\EI/)8I!/#<6T+1!DE#?*5+-R"O7/.:I3> 98].T2TL;Z)6L-4_M6XEEB)-
MS,2Q;@'Y02Y]<  <UJZ?X?O+3QKJNO27,#PW\$,/D*A#)Y>[!W9YSN/:@"KX
MKUS6=,U_P]I^E_8O+U2>2!S<1L2A6-F####CCIWQC(SD55U_7#>2Z'+/;C5+
M*UCENKFVL9)HV>0OL 0'*C"9.3SGC&*U/$'A^]U;7M!U&VNH(4TJ=YS')&6,
MI9"A&01C@GUYJEKGA75W\4+XB\-ZO#8WLD MKN&Z@,L,Z*25) ((89/(/Y<Y
M ,+4M0U/5!\/[K6=..GZBVL%9[?L"(I1D>Q !'UJYXK\8ZSX=MM6OF^Q1BRN
M(Q;V.TRO<6Y*!I'96_=Y+,!D ?+WS6IJ7A74KZ7P_*=4CDFTN\-Y-)-$<SN5
M8$  _(N&.!SC Z]\C5/AYJU_IWB;3(]<MTLM9NC>*7M2TR.2IV%MV"@V #C.
M.] %NXGU9_C);V<>H1+9KHKSK"T!( ,T:MR&'S':,-T'IU-59?&.NQ>'/&M[
MMT\W6A74D<'[I]CHL:OR-V<_,>];<WAK4F\7Z?X@CU.!9H[%K*[5K8D2*7#Y
MC^;Y3D8YW8'K6;)X'U*72/%MB=0M1_PD$SR[Q"W[C<@0C&[YN%'IS0 ZV\1:
M_;^)_#=KJ+6$EGKEO*5C@B97MW2,2<N6PX(S_",50U/QSK$?ACQ!X@LDM572
M=2>R%E+$S-(JNJ$DA@0Q+;@!QC YSFMJ;PMJ,VK>%KXWEJ/[$21701-^^WQ^
M62#GY>.>_-<38W,M_<WVN6/B#PF5GO9)A'JMJ1/$5;:BOB08*A1C(R/J: /7
M(1=&Q43/%]J*<NJ'8&QUVDYQ[9_&O,_#GBC4](\!S:I?745]=76K2V=NK1%"
MTSW#("S!B-HZX & ,5Z/I-Q<WFD6=S>0""YEA5Y8AG",1DCGG\^:XU?AS-+X
M8U#0+G55^S/>/>6$T,&V2WD,AD#,2Q#$$XX XSZ\ &C-KVIZ)XQTC1]3>WNK
M35TE6">*$QM%-&NXJPW$%2.G<$<YZU!\4+G4+3P@)+"[%L6O+>*7]WN+H\JJ
M5SD8'//J..*T8M OK[6M,U77)[62;3$D$"6J,JM(X"M(=Q_N@@+VR>3QB;QA
MX?D\3>')M-AN5MIS+%-%*R;U#1NKC(R,@[<=>] ',ZK'JG_"U=&CM[BT^W'1
M;D&=X6\M?WL?(C#9/TW#Z]JDL/'-\OAIWOHH'U5-:?10T,3>6\BN5\P)DMC:
M"=H/)&,C/&M_PCFJOXQL-?GO[21K:RDM7C6!EWEV#%A\QP 5  YXZFLD_#NY
MN- U73Y]56*ZN=7?5[2[MXB#;3LVX<$G< >.V030!L:%JFO3>(KRPU"T:33A
M LUM?_9F@^;.&B96)R>X(P,57\3ZWKECXKT#2-+-@(]4%RI>XC9C&T<>X'AA
MD<].^,9&>-+0-/U^!C/X@U:WO)PGEQI:0&&,#()9@2=S' ] .PY-0ZSX?O=2
M\6:#K,%U!''I1F)B>,L9?-38>01C YZ&@#)/B'79)[O2$E@&J:=;1&YF@L9)
MHY)W4L  "-J8 ZG)W=L<OB\6:Q-)X4T^\TX:7J.LB<W(E&\0&)<E5&>K<$9)
MP,]:DU;PIK*>*Y?$'AK6(+&>[B2&^M[NW,L4VS.QQA@0P!QUK'\7AEU/0=$;
M7K"&\A26]:35X 8;A\[01\RX8%F(53P/H* +,'BSQ$WA[QA>N--,N@R7$43>
M0X68Q)OR?G[@XP.AJ:_\;OI]MX;?4;F'3;?5+(32:A+ 7B6<JA6,\@(#N8Y)
M_AQGO4.FVVK:SX>USPV;G0&@FM6ACO-*A811M*&5PR[B"_.[AN_/49V(_#^J
MPZ986#3:?>6<-BMG<VMS$WES%< ..N.!R,'.>O% &'K%YX@D\2^!(O[2LXS=
MFX>410EXGD6!CN&'R5PQP,]\DFKEKK/BS4_%^N:1:R:3'!I5Q:Y>2&0F2*1-
M[*,-PV#UZ<#CG(2'X?W&G6/A:+3-4CCGT&24J\\!D21958. H8$8W?+R<8&<
MUK:+X>O=,\5:[J\UW!+%JIA/E+&5:,QIL'.<'(Y/ H P;CQCK.GW^D+>_8A)
M>ZN+"XL(E,AMHW+"-C*K$;\*K;3C(8\#%/F\0>*KK6?%NGV4VE0#1EBDADDM
MW?>&B,FTC>.>V[/&/NG/%>'X=ZW#HNEZ9_;]HT>E:HM_;2-9L7DP[,?-._YF
M^<],>];5OX6U*WU;Q/??;K9SK4<2*IB8>24C\L$\_-D'/:@#G[K7M8UR^^'-
M[:W<-G'J@DGD@,)=1)]F=N?F!*C) ''J<\5Z8,X&2">Y%<-#X%U&VTKPG#;Z
MI;+>^'F*I*]NS1RH8S&<KN!!P<]>M;6D-K@\2ZM'>WD-UI8"&V*0;#$W(9"W
M\9XR?3(^@ (?%FN:AHE[X>6T%N8-0U2*RG$B$L%8,<J00!]W'(/6LF37?%-[
MXC\5:38S:7 NE102P326[N6WH[;67>.> -V>,=#GC:\4^'[O7I]%>VNH(!IN
MH1WQ$D9;S"@8;>",9W'GFJ]MX:U&V\1>)-56[M6&L10QI&8V_<^6C*"3GYL[
MB3TH I:5XTNM=M/#$%M'#;WVL637DSLI=(40*&VKD9)9@!D\#).>AR_'LFMO
M\)O$L>NPVZS13*D$L!XGA$L>QRN3M)[C/:IT^'>IV6B^'/[.UF&#6M!1H8+D
MP$Q3Q,,,DB9SS@=#Q_+4UWPGJVO^"[[1[O5H&O[]D,UR("(HPK*0L:;L@?+W
M).23[4 6O[<U ?$9O#Q-L;-])-]&_EMYBN)0F"=V".<]!6)9>.]0FT"W::.T
M.JWFM2Z3;[498AM=AYC+N)P%4G&>3@9&<UKZCX<U:7Q78^(=.O[."Z2R:QND
MG@:1&C+A]R88$$$=SWK$'PUO1X>%F-;1=0MM6?5;"Z%O_JY"S-M<9PX.XYP%
MH ?:1:C%\:;A+FY@FD_X1W]S(L)3 ^T=&&XYYSTQQCZU5_X3GQ ?AU9Z^L>G
MF]DU/['+&8W"%?M)B&WYL@XQR<_2MZR\-ZZOC)?$E]J.GM+_ &;]A:W@MG53
M\Y?(8N2.<>O4\=ZRU^'^IKX)A\._VG:;HM0^V^?Y#8/[[SMNW=ZG&<]* -73
M-;UJ+QY<^'M6>SGC;3AJ$$EM"T9C'F;#&<LV[L0>._%87_"<:Y<^%M$\0V8L
M@NJ:DME]CDA9C"K2,BG(8$N-N2.G7IBNAN-(NK3QE)XMN+F'[-!I36DEO'$S
M/M#>86!SR<C&,5P.B3W]OIL&L6&N^#[Z61FND2>V/VIY'R2OR.<2G.WA<]L&
M@#V)A/\ 9B%:,3[>&*DKNQUQG./;->67WB;7=<^''AG5OM5O:7%[K,,-PL4)
M*L/M150,MD+\HR,Y/J.:]3#3/:A@BQS,F=C'(5L=#BN%A^'U]#X!T_P\-4M_
MM>G7J7MO<^0=C,LQE 9-V<9)'!H DUOQ==Z7KSZ)/J%CI]VUFDEC/=V[""]F
M.X,N[?A<$*,9S\W4]*[26X6UL7N;@[5BC,DA'8 9-<SK7AG5-;L;_3KZYT^\
ML[V$)MGMVS;R;<&1!D_4+D$$?>Y-=#:Z;#;Z-#I;%IH([=;<F0Y+J%V\GU(H
M YO3=6\3:MI^AZW9PV4EEJ#I)/:,"KP6S@D.'W?,X&W(QSD@8QFH%\2ZSK&C
MZUK&B-9K#IUQ-#!;S1,QN?)^^2P8;=Q!"X''!.<X"^&O"&O:!'#I+>((Y] M
M7W6\?V<BYV Y6-I-V-H]ADCC@5);>$-0TG^V[/2=0MX]-U::2?;-$6>UDD&)
M"F#A@>H!Q@^M %%/&FK:OJOAB/1ULHK/7;":Y!N8V9X615SG# , 6Z<9QU%,
MA\;ZK:^%M9NM0BAENM)U8Z?<7-M;L4$09,S^7DGA7R0#V]*U(_!CV6N^'+K3
MYX8K#1+22TC@="7D5PH)+9X/R ].<FFZ;X6UO2CJLEKJEHLU]JIU'F!MH!4*
MT3#=R"%'/8\XXH @E\:/:>''U.&^T_54N[V&STR6W^57:3:H\P G!5BQ(XX
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^+7T3Q?J$5YID9T"\F55^R,?/2.-7VG+_+D$\Y))/;'-N[OM3U'XB>%F@O\
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MD8@#CD4 =Q-,D$+RONV("QVJ6./8#D_A5/1M8L?$&D0:IILIEL[@$Q2%2NX
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M&D4:QQHJ(HP%48 'TIU '.Z#X<NM'UW7-1FU"*X359UG,2VYC,15 @&[><C
M'8<UE1>!+V'PMKOA]-:C^R:B]P82UGEH5F8LV[Y_G(W'!^7W![=O10!Q.H>"
M-0>71=2TK6DLM:TRU^QM.;;?%<0\95HRV1R,CYNOX8M:QX0O=4T*U@;6,ZM;
M7T6HI>2090S(>!Y8(PF., Y[Y)R3UE% '*:;X7U2S\4WNOSZQ!-<7=G';O$+
M,JBLA8@K\^0OS="2?>LJT^'>H:?X?\.6-KKL/VK0KEYH9I+(F.4-N!#Q^9U
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M/JFL6VHZW-;W(M()88(88BB9E 61VRQ))48 [ GKGC=GM+>Z4+<6\4P7D"1
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MGK:X,D1DV%@^<AAD8&,8'.>_;:#H&KZ.$DUWQ3)JD%HI$ >W6 (,8W2,"2Y
MR,D@<DD$\CDOAUH<OB/X2Z+87>HPR:4QWS6\<'[Q@LI;RV?=C&X#/RYQQ[T
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M^TBPM_MA0W7E+YQ3[N_ W8]LYH GHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDD,4N/,C1\=
M-R@XI]% " !0   !P .U+110 C*KJ590RGJ",@TV.*.($1HJ \X48I]% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA]O2EGMH+I EQ!',H.X+(@8 ^O- '#?"^ZLYAXK2TFA<?\)!=2!8V!^1MN&
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M!VK6\0R7FJ?#+6M?LK>=I]12*=(0O[S[(CK\F/>/S&QZR$5Z.1D8-(JJBA5
M50,  8 % ' :->^$O$6OV&M6.LS:I?0VKKDNH$$+#)$JA1CG& W.>G0TOP>M
M; _#C1KJ&&W-PJ2JTJJ"XS*V1GKV''L*[B*SM85D6*VAC60Y<+& &/J?6I(X
M8H01%&B \D*H% '$>/KB"'Q%X(62:-&.L9PS <>4XS^9 _&D:2V'QRVEX@S>
M&SN&1S_I //X5VTEM!,VZ6&-V QEE!-(;6W+;C;Q%L8SL&<=* /$%-A%\!I)
MXS;K(-8#AUV@Y%]P<^NS]*VO%^KZ;+-X^L8I8+"Z&FJ)MS;IM0/D,4V*3@(H
M."5!)Y.5QFO5/L=KMV_9H<9SCRQ3OLMOOW^1%NV>7G8,[?[OT]J /+K:XTV_
M\6?#6026T^=+N/FR&RPCBQ^((/X@^E9%W=?9=$\63VR^=96?B^.ZOH(?FW6R
MF)I/E'49&3]#[U[/]DMLJ?L\64 "G8. .F*6.V@BSY<,:;A@[5 S0!S-AJ7A
M37-5NM6TN6UO;@V/EW-[$^Y$B!RJ.<X!)).#SP<]JX/PYJ^G6/@#X=K<_98Y
M9)9!!?W+D0V;JKY+ $ L02H!.,G/:O88K2V@@,$-O%'"3DQH@"G\!0;2V,?E
MFWA,>[=MV#&?7'K0!Y!8WUI_P@?Q2@%\LTGVJ^D#-@,RM @5L  88YQQSSC-
M>H>&'23PGH[HRLILH<$'(/R"M V\#;]T,9WG<V5'S'U/K3TC2- D:*JCHJC
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MH%W;7UQ:ZM:SQ6 S<F)]_ECMP.N<'&.O:O)[FWBL?"-N+IHDTV[\:K<6$<I
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MEDWP^\/36JP%AIT,;O&!G(4%E)'?<3D>N:S?&%]:6_Q'\"K-<PQLL]V2'<#
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M!N#T)8 >N>*M6^MZ7=:0FK07]O)I[C*W*R#8><=?7/&/7BN-ENM-D^-NGO\
M:+5L>'I#&V]3R9D((/NNX_3-<=!J"6GA0:A%)))IFG>+KF:]^QMEHH"T@5\#
M^$%E;\C0!['8:UINII.UG>PR_9VVS@-AHCC.&!Y7CGFN3U'Q5Y_Q \)V.E:N
M)+.]:X^TVZ*I$BK"S(X8C)7(Z@X.*YKQ,FDZKX2\3ZMX0ENM4N[BVA2\N8Y&
M99(U=2T8[%O+WYQR <'J*T=4\2Z!J_CCX?WNFZA:S0B6Z&8V!,0>W(56 ^Z2
M<#!P>* /1-1U2PTBT-UJ-W%:VX(!EF;:H)X&2>E-DU?3H=0_L^6]@CNS&91"
M[@,4'5L'L/6N:^*\4DWPOUU8T9V$*N0HR<*ZL3^ !/X5DW/B'1]2^*WAFZLM
M0MY[9M/NU$\;YC+$QG:&Z9XY';O0!U8\:>&6>V5==T]C<R&*';.I$C9VX!^H
MQ]:O:EJUAIZB.ZO5MY)$9DQRX ZL%P>!D9)&!WKQF:YTX? SQ"T<UL';5Y&!
M5ER3]L!4_7:,CVKL+/7K/2/BMX@.MWD-M#?V=JVE7$\@6.2)%;>JN>,[V)QG
MG.: -+P#XBDOO D6K:SJ23,;FX0W+;5#@3.J8"@#D   =:V_^$KT :;/J+ZO
M9QVD#F*:224+Y;C^%@>0WL>:\ATG4X=.\&>&M2:2==(T_6[T7[6P.ZW#M,L;
MD 9 &[T[UK>*F\,R^ /&FK:+=/=&_MXDGO7F+1SR+PJKG@L!UQZCOT /4=/U
MO3-6FNHM/O[>ZDM'$<ZQ.&,;>A]._P"1JI=>+O#MB;L7.M6,9M"JW ,P)C9L
MX! [_*3CKQ5S24LO[.@FL5@\J2),/"!A@% '(ZX'%<3I%SIO_"S?'K2SVN1:
MV:L79> (W#@^W3/X4 =:/%6@-?6EDNL637-VH:WC68$R C(Q]1R/7M5BTUO3
M+Z^N;*TOH)KJUXN(4?+1?[P[?C7CMK=6$/P9\#-Y]NC)JUFQ.]00PF^8GW Z
M^U=AXL%]X;\5VGB+1K<W']KQ#3+F->09B";:4^P;*D_W30!W%CJ%IJ5N;BRN
M(YX0Q3?&<C<#@CZ@\57EU[2X;P6DE[$LQE6$*3QYAZ)GINY'R]:FTO3X]*TN
MUL(B62",)N;JQ'5C[DY)]S7FD]U/I&M376BZE;ZII=SK8BO=%N0#/;W!F 9X
M2.>&&_:1C'/T /1!XATAK>\N!J-N8K)MMTV\8A.,X?\ N\<\TR?Q-H5L+<SZ
MQ8Q_:83/#OG4;XPNXN.?N[1G/2O.[C5+'3;SXFZ?>7*17ERIEM[=C\\R&U W
M(O5AD')'3'.*AANM.>?X1S7,MN;=;.5"\A&U7%L@ )/0A@/QH ]-TSQ!H^LZ
M<^H:=J5K<V<9(DFCD!5,#)W'M@<\TVW\2:+=/<)%J=MNMD$DP9]I1#T<YQ\O
M^UTKRW7=/N/M'CS5M"@>73GDL'D2UZ7#Q.&GV8X)"\''4Y'7-=-HFH^#]<UN
M+7M,U&>_NX+-TEN))6VV\)YVR9P 2>@//!/:@#H/^$Y\*_\ 0P:?CR?/SYXP
M(\[=V?3/>M(ZQIRP6DYO(A%=L%MWW<2DC("^N1S7$_"VPTO5/A'IEL\-O*LM
MK+;W&T MAF;<I/49X_2G^ 5U&<)I6J)(3X8>2R$KCB=\8C<?2$C_ +^4 ='I
M.IV7EZO>'Q%#J%K'=-N?*!+0;5_=;EZXZ\\\U/+KFF7&GW[1ZM#:_9X\332$
M(;8L#M9@^,>HSUKSJQET>]TCQ_!>ZG]EMG\0*3<V\B[H6)@"29]!( 2>G!K1
ML=3U)=/\76&NW%A?&TTX;=8M@$6X1DDVI(,[0XY.!V8>HR =I8:C:6GARPNK
MK5TNXGAC"WK@+]I)'# #J6Z@"I%\1Z*VFS:C_:EHMG Q2:5Y0HB8=5;/W3['
MFO,M+OA96GPMU2XE7^Q8;%K:>;=\D%P\*JA<]!SN7)Z9/K4VOI&UW\1]5M9H
M_P"RI]"\B20,/+FNA&XX/0L%*@X[D#K0!Z):>*-"O]233K75K2:\>/S5@20%
MBN,YQ]"#CK6M7E+W6G177PJ,4]L@"MC:ZC :U(/YMQ]:]#TGQ#I.NS7T.FWJ
M7$EA.;>Y5008Y!U!R!GH>1QP: *5_P"+]+T_Q39Z!-,HNKB)YF)X" 8 !/J2
M>GM]*NWGB+1["X,%WJ-O"ZLJOO? 1F^Z&/12<C .,YKEM?O+?3OBUX<GO)5A
MBETZZAC9^CR%HR$'JQ[ <FL/2+RUA\$>,=#U]T75!<WIG@E/[RX\W)C=%ZMN
MRH7'< "@#U=F5$+LP50,DDX %8+^./"T<ENC>(--!N',<7^D*0[ X.#GUXSZ
MU+X1M;ZQ\&Z-:ZD6-[#91)/N.2&"C()[D=*\OLUT:Z^%?C&PD6VDO9=0ODC@
M !E>8R-Y( ZD[MN* /4M0\5^'])FFAO]9LK>6"/S98Y)@&1<@ D=1DD8]:DO
M/$>C6 !NM2MXUV+(6+Y"HW1F(X53V)P*X338K>/XJZ7I^J26TU[%X42"59&5
MBTOF ,.>I(W?@35GP[?6>F:SXVTSQ'+#!)-?/=+]H(436;1JJ;<_>"A2I Z'
MB@#MKC7-*M;VULY]0MX[F[&;>)G&Z8?[([_A4.J:OI\=MJ%L^L06$\-N6DF=
ME!M@P(60[N.O3/!Q7G<&@ZO9_!?0KUXY/[;T'&HV\;Y#[%9B8CWYA.W'J *Z
M2_F2?X<>(=:NAY)U.QGG"S84I$8BL2GT.W!(_O,U '0VVI6EEH%A<W6J)<1R
M11A+M@ ;EBHPP4=2W7 %<_X1\0RZEXB\6I-J@NM/L)X1;NP5!$IBW.#@#HV0
M<\C'/2N6M-7ATRY^&VI:A.B:(-'^SBY+?NH;EHD WMT4D!E!/3YO>J6I7:W[
M_$HZ*PNW,]A<^7;')GA18S+MQURH;IUS[T >M6&O:5J=U+:V=]#-<1*':('#
M!3T;!Y*GU'%:-<%X=OO"?B3Q'9ZQH]]=:EJ$-LR&1I'_ -'B;JL@. "3C"GG
MJ1P":[V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@'J,TM4=
M4UG3=%@2;4KV&UCD<1H9&QO8G  '<T 7=J^@_*C:N"-HP>HQUK'MO%>A7MI)
M=6FI17$4<YMB807)E R450,L<<\ \<T^+Q-HLVEG4H]1A:T$ODE\G(DSCR]O
M7?D@;<9YZ4 :<D4<J;)(U=>N&&13BH/4 UFP>(=)N;6ZN8[U!':/LN X*-$W
M'#*P!!Y& 1SGBGVVMZ=="Z\NYVFT4-<"9&B,0()!8. 0, GGM0!?VC.<#-(8
MT92I12IZ@CK6=9^(=*O[S[);WBFX,?FK&ZLA>/\ OKN W+[C(JA+X\\*PQM(
M^NV?EI.;=G#Y"N,9!(Z ;ASTYZT =#M7).T9/7CK2@ =!BL[4->TW2Y!'=W.
MV0QF;8B-(PC'5R%!(4?WCQ7,>*/$1L]9\(WUKK*QZ/>W$GGD,GDR1B%W#%L9
MQP.^* .V,<;2+(R*77[K$<CZ&DDBCF4++&KJ#G##/-<W<^)]/USPEK-[X=UA
M'EM()3YL&"T3JI(RK@XZ=Q4GAO65'@30=1U2Z+3W-C;LSD%GED:,$X4#+,>3
M@"@#HB >H!HVC.<#-4],U>PUFV:XT^Z2>-',3[<@HXZJP/*D>A -0ZEXATK2
M9&CO;L1ND7G2*J,YCCSC>VT':O!Y.!P?2@#2V*!C:,=>E(Z)(A1U5D(P589!
MJE/K.GV\=O(UP'%RGF0B%6E,B8!+ *"2O(YZ<CUJ,^(-+^RVMREUYL=TA>#R
M4:1I%&,L%4$X&1DXP,CUH T@BJ@15 4#  ' I0 .@Q67#XCTB>>PABOHV?4%
M9[08(\\*,G:<8. ,TR3Q3H4%M?7$VIV\45@X2Z:5MGE,1D @\Y(Z#O0!J-%&
M\BR-&I=?NL1R/H:<0&!! (/!![UB1>,O#L_VGR=6MY#;/''*J$DAY/N*!C)8
MX. ,G((J4>*-$_LVZU!M2@BM;1S'</,3&87'565L$'D<$9YH UZ8D4<2;(XT
M1<YPHP*R;/Q7H.H:FFFVFJ02WCQ^:D2DY9>IQV)&>1U'>I+KQ+H]E="VN+^.
M-_-6$L0=BR'HC/C:K'(X)!Y% &J !T&*0J#U -9FI^(M)T<L+^\6'8H:0[68
M1*3@,Y (0'GEL#@UH^=$8//\Q/)V[_,W#;MQG.?3'>@!VU?0?E1M7^Z/RK#L
M_&?AO4+VWL[/6;2>XN/,\E$?._9G=@].,'\C5BT\2:/>Z@EC;WR-<R(9(D*L
MOFH.K1D@!Q[KD4 :9C0DDHI)&"<=1Z4NU?0?E61=>*]"LG876IP0HDI@::0E
M8ED'5#(?E#?[.<TZ\\3Z-8HKS7\94P"YS$K2 0GI(=H.$_VCQ[T :NT#L.:1
M(HXXPB(JH.BJ,"LJ\\4Z#I[6JW6K6D1NXS+ #(#YB!2Q88[8!.>E1_\ "4Z+
M<:?!<V^I!X[N%I8'MT,CE!P7"A20 >I(P#UH V2B$ %5(!R,CH:7:O/RCDY/
M'4UYOX<\0'4/AM:7NK^*7M)Y]0D2.^!3?,%N&"HHQ@Y4 <#H:["]\6:!IUW/
M:76JVT=S!&))8MV652<#@<Y]NM &S@8QCBD  Z "L^+7M*FT5-9COX&TZ10R
M7 ;Y6R< #WSQCKGCK3+7Q)HUYJ+:=#J$(OUZVDA\N8<9_P!6V&QCG..E &AY
M:H9)(HT\UAR>FX]LG%<[X/\ #ESH%M>QWIM9I)[Z>[22('*>:Q8KR.WKW]!5
MCQ+XKLO#)TY+D.TE_=QVT85&(&3\S$@<8&3CJ3^-8!\4KI?Q#U--2UAET<:5
M!<PQRJ $9W<': H8\+GG)ZT =U)%',H66-74'.&&>:<0#U -4%UO3)-*AU..
M\BDLIP##*AW"3/0*!R2?0<T[3-8T_689)=/N5F$4ABE4 JT;CJK*<%3[$4 7
M2H.,@''(HVKZ#\JQM3\7>']&N9;;4=6M;>>*$SR1L_S*F0,D#W(^M.N_%6B6
M,"3W&H1K"T:2F4*S(B-]UG8 A%/8M@4 :^U?[H_*N2?0/$5MJ]_-9ZEI=S9W
ML_G;-0LV>2#Y0NU2K@,H X! ^M-N]2O4^*&CV<6H.VFW>FW$Q@ 7864H P(&
M3PW<D5H:/JNFB#6KX>(DOK2&Z<RR.Z^79X528PP & .>2>M &CI&EQZ18F!"
MK,\C2RLD816=CDD*. /0?F2<FKV!NW8&3QFLF+6K#5Q=65A?O%>1Q!ROEE)4
M5ONN%D7D<=<$5RO@+Q]IMWX9T"VUG78'UR]BR4D8!G<L< XX!(Q@<=L"@#OE
MBC1V=8U5W^\P&"?K3ZPK>YMKKQ1J5O;Z^\LZ6R+)81E&%J<M\_0_,?0YZ=*Y
M?0==DN?A.]_KOB1["9YKB)M3;8'7;.ZK@8QG"XP!]* /0DBCB+&.-4+'+;1C
M)]308HS*)"BF0# ;'('UKG[WQ?8:?XGL/#\C2O<7$#S-)Y;$*HP!T&"26[=,
M<XR*T+#Q!I>J17<MC=K.EHY2<HK'RV'53Q]X>G6@#3IBPQ*Q98D!+;B0HZ],
M_6H[*]M]1LH;RTE$MO,H>.0 X93T(SVJA/XFT:UN?L\]_&C"40%R#Y:R'HA?
M&T-T^4G/- &FT4;NKLBET^ZQ&2/I0\,4C*SQHQ4Y4E0<'U%<AXJ\3I8^)M#T
M'[3+;QWK3-=2Q(V]42/<H4X/5B.1R .V:W-,AN-$T4KJFJRZAY3,PN9(0K["
M?E#!>I (&<<]<4 :N!G.!FN,T_PUXDL8?[/DU32+RS#NPN;K3V:X(9BQW?.%
M9N3SC\.U<]::[)XD\)1^(YO&5QH'SS?:0(U,2Q%W6-5W#A@%4[ADGGU&.\G\
M3:)ILD%I>:O;K<-!YH61P'9 !\Q Z9R/J3Q0!?T_3[?3-.MK&W7$-O$L29QG
M"C JSM7!&!@]>*R[;Q-HMYHKZQ!J4#:>A*O.6P%(."#GD'/&.O(HB\2Z/-%>
MR?;XXA8@&Z$X,30@C(+*X! (Z$]: -..-(D"1HJ(.BJ, 4B0Q1G*1(O)/RJ!
MUZUC6OC+P[?7MI9VVKVTEQ>)OMT!/[P8W<'IG'..N.U3W_B71],F:*\OHX2C
M*DC$$I$6QM#L!M0G(QN(SD4 :I&1@]*8D4<8 2-% &  H&!Z5CB\M)/&@MDU
MPFY2Q8OI2E2 -Z_O3QD'D#KT-2P>)]&NKV&TAOXVEG9T@.U@DS)]X(Y&UR,'
M(!/0T :NU?[H_*FM%&^W>BMM.5R,X/J*Y3P[?W\WC_Q?I]U>RW%K9_8S;(X4
M>4'C9F V@9Y]>>!6YJ7B#2-'G@@U'4;>VEGR8DD< L "2<>@ /- &AL0)L"K
MLQC;CBA8T1 B(JH.B@8 K'3Q9H<NF0:C#?K-:W",\30HTA95.&;:H+8!X)Q@
M=Z63Q;X>AALY9-:L5CO$:2W;SAB1 "2P]@ <GMB@#9 QTI-J^@_*LK2?$^B:
M[93WFF:G;W%O;DB9PV/*P,G=G&./6GV7B'2M0O!9V]XIN&C\U(W5D,B?WTW
M;E]QD4 :6U?[H_*L"#1M6F\0/>:IJ<$^GV\S2V%K%;["A*E<NV3NP"V.!R<]
MA@?QSX72<0?VW:-*9S;!4?<3* "5&.IP1^/'6LA?&ND>(/!-[J/]L2:)"7DB
M6[9=KQA9&56&X8)8+G;R1G'6@#MZ9Y,7F^;Y:>9C&_:,X^M95UXFT33+A+.]
MU:WCN?)\W8[C>4&/F('KD8]2>*FL_$.D7^C-K%MJ$#Z<@8O<%MJIM^]NSTQ[
MT 7VBC=BS1H6*[22HSCT^E<YKGA^\U/Q9H&JQ-:BWTOS]\4A.91*FPCI@8'/
M?/M6A#XGT6;4$T_^T88[UP"EM/F*5P>A5' )!]0*NWVH6FF6WVB\G6&,LJ M
MU9B<!0!R23P .30!81%1 B*%4#  & *:D4<8(2-5#')"C&3ZUECQ3H?]GW=^
M^I0Q6]FYCN6F)C,+ 9VLK8(/(X(I+/Q7H.H:FFFVFJ02WCQ^:D2DY9>^.Q(S
MR.H[T :X '0 4  $D #/)]ZX;XD>*H],\':RVFZL]KJ-JF!)#'N"R<?NV8J5
M5B#TR&Y&*[..8)8I-*W B#LV,]LF@";:N,;1^5-2*.)-D<:(G]U1@5YMXC\=
M/J_PPU?7- O+BQN+64JC"+!*B;R\G>O&1D\8(KM['Q)HVI:I/IEGJ,$U[ F^
M2)3R%SC(]1GC(S@T :;(C(495*G@J1P:%C1$"*BJ@X"@8 K,D\2Z/%?Q64E]
M&DTLI@C+ A'E'6,/C:7_ -G.?:KE_J-GI5E)>7]U%;6T0R\LKA5'XF@"QM7^
MZ/RJI::=%:75U= EI[DCS'( ^49VJ .PR3ZY)K/L_&7AS4-672K36+66^=/,
M6%7Y88SQZG'4=138_&OAJ:]CLXM:M)+B6Y-JB(^[=* "5!'&<$?RZT ;I )!
M(!(Z>U-:*-I%D:-2Z_=8CD?0UF+XFT9M0BL?M\8GF9EBW A967[RHY&UB.<@
M$D8JC<^/_"5HI:?7[%5$YMRPDR XQD9'IN&3T&>M '1ON",4 +8X!. 3]:YK
MP=X<N?#UE<PWIM9I9+R:Y26('*B5RQ7D=L]>_M6K?:]IFG&-;BZ&^2,S(D:-
M(QC&,OA03M&1\W3D5#/XJT&VM[*XFU>S2&^ -LYE&)01G(]L=^@H UMHSG S
M37BCD96>-69#E21DJ?:L6+QEX?N+.&[M]22>*97>/R4:1BJ'#MM4%@ >"2,"
MJ^L>-])TJWT>=)OM,>JW$<5O)""Z%6Y+9 /0 X'4G\< '2D9&#TI,#&,#'I6
M'!?V5UXO\J#72\PL-S:6NW"J7!\YN-P;D+@GH>E3MXFT9+M+9K^-7DF,",0?
M+:7_ )YA\;2^1C;G.>U &H\<<D9C=%9#U5AD'\*545<[5 SR<#K6+>^+_#VG
M7%S;W6K6R3VRAIHPVYDSG (&3G@\=>*T[&^M=3L8;VRGCN+6= \<L9RK ]Q0
M!*D4<6?+14W')VC&3ZT^LS4/$&E:4[I>78C:-!)* C/Y2'HS[0=B\'EL#@^E
M8OC;Q8FB:'9S6=POF7]S!#%,B[P(Y'4,ZD @X4DCWQUH ZVBL;0;.XMS=SG6
M+B_L;EEDM8[B/#P#'S#=P6!/(R./>MF@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ KA/BW);KX(\NX:,![ZU^5R/F F0MQWP 2?:N[HH \[\<7UMHWB3
MPYKEX9QH&RXAN+JT9@(7D$921BG)4A",^]9VHW_AK3-&CU?2+'S+&_UJ!Y-4
MN_-DBCEYS<X8Y(7 4-P"Q]N?52,C!Z48XQ0!XU'-I%SJ?CZVU+4KW[+<RZ<Z
MWH3RY%&$"S A0H"OM.<8('>DU=O$VI>%/%.D^?;:[):Q6LD>I6485KN$2%FA
M<+D%PH8X7J&]Z]FH  & ,"@#SW6+NS\6>(O!EYH%U'<26MVUS-)$V3!;F,AU
M?'W2QVKM/.<^AKFVN;%_ 'Q0 E@+S:E>%,,,OE%V8]<G./?.*]E  Z #-+0!
MY>^NV+:_9V9D6SEFT&/R[Z*+S)KP9/[F,X(P#DD %CGC&,UA:-=6H\(?#&\N
M&"V=C=LES-*A$<+>4X&YB,#YB!GIFO;:, C':@#S&]A@EU_QGXALGC72I-#%
MK)<*1Y=Q< .<J>C84JN1W..H-9;:C%IGAKX<ZS=M<'1+2P^SWTUJ[YMI&AC5
M6;9R "K*?3/X5[%THZC!H Y?P<F@2G4=3\/QS/!>R*\MY))(PN9 ""5WGD 8
M&1P3QVKFO$^K6I\3^(]+8?V?<MI"[)(X=\^H@K)\J\'Y4S@X&>>H KTWH,"B
M@#Q^P>VO?"_@Z?3O$?\ 8FMVVCA+>XG4?9YE"QB2)PV >57IR,$C..++7,NK
MZ9X=U%M4B\+>)!:3M 2 ;69/, ="K=5;:CCN <C.*]6(!&" 100",$9H \FF
MUIQ_PKOQ%K=O#ID$=Q=I<NN1#&SQNJ,">BN1D9[,*HZCJ5I<:9\5RKD"=4,6
M]"N_-LH&,CJ3T'4U[00#U&:* /.]>U73=-\)>%+D06AMI+FV1;YTW161$9Q)
MQW'*C/ +<],'FWOK5=,^*L#7<LKS0;XY)X]C2AK4*I^Z!R>F ,]LU[110!Y=
M-=V*:Q\+C'/;A4CE'RL,*#:E?PRV!]>*@\,:WI$.B77@[Q)9FXUR&_F9K"6!
MG-XS3-(DB\$$'(^8\#&3@5ZQ1@9SCGUH \GGU/1=+\5^*-&\82WMNNIW'G6K
M*\PBNX&B2,Q@)U8;2,=>:](T:"VT_0+*""W>SM8+=52&9R6B0#A6))Y ZY-:
M! .,CI10!Y+X=MFU7X2>*+32/+?4)+C4-@C(WDN[[?\ OI< 'TQ6AX;U7PEX
MJO\ 1I[6._GUJPRWV>:6?-@2NV3?N.T#C;COQ^'I5-9-R,H)0L,;EZCWH \0
MBU3P^=$N?"5[XBLK*UCUIYA+=%X[E56X,A4J5V[BP(#;ONG) /%=)XDUFSE\
M2Z_IX9;*:31T,4T,7F3:DI5R%0X(V+GG R=V<@"MW2_#?B73K&/2G\06,^G1
MJ4$LFG$W)4^K&386Y^\5.3R0:ZJTM(;&R@M+=-D,$:Q1KUPJC 'Y"@#R#3-0
MT^:+X2>9/%B"%E?S.-K"UVCK_MX /J,=1706VKVOAOXK:^FN2I9V^H6MK_9<
MTORQLD:L'C5N@;>Q.WJ<UZ+00#U'2@#PM+RU'P2CBWA&77 0CJ5./MN_@'T7
MGV%=JMY8M\;I93<6Y"^'44/O& ?/9B,^NTY^G-=_THH \2M9K,?"&"X-X(3I
M^OFXB8*7C5A=LR>8%Y$9!SGZ$ \ ];X1U;0]=\;ZGK%KKFGSWUQ:10"RM92V
MV.,DER652QRV.G 'O72^(]&OM6CLI-.U/[#=6=QYZ;X?-BD.TKM=,@D<Y&",
M'!["DL-(U%[R"]UN\L[FXM]Q@6TM3"J$@J22SLQ."1U Y/!X( ,/XERI:P^&
M+R8[+:VU^VDGE(^6--KC<WH,D<^]5K'4+"7XR:E<>?"%_L. *SD*1^\=F'/(
M(!!([=Z]!HH \*T>_33? W@O5K@W#:/I]]>I?FU9M]MYCR".0A.0 #^3>]>E
M^#QX>NKG4]6\/+/+'>F,SWTDDC+<.H(&W>>=HP"1QSCJ#CJJ ,# Z4 <#?S6
M;?&W3(YG@+#19HPKD'#M*A"_4KNX[C-8DFHZ)I?B;Q1H?B^2]MUU*Y,UKM>8
M17<#Q(FQ1'U8;=N.O:O6:" <9'2@#S:/[%8?$GPC90I]DBAT6>%+>63<\0)C
MV(Q))W8![]C61'JEG:^&/B1.;.'5(QK$DAM3\RNA6)=Y Y*@@DX_NFO8** /
M+]'U*VN?BU'/'J3Z@MWX?V17"P[8Y&$^2(\#&T#W..03FL&S@M=7^!FF^&+3
MRFU_?''':K@36\PFRSLO5-JY))QQ]:]NI,#.<<T <)IUY:I\9->S<1#&E6X)
M+@<JTA;\@03Z5QWVJW?]G+5XA-&9#)<J$W#)9KEF48]2.1[5[;10!Y]JNH6M
MM\3/"U_)*/LL^F7,,4J@LLCDQD*,9R2 <"H=<L-0TGQM/9Z;$_V'Q9&(YFCX
M^S3H ))/;=#N^K(*]'K T?1-3M]2DO\ 6M774IDWQVH2V$*PQLP)& 3N;Y5&
M?0>YR ;D<20P+%"JHB*%10.% & *\>L)XC\&M7\*:G@^(XEN;=[)_P#737#R
M,T;JO5@Q96##CJ<\5[)28&<XY]: /-]2F73O&_P[M=1O8C=6UK=)<NT@X<P(
M,D]MQ!QGK7HTTT5O"TLTB1QH,L[L  /<FGT4 >+V-W;-^S3=PB>,RBUN$,>X
M;@S3.5&.N3U%=!=7EC-\1O SBXMW TZZPVX'!98POXG#8^AKTBB@#QI-8L;'
MP[XTF:WMKV$^)]Y$@+QQ*QBQ.RKR55@3QU(QFK=GJ=DOC/Q;(^I/=1W.APO'
M<RQ[5E $N2I"A=O( /0YQDFO6J* /&H[JRA\ ?"]1- C1:G9F0!@"F(W#D^G
M)&?<\U?T77-'L?\ A(O"GBJV:6_GU.>9+22!I/M\<C[HV08PW8>VT=,<>K48
M&<XYH \_FNX8?C/;YV"5?#DB>2C G?YRL$'O@' ].:X^WURPNK7P->12"VA@
MU?;)IUM ?+L<I*!&3MW&3/J>>2% KW"B@#A/#%U _P 5/&Z+-&69;': PR=L
M3!L>N"0#Z4WQ]<6D?BGP2+F6%0FIM(1(1\H\IP&.>@W8Y]<5WM% 'FFOZG8>
M&?B/+<:_+=6>DW^GQ16EY"\B11R(\A:-MG0G>#S5#4(-!TBY\!&RMC9Z,-4N
M)(OM1;HT;D.=_*@M\PSTX/%>M$ ]1FN<\0>'[S5]>T+4;>Y@BCTJ=YS'(A8R
MED*$9!XX/O0!YWXNTB\U>[\;:GX;C\^VFL;2.7R.5NY4DWR*I'WB(QM./7'7
M-=)K%Y9^+=>\&7?A^YCGFMKPW4SQ-DP6_ED.KX^Z6.U=IYS]#7H8  P!@4@
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MR2]"S3QM)!YD;HLZKR6C9@%< <_*3QSTKA)XKFYUSXE:1;),FHZG;1M9CRV
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MPVQ1[M I#RA, M@E3D]=N>@!(!W5EXBTJ_>\CANPLED ;F.=&A>$$9#,K@$
MCG/2FVOB;2+R]BLXKIA<31F6%)(7C\Y!U:,L ''?Y<\5Q7BF:U\;^"?$4WA&
MT,]U<6B(]ZMNT37 5PWD@LH+_*&'H-P'?B;6+NV\97/@V31'#7-MJ4=Y.%&&
MM851O,20?P$DA=IQD_2@#K/^$KT3^R[W4OMI^R6,K074GDO^Y=<;@PVY&,C/
M%)=^+M!L;N.UN-2B2XD@^T)$ 2S)QR !U.1@=3G@5YE?W\-CX7^)>B3K,-2G
MO;NXBMQ$Q+Q/&FUP<8V\'G_$5NV]U;R?$/PC*3M":),A,B%"C'R\ Y P2 V
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MRZ%U?3JB2S"(1KM7.U54$X +,>23\QYZ8T:** "BBB@ HHHH **** "BBB@
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M=HD0HRD$J05/0@@C\*T*@M+2&QMEMX%VQKD\G))))))/4DDDGN34] !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQ;3Y7@K@';]X=^1U/8 [.BL'Q)?7MG)IRP7,-I:33,EU.<-*!M)58D(.YF;
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M1&E!RRKQP ,X Z<5//X/N=0FTW^U=1@NH].OQ>V\@M2LXPQ94W[S\HR >.0
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MMQ% T:KY1D;<PW#EN3QTH JS:Q=:IXWN_#MG=O91V-DEQ--$B-([R,0JC>&
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ML>\3>7M+*"%RN\]P#@=.M=#-X1D?6= U!-3;.D><0)8M[3M*N'9V!&">2,
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M.0Q@*Y7=M..N.]>1KXE\9Q_#&R\='6XIC;GS+G3_ +(@2>+S2C9;&0V.F,#
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M2:\T;4($AGCF7:01M094\C() R* /3*R?$GB&S\+:)-JU^EP]M#C<((][<D
M>PY(Y)%<_:S^*TU;2KP&XGTN6-CJ*W7V=50%<J\/EDMU[,3QCOS7)^*]0U'Q
M1\%+_P 1MJ$D,5WB1+)8T,:PB<*JD[=Q; !)W=>V.* /8J*K7UXFGZ;<WLH)
MCMX6E8#J0H)/\J\]OO$VNV7PXL_':W_FDK%=W&G>6GDF&1@"BG;O#*&'S%CD
M@Y'.  >ET5P0N_$&K>.=>T:WUUK.TAL[>>!H[6-GC+[^/F!!^Z,Y!]L=:VO
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<(PQG. >!D9/09ZTNI>,;'3O$NEZ*4FDDOHWF\Q(7= BCC!4'))(Z=!UQD4
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M*UMI?)F,JLCQR?W&0C<&]L9J[I>O:7K4EVFFWD=RUI+Y4^S/R-C..>O'<<4
M:-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,=7#%Q@CICMBK^EP_P!G_$;PO8ZC-')>6WAHVLSL0?WVZ/C/J0&/J1FO3J*
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MTQ^=?2O*?M+*"!CS#D[1@9'!SCM7544 <'-+:GXX0B1HR?[ :(;L<.9P=O\
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M0K@M,GE(!CU!(8 ],YKF=/U>UNK_ .'M_&\BQ13RQR6EO:,L-DS0,!"H"Y+
M\<DDXSP#7M5% 'D:W%HV@_%0>9$6GFN/+Y&9 ;=57'K\V0,=ZM1WL-KKGPXO
MY2YMO[*GMS(B,X\TQQ83@'YB5(QZ@UZE10!D>*5L9/"NJ1ZDDKV+VSK.L6=^
MPC!VX[XKEO!ESJ<'B6;2Y-6@\0:6ED);?5 J^=%\X AE9>&)'S ]>#FO0**
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M.,X^;'IS3?!6OV%[H>A>'KO19_[<TI8H9+6>S;%LT8V&82%=HX!((.3G ZT
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M*($+D@DEB<!0!R220 !R37!V^L6>K?%W3+^P\^>T?1)8A.MM)LW&5& )*\<
M]>AXZU<^(K75G/X:U@037&G:;J0FO4A0NR(491)M')"EL\>M $%CXDW?$[6$
M:^OVTVVTB.=[:6!U\ES(02(]H8_*%.<'KUKI_P#A*M%^R:7="\S;ZHZ1V<HB
M?;*S?=&<<$^^.E<?;WT&L?%#4I[!9YH+GPZD44XMW$;-YLAQN(QWZ_AVKF[7
M4XY/ O@&P2WO6NM-U>S6]C%I)F IO# _+R>^!GB@#TJ?QWX:MM0EL9=347,4
M\=NZ+$[;9'^Z#A<8/'/09&3R*K6?B7P_IMCKFJR>(+BXLX+YEN'N-S+;/M7,
M48"YVC@X&>2>:H^%I8F^)?C9QQY[69B<J0) L.&VGO@\''0UR>HN)/!/Q-A1
M6:2YU*5K= I)F!2, H/X@2IY'H: /3+'Q9HFHZN=*M;W?>>49E0Q.JR(#@E&
M("OC/.TG%-N_&&A6(D:YOMD44_V:2?RG,2R_W"X&W/;&>O'7BN:U&>"3XA>!
M986#1):7:NZCY4W1QA03VR00 >XKD7U#04TG5_"FHZK+8Z<^L23,9K&?SD19
M][*&"E.74X?/"GD9H ]H6[A>Q%XA:2 Q^8I1&8LN,\*!DGVQFO-?$/C6;7/A
M5>Z[I4U_ILT5RJJ1$T>4^T^4/F(P25Y(4\$X->FP3Q75O'<02++#*H>-T.0R
MD9!![@BO%))"OP(OM%>WN1?V]X4D@:!P=WVW?@9'S?+\W&<#K0!ZOIWBC1M5
MU6?3+.\\R\AC\UHVB=-T><;T+ !USQE2137\6:+'>V]K)=LC7$QMX96A<0R2
MC(V++C86R",9Z@CJ*YS4)4G^+6F/;RC:^BW$0F3E0[.A49'&2 2!7.>%)M(N
M=&TWPMK>D:K)X@TYTC-E*UP8M\9PLP;/EA,?-G\@>,@'J>K:O8:'ILVHZE<+
M;VD(R\A!.!]!DFL^T\8Z!?"\-M?A_LAC$O[IQS)]P+Q\Y;H N>>*I_$CGX<Z
M_$H+22V<D<:*,EV(P !W-8?BLS#P9X8U2RMKF[M--N8+BZ@LRRR^2(F1BH4@
MY4MG''3VH ["Q\2:3J!OEANMCV'-U'<1M"\(QD%E< A2.0>E5U\9:$US:6YO
M&CEO%#VPE@D3SU/="5 8<CIZCU%<JR^&-?\ #_B/4M-LM3E@N-,DANKYEF\V
M4!21'&)>6(&?;.!SDXS?#^OZ'JNM^%&U'6HDOM*@:WMXA:3P^?+(BQ_,TB@#
M@8"@G)/7H* .UTW5](2\\0W::Y/<I;RJ;J.9B8[0A!\J?*."!GC/)J6]\7Z9
M9:?J5VR7K'3K<7$\/V.59-AW;2 RC(.QN>@P<D8KC(QI]Q?_ !&CU&*>6PN;
MBW#>2&WLGE(C/'@9;:WIGD4ELFM-IGBK15U'_A(; Z*_V/41&/.WLK@6[LO#
ML.OKSSU% '5V?CO1SHNDWNI7!LI=01-D<L$BY<H&(7*\KUPW0XX-6(/&N@W=
MK;W%K=RSBX222..*UE>0I&VUV*!=P ;C) YKA;F_MKOP]\-]JRXM;^U\[S(6
M7R]D#*S$$<*&(&[IGOQ71:]JB6_Q L[.>WFM89=.8I?VUJ9)IV,G-NKA3M&!
MN..3D8(QR ;<WC+P[!8Z=>R:K"MMJ+!;67G;(3^''0]<8P?2HT\;:)/IVJWE
MM-<3C2UW74*VL@E3C(^1E#8('!QCOG ->8Z3(%^'OP^M989XY;/7HVG26%E,
M:JTV6.1]T;ERW3GK732J;GQOXZC@4NUSH\,46T<2.J2@JIZ$C<./>@#6EU'4
M/&'P\M[_ $>ZO=,U"XAAF4Q6YSO*AM@\P %"3C<.,=ZVKKQ%8:3$Z:A<.TMM
M"KW3PV\DBQY'5BJD+G!//;FJ'P[NX[GP#H<:),KVUC!;RB6)DQ(D:AA\P&<$
M8R.*Y?Q@CVVM:SJ>@ZI)9ZS%&BSZ9<1^;!JRB,%55#R6()3Y>>.<9S0!Z;--
M';PO-*P6- 69CV%<W'\0O"TL=E*FJJ8+U_+AF,,@C+Y("L^W:I)!P&(SUZ5T
M$<Y6Q2XNE6!O+#RJ6X0XR1GVKQJ$!?@3HEHT;"X34(B\!C.]<7>XDKC(^7GZ
M&@#U32_%&CZQJ-QI]E=E[J!!(\;Q/&2A. Z[@-RY_B7(IH\6Z(;BWB^V$"YE
M,$$S0N(99.1M64C83D$  \X.*Y/6E>_^)\T=C.$DN/#$]M#<+]U96D!0;AQG
M'S8ZXYK%F4ZY\&[+PE#!)#XBB6VLS:,A$D$D<B9E/H@"EM_0@]<F@#TN\\2:
M78S313S2Y@94F:.WD=8V;&U695(4D,IP3W'J*HVGB^WO/&>H>'DMKI6LXHF:
M4VTFUG<OWQ@+A1AC@$DXSBN-\2B?3]:UC4_#FH2)J@FC2[T.ZCWPZG\B &-2
M,ABI ++D?+SCK6YI\ILOB]KBW$,Z_;[&T^SL(F97V>8'^8# QD=30!T^LZ_I
M?A^"&;5+Q+:.:58HV8$Y8G ' ]^O2JMKXOT2^M&N;6Z>91.]L$2WD,C2*,L
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M><1S3*&SN$BY (SE<@' - '?T5D2^)=-BN3"6G8"Y6T:5(':-9F( 0L!@'+
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M"K@G&><9XH Z6BL./Q?HTE_:6GGRHUZ";222!UCN,#)V.1AN.1SR.1FJD'Q
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MNFVUQ)"[3MY<Z6TDD<#NB2N5"J6 P#\R^PR,XK0O+N"PLYKNY8K!"I=V"EB
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M5R=@& 2,<G.!UJQH&J?V&=9\*ZYHE[=W<NHW$]JHM&EBOHY7+J2^"HP3SN(
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M1NQC.!G%>AT4 >.Z5?7.F>%+%6TZX6)O$-PT]R;!I9;.-GD9)40J2"<@!L'
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M6T<UHYAN'0.'49&'QN' //04:0TLGQ&T34X[/6YK>;298'N;NU>,"4O&2"I
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MXN6*P01+N>0@9.!Z =2< =S7,>%5E7Q_XTEDM;J**YGMF@EEMW1)0D(5BK$
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M/>G44 8OA_P^=$BD:XU.[U.]E"K)=W9&\HN=J@   #<Q]<DY-;5%% !1110
M4444 %1SPK<0/$S.JN,$HQ4X]B.1^%244 ,AACMX(X(8UCBC4(B*,!5 P !Z
M4^BB@ HHHH **** *.M:3;Z[HUWI=T\J0749C=H7VN ?0UEV?AN_7;'JGB.^
MU*U4@B"2&&,/@Y&\H@+=!QD ]\CBNBHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH P;OPX]UXOL/$'V[8UG"\"0>5D,KX+9.<Y^4
M8]/0UO444 %%%% !1110!B:_X>.M2V-S!J=WIU[8NSP3V^UA\PVL&1@588]1
MD=C4FGZ+/;R>??ZK<ZA=A&C261(XQ$#C.U44#)P.3D\>G%:]% $-K:PV5NL%
MNFR,$G&2222222>22222>I-3444 %%%% !1110 4444 %%%% !1110 4444
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M=YX8UD6:+.=KHW!P22#[_3&]IEA_9MBEN;B6YDR6DGF(WRN>K'  _   # '
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M(U"[<QG(P<8Z@C@<>N??> -NI6>I>'];N]%O+>T2R=HXUF6>%/NAE?@L.S4
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M(K=Y(W9-P!"D]._2O/4U[Q3%H/@G6CK4<C:S+;6MQ;/:)Y>98R?,R,-N!&<
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M2E55FW8R>%''0>] &5XKU'6[?Q?X9TO3-1CM;?4VN8YLVZN1LB+!@3W'4#U
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M$3;#RLS#=D*#DX]<>@%7]7UJ^F\6'P_8B\3RK 7<LEF(#(2[LBC]\=N!M).
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M+9X@B!5-K+M/')PV-Q].E $/A.'46\1>-F&LW3O%?"./SDC91^Y0@D!0>,X
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M\I!Z')XZFK>C?\)#JVF>'=>AUF/;=K'<7UK)&OE&*1-VR/"[@RD@ D\\Y]*
M.EL]1-W?7UK]BNX/LCJGFS1[8YLJ&S&<_,!G!Z<U;=MB,V"=H)PHR3]*X"+6
M]<\WQY -7M4DTV2-;.XO55(K<-$');:.0-QZYZ"K&@ZW?M\0I=&:ZO;C3I-(
M6]C:]B5'WB782H 4A2.S <CCB@#I/#OB"T\3:5_:-G'/'#YTD.V=0K;D8J>
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M C7[\:I@[L9_B/&<5R^E:W=^%/!WCG7WO;F^DL]7NXHXK@J59]Z(C,0H;T!
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MV_=R%!)(P0>3DFMGQ+K,]GJV@Z-;2_9Y-6N7C:XP"8TCC+MM!!&XX &0>IH
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M<&A'5T66-$:-D=E9%**/E( ZY(]: /0**X33Y_%EU/H.IVTDTMI<A6U".Y:
M0F-U!#1;,L""> 2<CKDU?^)6IZCHO@'4]3TJ\-K=VRJRN$5LY<*1A@1T- '6
M45P^HWFM:+J^GZ7+JMQ?RZS<R,ACAAC:WCCBW,D>[@Y..6R0,]3S534-3\8^
M'?"WB>[FC:Y%MLDTR28(\ZQL0)/,6/Y3LY8>H'- 'H=4M-U'^THIW-E=VOE3
MO!MNH]A?:<;UY.5/4'O7)6M_J<_C^VT[3M<EO-';3?M<S[(I-K[@JY<+P'!)
MQ_LG'%4+#Q!XDD\&ZQ=H;G4KNSUN:V?[/$GG?9HY0K>6N-I;:#CB@#T=W2.-
MI)&"HH)9F.  .YIP((R.E>2^)=:CUSX2>*+W3?$5U<Q(<!658IH!A5:&0;0>
MNX^I!QDCKN:Y-KMIXH\*Z-9:_<1P:C'=+-))!$SC9%N5AA ,C/'&.!D'N =]
M17G6MW>NZ3:ZE;OXBEN;FQTD2P?8X$\TRJ'+2S@J453M&!D9 ; )I)==UV_U
M'P"MOJ?V2/7+*26Z1($8!A;A\KD9!RQQVX&0>A /1))$BC:21U1$!9F8X  Z
MDFLK7/$ECX>>Q%\MSMO)Q DD4)=48]"Y'W1DCFO,?$^H:O-\.O'FG7>KW,[Z
M3=B&.Y"HCRQ.(SL?:H!^^0< 9^G%>KG3$EM88+NXGNQ%()-TI4%V!RNX(%!P
M<8&.PH O51UC58=$T>[U.YCFD@M8FED6%-S;5&20/H*XF3Q1=0>+GTC5[^\T
MBZDU!18>9"IM+RWW+\BOM/SE<YR0=Q !QQ73^-?^1#\1?]@RY_\ 134 :FG7
ML>IZ9:7\*NL5U"DR!QA@K*",X[\U9KRN&[\0^&M'\&:JNLF[T^\:RL;C3FMT
M5$25 JLC ;MRG&<DY]AQ6K:ZOK'B70=?UC3]4DLI;*ZN(;*!8T:/$/'[P,I)
MWD'/(P",<C) ._HK@+/Q)?\ B*TT&]6]:SAU#3&G-E9*&NGGRHW#<I B7GYB
M0,D9-9$7BKQ'?^!_!&IQZDL%YJ>IQV5V1 A6129 6QC@_NP<#'4T >JDX!/I
MZ5DZ!XAM/$45]):17$0LKR2SE6= I\Q,;L#)XYKG;&YU5O%@\)3Z[<3_ &2R
M-]<7HACCEEWR%8X^%V@* <D#)..G(+?AA'+#:^)XIIVGE3Q#=JTK* 7/R<D#
M R?;B@#NZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "LKQ)HB^(] N](DN9+>&[C,4KQJ
M"VT]0,\"M6B@#FM2\)-JECHUK-J<J_V5<Q743K$N9'C&%W=L<G.,?A4D'AA[
M;Q!J^L1ZE)Y^IQ1Q2(8E*QB,$*5[Y^8]<YKH:YVX\70QW3QVVFW]];Q7HL;B
MXM45UAE..JYW%1N ) ./P- &5:?#F/3[;0([+6[Z"?15EBMYU2,L\4F-RL&4
MJ>@P<4C_  V@;1-1TD:S?_9KW4/M[;@C,C^8), XY^8 DG/3MSGN*YZR\61:
MA#KK6VFWS3:/*T,EOM7S)G"!\( V#D$8R10 LOA=;CQ3'KT]XTDBV+6#VYB7
MRWC9@S9[Y)'KTXK/T#P&- DCMXM=U*?1[>3S+;392A2(YR 7QO8 \@$XX'6N
MKMIC<6L,S120F1%<Q2##)D9P<=QTJ6@#C;WX>VVH0^(XKG4KDKKKQR3;%53$
M\>W84..VU>#G.*M6G@Z2W\20Z]-KM]<WZ61LY#(D825=VX955&,'G QGN>N>
MHIDDL<*AI75%+*H+'')( 'U)('XT 8_A?PZOAC3)+".\EN8VGDG#2JH8,[%F
MZ=LDTU?#>WQHWB7[=+YK68LC;[%V>6&+CGKG)/.?PK=HH X^Y\!8\0W>JZ5K
MVI:4E^P:^MK8H4F8#&X;@=C$=2.?I60\07XSK!IU]':"#P\ENH*B1"1,Q\LC
M(.X+@X!S^%>CT4 <K<^ M,N-#6P,UPERE[_:*WZD><+K=N\WICVQC&.*NQ>'
M6^W3ZE=7S3ZG):_9$N/*"K#'G)"IZDX)))Z#L,5I?VC"VIG3X@TDZ())MO2)
M3G;N/J<' Z\9Z5;H YFR\%VMKX#D\(RW<\]BUN]L)2%614;/<#&1GTJ.;P8]
MQ#H:SZU=RR:1.+B.1XTS(X4H P  QM)&!CUSFNJHH YV'PLUOK>MZK'J4HEU
M>...5#$I6,(I52OO@GKFN/U[2H?#.F^&M ?5]4LK"R$CQZI';"5%(7:L<B[6
M7)#L02 /E]3D>I44 >?:3%J]]INH6T'BC4+[3Y+4K%>QZ>D$L,N1@1850X(S
MDXP..>N.RT2&]MM#L8=2F,UZD*K-(<99L<DXX)]Q5^B@#E5\!V!&O6]Q=7,^
MG:U*\T]D^T(DCA0S*0-V?E!'.!4]GX4,;:9_:6ISZC'I9W6BRHJD-M*AW(^^
MP4D \#DG!/(Z.B@#-\0:+;^(] OM'NV=(+N(Q.T9PRY[C/<5E-X0DDU/0M1G
MUFZGN=($FQI(T_>F1=C;@  /EX&,>O)KIZ* .1D^']C=V_B"VU"ZFN8-<E6:
M==H0Q.H 5D(Z8VJ><\BKOA[PS<Z.XDU#7[_6)8T\N!KO:!$O?A0-S' RS9/T
MR<]#10!A>(/#G]O76E3F^EMCIMT+N(1HIW. 0-V>V&/ Q53Q%X-76M6M-9LM
M5N])U>VC,(NK4*=\1.2CJP(89Y'O7455U+4;72-,N=1OI1%:VT;2RN1G"@9/
MU^E ' >+[:+2_P"Q+"XU;5K.%7EN9=8$(G#S;=H64;"N6#$C(  7 [8O:#;:
MGJEI?6/_  D=QJ>DW%JT2W4NGI 8G/&(\*H<;2V3@@$#D\BNCTW79+[5)[";
M2-0LGCB69)9T4QR*W& ZDC<#U4\_A6Q0!S=CX6N-+LM'M['6)D_LNV:U3S(5
M99HSL W@8Y&P8(([U5E\ 6/]AZ=IUK>7-I)87_\ :,5Q$J;O.)8L=I!7!WMQ
MC X]*ZZB@# L?#'V+Q5<:]_:,\LEQ;1VKQ2(NTHF2IR!G=DG)[YZ5B3_  TA
MFTZ]TY==U&.QGOOMT4*B,B"7S!(<$KEAN' )QSW/-=;JM_)IME]HCL;J];S$
M3R;907PS ;L$C@9R?85=H YZV\+O:>);K7$U.9[BXM4M662-2 J9*GC!W9))
M['/2LR#X=P6_AW2-)AU>\1M)O/MEI=!(_,5B7)!!4J1\[=O2NTHH 8L>V 1%
MV;"[=S')/'4^]<[9^$?+N='FO]1DOVT=6%H\D2J^6382[#[WR^@'J<FNBDEC
MA4-(ZH"P4%CC))P!]2:R;+Q';WOB;4=!6VN([BQBCE=Y H1U<D#;@D_PGJ!0
M SQ-X;3Q';V0%[/97-C=)=V\\(4E74$<A@01ACP:SHO 5J)O$#7.IWUU'KL
MBNHY"@Y\ORRX(48..W0>G3'6T4 <;;> Y$N]"NKKQ#J%S/HV\6[%(E!4ILVD
M!<'Y>IZGU%5IOAG%_96JZ+::Y?6NBZBS.;%4C81,QRP1B,A2>=O_ -?/=T4
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MW,.JZ>&2*]0)N=&X9'7;M93]!@\C%5]0\#6.I:%JFF3WEV&U6027MTFP2RD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>elicio10-qxexhibit312002.jpg
<TEXT>
begin 644 elicio10-qxexhibit312002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$MR%)2WF63?AR/NA@>I[C% &W-XU\/0:$=:DU "P63R7?RGW))G;L9<;E;)
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M.OR[A\C '!'()XQ]*71?%D%_X7TO5;J*:*>]AB*P+ ^Z21HPY$8(RPQDY'&
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MQJ5C(@6)(P<9(49.3CJ2?;&3G$^'%Q<SZ9K2W-U<7)AUN\A1YY"[!%?"C)[
M"NAOM:M+"Z2T833W;QF46]O&9'V X+$#H,\<]3P,T :-%<[/XXT"#0X-9:[D
M:PFE\@2QV\C;),[=K@#*'/&& YK5EU2VAU&WL'\T3SQ/,@\MBH5<;B6QA<;E
MZ^M %VBL%/&&CO?65J9)H_MV?L<TD#+%<$#.$;&"2.1ZCIFH+/QYH6H:BMC:
MRW4DQNGLS_HDH"2J,D.2OR]^N,X/I0!TM%<E\1O$$_A[PG--:><MS-)%"DL<
M3-Y8:1%8Y P#ACC/?I5&WM]'L/&FEM_;/B&.?4#(]IIMQ)-Y!98V\PL''H,[
M2>N"!S0!W=%<I<?$7P[;QWTAFO'6PF,5WY=E,Q@( )9QMRJC/4\=<9Q6I=^)
M-.M;B"W5I;FXG@-U'#;1F1C",9?CMR![YXS0!KT5SLWCGP]#IVEZ@U\QM-4=
M8[240N5=CG@G'RG@\'!X-6-)\4Z5K$E_'!)-#+IY'VF.[@>!XU()5B' .T@$
MY]J -JBL*W\7:1<ZC9V(DFCEOXVDLVEA9%N5498H2.< @^XY&15'2?$&@6>E
M:YJB:I>R6D&HR+<M>"0F*8[08D5AN"@E0% ZGB@#JZ*R+/6['6;F^TN-KB"\
MMD4SPR*T4B*X.U@?0X/(/&.U8WPMN[F^^&^D7-Y<S7-Q(LI>:9R[L?-<<D\F
M@#L**YK4/'F@Z;J-WI\\MTUU:",S116<KE0YP&X7E?\ :''(YR14^H^,-'TK
M>]W+,MM%,()KM86:&*0D##.!@<D GH#P2* -ZBN6O_B%X>TZYU"VDFNI+BPV
M_:8H;.5V0,"=V OW0!DMTY'/(K27Q/I$NF6.H6]T+B'4,"T$*EFG."<*HYX
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M"T8G4)'PI8 $-L9?QK:U:1O&G_")"RM;J"YL]3AOKL30/&;58U;>C%@.22%
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M.@DW)R,/PP^4'GI46E3/)\0?#NII;:S/!)I<T$EQ<6<D:K(6C.W9@",  ]
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MBJ)[BYDMX[*TE6)I'D"$^9NV+SC..@%<Y!X>U#0=$\!:?+97,DMIJS7=TMM
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MVU 1Y@63=MP6ZXW?+NQMSWK?EE6*%I6#%5&X[%+$CV R3^%>46-CJ,?PDO/
MUUIEV=:CCELH_P#1W,,VYR4F$F-NW!!))R,'C.*]/LH/[,TBVMY'>7[- L;.
M%+,VU0,X'))Q0!@:9\0M!U:-)[9KL6C0RSFZDM72%5C;#!G(P#QG'7!'?BK]
MMXIL)]:CTB:.ZM+R:$SVZ746SST'4J?4<94X8>E<+H^AZKJ'P(FT.&SN+;55
M68K!=0M$6;SVD5?F X88'IS6AIC6?BF$I;^#[K2=26VFCDNKZS\K[*SQE2(W
M/+$DC[O&W.<< @'2+XTT@W5A&6G6#493!9W;1_N9Y.?E4]><'!( /8FG7WC#
M3+!+R9Q<R6EC)Y5W=0Q%XX&XR&(Y.,C.T''?%<YX)UF_&BZ3X;OO#6H0ZGIJ
M1VTTDUOBV58QM\U9>C94<!><GTR:IZ/%>Z)X:\3>&=0TZ]GNY9[MK1X[=Y$O
M$FR5.\#:#EB&W$8ZGB@#JM3\<Z+I=^EDYN[BXDM3=Q):VKR^;&,<H0,-USQG
M !)Q3K[Q)83VD\$4=_,PM%N)Q;(RR6\;C*EN0RMC)VCYN.E<KH>CWFA>,?"=
MG/;W<R6.@-93726[M$LI:,A=^,8^4]^U6=,GO/#7C3Q1;ZAIVH3PZK.MW97=
MM;/,C_NPAC8J#L(V@#=@8[B@#5^%]Q/=_#30KBYFDFFDM]SR2,69CN/))Y-=
M#J^K6FAZ5<:G?-(MK;H9)&CB:0A1U.%!./>N$\$:XWA?X?\ A2PU/1]6CEG8
M6CD6AQ;L6PK29P54E@ :Z;Q__P D[\2?]@RX_P#1;4 06?Q!T*\U>RTY6NXG
MODW6DTULZ17!QDJCD88CVX]":=:>/=&OM2-C:IJ$LJ7ALI"+*0+%(%!^<D?*
M.<9..A[#-<Y);GQ1I'@:UL[:Y5["YM;ZXEEMWC6%(HSD;B "6)  &<YST&:M
M^%+*ZN(_'%F\%Y9O?ZG<26\T]M)&&1XD174L!GD'\J -UO&ND(MM.[3K87,W
MD0WYC_<.Y. -W4 D8#$!3V-6-5\46&DF[#I<7!LH?/N_L\>_[/'@G<W([ G
MR<#.*\_:PO\ 5OA#%X(ETR[@UI$BL65[=_*39(O[X28V%=J[L@\GCK6G;WM]
MX0\::_!?:-J>H6&KR17%I<V=L9\L(UC:.3'W3\HQGC% '8/XCL&M[26S\V^-
MW!]I@CM5W,\6 =_. !R.I'7'6J]IXPTG4=/L[JP>6Z-Y(\4,")ME+H"74AL;
M2N#G)';U&>3U]+K2/%VGZ[J'AR>_TNXTQ;.:"QA\][*57+K\HZKAMI(]/H*E
MU+1])O\ 3-/B;0M1T.&6XEN;6YTZ%HY[.3"@/((P=I?YLYSQC.#G !UB>)K.
M6WM7BANGGNI)8HK;R]LI:)BLF0Q  !4\D^GJ*OZ;J,.JV*W<"2HC.Z;94*,K
M(Q1@0>G*FO./[/O-5T/3+;Q/_:JWD%S=&RUNPMWBFB"L DCJH.SS%)R&'.!G
MDYK8T?Q)J>@^'=,'B2TO[N>XO7M5N[>SV_N]Y"33+QY>X8)XSSTS0!V=[>V^
MG6%Q>W<HBMK>-I99&Z*JC)/Y"LM_$]O$MR9[*_A-O;?:G5XADQ=R,$@GVZCT
MY%6?$*Q/X<U%9[%[^%K=UDM(P2TRD'* #G)'%<+HND:K;3:II&G7FH7WA^;2
MI!;_ -IPLDMK,WRK$KN S*1G@_=P/Q .O/BW2Q!HEQNF\C6BBV<GEG#,Z[E!
M_NG )YJK<^/='MY]4MTBU"XGTLK]JBALY&9 5+9Q@<8&<]#VS7#03WMQX<^'
MMHFAZP)=(OK9+T/9.OE%(71NH&X9YW#(]\G%=!IRSQ>*_']Q)8WRPW26_P!G
M<VDF)ML&QMGR_-AN.* -J+Q[H<]QIB1/=-;ZFRI:WGV9Q [L,JF\C&X^GJ".
MH(I+GQYI%O<ZI;)%J%Q<:7M^TQ0V<C,H92V<8Z8&<].1C-<6MI?)\.? -H=,
MU'[38ZE927,0LI2T2QD[RPV\ 9_'M6YI@FB\8^/+J2QOU@NH[;[/(;.7$VR$
MJVWY?FP>.* -B+Q]H4\VF")[IK;4V2.VO/LSB!I&&53>1C<>F/7(/((J34/&
MVD::]\9C.UOI\J0WMS''NCMW;& W.3]Y<X!QGG%<*EI?1_#3P)9MIFH_:K+4
M[.2YA%E*7B6-B79AMX '?OVJ/QC_ &MK.C>,]/DT;53="4&QAM+9E@FA&S$I
M88$CG!RI)(P %X)H [W5_'&D:-JLFF3I?2WJ6INO)@M)'+Q@@?+@?-U[=,'.
M*AM-;T1O$FKW,<VH_;+>PBFNHI4D6-(OF92J,!\QYS@?UK.A>>?XLV6H?V=J
M$=JVA-;^;):.%60S*X5FQ@':">3QT.#Q1%)+9?$SQ%J4FG:A):?V7 B/'9R,
M)60N61#C#'## [YH V9/&6GP:GI^G7%KJ$-UJ#E+:.2V(+8Y)QV '))Z4M[X
MSTG3RDEQ]H6R:X^RF^$68%EW;=I;KC=\N[&W/&:YKPK+.^IR^)=;T_46UW47
M2WAMC8SA+"V+@!-Y3:, EW;.":R?#]LMC8R>$]<\%W%_J,,[K%=/9B2UN4+E
MDD:0\*!D9SSQQD\4 >I:CJ-II.FW&H7TRPVMM&9)9&Z*HZ].M9MGXJL;O4)-
M/:&[M[Q;47BPRPDM)"3C>H7.>>,=>>E'C*;4;?P?JDNE6*7U\L!\JV>/>']?
ME_BP,G'?&*X[26E3XEV6K)IVO26<VB20-=7=L^XR>:C'*G[G /R@*#_"#GD
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M.<W::D#]CC@7+S8&6P#C&,'). .AJ(>,]'&E:G?R/<1KI9*WL#0,98"!GYE
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M,;2,SLA  "@GJ: &/XNT;2?['T]WO6DOK;?:#R))&D54!^]@[FQC@9.33?\
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M@2I7!(8'!Z'J.:\^NI=8L)?&UU8Z/>RFXU.UDC+6#,3"%C5Y(U9<.RX) YY
M."*U?#$4T7Q+U2Z73M76SO-.M_*NKR-_F*L^[<7.5/(^4X/^R!0!+;^-++7O
M FKZEJ]MJ-A8*UQ%(\,;;TC5V3ADR0V!R>@/?%=,=:L;*VTVWB^T7$UU"&MH
M%^>61%4$L23Q@$99B.2.<D5Y];6U_#\)O%&A/I.I"_#7R(@M7(E,DCE-F!\X
M(8<C('<BM)(KW2O%WAWQ%)9WDFFR:)_9EPJ6[L]K)N5PS1@;@"5VDXXQS0!T
MDOCG0X?#]]K,DLXM["1HKN/[.YE@D'560#([<].1SBI++QAI=_K<6DQBZCGG
MA:>W>:W9([A5QN\MB,-C(_#D9%<+KVB7T^A_$35+>QO&&N+#%96JV[F63RXP
MI?9C*[F)Z@<+GO6Y?B>?QSX'NH[*^,%O;W2SR?9) L1>- H8[?ER5/6@#K=+
MU>WU9KT6\=PGV.Y>UD\Z(IN9<9*Y^\O/!%0ZCXAM-/U!-/$=Q=7S0-<_9[=
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MPM,\.?V;XEU;6A>O+)J@B$T3( J^6I5=O?H><YS6[10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 06]G#:M
M*T2G?,^^1V))8XQR3[  #H*GHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ@'(8,<G/7J:H:GJ5]I'Q AMK[5IH]%U.PF,'RQ@6]Q%AF^;;G'EY(R3RI_
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M%V@BE5 L%PH#D%MH."F<9/4&F7.M:I:6NA6QGN'N==O)&4MY:O!"$>18UR
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MB]U_X2>%=3U&027DVK68E<*%W%;G;G X!.WM7J]PCR6\B1S-"[*0LB@$J?4
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ME'&-K*0!V!XR"*V=*T6'2Y[VZ\QY[V^=9+FXD !?:NU0 . H P!]>I)-:=%
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M:A/>R,=/_L[S^!A%9"8FW!E53\I(&<=LGO=,TW59_P"R+_4M4NEN+:&1)[9
MJ1W!;A6D49PP !P#@$G'%;]% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOFC:6*"/9+&96"':RMCY-OTI?%/Q#OO"'PVT&\5S?Z[J\$7DM.J@!BBL[$*
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MHYI8H98X85\L+&C @;,$Y)ZYJMX#^(>NVOB>7PAX[N +ZY"R6%Z$5!(&'"C
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M,\9!!V]<9S@@BNKH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"G?Z;#J1@6Y9V
MABD64PC&UV4AE+<9.& .,]0,YJY110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8!CN4$D)G.,UQNCOK>CR^+/"FH:H^L6%CIGGV][-_K8@ZL/*D/<X&1GG'/?
MSK2QLK/PO\*[ZWMX8KN2\M4>=5 =@]N^X%NI!P!CV% 'K,FIV$5XEG)?6R73
MXVP-*H=L],+G-<Y_PD5U:_$2^TF_NK2/2H=*2]1V7RRA:4I\S%L'[OMUK@/%
M>HZ?/X5\32V$L%JD?B"/S%GDWW$MPDT2LZY(\M0!P,'@9XZ5U9M=/U;XSW!G
MBM[R'_A'H70.!(A_?R<@=#P>OO0!WT4L<\22Q2+)&X#*Z'(8'H0>]/KB?A,0
M/AW91J?DCN+J-!_=47$@ _ 8KMJ "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+=[,KN%PLJF/'KNSC% &/]D\8?\ 0:T3_P %4O\ \D4?9/&'_0:T3_P52_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \V6U2_\ CAK,
M'VN>!O[$AR;>78W^L.?YBH_'?AO1-"\&Z186=G%%;+K5H27)9B6E&]BY.22.
MIS_*O0ETO3TN?M*6%JMQG/FB%0V?7.,T^ZL;.^"B[M8+@+RHEC#X^F: //\
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M;+<V5S#<P-G;+#('4XX.".*X#Q M_P"%O&K76DPLT7B>(6AVKD0WJC]W*?\
M9*;L_P"Y7?6%E#ING6UC;+M@MXEB0'KA1@4 5VUW24OQ8MJ=F+LOY8A,R[B^
M,[<9^]CG'6F7?B30[ W N]8L(#;;?/$EPB^5NSMW9/&<'&>N*\AU?6]+N=!C
MFM;BVT^&+Q0DKV)?=,C"Y^>68L25R<G P "!D]*Z[28],NOBQXJD9+:13IMF
MV6"GAA)N/XC&?PH [F34K&&Q2^DO;=+1PI2<R#8P;[N&Z'.1CUKF/"?B&YUG
MQ;XIM&U""\L+)[86K0JH50Z%F&1U.>.3V[5Y]X4U5+#3OAC<ZE.J:.(;N(S.
MW[N.Y.5CWGH#MW 9]379>#KW3Y_B;XY%I<V\GFM9.OE.#OQ"0Q&.N#P3ZT 7
M_'6M:KHMQX>&FW4<2ZEJL.GRB2$.%5]WS#IR,?2M:!-7M=64W6KVUS8K"S3H
MT C>,_PMD'[O#CI7*_%@V[MX.@N) J2>(K;</,V';AP3D$$=>HKL--T#3](F
MO)K82;;H)YJRRM("5!&<N2>AZ=.* *^D:K:VNA6DNH>)++4#-*T<=\#'$D[&
M0@(H4X)'"\=2*OV&M:7JLEQ'I^I6EV]LVV98)E<QGT;!XZ'\J\:M_L4GP4\,
M+)Y#1C7D7YL$ &\?(_[Y_2NGU6>PTWXEZZ[6XDMT\)>;-;0?*TH663(&.^W@
M?44 =Y::[I%_<FWL]3L[B8(7\N*96;:#@M@'D9XS4#^*?#\9C#ZYIJ^;*8(\
MW2?/(,94<\D9''N*\TT_5M.E\5_#N:/4;'[-]BN88[:W?<ELIAC"1%B2S/T'
M)R2/NBJ5S!8'X4_$:58[?=_:]X X SQ(I09^O3ZT >RWVIV&F1K)?WD%LC9"
MF:0+G')QGKQ6?J=_#-#I4MGXAM+*.>ZB9'.R07B$_P"J3)ZMD<KDUR3^(;/1
M?B<LVNW<5M97NC1+87<[A8MP<F5=QX#'*'W 'M53Q%#H=GH'@M='@CMM.7Q)
M;&UR3@J7<EE+'.TDDCV(/3% 'H5YKNDZ=/Y%[J=G;R_+\DLRJ1N.%SD\9/ ]
M:Q-9U;4K/XA>&-.AN5&GZ@EV9X?+&28XP5.X\]6[8Z5PWC;5=.N+'XA6D$D%
MA<+&JW$3MNGO7$0VLJL<*@7 ^49."<BMV[OK:Z\<?#B:&YBE22VO=K*X(;]R
M@X]>0: .M\6>)+7PEX:O-:NT:1(%&V)3\TCDX51]21].M5%M?%<FDB\.I6T>
MJ&/S/L7V<&V#8SY9/W_;=N]\=JSOBOH-[X@\!74&G1F:\MY([J.$=9-C9*CW
MQG [G%;</BW19?#BZX;Z)+,Q[FW,-RMW0KUWYXV]<\4 <[/\3;(_#";Q7"L4
M-R(G1+.XD (N%.TIV+8//')'I5+4O%<^CZKIT2^,+"\L=5FCAWL8!): !B\@
M9<*5.W:-P.">IQ@\[/H]UH'[/.NG4T^S7.H2/>-!)P8_,D7:I]\ <>IQ78>-
M[F#^W/ A\Z/#ZN&4[A\P\EQD?B1^8H T?#YU*/7YH;[QA::I$8&DM[..")9?
M++*5E=E//!V\*%.0>M;@UO2CJ T\:E:?;"Q40><N\D<D8SG(':N-O,CXS7"6
M;1K>/X7?R^0"7\_Y<UG>#-7\+ZOX0\.:7?\ ERZWIT\?^@.Q%S'=H2&D*Y!Z
MEF)/&"<T >AW>N:38726MYJ=I;SN0JQRS*K$GH,$]^WK4=[XBT33I)8[W5["
MV>$!I%FN$4H"< D$\9/2O,H+S0KQ?%/AOQ;K,]G<2:G.TEFY13<Q,^Z)H\H6
M8[0@ 4D_*/:M>TT_3+GXO7%I=6L,W_%.0 PW2K(Q/FMG<.06QC)H ])!! (.
M0>AHH  & ,"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9D#L@P 1QNP<\8SS0!UT=E:PB,16T*"+/E[8P-F>N/3-/6")&D9(D5I#ER%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ?:(0?G7)(ZC(Z].>E 'GGC;5["YTWX@V,4D6GW2 "6V W7%ZPC7$I!SB,#
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MU.>&&,C\ZX7X874?A_PHGAC698K/4])DECD29P@DC+LRRIG[R$-U'<&O00
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M/Y,T<G_%17K?(P/!<8/T-=U35C1,[$5<^@Q3J "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^7::@+KQ8FNRV\H6XG")&D#!!E?EX'J>>,UDF_L_^%Y(GVJ'<?#YC WC[YN
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M HHHH **** "BBB@ I%54&%  ] *6B@! JJ20 "3DX'6C:N[=M&XC&<<TM%
M"%02"0"1T..E*    , =J** "CI110 5A>(]&U'4WT^YTO4TL[FQE:54G@\V
M&7*E<.H*G@$X(/&:W:* ,/3='OOMT6H:Q<64UW"C)$+.U,2(&QDDLS,QX]0/
M;O6Y110 U8T0DJBJ6Y) QFG444 %%%% "*JKG:H&3DX% 50Q8* QZG'6EHH
M:^\QMY94/@[2PR ?>J>EZ7#I<4P0F2>XE,]Q,P^:60XR3[   #L !5ZB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N4^)-]>
MZ5X!U;4M.O);6\M8O,CDCP>=PZ@@@BNKKC/BNP/PTUN!<M--!LBC499VW#@
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M1;ZWNY)$1LQ2@1J8R !EB=_ YR<8%5+">W3Q-\1Y69529(#&Q&!(!;[3M/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 5K.RBLDD$99GE<R2R.<M(V ,G\ !
MQP  !TJS110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
0% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>elicio10-qxexhibit321001.jpg
<TEXT>
begin 644 elicio10-qxexhibit321001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$N(DD42+N59HVB8?56&5_$5X1K%A>_\ "#_"^[%C=-%IEW%]L"0.SP89,[E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR6G$$]G-"Q0$ L-Z#/)'2J4/Q!\-W%_=V$%W<S7=GG[3#%87#M%@X.X!..:
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M<JP/0@CJ*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MOHL4>N>$[VX>]DC'S&+<<DG'*G'\0RN!DBNTLOBKX,T[PUH]RTD]G;7D#/!
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MXX\,6GBCQ/X:T*PMHHDTJ07=Y-&@46T QMCR.A<C@=MN>E>G Y&1TH ****
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M.MNB"&YA7RY(V48#CDX..O8YZ56U;P5J/B+18M$UOQ"9]-!3SQ!:^5-<A2"
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M<$%3AD8=&4]B/\\5KT4 <7=^"M4U'PROAN]\2,^E[%AD>.T"7,L0Z*TFXKR
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MRYSR<@=@!76T4 >62?!Z^GO;FXF\>:X5NYC+<Q(VQ)2>""H;&,#'3H *]3
M&!THHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(/#'N4N74-&7*E0VTDX!##% '?T5G:GKNFZ.";ZY$>U/,8!&<HG]Y@H.U?\
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M#I=KIT=XL31Q !F;!RVW.T >OXT =O17/#QUX7/D8URS83R^3&ROD%\[<9Z
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ML9EEBCR2$!P2/[PSQQGGBG6_B71KO19=9M[^.738@Q>Y4$H OWCG'0=SVP:
M-6BN4FB\0S^(-0EM=99-)N-.8P*; 9LYL+L=2>92?G8J>F .]56U76?#/A6P
MUC7;O[2('$6H$Q",M"TA5)MH^ZX#(67IC<.H% ':T4 Y&1TK/U'6].TGB\N0
MC;#(55&=@@ZN0H)"CN3Q0!H450DUO38[&WO?M:207(!@:',AF!&?D"Y+<<\
M\54/B[P\-/MKXZQ:"VN9?(A<R8WR9QMQUR#U';O0!M45Q[_$GPZ^K:;8V5X+
MO[7+,C2Q(S+'Y:DMR!R<[1CT.>F,Z5EJ%DVOZVT>O&[^S1Q>?9+M9;/ ;^Z,
MY;!)!)/% &]17F%MKTGBC3M2U,>+)M"^QWTZ;A&OE+;(VSD.,;C][.<@GICB
MNXM=4LK+0=.FFU%[M)H$\J<H6DN?D!W!%&22/F( H UZ*RX?$6D7&FQ:A!?1
MS6TK^7&T0+EWYR@4#<6&#\N,C!]*M6&HVFIP--9S"6-7,;'!!5AU4@\@CN*
M+5%87BGQ39^%;&WN+H.S7%S';Q(JDY+, 2<#@ '/X8ZFKEQKVFVT4+R7!S,A
MDC1(V=V4=6V %L#(R<<9% &C15>QOK34[**\L;B*XMI1N26)@RL/8BB\OK;3
MX1+<R;%9@B@ LS,>BJHY)]A0!8HK(/BC15@2=[Y$C>X^RAG1EQ-Q\AR.&Y'!
MJU'JUC)JTFE+<K]OCB\YH""&"9QNYZC/&: +M%92^)='>_BLEOX_/F=HXL@A
M9'7[RJ^-K,,'(!)&#7)>'O&5MIDWB-/$NNKBWUJ2VMWN-JE8PD>!A0  "W7
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MU2>@)VG'TKB=7OK:;X??$Q S*\VL,\:2(5+ B'& 1U^4\=>*]S(!ZC-&,=*
M//-8NK5OBAX8%C<VP9M,O(XRC#:"PC\L<=C@X'L:XJYUNQ'P(N= NY/*UZR=
M([NRD!\X2"Y5BY7J0<YW=.>N:]XI-HSG S0!Y;?ZUI.D^/M9_P"$EN;RUT[5
MK>W?3[I'E2*553:\9V=\DD _WCZC*20Z-IGBWX=6=I!]DLH%OC#!<N2\:L@V
M%MYW*6/0'D=.HQ7J9 /4 TM 'E7BN1M*U?7=0\/ZK MW$L4=_H%XH:.^7REV
M^4!\P8J0HVYR1BMA;N)_C;;[V2.5O#I1HRPRKF=6V?7&3CTYKO" 2"0,CI39
M4,L+QAVC+*5#IU7/<>] 'B%EJGAYM!A\*WOB.QL[:SUEYUENB\=R%2X:3:RE
M=H8MQNW=#G&>*[1;NQ/QOEE,\'R^'44.6'!\]F(SZ[2#].:O:;X:\1V6GQZ1
M/KMA<:=''Y0D.G'[2R=.6,A3=_M%3D\D5U=M;Q6EK#;0+LAA18T7T4# 'Y4
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M!.)X[E)5^;;U X+[NF,G-=-IES:1?&#7#-<P>8FD6R-(S <JSE_R&"?PKO\
M SG SZTM 'AD5Q9Q_L_V<:RP+*-34[00&!%]NSCK]SGZ>U==::AI-K\7O$,M
M[=6D2RZ7:&.29U 9?GW88\8(Q]<>U>BUS=CX>N[;QOJFO2W%N\%]!% ( AW(
M(]V#NS@YW'M0!YYI$D7AC2O#L5Y;I8VMYJ]]-8WUQ&?] A;=L !X5I%/&[@9
M.0>E9U_>6W_"L_B!:/-(\S:\S@3QE7<-)"02,#D@$XP.AXXKWBB@#@;V[LO^
M%P>'O(G@VG2;A!L<8.6C*#CU ) ]JIPZ7>:=XSO?"<4#'0]4F&K*X^[$@;,\
M7T:01\?W9&KT>57:%UB<1R%2%<KG:>QQWK&\/Z-J%AYEWK6J+J>IRHL33I (
M45%)(55!..6))[\>@H W*Y#XI$#X9:\I4L7M_+10,DLS!5 ]\D5U]9]_I2:G
M<VQNFWVUO(LRP8X:53E68]PIP0/4 ]A0!-ID,MMI5G!,<RQP(CGU8* ?UK@;
MC7[+PM\3->'B1C!8ZM:VWV&YDC+1N(U97BR >=S$X]_<5Z12$ ]0#B@#RS6K
MO3_#FM^&]3NK2[TSPP;&>T1H \0M'9T9"X3!4,JC@]#UZ53\2)X;A\)07&DH
MRV%]XBMKIY;B1V%T=ZF24"0YVXZGH<$].3Z^0",$9'O2T <#XMN;73_'W@G4
M)66.SW7JM,JY4N\2[1QU+8X]:=X>O+4?%;QH?/B&;>Q/+ ?=23=^61GTKO**
M /*/#U_9O\*_&(%S"<W&IG&\<AR^W\\C'KFJBZK:Z-%X&U?59KE-";05LGNK
M:1P+:<B(_.4Y .S;]1[5[%2$ C!&1[T >875AX9DT:WFTC4KO1!=ZNUW9:LS
MLRO<F)MTA$IY1AN7G 8].HSTW@/4-2U#2;TZI':M<P7LD/VNT&(KP*%_>J/?
MH<<94UU) (P1Q2@8&!TH XGXI,(O#%E<OD0VVJV<TSXR$19ERQ]A5.WU:'3O
MBG>7^I7"Q:;JFF0KIUW,=D?[MF+QAFP 3NW =QS7H5(0&&" 1[T <;\.K&6T
MM=>N "MA>ZS<7-BI&!Y1(&Y1V5F#$>Q![U8\>065QIVG1W6JRZ3/]N4V=_&1
MB"<1N06SP5(W*0>N[%=701D8- 'CVKZAJEWX"O+C5DMIFTW7K9IM0LD(BNHD
M>(F;'L.&QP"I]*TIM3AUKXGWC:-=>8USX6:*UN$!V-)YS$%6Z$>XXX/H:].P
M,8P,>E  '04 >9^"O$'A_5/#_A[0KBQ,FO:5Y43V$MNWF6LL8VM*21A0!ELY
MYSCJ<5D_:;%_!WQ4Q- SS7MWL^89<&% F/7YL@>^:]BP,DX&3WI: ,SPW,D_
MAC2I8Y%D5K2+YE.<G:,_K6G110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%Y>VVGVCW5W,D,"8W
M.YXY. /<DD #N34]<5\28[Q=/T74;>&6>VTW5[>\O8HE+,85)RP4<G:2&Q[9
M[4 =%:>(-,OIKF""=_M%J@DFMY(7CE53T;8RAB#V('-<#'XEFUNUUO5EU/4[
M*;2M2E$$<%M(8G@BP/+==N"6Y))^9<]@,5K/Y&M_$W2-;TFYBFLK+39TO+J)
M@8V#E?+C+#@D$,V.V.<9%9?AJ_M5\(>.=TZ*7U+49$!."R-]U@.X.>".M $=
MK?KJ7AK1O$.H>,M4TDW44)O(U0A)I7*L!&&4[1GY?D!!!Y]3Z%J6NZ=I+;;N
M9@XC,I2*)Y65!U<J@)"^YXKS+5;B%O@)H<*R*TR1Z<C1CEE9)(BX(Z@@ D^F
M*UIM?M?"_P 2-8GUSS%TS6K2V-C>+$TL9\M6#1?*#R2Q8#OGWH [9M?TL6%M
M>I=">"Z7=;FW1IFE&,Y54!9N.N!Q5,^-/#BZ=;7[:O;K;7,_V>)VR"9,XV$8
MR"#UR!COBN*UJZM/#VN^']7N]-O-/\--8S68%H)(OL3-(KHSK'@J&51D8X/7
MD57\1)H,?ABQGTFTDALKSQ';7;/.9"US\ZF2;;)\VWU)ZXST() .MU?4IO%'
MA6:X\'ZU)#<Q7!C26&WW[I%X,;!P,*21EO2MB[\1:;IK21WEPP> +Y[1P2.D
M9/3<R@A<^A/<>M:B%60,A!5N05Z'WKRWQ8\FGZYKFI^']5":FIB2]T2[021:
MF/*3;Y:_>#%2%RN>5P<4 >HS(TL+HDKQ,P($B8RON,@C\Q7$^ _$V[X?:#=Z
MU>S37M\TD:N8VD>5P[\84'^%?R%=HTZQ6OGW!6%57<^]AA/7)KQ3X=ZE-X7L
MM O=2?[1I=_$]FK,O[S3)1([8(ZB-Q@DXZ@9.,4 >I7GC7P[8W-W;7&IQBXM
M%5IXD1G= <X^5023P<@<C'-7?[>TLZ5;:FMY&]G=;?L\B L92W0*H&6)] ,\
M&N2TR\LA\6O$=PT\(B.F6JK*6&T[2Y8 ]#@%<_A7'^&Y)M/\._#G6)5?^S-,
MFNX;\!3_ *.TNY8W<?P@9.2>@;WH ]5'BK1387M[]LVPV)Q=AHG5X.,_.A&Y
M1CG)'3FG'Q1HXGTV$W3>9J:[[-?)D_?#&<K\OIR?0<]*YS3K"'6/B3K.K6VR
M?19])BLIG4YCN9=[$X(X;:A )']['K7(MINO1>%741S?:/ ]R39L?^7Q48,/
M?'V<A?<O[4 =OX\UMXO!?B-M*O[BVU#38"[O''@HV,@99<<@@\<\CFMO^V;2
MPTZS:\ED::6 .$BB>:1@ -S;4!; R,G&.1ZURGBV*2/X1:]-<H4O=1MY)WC;
M[^^3&V/W*J%3C^[69J6K6>B>+-.U;6'O%T*^T>&VBO;224)#,CL2K^4<_,&'
M7N/8X /0$\1Z/+H\&K17\4ME<$+#)'EO,8G 55 R6R"-H&>#Q7->%]>DO_'O
MBZ%]2N)K"TBM&CCN4\K[.6$A<;2JD=!U&<8YKG[X6'A[4?".N6&G7-KX6@O+
MMYV=9&*--&%2=E;+*I.[KT#9XSBI8KG3]8\4?$( W4EC>Z3;KYUM Q,BB*4,
M4.,$X88]>,4 =N/&/A_SK6)M12-KM=UL98W19QZQE@ XY'3/!![U+J/BC1M)
MD=;V\\I8W6.67RG:.)FQ@.X!5"<C[Q'4>M><>'/$&@ZM?^#DOM?LX[K2(3%!
M$L<L;7$KQB, EU 7CL"<G'/8K;7>BVM[X@\,>+K74VNKG4)YK>",W#1W\,C[
MDV!#MSR%(.,8Z\' !Z\#D9'2L[5==TO1!;_VG?0VOVF588?,.-[DX '^/054
ML-?TN/68_"ZEX=1@LTF^SE6*JF ,!R,,1QWS^M8'Q2DABTOP_)< &!-?LFDR
MN1M#G/'?B@#=T[QIX>U9;XV&I+.;$;KA$C?>B_WMN,D>X!%3_P#"3Z-]ETVZ
M^VJ;?4W6.SE"-ME9ON@'& 3V!Q7*SV::W\2GU;2&CFMX=$EM;BYA8%))'<%(
M]PX) !)].,]17(VNKVLG@+P#8(MPUUIVL6:7D2V[DP,F\,&&.OMUQS0!Z=<>
M.?#-M?264NKP"YCGCMW0!F*R/]T' _7H,C.,BKD?B/2Y;N&UCN':29WCB802
M;)&0,6"OMVL0%;H>QKF/"TUM+\3O&S*R%I39&,X^^%APV/7!X/H:Q= EFTS7
M-'70-2_M+1KVZ?S-(NE#3Z82KEG5NJH"2N&X^88)W9H [P^+-$&E7>IF]Q9V
M<S07,GE/^Y=?O!AC(QD9R*EOO$>E:<RI<7+%V@-QLBA>5A$.KD("0ON>*\JU
M&^AL_!_Q(T.99AJ<VH7EQ';B)BS12!2K],;3Z_AU(K=NM9@D\0PV;PSV1FT-
M/*NH[-C/><G]R"5)55ZD8S\V<@#D [2X\6Z!:1V$D^K6R)J"[K5MV1*N-V0?
M3 ZFJ5SX\T*/P[JFLVT\EU#IH83Q1PN)%8#(!4@$ ^I&,<YQ7G6CW=NWACX7
MQR$JUK>CSA*A79B)QDY'0,0,],_2M#5A]KO_ (KP6P\V6XTZ 1(@R92MNX8+
M_>(. <=\"@#TS1M335])MKU%=?-C5F5HV3!(!. P!(YZUF:9XNM-3\5ZKH<4
M-PKV B5I'@<!G8,QYQ@  +@G&<G&>*M>%;ZWU#PQITULS-&+>--S(5R0HSC(
M&>>/J#7%3)<R>,/B'I=OYL6H:I8P?8&V, Q%LR[@V, !N,YZT =K%XJT6:ZM
M[=+T;KEREO(T;K',PZA)"-CG@\ GI6Q7D=W+'XD^%NA^'[$&+7X)+*'[*1ME
MM)(64.[+U50JL=QX.1CJ*]<H Y'P]J6IS^/O%6F7MX)[:S2S:V01A!'YBN6'
M')Y ZD]*R;_Q2XU[Q+IU]JMQIM[8HKZ9;1JO[]"@PZ@J?-8R$KMYZ 8SDU:\
M-W,#_%7QCME0^;%8B,@\.51]VWUQD9QTK)U[2[+Q!J6OIXCNGT_4;*96T2X1
MRCQ1!%*R0X^^2^X,!D\ <8% 'HFDRWL^C6,NHPK#?/;QM<1+T20J-P'T.:Y/
MPSJ&JW7Q'\7:9=ZK<7%CI9M/LT+QQ@#S8B[9*J"<'IS72>&I-2F\,:7)K*;-
M2:UC-RN,$2;1NR.QSU%<A:74'A;XJ>)[K695L[+68;26UNYCMB9HHRC(7/ ;
MH<$\B@#I)&O?^$Y@MQJ,XLVL9)FM@L>TNKHH.=N[HQXS53X@Z_<^&_#(O[=G
MBC-U#%<W21^8;:%F >0*002!TR",D<'I4^G7<.M>*GU*Q;SK"WLS;BY4?NY7
M=PQ"'^( (,D<?-C.0<177C#3)]&M[^*&:ZTZ>\:RG!MG)4 .&)0C)4%>>,8S
M0 :6EU/?:;J&E>(9=4T297\U7,<GS;?E8.J@XSD$'/)'3FK/C3Q/'X0\*WFL
M/%YTD8"0PYQYDC'"K],GGV!KA]-T;2])^)&ES^ [P&QN_-.L6=K+YEK&@7Y7
M.,A&W8 'Y #-:_CJV'C_ ,$ZM9Z$SR7^F7H"I)&R!IH2"4&X#.02 >F<<T ;
M]GHNL-8)+?>(+L:FZ;G,*1B&-B/NJA4Y4=.22?45I:(NH)HEFFJNLFH)$%N'
M48#N."P]CU_&LG2_'>A:C:1L]V+6^*CS-.G!6Y1^Z^5C<2#QP#GM6B^O6MO?
MZ9I]VDL%[J0D,$6PMC8-Q#,!M4X(ZGKP,T 7[EI4M9F@56F5&,:L< MC@'VS
M7'^!M=F\1!+V+55GB2T6._LYAB:"[SR< ?*I&0.QP".]=%XCL+K5?#FH6-E,
ML-U/ R1.X^4,1P&]CT/L37(>'KB+7_&T5^^FR:/K^GVS0ZM;L0/.5L"/!'^L
M3*DA^V,=Z /07#%&"$*V."1D _2N4\!:GJ.IV>M?VG=_:IK36+FT238$^2,@
M*,"NK9E12S,%4#)). !7#_#6XB>#Q,%D4EM>O)E ZE&8%6 [@]CWH 35(_$F
MF>)M"FM]>>[:^O/*NM,>*,0K!M)=X\#>-F!R2<DCUQ47Q \5C2=1L-+_ +=G
MT!)5,LFI+8^>@.=JQDD%5S\Q)/3:/6J7B-/#WC8:=J'AR2.;Q#!>P-#<PQLD
MT*K(/,\W(#*@3=PW4X Y-=9J?B3P\M_<:#J4H:=H06M9;=V$R,.BC;B3Z+DT
M 9&K:OJ&C:3X=TF'6#J&HZQ=K;KJ1BC!\LY=Y%51LR$X'!'()SWN:;J]S9>/
M;KPM=7$ES$]@NH6DLN-ZKO,;H2 ,\X(/7D^U<L_AF\T+P]X+O'CE*:'J#R31
M'YF@MI6<<XSGRU9,XSP#Z5J"6";XB:EXQ\PMHNEZ)]E^T1@NLK[S*Y3'W@J@
M X[G'4&@#T"L:]\5Z)IT\T5U?!# Z1SN(W:.%GQM#N 50G(^\1U'K5S2-6L]
M=TFWU.PD,EK<+N1BI4]<$$'D$$$8]J\A\:ZBE_H7CNP6WFLKJ*X&+*VM3FZ4
M>7_I$C[3D$#C!  49R30!ZSJ&OZ;I;R)=SNIBB\Z7RX7D\I.?F?:#M'RMR<=
M#Z&M!'62-74Y5@"#[5YAXHGC?4[O6=!UPZ=JZ6,9>TO(LV^I1 ,538P!W<L/
MEY^8<<UZ%8W-Q)H%M=361BN6M5D>T'5'V@F/\#Q0!5MO%>B7EY;VL%\&DNBZ
MV[&-Q'.4SN".1M?&#T)Z5F^-/$EKI_AW6X[?49K>_M;1W\VWA,GDOL)0.VUE
M3/'WL<'\:\]MM6M[N/P+>JD\*P:F5EL+:S=8;$F.0>4 %R6SCJ23U  -7H-6
MBTOPWX]\/ZSYD6KS2W]Q$CQL?M44B'8Z8'S#&![ <XQ0!WNBZY#!X2T"?4;F
M1[J[L86 5&EEF;RU9B%4%F]20*GD\7^'X=%;5Y-4@2Q20Q-(V05<'!0KC<&S
M_"1FN"T6[;2=?\(:QJ'F0Z/+X;33O.F0HEO< HQWY V[@H )X)6LWQ79,OA7
MXD:Q$#_96H75FUK@?+*4,8DD4=PS<9[[: /3;'QEX>U+5+G3;/4XIKRW0R/"
MJMDJ.I7CYQ_NYJOX=\:Z?K^EW>HXEM;:WFE0M<1/&-J,5R2P R<=.HZ'FL?4
MH[37_B!X2N]&>*8::+B2YG@P5BB:/:J,1T)8C"GGACCBN4A-W_PKO4+2UM+N
M>\TK7GO+NSB1T=XENO,(4C')7##!SQQ0!ZK8>(=,U*\N+.WN&%W;J'E@FB>&
M15/1MK@$K[]*Y'Q3XK235/"BZ/JMRJ7>L10R*D3+%<PD-N*N5PXR%^ZV.:S+
MPZ+XNT76;[PA#?76KOI,UK]LF><% >?(!D."Q.>!TQU&1FKJ/B32]6T3P&MF
MLOG6>L6@N;86[[[8K%(K*P XP>W<#(X% 'JNH:A9Z58RWM_<1V]M"NZ260X"
MBL>S\<^&K_58-,M=7ADO+B/S(8\,/,&,X!(P3CJN<CTJ3QKSX"\0_P#8,N?_
M $4U<*\=GXA\+_#ZRTEHI;^TN;*Y<1?>MHXTS*7_ +H[8.,DB@#OQXIT8V%_
M?"\/V?3Y&BNV\I\PLH!8,,9& 02<5%?>,_#NFM$MWJL,;36YN8UP26C !W8
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M_"4W(0>IP<YSP >EUG:]I7]N:%>:8;J:U^TQ[/.AQN7\^".Q'<$BN:M+^_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(Y)'OU$FI^#K_4K/24DUP-=66HQZC+<2VN[SI$! 4*'4(F#C R>!SG)/744
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M[PP!COFL-?AY=)X"M/"HUJ+9;7*SBX-D<MME\T#;YG][C.>GYUW;,J*68A5
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MMXI8DO;F2YCBESNBB9B8X\'E0%P=O8DULZ7K&F^((9WLV:5;:?R95EA9&CD
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MG!13^?K7;44 <[X>T/6[!UDUWQ$VK/$FR$+:K H]68 G<V!C/ &3QS71444
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ME,,R; <-N(;ECCMZYJW=^![Z/Q%/K&A^);K2Y+Q$6_C^SQS+.5&T. W"/CN
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M/''7/3B@"U-#'<0203('BD4HZGHP(P0:Y;Q#IR>(?$NA6D2C;I%V-0N)@/\
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MT\(8,(W(&Y01P<'(S5FHK:W2TM8K>+=Y<2!%W$DX QR3U-2T %%%% !1110
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M)YZYQVZ9SR" >FT5R7@C4]2NI=?T[4[PWLNEZBUO'<M&J,\917&X* ,C<1D
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M%;=S<>(K;X@6^AC7RUKJ-A+<;C:1[K9T=0?*XZ$-_'NQ[T =Y2,P52QS@#/
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M>,0*[1.-G0MU/S'&>/4&MSP'JNHZCI^JV^IW7VNXTW5;BQ%P45&E1""K,%
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M^$7T:SM;/2=1,5I!9BT:"Y@$R2 %CO(ROS?,?;GITQ G@.WM8_#<-E>R0P:
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MA90Z;IUK86P(@MH4AC!.2%4 #GZ"K%%% !1110 4444 %%%% !1110 4444
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MQC8@*^.ORD\<T ;%%<IIOC;3-9&NIYTUE#ITSP-<RQ-'@*BEGRPP"&8@ \G
M..:OZ7JFGV?A?3;E]7DOK>2-$ANY03)=$CC"@99CZ 9H W**R$\4:*]A>7IU
M"*."R)6Z,P,;0'&<.K ,IQZCFHK/QCX?U#4+6PM=3BDN;J+S8$ 8>8NW=P2,
M9 .2N<CN* -RB@G R>E9%MXGT:[OX+*&]4SW*LUON1E6<+]XQL0%?'7Y2>*
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M\_,X"Y0<-RV.A]#0!K44V.198UD0Y1P&4^H-4M:N+:UT6]EN[_[!"(6#708
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M>6VIP7<T:??M(D1O-60=4[)@XR2*])HH X'P%<69UCQI)YD.3K#S;R1S&(T
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M#X9*7VM!J=GYF]2NT)&X8\_P@D GIGO6Y97-F/&/Q(D>6$*]O; ,Q&& MRK
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M]QS0!Q%IIDWB/Q_J_BJ"-O[/CTDZ98NPQ]J8DLSKGJH)V@]#U'%<M:ZS9R^
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M)F4C_:'I79^(O^19U7_KSF_] -+HVEMI=DR37+7=U-(9;FY90IED( S@<
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M*SNT /E(2-J,1@L/?!(R>Q..IJS0!Y-'<VI'PG#RQ'R8OWF2/W9%KM^;T^?
MY[UT'A">%_B#XX$<B$/<6S)@_> @56(]<$8/O7<T4 <9XWU6'3-9\-K<1)!'
M-<2C^U&A\PV9\O "\$!GSM!((Z\&N'^T1K\-?B/:$W'G/J5VR">)E=PX3;U
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MYPP?@\\CZU#?:5H36&D+I\M]X88RW%SIU_\ ,-C';N\U9.@DSG:Q&=HZ$XH
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M2?\  8%6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!L@D,;"
M)E63'REEW 'W&1G\ZP_!WAV7PKX=ATB2]2\6%Y&258?+/SNSD$;F[L:WJ* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#"\8>'I/
M%7A>\T1+Q;1;M0CRF'S" "#P-PYXK9@65($6=T>4##,B;03[ DX_,U)10 44
M44 8.MZ#?:S?0C^VIK?23&8[O3XX$(N03WD/S*"."!U'I6]C P*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BO,-:\8>(;3XQZ;X.M;JU2ROK<S^;);;I(_ED./O '[GZUU>CR:[-J-TM
MSJ%M=Z;) &M;F"V,;+(&*LK L0>@(/&>: .DHKS3X7^,]=\7ZIX@AU26V$6E
MW"PQK!#LWY+C+$D_W1TKI/B#K-_X=\%:CK.FR1K<V:!U66/>K?,!@C(/?UH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 45R+>*-6?QW=>&;?3+)F
MALEO1<27;*&0MM VB,X.?>K>@>*3JNMZIH=]9?8M5T[8TL:R^;')&XRKH^ 2
M/4$ B@#HZ*** "BBJ%_?R6]]I]I JM)=2L&W?P1JI+-^>U?JXH OT450MK^2
MYUF^M55?L]HL:E^YE8%BOX*8S_P*@"_17*:WXHU/3O&.D^'[33K2<ZE%-)'-
M+=-'L\L L" C>O%2^'O%K:MK^K:!?V'V+5=-V-(B2^;')&XRKHV%/U! QF@#
MIJ**YR/Q!>-\0YO#DEM MLNF"^297)=B9-F", #H?7MS0!T=%%% !1534M3M
M-)M/M5Y*(XMZ1@GJS,P50/<DBK= !17+Z=XEO/$=Q=G0;:W.GVLS6YO;EVQ-
M(OWA&JCE0>-Q(YZ ]:T=(U._O+[4+/4-/6TEM2FTI+YBS*P)WJ<#C((P1U!H
M UZ*** "BBB@ HK'\4ZM<Z%X6U/5K2"*>6SMWG\N5RJD*I)Y /I_]<5DW?BN
M^M[CPBBVENT6MLJ3.7;=&3$9/E7TXZD_A0!UU%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.V6)/XU=WIN"[EW'D#/-9EIK5OK$6III-Q#)/9RO;;VY02A%;L<D L ?<$4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+^42(W5XW.Y)!ZJPS@^U+#:?VW\;[C4[<"2PTO2/L%Q)C*M.[EO+]#A3D^G
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MA^>/#^F_:L_:/LL7FYZ[]@S^M7Z "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>elicio10-qxexhibit322001.jpg
<TEXT>
begin 644 elicio10-qxexhibit322001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$N(DD42+N59HVB8?56&5_$5X1K%A>_\ "#_"^[%C=-%IEW%]L"0.SP89,[E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?#&DZ?87]]J30VE^@>UF-M*5E!&1@A>N#T/- '345G:AKNF:3I)U34;M+.S
MYDN 8SST&TC.?;&:I#QCH@N+2">XFM'O#BV-Y:RVZRGT5G4#/MG- &]16#X@
M\:>'_"LD":W?FS\_B-G@D*,>XW!2,_C5[4-<T_2[.&[N97^SS,B1R0PO,&+D
M!?N ]20!ZY% &A165>>(].L;V*R=YY+R2+SA;P6\DL@CSC<RJ"5&>.<<\5-I
M6LZ?K<,TNGW F2&4PR_*5*. "5((!! 89!Z4 7Z*PM=\9:%X9N;:WU>\>VDN
MCM@'V:5Q(>.%*J03R./>GZ;XLT35[JZM+*^WWEJ-T]J\3QS(/4QL W<=NXH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ;7FYD\ZS_U+L-I(Q)SD8X]1]<]=#I"R>'UTC5##?1&#R)?W6Q9%QCE<G^=
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MQA<<;/*Q_*M#Q!X=L/%.@3Z/J\?FP3*-Q3Y2K#HR]<$'IU_&L!O!NMR>$_\
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M:[8# P.E%% 'FNL?"S4]7UZ\U<>.M9M);H@%+7]VJH,[4 #=!D_F3U)K>O/
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2*76;3S(X1.R+)N.P]#@9SG/ ZF@#;HK/AUW2[C2(M6AOH9+"8 Q3(<A\G
M[DYXQUSQ3;+7]*U"VN;BVOHC':,5N=^4,! R0X;!7CGG% &E17"77B9KGXE>
M&K'3]3F:RNH+J2XM6BV*VU 8W&Y0Q!RW.2#CCI7=T %%9,OB;1H+L6TM_&CF
M;R Q!\OS?^>>_&W?_LYS[5B>+?%":=K^A:(+E[=;^:3[3+&A+I&D3, IP>2P
M49'(&>G6@#L:*\PM-4O+CQ)>^$YO%-ZR0VOFV]\L 242/(P57.,,$"CDX#9.
M:ZGPM?6\.AWMQ<^*DUE;>X<7-\X2..)@J[D&W@*.O4XW=: .FHK.L=>TS4;B
M>WMKH&>W4/+#(K1NBGHQ5@#M/KTJ*V\3:-=WHM(M0B\\Q&9%<%!)&.KH2 '4
M>JY% &M16'9^,O#FH7]O8V>L6L]S<F00QQODOLSNQ],'\C6Y0 45DP^)=&GO
M(;2._C,LY98"00DQ'4(Y&UR.>%)Z5S>K>(AJ'CIO"T>HW%C$NGF4S6Z$/Y[2
M;%&2IX !/H<\]* .ZHJKIT%U;:9;07MY]LNHXPLMR(Q'YK <MM&0,^E<7H%U
MK>L>+_%6FS^(;V.WTNXACMQ%#;@[7CW'<3$<\T =]17G_C&^UG2/AKJ6HVNO
M2RW$4R-;W:1QAGB:1%VL @'&YAE0.@-=+=W=K_PENG6O]N&&Y$,I_LQ2I\\$
M#YV&,C;CCIUH VZ*RKGQ+H]I=BVGOXXY#*(-Q!V"0]$+XVACQ\I.>:AM;NUG
M\77L,.N&>:*V02::I4K!\Q^<X&03G&">U &W162GB;1GO(K5;^/S)G,41((2
M5QU5'QM9A@\ D\&M:@ HKSGQI<^)?#FB0Z@GB.X\^XU..#REMX#''%)(0 ,Q
MEB0N!DD\U+XW_P"$C\/>#=?U&W\27<@BMD>W=X8!)&X8AAE8P""".V01UH ]
M!HK(T[Q+H^HZB^EVVHP37\4>^2%3SC."1V.#P<=#3G\2Z/%J$5E)?QK-+*8(
M]P(1Y!U0/C:7_P!G.?:@#5HK!D\:>&HKW[&^M6?VC[0MKL$F3YK=%X[_ ,LC
M-6(O$^C37L5I'?QF6:1HHCA@DCKG<JOC:S#!R 2>#Z4 :U%<[>^//"NG>;]J
MUVR3R9?)DQ)NVOUQQGID9],\UJ7&L:?;6L-R]RK13@&$Q R&48S\@7);CG@'
MCF@"]16.GBK0Y;6SNDU*!H+R86\$@)VO*3@)GLV>,'!J2?Q#I5O/>P278$]E
M#Y\\01BZIV;;C)![8SF@#4HKBCXOTO7_  3#J?\ ;;Z&ERZ%)L .OSY"#<"&
M) P<9ZFNFU'6M/TK O+C8Q0R;%1G;8.K;5!.T<9/04 7Z*S6U_2Q;6UPEVLT
M5TAD@-NIE,BC&6 0$D#(R>@R*MV5Y;:A9Q7=I,LUO*NZ.1>C#U% $]%%<1::
MKJA^*VIZ1/JTATNUTZ.\6)HX@ S-@Y;;G: /7\: .WHKGAXZ\+GR,:Y9L)Y?
M)C97R"^=N,] ,\ G@UHZCK>G:3Q>W(1MAD*JC.P0=7(4$A1W)XH T**BMKJ"
M]M8KJUFCF@E4/')&P974]"".HJ6@ HKG-.UX:K?ZM=K*8]+TJ=[7Y5R9I4&9
M&.!DA2=H ZD,>>,<OKGCA]8^'B:_H5[/9L+V%"HC&6C:X$8!++QE>?E/'3-
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M';OC(J/P]JW@_P 3ZAI%Y:B^FU?3PSF&>:?.GY3$F_<=H'&WWXQZCT@  8
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M^,%S!#X8T]))45SJMJX4MSM5\DX] .]7?BK<0O\ "O6V65&6:W"Q$,#O)88
M]:[:B@#SO4[NS/Q+\&?9;BW .GWB*488&5CV#CUP<#VKG?#%SX=O]!L?"_B"
M/47\1V$P5],::<%ID8E95P=NT_>W=!R?K[-28&<X&?6@#@?"4ME-\0_'15H9
M9&N;5E P2P6%1QZX;(]C7&#7;"\TOP?=1.+..W\0(9=+@@.RQR9>'.-V\D]R
M,Y.%KW*C H \RT>^T.V\7_$*/5I;5%EGAWI-@-+&;=<J >6Z]!Z^]<]I2S^"
MK/P;/XI-];::-+FM9)XWD7[)*\HD42;.0"@5?JOM7I6@>'KO2O$&NZE<W%O*
MFJ3I.(T0@Q%4" 9)YX'M71D C!&1[T >3:[#HEGX3M-7T6">/21XEM=1N;J5
MI&$@WKYDWS\A<\9Z'&1P<G1L]4L]4^*NK26,IGCN/#\2PR(I*R8DDY4XP1SU
MZ&O2< C!'%& .U 'B4VI6<O[.MG:K,//M_LD,B,""LBW"%EY[@ DCL.:Z6X\
M1V/AGXF:I<:_+Y6FZO8VPT^\92\1\O?NBR >27W8[_B*](I" >H!H \VU>UT
M\?V&=$U(>%;^"VG;3Q-&JP20EU+1R(V,;L(V.&'/&1QK^'?&=I%HGAV+7%BT
MW4]7,D<%O&C>7(ROC*G'"ME6&3_&.M=D0&&" 1[U6N[".^D@,S,8X9!*(AC:
MSJ05)[\$ CW ]* +5><Z?J%F/CGK)-U" =(AC!+C!8.25SZ@$<5Z-10!X9<W
M%F?@CXH6.6'S'U>9@%(W,3=!E..I^49'L*ZA_$FG>'/B/KC^()A'IVLVML=/
MNV4O%(J*RO%D C.6)QWW>XSZ72$ ]0#B@# T_5=&TJ#1=)C@.G?;Q(NGV?DL
MN50;CD ?)\N#AL'G'6N@HQ10!POPJBDMO#FI6<X(N;;5[N.;/7=YF[/XA@?Q
MKA$OK,_ *RTV611<VU[#%<0R @HPN]S*0>X4$D=AST->RQ:4EKK$^H6K^7]J
M ^U18RLC*,*X]&Q@$]P!Z"M"@#S;5Y5NOBI+#I]U$+F?PM-# RN/]8904&?7
MN/;FLWPI?>%M<L/#^EW4.HOX@TJ2'.G2RSAK6:(!2Y&=H0#)YX(XZG%>MTF!
MDG R>] "T444 >:VSIX'^*&OWFK-Y&D>(%@E@OGXBBFC!4QNW12=Q()P*[";
M5X=7L[FVT.[BN9G@D"W%O('CA;:=N6'&<XXZ]ZVB 1@C(I  H    ["@#QII
M8=6^"$'AB(!/$<*PV@L"<3QW*2K\VWJ!P7W=,9.:Z;3+FTB^,&N&:Y@\Q-(M
MD:1F Y5G+_D,$_A7?X&<X&?6EH \,BN+./\ 9_LXUE@64:FIV@@,"+[=G'7[
MG/T]JZZTU#2;7XO>(9;VZM(EETNT,<DSJ R_/NPQXP1CZX]J]%KF['P]=VWC
M?5->EN+=X+Z"* 0!#N01[L'=G!SN/:@#SS2)(O#&E>'8KRW2QM;S5[Z:QOKB
M,_Z!"V[8 #PK2*>-W R<@]*SK^\MO^%9_$"T>:1YFUYG GC*NX:2$@D8') )
MQ@=#QQ7O%% ' WMW9?\ "X/#WD3P;3I-P@V.,'+1E!QZ@$@>U4X=+O-.\9WO
MA.*!CH>J3#5E<?=B0-F>+Z-((^/[LC5Z/*KM"ZQ.(Y"I"N5SM/8X[UC>']&U
M"P\R[UK5%U/4Y46)IT@$**BDD*J@G'+$D]^/04 ;E<A\4B!\,M>4J6+V_EHH
M&269@J@>^2*Z^L^_TI-3N;8W3;[:WD698,<-*IRK,>X4X('J >PH FTR&6VT
MJS@F.98X$1SZL% /ZUP-QK]EX6^)FO#Q(Q@L=6M;;[#<R1EHW$:LKQ9 /.YB
M<>_N*](I" >H!Q0!Y9K5WI_AS6_#>IW5I=Z9X8-C/:(T >(6CLZ,A<)@J&51
MP>AZ]*I^)$\-P^$H+C249;"^\16UT\MQ(["Z.]3)*!(<[<=3T.">G)]?(!&"
M,CWI: .!\6W-KI_C[P3J$K+'9[KU6F5<J7>)=HXZEL<>M.\/7EJ/BMXT/GQ#
M-O8GE@/NI)N_+(SZ5WE% 'E'AZ_LW^%?C$"YA.;C4SC>.0Y?;^>1CUS51=5M
M=&B\#:OJLURFA-H*V3W5M(X%M.1$?G*<@'9M^H]J]BI" 1@C(]Z /,+JP\,R
M:-;S:1J5WH@N]7:[LM69V97N3$VZ0B4\HPW+S@,>G49Z;P'J&I:AI-Z=4CM6
MN8+V2'[7:#$5X%"_O5'OT..,J:ZD@$8(XI0,# Z4 <3\4F$7ABRN7R(;;5;.
M:9\9"(LRY8^PJG;ZM#IWQ3O+_4KA8M-U33(5TZ[F.R/]VS%XPS8 )W;@.XYK
MT*D(##! (]Z .-^'5C+:6NO7 !6PO=9N+FQ4C \HD#<H[*S!B/8@]ZL>/(+*
MXT[3H[K59=)G^W*;._C(Q!.(W(+9X*D;E(/7=BNKH(R,&@#Q[5]0U2[\!7EQ
MJR6TS:;KULTVH62$1742/$3-CV'#8X!4^E:4VIPZU\3[QM&NO,:Y\+-%:W"
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M+#P]J/A'7+#3KFU\+07EV\[.LC%&FC"I.RMEE4G=UZ!L\9Q4L5SI^L>*/B$
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M9>SY5@K$'CL<BM?1HO%7B#PMIUTFK1:%= S"=8+%)4N/WA E4/RH8#=[[LT
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M:,D8#KC*^XR"/S%.HH @L[2&QM4MH%(C7)Y.222223W))))]34]%% !1110
M4444 %8'C/P]-XJ\,76BPWD=H+@INE:$R8"N&X&X=UK?HH 9$)!$HE96DQ\Q
M1< GV&3C\Z?110 4444 9OB#39=9\/:AI<,Z6[7EN]N97C+A0ZE2<9&3SZT[
M0]/ETK0K'3IITG>U@2#S$C*!@JA0<$G'3UK0HH **** "BBB@ HHHH ****
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MY=F=F8(#G;NP!W([#)'IM% '&Z-XIT*R\.7UQ8VVIFQTY?,FEELI%DF=R2Q
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MRLKVZN)KN-+*-9)U>QG5U5B0IVL@."01GIZUT4;B2-9%^ZP!'T-<?\4XH_\
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MP 8&!@DYY%8NE>/[W6K30M.$45IK.H7ES9W+ ;DA^S@F5D!ZD_+M!Z;N<XY
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MC\P]B,C/K4FL>#M2UFQTN637_(U[2Y"]KJ<%H%'*A6#QEB&# <X('MVKL**
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MC2='BT?59].U329));>_\L2%VD.9=Z<!@Y.2*[-+6WCE,J01+(>K*@!_.I:
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M[=Y =VQ]X^4DYP0?8@\UWU% %/2K)]-TFTLI)_M#6\2Q>;LV[MHQG':KE%%
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M] >@]ADXINF0:S;?%,VVI^(9[QK?0HYI&6".-&S,0P"8.T'8"2#GWQ@#3L_
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MB@ HHHH **** "BBB@ J*YN8+.VEN;F9(8(E+R22,%55'4DGH*EKSKXQRO\
M\(]HMHQ(L;S6K6"]]#"220?;('Y4 =,/%]@;(Z@;;4!IH7?]L-H^PKUW8QOV
MXYW;<8YSBMFTNHKZR@NX"3#/&LJ$C&589'Z&I=J[=N!MQC&.,5R(OY)O&/\
MPB.G7#Z?9Z=IB3L\*J78LVQ$&\, H5<GC))'/!R =<$4'(4 ^N*6O*=1\8^(
MK?PIKR"\C35-$U:*R:Y$"D7$3R(%8CHK;7YP.HXQ6S-/XB@^(*:#_P ) S6M
M_ITEUO-I'NMG1U4B/C&"&_CW8QWH [VBO*;KQ5XCMOAWK5VNIJVH:3K3:?\
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M1&L9\LBW;E=R'D].<CTQ5O3]4U6;Q+XRTJ34I7BTZ&V>UD,48>,O&S-T7!Y
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M(_,=(E+OMY_A'/8_D:AT75K;7M%L]5M!(+>[B$L8D&&VGID<UPVBPW9\5?$
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M@CXPGN=1NKHFYO$Q/L/(G(W9"@Y./7'H!79QZCK.D>.]&T^[U3[78ZI93R&
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MP#YN\[_F.?NXP,8YY,?B+Q7J.DW\<6M7%SH5M<6,1M[Z&%)K>.[.[>DK%6P
M=F.@(R<^@!Z+145LQ>UB8R+(60$NAR&XZCVJ6@ HHHH **** "BBB@ HHHH
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M6=F1B#]X$>O7->JT4 <QIWA*>Q\27.O/K5S<7EQ9I;2+)$@C8J6(; ' &[@
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M\]"%\VX^7]V&8'&%);'4_0$5:'@6/^R?$.G'5;DQ:[-)-<ML3*&10K!..!@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOYT,D"R1O&)U'5HRP <8YRN>.: -:BN=_P"$[\+?:1;_ -MVIE-P;7 )(\T
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M!) G(\P$!@ 2,9P0=N<\]*=)XX\,Q7WV)M8M_M'VE+78I+?O6Z+P,>GL,C-
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MT4U#E%)]*=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ1,RD?[0]*[/Q%_R+.J_]><W_H!I=&TMM+LF2:Y:[NII#+<W+*%,LA &<#@
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M<X8/P>>1]:AOM*T)K#2%T^6^\,,9;BYTZ_\ F&QCMW>:LG029SM8C.T="<4
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MD# )^E+10 4444 %(P)4@$@D=1VI:* *]G9Q6,!BBW'<S.[L<L[$Y+$^I/\
M@,"K%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 V02&-A$RK)
MCY2R[@#[C(S^=8?@[P[+X5\.PZ1)>I>+"\C)*L/EGYW9R"-S=V-;U% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!A>,/#TGBKPO
M>:(EXMHMVH1Y3#YA !!X&X<\5LP+*D"+.Z/*!AF1-H)]@2<?F:DHH **** ,
M'6]!OM9OH1_;4UOI)C,=WI\<"$7()[R'YE!'! ZCTK>Q@8%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M7F&M>,/$-I\8]-\'6MU:I97UN9_-DMMTD?RR''W@#]S]:ZO1Y-=FU&Z6YU"V
MN]-D@#6MS!;&-ED#%65@6(/0$'C/- '245YI\+_&>N^+]4\00ZI+;"+2[A88
MU@AV;\EQEB2?[HZ5TGQ!UF_\.^"M1UG39(UN;- ZK+'O5OF P1D'OZT =/17
MGVE^/VL?A+!XS\0.DDDL6\0P)L#.6*JB\GK@<GW-6_"\_B[Q%H5OKEWJ-GIY
MO(Q-;6,=IYB)&>5WL6#,2,'@KUH [:BO,?&7B[Q5X8^')UR9;.'58KUX)83$
M6B9/-959<D'E0I!SWJQXA^(S^$OAUI.LWB+>ZMJ<,;00*NQ2[(&/N%7/U.0.
M^0 >C45PNOW_ (N\-^#9-?>\LKR\M(Q/=V7V?9$5_C5&!W @9P3G..E=%X5\
M1V?BWPW9ZU8AEAN4R4;JC X93]"#0!L45Y9X]\4^,?!GA%M<>ZT]I9+XPQVI
MM#A(B7VY;?RVU03P.M=5I#>)KF6RGN+^UDL+O3_-9H[78\,QV%1RQ#*07[#I
M0!U-%>9?"CQCKWCG3]6N-3N+:)K6<01"W@P.F=QR3GZ4?"SQCK_C>#6GU*XM
MHC93B"+[/!C/7YCDG/3I0!Z;17DGP]\;>)?&6EZG=7FJ:?8M:W:6L96Q+AF<
M@+D;Q_$0*V?%WB/Q/X8^%TNN3/:+K%I)LF7R28I09O+! SD J0PY[T >A45Y
M)KOC_P 3>&O 6@>+Y)-/O8+\0?:;-K=HV'F(7^1PYZ8(Y!KU2UNDN[&"[4%8
MY8EE ?@@$9YH GHKAO 7Q#@\::GK]FJ"-K"Z(@&,&2 \*V#WR"3Z;A6?\2/&
M&N>%_$GABQTR:V\C6+GR)!-!O,>&C7*D$?WSU]* /2:*\YT;QOJ[?$W4? VJ
MBVE>*#SK>_M8BAQM5L.A+#.&Z@]NG/&7X&\;>)/%4_B*.]U.PLDTNZ2WC=;(
MMO+NRC(W^JC\Z /6J*X+Q%KOB?P[\,;_ %FZDM/[8L7?)6 ^5*GG;%.TG(RA
M!Z]:O^$]7U77OAU:ZU<7,27]U;M,"D/R(03@;<Y(X]?RH ZZBN4L'\4:E;Z1
M-'J%I#!-8K/=2M:;BTK $*@W#  SUSVKB_ WC+QKXW\-ZU?6]UIL5[8RF.&#
M[&2LQ"YP3OX)Z9H ]?HKS+6O&.O6/QDTGPA!<6PT^_@\]I&@S(G$A*@YQ_RS
MZD=ZN:WXXU"[\?0^"/#*VXOEC\V^OKA"Z6R8!PJ C<V"O4XRP'K@ ]!HKFIE
M\4:=>Z:JWEOJ-E+<".[9[;9+$N#\R[3M(R #QD9Z^G/^&_&EUXPU36[>SUBT
MT^\L;N2WM].EA#%T3CS'R0QR<\*1MQSF@#T6BJ&B37]QHEG+JD2Q7[1@W$:
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]H\8_P#0,T+_ ,&,W_QBC[1XQ_Z!FA?^#&;_ .,4 =#17/?:/&/_ $#-"_\
M!C-_\8H^T>,?^@9H7_@QF_\ C% '0T5SWVCQC_T#-"_\&,W_ ,8H^T>,?^@9
MH7_@QF_^,4 =#17/?:/&/_0,T+_P8S?_ !BC[1XQ_P"@9H7_ (,9O_C% '0T
M5SWVCQC_ - S0O\ P8S?_&*/M'C'_H&:%_X,9O\ XQ0!T-%<]]H\8_\ 0,T+
M_P &,W_QBC[1XQ_Z!FA?^#&;_P",4 =#17/?:/&/_0,T+_P8S?\ QBC[1XQ_
MZ!FA?^#&;_XQ0!T-%<]]H\8_] S0O_!C-_\ &*/M'C'_ *!FA?\ @QF_^,4
M=#15/37U)[8G5(+6&?<<+:S-*NWC!RRJ<]>,5<H **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAHE@+2.3S4@^SKL5_P"\%Q@'WJ?^P=(-\U\=-M#=O%Y+3&(%VC_ND]2OMTH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *"0!DG HK(\5B<^#];%KG[0;"
M?RMO7=Y;8Q^- &<OB&[U#PQJ&OZ:8%M8XI9+,2QEO.6//SM@C 8KQCM@GK@<
MX?B#K6F>$]"\4ZK;6$^F:BT2SQVJ/'+;>9T8;F8.!W'%:>BF/_A1]F8\!/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6]C:P6L"](X(PBC\!Q5BN0\2>-1H'BO0]+,&ZTNY1%>7':!I PA'_ F1OP%
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M\RW1O* Z;<CY?PKBX?$FJGQ ?"UQXATQ;HV\MU%J,*J2R[U6)&0G;OY8L!U
M&,9S73>&6UGR;I-<U33KV[2104L8RJP?*,J<DDDG)YQUH W:RH_#&@0KMBT3
M347SQ<86U0?O1G#]/O#)YZ\U;M-3T^_DDCL[ZVN'B_UBPRJY3Z@'BDCU33YK
MY[&*_M7NT&7@693(OU7.10!"/#^B@7(&D6 %U_Q\?Z,G[[_?X^;\:;<^'-#O
M-/BT^YT>PELH3NCMWMT,:'U5<8'X5,VIV,SBUAU*V%S(7CC595+;E'.%SR1U
M(JIH>M'4I+^RN%2/4=.F$-RB?=.5#(ZY_A92#['(YQF@"Y9:3IVFM(UA86MJ
M9<%S!$J;L# S@<\4RZT32;Z[2[N]+LKBYC^Y-+;H[K]"1D5?HH ANK.UOK9[
M:\MH;B!QAHID#JWU!X-5GT329=.73I-+LGL5QMMFMT,0QZ+C'Z5?HH H#0](
M%S%<C2['[1"NR.7[.FY%] <9 ]A1!HFDVL-Q#;Z790Q7.?/2.W15ESUW #YO
MQJ_10!G66@:/IMC)8V6E65O:2DF2"*!51\]<@#!_&N:\5>$OMJ>'[/2=(L1I
M]AJ27EQ  D<;(%=2H3&"3NSS@<5VU% %.#2M/M[6:VAL;>."?/FQB(;9,C!W
M#OQQS4%MX=T2S-N;71["$VV[R#';(OE;OO;<#C/?'6M.B@"I8Z5IVF>9]@L+
M6T\UMTGD0K'O/J<#DU;HHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KFO'VL7_A[P7J.L::\*W%G'Y@6:/>K<@8."#W]
M:Z6N,^++*OPL\0%F !M\<GN66@!U[>>+[#PZNL6TVFZFT< GELC;/"TB[=Q"
M.';#8Z94YK5TGQ9I&K>&K'7ENXK>SO%!0W#A,-R"G)Z@@CCTK/O?%>EZ)X.@
MN&N8I[AK15M[6%@\EQ)L&U%4<DD_E7$^'K&/P7I/@71=5$%KK!2[G2[NY"(K
M7=RZ[0P#OAPN"<#YC[$ ]$UKQAHNB:"NL37]O):RL$@:.52)F)P I'!YZGL
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M\42)&=%WNJ[M4A49.,G#<5P7CO1[[P8FL:MHD#2Z)K4+PZG9)TMYG4JMP@[
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MMJ8VP9-O!._9MSR>?3CO: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M645Z]['9VZ74@P\ZQ*'8>A;&35FB@"F-)TT*ZC3[0!_OCR5^;OSQS0=)TTA
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M\FSM8+:+.=D,81<_05/110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
910 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Nov. 10, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Entity Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Elicio Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-3430072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">451 D Street, 5th Floor<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">209-0050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ELTX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,489,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001601485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,611<span></span>
</td>
<td class="nump">$ 17,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash, current</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">854<span></span>
</td>
<td class="nump">1,897<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">21,465<span></span>
</td>
<td class="nump">20,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="nump">5,019<span></span>
</td>
<td class="nump">5,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, noncurrent</a></td>
<td class="nump">702<span></span>
</td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">770<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">28,284<span></span>
</td>
<td class="nump">28,178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">321<span></span>
</td>
<td class="nump">1,038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">5,213<span></span>
</td>
<td class="nump">8,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="nump">981<span></span>
</td>
<td class="nump">901<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">6,515<span></span>
</td>
<td class="nump">11,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantLiability', window );">Warrant liabilities</a></td>
<td class="nump">3,877<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">4,356<span></span>
</td>
<td class="nump">5,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of debt discount and debt issuance costs</a></td>
<td class="nump">9,720<span></span>
</td>
<td class="nump">20,034<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">24,468<span></span>
</td>
<td class="nump">39,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies - Note 9</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value per share; 300,000,000 shares authorized; 17,273,107 shares and 11,043,837 shares issued at September&#160;30, 2025 and December&#160;31, 2024, respectively; 17,258,652 and 11,029,382 outstanding as of September&#160;30, 2025 and December&#160;31, 2024, respectively</a></td>
<td class="nump">173<span></span>
</td>
<td class="nump">110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 14,455 shares outstanding</a></td>
<td class="num">(150)<span></span>
</td>
<td class="num">(150)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">229,778<span></span>
</td>
<td class="nump">183,004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(225,954)<span></span>
</td>
<td class="num">(194,101)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">3,816<span></span>
</td>
<td class="num">(11,312)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity (deficit)</a></td>
<td class="nump">$ 28,284<span></span>
</td>
<td class="nump">$ 28,178<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -SubTopic 210<br> -Topic 954<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477220/954-210-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">17,273,107<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">17,258,652<span></span>
</td>
<td class="nump">11,029,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, shares outstanding (in shares)</a></td>
<td class="nump">14,455<span></span>
</td>
<td class="nump">14,455<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5,039<span></span>
</td>
<td class="nump">$ 7,208<span></span>
</td>
<td class="nump">$ 19,823<span></span>
</td>
<td class="nump">$ 22,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">3,006<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
<td class="nump">9,049<span></span>
</td>
<td class="nump">8,563<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">8,045<span></span>
</td>
<td class="nump">10,344<span></span>
</td>
<td class="nump">28,872<span></span>
</td>
<td class="nump">31,510<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(8,045)<span></span>
</td>
<td class="num">(10,344)<span></span>
</td>
<td class="num">(28,872)<span></span>
</td>
<td class="num">(31,510)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIncomeAndExpensesAbstract', window );"><strong>Other (expense) income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="num">(1,811)<span></span>
</td>
<td class="num">(5,617)<span></span>
</td>
<td class="num">(3,177)<span></span>
</td>
<td class="num">(3,279)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of pre-funded warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,924)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,502)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange transaction (loss) gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GrantRevenueNonoperating', window );">Grant income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">415<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="nump">472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(426)<span></span>
</td>
<td class="num">(137)<span></span>
</td>
<td class="num">(796)<span></span>
</td>
<td class="num">(221)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other (expense), net</a></td>
<td class="num">(2,038)<span></span>
</td>
<td class="num">(8,494)<span></span>
</td>
<td class="num">(2,981)<span></span>
</td>
<td class="num">(6,384)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,083)<span></span>
</td>
<td class="num">(18,838)<span></span>
</td>
<td class="num">(31,853)<span></span>
</td>
<td class="num">(37,894)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (10,044)<span></span>
</td>
<td class="num">$ (18,802)<span></span>
</td>
<td class="num">$ (31,709)<span></span>
</td>
<td class="num">$ (37,899)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common share, basic (in dollars per share)</a></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="num">$ (1.39)<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="num">$ (1.39)<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares and pre-funded warrants outstanding, basic (in shares)</a></td>
<td class="nump">16,692,476<span></span>
</td>
<td class="nump">13,582,345<span></span>
</td>
<td class="nump">15,247,864<span></span>
</td>
<td class="nump">11,720,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)</a></td>
<td class="nump">16,692,476<span></span>
</td>
<td class="nump">13,582,345<span></span>
</td>
<td class="nump">15,247,864<span></span>
</td>
<td class="nump">11,720,527<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GrantRevenueNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue, Nonoperating</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GrantRevenueNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482014/830-20-35-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481956/830-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481926/830-20-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481839/830-10-45-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (o)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIncomeAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIncomeAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) - USD ($)<br></strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Conversion of Convertible Debt</div></th>
<th class="th"><div>Conversion Of Convertible Preferred Stock</div></th>
<th class="th"><div>At-the-Market Offering</div></th>
<th class="th"><div>July Public Offering</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Conversion Of Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>At-the-Market Offering</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>July Public Offering</div>
</th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Conversion of Convertible Debt</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Conversion Of Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>At-the-Market Offering</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>July Public Offering</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,603,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">$ 11,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">$ 153,827,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (197,000)<span></span>
</td>
<td class="num">$ (142,203,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">5,062,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,056,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">903<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon the exercise of common warrants</a></td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(73,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(73,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,827,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,827,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,219,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="nump">4,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">159,218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(270,000)<span></span>
</td>
<td class="num">(154,030,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,603,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="nump">11,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">153,827,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197,000)<span></span>
</td>
<td class="num">(142,203,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="num">(5,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(37,894,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,784,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="num">(18,986,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">161,355,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202,000)<span></span>
</td>
<td class="num">(180,097,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,219,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2024</a></td>
<td class="nump">4,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">159,218,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(270,000)<span></span>
</td>
<td class="num">(154,030,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 303,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 302,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon the exercise of common warrants</a></td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(7,229,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,229,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,258,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="num">(1,652,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 103,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">159,892,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(238,000)<span></span>
</td>
<td class="num">(161,259,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,803<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
<td class="nump">$ 1,080,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,000<span></span>
</td>
<td class="nump">$ 1,075,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,353<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon the exercise of common warrants</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(18,838,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,838,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,784,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="num">$ (18,986,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 108,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">161,355,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202,000)<span></span>
</td>
<td class="num">(180,097,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">11,029,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="num">$ (11,312,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">183,004,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
<td class="num">(194,101,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">$ 835,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">834,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of senior note payable into common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,141,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants', window );">Issuance of common stock and warrants from the January Offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of common stock and warrants from the January Offering</a></td>
<td class="nump">9,143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon the exercise of common warrants</a></td>
<td class="nump">716,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">517,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(11,209,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,209,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,983,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2025</a></td>
<td class="nump">$ 8,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">214,348,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(144,000)<span></span>
</td>
<td class="num">(205,310,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">11,029,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,043,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2024</a></td>
<td class="num">$ (11,312,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">183,004,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(175,000)<span></span>
</td>
<td class="num">(194,101,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Dec. 31, 2024</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="nump">31,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">$ 144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (31,853,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2025</a></td>
<td class="nump">17,258,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,273,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2025</a></td>
<td class="nump">$ 3,816,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">229,778,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,000)<span></span>
</td>
<td class="num">(225,954,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2025</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,983,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2025</a></td>
<td class="nump">$ 8,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">214,348,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(144,000)<span></span>
</td>
<td class="num">(205,310,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, beginning balance (in shares) at Mar. 31, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">2,016,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,013,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Issuance of common warrants associated with June 2025 Promissory Note</a></td>
<td class="nump">641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,561,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,561,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,277,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="nump">1,834,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">217,762,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70,000)<span></span>
</td>
<td class="num">(215,871,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Jun. 30, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">787,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,535,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,527,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon settlement of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of common stock upon the exercise of common warrants</a></td>
<td class="nump">2,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,703,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">698,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">698,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation adjustment</a></td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,083,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,083,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Sep. 30, 2025</a></td>
<td class="nump">17,258,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,273,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2025</a></td>
<td class="nump">$ 3,816,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (150,000)<span></span>
</td>
<td class="nump">$ 229,778,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (31,000)<span></span>
</td>
<td class="num">$ (225,954,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, ending balance (in shares) at Sep. 30, 2025</a></td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of preferred stock and warrants for common stock issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Stockholders&#8217; Equity (Deficit) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Conversion of senior note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_PurchaseAgreementMember', window );">Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketOfferingMember', window );">At-the-Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Stock issuance costs</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (31,853)<span></span>
</td>
<td class="num">$ (37,894)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">155<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-of-use assets, operating leases</a></td>
<td class="nump">687<span></span>
</td>
<td class="nump">637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_InterestExpenseNoncash', window );">Non-cash interest expense</a></td>
<td class="nump">603<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CostsExpensedUponTheIssuanceOfWarrants', window );">Costs Expensed Upon The Issuance Of Warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">3,177<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">1,925<span></span>
</td>
<td class="nump">988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on disposal of property and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,043<span></span>
</td>
<td class="num">(580)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term prepaid assets</a></td>
<td class="num">(170)<span></span>
</td>
<td class="nump">2,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(717)<span></span>
</td>
<td class="num">(2,385)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_IncreaseDecreaseInAccruedExpenses', window );">Accrued expenses</a></td>
<td class="num">(3,202)<span></span>
</td>
<td class="nump">1,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred research obligation</a></td>
<td class="num">(1,169)<span></span>
</td>
<td class="nump">613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(669)<span></span>
</td>
<td class="num">(702)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(30,155)<span></span>
</td>
<td class="num">(28,324)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of related party convertible note</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">19,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="nump">9,143<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock and common warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">22,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from the exercise of common warrants</a></td>
<td class="nump">1,293<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts', window );">Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs</a></td>
<td class="nump">11,385<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from the June 2025 Promissory Note, net of issuance costs</a></td>
<td class="nump">9,866<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_PaymentOfWarrantIssuanceCosts', window );">Payment of warrant issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(549)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from the exercise of stock options</a></td>
<td class="nump">145<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">31,832<span></span>
</td>
<td class="nump">42,094<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency on cash and cash equivalents</a></td>
<td class="nump">144<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">1,821<span></span>
</td>
<td class="nump">13,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash at the beginning of the period</a></td>
<td class="nump">19,492<span></span>
</td>
<td class="nump">14,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at the end of the period</a></td>
<td class="nump">21,313<span></span>
</td>
<td class="nump">28,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Components of cash and cash equivalents, and restricted cash</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">20,611<span></span>
</td>
<td class="nump">26,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">702<span></span>
</td>
<td class="nump">2,011<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">21,313<span></span>
</td>
<td class="nump">28,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfPreFundedWarrants', window );">Fair value of pre-funded warrants at issuance date</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_FairValueOfCommonStockWarrantsUponSettlement', window );">Fair value of common stock warrants upon settlement</a></td>
<td class="nump">2,128<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantIssuedStockIssuance', window );">Fair value of common warrants issued with January 2025 Offering</a></td>
<td class="nump">9,719<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantIssuedDebtIssuance', window );">Fair value of common warrants issued with June 2025 Promissory Note</a></td>
<td class="nump">641<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SettlementOfPromissoryNotesPayable', window );">Conversion of related-party senior note payable and interest into equity</a></td>
<td class="nump">20,176<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts', window );">Accretion of convertible notes discount from issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_VestingOfRestrictedCommonStock', window );">Vesting of restricted common stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accretion Of Convertible Notes Discount From Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CostsExpensedUponTheIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Costs Expensed Upon The Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CostsExpensedUponTheIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfCommonStockWarrantsUponSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Stock Warrants Upon Settlement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfCommonStockWarrantsUponSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_FairValueOfPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value of Pre-Funded Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_FairValueOfPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_IncreaseDecreaseInAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_IncreaseDecreaseInAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_InterestExpenseNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_InterestExpenseNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_PaymentOfWarrantIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Warrant Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_PaymentOfWarrantIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SettlementOfPromissoryNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Settlement Of Promissory Notes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SettlementOfPromissoryNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_VestingOfRestrictedCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Vesting of Restricted Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_VestingOfRestrictedCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantExercisedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Exercised, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantExercisedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantIssuedDebtIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Issued, Debt Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantIssuedDebtIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantIssuedStockIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Of Common Warrants Issued With January 2025 Offering</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantIssuedStockIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of the Business and Financial Condition<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Description of the Business and Financial Condition</a></td>
<td class="text">Description of the Business and Financial Condition<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Elicio Therapeutics, Inc. (&#8220;Elicio&#8221; or the &#8220;Company&#8221;) is a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#8220;ESC&#8221;), an investment company, Elicio Operating Company, Inc. (&#8220;Former Elicio&#8221;), and Elicio Australia Pty Ltd. (&#8220;Elicio Pty&#8221;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#8220;Elicio&#8221; throughout these condensed consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Liquidity and Going Concern</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has experienced net losses and negative cash flows from operating activities since inception. As of September&#160;30, 2025, the Company had an accumulated deficit of $226.0 million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September&#160;30, 2025, the Company had $20.6 million in cash and cash equivalents. The Company&#8217;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#8217;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it might have to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Grant Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Not-for-Profit Entities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and that the grants are not within the scope of ASC 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant. Employees also track hours worked by using the project code.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Please refer to Note 2 &#8211; &#8220;Summary of Significant Accounting Policies" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's significant accounting policies.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2023-09&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#8217;s consolidated financial statements, once adopted. The Company is currently evaluating the effect that adoption of ASU 2023-09 will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(&#8220;ASU 2024-04&#8221;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is currently evaluating the effect that adoption of ASU 2024-04 will have on its consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash equivalents at September&#160;30, 2025 and December&#160;31, 2024 were held in U.S. Treasury securities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">There were no transfers made among the three levels in the fair value hierarchy during the periods presented.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the warrants assumed in the merger (the &#8220;Merger&#8221;) with Angion Biomedica Corp. (&#8220;Angion&#8221; and the warrants, the &#8220;Angion Warrants&#8221;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the nine months ended, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the year ended,</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion Warrant liability was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:59.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">80.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed an underwritten public offering (the &#8220;Public Offering&#8221;), consisting of (i) 500,000 shares of the Company&#8217;s common stock (the &#8220;July 2024 Shares&#8221;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#8220;July 2024 Pre-Funded Warrants&#8221;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock (the &#8220;July 2024 Common Warrants&#8221;). Each July 2024 Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. As of the current reporting period end, the outstanding July 2024 Pre-Funded Warrants are equity classified. The Company identified the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Refer to Note 6 and 8 for further discussion. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. At the Company&#8217;s annual stockholder&#8217;s meeting in November 2024, the Company obtained stockholder approval for GKCC, LLC (&#8220;GKCC&#8221;), together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) (&#8220;Stockholder Approval&#8221;). As a result of obtaining Stockholder Approval, certain July 2024 Common Warrants are equity classified while the remainder of the outstanding July 2024 Common Warrants are liability classified and are subsequently remeasured at each reporting period end. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three and nine months ended September 30, 2025, the Company recognized a change in fair value of $1.8 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and $3.2 million, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Components</a></td>
<td class="text">Balance Sheet Components<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Prepaid and Other Current Assets</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">854&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Property and Equipment, Net</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,707)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">328&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Depreciation expense for the three and nine months ended September 30, 2025 was $0.1 million and $0.2 million, respectively. For the three and nine months ended September 30, 2024, depreciation expense was immaterial and $0.2 million, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Other long-term prepaid assets </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $0.8 million and $0.6 million for September&#160;30, 2025 and December&#160;31, 2024, respectively.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Accrued Expenses</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock', window );">Research Grants</a></td>
<td class="text">Research Grants<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#8220;GI&#8221;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $2.8 million award, $2.3 million was received in September 2022 and the remaining $0.5 million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $0.5 million payment was applied as a credit to the second grant agreement described below. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million, with such amount received net of the $0.5 million credit described above.</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">three and nine months ended September 30, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, the Company incurred </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$0 and $2.2 million in research and development expenses related to this project, respectively. As of September&#160;30, 2024, the grant funds available for the second grant agreement were</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$0</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and the deferred research obligation was </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$0, as the second grant agreement activities were completed in the third quarter of 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. For each of the three and nine months ended September 30, 2024, the Company incurred $0.2 million in research and development expenses related to this project, all of which was reimbursed from available grant funds. For the three and nine months ended September 30, 2025, the Company incurred $0 and $0.8 million in research and development expenses related to this project, respectively, of which $0 and $0.8 million was reimbursed from available grant funds, respectively. The third grant agreement activities were completed in the second quarter of 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The award money for the three grant agreements was recorded as contra-expense to offset the research and development costs incurred. Following completion of the third grant agreement with GI Research Foundation, during 2025, the remaining $0.4 million of the grant funds were recognized as grant income, as there were no further conditions to be met.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock and Stockholders' Equity</a></td>
<td class="text">Common Stock and Stockholders' Equity<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Authorized Shares</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">At-The-Market Equity Programs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In May 2022, the Company filed a registration statement on Form S-3 (the &#8220;Prior Shelf Registration St</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">atement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $100&#160;million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $21 million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#8220;2022 ATM Program"). During the nine months ended September 30, 2024, the Company issued and sold a total of 650,179 shares of common stock at a weighted average price of $8.42 per share under the 2022 ATM Program for aggregate net sale proceeds of approximately $5.4 million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2024, the Company filed a registration statement on Form S-3 (the &#8220;2024 Registration Statement&#8221;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Sales Agreement with JonesTrading Institutional Services LLC, as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#8220;at-the-market&#8221; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#8220;2024 ATM Program&#8221;). During the nine months ended September 30, 2025, the Company issued and sold 1,176,449 shares of common stock at a weighted average price of $9.68 per share under the 2024 ATM Program for aggregate net sale proceeds of approximately $11.4 million after deducting sales commissions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, the Company entered into a subscription agreement (the &#8220;March Subscription Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, providing for the issuance and sale by the Company to GKCC of pre-funded warrants (the &#8220;March 2024 Pre-Funded Warrants&#8221;) (the &#8220;March 2024 Offering&#8221;). Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds to the Company from the March 2024 Offering were approximately $6.0 million. Refer to Note 8 for additional information. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offerings</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In July 2024, the Company closed the Public Offering, which resulted in net proceeds of $10.9&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Public Offering consisted of the July 2024 Shares or in lieu thereof, the July 2024 Pre-Funded Warrants, and accompanying July 2024 Common Warrants. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $5.00 per July Share and accompanying July 2024 Common Warrant, and each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $4.99 per July 2024 Pre-Funded Warrant and</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">accompanying July 2024 Common Warrant, which represented the combined purchase price per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant less the $0.01 per share exercise price for each such July 2024 Pre-Funded Warrant. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The July 2024 Common Warrants have an exercise price of $5.00 per share, are immediately exercisable and will expire five years from the issuance date. Refer to Note 3 and 8 for additional information.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#8220;Investor&#8221; and, collectively, the &#8220;Investors&#8221;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the &#8220;January 2025 Offering&#8221;): (i) an aggregate of 1,261,830 shares of the Company&#8217;s common stock (the &#8220;January 2025 Shares&#8221;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#8220;January 2025 Common Warrants&#8221;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. The January 2025 Offering resulted in net proceeds of $9.2&#160;million to the Company after deducting the placement agent&#8217;s fees and related offering expenses. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into a note purchase agreement (the &#8220;June 2025 Promissory Note Financing&#8221;) with GKCC pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#8220;June 2025 Promissory Note&#8221;) in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock (the &#8220;June 2025 Warrant&#8221;). The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. Refer to Note 11 for further detail.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of September&#160;30, 2025, there was an aggregate of 806,700 shares of common stock available for issuance under the Company&#8217;s equity incentive plans, including 462,097 shares available for future grants under the Company&#8217;s 2021 Incentive Award Plan, 177,295 shares available for future grants under the Company&#8217;s 2022 Equity Incentive Plan, as amended, and 167,308 shares available for future grants issuance under the Company&#8217;s 2024 Inducement Incentive Award Plan. Refer to Note 8 &#8211; &#8220;Stock-Based Compensation" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock Options</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,890,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">656,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(31,918)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(51,106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,464,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,345,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.36</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. 656,099 stock options were granted during the nine months ended September 30, 2025. The weighted average grant date fair value per share for the stock option grants during the nine months ended September 30, 2025 was $7.40. As of September&#160;30, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $5.1 million, which the Company expects to recognize over a weighted-average period of approximately 2.7 years. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Stock-based Compensation Expense</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,925&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">988&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#8217;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3.4% - 3.6%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7% - 4.3%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3.4% - 4.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years (for employees)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5.8 - 6.1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5 - 6.1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5.0 - 6.1</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">110.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">104.6% - 104.8%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">106.9% - 110.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">79.5% - 104.8%</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the condensed consolidated financial statements for the period ended September&#160;30, 2024.</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Employee Stock Purchase Plan</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#8220;ESPP&#8221;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#8217;s initial public offering. The offering period and purchase period was determined by Angion&#8217;s board of directors. No offering periods or purchasing periods were active as of September&#160;30, 2025. As of September&#160;30, 2025, 275,309 shares remained available for purchase under the ESPP and no offerings have been authorized.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants And Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In accordance with FASB ASC Topic 815, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Derivatives and Hedging</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASC 815&#8221;), certain of the Company&#8217;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the March 2024 Pre-Funded Warrants were liability-classified, with a fair value of $6.6&#160;million, as determined by the Black-Scholes option pricing model as of the grant date. The Company recorded the $0.6 million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024 and nine months ended September 30, 2024. As of September 30, 2025, the March 2024 Pre-Funded Warrants were classified as equity due to the receipt of Stockholder Approval in November 2024, as discussed in Note 3.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Notes 3 and 6, in July 2024, the Company closed its Public Offering consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Upon issuance, the July 2024 Pre-Funded Warrants and July 2024 Common Warrants were liability-classified, with a fair value of $6.8 million and $6.5 million, respectively, measured using the Black-Scholes option pricing model as of the grant date. The Company recorded the $2.9 million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As of September&#160;30, 2025, certain July 2024 Pre-Funded Warrants are classified as equity, following Stockholder Approval in November 2024. For the three and nine months ended September 30, 2025, the Company recognized a loss of $1.8 million and $3.2 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in fair value remeasurement, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Following receipt of Stockholder Approval in November 2024, the Company remeasured the March 2024 Pre-Funded Warrants and the July 2024 Pre-Funded Warrants, held by GKCC, at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. As a result of obtaining Stockholder Approval, the March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants held by GKCC and its affiliates met the equity classification requirements under ASC 815. During the quarter ended December 31, 2024, the Company reclassified the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. The Company will re-assess the equity classification for the remaining March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants at each reporting period end. During the nine months ended September 30, 2025, there were no changes to the equity classification.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As disclosed in Note 6, in January 2025, the Company closed the January 2025 Offering pursuant to which the Company agreed to issue and sell: (i) the January 2025 Shares and (ii) the January 2025 Common Warrants. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $9.7 million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables summarize information regarding the warrants outstanding and warrant activity at September&#160;30, 2025:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:25.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Warrants Outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Angion Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,041,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2025 Common Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261,830&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Warrants Outstanding at September 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188,021&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of September 30, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Warrants</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted <br/>Average <br/>Exercise <br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,081,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,365,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(258,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at September&#160;30, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,188,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Legal Proceedings </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company may be exposed to litigation in connection with its products under development and operations. The Company&#8217;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">License Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In January 2016, Former Elicio entered into a license agreement to license certain intellectual property from a university, which agreement has been amended from time to time to license additional intellectual property and to adjust fees and milestone and diligence requirements. The Company is required to pay certain contractual maintenance and milestone payments related to clinical trials and product sales and royalties on product sales over the term of the contract, with royalty payments commencing in the calendar year of commercialization. Royalty rates range from 0.25%-2.00%, depending on whether commercial sales relate to a licensed product or an identified product, and the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions. During the nine months ended September 30, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $0.4&#160;million. No such expenses were recorded in the nine months ended September 30, 2025. No commercialization royalties have been achieved to date.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is required to pay a total of up to $20.9&#160;million upon achievement of certain late-stage developmental and commercial milestones. The developmental milestone payments will be recorded when each milestone is achieved, and the commercial milestone payments and royalties will be recorded when the sales occur.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Future minimum annual maintenance payments are $0.1&#160;million for the year ended December&#160;31, 2025 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Operating Leases</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#8220;Boston Lease&#8221;).</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a right-of-use (&#8220;ROU&#8221;) lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $0.7&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of September&#160;30, 2025 and December&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately 6,157 square feet for approximately $0.2&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Lease expense for all leases for the three and nine months ended September 30, 2025 was $0.3 million and $1.0 million, respectively. Lease expense for all leases for the three and nine months ended September 30, 2024 was $0.3 million and $1.1 million, respectively.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2025 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,356&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into a securities purchase agreement (the &#8220;Securities Purchase Agreement&#8221;) with GKCC, an entity controlled by a member of the Company&#8217;s board of directors, pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#8220;Convertible Note&#8221;) in the principal amount of $20.0 million (the &#8220;Convertible Note Financing&#8221;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the nine months ended September 30, 2025, the Company recorded an immaterial amount in other expense related to the accretion of the discount of Convertible Note debt issuance costs. During the nine months ended September 30, 2025, the Company recorded accrued interest expense of $0.1 million related to the interest due on the Convertible Note but not yet payable.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million to GKCC, an entity controlled by a member of the board of directors of the Company. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus 5.00%, provided that the maximum interest rate shall not exceed 12.5% per annum, with an initial interest payment date of July 1, 2026. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of 49.99% of the number of shares of the Company&#8217;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrants, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company received net proceeds of $9.9 million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of September 30, the net carrying value of the June 2025 Promissory Note was $9.7 million and the debt discount for the June 2025 Promissory Note was $0.3 million. Accretion of the discount on the June 2025 Promissory Note was $0.4 million and $0.5 million for the three and nine months ended September 30, 2025, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company did not record a provision or benefit for income taxes during the three and nine months ended September&#160;30, 2025 or 2024. As of September&#160;30, 2025 and December&#160;31, 2024, the Company continues to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On July 4, 2025, H.R. 1 (the &#8220;Act&#8221;), formerly known as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The Company is currently evaluating the full impact of the Act on its financial position, results of operations, and cash flows. However, the Company does not expect the Act to have a material effect on its financial statements. The impact to the Company&#8217;s income tax expense and effective tax rate for the three and nine months ended September 30, 2025 associated with this legislation is not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 740<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock and preferred stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock and preferred stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three and nine months ended September&#160;30, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(18,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(31,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(37,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average of common shares and pre-funded warrants outstanding, basic and diluted</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,692,476</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,582,345</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,247,864</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,720,527</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(0.60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2.09)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3.23)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:72.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.906%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819,302</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,448,769</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,019,326</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,268,071</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Private Placement and Subscription Agreement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#8217;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the March 2024 Offering were approximately $6.0 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Public Offering</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#8217;s board of directors,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Jay Venkatesan, a member of the Company&#8217;s board of directors, and trusts affiliated with Jay Venkatesan, purchased 1,600,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants and 200,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants, respectively, with such July 2024 Pre-Funded Warrants and July 2024 Common Warrants subject to the terms and conditions of the July 2024 Pre-Funded Warrants and July 2024 Common Warrants. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The net proceeds to the Company from the Public Offering were approximately $10.9 million.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Convertible Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#8217;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Senior Secured Promissory Note Financing</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0 million. The Company received net proceeds of approximately $9.9 million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#8217;s common stock.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text">Segment Reporting<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#8217;s Chief Operating Decision Maker (&#8220;CODM&#8221;), its Chief Executive Officer, manages the Company&#8217;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Other segment items include interest income, interest expense, grant income, and change in the fair value of liability-classified warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. All long-lived assets are located in the United States. The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:44.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,984</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,083&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,853&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:71.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GrantRevenuePolicyTextBlock', window );">Grant Income</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Grant Income</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Not-for-Profit Entities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, and that the grants are not within the scope of ASC 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant. Employees also track hours worked by using the project code.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Basis of Presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;U.S. GAAP&#8221;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#8220;ASC&#8221;) and Accounting Standards Update (&#8220;ASU&#8221;) promulgated by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Standards Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Recently Issued Accounting Standards Not Yet Adopted </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In December 2023, the FASB issued ASU No. 2023-09, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2023-09&#8221;)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This ASU requires disaggregated information about a reporting entity&#8217;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#8217;s consolidated financial statements, once adopted. The Company is currently evaluating the effect that adoption of ASU 2023-09 will have on its consolidated financial statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-03, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (&#8220;ASU 2024-03&#8221;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#8217;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2024, the FASB issued ASU No. 2024-04, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Debt &#8211; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments </span>(&#8220;ASU 2024-04&#8221;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is currently evaluating the effect that adoption of ASU 2024-04 will have on its consolidated financial statements<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GrantRevenuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GrantRevenuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30, 2025</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,189&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,877&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,872&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">&#160;Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Money market funds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total assets</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">12,100&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Warrant liabilities</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Total liabilities</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,827&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,828&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_________________</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">The following table presents a summary of changes in Level 3 in the fair value of the Company&#8217;s common stock warrant liability (in thousands):<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:72.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.695%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the nine months ended, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">For the year ended,</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Balance, end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of the assumed Angion Warrant liability was estimated using the following assumptions:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"><tr><td style="width:1.0%"></td><td style="width:59.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.409%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average strike price</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">76.00</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Contractual term (years)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.7</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Volatility (annual)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">80.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Risk-free rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Dividend yield (per share)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prepaid and other current assets consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid research and development contract services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,206&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Advanced professional fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Prepaid insurance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total prepaid and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">854&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net was comprised of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Equipment</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,661&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Furniture and fixtures</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">242&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Leasehold improvements</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total property and equipment</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,035&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: accumulated depreciation</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,707)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,552)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Property and equipment, net</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">328&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">483&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,167&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,688&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Accrued research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Other accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total accrued expenses</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,213&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8,415&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes information and activity related to the Company&#8217;s stock options:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Number of <br/>Stock Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average <br/>Remaining Contractual Life <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Total <br/>Intrinsic Value <br/>(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,890,932&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">15.69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.78</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">920&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">656,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options exercised </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(31,918)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited (unvested)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(51,106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding as of September 30, 2025</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,464,007&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">13.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6.96</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">10,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Options vested and exercisable</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,345,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">19.92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.36</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Components of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">264&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">755&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">414&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,925&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">988&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Schedule of Black-Scholes Option-Pricing Model Following Assumptions</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3.4% - 3.6%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7% - 4.3%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">3.4% - 4.2%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">0.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected term in years (for employees)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">6.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5.8 - 6.1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.5 - 6.1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">5.0 - 6.1</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">110.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">104.6% - 104.8%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">106.9% - 110.4%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">79.5% - 104.8%</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsAndRightsOutstandingAbstract', window );"><strong>Warrants And Rights Outstanding [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Outstanding Warrants</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following tables summarize information regarding the warrants outstanding and warrant activity at September&#160;30, 2025:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:25.315%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.409%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Classification</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Warrants Outstanding</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average Remaining Contractual Life (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Elicio Warrants</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Angion Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2024 Pre-Funded Warrants</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,600,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Perpetual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2024 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability-classified</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,041,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 2025 Common Warrants</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261,830&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.80&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2025 Common Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity-classified </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Warrants Outstanding at September 30, 2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,188,021&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.69</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of September 30, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.137%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.279%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.679%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Warrants</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted <br/>Average <br/>Exercise <br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Weighted Average Life (years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,081,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3.85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Issued</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,365,055&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(258,500)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at September&#160;30, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,188,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsAndRightsOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsAndRightsOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock', window );">Schedule of Quantitative Information Regarding Operating Leases</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):</span></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating cash outflows from operating leases</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,012&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average remaining lease term&#8212;operating leases (in years)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted-average discount rate&#8212;operating leases</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2025, maturities of lease liabilities were as follows (in thousands):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.673%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Amounts</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2025 (remaining three months)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">338&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,378&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less present value discount</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,041)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liabilities</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Less: operating lease liability, current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Operating lease liability, noncurrent portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">4,356&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Quantitative Information On Operating Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Net Loss Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Basic and diluted net loss per share attributable to common stockholders was calculated for the three and nine months ended September&#160;30, 2025 and 2024 as follows (in thousands, except share and per share data):</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three Months Ended <br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Numerator</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(10,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(18,838)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(31,853)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(37,894)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Weighted average of common shares and pre-funded warrants outstanding, basic and diluted</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,692,476</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,582,345</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,247,864</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,720,527</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Net loss per share, basic and diluted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(0.60)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1.39)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(2.09)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(3.23)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share</a></td>
<td class="text">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"><tr><td style="width:1.0%"></td><td style="width:72.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.904%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.906%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine Months Ended <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">819,302</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,555,319</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,448,769</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Total </span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">6,019,326</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">3,268,071</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, by Segment</a></td>
<td class="text">The following table presents certain financial data for the Company&#8217;s reportable segment (in thousands):<div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"></td><td style="width:44.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Three months ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Nine months ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2025</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical trial expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,757&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, manufacturing and controls expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">476&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,534&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other research and development expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,849&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and grant reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(544)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(754)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(888)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee related general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,782&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional fees and other general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,984</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment net loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,083&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,853&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,894&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"></td><td style="width:71.848%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.121%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">September 30,<br/>2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%">December 31,<br/>2024</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,284&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,178&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Description of the Business and Financial Condition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 225,954<span></span>
</td>
<td class="nump">$ 194,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 20,611<span></span>
</td>
<td class="nump">$ 17,618<span></span>
</td>
<td class="nump">$ 26,016<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th"><div>Jun. 01, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=angn_AngionCommonStockMember', window );">Angion Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split, conversion ratio</a></td>
<td class="nump">0.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_AngionCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_AngionCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair value measurements, recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">$ 6,189<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">6,189<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">3,877<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">3,877<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">6,189<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">6,189<span></span>
</td>
<td class="nump">12,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">3,872<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">3,872<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities, Fair Value Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantsFairValueDisclosure', window );">Warrant liabilities</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - Warrant Liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, beginning of the period</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance, end of the period</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=angn_WarrantLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=angn_WarrantLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details) - Level 3<br></strong></div></th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Weighted average strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">76.00<span></span>
</td>
<td class="nump">76.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Volatility (annual)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.803<span></span>
</td>
<td class="nump">0.749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0.038<span></span>
</td>
<td class="nump">0.044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Dividend yield (per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrants, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479328/805-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 43<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479303/805-10-55-43<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=angn_MeasurementInputStrikePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=angn_MeasurementInputStrikePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 31, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2025 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage', window );">Sale of stock, beneficial ownership limitation, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.1999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,811)<span></span>
</td>
<td class="num">$ (5,617)<span></span>
</td>
<td class="num">$ (3,177)<span></span>
</td>
<td class="num">$ (3,279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares) | shares</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares) | shares</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SaleOfStockBeneficialOwnershipLimitationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Beneficial Ownership Limitation, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SaleOfStockBeneficialOwnershipLimitationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_PrepaidResearchAndDevelopmentExpenses', window );">Prepaid research and development contract services</a></td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">$ 1,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AdvancedProfessionalFees', window );">Advanced professional fees</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">444<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_OtherPrepaidExpensesAndOtherAssetsCurrent', window );">Other prepaid expenses and other current assets</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 854<span></span>
</td>
<td class="nump">$ 1,897<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AdvancedProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Advanced Professional Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AdvancedProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_OtherPrepaidExpensesAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Prepaid Expenses And Other Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_OtherPrepaidExpensesAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_PrepaidResearchAndDevelopmentExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Research And Development Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_PrepaidResearchAndDevelopmentExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 2,035<span></span>
</td>
<td class="nump">$ 2,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(1,707)<span></span>
</td>
<td class="num">(1,552)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">328<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">1,661<span></span>
</td>
<td class="nump">1,661<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">242<span></span>
</td>
<td class="nump">242<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property and equipment</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">$ 132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Components - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 236<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Other long-term prepaid assets</a></td>
<td class="nump">$ 770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-11<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-12<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476148/220-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Components - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">$ 761<span></span>
</td>
<td class="nump">$ 1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">1,688<span></span>
</td>
<td class="nump">2,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedResearchAndDevelopmentCurrent', window );">Accrued research and development</a></td>
<td class="nump">2,714<span></span>
</td>
<td class="nump">4,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedOtherOperatingLiabilitiesCurrent', window );">Other accrued expenses</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">26<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 5,213<span></span>
</td>
<td class="nump">$ 8,415<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedOtherOperatingLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Other Operating Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedOtherOperatingLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedResearchAndDevelopmentCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Research And Development, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedResearchAndDevelopmentCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research Grants (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>agreement</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5,039<span></span>
</td>
<td class="nump">$ 7,208<span></span>
</td>
<td class="nump">$ 19,823<span></span>
</td>
<td class="nump">$ 22,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_NumberOfResearchGrantAgreements', window );">Number of research grant agreements | agreement</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GrantRevenueNonoperating', window );">Grant income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 415<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member', window );">Research Grant Agreement with GIRF Sept. 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrantReceived', window );">Grant award received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member', window );">Research Grant Agreement with GIRF Sept. 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrantReceived', window );">Grant award received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementCredit', window );">Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred research obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member', window );">Research Grant Agreement with GIRF Aug. 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementGrant', window );">Grant award</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds', window );">Reimbursement from grant funds</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GrantRevenueNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grant Revenue, Nonoperating</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GrantRevenueNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_NumberOfResearchGrantAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Research Grant Agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_NumberOfResearchGrantAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementGrantReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Grant Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementGrantReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research And Development Arrangement, Reimbursement from Grant Funds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 730<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483041/730-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock and Stockholders' Equity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>May 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember', window );">Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member', window );">At-The-Market Equity Offering Sales Agreement 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember', window );">2024 Registration Statement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July 2024 Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July 2024 Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July 2024 Public Offering | July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July 2024 Public Offering | July Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July 2024 Public Offering | July Pre-Funded Warrants and July Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember', window );">At-The-Market Equity Offering Sales Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_SaleOfStockAggregateInitialOfferingPrice', window );">Sale of stock, aggregate initial offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember', window );">January 2025 Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember', window );">January 2025 Public Offering | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember', window );">July Share And July Common Warrant | July 2024 Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share of shares issued (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">281,697<span></span>
</td>
<td class="nump">106,823<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">615,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="nump">$ 9,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Weighted average price (in dollars per share)</a></td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="nump">7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | January Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Weighted average price (in dollars per share)</a></td>
<td class="nump">7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Weighted average price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.68<span></span>
</td>
<td class="nump">8.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.68<span></span>
</td>
<td class="nump">$ 8.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | July 2024 Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | At-The-Market Equity Offering Sales Agreement 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares sold in offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,176,449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_SaleOfStockAggregateInitialOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Initial Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_SaleOfStockAggregateInitialOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_A2024RegistrationStatementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JanuaryPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JanuaryCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=angn_JulySharesAndJulyCommonWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_AtTheMarketEquityOfferingSalesAgreement2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">806,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">656,099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation related to unvested stock option awards | $</a></td>
<td class="nump">$ 5.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation related to unvested stock option awards, period for recognition (in years)</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">275,309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized for issuance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_The2021PlanMember', window );">The 2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">462,097<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_The2022PlanMember', window );">The 2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for grant (in shares)</a></td>
<td class="nump">177,295<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=angn_Inducement2024PlanMember', window );">Inducement 2024 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Shares available for future grants (in shares)</a></td>
<td class="nump">167,308<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_The2021PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_The2021PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_The2022PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_The2022PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=angn_Inducement2024PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=angn_Inducement2024PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Share Option Activity (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Stock Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at beginning of period (in shares) | shares</a></td>
<td class="nump">1,890,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares) | shares</a></td>
<td class="nump">656,099<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares) | shares</a></td>
<td class="num">(31,918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (unvested) (in shares) | shares</a></td>
<td class="num">(51,106)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding at end of period (in shares) | shares</a></td>
<td class="nump">2,464,007<span></span>
</td>
<td class="nump">1,890,932<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options vested and exercisable (in shares) | shares</a></td>
<td class="nump">1,345,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Options granted (in dollars per share) | $ / shares</a></td>
<td class="nump">7.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Options exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">4.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (unvested) (in dollars per share) | $ / shares</a></td>
<td class="nump">6.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">13.81<span></span>
</td>
<td class="nump">$ 15.69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options vested and exercisable (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Option Activity, Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options outstanding, weighted average remaining contractual life (in years)</a></td>
<td class="text">6 years 11 months 15 days<span></span>
</td>
<td class="text">6 years 9 months 10 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested and exercisable, weighted average remaining contractual life (in years)</a></td>
<td class="text">5 years 4 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Options outstanding, total intrinsic value | $</a></td>
<td class="nump">$ 10,525<span></span>
</td>
<td class="nump">$ 920<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options vested and exercisable, total intrinsic value | $</a></td>
<td class="nump">$ 5,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 698<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
<td class="nump">$ 1,925<span></span>
</td>
<td class="nump">$ 988<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="nump">755<span></span>
</td>
<td class="nump">414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="nump">$ 574<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479983/718-10-S45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details) - Stock Option<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years (for employees)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">110.40%<span></span>
</td>
<td class="nump">104.60%<span></span>
</td>
<td class="nump">106.90%<span></span>
</td>
<td class="nump">79.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">104.80%<span></span>
</td>
<td class="nump">110.40%<span></span>
</td>
<td class="nump">104.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years (for employees)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term in years (for employees)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6,509<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,924<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Loss on fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,811)<span></span>
</td>
<td class="num">$ (5,617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,177)<span></span>
</td>
<td class="num">$ (3,279)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants | March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants | March Subscription Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="nump">$ 6,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July 2024 Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_WarrantExercisedFairValue', window );">Fair value of common warrants at issuance date</a></td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Loss on fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="nump">2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember', window );">January 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember', window );">June 2025 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember', window );">July Pre-Funded Warrants and July Common Warrants | July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_GainLossOnIssuanceOfWarrants', window );">Loss on issuance of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_GainLossOnIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Issuance Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_GainLossOnIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_WarrantExercisedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrant Exercised, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_WarrantExercisedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Outstanding Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">6,188,021<span></span>
</td>
<td class="nump">5,081,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_WeightedAverageMember', window );">Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember', window );">Elicio Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">144,814<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember', window );">Elicio Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 53.59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember', window );">Angion Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">3,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember', window );">Angion Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 76.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,032,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember', window );">March 2024 Pre-Funded Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">July 2024 Pre-Funded Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July 2024 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">2,041,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember', window );">July 2024 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 5.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember', window );">January 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember', window );">January 2025 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember', window );">June 2025 Common Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Number of warrants outstanding (in shares)</a></td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms', window );">Weighted Average Remaining Contractual Life (years)</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember', window );">June 2025 Common Warrants | Weighted Average</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Weighted Average Remaining Contractual Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_ElicioWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_AngionWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_March2024PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_January2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_June2025CommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Warrants Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightRollForward', window );"><strong>Warrants</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding beginning balance (in shares) | shares</a></td>
<td class="nump">5,081,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares) | shares</a></td>
<td class="nump">1,365,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightExercisedInPeriod', window );">Exercised (in shares) | shares</a></td>
<td class="num">(258,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Outstanding ending balance (in shares) | shares</a></td>
<td class="nump">6,188,021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Outstanding beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod', window );">Issued (in dollars per share) | $ / shares</a></td>
<td class="nump">7.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">5.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Outstanding ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward', window );"><strong>Weighted Average Life (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLife', window );">Outstanding beginning balance (in years)</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightWeightedAverageLife', window );">Outstanding ending balance (in years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightExercisedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercised In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightExercisedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Exercise Rollforward</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant Or Right, Weighted Average Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Weighted Average Life</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Jan. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5,039<span></span>
</td>
<td class="nump">$ 7,208<span></span>
</td>
<td class="nump">$ 19,823<span></span>
</td>
<td class="nump">$ 22,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Royalty expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct', window );">Aggregate sales milestone payments per product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,900<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_RoyaltyRatePercent', window );">Royalty rates (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_RoyaltyRatePercent', window );">Royalty rates (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | University</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CommitmentsAndContingenciesDisclosureLineItems', window );"><strong>Commitments and Contingencies Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_CollaborativeArrangementFutureMinimumMaintenancePayments', window );">Future minimum annual maintenance payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CollaborativeArrangementFutureMinimumMaintenancePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Future Minimum Maintenance Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CollaborativeArrangementFutureMinimumMaintenancePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_CommitmentsAndContingenciesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commitments and Contingencies Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_CommitmentsAndContingenciesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_RoyaltyRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Rate, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_RoyaltyRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_UniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_UniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 901<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSecuredLinesOfCredit', window );">Proceeds from secured lines of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=angn_BostonMassachusettsMember', window );">Boston, Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Operating lease, expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease, right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember', window );">Newton, Massachusettes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of office space (in square feet) | ft&#178;</a></td>
<td class="nump">6,157<span></span>
</td>
<td class="nump">6,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_LesseeOperatingLeaseAnnualRentExpense', window );">Operating lease, payment per year</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_LesseeOperatingLeaseAnnualRentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Annual Rent Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_LesseeOperatingLeaseAnnualRentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSecuredLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSecuredLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=angn_BostonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=angn_BostonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=angn_NewtonMassachusettsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Quantitative Information about Operating Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 1,012<span></span>
</td>
<td class="nump">$ 1,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term&#8212;operating leases (in years)</a></td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate&#8212;operating leases</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2025 (remaining three months)</a></td>
<td class="nump">$ 338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2026</a></td>
<td class="nump">1,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2027</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2028</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2029</a></td>
<td class="nump">1,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour', window );">Thereafter</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total</a></td>
<td class="nump">6,378<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less present value discount</a></td>
<td class="num">(1,041)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">5,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: operating lease liability, current portion</a></td>
<td class="num">(981)<span></span>
</td>
<td class="num">$ (901)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability, noncurrent</a></td>
<td class="nump">$ 4,356<span></span>
</td>
<td class="nump">$ 5,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee&#8203; Operating &#8203;Lease&#8203; Liability&#8203; Payments&#8203; Due&#8203; After&#8203; Year&#8203; Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,143,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,720,000<span></span>
</td>
<td class="nump">$ 9,720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,034,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Other expense related to accretion of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">$ 26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | GKCC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightOwnershipPercentMaximum', window );">Ownership maximum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember', window );">June 2025 Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants, contractual term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from Issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Net carrying value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Other expense related to accretion of discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightOwnershipPercentMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Ownership Percent Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightOwnershipPercentMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-4<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=angn_GKCCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=angn_GKCCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_June2025WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax provision (benefit)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (10,083)<span></span>
</td>
<td class="num">$ (10,561)<span></span>
</td>
<td class="num">$ (11,209)<span></span>
</td>
<td class="num">$ (18,838)<span></span>
</td>
<td class="num">$ (7,229)<span></span>
</td>
<td class="num">$ (11,827)<span></span>
</td>
<td class="num">$ (31,853)<span></span>
</td>
<td class="num">$ (37,894)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average of common shares and pre-funded warrants outstanding, basic (in shares)</a></td>
<td class="nump">16,692,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,582,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,247,864<span></span>
</td>
<td class="nump">11,720,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average of common shares and pre-funded warrants outstanding, diluted (in shares)</a></td>
<td class="nump">16,692,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,582,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,247,864<span></span>
</td>
<td class="nump">11,720,527<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.60)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1.39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.09)<span></span>
</td>
<td class="num">$ (3.23)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">6,019,326<span></span>
</td>
<td class="nump">3,268,071<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Shares issuable upon exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">2,464,007<span></span>
</td>
<td class="nump">819,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Shares issuable upon the exercise of warrants (excluding pre-funded warrants)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities (in shares)</a></td>
<td class="nump">3,555,319<span></span>
</td>
<td class="nump">2,448,769<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2025</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,365,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock and common warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 22,882,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,143,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261,830<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of common stock and common warrants from the January 2025 Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from Issuance of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember', window );">Senior Secured Convertible Promissory Note | Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember', window );">Pre-Funded Warrant | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Equity-classified broker warrants, number of shares of common stock to purchase (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,573<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_AccruedInterestPremiumForConvertiblePreferredStock', window );">Accrued interest</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember', window );">March Subscription Agreement | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of Stock, Consideration Received on Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of Stock, Consideration Received on Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | Yekaterina Chudnovsky And Jay Venkatesan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from issuance of common stock and common warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember', window );">July Public Offering | Pre-Funded Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of equity-classified broker warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember', window );">Purchase of Warrants | July Public Offering | July Pre-Funded Warrants and July Common Warrants | Yekaterina Chudnovsky</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember', window );">Purchase of Warrants | July Public Offering | July Pre-Funded Warrants and July Common Warrants | Jay Venkatesan and Trusts Affiliated With Jay Venkatesan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_angn_ClassOfWarrantOrRightIssuedInPeriod', window );">Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_AccruedInterestPremiumForConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Interest Premium For Convertible Preferred Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_AccruedInterestPremiumForConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_angn_ClassOfWarrantOrRightIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Issued In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">angn_ClassOfWarrantOrRightIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>angn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=angn_SeniorSecuredConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_PreFundedWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_MarchSubscriptionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=angn_JulyPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyAndJayVenkatesanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyAndJayVenkatesanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=angn_PurchaseOfWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_YekaterinaChudnovskyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2025 </div>
<div>USD ($) </div>
<div>entity</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 5,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,823<span></span>
</td>
<td class="nump">$ 22,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Employee related general and administrative expenses</a></td>
<td class="nump">3,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,049<span></span>
</td>
<td class="nump">8,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(10,083)<span></span>
</td>
<td class="num">$ (10,561)<span></span>
</td>
<td class="num">$ (11,209)<span></span>
</td>
<td class="num">(18,838)<span></span>
</td>
<td class="num">$ (7,229)<span></span>
</td>
<td class="num">$ (11,827)<span></span>
</td>
<td class="num">(31,853)<span></span>
</td>
<td class="num">(37,894)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">28,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember', window );">Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecoveryOfDirectCosts', window );">Contract and grant reimbursements</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(544)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(754)<span></span>
</td>
<td class="num">(888)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Employee related general and administrative expenses</a></td>
<td class="nump">1,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,782<span></span>
</td>
<td class="nump">2,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherGeneralAndAdministrativeExpense', window );">Professional fees and other general and administrative expenses</a></td>
<td class="nump">1,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,289<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,259<span></span>
</td>
<td class="nump">5,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">2,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,984<span></span>
</td>
<td class="nump">6,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">10,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,838<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,853<span></span>
</td>
<td class="nump">37,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total segment assets</a></td>
<td class="nump">28,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_ClinicalTrailMember', window );">Clinical trial expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">1,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,491<span></span>
</td>
<td class="nump">9,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember', window );">Employee related research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,995<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,696<span></span>
</td>
<td class="nump">6,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember', window );">Chemistry, manufacturing and controls expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,486<span></span>
</td>
<td class="nump">3,534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=angn_OtherMember', window );">Other research and development expenses | Reportable Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 1,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,909<span></span>
</td>
<td class="nump">$ 4,849<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of general and administrative expense classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecoveryOfDirectCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecoveryOfDirectCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-18<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=angn_ReportableSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_ClinicalTrailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_ClinicalTrailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_EmployeeRelatedReasearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_TranslationalMedicineAndCMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=angn_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=angn_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>269</ContextCount>
  <ElementCount>271</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>74</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Deficit)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Stockholders??? Equity (Deficit) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Description of the Business and Financial Condition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition</Role>
      <ShortName>Description of the Business and Financial Condition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponents</Role>
      <ShortName>Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Research Grants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ResearchGrants</Role>
      <ShortName>Research Grants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Common Stock and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommonStockandStockholdersEquity</Role>
      <ShortName>Common Stock and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.angn.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/FairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsTables</Role>
      <ShortName>Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/BalanceSheetComponents</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/StockBasedCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/Warrants</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/Leases</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/NetLossPerShare</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.angn.com/role/SegmentReporting</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Description of the Business and Financial Condition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails</Role>
      <ShortName>Description of the Business and Financial Condition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails</Role>
      <ShortName>Balance Sheet Components - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Research Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/ResearchGrantsDetails</Role>
      <ShortName>Research Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/ResearchGrants</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Common Stock and Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommonStockandStockholdersEquityDetails</Role>
      <ShortName>Common Stock and Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/CommonStockandStockholdersEquity</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Share Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails</Role>
      <ShortName>Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsNarrativeDetails</Role>
      <ShortName>Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails</Role>
      <ShortName>Warrants - Schedule of Outstanding Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Warrants - Schedule of Warrants Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails</Role>
      <ShortName>Warrants - Schedule of Warrants Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/CommitmentsandContingencies</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Quantitative Information about Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/DebtDetails</Role>
      <ShortName>Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/Debt</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/IncomeTaxes</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/RelatedPartyTransactions</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="angn-20250930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Segment Reporting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.angn.com/role/SegmentReportingDetails</Role>
      <ShortName>Segment Reporting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.angn.com/role/SegmentReportingTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="angn-20250930.htm">angn-20250930.htm</File>
    <File>angn-20250930.xsd</File>
    <File>angn-20250930_cal.xml</File>
    <File>angn-20250930_def.xml</File>
    <File>angn-20250930_lab.xml</File>
    <File>angn-20250930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="732">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>84
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "angn-20250930.htm": {
   "nsprefix": "angn",
   "nsuri": "http://www.angn.com/20250930",
   "dts": {
    "inline": {
     "local": [
      "angn-20250930.htm"
     ]
    },
    "schema": {
     "local": [
      "angn-20250930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "angn-20250930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "angn-20250930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "angn-20250930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "angn-20250930_pre.xml"
     ]
    }
   },
   "keyStandard": 226,
   "keyCustom": 45,
   "axisStandard": 26,
   "axisCustom": 0,
   "memberStandard": 26,
   "memberCustom": 47,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://fasb.org/us-gaap/2025": 1
   },
   "contextCount": 269,
   "entityCount": 1,
   "segmentCount": 74,
   "elementCount": 574,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 732,
    "http://xbrl.sec.gov/dei/2025": 30,
    "http://xbrl.sec.gov/ecd/2025": 4
   },
   "report": {
    "R1": {
     "role": "http://www.angn.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RestrictedCashCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesIssued",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "longName": "9952153 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
     "longName": "9952154 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-51",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-57",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
     "longName": "9952155 - Statement - Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Stockholders\u2019 Equity (Deficit) (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-15",
      "name": "us-gaap:AmortizationOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition",
     "longName": "9952157 - Disclosure - Description of the Business and Financial Condition",
     "shortName": "Description of the Business and Financial Condition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952158 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.angn.com/role/FairValueMeasurements",
     "longName": "9952159 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.angn.com/role/BalanceSheetComponents",
     "longName": "9952160 - Disclosure - Balance Sheet Components",
     "shortName": "Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.angn.com/role/ResearchGrants",
     "longName": "9952161 - Disclosure - Research Grants",
     "shortName": "Research Grants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.angn.com/role/CommonStockandStockholdersEquity",
     "longName": "9952162 - Disclosure - Common Stock and Stockholders' Equity",
     "shortName": "Common Stock and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.angn.com/role/StockBasedCompensation",
     "longName": "9952163 - Disclosure - Stock-Based Compensation",
     "shortName": "Stock-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.angn.com/role/Warrants",
     "longName": "9952164 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "angn:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:WarrantsAndRightsOutstandingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.angn.com/role/CommitmentsandContingencies",
     "longName": "9952165 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.angn.com/role/Leases",
     "longName": "9952166 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.angn.com/role/Debt",
     "longName": "9952167 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.angn.com/role/IncomeTaxes",
     "longName": "9952168 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.angn.com/role/NetLossPerShare",
     "longName": "9952169 - Disclosure - Net Loss Per Share",
     "shortName": "Net Loss Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.angn.com/role/RelatedPartyTransactions",
     "longName": "9952170 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.angn.com/role/SegmentReporting",
     "longName": "9952171 - Disclosure - Segment Reporting",
     "shortName": "Segment Reporting",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "angn:GrantRevenuePolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:GrantRevenuePolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.angn.com/role/FairValueMeasurementsTables",
     "longName": "9955512 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsTables",
     "longName": "9955513 - Disclosure - Balance Sheet Components (Tables)",
     "shortName": "Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.angn.com/role/StockBasedCompensationTables",
     "longName": "9955514 - Disclosure - Stock-Based Compensation (Tables)",
     "shortName": "Stock-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.angn.com/role/WarrantsTables",
     "longName": "9955515 - Disclosure - Warrants (Tables)",
     "shortName": "Warrants (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.angn.com/role/LeasesTables",
     "longName": "9955516 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.angn.com/role/NetLossPerShareTables",
     "longName": "9955517 - Disclosure - Net Loss Per Share (Tables)",
     "shortName": "Net Loss Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.angn.com/role/SegmentReportingTables",
     "longName": "9955518 - Disclosure - Segment Reporting (Tables)",
     "shortName": "Segment Reporting (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails",
     "longName": "9955519 - Disclosure - Description of the Business and Financial Condition (Details)",
     "shortName": "Description of the Business and Financial Condition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R33": {
     "role": "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "9955520 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R34": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
     "longName": "9955521 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails",
     "longName": "9955522 - Disclosure - Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value, Liabilities, Measured on Recurring Basis, Unobservable Input Reconciliation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-108",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-109",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
     "longName": "9955523 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-115",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-115",
      "name": "us-gaap:WarrantsAndRightsOutstandingTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955524 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-159",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R38": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
     "longName": "9955525 - Disclosure - Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "shortName": "Balance Sheet Components - Schedule of Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "angn:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "angn:PrepaidResearchAndDevelopmentExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955526 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
     "longName": "9955527 - Disclosure - Balance Sheet Components - Narrative (Details)",
     "shortName": "Balance Sheet Components - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R41": {
     "role": "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
     "longName": "9955528 - Disclosure - Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "shortName": "Balance Sheet Components - Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.angn.com/role/ResearchGrantsDetails",
     "longName": "9955529 - Disclosure - Research Grants (Details)",
     "shortName": "Research Grants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-135",
      "name": "angn:ResearchAndDevelopmentArrangementGrant",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
     "longName": "9955530 - Disclosure - Common Stock and Stockholders' Equity (Details)",
     "shortName": "Common Stock and Stockholders' Equity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
     "longName": "9955531 - Disclosure - Stock-Based Compensation - Narrative (Details)",
     "shortName": "Stock-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails",
     "longName": "9955532 - Disclosure - Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Share Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails",
     "longName": "9955533 - Disclosure - Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Components of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
     "longName": "9955534 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "shortName": "Stock-Based Compensation - Schedule of Assumptions Used to Estimate Fair Value of Stock Option Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-176",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-176",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.angn.com/role/WarrantsNarrativeDetails",
     "longName": "9955535 - Disclosure - Warrants - Narrative (Details)",
     "shortName": "Warrants - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-188",
      "name": "angn:WarrantExercisedFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
     "longName": "9955536 - Disclosure - Warrants - Schedule of Outstanding Warrants (Details)",
     "shortName": "Warrants - Schedule of Outstanding Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails",
     "longName": "9955537 - Disclosure - Warrants - Schedule of Warrants Activity (Details)",
     "shortName": "Warrants - Schedule of Warrants Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "angn:ClassOfWarrantOrRightExercisedInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.angn.com/role/CommitmentsandContingenciesDetails",
     "longName": "9955538 - Disclosure - Commitments and Contingencies (Details)",
     "shortName": "Commitments and Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-222",
      "name": "us-gaap:RoyaltyExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.angn.com/role/LeasesNarrativeDetails",
     "longName": "9955539 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails",
     "longName": "9955540 - Disclosure - Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "shortName": "Leases - Schedule of Quantitative Information about Operating Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails",
     "longName": "9955541 - Disclosure - Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "shortName": "Leases - Schedule of Maturities of Lease Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.angn.com/role/DebtDetails",
     "longName": "9955542 - Disclosure - Debt (Details)",
     "shortName": "Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-238",
      "name": "angn:ClassOfWarrantOrRightOwnershipPercentMaximum",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.angn.com/role/IncomeTaxesDetails",
     "longName": "9955543 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "us-gaap:IncomeTaxExpenseBenefit",
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:IncomeTaxExpenseBenefit",
       "us-gaap:IncomeTaxExpenseBenefit",
       "us-gaap:IncomeTaxExpenseBenefit",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
     "longName": "9955544 - Disclosure - Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "shortName": "Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R58": {
     "role": "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
     "longName": "9955545 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "shortName": "Net Loss Per Share - Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.angn.com/role/RelatedPartyTransactionsDetails",
     "longName": "9955546 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-247",
      "name": "us-gaap:ProceedsFromIssuanceOfWarrants",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.angn.com/role/SegmentReportingDetails",
     "longName": "9955547 - Disclosure - Segment Reporting (Details)",
     "shortName": "Segment Reporting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "entity",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "angn-20250930.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "angn_A2024RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "A2024RegistrationStatementMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Registration Statement",
        "label": "2024 Registration Statement [Member]",
        "documentation": "2024 Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r41",
      "r777"
     ]
    },
    "angn_AccretionOfConvertibleNotesDiscountFromIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AccretionOfConvertibleNotesDiscountFromIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion of convertible notes discount from issuance costs",
        "label": "Accretion Of Convertible Notes Discount From Issuance Costs",
        "documentation": "Accretion Of Convertible Notes Discount From Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AccruedInterestPremiumForConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AccruedInterestPremiumForConvertiblePreferredStock",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued interest",
        "label": "Accrued Interest Premium For Convertible Preferred Stock",
        "documentation": "Accrued Interest Premium For Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "angn_AccruedOtherOperatingLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AccruedOtherOperatingLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued expenses",
        "label": "Accrued Other Operating Liabilities, Current",
        "documentation": "Accrued Other Operating Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccruedProfessionalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued professional fees",
        "label": "Accrued Professional Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "angn_AccruedResearchAndDevelopmentCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AccruedResearchAndDevelopmentCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued research and development",
        "label": "Accrued Research And Development, Current",
        "documentation": "Accrued Research And Development, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r113",
      "r552"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r57",
      "r119",
      "r549",
      "r586",
      "r587",
      "r1034"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Loss",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r7",
      "r15",
      "r413",
      "r416",
      "r481",
      "r582",
      "r583",
      "r911",
      "r912",
      "r913",
      "r969",
      "r970",
      "r971",
      "r972"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r777",
      "r1094"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r602",
      "r969",
      "r970",
      "r971",
      "r972",
      "r1035",
      "r1098"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r337"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r78"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common warrants associated with June 2025 Promissory Note",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r29",
      "r78"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AdvancedProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AdvancedProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advanced professional fees",
        "label": "Advanced Professional Fees",
        "documentation": "Advanced Professional Fees"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r888"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r814",
      "r824",
      "r834",
      "r866"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r817",
      "r827",
      "r837",
      "r869"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r889"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r862",
      "r870",
      "r874",
      "r882"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r367",
      "r373",
      "r374"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization of debt discount",
        "terseLabel": "Other expense related to accretion of discount",
        "label": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r63",
      "r283",
      "r1047"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r283",
      "r959",
      "r1047"
     ]
    },
    "angn_AngionCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AngionCommonStockMember",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Angion Common Stock",
        "label": "Angion Common Stock [Member]",
        "documentation": "Angion Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AngionWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AngionWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Angion Warrants",
        "label": "Angion Warrants [Member]",
        "documentation": "Angion Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AreaOfRealEstateProperty",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of office space (in square feet)",
        "label": "Area of Real Estate Property",
        "documentation": "Area of a real estate property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "terseLabel": "Total segment assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r94",
      "r114",
      "r137",
      "r139",
      "r140",
      "r177",
      "r187",
      "r205",
      "r209",
      "r218",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r403",
      "r405",
      "r451",
      "r537",
      "r538",
      "r545",
      "r640",
      "r735",
      "r736",
      "r748",
      "r777",
      "r792",
      "r793",
      "r805",
      "r992",
      "r993",
      "r1052"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r120",
      "r137",
      "r139",
      "r140",
      "r218",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r403",
      "r405",
      "r451",
      "r777",
      "r992",
      "r993",
      "r1052"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r768"
     ]
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsFairValueDisclosureAbstract",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets, Fair Value Disclosure [Abstract]",
        "label": "Assets, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreement2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2022Member",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2022",
        "label": "At-The-Market Equity Offering Sales Agreement 2022 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2022"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreement2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AtTheMarketEquityOfferingSalesAgreement2024Member",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement 2024",
        "label": "At-The-Market Equity Offering Sales Agreement 2024 [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement 2024"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketEquityOfferingSalesAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AtTheMarketEquityOfferingSalesAgreementMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-The-Market Equity Offering Sales Agreement",
        "label": "At-The-Market Equity Offering Sales Agreement [Member]",
        "documentation": "At-The-Market Equity Offering Sales Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "angn_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "At-the-Market Offering",
        "label": "At-the-Market Offering [Member]",
        "documentation": "At-the-Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r877"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r878"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r876"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r875"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r961"
     ]
    },
    "angn_BostonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "BostonMassachusettsMember",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Boston, Massachusetts",
        "label": "Boston, Massachusetts [Member]",
        "documentation": "Boston, Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Axis]",
        "label": "Project [Axis]",
        "documentation": "Information by project."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r533",
      "r1061"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r111",
      "r715"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Money market funds",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r1036",
      "r1037"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash at the beginning of the period",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at the end of the period",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r67",
      "r134"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of cash and cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase in cash and cash equivalents",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation",
        "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r67"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r850"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r848"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r116",
      "r117",
      "r118",
      "r137",
      "r140",
      "r167",
      "r168",
      "r170",
      "r172",
      "r179",
      "r180",
      "r218",
      "r252",
      "r254",
      "r255",
      "r256",
      "r259",
      "r260",
      "r291",
      "r292",
      "r294",
      "r295",
      "r297",
      "r299",
      "r302",
      "r303",
      "r306",
      "r309",
      "r316",
      "r451",
      "r593",
      "r594",
      "r595",
      "r596",
      "r602",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r628",
      "r648",
      "r671",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r893",
      "r964",
      "r966",
      "r973"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r179",
      "r294",
      "r302",
      "r303",
      "r304",
      "r306",
      "r309",
      "r314",
      "r316",
      "r411",
      "r593",
      "r594",
      "r595",
      "r596",
      "r749",
      "r893",
      "r962",
      "r964"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of equity-classified broker warrants (in dollars per share)",
        "netLabel": "Weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Outstanding beginning balance (in dollars per share)",
        "periodEndLabel": "Outstanding ending balance (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r142",
      "r317"
     ]
    },
    "angn_ClassOfWarrantOrRightExercisedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightExercisedInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Class Of Warrant Or Right, Exercised In Period",
        "documentation": "Class Of Warrant Or Right, Exercised In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightIssuedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightIssuedInPeriod",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in shares)",
        "label": "Class Of Warrant Or Right, Issued In Period",
        "documentation": "Class Of Warrant Or Right, Issued In Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity-classified broker warrants, number of shares of common stock to purchase (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r317"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails",
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of warrants outstanding (in shares)",
        "periodStartLabel": "Outstanding beginning balance (in shares)",
        "periodEndLabel": "Outstanding ending balance (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightOwnershipPercentMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightOwnershipPercentMaximum",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership maximum (as a percent)",
        "label": "Class of Warrant or Right, Ownership Percent Maximum",
        "documentation": "Class of Warrant or Right, Ownership Percent Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Class of Warrant or Right [Roll Forward]",
        "documentation": "Class of Warrant or Right"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Table]",
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price, Exercises In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued (in dollars per share)",
        "label": "Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period",
        "documentation": "Class Of Warrant Or Right, Weighted Average Exercise Price, Issued In Period"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightWeightedAverageExercisePriceRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Class of Warrant or Right, Weighted Average Exercise Price [Roll Forward]",
        "documentation": "Weighted Average Exercise Rollforward"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightWeightedAverageLife",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding beginning balance (in years)",
        "periodEndLabel": "Outstanding ending balance (in years)",
        "label": "Class of Warrant Or Right, Weighted Average Life",
        "documentation": "Class of Warrant Or Right, Weighted Average Life"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageLifeRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightWeightedAverageLifeRollForward",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofWarrantsActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Life (years)",
        "label": "Class of Warrant or Right, Weighted Average Life [Roll Forward]",
        "documentation": "Class of Warrant or Right, Weighted Average Life"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Remaining Contractual Life (years)",
        "label": "Class of Warrant or Right, Weighted Average Remaining Contractual Terms",
        "documentation": "Class of Warrant or Right, Weighted Average Remaining Contractual Terms"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ClinicalTrailMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ClinicalTrailMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial expenses",
        "label": "Clinical Trail [Member]",
        "documentation": "Clinical Trail"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "angn_CollaborativeArrangementFutureMinimumMaintenancePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "CollaborativeArrangementFutureMinimumMaintenancePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Future minimum annual maintenance payments",
        "label": "Collaborative Arrangement, Future Minimum Maintenance Payments",
        "documentation": "Collaborative Arrangement, Future Minimum Maintenance Payments"
       }
      }
     },
     "auth_ref": []
    },
    "angn_CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate sales milestone payments per product",
        "label": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product",
        "documentation": "Collaborative Arrangement, Rights and Obligations, Maximum Aggregate Milestone Payments, Per Product"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r1029"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies - Note 9",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r88",
      "r546",
      "r627"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_CommitmentsAndContingenciesDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "CommitmentsAndContingenciesDisclosureLineItems",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Line Items]",
        "label": "Commitments and Contingencies Disclosure [Line Items]",
        "documentation": "Commitments and Contingencies Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "angn_CommitmentsAndContingenciesDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "CommitmentsAndContingenciesDisclosureTable",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Table]",
        "label": "Commitments and Contingencies Disclosure [Table]",
        "documentation": "Commitments and Contingencies Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r244",
      "r245",
      "r698",
      "r984",
      "r989"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r797",
      "r799",
      "r800",
      "r801",
      "r802",
      "r969",
      "r970",
      "r972",
      "r1035",
      "r1093",
      "r1098"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r628"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "periodEndLabel": "Balance at end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r628",
      "r646",
      "r1098",
      "r1099"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.01 par value per share; 300,000,000 shares authorized; 17,273,107 shares and 11,043,837 shares issued at September\u00a030, 2025 and December\u00a031, 2024, respectively; 17,258,652 and 11,029,382 outstanding as of September\u00a030, 2025 and December\u00a031, 2024, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r292",
      "r298",
      "r548",
      "r777"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive loss",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r122",
      "r124",
      "r128",
      "r535",
      "r556",
      "r557"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred research obligation",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322"
     ]
    },
    "angn_ConversionOfConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ConversionOfConvertibleDebtMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Convertible Debt",
        "label": "Conversion Of Convertible Debt [Member]",
        "documentation": "Conversion Of Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ConversionOfConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ConversionOfConvertiblePreferredStockMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion Of Convertible Preferred Stock",
        "label": "Conversion Of Convertible Preferred Stock [Member]",
        "documentation": "Conversion Of Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion Description [Axis]",
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Stock, Name [Domain]",
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r20",
      "r21"
     ]
    },
    "us-gaap_ConvertibleDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConvertibleDebtMember",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Notes Payable",
        "label": "Convertible Debt [Member]",
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r262",
      "r263",
      "r273",
      "r274",
      "r275",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "angn_CostsExpensedUponTheIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "CostsExpensedUponTheIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs Expensed Upon The Issuance Of Warrants",
        "label": "Costs Expensed Upon The Issuance Of Warrants",
        "documentation": "Costs Expensed Upon The Issuance Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r145",
      "r146",
      "r265",
      "r304",
      "r487",
      "r494",
      "r544",
      "r717",
      "r718",
      "r719",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r1030",
      "r1031",
      "r1032",
      "r1033"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r137",
      "r138",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r250",
      "r251",
      "r261",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r277",
      "r284",
      "r285",
      "r287",
      "r411",
      "r466"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r42",
      "r43",
      "r86",
      "r87",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r775",
      "r962",
      "r963",
      "r965",
      "r968",
      "r985",
      "r986",
      "r987",
      "r1046",
      "r1048",
      "r1062"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Principal amount",
        "terseLabel": "Debt instrument, face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r466",
      "r467",
      "r744",
      "r745",
      "r775"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stated interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r263"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r286",
      "r411",
      "r541",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r775",
      "r962",
      "r963",
      "r965",
      "r968",
      "r1046",
      "r1048"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r775",
      "r962",
      "r963",
      "r965",
      "r968",
      "r985",
      "r986",
      "r987",
      "r1046",
      "r1048",
      "r1062"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r32",
      "r35",
      "r40",
      "r76",
      "r77",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r268",
      "r273",
      "r274",
      "r275",
      "r276",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r286",
      "r411",
      "r541",
      "r743",
      "r744",
      "r745",
      "r746",
      "r747",
      "r775",
      "r962",
      "r963",
      "r965",
      "r968",
      "r1046",
      "r1048"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt discount",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "documentation": "Amount, after accumulated amortization, of debt discount (premium)."
       }
      }
     },
     "auth_ref": [
      "r995",
      "r1045",
      "r1046",
      "r1048"
     ]
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid and Other Current Assets",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Depreciation",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r26",
      "r132",
      "r720",
      "r721",
      "r723",
      "r725"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r335",
      "r339",
      "r368",
      "r369",
      "r371",
      "r759"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Black-Scholes Option-Pricing Model Following Assumptions",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r997"
     ]
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of equipment",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r232",
      "r959",
      "r983"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r809"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, basic (in dollars per share)",
        "verboseLabel": "Net loss per share, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r129",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r165",
      "r167",
      "r170",
      "r171",
      "r172",
      "r176",
      "r290",
      "r372",
      "r396",
      "r401",
      "r424",
      "r425",
      "r536",
      "r558",
      "r727"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net loss per common share, diluted (in dollars per share)",
        "verboseLabel": "Net loss per share, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r129",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r167",
      "r170",
      "r171",
      "r172",
      "r176",
      "r290",
      "r372",
      "r396",
      "r401",
      "r424",
      "r425",
      "r536",
      "r558",
      "r727"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Loss Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r173",
      "r174",
      "r175"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of foreign currency on cash and cash equivalents",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "angn_ElicioWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ElicioWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elicio Warrants",
        "label": "Elicio Warrants [Member]",
        "documentation": "Elicio Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "angn_EmployeeRelatedReasearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "EmployeeRelatedReasearchAndDevelopmentMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee related research and development expenses",
        "label": "Employee Related Reasearch and Development [Member]",
        "documentation": "Employee Related Reasearch and Development"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r1024"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards, period for recognition (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r370"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation related to unvested stock option awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1025"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option",
        "verboseLabel": "Shares issuable upon exercise of stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r891"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r807"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r887"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r99",
      "r100",
      "r101",
      "r125",
      "r126",
      "r127",
      "r147",
      "r148",
      "r149",
      "r151",
      "r158",
      "r160",
      "r162",
      "r178",
      "r219",
      "r220",
      "r231",
      "r289",
      "r318",
      "r372",
      "r386",
      "r387",
      "r393",
      "r394",
      "r395",
      "r397",
      "r400",
      "r401",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r468",
      "r470",
      "r481",
      "r555",
      "r582",
      "r583",
      "r584",
      "r602",
      "r671"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r856"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r814",
      "r824",
      "r834",
      "r866"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r811",
      "r821",
      "r831",
      "r863"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Change in fair value of warrant liabilities",
        "terseLabel": "Change in fair value of warrant liabilities",
        "negatedLabel": "Loss on fair value of warrants",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r762",
      "r764",
      "r770"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r762",
      "r764",
      "r770"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Measurement Inputs and Valuation Techniques",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r770"
     ]
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r449",
      "r450",
      "r712",
      "r774",
      "r1043"
     ]
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r448",
      "r450",
      "r712",
      "r774",
      "r1042",
      "r1043"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r440",
      "r441",
      "r443",
      "r448",
      "r489",
      "r490",
      "r491",
      "r712",
      "r744",
      "r745",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r768",
      "r770",
      "r774"
     ]
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByLiabilityClassAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability Class [Axis]",
        "label": "Liability Class [Axis]",
        "documentation": "Information by class of liability."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r442"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r431",
      "r768",
      "r1039",
      "r1041"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r436",
      "r438",
      "r439",
      "r440",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r534",
      "r768",
      "r771"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r324",
      "r329",
      "r330",
      "r428",
      "r441",
      "r448",
      "r489",
      "r712",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r768",
      "r774"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r324",
      "r329",
      "r330",
      "r332",
      "r428",
      "r429",
      "r441",
      "r448",
      "r490",
      "r712",
      "r744",
      "r745",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r768",
      "r774"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r428",
      "r429",
      "r430",
      "r431",
      "r441",
      "r448",
      "r491",
      "r712",
      "r744",
      "r745",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r768",
      "r770",
      "r774"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value by Liability Class [Domain]",
        "label": "Fair Value by Liability Class [Domain]",
        "documentation": "Represents classes of liabilities measured and disclosed at fair value."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r442"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "documentation": "Disclosure of information about financial instrument liability measured at fair value on recurring basis using unobservable input."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r437",
      "r442"
     ]
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r437",
      "r442"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r427",
      "r428",
      "r429",
      "r431",
      "r768",
      "r1039",
      "r1041"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in fair value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3)."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r442"
     ]
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance, beginning of the period",
        "periodEndLabel": "Balance, end of the period",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r442"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r426",
      "r428",
      "r429",
      "r430",
      "r431",
      "r440",
      "r441",
      "r443",
      "r448",
      "r489",
      "r490",
      "r491",
      "r712",
      "r744",
      "r745",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r768",
      "r770",
      "r774"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value measurements, recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r768",
      "r1036",
      "r1037",
      "r1038",
      "r1039",
      "r1040",
      "r1041"
     ]
    },
    "angn_FairValueOfCommonStockWarrantsUponSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "FairValueOfCommonStockWarrantsUponSettlement",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common stock warrants upon settlement",
        "label": "Fair Value Of Common Stock Warrants Upon Settlement",
        "documentation": "Fair Value Of Common Stock Warrants Upon Settlement"
       }
      }
     },
     "auth_ref": []
    },
    "angn_FairValueOfPreFundedWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "FairValueOfPreFundedWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of pre-funded warrants at issuance date",
        "label": "Fair Value of Pre-Funded Warrants",
        "documentation": "Fair Value of Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign exchange transaction (loss) gain",
        "label": "Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r455",
      "r456",
      "r457",
      "r458",
      "r668"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r870"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "angn_GKCCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "GKCCMember",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GKCC",
        "label": "GKCC [Member]",
        "documentation": "GKCC"
       }
      }
     },
     "auth_ref": []
    },
    "angn_GainLossOnIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "GainLossOnIssuanceOfWarrants",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on issuance of pre-funded warrants",
        "negatedTerseLabel": "Loss on issuance of warrants",
        "negatedLabel": "Loss on issuance of warrants",
        "label": "Gain (Loss) On Issuance Of Warrants",
        "documentation": "Gain (Loss) On Issuance Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on disposal of property and equipment, net",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "verboseLabel": "Employee related general and administrative expenses",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r650"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r61"
     ]
    },
    "angn_GrantRevenueNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "GrantRevenueNonoperating",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant income",
        "label": "Grant Revenue, Nonoperating",
        "documentation": "Grant Revenue, Nonoperating"
       }
      }
     },
     "auth_ref": []
    },
    "angn_GrantRevenuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "GrantRevenuePolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant Income",
        "label": "Grant Revenue [Policy Text Block]",
        "documentation": "Grant Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r240",
      "r241",
      "r407",
      "r408",
      "r409",
      "r410",
      "r433",
      "r437",
      "r442",
      "r452",
      "r453",
      "r454",
      "r579",
      "r581",
      "r655",
      "r711",
      "r712",
      "r762",
      "r763",
      "r766",
      "r767",
      "r769",
      "r774",
      "r1027",
      "r1028",
      "r1064"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount is reported."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r241",
      "r407",
      "r408",
      "r409",
      "r410",
      "r433",
      "r437",
      "r442",
      "r452",
      "r453",
      "r454",
      "r579",
      "r581",
      "r655",
      "r711",
      "r712",
      "r762",
      "r763",
      "r766",
      "r767",
      "r769",
      "r774",
      "r1027",
      "r1028",
      "r1064"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r141",
      "r378",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r388",
      "r390",
      "r391",
      "r392",
      "r543",
      "r589",
      "r598",
      "r761"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax provision (benefit)",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r97",
      "r137",
      "r161",
      "r162",
      "r177",
      "r195",
      "r209",
      "r379",
      "r380",
      "r389",
      "r559",
      "r722",
      "r724",
      "r726",
      "r761"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "angn_IncreaseDecreaseInAccruedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "IncreaseDecreaseInAccruedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Increase (Decrease) In Accrued Expenses",
        "documentation": "Increase (Decrease) In Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred research obligation",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r496",
      "r958"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r897",
      "r958"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other long-term prepaid assets",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r958"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other current assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r862",
      "r870",
      "r874",
      "r882"
     ]
    },
    "angn_Inducement2024PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "Inducement2024PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement 2024 Plan",
        "label": "Inducement 2024 Plan [Member]",
        "documentation": "Inducement 2024 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r886"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r886"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r810",
      "r886"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense, debt",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r281",
      "r288",
      "r746",
      "r747",
      "r1096"
     ]
    },
    "angn_InterestExpenseNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "InterestExpenseNoncash",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Interest Expense, Noncash",
        "documentation": "Interest Expense, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r191",
      "r722",
      "r726",
      "r915"
     ]
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r190",
      "r209",
      "r735",
      "r914"
     ]
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock and warrants from the January Offering",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "angn_January2025CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "January2025CommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2025 Common Warrants",
        "label": "January 2025 Common Warrants [Member]",
        "documentation": "January 2025 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JanuaryCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JanuaryCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January Common Warrants",
        "label": "January Common Warrants [Member]",
        "documentation": "January Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JanuaryPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JanuaryPublicOfferingMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "January 2025 Public Offering",
        "label": "January Public Offering [Member]",
        "documentation": "January Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan",
        "label": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan [Member]",
        "documentation": "Jay Venkatesan and Trusts Affiliated With Jay Venkatesan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JulyCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Common Warrants",
        "verboseLabel": "July 2024 Common Warrants",
        "label": "July Common Warrants [Member]",
        "documentation": "July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPreFundedWarrantsAndJulyCommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JulyPreFundedWarrantsAndJulyCommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants and July Common Warrants",
        "label": "July Pre-Funded Warrants and July Common Warrants [Member]",
        "documentation": "July Pre-Funded Warrants and July Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JulyPreFundedWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Pre-Funded Warrants",
        "label": "July Pre-Funded Warrants [Member]",
        "documentation": "July Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulyPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JulyPublicOfferingMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Public Offering",
        "verboseLabel": "July 2024 Public Offering",
        "label": "July Public Offering [Member]",
        "documentation": "Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_JulySharesAndJulyCommonWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "JulySharesAndJulyCommonWarrantMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July Share And July Common Warrant",
        "label": "July Shares And July Common Warrant [Member]",
        "documentation": "July Shares And July Common Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "angn_June2025CommonWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "June2025CommonWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June 2025 Common Warrants",
        "label": "June 2025 Common Warrants [Member]",
        "documentation": "June 2025 Common Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_June2025WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "June2025WarrantsMember",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "June 2025 Warrants",
        "label": "June 2025 Warrants [Member]",
        "documentation": "June 2025 Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r479"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r480"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r474",
      "r480"
     ]
    },
    "angn_LesseeOperatingLeaseAnnualRentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "LesseeOperatingLeaseAnnualRentExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, payment per year",
        "label": "Lessee, Operating Lease, Annual Rent Expense",
        "documentation": "Lessee, Operating Lease, Annual Rent Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r963",
      "r968",
      "r1062"
     ]
    },
    "angn_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee\u200b Operating \u200bLease\u200b Liability\u200b Payments\u200b Due\u200b After\u200b Year\u200b Four",
        "documentation": "Lessee\u200b Operating \u200bLease\u200b Liability\u200b Payments\u200b Due\u200b After\u200b Year\u200b Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r963",
      "r968",
      "r1062"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r963",
      "r968",
      "r1062"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r963",
      "r968",
      "r1062"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r478",
      "r963",
      "r968",
      "r1062"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025 (remaining three months)",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less present value discount",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r478"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.angn.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r469"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r42",
      "r43",
      "r44",
      "r46",
      "r47",
      "r48",
      "r49",
      "r137",
      "r139",
      "r140",
      "r218",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r404",
      "r405",
      "r406",
      "r451",
      "r626",
      "r729",
      "r748",
      "r805",
      "r992",
      "r1052",
      "r1053"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r89",
      "r551",
      "r777",
      "r792",
      "r793",
      "r962",
      "r967",
      "r981",
      "r1044"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 equity (deficit)",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r110",
      "r137",
      "r139",
      "r140",
      "r218",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r404",
      "r405",
      "r406",
      "r451",
      "r777",
      "r992",
      "r1052",
      "r1053"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r1036"
     ]
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, Fair Value Disclosure [Abstract]",
        "label": "Liabilities, Fair Value Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/DebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, net of debt discount and debt issuance costs",
        "verboseLabel": "Net carrying value",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r985",
      "r986",
      "r987"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r28",
      "r985",
      "r986",
      "r987"
     ]
    },
    "angn_March2024PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "March2024PreFundedWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March 2024 Pre-Funded Warrants",
        "label": "March 2024 Pre-Funded Warrants [Member]",
        "documentation": "March 2024 Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "angn_MarchSubscriptionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "MarchSubscriptionAgreementMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "March Subscription Agreement",
        "label": "March Subscription Agreement [Member]",
        "documentation": "March Subscription Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r246",
      "r247",
      "r248",
      "r249",
      "r333",
      "r363",
      "r364",
      "r365",
      "r375",
      "r431",
      "r495",
      "r578",
      "r580",
      "r588",
      "r618",
      "r619",
      "r678",
      "r680",
      "r682",
      "r683",
      "r685",
      "r693",
      "r694",
      "r696",
      "r697",
      "r708",
      "r709",
      "r740",
      "r749",
      "r758",
      "r762",
      "r764",
      "r765",
      "r770",
      "r771",
      "r772",
      "r773",
      "r787",
      "r994",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputExpectedDividendRateMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (per share)",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputPriceVolatilityMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility (annual)",
        "label": "Measurement Input, Price Volatility [Member]",
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r770",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "angn_MeasurementInputStrikePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "MeasurementInputStrikePriceMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average strike price",
        "label": "Measurement Input, Strike Price [Member]",
        "documentation": "Measurement Input, Strike Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r429",
      "r430",
      "r431",
      "r762",
      "r764",
      "r765",
      "r770"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r430",
      "r431",
      "r762",
      "r764",
      "r765",
      "r770"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r246",
      "r247",
      "r248",
      "r249",
      "r333",
      "r363",
      "r364",
      "r365",
      "r375",
      "r431",
      "r495",
      "r578",
      "r580",
      "r588",
      "r618",
      "r619",
      "r678",
      "r680",
      "r682",
      "r683",
      "r685",
      "r693",
      "r694",
      "r696",
      "r697",
      "r708",
      "r709",
      "r740",
      "r749",
      "r758",
      "r762",
      "r764",
      "r765",
      "r770",
      "r771",
      "r772",
      "r787",
      "r994",
      "r1054",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r873"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r69"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net loss",
        "terseLabel": "Net loss",
        "verboseLabel": "Net loss",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r69",
      "r90",
      "r101",
      "r108",
      "r121",
      "r123",
      "r127",
      "r137",
      "r139",
      "r140",
      "r144",
      "r150",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r169",
      "r218",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r290",
      "r293",
      "r296",
      "r300",
      "r372",
      "r396",
      "r401",
      "r425",
      "r451",
      "r554",
      "r647",
      "r669",
      "r670",
      "r722",
      "r724",
      "r726",
      "r803",
      "r992"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Issued Accounting Standards Not Yet Adopted",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "angn_NewtonMassachusettsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "NewtonMassachusettsMember",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Newton, Massachusettes",
        "label": "Newton, Massachusetts [Member]",
        "documentation": "Newton, Massachusetts"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r818",
      "r828",
      "r838",
      "r862",
      "r870"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other (expense), net",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r739",
      "r976"
     ]
    },
    "angn_NumberOfResearchGrantAgreements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "NumberOfResearchGrantAgreements",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of research grant agreements",
        "label": "Number Of Research Grant Agreements",
        "documentation": "Number Of Research Grant Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingCostsAndExpensesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r722",
      "r726",
      "r730",
      "r975",
      "r977",
      "r978",
      "r979",
      "r980"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesNarrativeDetails",
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, current",
        "negatedLabel": "Less: operating lease liability, current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesScheduleofMaturitiesofLeaseLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liability, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r472"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash outflows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r473",
      "r475"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r471"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets, operating leases",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r959"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate\u2014operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r477",
      "r776"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.angn.com/role/LeasesScheduleofQuantitativeInformationaboutOperatingLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average remaining lease term\u2014operating leases (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r776"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialCondition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of the Business and Financial Condition",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r102",
      "r103",
      "r105",
      "r590",
      "r591"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign currency translation adjustment",
        "terseLabel": "Foreign currency translation adjustment",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r7",
      "r83"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxAttributableToParentAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss):",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Alternative [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Professional fees and other general and administrative expenses",
        "label": "Other General and Administrative Expense",
        "documentation": "Amount of general and administrative expense classified as other."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r1097"
     ]
    },
    "us-gaap_OtherIncomeAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherIncomeAndExpensesAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other (expense) income",
        "label": "Other Income and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_OtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "OtherMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other research and development expenses",
        "label": "Other [Member]",
        "documentation": "Other"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r854"
     ]
    },
    "angn_OtherPrepaidExpensesAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "OtherPrepaidExpensesAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other prepaid expenses and other current assets",
        "label": "Other Prepaid Expenses And Other Assets, Current",
        "documentation": "Other Prepaid Expenses And Other Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r816",
      "r826",
      "r836",
      "r868"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r819",
      "r829",
      "r839",
      "r871"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r819",
      "r829",
      "r839",
      "r871"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "angn_PaymentOfWarrantIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "PaymentOfWarrantIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of warrant issuance costs",
        "label": "Payment Of Warrant Issuance Costs",
        "documentation": "Payment Of Warrant Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r862"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r855"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "angn_PreFundedWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "PreFundedWarrantMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrant",
        "verboseLabel": "July 2024 Pre-Funded Warrants",
        "label": "Pre-Funded Warrant [Member]",
        "documentation": "Pre-Funded Warrant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r302"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, shares authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r628"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r901"
     ]
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseOtherNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsNarrativeDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term prepaid assets",
        "label": "Prepaid Expense Other, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r716",
      "r741",
      "r982"
     ]
    },
    "angn_PrepaidResearchAndDevelopmentExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "PrepaidResearchAndDevelopmentExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid research and development contract services",
        "label": "Prepaid Research And Development Expenses",
        "documentation": "Prepaid Research And Development Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and common warrants from the January 2025 Offering",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Issuance of Common Stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "angn_ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock from at-the-market offerings, net of issuance costs",
        "label": "Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs",
        "documentation": "Proceeds From Issuance Of Common Stock From At-The-Market Offerings, Net Of Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from Issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r593"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of related party convertible note",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock and common warrants",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromNotesPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the June 2025 Promissory Note, net of issuance costs",
        "label": "Proceeds from Notes Payable",
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of property and equipment",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "us-gaap_ProceedsFromSecuredLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromSecuredLinesOfCredit",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from secured lines of credit",
        "label": "Proceeds from Secured Lines of Credit",
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exercise of stock options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r12"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from the exercise of common warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r957"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r497",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r713",
      "r721",
      "r724",
      "r726",
      "r750",
      "r751",
      "r786",
      "r787",
      "r788",
      "r791",
      "r794",
      "r896",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r990",
      "r991",
      "r1063",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Clinical trial expenses",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r212",
      "r497",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r713",
      "r721",
      "r724",
      "r726",
      "r750",
      "r751",
      "r786",
      "r787",
      "r788",
      "r791",
      "r794",
      "r896",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941",
      "r942",
      "r943",
      "r944",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r955",
      "r956",
      "r990",
      "r991",
      "r1063",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "us-gaap_ProjectMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProjectMember",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Project [Domain]",
        "label": "Project [Domain]",
        "documentation": "Planned program of work."
       }
      }
     },
     "auth_ref": [
      "r498",
      "r533",
      "r1061"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r479"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r112",
      "r553"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r479"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails",
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r479",
      "r542",
      "r553",
      "r777"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r479"
     ]
    },
    "angn_PurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "PurchaseAgreementMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase Agreement",
        "label": "Purchase Agreement [Member]",
        "documentation": "Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "angn_PurchaseOfWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "PurchaseOfWarrantsMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of Warrants",
        "label": "Purchase Of Warrants [Member]",
        "documentation": "Purchase Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r246",
      "r247",
      "r248",
      "r249",
      "r323",
      "r333",
      "r363",
      "r364",
      "r365",
      "r371",
      "r375",
      "r431",
      "r492",
      "r493",
      "r495",
      "r578",
      "r580",
      "r588",
      "r618",
      "r619",
      "r678",
      "r680",
      "r682",
      "r683",
      "r685",
      "r693",
      "r694",
      "r696",
      "r697",
      "r708",
      "r709",
      "r740",
      "r749",
      "r758",
      "r762",
      "r764",
      "r765",
      "r770",
      "r771",
      "r772",
      "r773",
      "r787",
      "r797",
      "r988",
      "r994",
      "r1039",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r182",
      "r246",
      "r247",
      "r248",
      "r249",
      "r323",
      "r333",
      "r363",
      "r364",
      "r365",
      "r371",
      "r375",
      "r431",
      "r492",
      "r493",
      "r495",
      "r578",
      "r580",
      "r588",
      "r618",
      "r619",
      "r678",
      "r680",
      "r682",
      "r683",
      "r685",
      "r693",
      "r694",
      "r696",
      "r697",
      "r708",
      "r709",
      "r740",
      "r749",
      "r758",
      "r762",
      "r764",
      "r765",
      "r770",
      "r771",
      "r772",
      "r773",
      "r787",
      "r797",
      "r988",
      "r994",
      "r1039",
      "r1055",
      "r1056",
      "r1057",
      "r1058",
      "r1059"
     ]
    },
    "us-gaap_RecoveryOfDirectCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RecoveryOfDirectCosts",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and grant reimbursements",
        "label": "Recovery of Direct Costs",
        "documentation": "Return of or reimbursements received in relation to direct costs and expenses previously paid or incurred."
       }
      }
     },
     "auth_ref": [
      "r58"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r811",
      "r821",
      "r831",
      "r863"
     ]
    },
    "angn_RegistrationStatementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "RegistrationStatementMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Registration Statement",
        "label": "Registration Statement [Member]",
        "documentation": "Registration Statement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Axis]",
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r485",
      "r486",
      "r1051"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Domain]",
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r1051"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transaction [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r217",
      "r485",
      "r486",
      "r487",
      "r651",
      "r652",
      "r655"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r483",
      "r484",
      "r486",
      "r488",
      "r599",
      "r600",
      "r601",
      "r653",
      "r654",
      "r655",
      "r675",
      "r677"
     ]
    },
    "angn_ReportableSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ReportableSegmentMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reportable Segment",
        "label": "Reportable Segment [Member]",
        "documentation": "Reportable Segment"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r145",
      "r146",
      "r265",
      "r304",
      "r487",
      "r494",
      "r544",
      "r717",
      "r718",
      "r719",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r1030",
      "r1031",
      "r1032",
      "r1033"
     ]
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r1026"
     ]
    },
    "angn_ResearchAndDevelopmentArrangementCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ResearchAndDevelopmentArrangementCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit",
        "label": "Research And Development Arrangement, Credit",
        "documentation": "Research And Development Arrangement, Credit"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ResearchAndDevelopmentArrangementGrant",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant award",
        "label": "Research And Development Arrangement, Grant",
        "documentation": "Research And Development Arrangement, Grant"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementGrantReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ResearchAndDevelopmentArrangementGrantReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant award received",
        "label": "Research And Development Arrangement, Grant Received",
        "documentation": "Research And Development Arrangement, Grant Received"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchAndDevelopmentArrangementReimbursementFromGrantFunds": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ResearchAndDevelopmentArrangementReimbursementFromGrantFunds",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reimbursement from grant funds",
        "label": "Research And Development Arrangement, Reimbursement from Grant Funds",
        "documentation": "Research And Development Arrangement, Reimbursement from Grant Funds"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/ResearchGrantsDetails",
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r711",
      "r722",
      "r723",
      "r735",
      "r1060"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/ResearchGrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grants",
        "label": "Research, Development, and Computer Software Disclosure [Text Block]",
        "documentation": "The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r710"
     ]
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Aug. 2024",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) August 2024"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Sept. 2023",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2023"
       }
      }
     },
     "auth_ref": []
    },
    "angn_ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research Grant Agreement with GIRF Sept. 2022",
        "label": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022 [Member]",
        "documentation": "Research Grant Agreement With The Gastro-Intestinal Research Foundation (\u201cGIRF\u201d) Sept. 2022"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r812",
      "r822",
      "r832",
      "r864"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r813",
      "r823",
      "r833",
      "r865"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r820",
      "r830",
      "r840",
      "r872"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash and Cash Equivalent",
        "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r84",
      "r111",
      "r134",
      "r547"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, current",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r899",
      "r960"
     ]
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RestrictedCashNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash, noncurrent",
        "label": "Restricted Cash, Noncurrent",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r900",
      "r960"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/DescriptionoftheBusinessandFinancialConditionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedTerseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r78",
      "r550",
      "r585",
      "r587",
      "r597",
      "r629",
      "r777"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r99",
      "r100",
      "r101",
      "r147",
      "r148",
      "r149",
      "r151",
      "r158",
      "r160",
      "r162",
      "r219",
      "r220",
      "r231",
      "r289",
      "r372",
      "r386",
      "r387",
      "r393",
      "r394",
      "r395",
      "r397",
      "r400",
      "r401",
      "r412",
      "r414",
      "r415",
      "r417",
      "r423",
      "r468",
      "r470",
      "r582",
      "r584",
      "r602",
      "r1098"
     ]
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty expense",
        "label": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "angn_RoyaltyRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "RoyaltyRatePercent",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty rates (as a percent)",
        "label": "Royalty Rate, Percent",
        "documentation": "Royalty Rate, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "angn_SaleOfStockAggregateInitialOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "SaleOfStockAggregateInitialOfferingPrice",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate initial offering price",
        "label": "Sale of Stock, Aggregate Initial Offering Price",
        "documentation": "Sale of Stock, Aggregate Initial Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "angn_SaleOfStockBeneficialOwnershipLimitationPercentage": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "SaleOfStockBeneficialOwnershipLimitationPercentage",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, beneficial ownership limitation, percentage",
        "label": "Sale Of Stock, Beneficial Ownership Limitation, Percentage",
        "documentation": "Sale Of Stock, Beneficial Ownership Limitation, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sale of stock, consideration received on transaction",
        "terseLabel": "Sale of Stock, Consideration Received on Transaction",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares sold in offering (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average price (in dollars per share)",
        "terseLabel": "Share price (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScenarioForecastMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioForecastMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forecast",
        "label": "Forecast [Member]"
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "srt_ScenarioUnspecifiedDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScenarioUnspecifiedDomain",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Domain]",
        "label": "Scenario [Domain]"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106",
      "r163",
      "r334",
      "r894"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Expenses",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded From Computation of Net Loss per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Net Loss Per Share, Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r974"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofComponentsofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1036",
      "r1037"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponentsScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r479"
     ]
    },
    "angn_ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Quantitative Information Regarding Operating Leases",
        "label": "Schedule Of Quantitative Information On Operating Leases [Table Text Block]",
        "documentation": "Schedule Of Quantitative Information On Operating Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]",
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r143",
      "r144",
      "r485",
      "r486",
      "r487",
      "r651",
      "r652",
      "r655"
     ]
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "presentation": [
      "http://www.angn.com/role/ResearchGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "label": "Research and Development, Contract to Perform for Others [Table]",
        "documentation": "Disclosure of information about research and development arrangement accounted for as contract to perform research and development for others. Includes, but is not limited to, royalty arrangement, purchase provision, license agreement, and commitment to provide additional funding."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r1026"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r338",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r371"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r11",
      "r80"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Stock, Class of Stock [Table]",
        "documentation": "Disclosure of information about stock by class. Includes, but is not limited to, common, convertible, and preferred stocks."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r76",
      "r77",
      "r78",
      "r116",
      "r117",
      "r118",
      "r179",
      "r302",
      "r303",
      "r304",
      "r306",
      "r309",
      "r314",
      "r316",
      "r411",
      "r593",
      "r594",
      "r595",
      "r596",
      "r749",
      "r893",
      "r962",
      "r964"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://www.angn.com/role/WarrantsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Outstanding Warrants",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r996"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r806"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r808"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r94",
      "r177",
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r210",
      "r211",
      "r216",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r242",
      "r243",
      "r398",
      "r399",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r732",
      "r735",
      "r736",
      "r742",
      "r790",
      "r1063",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r181",
      "r214",
      "r215",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r537",
      "r538",
      "r539",
      "r540",
      "r615",
      "r616",
      "r617",
      "r679",
      "r681",
      "r684",
      "r686",
      "r693",
      "r695",
      "r696",
      "r697",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r714",
      "r728",
      "r750",
      "r752",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r789",
      "r797",
      "r1063",
      "r1065",
      "r1066",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/SegmentReporting"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r177",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r199",
      "r201",
      "r202",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r216",
      "r731",
      "r733",
      "r734",
      "r735",
      "r737",
      "r738",
      "r739"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r201",
      "r202",
      "r209",
      "r735"
     ]
    },
    "angn_SeniorSecuredConvertiblePromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "SeniorSecuredConvertiblePromissoryNoteMember",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Secured Convertible Promissory Note",
        "label": "Senior Secured Convertible Promissory Note [Member]",
        "documentation": "Senior Secured Convertible Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "angn_SettlementOfPromissoryNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "SettlementOfPromissoryNotesPayable",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of related-party senior note payable and interest into equity",
        "label": "Settlement Of Promissory Notes Payable",
        "documentation": "Settlement Of Promissory Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r365"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r338",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r371"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for future grants (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares authorized for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option Activity, Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (unvested) (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in shares)",
        "periodEndLabel": "Outstanding at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Stock Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding at beginning of period (in dollars per share)",
        "periodEndLabel": "Outstanding at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (unvested) (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofAssumptionsUsedtoEstimateFairValueofStockOptionAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term in years (for employees)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r362"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, total intrinsic value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options vested and exercisable, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options outstanding, weighted average remaining contractual life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share of shares issued (in dollars per share)",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r135",
      "r136"
     ]
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r92",
      "r93",
      "r94",
      "r107",
      "r177",
      "r184",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r210",
      "r211",
      "r216",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r234",
      "r242",
      "r243",
      "r398",
      "r399",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r732",
      "r735",
      "r736",
      "r742",
      "r790",
      "r1063",
      "r1065",
      "r1066",
      "r1067",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r116",
      "r117",
      "r118",
      "r137",
      "r140",
      "r167",
      "r168",
      "r170",
      "r172",
      "r179",
      "r180",
      "r218",
      "r252",
      "r254",
      "r255",
      "r256",
      "r259",
      "r260",
      "r291",
      "r292",
      "r294",
      "r295",
      "r297",
      "r299",
      "r302",
      "r303",
      "r306",
      "r309",
      "r316",
      "r451",
      "r593",
      "r594",
      "r595",
      "r596",
      "r602",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r628",
      "r648",
      "r671",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r893",
      "r964",
      "r966",
      "r973"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r99",
      "r100",
      "r101",
      "r125",
      "r126",
      "r127",
      "r147",
      "r148",
      "r149",
      "r151",
      "r158",
      "r160",
      "r162",
      "r178",
      "r219",
      "r220",
      "r231",
      "r289",
      "r318",
      "r372",
      "r386",
      "r387",
      "r393",
      "r394",
      "r395",
      "r397",
      "r400",
      "r401",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r468",
      "r470",
      "r481",
      "r555",
      "r582",
      "r583",
      "r584",
      "r602",
      "r671"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.angn.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r181",
      "r214",
      "r215",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r537",
      "r538",
      "r539",
      "r540",
      "r615",
      "r616",
      "r617",
      "r679",
      "r681",
      "r684",
      "r686",
      "r693",
      "r695",
      "r696",
      "r697",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r714",
      "r728",
      "r750",
      "r752",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782",
      "r783",
      "r784",
      "r785",
      "r789",
      "r797",
      "r1063",
      "r1065",
      "r1066",
      "r1068",
      "r1069",
      "r1070",
      "r1071",
      "r1072",
      "r1073",
      "r1074",
      "r1075",
      "r1076",
      "r1077",
      "r1078",
      "r1079",
      "r1080",
      "r1081",
      "r1082",
      "r1083",
      "r1084",
      "r1085",
      "r1086",
      "r1087",
      "r1088",
      "r1089",
      "r1090",
      "r1091",
      "r1092"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r178",
      "r291",
      "r292",
      "r294",
      "r297",
      "r470",
      "r497",
      "r592",
      "r603",
      "r614",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r628",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r649",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r671",
      "r724",
      "r726",
      "r798",
      "r1095"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders' equity (deficit):",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StatementScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "StatementScenarioAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scenario [Axis]",
        "label": "Scenario [Axis]"
       }
      }
     },
     "auth_ref": [
      "r104",
      "r106",
      "r163",
      "r334",
      "r894",
      "r895"
     ]
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r148",
      "r149",
      "r178",
      "r217",
      "r291",
      "r292",
      "r294",
      "r297",
      "r470",
      "r497",
      "r592",
      "r603",
      "r614",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r628",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r649",
      "r650",
      "r656",
      "r657",
      "r658",
      "r659",
      "r660",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r671",
      "r724",
      "r726",
      "r798",
      "r1095"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r815",
      "r825",
      "r835",
      "r867"
     ]
    },
    "us-gaap_StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock and warrants from the January Offering (in shares)",
        "label": "Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants",
        "documentation": "Value of preferred stock and warrants for common stock issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r998",
      "r999",
      "r1000",
      "r1001",
      "r1002",
      "r1003",
      "r1004",
      "r1005",
      "r1006",
      "r1007",
      "r1008",
      "r1009",
      "r1010",
      "r1011",
      "r1012",
      "r1013",
      "r1014",
      "r1015",
      "r1016",
      "r1017",
      "r1018",
      "r1019",
      "r1020",
      "r1021",
      "r1022",
      "r1023"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable into common stock (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r32",
      "r51",
      "r54",
      "r78",
      "r278"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r78",
      "r593",
      "r671",
      "r688"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon settlement of restricted stock (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r78"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/StockBasedCompensationScheduleofShareOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)",
        "negatedTerseLabel": "Options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r78",
      "r348"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of senior note payable into common stock",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r78"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r50",
      "r51",
      "r78",
      "r602",
      "r671",
      "r688",
      "r804"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon the exercise of common warrants",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r78"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r51",
      "r54",
      "r55",
      "r78"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity (deficit)",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r54",
      "r55",
      "r70",
      "r630",
      "r646",
      "r672",
      "r673",
      "r777",
      "r805",
      "r962",
      "r966",
      "r967",
      "r981",
      "r1044",
      "r1098"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock and Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r301",
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r315",
      "r318",
      "r411",
      "r422",
      "r674",
      "r676",
      "r692"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://www.angn.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock split, conversion ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficitParenthetical",
      "http://www.angn.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.angn.com/role/RelatedPartyTransactionsDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://www.angn.com/role/BalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r898"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of noncash investing and financing activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r861"
     ]
    },
    "angn_The2021PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "The2021PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2021 Plan",
        "label": "The 2021 Plan [Member]",
        "documentation": "The 2021 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_The2022PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "The2022PlanMember",
     "presentation": [
      "http://www.angn.com/role/StockBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The 2022 Plan",
        "label": "The 2022 Plan [Member]",
        "documentation": "The 2022 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r860"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r880"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.angn.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "angn_TranslationalMedicineAndCMCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "TranslationalMedicineAndCMCMember",
     "presentation": [
      "http://www.angn.com/role/SegmentReportingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chemistry, manufacturing and controls expenses",
        "label": "Translational Medicine and CMC [Member]",
        "documentation": "Translational Medicine and CMC"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r884"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r882"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r885"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r883"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.angn.com/role/CondensedConsolidatedStatementsofStockholdersEquityDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, shares outstanding (in shares)",
        "negatedPeriodStartLabel": "Treasury stock, beginning balance (in shares)",
        "negatedPeriodEndLabel": "Treasury stock, ending balance (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Treasury stock, at cost, 14,455 shares outstanding",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r54"
     ]
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r402"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r879"
     ]
    },
    "angn_UniversityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "UniversityMember",
     "presentation": [
      "http://www.angn.com/role/CommitmentsandContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "University",
        "label": "University [Member]",
        "documentation": "University"
       }
      }
     },
     "auth_ref": []
    },
    "angn_VestingOfRestrictedCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "VestingOfRestrictedCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting of restricted common stock",
        "label": "Vesting of Restricted Common Stock",
        "documentation": "Vesting of Restricted Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r849"
     ]
    },
    "angn_WarrantExercisedFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantExercisedFairValue",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants at issuance date",
        "label": "Warrant Exercised, Fair Value",
        "documentation": "Warrant Exercised, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantIssuedDebtIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantIssuedDebtIssuance",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants issued with June 2025 Promissory Note",
        "label": "Warrant Issued, Debt Issuance",
        "documentation": "Warrant Issued, Debt Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantIssuedStockIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantIssuedStockIssuance",
     "crdr": "debit",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of common warrants issued with January 2025 Offering",
        "label": "Warrant Issued, Stock Issuance",
        "documentation": "Fair Value Of Common Warrants Issued With January 2025 Offering"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrant Liability",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantLiabilityMember",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Liability",
        "label": "Warrant Liability [Member]",
        "documentation": "Warrant Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofAntidilutiveSecuritiesExcludedFromComputationofNetLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issuable upon the exercise of warrants (excluding pre-funded warrants)",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r795",
      "r796",
      "r799",
      "r800",
      "r801",
      "r802"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and rights outstanding",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "angn_WarrantsAndRightsOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantsAndRightsOutstandingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants And Rights Outstanding [Abstract]",
        "documentation": "Warrants And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, measurement input",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantsAndRightsOutstandingTerm",
     "presentation": [
      "http://www.angn.com/role/CommonStockandStockholdersEquityDetails",
      "http://www.angn.com/role/DebtDetails",
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueMeasurementInputsandValuationTechniquesDetails",
      "http://www.angn.com/role/WarrantsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, contractual term (in years)",
        "label": "Warrants and Rights Outstanding, Term",
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1038",
      "r1039",
      "r1040"
     ]
    },
    "angn_WarrantsAndRightsOutstandingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantsAndRightsOutstandingTextBlock",
     "presentation": [
      "http://www.angn.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants And Rights Outstanding [Text Block]",
        "documentation": "Warrants And Rights Outstanding"
       }
      }
     },
     "auth_ref": []
    },
    "angn_WarrantsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "WarrantsFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.angn.com/role/FairValueMeasurementsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant liabilities",
        "label": "Warrants, Fair Value Disclosure",
        "documentation": "Warrants, Fair Value Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "srt_WeightedAverageMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "WeightedAverageMember",
     "presentation": [
      "http://www.angn.com/role/WarrantsScheduleofOutstandingWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average",
        "label": "Weighted Average [Member]"
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364",
      "r431",
      "r493",
      "r708",
      "r709",
      "r770",
      "r1054",
      "r1056",
      "r1059"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares and pre-funded warrants outstanding, diluted (in shares)",
        "verboseLabel": "Weighted average of common shares and pre-funded warrants outstanding, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r172"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://www.angn.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares and pre-funded warrants outstanding, basic (in shares)",
        "verboseLabel": "Weighted average of common shares and pre-funded warrants outstanding, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r165",
      "r172"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "presentation": [
      "http://www.angn.com/role/NetLossPerShareScheduleofNetLossPerShareBasicandDilutedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "angn_YekaterinaChudnovskyAndJayVenkatesanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "YekaterinaChudnovskyAndJayVenkatesanMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Yekaterina Chudnovsky And Jay Venkatesan",
        "label": "Yekaterina Chudnovsky And Jay Venkatesan [Member]",
        "documentation": "Yekaterina Chudnovsky And Jay Venkatesan"
       }
      }
     },
     "auth_ref": []
    },
    "angn_YekaterinaChudnovskyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.angn.com/20250930",
     "localname": "YekaterinaChudnovskyMember",
     "presentation": [
      "http://www.angn.com/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Yekaterina Chudnovsky",
        "label": "Yekaterina Chudnovsky [Member]",
        "documentation": "Yekaterina Chudnovsky"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481142/505-10-45-2"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-10"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-5"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-10"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "SubTopic": "210",
   "Topic": "954",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477220/954-210-45-5"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481003/205-10-S50-2"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "7",
   "Subparagraph": "(SAB Topic 1.B.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-7"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480530/250-10-S99-5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-11"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479983/718-10-S45-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-30"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-32"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482804/825-20-50-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481839/830-10-45-17"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482014/830-20-35-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481956/830-20-45-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481926/830-20-50-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-11"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii)(B)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479664/932-10-S99-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-20"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-28"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477385/932-360-S50-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "740",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478322/948-310-S50-2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-10"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-12"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-11"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-18"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-24"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-18"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-41"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-182"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "184",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480401/815-10-55-184"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482881/825-10-55-12"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-10"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-3"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/210/tableOfContent"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-10"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-12"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-21"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(m)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(o)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(p)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(r)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(s)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(t)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(u)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-22"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-30"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-31"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-32"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "33",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-33"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476148/220-40-50-6"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r973": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r974": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r975": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r976": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r977": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r978": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r979": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r980": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r981": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r982": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r983": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-5"
  },
  "r984": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r985": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r986": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r987": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r988": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r989": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r990": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r991": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r993": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r994": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r995": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r996": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r997": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r999": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "730",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483041/730-20-50-1"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7A"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-13"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-1B"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>85
<FILENAME>0001601485-25-000124-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001601485-25-000124-xbrl.zip
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MS(U94K ()1WTE-5ZE>.@QV3\9Q_T;LG;2:&GY%<A),M,QGN8H'A2(!8T/Y5
M*,P%@TXS63/U,KX[]@L88A-<3K*;VM+C\8)"I5)MB?V\+"2%N2@.(_1>#['U
MTX?8^CEUE) 59H,D7"99B;DHS,5<2F\JP%P'B=QL*(79>,HY,WM=#2QWJMNC
M!O)J:B<KS$4Z*C(8/;>, H6Y8 :S'%@7F+0!@$Z>_@YSV36,V%:GS((H2A29
M"^Z8Q+KX3E[T\35=SQ)3?_N/JZLZ;89%63[,18\JHUU+Z&LGJV<:3:JH$ZDR
M&P6ZA#N8UCC DU7*&\NWB'?];HP#<":^ 6]0RP4^'5-Z-[S67=NR7[Q[XCZ.
M=)?\.MM\@[*'5)3%9V8#2C7E<TFY>2JS0:&3\+FP3@5,R#"S,: :\;8LN64V
MBL-."^D]25'_0WX"^5W+UJ]&@6D[K][/W)+['L@8[FV&65^+3+#E,&?@&B/=
M(W-*U;=C=CE=UF65V3!;943D'_KLOXB-8N+I-BS@R0T\6,EP:(TMQ#=F-JY<
MP^6G1O+#7-SS (6.4E,$0#E((I P%T!%D-R[CAD8H%D?B?MJ&<L@N1I;-F9N
M@5:QQKF'4W\-/,LFGO<8+M=;>O #F3JNKS^/2?1E3>-YS(5?.2 .T1"Y :+#
M7("7 Z+4L$2'N1 R!T2IL8P.<['F/8"(H\.1E_) P _!UK9@;'XEKV3L3%,P
MJ])(*<FXZ# 7K>9(8=3J8"[VS9'"J#G"7"2=(X51.X6Y@/(>I-#(Z9@>HNE@
MN)IP$YL 3*Y^SS^1C"%XE&6<,!DOY?!@Q2*I6J3T3.%1EAE2M;CIF<*C)-NC
M6[4HZIT_(FZ=@5"2E=&M6O2T]D HR9[H5BUJ6GL@E&0Y=*L6%*T]$,JR$9B+
M>;+,I++V;^;"C2PSJ:R]E;E('\M,*FO?8R[>QC*3RMJ3F(MZ,<:D@@K;N\R%
MD]BENWI8']E/UON%2SPG< WBA?\<$=VDZS&MU\$7^ ]EAZ7VGU6BJ:;1EPQ5
M,13-T"1#Z_5T13)%L3?\7_3I%[_Q_-D8V#*Q[-:(#DVY4+I3__.;9?JC"TD4
M_T^#7C?XXDUU>_#EV?T$OP[_#F\RO]7@"R5B?,=GQX7EM0QL0CSUR$7\QV?3
M\J9C?0:O/@:6M.B//D]T]P66\.SXOC.YZ, *:*&SH8];^M@"+B$9HJ\7BVN+
MX0)]((-OQD^.OF[#5Y^2GVO]MB9N_DIL2_3S3_1^;OQE3)>IWZ"_@3=! OS2
M4!IK+QLM'ZX43"= 8OP%5OAYJINF9;]<B(($]X@?\(F^^29>A+3PG2DE!'WS
MD @&P73T1LB,^')8CN->X(/P64- 3&NH3ZSQ[.)OEZZEC__6]'3;:WF K&'X
MM6?]BUQ(R&;ZS[?P_7KP:\J1Z'TE&6G[X_;FZ?JK\/AT^73]N,KYI267N\;'
MZZL?#S=/-]>/PN7M5^'ZOZ_^?GG[V[5P=??[[S>/CS=WMR=?N)QJX7_HW@B
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MN%V8+H'R[NM^X,WAV&\,_H<DXB9"E%0GW#K"/'UBOU%:,=Q1=@ G)I;O ^_
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M0:[)O+&3JP=J(GWR<;1%+C22Y%2)_"&1TO]WU6Y9ZB PT=T7RPXI(Z]J#X,
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MLHYYG&L6)'_4' <NH-[GR@F9\'WYQ)JME_M@V:!4G0#N87I-@;P;!#?64:B
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M\G[!10(MM?5Y%-"P^*#?[!_EYG"@51IHJ4W.HX"FT);4_0[7:&<+M-1VYE%
MPP$\O6;_*">:]SX_"A5A[W/@X-0E(W 0K%<29==%E:L7Q_=!+[MS-_\]._W)
MHUNT\/H+16QWIZL)$RU);)\XJS0NWS:B&JVP?'M,J^X%?=ZXE)?^') Y0=7+
MU;)V";>+[65QE[;YM*#_HF\L[#1WPR?]_=YQZ1>^[UK/@:\_C\F3<Z_#;39E
M'*D=V&+XJ.G:P&U/.D;I<,.F=LE3? ZWBL)M3XY'Z7#K87GPT<-X.=XJ%]\O
M'7G]QB"'\8_<-]OBFXDBSM-9\<JV'P$4>$:VDQHG<U+_6LQ14VJDL1JE27O
ML4%1Q&*?.6:CA<<=1TWCK,(A-!>J,Q6JM(<Y.0I51PR/=O)HALV%B@L5>T*5
M]N J3Z&2Z#%63SQF7A 7*@:0QH7J.&<Q3Z&2HR,[IH6J+OE@FP,*<3Z8, U/
M[B8XBF $GGI3>-8]RQ!TVQ1,:QSXQ,SH,"8/4Q4@O^D$SV/"J,I(T(BZSNE5
M1L979BO 1-]UI\ZX)^XC8F.GZRAO51W7NFO#NWOQ;7Y%@,WU@KC0"\KNP&K.
MR_@:HGO30M3&0&QWD]/4<TTQV 61DD*G7*;/7J:[N0M3YS"I/G A6Y5+%]SC
M]H9C7"[37*9K+M-2[C+=.TRF#US(5IGN-P9R>X-OSF6:RW3-9;J7NTQKA\GT
M@0O9)M-=G#[3EI-IXTS+=(F]-%>2(6FKJ-54R!,G0OY!_T%,08>UZR]D);C@
MT;#"AM'?@A/XG@]?PINDCD"D2O18C1.%!$RP_QA]6;X2V9V1%!)^I\\LK@MK
MS,3+D(>WP>29N'=#*KC>W8)5D1"G"?\M2;ATFM5&JBZQZ,SKQ9JI;K.KR4VU
ME\S+RZD172X K4ZM-1?$36[NB05Q5[PMQ]7F)HBT\UFSTY>;BII,'.."R 7Q
M"$&42A3$72&R'%>;FR!B+*W3E-5>L]]-YG!Q0>2">(0@]DJ%]J[(5H[KS4EQ
M]$$0I69/%IL=.=D2M.J"N,>K-BUO.M9G^(9DN]R>XU6<<,<0[A,M7(BC#4NA
MEHGNOEAVF&PBKZI:@V!#SIRU*KW-A>7#(XS=>E;&..+3B BZ@678NCT#N1-L
MQ\>0BPL?VX(%"WQQ];$PU5U?<(:"/R(> >6F!Z:% 1O0:B9V=Z)_T40:'3\>
M6K9N&[!:>"OX ,L]O/9J0&:)1-&"U Z\P]3Q+%0[%R[!@I%7\OG-,OU1%/5<
M_E6D6L3%3_1G6 %H]*T_*8CVDKAO2Z.D[JY%I);^BVM$]6RI_6>5:*II]"5#
M50Q%,S3)T'H]79%,4>P-_Q<[.4<_&KF+<-X+:3V[1/_9TH?P6A?Z^$V?>0C.
M920"#*,%*5C]O$ZEK;08#G.F12@$L$4YX8CQ"PSLN7@5K$0O>07"R,4]^B_[
M>2&!+_R$8H^2<87[.\#\RR=]L(G1Q<-P;Z(?1>'U]YNKFSOAZ>_7#Y?WUS^>
M;JX>F\+-[55;V"J?I:[W:JYAKI8US.-<KR#Q'WW'^#ERQL!#CP[,ZGT6KO\,
M+'\F?/A*AI9A^1_9?+T/E@U*U0G@%J;7Q$GN!%,21U0!3\"P\CU65S[?!;8O
M<&GSZV[9^^B^N=#IU"Z$=8_UJ4<NXC\^QWNN9=.%T!]]CNX>;02=Y, +^KSP
MZTC;:?VV+&NH\")+)WIPI O;\&*?DI\K:KNG*AN_$MO2_V'9.$G[BMVVBG39
M_88I/Y=E-=,O^)KXFDZQIEY;[O5R6I.B;'Y&'>@$:U+DJFH[)J^*?.LUAT<6
MZ3'[VBU<YRUU&#!E@Z;C7TT[25I"0?9,+U4%S%68<T!-R8);CYT!-9_ &_4"
M=W82>AXH-56E[24L'YU6?7QJSR#=^NYURVQ9-IN+N]*G&!RK#")#"A5Y(),2
M=(813((Q=;[#WHU?GMU/:ZU"OB^W"F&7IM60\B6"LRE*462E,J)4";:'\Z#8
M9/ARF.UO;"YQ=]1O!SC+=Q)8O6JS\R)U-CDOS"PZHP9*71)>.7T2)@T<KZ/W
M4^C0+L'UI?TE#>"7W\>ZOA3FZ.;HKLCO6=T3R[_JU%U3<I"0?BH)^54?Z[9!
M!)T>4G\E!L%$/D&1FH(LRFH*3[E\YJ1-3*W N))UIN62>=I?SN2\N?VVH0?2
MQ+&IYW1\HJE&4S=%56GV-TQS/ZS[<ODMQO(I6F:MQ5@ZM!U3L\Q,B[$C!6M#
MA['^[O[GRX&(T./?T#*LA\TMI61#GAJ*R7EIZ.VU[YM5M+9'1<=G5115D;Z.
M;I1-/_=P)*/:5#LY="AG&F]<+=='+6?J_*BE[/R83D%CD70GJ:"YK'!985-6
M,G4>%K/;,-EZHO84[-ZM-$4QKTDL7)"X(+&WZ4AIFWBGVW6P(T"/6VA<6.HI
M+/(1PI)Q_^F )&EJ4Q(E+DU<FNHH3>KIA*E+8[N*=,PHEI)DB:U3"I:NJNJ<
MN+VB1*N&;SPOH =<SG#>L@\%01BZSD30_98_(JV)[OXD6#P^A&?8+Q5-R,J8
M><AR^#1KUR!E3_B4ZCZ$ C&_!LCB>UB6$[55N25O]*OLL50<,2IVF_T-;3T/
M:TE2L18_E8?3)N-421$324+IO_1Q0):0E-P\L:<-APG+,*%E^?)GSA/.$\Z3
MO-1IPCW)29UJC4%?.3JHS('"A9?SA/.D0@HU,=@Z'X7:%U&A)L\<6 (*6_XV
M2U?5(#\Y8_PFF,*?Y)VXAN71;YTIXC5-;6_Y[,J8#U=Y/59$V(9^>1<R_3K"
M@9DUA-/'=+AF5^[GE)W P$%0'8%UF-'"><)YPGG"><+HIIASM&3+?I@T].7&
M(*_"' X9+L:<)YPG55"M1\1-4JM6A775RI;KR])5]4Z#N7)L6(B'0N(,!8_8
MEN/2.0K"5)_1]M:6[3LK$9:F8-.<&,&*0S"&XX6]S/]ZA.!UU@7O<N( A?Y%
M>]S?#;^%8QGLERM\V%S&N@L94QL#L9U,N!" 5&/X@R?O,*N5MT2!NL=$@1;
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MX7]HCR&: [3D$=!TV-YG(?0,A ]?R= R+/^C\ &=#,L.B/F1S5?]8.',<">
M6YA>4R#O!D%G L])!7T";H?OL;KRP-8#T_)WD3:%$-"M:&WGAW6/]:E'+N(_
M/L?;F&73A= ??8[N'JE[=$G77"KZO/#K2!%J_;:B**@+HR2YZ,&1FFS#BWU*
M?JZH[;XD;?Q*;,\_9W*_3_N*W;8J[WW#E)_+LI+I%WQ-?$VG6%.O+7?[.:U)
MD;7:T@G7M)M.FR,NLK0IY.(Z;^MY5"?SXK3$([.&AHO?;7NI\I_#_*G0Z$D]
M_7 GG>M#FSC1+$_J; 9N9)]$%L?NL&_ER+AHVWEJ@S/=^K"9:,NRV5Q<U..4
M1?"%Q"CR/"@EO@PCF 1CZLK1+BH"#?ZL]%(1OJ=K(L%E=SMMV120R"5G44 J
MP>$G!]0+H[Q=#L7\C<TEKD>&-N PBU'+DG^__01ELR2D/KBNG(R$Y06I5<Q^
M0J0[J#HW,E_2N&1NFOR\B<DQ6V',%GQ9#=K%I:GF_DJ,J)A;HL7<2JV*N2.>
M,%TB>%P3S<WU@1WIA*7<7;DQT)I=46GVY*.K4S-QK*16* 7"K?2.DA1MZ1-E
ML[UQE01K4]YYFNG!^\HSN@I(R]%YL%40D_/2T%E+N#ORJ4JXNVH.)=Q5 !S7
MR_71R]D*@N0\"^BZG6/+M[FP,("@,Q*63+)2?+$/M@SI*,V^?'1?)RY(#*#K
MC 0IVZZ3&%ESU*Z#34.TI,3P78<+2QV$)6W[U!SVGS[Z.W)3%G-HHLJEB4L3
M>S;< >T$,\J0!C(D-97CVPT6+D>G;KN[JY K5UC0NK$;SPOH<8TSA+>C>:@>
M<E<8NLY$T/V6/R*MB>[^)#Y<,H1GV"]-P:;_$JSXQX;CA84[?\T$L]6N:)V#
M!H_C8O$EB!F_RA4N9HZY[AQS/;$Q$-O)SC4"T'(,?Z0^0*S.^=0&*+(<X\P:
MXNSO"7$N@>-K@,@-!]"'8<Y;\D:_RASO[$F-05?J-)5N7KU2&6C/<E9PVJ2+
MTG2<2T+IO_1Q0):0E-CH>C* A<.$99CPH9Z<)YPG.:O31,O!@]1I-J>BIS0&
MG:;8X?J6:1QQV>8\X3S)6=\F&HR?0M^J5-]V94;T;0U2:C,&:8(I_DE\?TQ[
MI^#WX-GZKF5@L9BW4C);AWA&Q>:_G32>\3!G/+WL\DUW33J&_IOC#HGE!^Z2
M@[H4S>@T!MJ&DPP^?I(A(/&1H)PGG"><)U7DR:G"!IGVOR4C%K/)DH="'$(,
M08B+-><)YPD[$8-#56V/(55;@VG*FX,%E"6M9QU;K!K.9$ILCW;(K54@H&*A
M/!Y>Y3SA/.$\X3SA/&'-ITZ598D19FI27"U9% _DS\#R+)\\$O?5,DAH(3X0
MPWFQZ5VHL;C)$.PW!HJ<G'C&,<80QKC<<YYPGIS6Z2Y#%VLLZ>+:'N%_<USX
MIRT8@>L2VY@)O@LW&U/>"?J<[;5RTBL6/>,13<X3SA/.$\X3SA/.DWKR)%-/
M@6[:.?!TXL'*K(,;VW F)#+ZKB*;[PE-OO"YE[;YM#  %V8_/45[TM_O'9=^
MX?NN]1S0D6A/SCT8_K:_P8;OBXW!ADKJS,T(..BX(C@3GF1K+I)PVUE5!!(;
MBJ"VA^O %F&<;HQ-=?STB@7<>!"4\X3SA/.$\X3SA/.$\X3SA$&7J9N89;#%
M90*+.O21<#IDU@KDODS;R&WJ!)S>Y^&H808UJ1WMXU"CL(.:&AQXIQD#];ON
M&J-X!I1:*^^Y-A-&,E:K=_<-&,ES!E0?9XR(35G2FEI?8[YG:$9A/G#PWWFC
M<I/1D9C3<4"C]#Z.YQ"/[FG",58=C&6=K=153C5;J=^MX6PE#L6\G*S$K)5C
M)D3T>W6;2\2!EM.^FIA$DG<_^#[.5.AH8.#U^<9[/B#,INV.&?&11)S6&,@]
MKNTXT)) 2XR_*&R6C":BWE.;HL*1>!Y(S 3$-#TZCL.?U!BHS?X&/<C:KEO;
ME*+K=^(:ED>;>X9=/9TI<H#G&+$HI5L" D=U[J1?WH5,C]%@9HT4:')CH#05
M[>C^.OPXK$AIYP?;3/&$)QMPGG">%&&Z'M')<\M^F#1>\1R?S^!B&C-<CCE/
M.$_VVX59=&LO49=8@&Y5&=*M-4B2RG^P!X5(O8($U:DAW"VS100)#ASOH74:
M@VXOF>C(BU$9 A(O$&:*)[QHF_.$\X2QH,"!/>>U;F.05[XP1Q"7:LX3SA/6
MW(V<0P2':MH>.YKVU,D"IO7*0M1@Z#H30?=;_HBT)KK[DV#@8$B0OW,.T*76
M(EI0G0C?(2D%/>F8:,&58\,+>_"<NV'XMV\]C\DC,>!2W\I>B*!ARW:UV9?X
M</5JHFS3)I&HT4Z_2:0 6'*'T!H#GI["-'SXT1#G">=)SFHV355J?FI6$478
MJH\O8.4 XD+-><)Y4J&@1Z(<MF!%*Z&BY4D2?*#IV:4^\/@PYPGG"3]'X3SA
M/&$MB^#T0_3 VP9+<$/K%(XQAC#&Y9[SA//DM'D&9>ABA25=7-NV!><XT+1B
ML3,>S^0\X3SA<7_.$\X3SI-Z\B23L;ZGC6?)TPL5407+G><M,(TWK@.8XDGN
M#GOI.J##D ZH[9%Z+<>85BS,QD.?G"><)_R(@/.$\X3SA/.$\X3!40"]M#,G
MCAE(J8C=QJ#7E.5D^73F&0 <-(48AME D_"Q"P%-CQG0U."0.\T0TW\$-A$4
ML88S3"-^U'BZQI8B^^[I9I@J8C^<8=KI-_N]O*I&RI_YDGHAAX9A:XS*39M'
M8OA0]N%6BHB5]KE5)G&,50!C66>8]GHGFF&J2&(.,TPY%.L Q4WZ+C'CZHBI
M?HHD'3O#E .M.D#+A+-^P;/4%$D.9YCVM;S.+SD(*P#";-HN4;MTE+93&@-9
M24[,Y=KN[('63QN#RD'OX:B(K@2.[3&A*([$NB(QT66N."1V (G-;B>Y_S*$
MP]HF%9W'(-/J'%P<$A#MRV4/,E6D;F/0:2J=HZ-7_$2,'VUSGG"><)YPGAP>
M-^H?T50NY; ]1>J!'W]T9V2.&2['G"><)]71K6F.NH]5K7V&5&L-\J0.F6-J
M$__\9IE6IX;P]'&"PV:9*I*&,TB2QQV\&)4A(/$"8<X3SA/.DRKRY%1Q@<,F
M["FRV!@D<^@X@AA"$)=JSA/.$V:B!(<J6HD=15O;=(&CIIC6(4)0E\#>E@B!
M>DR$X):\T:\R%QO(<F.@-?O'U[[P*#%[>S+G"><)YPGG":,;X:8H0:)_1'KC
M=6D/3%JH2F-P?"2<XX3++N<)YTF%].D1P8"=^E1E2)^>.DW M%Z9\?O!Z1?N
M@^>Q90AWD=/?I D$<+45_])P/)]V9/EK)NPD*HT/F%6SP%?\'E>XF#FDN@M(
M=1H#L9T,(PE R/'R^%)*_EI$-.H2A-P2T>B7$]' >@A); (!& E)\ICV\?M8
MFFKT0_:Q'CN1:PX3?AS%><)Y<@IUNF<D;$IUFJW:6,9^;DVQQ_4MTSCBLLUY
MPGF2K[[5]DR1*4;?:E3?]EEQ@VJ;F4&YUZ(3>3%",Q_)R[,OJJ8Q>>":\X3S
MA/.$\X3SI+A2AU0')Q@$IR;%U9)%\4#^#"S/\LDC<5\M@X1FX@,QG!>;WH5:
MC!ML045L#!1)9>3 CF.,RSWG">=)^<409:ABB2557-L6"]$ 7L&()O *_F+H
MKJ#/V5XK'[UB$30>U>0\X3SA/.$\X3SA/*DG3S*=DB4ZGZ\:ZW?^B+AH@[MD
M!&:X]4K":9"1J7<567I/:.B%C[NTS:>%V;<P]FE-\Y/^?N^X] O?=ZWGP->?
MQ^3)N0=SW_8W6>XR6.Y=1D[3.-ZX#J@(3W+TUTM7 0I#*J"V!^K &V'L>/5J
M<%BQ(!L/?'*><)YPGG"><)YPGG"><)XP."M.DU/.B@.+.G24OH-9G3616,&!
MA?UF_ZC)F1PUS* FX6,7 IH..Z"IP2%W;R/;?]7'M,!?I]7]CV3JD\DS<05%
M; JR**NU<J CID23)D-B7R@ !],)GL<DG#99_6&A&:OL-65/E?T5[1E!:Q3"
MROJ[P/=\W49B9*VM5[H@U&*SUU>;2J^7[]3NHQA:4K2V-*R6'J>C4/UK&:Q.
MS6(69':3S9:F$?J^2>9*#P4QK]$>%99 OG.D,0*W;!W[6LX^N43W G=&(1GM
M(]&=,NX;6/JM-M5.LO;[T$G3500KWR[X=I'=QU>/F >?W#BP*+B3+ GF8LC%
M\-S$,),4IFE,NR9\V0(FJ@B2V96:RH9-\NS,.BZB7$2S[Y1I YNI=DI5:@QD
M4>8[)1=#+H:9Q##1-S:#&&;<,V4\9!";HI8,1G(YY7+*Y727G"9ZJA8GIPH]
M#-3ZR=39RH@I/43\1!.$XR;4\T;@@R_/+EX2O4G\9?PN$]U]L>QP4?*J !D$
M6.+F@Q$MQ@B]S076+EO&;M3(F&[[-"*";F#G*MV> 8D$V_&))^@N?&P+%BSP
MQ=7'PE1W:5MQ?T0\ LC2 ]/R:<LKVR1VV/S*I@37\>.A9>NV :N%MX(/:(UU
M.RV)&JGH&KV%TH47GSH>+;N^< FF>K^2SV^6Z8^BC.+E7T7($1<_T9]AV8&_
M_2<%,4P2]TDUY4]_K?7YTG]QC2ACEMI_5HFFFD9?,E3%4#1#DPRMU],5R13%
MWO!_T;V,?C1RXW5/]1?2>G:)_K.E#^&U+O3QFS[S$.[+O '&1 M"B*T3:2LI
MAL.<21$*#J@9QZ79_!>@'8B+5\%*]))7((Q<U*M_V<\*";3A$^H1E*8KU,D@
M&E\^Z8--?-XB(^(.-9)!&^VZS5Y-?*R:VI;:0$%__?WFZN9.>/K[]</E_?6/
MIYNKQZ9P<WO5%K:^6-%J=>=ZK^9:\&I9"S[.=1]EMNZ-A&]CY\UC\R4^6#:H
M=R> 6YC>1T;7.-]YMB]P">+=+0BG&_EB2Z!6 ZQ[K$\]<A'_\3G.5;%LNA#Z
MH\_1W:-]I#--& WT>>'7D;;4M+8DRZ@PHS2DZ,&1+FW#BWU*?MZ3VIK8W_B5
MV)8V?K[M5I+4[BF;?[+M5ML_5_I:/HN2VVI/WGFK/:E;.X^$M<1E&SR8$!#E
MIW+=PB?"[W#9R!.N0968 M7B*SE=*Z;R,919<C/3VLLLTDP6Y4Z*%+?][UAS
M(JE9@)-[V6!1XY(VOR[=8H>XQ88#DIPI05,-O!IT.%_!X"=KF^\NY&RCQ?&0
M.BAC.=^5U79N5JA0UXM(5YB=Y1WK%/FJ500KT2^BB$1V5<5^;<U^)SDB.W/L
MJ@*A8@[\"@ _[0G+<<#O /![S;Z6[%5X<N#7Q6;9S/NE+I2"[P@N 6X;%KBG
M=K2'X:?XMX'&38!!!G#4-UDV%\>;-F4;,"<S4^B_+8S:^)1/I:N KV0*K+=V
MSXXXT[XP>UI#+9-NDRK#NI7<\JH8V,7/'0Y[1M/N@T,/W.+:M_%A3K]=3K#7
MTK_"%KS.4*!T:3G#%NQH@NYYQ/>:2[O:F.@>V=X#J$;5NSDJPKN8?-^1>@_X
MD+OA#X]<(GF7&7#]CJVL-S6H5ON-0;=_='4?+_AF!3)[E&4>D-$ ,@HKD#D;
M@_'6L5O4)< <#9=XOD!"%G'K,972U&U8^4U$NPC=0%,DZ0:0=T0 N9B, G$C
MLJ*HV*(7,Z)":@SZR2QQ;DJ>U)0TR;,OF)9GP,MMG^EPIOO_'I-QF99WPZ]
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M]8@ Q+!60H8$@'J\\0#1XDH4MIJ@M8E=^T^Z7S&\&59TX_T2@?D7,$N9)45
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M14R*87 ER.$+>( #9XVI6Q3  W+6-?&((',QE&P4?@GE5Q*^.(19*T7C"F#
M(OVE,A';H1Q:CEF@J# 5_6,MSC^X_HUY?T#QT2=S?0$4N*2%4JDJ9SQ,Y*LQ
M7)M_&>P>E*ZEX(08QT2U$\.-N"B>U>F Y0ZJCPX;N/9WJZ];/'-); (SJPW0
M23;'<,:@T*(,<.+*&$VU<92YPYY-B\*C(!S^[5J:K6I<J?*CFNEK0J#BT6OA
MDZ,[@'Y1IM 7/).'TD;Y,GG$%31+!GS5(&4:?3P!$Y,'7*<%\:-8Z*=4><$)
MO@AN7FJ.4.H%ZHF$2MO5'4^)\Q72$):$%=8IHP/PPIWBKLV<T@*)JB9Y-KF
MC093,0\3(\0D_Q@F@XED'KB&@TL(06]W%,#S&0O?%8G 0.#MK1:C!C+L.[)\
M(</ZF3*L?]GIU4J&^1X7Z5+ZX3,W1 2++3"M%0Y17'KIA0I1E'E\$D^_5I(-
M(1QX^^,\GAD+A6I*PC0%^+O)^VG+@7WK)5"T0[L-![+]\ '9QHGQ.& C3*&D
M$^(E?N-0L)9%)H>P%05M?Y"8B*62*0JO)W!CMO(*$Q3$)_$<Q7BFAFU^[AR<
MY'_$)6%F04NPF YD'6P+<U[QTH_2C%D\'U9DV_G*KJ*C_;H.V!/L=<I\V>,E
M6 B^$3*EO4@_F)1A-N^%LLD$4*,()=Z!</O(F;CN\7 U7I7I+15N@)5SYIBZ
MPPWUW<:($QP1\+DH H0%A[[^Z*>L.":F!O-7DM,#1'HTP<90R9DB3CE0&(3L
MH"J[#>4A&IS??&0;[7HOG=V3^RTO>OZBV7XV.>6C^%0@O<.PE$A GNF*Q>TD
M+Z\]Q)4&EQVYX4K5<J5'=^J080"\Z1)L@_>$<X&RX?O1-,MVTK E5]$8>CJ>
MSTIB")=RYXB+_&P,PB5O$#R%1^%32$]"^EB8KV!)6RWN!0P]=:FLP[=9S G?
MR)4KRH5>$B4B:+R%1XMR-NW[BA06VN?."DMUN2J> I,6?!@GIJZ.*6!17Z6G
M7P_V@G-$_#0<^L!SNH*>WTA.]\0Q[X6\""BY/^I<=LG*QPIF'L42]]DB[.CW
M3:6'WQFV8[E<_/OX$O/%'N[4,I *T">N2/4W%"GT\_DY$9Y$L<-A(R*ZH-A^
MCFFP!$U2 ?SFP)M=9JG^*O"4BX>)8G/%YG7R'.:S4']V4*A^XBM=S5ZD/58L
MW5]VQ.(+F79QOIG'>P=5\J#^%CPHCDL5EBD,!C4J4PB:B?2V*E/PQRZ$E()X
MN*+?B7/6?B<>KJ!9-_0XZ1M3\&'!<90M1:#GEXS'/,X63'5U=C_W]W5-=4#7
MAOHUJ(,1:U/OC1]>[(\RTBA-(F'W)1+K:FB&/U&-JZ\P<!^6E]\=37$,:"E4
M/A4N(%H*R&&1Y#PTV,@@#Z 71^7>(6$8:,BG,.@+=^E846"'K</00Q8:L[#V
M8"V]HQ]-%W:MVN\_%/2  %!I<T$:E05VUR75EJYL]L'[XZ/7ATXS"%ATT\=H
MC  3MC8:Z]$I\I^#I*1VAR<FB39[XLWBYS;\]&O\^_ZPW1V.$W_JM.7$[],>
M)<OMH3PI]:CT[WOC?K.H@R^JV\M\5$X3QZ2NI/YE73EV74(/4IX0=,BFG<GI
M7'X_",EK!1%IF+D+($+M73E/("F] L4*M0@)-Y35G+DN$/J*W%.2-_N(;K7-
M\X=3MX%3(3CU&CCEP.D)/9MEF%'E'>!#.H]XQ"5>'^1V"NWR<G) W1)!\\TT
MV%H"W>D/Q@M)J_0H#E%5SD^2CB?6(YI=]MH)2AP&0'D&]SMY(WNV:%OF8JA\
ME';?!0^M=+_O@EL^:"?P@GLMU0B_TTEN!I[=/2K!A"X[T*R/,ZA;\GCG&8:E
M#JRF7?,; CM? DN9-;$C@65.GNA7/NJZH:Z&NFI)7=TC4%=ULZ<;ZJH#QC74
ME49=O6,IAX-340YK/W&FKE>=X/34@D6Z3SPKC*))9>?TO25F6F[+I\],<RQM
M'K6M@GD.*V*>I0ZHIL-4&X(Z7X+*L:P+$E2VKE_=U/&&FNJ 80TU;6E)5T)-
ME8_S;JBIH:9:4E..Y5R=LC<Y%65/&'S>"CS8\M3 "OQ49>X/[;*W<F@FA\[*
M1?>;I9WJT@[M><CJX+8'/O4O&CSBA'-82T;]$_9[5D+HS$1-BE^!NM(+9-A1
M;QM4-\D^F9;JJ)TUZ'\:Z)_B!2B'_OF*UD"^N.JUQJ-N0P$-!=2+ E(L]WP*
MB"-Y]^)JT"!X@^#U0O 48[IR%M_C+'Y4$PIH8LN'BBWOF*M^Z-ARDFE7+A-"
MU/QMVLIOR2-9)4!.G\7F!*=#E<0[FI+[2I[;Z0#KG5K7$&M#K&4"WV6(M8!6
M-*C(\&WHM:'7MTFO.:'U/'J-D^2P C.](<>&'-\F.>;$YBL6GZ.*G I'IE>R
MJ7^EQC%-6YH3:K;2+*KHHIJV-(*;QH;R-%UIFJXTV\")2[BF-TW3FZ;I37,0
M/;CI3?.&S+CS-]3Z1RH_'HPOKN1N"ZR*VM<?-P7^#87M0&&#P[?/&$R:]AD-
M=;T)ZAH>GKJ&U:5J-]15!XQKJ"N-ND9'T@Z'\LEHAV=3ZE2BTTJI&J>WQ!_>
M6@ENCO5860GNL%L5/VB*VNN 90U%;6DM5M$B8EA=Z]*&FNJ 80TU;6D=5D)-
MU65;-]14!PQKJ&E+:[ Z;6]P,MI>TW&E65HMEG8V;HBFXTI3CYSN6:BPX\IP
MV'1<:="_INB?X@:HNAQ_.+JXZK;&W;J4XS<4T%! MNF^1<>5(:8:-0C>('B]
M$#S%FJZ<Q4\XBQ_7A *.D$A<C^XAVZ3<-G6535UEF8!K93U$1OO*<6J*H!MB
M?2O$FA/+K;8(>B179,HU]-K0Z]NDUYQH<>D>(J-N!89G0XX-.;Y-<LP)-U<L
M/GL5F<FU["%2S2%W\PZYB^U!_F_S?U$+N*K5;!8R)R_FG?Q>NC-FNJLR5=(,
M::;8BQ;]5V)!QGI+4@Q5LICM6-K,@2OI D!09\$0+55FV/BM:=!)*7C)5-$5
M8\8D>\&88[>EIX5F^U]J_)4V?Y"%K[+8$E\EV<QQ=+@?GJY(!BY57\-]MF:W
M-UP%' ^_NTO8^2RC%4P8._[MVHXV7T=*I+O=]N" 1=)= /O-!H EQ9$>V<JA
MGA><H'H=:GPQ(-![[3#$3Z(GAO3*+"8MF$Y']WO[$:!L,07(>PU@G+D6$7\[
MAE\G Z:G!6Z0=FF8DF/!H^;,LJ6EHC))69K&,V&@L[ 8DW3L76 C)/"[.; \
MZ05YGK30F*58L\5:4@$DXIX5K,A4;6D%6(U-!=33!E-XO^:<=O@J?*18G  T
MHGJ0 7)Y9I;T#O]&%T:W\_$;?44?Y(_OI5?-64C7QC.*H$^:"?<"*Y5N3&O5
MEMZ)6_C/XA;"T? [6U+HZ>))GL\V> V>ZTR'Y6ES#=:GV)+H/\%7\ =;^U]H
MQLJ%K<#6V$]FS30;3A"HGL&+F+7D_.G%Q&)_D'CKMO1?$>:P*3HW1:4O'T,R
M\QL1$E/OC1](2H@XGY +_6Z84SBG%Y0@=[@J^-DT9G"7@N+P"5[S23=G?P22
ML\]%MV:X3+UVQ'>X" 92=@7+<"R7B5,T==U\)1REYE4".^$,)3A#0,0U@F"V
M4(QG1J@>P&<3ZP46W)A+P,,U^:I&'X'AFDN@&\!+6*)W7+X[=BV]HP>9+J"C
M:K__$&.R$1J!W\3&:.O!AF%S=6K--9FT^UR_*M.9:]1MCW+Z,95I[30IUR4J
MJ]]4=>W")H.\1R48-\=OKE[E5=7TDCJ!GC5?3(LX@@&_2, #G(4M,9!9:DLJ
MT.]G=S@4;6<3 ]TQ@+1FBB6@DQR@JB4N-W2QQ9'[>K<$*O=_3:U?KU#M/@A)
MU 4$X6Y['@3Z!2!P?"P](,:?Q,B.9+_2)VYVMZ0I ]W)0/U2J(?<#-I3??\9
M^AS/WZLXSO8J^J:2L(_0:?,OL-9B9I$=M8OLJ!7E&5IK>E:2OW%0>6S@I+W_
M#:V=(:U-:D)K0Z"U4R6VX^L-1]5!=BQ3.AQEW)#3"AU5@9,J5<7LEMMQ(O<[
M298@YPS!VI8EI'"$WQ3-^&K:MA<"NC-N%0OU0SN)38PNKOHUR9*M($_\+)'M
M73ELBTUQLF'=\%>MT [+$^*5SN_K@7+'%QF-"5S*!&:&6HGQVZ3C-.DX$5Z:
M,V'K8,K\I!G,U5!Q0\6G[?X:=\XU-?;X2D[E"E,TG?#7C;2(T\HE^F0Z"RG
M94JL<4/([67B4/*.BUE_C@D4@UDX&%>.)Z%XLSAL^$UQPCDITD*QP_D_F/0C
M\EB\M):9XK!GTUJWI=\-BP&@_@/7/8/U8-/"=+ A&"4XF3.-L@XI<8AW8^57
M! D]6<_W$A+#J36A;=#*:<>*XUC:U.7Y*[#SZ0:XWK'V<[L5?HR8A*)AI(_9
MCF3!*^WW<;C&[XS\K)O&\R7/K/3SG#1\$#^/L\M>VT@:DS3;=C&K=!W#H"EC
MA@20!9Z-T'%M+\7ODPX<\?)QMC!U *BY(NZ/66-XP=)4F8Y9J8#%L'5+7^.W
MF)+I^-A *7/1I[S""VF=F.!J\S15?)>XD6]!6ZYT1.BY92XE6Z&WSS&7:\XL
M"Q/=##6:AP78Q9390EH&0D7"LVYA3IRR@J?-$ GX<O-AA8N$-2B4JBL@1ON5
M;*8S^E9!"M9U>CZF!ZXXB<+;28(@+)*HG@/& W <<+0LL+%^KOAK@I0\;ZVQ
M>UJ2I=E_7,XQA3-")"T_J]!_''*9=BP';8L\/]Z*[=I0LQ/^X(+O)C">L.C&
M^T6FWVQA:'^ZS'Y"$,43_\:Q%+\SH$LOF32*<Z$,0D2^)&H,4AM#"/>A(-LZ
M?,K@J#T9],JF# XF[6%_6$UVWJC=[XPJ21GLMCN]BE(&<5'9<S.;M*$F;2B
MP('\B< E#FI2_HL^H!B%A2C/R)8L[0^1DG[D9)I#PR+F:"@45RFU]U%AX_/0
MF\_R+3PPZW&A8*7=IJ>P%_8Q=#>5%$^- ^7C![[*O@?-RU%(*0MY'<C+X'L.
M.H'6T;VX&@W;";UABTSUK''F2H/8M4?L_EX1NU<(L0^40<$/Y,!=7F_@"MRT
MJ^AD"TGO,$_=3AE;6DZIJ!/:I9AS\J ,2CT!@")5SK"HV0?5M1!F 5;U+ZZZ
M[4EJH=,^];A3 /EP#R ?7%SUVJ-,D!]4<3PP%?\S<(J\4PP#B#F/@ L(G.TR
M5&HC5@P7#8FX1(GT.(A%8[:2*)?= !.']5O2Z.)JW&GW$H1<)<&@[8(ZA\:3
M7ZK651M2DL?[Q=LQ:&?]0)"^030]9\WSA^^C1]=\87%UIJ0TV2\I36JWI$D'
M5;9X[Y]RU'Z*1+V%[G_NZ-_M[!?7Y(NK?KMDHODIHM8YVSB?M1=-Q53;M8;M
MB=ZMF"79Z#1J3)TTJI(KI*J</L9A:NM6W<CX%$FQL3"JP.#N<3"XNG&M)XS!
M*8F(I]H@[\Z0_N[J:VISUXJD?&'_2LJAXJE$KY;F.,R05NY4UV:2.9\SZO$6
M;F_VP'^[%[]Y#<A:U+!0@_WR?@COM/=2*LZ3\++C.!^)Y74V<?X1T[ON*'7M
M,_6>>Z"2$PJ?V-_9*_UD%^O%&41")OV+JT&GT^HDQ$*XE+4+M?\*P\B'ML07
M%P#IG09P65GL<HX 5X.^<J(3&^7EP ;*PZZ?";L;S R]GPNV<6\1T_A.K.=^
M_NBW-[Q1=)VIG]8>>Q$7E@<J-AQHC?/!6@"$#P"M+QQ:FUWO>%8;P!2 *I[D
M ]0Q 8VMV4*QF>2N\&-ID YJ!=(A]HSM50+2&W[))CC;TBTF3F:!WDL=1;C;
MIN[W0=S@"G!9!*,5!WE,M-L@IBQBZ,V4_KI5@+0[S R0)A[/K5C! R[ _]$_
M$SD)[J.+JTZ[$Z\?D'PUO"79[O3?;.;@9F8@R!2 BJ(B]^=M6'GR]%)S>/D"
M)HJN+!.5>I4S7MYYDUE+G]=DXG];NO8OQ'1*3'&UV,JTB/OR2CRLS>/,W@Q4
M@^S'2K 7+_DT2"7GB;*>Q$!#Q.$IYM%E;N 4[C&<+XX@$!FY=.<2<2*<$2ED
ME.C&RBD;P&K#>N"-\ MJ-'2_G=R=T6:Q%HST8I$.G 2?C:W!Q2(3'9!@YNJ*
M$\O!#R<5^SG+JF;!X<,2XSF^E+6,"//"1/(Z;^=I,:!^%ETVAW]2#\]N6_J!
M^<ZXM.\FK&I(X!F3I)B[%CX05F'/7+C5-&)T'#V;@Q#GX##$.0;AG93%<"CB
MW,!Z($PG457@H4G.E!? -WF#6/IIR1BA)2SKN_G"<P#CFIHYQ84S-?P(S&:'
ME<)S$0]^^\?-34OZ^O7&;RN+WP2BTC&?&2$*E75HN//YG$JJ&.*D"1@ &CLG
MZY+62D1ON_O^)3)>[!'.# 0B+OL3,]A<FX%">_]J,,M>:*NO/N0!ES 74WEF
MB8;)!#2*27L2CXG\(DW]QTJF]]S0D:(>8+N(^+!)W)WEZH(C6>P9R9S.79SM
M=\56E3\E6J_TC=>;A('*?_?[[GI?/X:.Y5H<2R!7K['I+' N5W?P/?PP\="3
M;FOY:)K!79,XM?2ZT'3.LH!%*1HAK]A6LA!(>FR0?1YF10 L_#&9(ZLY7/9T
MZVF\%I:\*S9"(=;Q4XHD+U.;\2CI@G PGPVJME)$2=)&212<42:;C;/7Z+B"
M07ZOB6N?XP6<U:>SH4=F8 @!F27$)B2 J Y_>"=9Q0GD=OBG$Y"J?&6Q0\=C
M+GD>XWV=AXRQHF[J>;20JV!!#R@8^OK$"]?"!&.I,37/9S>D?27P-9]S789Y
MHE_T9J027Y+>J&4.9(!W.F+& O)S8':>]L#+T<#$7\!MJ/9A766D",[!X0W_
MXRJ6@\5;H-DART0]$IC-4I([E_^3,)PA7@2+&*+UQ],^F_35V5B>]7NSWF0V
MD6>3T4CIR6JG,YK_WQ"[AV>A@SS>VTG'"QWPI$F![7M.QE(E9X_N:J43V!5=
M]"!YQ(D8P206.U8Y-NAT8RWCX;MXRWCQ0(F>2+AH&GC V[1M%R](>&TWIYE[
MI>= S_D :A#8Y@5.!DS"E:)Q87]/JN*-,"YYB=\.Q8*?1;GFC6D[]HVRHC6!
M1!2OO#94>B%_3W"<":?9*UL'>#R>%H:G2?#TC'515"U<ILQOHA/4]<5F!]2S
MM$_N=,#\ZFPQ#F \JJBV3VX/Y>PRNC+C ,H-%LA:5#?[Y4>J[:LLL'*BA7T'
MWO^;K>KS>!_.7,%Y0<0$5?1FF2O2WV:B_$)"EYDV"\VN;OIFO_%>OKV,8?4"
MKWX(M +%X7. 5+<_5ZBK)S0^''3ZV/BPXGFU)]VMJR&<LR.<E('M90BGU"#+
M08?BO-W.L/9T==!\\L-AQ[7Z@D:KBB&+.:/H#X8#6%R<%DJI.K4.O55)%0^,
M#R$H?F')@@3C\+V=)[<VK9MK@QA97+,,8HP ,?KQ6K/C(,8YYT-[MH5FV*Z%
MQW.L-.B:(W8*Q_-\<@*,=QX4DW!Z?''5[^_<IWZG5-!*=>,WCQ,IS*X,3DPN
MKGK]JBRI1J]+/%+N?E\)1L>$>I[J26Z4O1+*'L%6(+IG^$0#$"+LD8#\<N?B
M:KAS1_!&^:L-HF0I?SLABHS^IIV[3M=+&Y1$GZ4:NH2>3 <,WU5.Q*T93]$T
MMC^47BTX1F&&T;VX&@^J4K7KU::^&3;1T&0M[)ILFBSG^Y9[5.,TJ3BF='"2
M+5#LF#F%01Q9'_-%O/D$'RR&:=4O+$@3^26:J2.VV0EN4::P*==)OR46VS\4
M,G9Q)3C3,^)E"OUW807Y",_L<FHQY8]+90Y+_*#HK\K:1CB'DW8TPWOX"+-@
M-W><NJ_YO&(BXWBB8L(EG>P'WE(>KH*5*$=>@;2PD+C_DI_EB+1(C>,QD0H;
M._+$/>6J2-X4+3,/N5)5\_TE2R(+O/UZ=W-W+SW]]^V/ZX?;WY_N;AY;TMWW
MFXR<^D.126S!1":8W4G%E[\;BJMJF-MVAXO0EG@N(I7V)IQ*^T4S%(.*-QZ#
MI-IW-U[JY/LB1SC).,$KRKM)(M[TW,UZ9VEBNK&S)B/G]D]7HPAN2_K.G!T2
M-+VG/NB*X8!\]!\<3\'$SK2GDX(9 A8+@&4PAX8K4*JV9C<9F$T&YIEF(#89
MF#7)P/0-J -'2WU.GAPEW3HEYRW8U 5V?>J&L]R=Y)G.*9K!;Y9IE\X8DREC
M;#BL>!YC_D'5VYO5D->YDE>O<U#R&IX0>1TH=G\LP?O%M0 Q7(O7C<_A +%
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MV+:[%$73AND$E1>\(&+*=/.5%T1'5Z:(0EK^)-/0U_!BFY?$4-6&YBU:69J
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M"TO>!%,J,.;SBCN/<<&EHK)#Z/"!B BO@I4H1UZ!M+"0+O^2?Q8R*-)/Q!&
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M=ZWB(P[O[89</MHNT9<X>%%)"$TV(60#/L%?$5#]!EC_%63%O7$G#C<@L"2
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MJN[^D[KL? UU?R+ZX;/ZCK#;=WL71#X\MY9%_8NK[F"<6)T7<X#M)Q5J/T;
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MZ?5WC")7@"+]&D7."44.&=;J4EBK.SA&#'J^&'#(&$R7"_T[N_*,U?ZO13C
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M@'UVCS&SID:239%D10K"KAD-S3/L#XK3MY\>AYXO#JS(,=@U#G0P2[C?WCJ
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MW6Q<9C]V4**%/&2/_A#_BE%UH>C=0@[V7/+/.HOSS^I,LCJ3;(-,LN,4^#*
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M6HP$!EI+/L.*=Z8OG4D/('S2$O3AQU.9S<O!2>/:PTP5Q\78=/)F=5(K3)V
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M"7MFWJ!X^5,@>C+*24V2_89U#6^D7"5*<4QB4.4-FA/OMZVW9<Z9%ORVS,^
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M\9,Z&H(K<#A;+.=HI'07C'(C#1H21TPYXR+D"3QL3:17BA>$V_FNIS)F)O/
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M0U)U'?;V_;"IX<-/H(JFG?N2-@AT/2J_6;^GJ1]&%-GV(G?.1",0/K([@;Q
MU:0 N<%+YV$!_.E6I0:$E\6= :CKH+I&Q^-^=HNC&KK! :R/HT5"7! .,6MY
M]F'R3K,.D]=A\F<0)O^ ,0Q"7N0OJ28#_,B%[1'/76)'RF -',5U,[]1S'FA
MB9H(!HX\R<>)Y^:%B'I4LG2:&8^#O]EO7*R:GVHSWD.0&+KM1E:!IH1GK+8T
M+,[ZCV;6C90"Y/*<<4LI8?@>-"J3H@-I%AE6%&$*9,1-6_62WS&*.OJ\V^S2
M/S/VC)DQ,'6G-6A.]]+KG]H@"XP'Z<WB78+"Q1<02H77_S'75+[-XTWM[A,X
MB9:ZA&[@3$:G@2V(0,V*2"[1H?^.V"G__3X!:FA<DQGV.ZL'7YWP^TFKH"L=
M0ZD>!BJ.IH=)>LEH7N1%2CSP*1TH)P#U&<.ZF6D&S5.?$FA3#MS'%OC5/[)X
M)J%7MT%BA_P;"*,O@0^DBMBT"G>D(H3H\X2'>(\8D+KE/V%0W4J:7J7$D9QR
MX;&.CP;0=:GQ3%N_IUER3\;+HD$2&JV.=='JO12OZ.E6;R3_E=HH.GF\(MK(
MO$!EZB2O28)8(X'99K*"V:.MR>R9$O)AVRKCU>=R9V;A*!1'"S:5YL^LTXC-
M04&"45Y,O*!MAR'^&<93;(_XERRY2B*7*.2DLX&$G@Q1JBR>U!5Q]^%=$B@*
M8I6_BT?%!*35UT-LS W]A7"C4^K @Z. XA!/8S=I.XAI'S'6>TFGDY^)QN>K
M4\ 4\FQG1E%4)5%];#LGK;+T^]1K(K]GTQ1SCN$A\A#Y4D5!*+G8+<1VPIS<
M3FX[Q58.]:9;- 0E#5%+ A5>+P47$3+\][V/*U,<MF&D,3NZY'L/[E-A)&76
MEZYERM@8:H03. %%L)-;("2?L7)FDB=?R0)R5&LQ9(RF!JK&V[(GCGB01J<3
M@";S3_;ZR)9BVI$]@4@H>W/.9BXYQP'I52P9,4R"11FQ6(QR,10>D'/$_?$1
MU)BPA_XF/PS)"EYPWJ=J/+D\KB4/R#& $H9<4>P<K\IRFZ/)1(VFC#JD-SVL
M^@7.B@E]K)J\ Z0: _=3U'JKJ'$%.3/.X4.\PAUGJ[(K-HU=+UA.\VT23RLR
M W9V2]+EU)/$S>EI-3 '$U/2YI"19&Z%J\+)IQQ82#J5$H@S-+,>?,WUL:H2
MSN#[*)XW8GZ[YFW3])/4([[\WHZ1;[U+4REN5"10LBR*HFF02L+RIXM^G%1"
MEP8R,Y=&DH^$+@Z$+J/Q<8;&QZ\6$SGCF5U,*%.>Y5P^21:;3!4W"Y.\F"2O
M'"4]-O((4_$^-USGNW!EOXC<\V:U\V\1\I&W_?:_AL'/;Y^]R[JUV&5=P>+N
M-%_4CN[:T;V%H[LUR!+K7FFA((>(%KY@$M/-C7'[[=</7XV;SQ]OO_Y^_>WF
M]O/&CJA.YQ@=4:V&\0D,2I=- 8%VY0G; A\IYPC]"NC6=["%:EH,$L9D,^)7
M*J?9I://TJ-C@Q?+D;TCK!'P(YD']2#TQY17Q@F3^7$^VN0X)\>F(@RE02;Q
M7&VDA*H)PCJ/AG'M1I.DN$Q+C>;V0Y'TU\NFV+0W,)IE=L4LP,8S24,#T!NQ
M[U(TU[OK9]KJL\PDJ(Q\&:/@!&X9FT>C::YZAM+[3.W@N'5M3[G.T11=H<*O
MD>"J&K3WDQHS2MHQ9:$+X A65L4D]?VDO-ZZOT?_1B2X>B=1%KA,DITP9!Q9
M:?:MZGZJFL!X&<!SJ4%Y?VOM* ZF[$CX-8P[] VEW]*9V(4=8@4;.B[H%+)-
M*VP>LPDCB_I.R=86\KBIBXA=)F5=+]@+/A)33D]6%LC(P:[_F&U/E@,;!DO<
M#<]%36GO1DVYW(6:0L"NU91GJ:8L-2D.*<.O&Q1V-#YR<<[IRN\;O=5C8<:0
MK!_&W( )_ BD#!82TPP*.'W#^(<?&^&$&+,-LHQZZO+P6F7PXG/I<)&T:D5*
MGU -;HF<" ,D,J5 A^VB I'$N9./EX29@$DR8E7:U*I(@P<QR9P]GC9)4_12
MZSI7"J;:"6KA"V^M@,U08#MXBB>05%*3!+"K%D&?I-G$"D1I#7BE0A@=W"H?
MG*I-\H!/P&BJ!D"8E49>#>W)_8%W+TFC*YP*.USJN0C^SFX$_U4M^&O!OZ7@
M/[R4;V.5%!?F"'30WJD6,Q\X#UE+?D;^]@?;H-*LKZ83/)T"\-GWQ.:Y/MWV
M,;I8.M@P96R17?_'#,35G? P9SJ]L%.ZG,W+0;N]8[R=;L/X'6MF[ZRQ "K2
M\OJ>R:T<6[\/NI6>*IJ\237<TS5KWJ>QM%RQQHJ0F@=WF\:BE3?(#XH9":'Q
M7\Z/U_#\YYB&I%+0#$[]%06Q?=%[87C6% XJ[-%KP!@,$;::PU[K.@BNN8KQ
MHVO=OS 8VH Y/Z+78^>'& $<W!!$.J+3^&)PB>BR]ILV?PWH:+*Z\K]^SKSN
M;?[?IC'U1YPZ!H#9;&_?@JD7K;FU?K,*!'*PKO2BUHNW27.BE6!(,[(LFS+3
MN.FQK,MZ!$$387<6%W!>&4FS&*PB*Z0N2*JK&34ERU4T/5(O+55$Z!N8'QZ.
M9?%U6HF8-,-/^U[@BIPA#.>_:+VT7QERMIR6K:\]@"6*HUPKN88TN9^]]=/=
MB?73:^W"^NE<EE@_ZCDXH7T!L$),?,V)H$N\8D]D&F4V*7Y,G*$3O:GMI=W9
M2V58H*>LXVL.&M(EQ>*R8<!_/O!]A^MFKL$^N8EDPCP"N+L+:O8W"\5K]<>;
MD1,"BYV_=CQZ/_WH339S']D4%5:"'B"Y"6$&?YT25:/)A!4%\/\C]6;Y=0.^
M^KGX>;]QV2O_IMEH5?R\T^M5^L6B/?7ZC>95]\@VU6GT+ZN^>]][NFIT*ZZT
M_SU=-GJ=P='MJ=7NKUH)*!(I^[]?=%ZH9Q1MHE*-3_U,E)7(P(17,+EGEPC\
M1_Z[G2PG>8"DZM8L,J@K@H'L2W4J?]V>_3!:9<DL>1; R^R&'PY6VEG(OR4/
M-,BU_)F&5";<,!HM J(Z6!./50+K<P?4>PI(S#+VZ(;0:O4*SQTQ%&X\4%QF
M/A?58N&?ZB5<(TT9N#Y2A=6O "+,\%@#1MMPIS7!7.TQ>0.DJIT>^,&V7@/H
MJ\^X'I#*T?2D(?@>"+V&X#80W)E,7<XA#D"_L,:A7!U-3D1OM'8'MXT @2-F
MRL&P-(1_*#<'@.D8W1S+MR7=' ([H?JMYL6_?L@-=5JMQB0"XGR' -=3(+\D
M17/%<JHO6OL_K>2E^]+22E[H7]4Z1$E'=69]U6ZCTTSZ'"SN.-C0'3+2.[(U
M%A]:N)_;>]9F=E-G-'+%P>)#*"G^W^;ZX2JX'3./;^^.Q]><_%@X>7LE)R_6
MNM:<_+P?JWGOD?'>=J/U'__VH_?A3<V!SXX#M[?5I5L#&M3RKI'PRE:GUUS)
M4*^:ES5#K1GJ<V6H[9JAGBM#W5:EK1GJT3]6,]3C8JBM9JMQ\_GNB;GI >_X
MEZ^?C!N/QZ09[WT[IM3'W9__^3Q6D_3QD?3=NU^?%TE_LW[XGC^=@\E%\WNP
M^L>>B*E5TWA-X^=)X^^N/SU[&G]GN7;,762-3X[W':>MUA1?4_QY4OS[#Q^?
M/<5K#?%K@J\)_KP)_M/U+\^>X#]90^'6M%[3^IG3^I>O'YX]K7_11RK7)%^3
M_#F3?/?9D/L[:BC_!6?^T:P!BX<FO+<BR\#Z'>,EMVB@:4#8 @&7,(A)\' @
M#[O%<F\Z520&+/-5S1!JAI!E"#]3(?BZ?78J-P[<3U5+>1N*_UOYGW5JZCNY
MODD75^N>/M?L1Z+-!?*3U^U^?EG\Y$#0H4X_G 1B)/_!WM-V)F^ .X?;^B3T
M54T[L5'+.LD$LF%.YO%*R00TS@W[7,L)W;))"TV+4XU/A]SWY2LUH@OP+=A.
M!EXY\T.1&4T*.U5O7'\N]]J=.->_^!4(M;.%]-8H>^U#4]I9XXF;T_1VTYPF
M'09;M^:L6\UL,CJD7:H[Z"3=.6!'.R*.NYN_?;[^]L?7#W?K,K>GZU?'PT\T
M <)3*;+#I]?BZ?S#1$K@8*A1C VYK3BDJ6;). HYK50.B,16UO":H9A8[EB)
M&T)@-<<3&U#''OR(UK/B:.+3I-%J79PWZ+.\N-%@@- [E2Y!O4:_7ZUYR\(V
M.E>-7K>SHXX\O?[..LT,JO4;6K2G+K::6;[4FO;^-C;2U?'9TPL:I7RZ>7=S
M:^#$I.LO'_[X=O/NSC1N/K_+VL/EC2UZ!^MKL>?'#H 0)^-@^67^^B#.I"=W
MG=%I?PY_-K[>_O+AZS?CW>WGSQ\^??I'&>)O<#[5QG:/+2W6/"-V!7EM5+C4
M-3$S.<HR37T/Y_GL/VB-=UL=;KS[1/GT!VE4<5CCD(#\U0<(1VA#>,)UYWNQ
M'VB=UTX$A[2K6Q2'!%7%G:XW6OADCO-R217BJQ*Z6]M]6F[X5=;KZ6 9EU"_
M7:+J+S(H*[ZH;+^U"?$\38B<0MSJ[EDC+IH5>1VV5M%K%7W_9ST:-07U]R]?
M/WSX=OV[<??K]:^+I%&MPM<J_'-3X4$+%9$U->XFUJ36WZOLE#7V.QPB+>[G
MI,07JL5/YC OEY6\X]'2[Z]MVX\]FN6YL7K_7"9[7"X.GOX\]$=S^)])-'7?
M_G]02P,$%     @ %(%M6WF"Q?D>$@  N\X  !$   !A;F=N+3(P,C4P.3,P
M+GAS9.U=6W/;.+)^GU^!HZW:,UL5Q99LQ[%WG"W%B5.>]6UE9V;W:0HB(0D5
MBM0 H"__?M'@5;P!E*599*AYR%@DNM'=7[/1:(#@3_]X7GCHD3!. _^L-WB[
MWT/$=P*7^K.SWM>'B_[[WC\^_/##3__7[__[X_@*?0J<<$%\@<X9P8*XZ(F*
M.1)S@GX-V#?ZB-&=A\4T8(M^_X,B.P^6+XS.Y@(-]X='2;/D+CL]?(<G[LGQ
MI$_>'[_O'TX/G#X>'D[Z^P-R/' G>#!\?_AF=OK^Y.#XQ"'O^H?'9-@_/#IY
MWS\Y.)0$ W)T[ [?G;AXH)@^\U/NS,D"(ZF:ST^?^5EO+L3R=&_OZ>GI[=/!
MVX#-]H;[^X.]?U]?W:NFO;BM1_UO*ZV?)\Q+VA_LP>T)YB1ICOV9O](<+KQU
M@L4>J+I_<K"?M 0^M($S];G OI-R=@7KBY<EX=4T\O8>W(9^#J6E^@>#?$^N
M2,GRW1SM13=[" O!Z"04Y$("]8E,<>A)DM#_/<0>G5+B2B_P"."\TB!W6V V
M(^(&+PA?8H=HK/#A!X0 &+I8!DP@OT0VQ7RBQ.1,*+(>BD"\"APLE&]"2YYH
M5&J_1SS!X5<??KU]YFYOS[S7D/=G&"];]9RGB7J/K[21H,D3JL2H)(%?_82N
M#Y?Z@Z%TB;5ER/R\G0P)W2MEJ/3N.E!TE.HW-Q2C^FDQ-$)" -J;XJ_H.7'>
MSH+'/9=0$P\L-H<_VOC<"A/BN&WZ3)K#'Q5]8M\/A**'*_&UY9+ZTR"Z("^!
MDYPFGC(FTR1NE6)O'*D')R<G>^JN#'&*&#.'!1YI;KRW9,&2,$$)S\=MQ6#.
MR/2L!V&JGX2HWY:,O)62)$U*':RZ.]R6/1 N0Z32]RI3*&$!CG?6XQ('CT0F
MLEE_ETS;ZB])J$__%-I[>-)6>TE"O.]><0=[;167)$[HK>/U0/X@[R/JGO7.
M YEV]A!<^SJ^K$X@5']1PX13PBMSO@_[ZK\!ZF?9:1\IJI_VBFT+7$).W%O_
M@_J[^#C'Q'&3!L*"08SI5I^?2K+X8F*X1G/Z+O$EL?R#!QYU(3O_B#W(">[G
MA AN9FLMEP8@3DZ.AH,C .)>FI&D2,0\49XIBKFBB.T.J9R-[S"3ZLV)H%+@
MS<"VRE*+X7 =#-&/*[W\K>N8I@;DP?16!F4E(\>^;+20ZLXE 7TD5P%?_]%L
MT846\P,SS+,N43!%6:=(]HI6ND70[\X),H3N1>!\FP>>2QC__'M(Q8N<6E.'
MBHW@7\]="_WA.M#G^_OK7]X/!\=_1U&_Z,>XYUT(,,%G,^%^C:ZT?G&T+;_8
M#17UX)UC/K_P@J?-C H9-RW:[]9!&_@CU4&',/Q$N,/H$K@%4^G$'T-.?<)A
MX+V@ODR)*/; >JH_$QC;,=0B>0QS(<H=+^ A(_ CXP^@0;T^Z4*-VVDG*.VE
M0W#>AXL%9B\R;M*93V6$PKX8.4X0^H+ZLSOI^8Z<3YO@:,A)"^#[(H Q8Q5?
M,]8HXXT2YAW"[0)3]@OV0G)-,-A)!243F*H)M:B<%%$!/D@Q0GE.'8(@/\F$
MY#_P33&HH=2!\&Z_",+*)!1EK#J$PE@*CYDS_\*PH?4+%%JK#XI63QB@B$.'
MC"T];!'X*LN50V<YU39+VS0\M( ,BX!$+*/L6XWI>:[_'V?@'8))J?\1J]1X
ML91Y+#9-QFHHM9 <E 9M8-17G%">58=0^!4SXYB4MM5:^K!HZ82T0Y:%YYT*
ME6^H>I_* HEOFJDVD6OM?U05?&)N<1TPQZ]#H%S)+-#,_G%+K:G?%4T=$7;(
MII_(Q*A JMII[5DQ-9Z(#EGSTI<&(P_XV<Q-\\VUMBW-6B-JI,@[9.,;(F#I
MXXZP^SEFQ,3.11*MK4MS4<E!+;@@R0,I)AVR^)AX4)N\PTR\/,A,@&-'+4J9
M385J:'48')>FHC$KI'BA/+,.87%/9I (C GL/Y-)@%'*7:31VKXT(8U9H)1'
METQN5';<?"'3L*!Y=#0HPV5<T$0_)G]U:9FHLD3Y@">>&7Y-Y%JP2K6%FCHG
M^C'BV"5<JLN6YL TTFN1*948ZHJ?782FNFYC#DTCO1::4DVBKOK316B2^HPY
M& 4*K?E+)8F$01?-'=4(S(V]TEYKZIJ21!<-79BVF5N\FE!K^E+UHCSKZR(,
MQ>E#BYA?3:D%HKQ 7YQ^=!&'5MM8/A&!J6>$TEI\M1B62BAK[)*!+6VJNR[!
M;#8Y;(%O.X8Z8(>ENDR;R68'\:R<+,*;T6[HD6":WAYQ3M1RT17%$^I1>,LH
M)G$#?TR<D#%I3)GRTC;H;[-[K:^4"A-U<UWI1;%(X$99JS<HDDM%B)QD";6+
M9)1(A4-*NIV7-<!L@.Y7/YAPPAYA@+WTEZ$<OYU 1F:/XI8CRQ\OE-8CC:LO
M]1Z9D_9-DQ^^07FAD9(:K8J]<]4&K\C=5K:#X 0WHL(!<>8^_3UL-1)NJ6>M
MTY4*2VV=+M\J<J0H(J9"H4RJG4\EYKR!(H6@C^2U+E)BI$6\5*^J1SQEWDG@
MJBNVV3-YQ\@24U<Z^ZV<,;!S&6!E@R@I: 'K)KK1@EZJDM76CU>?\[AS]42K
M[E'<?Y+\[!RC"C'U*OZ+-!KLOES"XW1#Q$9]HK$'K3N4*GG&[A#UJ_PA[?F-
MJD;M/"$QVCK!W9"3%ME2H; !V5UX;WK&1H[#0N)^?H8%G%:YW)J<M=B6:H^&
M3VW<'THZ["3<JR\^M$"SFE +5JG(6'AQHI,@Z%Y_: &+*2L=4 >EHJ'1"Q6=
MA*]ZH7R=X<Z0DQ:\\O:BNL7WK@]WU1;/!B6UAGBKUD!&CK12NZ?Q%=RU&)?J
M8@T8YX>]:%4TZA0EO>ZPKT GRQSB(R1*;>/488,>T;I/K9\8OX95\)-<WI2<
M8E%%%(NS<Z *,$><APOUH/&OLI$(/G-!%UB0M&85@QR'@"?,W%;KA-OL7^M8
MYCN\"GEW)A4"L9 (4")8ONJ6>%T:JY1XG72T9//6.CE%+:T6X/H]9%W/&A)#
M9(_:;2C@P&$X*#RYN09&1ORTN)7*6#G<\@]BKH_<]L =G-+\R94U<CYS9EH@
M2U6K&B#3RYU.YQI>X6TY@=9PT>)6JD@UO@_<2;"B/;+KC&<UE%I02I6G>)MN
MU\>RR Q9M/I7*$,)%<H@ESY\ND()B"=!*.+C+?U91-0:M5?UHD/XL%2R2A'.
M!\M\SRC7-5)]H[3S=!OWSB>FUUB$3.V?":;J7FY'S2N<P(2M%O52K:L2]:PK
M^*6:K.Q.VZ%L!,=O@RWA+!GOD-X:TG"H0ZO]Y1/C1?/#4AT2J#MIY=SA$"V,
M74&EM7FIII<_6:*3MB^\0)3%GL(-V.?IR!3\$_5"0=P6.+VR!RVFI7):Q;M,
MJY&NW."-VL?JJ#E&W/_.&_)8C63JYX)A9/)W#YM_U9CP^=GQ0I>X%RQ80.$R
MC/1.H5W&?#;A+9N10.M-I=J=UIOR@J%,,I2(AD VE!-NQ067V?MV'?2WNC-3
M6NVG:&:A1;Q4]:L_?:63&!5?;6RSSE)#JL6D5,"K>"WRSPW%3WNKWSR+?J]\
M%PV^BA9_7E$!!;;_+2YI)HG[2T].S[E@TH'/>E/LP5><X%-N:>TVU]"GG@?O
M;YSU! OA:T_PL<E3&:!HX#ZHSS%%'P<4R:U)M%_LK.<PXL+7)W@H^Z(B! F_
ML"!<GO6BEE2010]%WW2*KBP"7^+'7B[E'6">??RMI-(73'V(E;?^)><A]'@[
MS<Z#K%&OF4BOJAM&WR/YHW4% <?DD?@AN9'C6%)4J=>SEL!:'>]"YLSE['(T
M8T3=NB:+"7S#*U,QDCC2L+9Y&P6--$F_EGKJ!@OI/P:ZC,3#G%QC]HV(V^F4
MP"M1S=HT$-B@S\^A]W(73CSJF*E3W]X&;<X#/_XF\>TT^EM0*1),M)O5,B"T
M6+\[1B06C$3;&-?2M)J%#3I?^H+(05S$^V=DS',PG]?&Q[KFKXB.+IEL+SB>
M!USP6%CWZS+P9;AH,>R9DMNJ_J4OQQX,N[2B_U_ZA=WM#4!K*6U5^HX%#B$N
MAXEB!E9N1S+<J!@X^ W\G5 HZ&O-L]$^K#4D?H$+J:,;FJ:9RMH\*MV,=@LO
M]5V$ODM<;8!H)K(5V)S4.9=-Y(8X=T^$B*A,5#=@8JLI<DX:C\Z)O^JF>I4D
MWX6:D'>UTW*5PG(E/S\3YE Y8*<>JE.RBL+:.)4]51!S@@7E/& O-X$@7(9>
M$+E671-26\&%](.(8F*M9(?2%IP8E!^,F\>H]9C9:II?9$(N<XO;Z5C^P:@C
MU$;L)"+7&D%'9JNZZ3Y&WQW3V5SPW ;24:QJW?S,C';C$[/H"EC9G[U2PP?R
M+#YZ3;@:4F]Q]BF27EJ6Z-1Q7R]Z#1MI+-$K6=.ZK=MC=NL7-IBI@PGURK^>
ML246&ODSR307<C2EOKKF-I11DF<N32"RY1;M<UI)8^OJ07&=HQFSNM8V0%8\
MJ^E>1N=OY$X.A*19*0-"&_0KSD<URP(UK6W01%7%B[-K.;K!]2@>)!<-JNNM
M^%BK_1J*VJ936^3L1>@>PV@<O05)? +?4L?>[9-/&)_3Y15=T&B5^4[.,F&U
M?-8P0UN#58NAHL68L)0ASBS*P!%4R?$9\FGZ)/,R+U!'#VFKS(;4ZP^&VYV2
MNH_0BRNGTE/"8=$'>Q>D0=UZ DLU5(>*Q2 E<(SBH\ZB(\;B \=J56[!P5(;
MQ.L>U3ZJ4]^,V-9D+Y9>@97-*;)-[(;:Z^EM-<#*Z4+ICHE?J9@_S,D7+)4.
M8$44ZBC82QI?!'+<55'ZR^7XXIXLQ7!_.&P>X+;0D0TCXX;4>BOU.OA##+C2
MTY_$@J-P%G)PC<.MF[#<E4TV7(V^(T@D9ZJITK@VBIF26SI^F8D_)@ZAC\1]
MI14R-M^K-<[C 65=,R3TM@]IM0J,"5U,0L;5#U@%4<#"7+(^L7T=4VN7VFY"
M"&)J@:0B,M:;0TNWG2D;E=%Y1ICA_%N])E%9_M#/Q?6T=L3]&04-@.^]G#<;
M[(YM)+%!I]R>HNBHPV1G$50.>.IC^HQS#496Z _)Q1K ZNELT.X:HL6]9)Y\
M\,AP4[>>S@;M#%UN(W[['>JMS]#78&2#_C]C/Y0#;JN-\$TD%NG4JHC=1&*#
M3O?$IP%3[US"5I#<[O7\5J%F)=OQL$+KK.0^FLE':";'A4MXQPQ[B>.IM3V3
MFKV&@:5S(AE49,@8W,F^FL&M:&@#@I%80U/YA[;)?^F[H9-&;KT:]>UMT$;E
M(DJP=HN6>CH;M(N#N)3S:(W87T]FA6ZA#\_'D>F:;'5K&S3Y#)^-#,STJ&YK
M@Q;1CB<S+:K;VJ!%XB?MUON;:&S0ZMS#G*?ON-PRM=/R5P+_$G<DLQX\(V,"
MS.3P#^<L@I(A]AX(6S2\;_8ZKEO:MYH0K6N6<>!Y%P&#<Y-KWYO4TOVO]^16
M2AB]'7$)VS&D&.U@+=)N2T%5JEM7P?3-B/5TK""W4LW"(Y:(K=+V=;W7F*>5
MGMTD_6N\O@W?+<;YY""C;9@G^<$W;Z$*UM^/D:[H=%,/4XG5]_ ,@="O<H6(
MP7;6CMJ,\=DITJ/BT=3I#O:'XHMHJZ<DF'/8 +*N.)W+ELP))\J7U\3XJT_5
MV0ZZ3>_E=E8DK"8VOZ*^LA!_%7(Y+O_KYW(<O&!/O(RQ(/&6V?HU[(JFVPVN
MT(<1<B!$$)T-GE]35R]WP6;*B4=G2@I^C9_I(ERD=<AKZA$N I_$;^7#28!W
M+'!#I]X06^O/UBT1=0I?A$)Z\[6<;$D5KS$LK_L@3Z);:POJ&=IJHH\!H'HM
MQRCLS$-.A&X&WT!@0S2\(4_M]&D@L$&?*\(Y(:OO_8U\/X2->NE.^EI_-:2V
M]87@*O'35\Z29^M32$930=A_"&870<A:&<. FZU/[I=_GI\WNW:^A0V^'.\:
M3XZ:NF-D0<.%3/5K#]32;4!OQ<K:W6B54X3TW: X9XD'Y';SC%HFFYYKK)/^
M) <69N=MF1UP6&YO@W/_AWR3:9+,7O'Y/'3]X)%_TTPGFBALT.AG_/(+\4%&
MCGV9'3ZPD,LT<3J5 1,._H4-Y"MM="ME:[*SP1956,$N27/UVW"P0>-S3V:S
M#O8>&*:>YFS$JJ8VZ/!YL?2"%T+BDZK',.*7=S-K5A%;\;!!:W42=W0$,Y9P
MN-21TW:8U%]K\@4#0AOT4V^=-6NRTL0&F:/SN$&*^(1NW6[EFN9_J"[J+&WN
MS,D"?_CAOU!+ P04    "  4@6U;V8PUH4X9  !\\   %0   &%N9VXM,C R
M-3 Y,S!?8V%L+GAM;-U=67-;MY)^SZ_0>%ZG8^Q+ZB937N*4JQS;93MS[SRQ
ML#0L3BA2<TAYF5\_C:/%DDQ)E(A#';DJ)8<417Q ?^CM= /_^,\O![.]3]@M
MIXOYKX_XS^S1'L[3(D_G'W]]]->'%^ >_>=O/_WTCW\#^-?3=Z_VGB_2T0'.
M5WO/.@PKS'N?IZO]O=4^[OUST?T]_13VWL["JBRZ X#?^C][MCC\VDT_[J_V
M!!/Z]&.GO^U^42;$[&T$=-:!*C)!$"H"XVAYCH$+I_[CXR_.2^L3&E 6!2CM
M'7BIZ \X:IN%\3GP_DMGT_G?O]0?,2QQCZ8W7_8O?WVTOUH=_O+X\>?/GW_^
M$KO9SXONXV/!F'Q\^NE')Q__\MWG/\O^T]Q[_[C_[=E'E]-U'Z2OY8__]>>K
M]VD?#P),Y\M5F*<ZP'+ZR[)_\]4BA56_ZC?BVKOR$_45G'X,ZEO !4C^\Y=E
M?O3;3WM[Q\O1+6;X#LM>_?>O=R\O#!GF'^<_I\7!X_K+Q\\6\XSS)6;ZG^5B
M-LU5R$_#K*)_OX^X6M(<^N]<?3W$7Q\MIP>',SQ];[_#\NNC^HU0A<V\9!7)
MOV_PK8^_H4UAEHYF_>*\HM<GWUWA-02.7U9(?W&\2J<CSQ;IPH=F54:+[O0O
M9R'BK']W<K2$CR$<3MZO%NGO_<4LTQ;Z_7^/IJNO$Y8L43)8D%)$HFO(X$WR
M@"AC-I9IR^7%!:N36M*L>MF6L(R]@$^&>%Q7\C'.5LO3=_JU[=?U:A3'ZWGW
M>7V@[;T\ZK[VW_QL<7"PF/]7F!WA)/O".08!"26CV3$#SF7BG@\2:7LXF77C
MV5V%Y>(<S['F29?V%ATM!FFT1WN?L6J?7Q]!K]V.D84N?<>GBSOKY!./ET<'
M!_V7PG2%!Z=_7[K%05,BK!8#K/^QL&DFV[+A&$"/Y1B%"2KP.BNM#:%@I'0<
M>@[1VJQY=O3[UAR_C&$3Z8MOTG](PM]JN9L)_1VNPG2.^??0S<D=6#Y)9/KK
M&F-^CF6:IJN)-4+HP@LDSS@H3^""=!I$Y%9J9CQ+IC$-;D:U"3'DPR1&8Y$T
MH\HY'&_(%^R(P(<=[I,]GG["E^1/'N"KQ7+Y&E=ORH?P9:*LD@Y3 (V)G#D;
M(X3L!1BNF#0VAB!*8][<$N(F)%(/DT1#"JL=HW*>UJ4)L[=AFE_.GX7#Z2K,
M)I'+&)%SBA:(XTI:!2Z1.M3$;N-DJ;]KS9SU4#9AB'Z@#&FP^,V8\&H:XG1&
M>'#Y[*CK*/:<1.4%4\Y!2,R3CNM](!T@1^N*L8&9F!N3X'L4V\[KS2%V)-OY
MQU?DZ>'I]W\]G:-.F0D?,V1+$;$BSPZBEQ06JTP*GOL8C&L\Q^L1W=+;'I3O
M6W+B,M\;BJ*E2>V.,*^9*=-"&XX,2E8!E%$.HL0")M<58%E(/X#Q7 ]F3$YX
M8U*T$4##$&R^ZD):_7.ZVG]VM%R1E>Z^8ZK2Z(T4#@068JK)DDPUO4R6%:2Y
M%N-\\[#L9EQC\L@;LZ2Y6%HJD,71?+5\&[Z&.,,S+%[HG&IH4$B%J1PB.&\T
M8%$%Z3<*([;7'FN0C,G#;J\ZMEWZ=C18+G'U;5;DHJ6L"\U*6/+@R"L,CCE@
MSL@HM8DN-;<=YP%L.YNW'1Z22_K[E\.:ZWTR/XY@+LY1)<<X\PD$N:2TVX*&
M:)!T= BTP-&(Y%LS? -88W*?[LZ)RTQO+8]VYC(L]PE._:<&1)_"C* LGZR>
MA:[[2I[><5ZMJ)PS>@NL5,5,+VA'N@ NLR2+-T;KYFG,38"-R:UJ1Y;V,FF8
MZURNNFE:88_N=+)H@PO<6DB!@E[E> #O<P0R 2EJHWT.JGEZ<PV0,?E/[>BP
M_9HW-I(3$US17ADH)I)C'VR (!E!$3X9)CA!&\8Z;F\6%Q3"KKZ^G87YBK98
MW5Z']3']:UQ-C%6)1=I0UM$V4JP(($7L(5$,@XEF*3 UMX=7XQF?(;R5W+^W
M@(V6OAF9+V8SWM5E?%/^(NM<)SMQ.A<N,P/TW(#B)D%0G&)9%621,B*3K=EP
M+:#QF;JMZ-!N\0>* &0B^(XTMK16@$*5B)(\@V>>V<PP(+.[BP#&8,NVDO?=
M%W<@W^7U8IY.T*0B0D'RGQ#K(X"D%41=$&1@,2B7+9>MS=E56,84[#>0>I,E
M;T: BT%8'X&=@\2SS]96?]K4PCGO& 3F!'EL2I)3Y1F6UBRX%M"8GILUL?^M
M%G^()V;DD*QY-EB2D)*3!0H\DAF*LI:34%A>R'7GD7/AFS]^OPE3BPJEZ>J@
M#RCGM0:PVF"<)QIOPI6R/-004CD*4@R7X!4)@7%% D<N1 H#%"M= 6=,_F]3
MIJRK8FHADF;[8MW\F)'2>@0K,\VO>)IIU@QLD2$F@8PC:TR-F[@_FH=H[1FQ
MI0"&4) 3PRU*71A(;S,H6PQ$0@0N1L%SP%!RZQ3@N>''Y T/*OJ[+OD@,O>Z
M^" (N>:!M \R#9Z\,V!:%VZE<%Z)7<F\24%,,%%+1=%&"8XDPT1]LB0LN1GH
M,GDP%'NT#NKN5@MP#X;M5M*^AK9W6>NMV5M['";_#%T7YJNSQ\H3QEP4CI.6
M9%F"DIZ\RAP\8"HV!T8A:+Z4P_F^)6/M-X_4$MU)A-LOW4 9N3,PY^.$D#BY
M0@IT"KS"TD!12  MR4F*15'XV/J9Y8V@1FJ;MMK/;271SC@MYA\_8'?P'./J
M'!9C:U='TB!3536UZ#(44C76"Y-],"JRUKG:]4C&E+YIIMJW7_-+\O_'X\O+
M\XI>-^O">[^BGWTXM2@G/*;?AAI:G2O@KJ7;%_%MT:)WBR$'Z=^[ZY0;-?>]
MQM6W>OB)CD+&9",0,1RH3(&KDUP#6L=B0%N('HUWXP4 VRH9(OGB5/T=?^M)
MTFHB8BUU*@$P"TV.O64T,^$H"..9*:5R$JW+!J\$,R8O\N[ROZQLVJQ]>X?D
MW/0,*^@8C<QY3$ C1P@4WH&P&%-1 F5J7>RP!L:8/-!VXM]VO0<5?'2.2YDR
M\)0\**$IH$F.)B:X\3;(B,,]$6ZGW9XMEGV>\61?T;2"4US51KB<:K;"<?#.
M" C::&U0N]+<>;J,850-RMN*_OOT[A8+WK(S^7+SVEGCFF,9!=:ZI/K(16&O
M6G4!HU)4-B3:@>VKX:^$L_76O:)7[\6B(_[,C],3Z>L'BG>7(?4LF^?^U0GG
M\O\<+5<GE2D]HK>+KO_%:M5-X]&JEBI_6+P-O1N<G4G*&P\R! 6J< ?>V$ _
M2&OQK&6*S97"+B<X)C>C%8>_LSJC94RS[7_11$OGBC<. ;&66^4LP7%%7A63
MF6G'N+1Q=Q[Z_3HO0Y'J[BO>3NA7.M-)(>J( K0T!917DDR0)W32%F2._"O>
M^G'>AH',[6?Y(DR[OB+ZVS9\4T[RF4L28<DA!0%,UBKIE MXGRQ(DYPL-IKH
M6K? 7@MH5*Y.&X)<9GX[@;1Y+/!'F,[K)GPS?[E<'M5SCL[!">1P4;PB0 A)
M6SP%!M$H#B:A-LJC"9=WPA6/"*X;94SZKJW,VRYP,\WW?+H\7"S#[(]N<73X
M>K&BUZFOJSC"?)8?^P;[]..3$ )YXJ5J:(-0Z]# %VE :$^T5"3TYD=2W1'J
MF!XZ#*-&=B'#9H2[VE4\1?@4"WVF>A6&O(J4#0.)F$&I)"$B2L@Y1Y5K?J1Y
M,]4MX(WI$<9 ]FD@636R5E5MOL-/2#P_/_^)M,BBS0DT:O)(DS?@DN=0S68J
MZ&V^G'R^RE)=,<*8"DZ'L%(M%K:9PG@Y_X3'OM'Q]%[.5]C1.Q,EG-.:T!C9
MIYJ\!R\E_; ^:&,9\Z%UB<I56#8AA'F0A&@JA8:<.![]9&872&IETE)E#T76
M0E#+*(!$E@"+QB 5#]ZT+L6Z!LXFS+ /.XII)8R&&=Q+>61+<91COC9_UAX*
MQAU$KDEO&2$0;8JH6I]\='WB_DXM.4A+4[N=GY-FGBWZCL!3\>E(,4*T"5*5
MG#)*0Q3H0.F@LO)2R>8'%%P+:%RYT"W8L*9-IY$8FK']#YS3;IL1HB?Y8#J?
M+E=U[WTZV]I&.!%B)%#1ZEI^4CN?:V5T5#S:F)UBK?,Z-T :4Y#?E!TM17%_
ME4"U >W%;/%YF**?;]\^>'W/%1-I5\I3!WC;+3Y-Z=N>?OV+H+R<OYC.PSR1
M[7M"@=*GXZ*RE"WGC'O0,1*GHE 0BR:Y:RY2B>BR;NVI;HZNP4D!B4*^Y0O:
M6R>YK-^_8)>F=3>)7+*B\8&\09JY(P\C"I'KOJ)W2TRYM([@K\,S)KLT$'_6
MG";01CP-FTN_(:*M^PF[U33.L%9-3@+7:)@F0*G.3UD+P:("IX(OR6@E>/O6
MTBOAC,E0W0-=MA'.(&Q9DS2W5CIE/ /+=64PRQ"8<D!1BQ'9".M8Z]-[KT<T
MJG3S[CFSI8C:9 ;7 SIW!G[]Q9/5AWW\,W1_UV?8!;MZ^GG_//OT+WK7<!(P
M,Y,8UIIM<@KK@<>.F Z>R\"E=H@\W.04M08UJLSSL!R[5WD.HL1>+U9X>H[C
M)*ADC- (TFL%*J"$Z"DBX"4+]*F0"1[@)*6U6$:5U-Z]XKJS6!JIK/#UPN/_
MBZ3-]<@GP3@P']7Q<:\^>PL\&M0EA2QRW$P)73?,+;/8 ^<J=Z%7FBWZ()JB
M5VUO#OL.E5.?/4]B4-Z+1+Y7*;5JG#GPC'SV$I+52A617.N2M!M!W3++_9")
M,XR@!G:7W^-\NNC.]Z=-O, HO= 0)0_U#@X&WIL,QB8K(PHC2NOFC$VQ;<(F
M]^.RJ9G86M;$KEN$L_K_<XN0E4:1ZZ%$_:6*00APAMQ^'BW/NC"NPP M;1NB
M:UL;K'T@5R KD+;6IRKG(>C,(0:B08F.F=B\-/2VM<'WG,S:EB'7EPK?1@#M
M"N;PL,,T[1=EHIDQ3I%BYR%D4!A-/=P]T$L;4M16*ME:B9X?_P'DIUHSX,[+
MOYO#4)\<U'Z&_^OAG3[U4<84FBW-SW%13Z8BE>V2!(-6>A,-\ZIUT]!M,3Z
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M?U4")Y2!$E5A7JG@;X>0MZAWVQ..2[M-Y-B#Q?=R,KY($+M8^0_G?Q^/_K7
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MI_35?V-:%8:4&!F350E::E#H.#B3 MB$7(0D% ^MC^0>EG'X2Y1A"7D[Q^G
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MXZ>2HO1A'N;+3UR]?%?=%U9=:#&R:+4'L8P[*FZA-A$D9PZ#STC_:=YTZUY
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M7"C*NF3,GWTUAF5I?WTU=E'V4PFMW:SNX(@JRER3!%(B<QDE!'018D%)IK1
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MC&BA2*Q54-G02KT!:0E8\J+HYCT [P5T;"9D,^'W,2_J)J;U"] !5$^6XT9
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M!\QR#4I:.N'(/JJM9IPA-@==2B=-;OKT(]'DWH(;O"!:1,]"+(I<[*P(7')
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M_B39*(-,"3DF$Z"-M'NX%;IO]& 7:#T9 X./I7_((FBDP!WFTC]&^GV<#_=
ME$I;]-Y#B<[2IDAO1$2?(8>4$O,Z6]>IB^13)L8#5L+PO-A%Z*WC!UL&/GO'
MM5;6@,BUY)=Q#H%A!LDBIR^$-:Q;NN%SF):]D_P[3,O>17BM,TC7,V)O3X>-
MSA0C0ZV3+'32F3I+SS'00GJ-,NIXNV'7 V-VG_* W4?KLX'P>MBO+_/9?_K7
MHJ8G3<Z^3,;+8LKEIN2X0R43%*WY*K71)]JC+-<1.2],Z]8[]KV CL6^:R?U
MAOD>:W"W,*WMBPZ@>K+N-@(ZC%W74'&3OJ3>PRZQ&5R6Z(,@RF.A#5#E0N!,
MC&"]+A*C#LRWS@0;D H/6')#,V$78?<2]ZECX3_,)^FW=<>F;+0PR("SI&I=
M>X:X+&YG6# :%I)LW8WZ#HCA38,&RKD3[ME'L@U-O(RCD]?X*9S^-)[3&I<\
M3IES)Z0 ,GMJ6R\9(7C+R-JQ3'NI(ZWN'B7/,/WUT^3K]_31*_W2%U=JW?#
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M- EXYOD$5/W^#*&)#:$FJY6J;,_+4?U -_?._K56$",I1 .T<F<A,S->+H"
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M$*!BL,>C+=.'ZEHT]:MUI;.7][J["9G(),0Q3Y0184& TSA,L$]#FNO-ILQ
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M!&$T"['PHPB3Q&,X3_,8YTF<Y"P+8P*+^AI3GGBI^:4LQ!.ZI]4_18/DNN!
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MUTS8X)<YL'O3-3#6Y<E^$\O;NT;P:[70TUO1_T5\K)9,+"(B/9F)'(M ZH2
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M:7:0YN=/2',$. ]T_YH,SE5?%'R8;3J+N^86*791QR_>,8RV8W8LH^]UV?[
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M;3_CJB=I<7AGB"/@4-4].I8GIOHNYAXG^WF,5_T9W*?)@;,XTG0/X(7GE2Z
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M'&:#X%N'Y\[+KW4;F>H+J8.+LQI.-_71U7GG^+'^4Q\A[7DRWT&80C6^DY@
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MHG/I)V5[IH-VA#42OXTA87^@,R2AZR.=D[1>YE!G2.RSQSJ#@^S6GH_J _A
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MZ%%QGT>AQP=8-HDO[^^7G3]Z7?"N+?"M*)@BL+MW!<Q7!<TYZ0GMAHTV>_6
MD;W+?I-DLUIAX*KE,8CVO"V.;6 Y:FEL-8FE?IQJUO1^68AWC;BO%QG/HY0)
MCCU.?$R4)X SXF<X9ER$D>^1C(&*F0V3F_HDIVT,5NX:@Y5]8S#TNV8!M3P
MZYB-X&=H4)RA K0@EP$"-QI&<KJR$L/$YC4+1H(?V0&S45;5BFJA"YTI\_):
MESHKVR)(>S&\5Y7@RV;!61HK'Y;CE&4I)@GA.$\SCL.8",D3[O, 4KG(B.C4
M1J E JK;8X;5L*I/A0!,X3<,(,4!VF-A/V2NG-^I( *5.7(.E6W)(P>000LA
M@60?*8ID-M><!9) TCTKE@0;:^<3?1#-*UK??=0-Y[G@/SW]K=:M*]\5CZ+6
MKM@U:Y:/[1YENW'@RCUBA!$<)2+ A,4!IB*+<!S&$0]93KU(0/PD. M3FTW%
M#9*K\NNF=]R&$T2WK, \)PN4S;RI:;$#>E@:M@TG*']"WVMF%'H_H"T_J&?H
MZ4K?15RMVS-,[>BWCK\.3?273LIBDJV</5Z./#4+!F;UWNP!>N[173"3G2G[
M613JTUDI>WG-[Y=%7VGN46PNV;'8B\(@9%A$NDE1$F:8^AG#62J%E_IQGE%0
M;'>$WL1&JJ?>1D/H 7V8:1I#S4\#/XU$@O-<;8A)Z/LXS[P0!SS).)&4>*%G
M5G)B MRLRD^\N7]8E4]"H$JLVK84MV>AM(P,CV%J9ML=X@0SY/N?UB'IS:UQ
M=P;94$A'UG>,VJRFUE#TYW;5=)C-5KE\HJOF2?=X^BC4MU$TB]S+LS!0+IZ7
MQA23P _5_CBDF&=>E+ @I9(9.7MGYI_82/8$4:5;E:#O:8TH>N@H&_9N.X>+
MR0[X(FF!F]U>4$VLO7G-@.6*CR6$;& ODM1RKPJ2&+@I/2O/\/[S>-B,6\VS
M/!_N*L\_9N=U;5;3OOU(>W;_$U6NWOZEN@]EZ_4)WF5.M:>O^W_7+4 _E,W?
M1:/K@-X6R_\2?/]^QH($/(XC&N%(Y)GR0IC$J0[.R80P7V8^3<PZ <W*]<3&
M[6]%M26K>YKOKC!N')NF1.M>A(/[68BV L&<FGE>M)EK](=[?3!KW?*+6X;1
M1_IT'&+;LMZE&E[U=\FNNEZYNLCQDVC0CNTK='U?KEV>X<^*L"/O;AZ>9_41
M9WT-SSW->8E;M/Q^?/A"\Y61_[G__,1V66DT>M1YA94LJ_NVZ;U!->+ST@V;
M1%O!8!9K4";T>TO=5>_N9\+8]>O>3#)?C^YG;!_TY7[^-Z>Q^FV9GEU$;9&%
M1,19DN'4RT-,XBS&&24"LX"E7#=.E"R$Y.F9DYXX<4\Q@I@.-*^[V/)>I2['
MP?E3L%X4E+\0+&?!^%WQ+O-@_.01^ %PIHV\GR+\1XBX#P!B&&D?FL'. 'WJ
M]A4?:=4\?5'N:DW;LF[00ZNQ::;,">@V1BUIM$][DM,F4T$=?>&CY&;]KDV%
M?_XU&X^SK=LBI*BJW@E55&ZJMJ Y;_L3* >G=7,784:("*CN#<)TI>V$JJ64
M!#A.DB )1>9[408KWF)"=FK/=,-$%PVX0@^T0H]MOXSOU5+*R]6*5K6.D*):
MLV,8(P5":V8DW ,&]'BW6'WNL%(LZ)S!CHF^RXABH[M5Y+*T"T1N9_5=C(C.
M7.0% L1QI1?0:)M[N_HJJ)ZM:Y=0U^O[=D?[>BD59:%DM+K."YEU8G/1WW;=
M<H-V[* =/W97?D'@C>^ I\,-9C6@D$UR6]@&"LM+Q"!2,]XMMH'@\,JQU0P6
M,2Q1;D-FU_>-<2CK<-C4?L.;&]3=F#NLE#@<<QZ5U2"P92\F<+6WDA 6USHM
MBUUXZ]E<\T6Y3@MQ$.PZ\XAE'[^RN%5?[/UKD3=?U!2Z4?E"*B\\]1.&/5^W
MP?%#@G.6JO](ZK%01FE "<0Y/T5D8I72)+&FB331*Z3)JCVH(@R\E',2(#,7
M^U*Q82K62OP%)C&\1=^ 2*X:\YTB,6\[O@$ACYKP#3UKIY*OQ4,EV+++"XE(
MF 9)FF"6>A$F.6.8<I_AG,=*"_5E\4!"5'%_\HE5<)\43.<.$##3-5NY8#IF
M)!)8J4[Q[DB9#J:>58E."?5<>4X^8Y%7MVU_>2/U?5?=_%IYC9N.9W][4+\0
M3;-J#_\7J1 \](,0"QHS3$+.<!9[*?;SW/-SGF4>-XH\@2E/K&YM<]8NV%1*
MG:^BN.FS4K[V_*#U@_[=EB-  AL(XF&5G10XF#[O-;2]D:ACI*\NO&$%:5[0
MY\DQ Z0#3H6=7:*@2PQA:80V. PF&((FG"_UT$;.@Z1$JPFLS]"[1EOOR[J^
M?J3+E3Z8_U+NT>TJ#]6OEZNU3FO9G&WE1/BY] /,$GTLD'@4IS+.L @B&JDM
M1^['($_'FI.)[?0'I6.5_JS!I^B6P)HY4+/ !;/..A>A[ZCWO>;J![3E2Z=>
M[IN:GK4KU#,WU>6VRR!R=])NR<?<!^^7P77B'/["">ULVF=V)_AZI:SG^)WA
MLF@I?BG[5*ZW9=5V'ZR[7#-&F?!YRG B4P\3DF?*R*4A]FD8!B')99R"\JS=
ML3:QU=LPJGW3[35X.G@-ON=7JWK/,5+_01W/HSEQ4[]),ZOZ,N\'9F;/O8Z+
M7P'8P+I'RY'%=<C8K";8/:#/;?($%"R-M#Y]UF2ZHR4='2^+MNR5#MC2S)=A
MS!.<^T&*2<!"G"K'$A,_4MO^.&*>9U1\QHC:/,?&.YI6<>UAO RMFRL48 8+
M# #<$)D(YLJV#-*:UUR8B'UD 8P&P?O]O"D:-=V;;VV.VE*')+J&MXN416F4
M102'A"A=]I,(Z^H"./:IE\8)SR)IM%$<(C*U"K=DT9MO:$>X[^=KWA3H+$##
MRNM*;*#.6D@,ZAPT)I)5%Z&SD\[646A,K/WN0J//6G?B>Q!5\_11O=!&]T]7
M>MZN[>^WI0EY["<B\!F664XP$5&.J=0:FBD=#7.?,TZ!K?A&2$Z=D=$S<(5:
M%EK7>,O$!24>#; T6WK=(@3390?@V'3D,Y3774N^,8)S]^0S!.!$4S[3D;9U
MD8M'16"IG'A]#-YW]PE(&'DRC91-4(:!I!'#E+(<>S[+4T;#)(==*3])96(S
ML$=3WPH6M;Y.K#<KP,*N)P$R4_2+Q8;I]K[$FI[#GD=&$CDKZWR*QLSEFP?$
M/"[3//2PQ9'XW\4_E5M>+0OZZF[-B_*Q_N=3_]W%4N1IG/E8;8E]3&1,<99+
M'V<9#S*1J&UR'A@?@)^G,[%J[@BC'67 X>P 0,.*Z5!LF&J>E'A</T&B TZA
MW4!@=^8,>_FP4^5QN0;/D >&SW=B/"[#P?FPP>/PS.L/9?%IO1*^ET?^=55=
M\_*A$?SMBMZ:)F&?GV'J(]JRP)HRTJ2QOW\N@7HNS+.R!W 8-C3N((#9&0/I
MT>^:!4<7*L9EM,KA'IAVMG3N<='V,[L-GK;P!'ZFRT(?F-X4[^IZK4M+;,O
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M6BA[E&5U6'8]UISPG,2)LA%#$:3*;O0%SCP_PXP3WZ.Q3/R,SYN6E<JT+==
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MQY&4/B92$DREGZN39Q;0G#$B(EA7$0.B(RN/]S*7I<Z.4L](A=HWM,J6BR>
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MCDM4[#20U2<"TTFF0O;JJ,%!IM-9IO(<Z##CE^RRLG2[)]V&]>MW?EMM/T1
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MIT$88N)G/J9Q$& 1QSS)=5Q"3F$550=I0A:(50W5+@>ZHJ=0/"#1,@'3(L,
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M#UF:,JI)HY;V#'U<K=;%:@V(V^Z#8-BN<20]4 OU".ZXU*:AC%8V3]^XDQE
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M:.P3ST'I,X4U^N>FD(T;0?WM6=ECJ_(5:8YFJ&@6JXV--HBGF:YS@1+P9'0
M4$T3M43'*0AW3JP1ZL =D'FS\F_GA.VK^G;V>9OHKU7Q72V6NO=B\_-ZH89\
M4#C+LI2BKB;7N@$Y#20/$H:C.,@Q\>,$LSR7V&<R\-5R3[/0J(,JE/#(*W_/
MB;:S.[R@'3.0<I!@6 U<,B.!!5, QCC9N* A@$&"L,8!SC+DZNH/#1A4!1>^
M/X0*,-Z$ 5-P*0_#HRS>AWN#MM=\!5N^5HL*[ JZ]/[(NO'236_+AKDKZ*+\
MPWX@%Z+#--V U"/X@89DM'("71QT,@_0D%A=]\_@LY9UW?:Q+&V*\\ZK(-)
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M+>=7WICW+KG:.^3>1C=@FQ.M9GQ>>OHT(U,O.'/F^?$.5&L[L=XFBR^3D>]
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MY-UTG?'>_605*6I6?RB[M-J_,6F<&;U^%'+<L>'O7ZJ",''P"&CJ)QRD088
MY $21I D %+?YTF689XK(>>]#/N.CR0]2Q[K:=J!GEUXAA7#XJ]VWC1#Y@IM
M4^N9OJDW0Z/4G4PR9-1)=>4-<GF]8+NGO%:T!9NG.IF2I5JHVF7^=352=3(Q
MVNU4W7"A#\;:TKR]OY.M=SXJXK"<?<^=Y6C)>;?%O?3Q]FV":LLP*+.2&2&0
MGAYQ,0C228'&&*33#[Z0Q_1[FX2FM)GZ8>Y3EF" 62#=)1^#C.$,9.(PB1EA
M09#HE?TOQ_M"OM*=9.BU>$H:,[N0F^1FOE[01^H$^FLZ2/J3\5J\(PW._UJN
MD?Z46/>+#%BXK%-UWV)G!)_5=1-K5KZ?0YJ&!*",M/48&<"^[X, 89HE6>)3
MI%53/DO1]1T?(95$1"%CJR.O(;K\9-6R#'4%JEEUJVK1L\4#:5#UK;9&Q*_Z
MYH 6HXC*DEKNMGR>WHOT3YX5_UQ'Y/D7+\0T[8'SI$UZ7[%_;F5/P;>;>U24
MJRB+4!;B # 2^[*3'Y&^)P2,)TF6(\00YT80I>=I.C8'(\+>CK+WO:-M"A8Z
MH4$U:V!9+WKVP% EYBB<\T+:!M6<H/@R&)GS*C@+>:GPJH,KS>$"]>V6K8*<
M)M3/$8B%>P @I%1VC((@Q3P/XXQ'<1;IE%RK$M8R#885V!8O)<<JLW /::@(
M^U>/S4;X3N)P5ECL Z<K^1*WBV.RK^="\80RM.X03[UO& 23]3@_-FOQ1OWN
MGULQ]N=-,^IVOB^3B!(>DYS&@.! N!$XI2!+TU V(PBS(,-QGFBU%E&F[-B9
MZ,!6NI*R]DPQ9NS?O(XUS?B3LE(5HT<N5*5YWFC)>M_=U'_HRF<KG*),=]E@
MB*XZCD(9V@,8I#3_)RJWJ'KZLL7K@MST8*]]);]/_2C#8088S!, 4X9!CG/I
M8:29,!I1FOCJJ)03A!R;AIZRK/*/O8Z^-S"@D8TZI:EI V!3?KWU/HC^3&H3
MW(<I\342:BVIP2PI]HPZ+.6Q*H@VF8LZ]?YR^:0*4ASDA*H\;U)J(?Y0$+2^
MK5"Q[C\S&$ <$G'8"9,HE.UQ(Y"3+ 8Y8H0(.Q7Y>:A>)G%,P+6+TE/TFDK6
MNO? 4CI8-*>4HF!Z+A15S^3LI&RIF5B:4U+JI.Q?)JUANOV!U+82X\]+,IW4
M?N*]!1/2SW-]F$P^\9PA,AUK.K L69J^8C[APC(D( L@!%!H"&11%H#<IPC&
M<12A0"LT<C"ZX_B'K*\73I[FA<BA_%F>(4P( R$+8P#%5P)RBC'P(4NSA$#&
MH5)1V>7RZYM*&_+'- SR$.8@P)P*^4D*,L(Y$'YKQBA,XYRRU2.K\,:Y!L94
M%M6!VL'46"Z]G4$*-$ *2DJ_>M>-V KQMFDQ"9J-]P79O>\Z*9@M:,&#L9>%
M$SPEUA&$X,F']//W;BMZ757O?CX45;LEOD6-<C/U4^\ZMAQ[8IZDIMXR_:2<
MT^O'AHAZ2TCLE2W&]2B?P5.56"M'<4HLHQ3%DP,NEJ$X)<XX07'R.8-3C,QX
M8!TRQIM-*;:!IA"F3H9QZK=]^8B$T)"-121F^9M-W=0K@H,TY@$%>42A!-],
M  X3#(3;0M,,$QIP)7@B8PX62 -A T8-V3/EE9*K74U:!VE3](R)!VLMW$XC
MU2L<IEPK5,\@['5YP[T1/U[+D#=PU($X#3QY;Y;0I<:1S;5.S<YT+G2K=P"\
M1"^3)T2C@9<[0EXB]\$9\Z*!3-M_2^3FYNF+^)::ZY+*R/V#_/B$0[;B44Q8
MF&*09+$P[2F- >((@S"(4H9H2A.JE<0S1<RQ%1](MY=M;*!K@)(^J;  L0BC
ME(,@225,*Q7'>98@D(48AGX29S!+= [QUA2F?Z9?1F%J)SY;:M#;K :J5UY+
MMU7$N[TB/D\HPJ#U^KR$UMJP3Y!:N"7[O-#'[=D5WC',2F!W+3H$>]A4'9(]
MWU3WSSIR<QX$R!<FT8\Y 9!1###W4T R)"PBB2&$2D%]':*.36//@K?CP1LQ
M<4%'="5]JAD VUK2,P06%*2?G: AL:W$!!62R^8D:"CA*!U!YUU3WZD'-FQ3
M'[K.2=?;YL>F*O[%Z KRD(4T1(!Q>?^7T@SD"<,@R +A/:4920,ES'8U<L[]
MIP'$\;#3'MHQ8-[!;$:/JCZ"+>WH>@F#8GI\\+Z=[IZV32]!149K?L(DL84]
M!17!CWT%I;=,@\S7=/-@%F(>O^DZ>M63,@HO'TBH&EPV%>[RT+*:K :!Y5,B
M71!6/AANX:#R*5&.0\HGG[J@X+WO1=W6(0Y8RZN(^XCELB%]D&$ ,4,@AU$$
M_#2.LR2->!#GVN7IIR@YWQH%K7W9>-O(I-L#BJZENK7J\I-J5/2@;2A'TVT>
M]Y6_ZNJI]]CNEBNKIT2S60=]DL[R5<M3XIZL,9Y\07\'E-7*UZ39HO7Z2=9S
M_%>]N\#=YYDK[HDJ8SE>PH?  CTO;:&*]UC_;V^?"J"^@RII:'Y/M:T<O26L
MK!?+.?JZDAMMQDH$%MN>=<0=;]A:[^DM=,J*U;NR*9JGOFYX=YC^UJ!F6Z_R
M&*,(^3&($$5R!X]!GLJ]/.9I2&":DTPI9VN.D.LDC);T4+\^"O-TU-76_*RR
MIM>Z317HK7%3Z947LZIH$XM8#-$M8O'#?A'/#KS(XE45;UBTRL\;)' <-Q?H
M02SZ?JSU"F99E*4! U&8$0##+ <9$TYWPL(\2?TPRF)U[/Y9<@ND9D@'VR W
M?5Y3T^O5OOQZJ_94JY /<H_N-/+.A48T4B2L:L8L'^)2#>GE/B@+/)GH,#_*
M<ED-RA(=I#"HOV6(S5B_66]J=KOY5#X4,BFB[1"F>M0X/X)K2]42]EK*$G[L
MMKAO4X@_??[R88S?J'Z^F%#&_*G"CA[T+):J"OJF;S;1*R<E-8>P/#WLLCB6
MDZ(=@5E./VV<0408HW777&V7M?26X685HC#)A<L!PC2EXEB $I#%/  H2WQ(
M_8@@HE6^/T'+??Y02_E9FF>;$MJ6\M>[4O[^%W\.7<O;-YH?S#NH[-4KZ551
MMEH@T)(*]=;^H?;&R8F2KM4TFCGA[&71G*6T=!+-G,@G<FAF7S&S!3ODD'%A
M&X\HA)%8]"GT <Q2<>*@F $:<H1C0C"*L$Y.W D:6FM?/Q6N;1W;?KF;CO:F
MU"QS.J47M>5ZH;1ZRW2/W7-0^&1O?4Y(8VE=GJ*PZ'J<$/'Y.IQZU*@&'=7U
M#?];M^_<5&V;HUVOZ[[#==_G:$7R&&)Q^  H2N*NXVB6^AD0O^>4YFF>I42C
M.%V=LN-]>M^2_;[O#_8+JCTD[]TD$XJW;OKZ5(@6N-*29DA?<B']EIX/\7UU
M+=:N1NWL>V:&'FNNE*95)N]&>:;U\Q:5J%MEKZ^(F?)[C0&7K,O7E_-9P;[!
M &9NSU?6H*)D=&@G?4W$1[5MP5??,EZ0HEFE)(XP$P8VP2$7)R',09ZA'"""
M><!1%+* ZIR$YDFZC[T.!#W:4=3SB124AA/A,T9! )(LB !DXB?DLQ3$L=!=
M0!**N4G3.TNZN[C#W1(J5/,R[7Y->AO20-L;B'N_C!73T[?HA*H+:\DG52"X
MJ(NJKH#G'JO&FV:6]'<QO/2#;\IO:,UN^$&YQZ[68Y61-(S"* 99'*0 IG$
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MLKC^=O,&U3^^5)O'@C+ZV],?M<S9W!T[KTE3/!9-(9;Z4/L),8]8S C 09P
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M<7"@'1*?KKN\I];/V98MOM 7)J:N;%:<\R2CC( H0PF 04B!^&<,4LI#R),
M,[T^(;H,.%Y. P-@2/VB/0LMMMC_^I]9&(3_9]_R8VT0I-)6N9I'[5*1>JOY
MJ,7L+I^NY\8;V&DQR*Z\GB.+& R&NK"%L:!+?ED,!4/E'&$DF(YS*3;9Z4R"
M-M1^T_4;'PYMS^"L@AAC'-$(1$&( 41Q#! A 8BB(/49AB3!>ME6%[/D.KUJ
M!'G5,N-UW.Q.M:;@8L93H&;+EE6LGG4[F0^UCQ1>]2J^&G486@0M[%)-68<(
M,V;HA7#!+E7@>3"PBT>^V&)*4C\V:_%NW75,D#C-/0YM?5-]E;9[=%&6H#A*
MDX  G/@40.[' "/I\^&$83_A+$RYH:'4XV1!^WBS3Q 84)B-L1=U]:UM%=UI
M4=,8/M]@>J;^;>@6+OG:H5K7XO/U.MZ6,HIFBK)O"S7Y>"D3:*:N"<MG.*"9
MP?M2R9-9\_1%?*/-=4DEQ;;3Q:T8[^WF'A7E*@[#" 78!R%.V^:S/LBBT!?V
M#<7<IQE%OM;Y58&FZT2)37D'/A:/PA^Y%;]O<_5:U$GO>T=?L[!718MJ!LNR
M;O1,TP5JT38X&H):,BTJ%!<U(AHJ>&XN=%XU;4 MC$N'M_]V*Y$\Q)&TV- V
M)>LKJYNJ(.+HVC[5I9RSYH:_WU2<%8T,Z*]B2&(. PP"2L3)T8<)R!/$@4_R
M%"91%B98*[/J4H9<W_\<MP%ILRN][<.F:Y[%?HI#?5&?:A2BVQ#[PJE1])T6
M5+BF"]4JMF/-ZWCS.N:N!E2"/8/]*7ZHOQ'&3.*<[MFTV;#;CL*LM?B^D)V%
MFX+;4=YQ&W%+XYJ9T6<QOL/"G-'Y2>(DD56$.?5ECGF0RX+P@"* A>4$"8MY
ME#(>AT2KVZP6]86N"785XH.5[.L92^H]5 SP;2E32W8ME$9)Z%<>EGR:ESCJ
M34::)#1,,@(R'&0 8L@ IA !P5X"(TPS"*%>=;ZSZ;!3LC_:N5[KG*CM7,[T
MK+=-'=WA'!5_WHP5V7)C;S<R4H*EK4>/]J+[C)%:GF\J9H-<&I)\=_^PWCPQ
M]HU5CX6$[CE9';IN/XVV/DK"[-V5LO"SV_3>;.JFZYBPXC@/<2+V%Q)FPKB%
ML?#.?1P("Y?[&28QQ+[63N.$2]>AS/9: I^_EGC7-?NDK2'L.Y%)/@?X93,4
M,#<3JAL/?:%ILGQQ=/$,71 H=:!!ZT%4FSR^4(#5@9K/!U]=$#,\./3.UG5)
MNXCO:%M992GF/L4I8&D4R=@* WD<BO] CBF/61A1K'5.F"#F^EBPZY4J5G#5
M7708%YY.*DW1=[2D"DU7<:R%_KKG1D$+^EZA@GBVG, I4LOZ? I"'[EX*N]<
M[-$]@^AO_45!\:U$^6?T>7- CCGWQ0F4A3$4J]Z/Q(*'"4!9G,-0_#*@2E5P
M%_*QX 6SC-9]W-0'G2]:WMIUTG-G['UI*5_;OW*E4O/;YE-]1(ZTN= MLY%Z
M[+M'6ER\E -DHJH)%\=H.#-+]Y6M)3K%%U0U3[?"G-:RF&Y3#O?*#"9A3GW@
M![&$OX090#2FXJ<@1GY",45:N863U!Q;K9ZVUQ+W1M0-;Y2G-:=FC*SI0\_D
M7* *;8.B)*(ELS%-:U'CH"3V<Q.@]M+",(]],M^[[FY4VIXNF+8*>89($L8
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M $6)#R)$\@SCG(@_KAY:Z(!O#:H:M2C%0MSKK.?G,JAG;(U I%'C8797E+)
M49[6NT';8A<JOY.JEK_J"E\6KGM1G7#*F9A4" &G.1?^0D0 SOU(7N&F$8]\
M'A+83_B[4K%1^*N=[D$"T\EF)?V+3K-: .P53IQF'-UB*=0!V-D1-MH@D-=*
M]'IJI#2GX)543JER_9>JI]*<"MM55KKD[60>]LFT-_Q=R3=BD;9<799T>&;(
M%\HW[+EI 2KV_-A)-#RGO&GK[5!O>M;7LLHNSBN<48"UE,)S=%XTFW!&^+E$
MPKG7%S[&?"Q*]J%A]_4*D9AS&=M".0R[#E]Y$N4 XH1 /\QXC/60("]FR746
MQ CV<=ZGP<<^C?==LNJUO.K6BUX^7XX]3Z-96-BI5)N Y5S%(YV]M!>X9^BO
MX> =*=":[W8\LIFA?=/F7[27S%]0=5-]:R262HLB/P IK5 :93019WV64W'@
M1Q@!!'T,0IXE/J(P#/)(QY(JT'1L*M^,LDZNO =4>8^2NI63NHI&U6R=93WI
M!OY;%7WK5"3HRQ22CH.N%\4>;<V>I=*0V)(I4J&XJ*W14,%S8Z+SZL76HL,$
M[QI0K!!C$4IB#/P02@\KH  A(GY*<>I#/XUBGAE:B#&=1:U"WRN@Z+JQ&.,2
MG5.9M@DP5<0ER[ZC>=6WI'&RSD^)97]M'U!YJ?5\2M2)-7SR<0>MW;\R>2,^
M_/&65??!*@XPY#+:SY(\!3!*$X!\V;HEQH3#!#(_1-9:NY]@P/%*/VKM7@TL
M='@"GACS_DR']]84/#'A(FA: NU)4#,1+E6K9SOFF[WOV.F>\"1#"[5ZG]#$
M$JW>3Y%_/:W>)Y2CU>I]:IR7N<_^O4V:_5!V*/:_5YNZ7@4LI3%-?<!]0@'T
M\P!D$68@"K,\2V.?$$VT+_L\.K9_ PCCG:1\B7?C8GJ6N8*\4.DO=]W8,>Z)
M&1M: [;,OX)PT;QF7SI^-,'A7R.@-*]BV[>#4Z0,"Z&$R1%KI>EO#CYORIV+
MM0IS'"4)I2#-8"R\32Y,LR_^0V,,4X(")D9<E>Q.'FS5C/,$-:7UGG?K?4Q3
M>=D/M,W0J:;TI&8C+Y7=K"II$+JG>N6-Z5HL/YH7SE:QT02E94N+YD4^*B12
M>$7_0O^V0C)=0%B1ZY]%K7IG?_B68Q>G)S;>8?]=_=+]F8#S]^KFLNFMKA-B
M>=\E24N BZ?E,+H!?S;48I?<IT48WV.?><)@'6P:M&ZWSQ^;M7CE:U-JY+"<
M?MOUNI!$O1%5<2AOME6IG9=R1G:%I7*QV)I+QE!BO74S*939^CD]Y'+K:%*D
M@_4T_:29F_@>%55[=_&)(8F )TW=WXKFQQ_E!M>L>I0(2Q_*AVU3RWR4DA3K
MHG5MQ;^V5=4W*:T_%@B+OS1/OZ.BE"V7/I1DO:6,?BB'AC$KGT5QPO,,D 1B
M  D* 4H#'Q"><,)B/^*I5J;(8IR[O@_Y(;<8>=+D0J+NBE3/A5UN#M4<XE<Y
M,WK63(K07<!>>2,IO#^%&-Y8#J\3Q#N4Y,K;R=+VR*JOO)TX5YX4R/M%BO2K
M-P@EYW\0RY[WOOA,6#H++,?WHB>+Q:?C^3EE>0;TO;T/95V()_?>XT?%Y+7I
MEUT>Q5N:WHE#0VTYUTQ-1",_:&+8Q7RA>='&_I#"TV8^T9=J0QBC]7O!W!XB
M9( &605!3)/$Q\)]X50F:N4@QR0!S/?E=2Y)0Y[H.#+3Y!Q['P/Q#@BHF,(,
MZG\Q0 ?I^2@S.E5S+.QI2F^%'RII# CTMSEE:&_9:C):VF=GB"VZ.:H)_GQ'
M4WQ+'X+SF]SRQ![W[B=I'?3/Z)ZMF""5,Y_*#D8(P QF !/( )8I\*F?,DYC
M5>3-4P0<+_:!I#?0]"11=9C-DSJ97KHV)-6\!=034@M*<TH2(P3-DP,N!IPY
M)<X8+W/R.4<9!_7,C=G[3<59(:O\=]=FDR6W$A>7T B"&.9$[-IY!K($<I!%
MB+.8IU&4*B&QO)0 CDU#SXW,4MB67=?(7Y<IJ;8]T6JNQ&N>/DU[IY#U4*NF
M/8RD&N<^O)YZ:T?3LE3*A&WV7U<^A:/)T4ZV<,6'V58WA$L*5J^RG 8PR&*0
M^F$*8 H)R%*$ (F2./33+$\X7C4RT*^V"XW&UMH@=A0T[W?6>WIZV\!8"6H6
MVE T/>/Y44$>;2-V@G-+]F4\\J)+_X1(SU?EJ4<,6YN434&+]59B.O6NIQA4
M.IT]:'B,L.\G60#2@#, ?=\'* H2<19+49;X'%(>:K4WF2'HV/<:D_?V]*_:
M@XLFVKJR#M46H4W-Z*W,"Y6BW_)$45);;4_FR"W;^D11^*/V)ZKO&32E+>OR
MFOZC_E)5WQ[)F[KI86956].>?MUU-%4X(ZWK3?^QK9O.\Q8NQ!XBO&W4H]&B
M]HP2YB]"+,BO&2-5$GT>BEBO<>VTE&;M:\^,N5P3VVFA#EK9SCQJ '7[FYBE
M3?D)U34B/[8U:YJZ_^@2# GE&084DQC A""0Y9B!W$_B '+&,(7*6+9GR3A>
MH1W=*^^ L@: ZGGU3*])>T+K+<N3\IH @I\77 ,:UHH"S+!?]29>#])U5JQ)
MS-;S;R\'RCHKP0'JZOS3^OO]IZ9:RU*V^H;?5E0<YK6[T9\?P;%-^83$2X4X
M';?4Y;7@B50 ]4U_0A/S^[X=)>C9&"7YO>_6V];/RVKD $P,NY@/,"_:V U0
M>-IITQ+8[P0!RV)$N#B7QR0 ,(<$H#B5*!4HH#DE2+$QH1EYUZ=TW0X1T$F[
M#>BB:8F!!C5/\]K*<]NT!+IL6F*@S86:EIS_)%TU+8%.FI; 5]RT!%II6O)\
M%,-;=IF\U6&;O-U*.MUE1YL"^IG]V?ZE7O$\35.:R:3\, (0BM-=QI XV"4X
M#5'&><CU*O55J#JVUN>ZWUUYI5@JXI>[5#<RV3KY K6J15BM*TO/,'<=[3KZ
M7L? [M:WSW\77'0/V*Q^UY':UN6L$LUE;U1UU'!T#:KULJD!$;Z]-$D?=TG8
M61@&A-$4A'$,A;4(0I!C3 #/HRS!(<_]0"O]]9B$ZRRX@> E2*S'>E%=[I=(
MJ[NVM00U6,3G9+&V8H\(++P\SPEXO!;//JD?"OFZ7;/ QW$@2V?IYJ%A]/T:
MW:G&0<Z\[GA52:J>) N"@V-_SX%Z^..<]/.Q#PN"ZRVP&9F][Y*\I6#'C'!&
MD8YS8RX6YI@1:ASCF'O4$&H3U3^N2RK_3SKDC\(-+YOZNGF#JNI);*GM9KI*
M?!8R&G"0Y)@*+]E/0)Z3$ 0\]2DA:8*Y5NZH$E7'ZU42[\HZY ]LSX8F\*:2
M CD*T@RG$/ LY@#2F !$@@#XC),D)Y $C*X>684W+Z;",?77J40U!\.Z8O1,
MXDXC[0][#BRBFNH(: OC5(GFLHBG.FHXPC_5>OE"9('KNF9B\)*.,L3Z^E-Z
MLR\M%0]\WI350:6I?+\-B=TR\J,L_BD.-+>R1G4%8Q;SD$4@9WD 8)ISD#$.
M 4Z#$ 5!B+-4ZQ#BDEG'AGQ?JGY0J=[7I<NEN&/,VW/F?6]YTSSV.)U3-?OV
M6F9*SRPZFB1S0 "'VK.- >""U9<I^W>H]+.5_BYIZFT,==6LWD@L(%8]H*IY
MDFF"+>Y7$@I+S@,("(\2 #'D()=!:$P0)@E",,F4C/DY JX]Z1')/CMU&BI,
M32O3YM"&K)J>G:Z8RL9I3I8I@R+>'1D3\:^](3D[["*+?TZH8<'./K<PHO/8
M<&SONWJ9KT7]W^\KQ@:8PZ^H89_03]E;><5RG$6<<^ 'A,@6Q1C@@&<@1RRE
MF,?B=&>WKM(2XZ[#88*RQP5IKQB0.BM!_,J[[\@O! "M.YN*0>Q7.$>:H?'+
MH:)'+MU(FBNOG7DID+?#:/W:SORGF9E?#D+:<!I>&E=:E^W751QI>3*L(5";
MTK^XMU&?@@-S[&<AE3X?16(#22G(XHP"@D*$*>)1A$V[&BV2%S;NY6/<M$@I
MJ<N*A+I.WUXXB[4;LY+8[TVT9,;0K'@3_8@NRON18!WORJ9HGCZ49%,];*K6
M"K2WDZV363V]V5"VXA%"#*,4A#@.)(X- RA/&> LS8(D(SC'RC@V"O0<K\".
M ^^ A:NNBYYLI]<SXDE.U+%N5-0XO5P=*$=O\=K0BQ8\CH:T1F@Y*N,O!IZC
M(>P82T?G-?W4@<^;\C/;#)4YB@D#!R\Y7JN"%OC\[D;Q@NQ8I.DE=Y$T>HMK
M$,1R1>-)[HTN]P]'6NQ*_Z0 XXO\TP^XJT_H/QR4Y#G)8PZ".)2U"9$/4!AB
M@,1FQQ-"$YPKQ2GT23M>45I)X/:3Z:V7([RN4@1W50C.*A!>9?7!LH4']HL.
M7FO!P>7%!E8*#60FP;-L@J^L;JJ"-(SVV0:'OQ@]V>4M"Y>HDOT,W[+N_SM0
M:<'N@#HH@Q#OA BD6659%.9!E '2EBWD:0@R3!/ $.%A&/I1GN<Z,$K+LJ^U
M(>@C-7T6J['HN9$@;L1>DM*"4ZP8"GFU$Z<99Q&<73W/F9)=! ;6O>X).8W/
M?GGP0B>2-\CD_3)(]>N5MQ-LCXPJ1?,ZV=JAWQ:UL$U-4<IJD+X'Z::TF[NU
M_'193 );D/G%L\F6GYA3:6DOP(4A2ADAE5@F7ZH-9[6$OD'K]XS5;[95)=A9
M!1'/"9&=;GC. 0S"%. X3P'S4W'D" (_]2,MC+))<J[/&!UQ[V%$W>-,%P1P
M1F5J)M^>(C3/#;T.QH0]25G8[8ZV13 R)1EM09%-$UL6B$Q)\",8,K6WSJWS
M\;Q]%#_]Q_\8?B/^@X41^8__\?\!4$L#!!0    ( !2!;5M,YJ.G7IT  (!&
M!P 5    86YG;BTR,#(U,#DS,%]P<F4N>&ULW+U9=UM)DB;X7K\B)N9U+,/W
MI4Y5]=$:HQZEI):4E3WS@N.KB$H08 *@0JQ?/^877$ 2 $' +ZZ'.KM"%$G!
M;?G<W,S<W.S?_L>/\\DOW]-\,9Y-__U7^A?RZR]I&F9Q//WV[[_^[>M;,+_^
MC__XEW_YM_\#X'^__/S^E]>S<'F>ILM?7LV36Z;XRQ_CY=DOR[/TR]]G\W^,
MO[M?/DW<,L_FYP#_T?VS5[.+J_GXV]GR%T:8O/FUFY_._U4HYZ/5'I+1!D3F
M 1P3'@A-FD;O*#/B__KVK\9R;4-2('1B(*0U8+G ?T"3U)$I&QWM/G0RGO[C
M7\M_O%ND7Y"]Z:+[Z[__>K9<7OSK;[_]\<<??_GAYY._S.;??F.$\-]N?OO7
MZU__\>CW_^#=;U-K[6_=3V]_=3'>](OXL?2W__W7]U_"63IW,)XNEFX:R@*+
M\;\NNF^^GP6W[*3^)%V_;/V-\C>X^34HWP+*@-.__%C$7__C7W[Y926.^6R2
M/J?\2_GS;Y_?W5O23;]-_Q)FY[^5'_[V:H9@0#*[?[:\NDC__NMB?'XQ23??
M.YNG_.^_EG\$19_$<E(6^S]7__"WNS4OYFF!0.EX?(_?N/[W997GK9]^+-,T
MIA4_-Y\^F85[OS0ITIS=_LN)\VG2?7<4TWC4?>H+OUC.75B.HK$RT<B1 >U
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M_Q'X5S"9:,B1!<Z]3I37GW3Y@(AA(5-!L=N;C1P@Y09@LJ&YQ34C @D*&),
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MY ;CZ_G\"CVCK@?<B-GL#?7E56=YDZ*2 *LL_H=;E:65DE>O0MJ+L&%+D 8
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M0\L368:N27 6B+>>HJ2XKSY3=3_*6LFJ#'"B]J"ZH6M_;YH3;MI8$H,IQ40
M1<O+<*++%0M#[]AP;C.-+KD'76Z>Z*/9W&G8AT)G/4BW@1-PMZA&V7%M"./
M%9,8\*,Y=C(DC*22)1YWE6*U+TAW4S1P%[;^@-6#0JJ=B@-4;^Y1B/C$L,P3
MU'36(_)DE9X]R?44]9\L<).5,:!R,%!:Z8*53@&5Y8%'#HS2VL]*3U+_66$N
M;)?U0A=(>I452!9B>97"T UW!((RU#H2*:>]E5%5XJ&1M,ZQZ.MS!/"S5=V
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MXU976UF=H$"Q$([GJKG</T8H#5ZA\D@;4,!<8&**5YSM)::5K(F!KJI>O&\
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M)J/%R([ODDH^ST8^7BDL6,16 ]]B7 ]D,#9%)(6F@KH<G>]6--'UBTT$(PN
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M#U8F@<$9I#F'%FL&OS,<F6"$LTPG$DL' YY2T'H(M!"$SN=Z[4MJ7UQA75L
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M@$Z>ES&=?%U,_;_NQB &*:B,&!'L>1Y0$9!;3:G 0*&3V'I6>@+],R+J0J:
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MW*2E-<Q^:BH_6Y= PK,1Y658W\!U]?"ZMLVH#Y,TG=VLY/3+[>:'Z[>U1&7
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M?*!:)FF!R_(HVRI+^#TL.IW$NYV6>!#=LV2UC-)SI7B8-6W)[>TR?IMNFBG
M/G,9K%^9UGV5[2G?J?;874C"79C8H-A_'TW7C7LOT_^:WL0WN>'![/:C_6,(
MV1_\6+V'\Y((Z,+/!F$ ._[WTHY':>0WU'^S?_X2)S&-%KV3)<[Z8+VG^I)P
MZ,K7MB !:FQL)QN"/]S\R.-O8 -N-!XM;LO8;N=]L5YN0"%0G,;9=CRPDB;>
M@67K)1 4<,+:M/5V$%C8C]Y>MI,0FXIU'>=10Z\"TS@'O_!+_/=R-+O7*V64
M\@F?Z23DID)?I_.PU2R@SS^'R@!ZNG*1[)\#Q!;(_/EL;W^??XZS5>>FB8^E
M$W^ZK-_C7 -S^N?ZW"]2[<'U!"D\/I';NZ_](/1G],O<5_(-J(GKZ>RV=^K(
M[A7KB6F;W]..FZ\=2!Z/M\D;Q4)))/L7KI=]=5 4T]/X4EETG^.T@)P>5JF9
M4W*<U],#&Z^?Y ,D?2HBCNVUZM5"GRB4/4SX3Z[B2]XT_\E/_$]^XFFR"?_W
MVW3EC_<]'D]7JI9&=>AT[-QL;0&,Q_=DE3D:V\O5N]9WLGO:9>^UA7)]O5A5
M+4WFD]\M'-ZORYN;==QJOIA\<^/WT]G%C[$;_W-60F8G?ZVFI;9/8M,"[&M
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M?PS;1>>GZ6)#:IEX?_>O-!+^[RGG _P;7J-O?I!_<78>_^=_^_]02P,$%
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M,#(U,#DS,"YH=&U02P$"% ,4    "  4@6U;>8+%^1X2  "[S@  $0
M        @ '-,P$ 86YG;BTR,#(U,#DS,"YX<V102P$"% ,4    "  4@6U;
MV8PUH4X9  !\\   %0              @ $:1@$ 86YG;BTR,#(U,#DS,%]C
M86PN>&UL4$L! A0#%     @ %(%M6PH6H8VH50  ^;<# !4
M ( !FU\! &%N9VXM,C R-3 Y,S!?9&5F+GAM;%!+ 0(4 Q0    ( !2!;5LX
MYA/*,/P   SI"0 5              "  7:U 0!A;F=N+3(P,C4P.3,P7VQA
M8BYX;6Q02P$"% ,4    "  4@6U;3.:CIUZ=  " 1@< %0
M@ '9L0( 86YG;BTR,#(U,#DS,%]P<F4N>&UL4$L! A0#%     @ %(%M6\M9
M@HZ3!@  IQ   !D              ( !:D\# &5L:6-I;S$P+7%X97AH:6)I
M=#,Q,2YH=&U02P$"% ,4    "  4@6U;TIRKZY@&  "_$   &0
M    @ $T5@, 96QI8VEO,3 M<7AE>&AI8FET,S$R+FAT;5!+ 0(4 Q0    (
M !2!;5N&,?;Y60,  -X%   9              "  0-= P!E;&EC:6\Q,"UQ
M>&5X:&EB:70S,C$N:'1M4$L! A0#%     @ %(%M6UO^<,A> P  ^04  !D
M             ( !DV # &5L:6-I;S$P+7%X97AH:6)I=#,R,BYH=&U02P4&
2      H "@"F @  *&0#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>angn-20250930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:angn="http://www.angn.com/20250930"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="angn-20250930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-11-10</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">angn:ConversionOfConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:AngionCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-01</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">angn:WarrantLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">angn:MeasurementInputStrikePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFSept.2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis">angn:ResearchGrantAgreementWithTheGastroIntestinalResearchFoundationGIRFAugust2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:A2024RegistrationStatementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:AtTheMarketEquityOfferingSalesAgreement2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">angn:JulySharesAndJulyCommonWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JanuaryCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JanuaryPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2021PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:The2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">angn:Inducement2024PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-03-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:MarchSubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:ElicioWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:AngionWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:March2024PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyCommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:January2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:June2025CommonWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-01-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:UniversityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-02-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:BostonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">angn:NewtonMassachusettsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-08-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:PreFundedWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-31</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">angn:GKCCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">angn:SeniorSecuredConvertiblePromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:JayVenkatesanAndTrustsAffiliatedWithJayVenkatesanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">angn:JulyPreFundedWarrantsAndJulyCommonWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">angn:PurchaseOfWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">angn:YekaterinaChudnovskyAndJayVenkatesanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">angn:JulyPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:EmployeeRelatedReasearchAndDevelopmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:TranslationalMedicineAndCMCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">angn:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-09-30</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-30</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001601485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">angn:ReportableSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="agreement">
        <measure>angn:agreement</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="entity">
        <measure>angn:entity</measure>
    </unit>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-26">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-27">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-28">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-29">0001601485</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-99"
      decimals="INF"
      id="f-439"
      unitRef="number">0.1</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2025-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-39990</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Elicio Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">11-3430072</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">451 D Street, 5th Floor</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">02210</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">857</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">209-0050</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">ELTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-23">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">17489516</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-31" unitRef="usd">20611000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-32" unitRef="usd">17618000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-3" decimals="-3" id="f-33" unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-4" decimals="-3" id="f-34" unitRef="usd">1178000</us-gaap:RestrictedCashCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-35" unitRef="usd">854000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-36" unitRef="usd">1897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-37" unitRef="usd">21465000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-38" unitRef="usd">20693000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-39" unitRef="usd">328000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-41" unitRef="usd">5019000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">5706000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-3" decimals="-3" id="f-43" unitRef="usd">702000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">696000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-3" decimals="-3" id="f-45" unitRef="usd">770000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-47" unitRef="usd">28284000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">28178000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-49" unitRef="usd">321000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">1038000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-51" unitRef="usd">5213000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">8415000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-53" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">1169000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-55" unitRef="usd">981000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">901000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-57" unitRef="usd">6515000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">11523000</us-gaap:LiabilitiesCurrent>
    <angn:WarrantLiability contextRef="c-3" decimals="-3" id="f-59" unitRef="usd">3877000</angn:WarrantLiability>
    <angn:WarrantLiability contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">2828000</angn:WarrantLiability>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-61" unitRef="usd">4356000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">5105000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-3" decimals="-3" id="f-63" unitRef="usd">9720000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">20034000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-65" unitRef="usd">24468000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">39490000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-67" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-68" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-69"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-70"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-71" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-72" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="INF" id="f-73" unitRef="shares">17273107</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="INF" id="f-74" unitRef="shares">11043837</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-75" unitRef="shares">17258652</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-76" unitRef="shares">11029382</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-77" unitRef="usd">173000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">110000</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="INF" id="f-79" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-3" decimals="INF" id="f-80" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-3" decimals="-3" id="f-81" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-3" id="f-82" unitRef="usd">150000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-83" unitRef="usd">229778000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">183004000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-3" decimals="-3" id="f-85" unitRef="usd">-31000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-4" decimals="-3" id="f-86" unitRef="usd">-175000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-87" unitRef="usd">-225954000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-88" unitRef="usd">-194101000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-89" unitRef="usd">3816000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-90" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-91" unitRef="usd">28284000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-92" unitRef="usd">28178000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-93" unitRef="usd">5039000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-94" unitRef="usd">7208000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-95" unitRef="usd">19823000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-96" unitRef="usd">22947000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-97" unitRef="usd">3006000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-98" unitRef="usd">3136000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-99" unitRef="usd">9049000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-100" unitRef="usd">8563000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="-3" id="f-101" unitRef="usd">8045000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-6" decimals="-3" id="f-102" unitRef="usd">10344000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-103" unitRef="usd">28872000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-7" decimals="-3" id="f-104" unitRef="usd">31510000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-105" unitRef="usd">-8045000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-106" unitRef="usd">-10344000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-107" unitRef="usd">-28872000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-3" id="f-108" unitRef="usd">-31510000</us-gaap:OperatingIncomeLoss>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-5" decimals="-3" id="f-109" unitRef="usd">1811000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-6" decimals="-3" id="f-110" unitRef="usd">5617000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-111" unitRef="usd">3177000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-7" decimals="-3" id="f-112" unitRef="usd">3279000</us-gaap:FairValueAdjustmentOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-5" decimals="-3" id="f-113" unitRef="usd">0</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-6" decimals="-3" id="f-114" unitRef="usd">-2924000</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-115" unitRef="usd">0</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-7" decimals="-3" id="f-116" unitRef="usd">-3502000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-5" decimals="-3" id="f-117" unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-6" decimals="-3" id="f-118" unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-1" decimals="-3" id="f-119" unitRef="usd">0</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal contextRef="c-7" decimals="-3" id="f-120" unitRef="usd">3000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-6" decimals="-3" id="f-122" unitRef="usd">-1000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-1" decimals="-3" id="f-123" unitRef="usd">0</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax contextRef="c-7" decimals="-3" id="f-124" unitRef="usd">143000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <angn:GrantRevenueNonoperating contextRef="c-5" decimals="-3" id="f-125" unitRef="usd">0</angn:GrantRevenueNonoperating>
    <angn:GrantRevenueNonoperating contextRef="c-6" decimals="-3" id="f-126" unitRef="usd">0</angn:GrantRevenueNonoperating>
    <angn:GrantRevenueNonoperating contextRef="c-1" decimals="-3" id="f-127" unitRef="usd">415000</angn:GrantRevenueNonoperating>
    <angn:GrantRevenueNonoperating contextRef="c-7" decimals="-3" id="f-128" unitRef="usd">0</angn:GrantRevenueNonoperating>
    <us-gaap:InvestmentIncomeInterest contextRef="c-5" decimals="-3" id="f-129" unitRef="usd">199000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-6" decimals="-3" id="f-130" unitRef="usd">185000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-131" unitRef="usd">577000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-7" decimals="-3" id="f-132" unitRef="usd">472000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-133" unitRef="usd">426000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-6" decimals="-3" id="f-134" unitRef="usd">137000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">796000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-7" decimals="-3" id="f-136" unitRef="usd">221000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-137" unitRef="usd">-2038000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-138" unitRef="usd">-8494000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">-2981000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-140" unitRef="usd">-6384000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-141" unitRef="usd">-10083000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-142" unitRef="usd">-18838000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">-31853000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-144" unitRef="usd">-37894000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-145" unitRef="usd">39000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-146" unitRef="usd">36000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">144000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-3" id="f-148" unitRef="usd">-5000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-149" unitRef="usd">-10044000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-150" unitRef="usd">-18802000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">-31709000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-152" unitRef="usd">-37899000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-153"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-154"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-155"
      unitRef="usdPerShare">-1.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-156"
      unitRef="usdPerShare">-1.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-157"
      unitRef="usdPerShare">-2.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-158"
      unitRef="usdPerShare">-2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-159"
      unitRef="usdPerShare">-3.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-160"
      unitRef="usdPerShare">-3.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-161" unitRef="shares">16692476</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-162" unitRef="shares">16692476</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-163" unitRef="shares">13582345</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-164" unitRef="shares">13582345</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-165" unitRef="shares">15247864</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-166" unitRef="shares">15247864</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-167" unitRef="shares">11720527</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-168" unitRef="shares">11720527</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="INF" id="f-169" unitRef="shares">11043837</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-170" unitRef="usd">110000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares contextRef="c-9" decimals="INF" id="f-171" unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-172" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-173" unitRef="usd">183004000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-3" id="f-174" unitRef="usd">-175000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-3" id="f-175" unitRef="usd">-194101000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-176" unitRef="usd">-11312000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-13"
      decimals="INF"
      id="f-177"
      unitRef="shares">106823</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-13" decimals="-3" id="f-178" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-14" decimals="-3" id="f-179" unitRef="usd">834000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-15" decimals="-3" id="f-180" unitRef="usd">835000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-13"
      decimals="INF"
      id="f-181"
      unitRef="shares">1628</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-14" decimals="-3" id="f-182" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-15" decimals="-3" id="f-183" unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-15" decimals="-5" id="f-184" unitRef="usd">300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-16"
      decimals="INF"
      id="f-185"
      unitRef="shares">3500573</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-16" decimals="-3" id="f-186" unitRef="usd">35000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-17" decimals="-3" id="f-187" unitRef="usd">20141000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-18" decimals="-3" id="f-188" unitRef="usd">20176000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-19" decimals="-5" id="f-189" unitRef="usd">800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants contextRef="c-13" decimals="INF" id="f-190" unitRef="usd">1261830</us-gaap:StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-13" decimals="-3" id="f-191" unitRef="usd">13000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-14" decimals="-3" id="f-192" unitRef="usd">9130000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="c-15" decimals="-3" id="f-193" unitRef="usd">9143000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-13"
      decimals="INF"
      id="f-194"
      unitRef="shares">68500</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-13" decimals="-3" id="f-195" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-14" decimals="-3" id="f-196" unitRef="usd">715000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-15" decimals="-3" id="f-197" unitRef="usd">716000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-14" decimals="-3" id="f-198" unitRef="usd">517000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-15" decimals="-3" id="f-199" unitRef="usd">517000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-20" decimals="-3" id="f-200" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-15" decimals="-3" id="f-201" unitRef="usd">31000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-21" decimals="-3" id="f-202" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-15" decimals="-3" id="f-203" unitRef="usd">-11209000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-22"
      decimals="INF"
      id="f-204"
      unitRef="shares">15983191</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-205" unitRef="usd">160000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-23"
      decimals="INF"
      id="f-206"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-207" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-208" unitRef="usd">214348000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-3" id="f-209" unitRef="usd">-144000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-26" decimals="-3" id="f-210" unitRef="usd">-205310000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-27" decimals="-3" id="f-211" unitRef="usd">8904000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-28"
      decimals="INF"
      id="f-212"
      unitRef="shares">12499</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-29" decimals="-3" id="f-213" unitRef="usd">50000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-30" decimals="-3" id="f-214" unitRef="usd">50000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-29" decimals="-3" id="f-215" unitRef="usd">641000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-30" decimals="-3" id="f-216" unitRef="usd">641000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-30" decimals="-5" id="f-217" unitRef="usd">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-28"
      decimals="INF"
      id="f-218"
      unitRef="shares">281697</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-28" decimals="-3" id="f-219" unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-29" decimals="-3" id="f-220" unitRef="usd">2013000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-30" decimals="-3" id="f-221" unitRef="usd">2016000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-29" decimals="-3" id="f-222" unitRef="usd">710000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-30" decimals="-3" id="f-223" unitRef="usd">710000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-31" decimals="-3" id="f-224" unitRef="usd">74000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-30" decimals="-3" id="f-225" unitRef="usd">74000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-32" decimals="-3" id="f-226" unitRef="usd">-10561000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-30" decimals="-3" id="f-227" unitRef="usd">-10561000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-33"
      decimals="INF"
      id="f-228"
      unitRef="shares">16277387</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-229" unitRef="usd">163000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-34"
      decimals="INF"
      id="f-230"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-231" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-232" unitRef="usd">217762000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-233" unitRef="usd">-70000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-234" unitRef="usd">-215871000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-235" unitRef="usd">1834000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-39"
      decimals="INF"
      id="f-236"
      unitRef="shares">17791</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-40" decimals="-3" id="f-237" unitRef="usd">88000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-5" decimals="-3" id="f-238" unitRef="usd">88000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-39"
      decimals="INF"
      id="f-239"
      unitRef="shares">190000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-39" decimals="-3" id="f-240" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-40" decimals="-3" id="f-241" unitRef="usd">2703000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-5" decimals="-3" id="f-242" unitRef="usd">2705000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-41" decimals="-3" id="f-243" unitRef="usd">300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-42"
      decimals="INF"
      id="f-244"
      unitRef="shares">787929</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-42" decimals="-3" id="f-245" unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-43" decimals="-3" id="f-246" unitRef="usd">8527000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-41" decimals="-3" id="f-247" unitRef="usd">8535000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-40" decimals="-3" id="f-248" unitRef="usd">698000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-249" unitRef="usd">698000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-44" decimals="-3" id="f-250" unitRef="usd">39000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-5" decimals="-3" id="f-251" unitRef="usd">39000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-45" decimals="-3" id="f-252" unitRef="usd">-10083000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-253" unitRef="usd">-10083000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-46"
      decimals="INF"
      id="f-254"
      unitRef="shares">17273107</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-255" unitRef="usd">173000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-47"
      decimals="INF"
      id="f-256"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-257" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-48" decimals="-3" id="f-258" unitRef="usd">229778000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-49" decimals="-3" id="f-259" unitRef="usd">-31000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-50" decimals="-3" id="f-260" unitRef="usd">-225954000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-261" unitRef="usd">3816000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-51"
      decimals="INF"
      id="f-262"
      unitRef="shares">9603723</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-51" decimals="-3" id="f-263" unitRef="usd">96000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-52"
      decimals="INF"
      id="f-264"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-52" decimals="-3" id="f-265" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-53" decimals="-3" id="f-266" unitRef="usd">153827000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-54" decimals="-3" id="f-267" unitRef="usd">-197000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-268" unitRef="usd">-142203000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-3" id="f-269" unitRef="usd">11373000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-57" decimals="-5" id="f-270" unitRef="usd">100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-58"
      decimals="INF"
      id="f-271"
      unitRef="shares">615363</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-58" decimals="-3" id="f-272" unitRef="usd">6000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-59" decimals="-3" id="f-273" unitRef="usd">5056000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-57" decimals="-3" id="f-274" unitRef="usd">5062000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-58"
      decimals="INF"
      id="f-275"
      unitRef="shares">903</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-59" decimals="-3" id="f-276" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-57" decimals="-3" id="f-277" unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-59" decimals="-3" id="f-278" unitRef="usd">324000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-57" decimals="-3" id="f-279" unitRef="usd">324000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-60" decimals="-3" id="f-280" unitRef="usd">-73000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-57" decimals="-3" id="f-281" unitRef="usd">-73000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-61" decimals="-3" id="f-282" unitRef="usd">-11827000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-57" decimals="-3" id="f-283" unitRef="usd">-11827000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-62"
      decimals="INF"
      id="f-284"
      unitRef="shares">10219989</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-62" decimals="-3" id="f-285" unitRef="usd">102000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-63"
      decimals="INF"
      id="f-286"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-63" decimals="-3" id="f-287" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-64" decimals="-3" id="f-288" unitRef="usd">159218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-65" decimals="-3" id="f-289" unitRef="usd">-270000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-66" decimals="-3" id="f-290" unitRef="usd">-154030000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-67" decimals="-3" id="f-291" unitRef="usd">4870000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-68"
      decimals="INF"
      id="f-292"
      unitRef="shares">3391</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-69" decimals="-3" id="f-293" unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-70" decimals="-3" id="f-294" unitRef="usd">13000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-68"
      decimals="INF"
      id="f-295"
      unitRef="shares">677</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-69" decimals="-3" id="f-296" unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-70" decimals="-3" id="f-297" unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-71"
      decimals="INF"
      id="f-298"
      unitRef="shares">34816</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-71" decimals="-3" id="f-299" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-72" decimals="-3" id="f-300" unitRef="usd">302000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-73" decimals="-3" id="f-301" unitRef="usd">303000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-69" decimals="-3" id="f-302" unitRef="usd">350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-70" decimals="-3" id="f-303" unitRef="usd">350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-74" decimals="-3" id="f-304" unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-70" decimals="-3" id="f-305" unitRef="usd">32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-75" decimals="-3" id="f-306" unitRef="usd">-7229000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-70" decimals="-3" id="f-307" unitRef="usd">-7229000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-76"
      decimals="INF"
      id="f-308"
      unitRef="shares">10258873</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-76" decimals="-3" id="f-309" unitRef="usd">103000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-77"
      decimals="INF"
      id="f-310"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-77" decimals="-3" id="f-311" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-78" decimals="-3" id="f-312" unitRef="usd">159892000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-79" decimals="-3" id="f-313" unitRef="usd">-238000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-80" decimals="-3" id="f-314" unitRef="usd">-161259000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-81" decimals="-3" id="f-315" unitRef="usd">-1652000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-82"
      decimals="INF"
      id="f-316"
      unitRef="shares">5353</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-83" decimals="-3" id="f-317" unitRef="usd">21000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-6" decimals="-3" id="f-318" unitRef="usd">21000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-82"
      decimals="INF"
      id="f-319"
      unitRef="shares">348</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-83" decimals="-3" id="f-320" unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-6" decimals="-3" id="f-321" unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-84"
      decimals="INF"
      id="f-322"
      unitRef="shares">9803</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-85" decimals="-3" id="f-323" unitRef="usd">48000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-86" decimals="-3" id="f-324" unitRef="usd">48000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-87" decimals="-3" id="f-325" unitRef="usd">500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-88"
      decimals="INF"
      id="f-326"
      unitRef="shares">510000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-88" decimals="-3" id="f-327" unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-89" decimals="-3" id="f-328" unitRef="usd">1075000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-90" decimals="-3" id="f-329" unitRef="usd">1080000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-83" decimals="-3" id="f-330" unitRef="usd">314000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-331" unitRef="usd">314000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-91" decimals="-3" id="f-332" unitRef="usd">36000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-6" decimals="-3" id="f-333" unitRef="usd">36000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss contextRef="c-92" decimals="-3" id="f-334" unitRef="usd">-18838000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-335" unitRef="usd">-18838000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-93"
      decimals="INF"
      id="f-336"
      unitRef="shares">10784377</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-93" decimals="-3" id="f-337" unitRef="usd">108000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="c-94"
      decimals="INF"
      id="f-338"
      unitRef="shares">14455</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquity contextRef="c-94" decimals="-3" id="f-339" unitRef="usd">-150000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-95" decimals="-3" id="f-340" unitRef="usd">161355000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-96" decimals="-3" id="f-341" unitRef="usd">-202000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-97" decimals="-3" id="f-342" unitRef="usd">-180097000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-98" decimals="-3" id="f-343" unitRef="usd">-18986000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-344" unitRef="usd">-31853000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-345" unitRef="usd">-37894000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-346" unitRef="usd">155000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-7" decimals="-3" id="f-347" unitRef="usd">236000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">687000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-7" decimals="-3" id="f-349" unitRef="usd">637000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <angn:InterestExpenseNoncash contextRef="c-1" decimals="-3" id="f-350" unitRef="usd">603000</angn:InterestExpenseNoncash>
    <angn:InterestExpenseNoncash contextRef="c-7" decimals="-3" id="f-351" unitRef="usd">82000</angn:InterestExpenseNoncash>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-1" decimals="-3" id="f-352" unitRef="usd">35000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-7" decimals="-3" id="f-353" unitRef="usd">26000</us-gaap:AmortizationOfDebtDiscountPremium>
    <angn:CostsExpensedUponTheIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">0</angn:CostsExpensedUponTheIssuanceOfWarrants>
    <angn:CostsExpensedUponTheIssuanceOfWarrants contextRef="c-7" decimals="-3" id="f-355" unitRef="usd">549000</angn:CostsExpensedUponTheIssuanceOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-356" unitRef="usd">3177000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-7" decimals="-3" id="f-357" unitRef="usd">3279000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-358" unitRef="usd">1925000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-3" id="f-359" unitRef="usd">988000</us-gaap:ShareBasedCompensation>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-360" unitRef="usd">0</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-7" decimals="-3" id="f-361" unitRef="usd">-3502000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-3" id="f-362" unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-7" decimals="-3" id="f-363" unitRef="usd">3000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-364" unitRef="usd">-1043000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-3" id="f-365" unitRef="usd">580000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-1" decimals="-3" id="f-366" unitRef="usd">170000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets contextRef="c-7" decimals="-3" id="f-367" unitRef="usd">-2233000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-368" unitRef="usd">-717000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-7" decimals="-3" id="f-369" unitRef="usd">-2385000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <angn:IncreaseDecreaseInAccruedExpenses contextRef="c-1" decimals="-3" id="f-370" unitRef="usd">-3202000</angn:IncreaseDecreaseInAccruedExpenses>
    <angn:IncreaseDecreaseInAccruedExpenses contextRef="c-7" decimals="-3" id="f-371" unitRef="usd">1095000</angn:IncreaseDecreaseInAccruedExpenses>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-1" decimals="-3" id="f-372" unitRef="usd">-1169000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability contextRef="c-7" decimals="-3" id="f-373" unitRef="usd">613000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-374" unitRef="usd">-669000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-7" decimals="-3" id="f-375" unitRef="usd">-702000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-376" unitRef="usd">-30155000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-377" unitRef="usd">-28324000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-378" unitRef="usd">0</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-379" unitRef="usd">42000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-380" unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-381" unitRef="usd">3000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-382" unitRef="usd">0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-383" unitRef="usd">-39000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c-1" decimals="-3" id="f-384" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt contextRef="c-7" decimals="-3" id="f-385" unitRef="usd">19727000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-1" decimals="-3" id="f-386" unitRef="usd">9143000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-7" decimals="-3" id="f-387" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-1" decimals="-3" id="f-388" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-7" decimals="-3" id="f-389" unitRef="usd">22882000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-390" unitRef="usd">1293000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-7" decimals="-3" id="f-391" unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <angn:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts contextRef="c-1" decimals="-3" id="f-392" unitRef="usd">11385000</angn:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts>
    <angn:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts contextRef="c-7" decimals="-3" id="f-393" unitRef="usd">0</angn:ProceedsFromIssuanceOfCommonStockFromAtTheMarketOfferingsNetOfIssuanceCosts>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-1" decimals="-3" id="f-394" unitRef="usd">9866000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable contextRef="c-7" decimals="-3" id="f-395" unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <angn:PaymentOfWarrantIssuanceCosts contextRef="c-1" decimals="-3" id="f-396" unitRef="usd">0</angn:PaymentOfWarrantIssuanceCosts>
    <angn:PaymentOfWarrantIssuanceCosts contextRef="c-7" decimals="-3" id="f-397" unitRef="usd">549000</angn:PaymentOfWarrantIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-398" unitRef="usd">145000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-7" decimals="-3" id="f-399" unitRef="usd">34000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-400" unitRef="usd">31832000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-401" unitRef="usd">42094000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-402" unitRef="usd">144000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-403" unitRef="usd">-5000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-404" unitRef="usd">1821000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-405" unitRef="usd">13726000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-406" unitRef="usd">19492000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-56" decimals="-3" id="f-407" unitRef="usd">14301000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-408" unitRef="usd">21313000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-98" decimals="-3" id="f-409" unitRef="usd">28027000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-410" unitRef="usd">20611000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-98" decimals="-3" id="f-411" unitRef="usd">26016000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-3" decimals="-3" id="f-412" unitRef="usd">702000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents contextRef="c-98" decimals="-3" id="f-413" unitRef="usd">2011000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-414" unitRef="usd">21313000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-98" decimals="-3" id="f-415" unitRef="usd">28027000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <angn:FairValueOfPreFundedWarrants contextRef="c-1" decimals="-3" id="f-416" unitRef="usd">0</angn:FairValueOfPreFundedWarrants>
    <angn:FairValueOfPreFundedWarrants contextRef="c-7" decimals="-3" id="f-417" unitRef="usd">13382000</angn:FairValueOfPreFundedWarrants>
    <angn:FairValueOfCommonStockWarrantsUponSettlement contextRef="c-1" decimals="-3" id="f-418" unitRef="usd">2128000</angn:FairValueOfCommonStockWarrantsUponSettlement>
    <angn:FairValueOfCommonStockWarrantsUponSettlement contextRef="c-7" decimals="-3" id="f-419" unitRef="usd">0</angn:FairValueOfCommonStockWarrantsUponSettlement>
    <angn:WarrantIssuedStockIssuance contextRef="c-1" decimals="-3" id="f-420" unitRef="usd">9719000</angn:WarrantIssuedStockIssuance>
    <angn:WarrantIssuedStockIssuance contextRef="c-7" decimals="-3" id="f-421" unitRef="usd">0</angn:WarrantIssuedStockIssuance>
    <angn:WarrantIssuedDebtIssuance contextRef="c-1" decimals="-3" id="f-422" unitRef="usd">641000</angn:WarrantIssuedDebtIssuance>
    <angn:WarrantIssuedDebtIssuance contextRef="c-7" decimals="-3" id="f-423" unitRef="usd">0</angn:WarrantIssuedDebtIssuance>
    <angn:WarrantExercisedFairValue contextRef="c-1" decimals="-3" id="f-424" unitRef="usd">0</angn:WarrantExercisedFairValue>
    <angn:WarrantExercisedFairValue contextRef="c-7" decimals="-3" id="f-425" unitRef="usd">6509000</angn:WarrantExercisedFairValue>
    <angn:SettlementOfPromissoryNotesPayable contextRef="c-1" decimals="-3" id="f-426" unitRef="usd">20176000</angn:SettlementOfPromissoryNotesPayable>
    <angn:SettlementOfPromissoryNotesPayable contextRef="c-7" decimals="-3" id="f-427" unitRef="usd">0</angn:SettlementOfPromissoryNotesPayable>
    <angn:AccretionOfConvertibleNotesDiscountFromIssuanceCosts contextRef="c-1" decimals="-3" id="f-428" unitRef="usd">0</angn:AccretionOfConvertibleNotesDiscountFromIssuanceCosts>
    <angn:AccretionOfConvertibleNotesDiscountFromIssuanceCosts contextRef="c-7" decimals="-3" id="f-429" unitRef="usd">26000</angn:AccretionOfConvertibleNotesDiscountFromIssuanceCosts>
    <angn:VestingOfRestrictedCommonStock contextRef="c-1" decimals="-3" id="f-430" unitRef="usd">0</angn:VestingOfRestrictedCommonStock>
    <angn:VestingOfRestrictedCommonStock contextRef="c-7" decimals="-3" id="f-431" unitRef="usd">25000</angn:VestingOfRestrictedCommonStock>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-432">Description of the Business and Financial Condition&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Elicio Therapeutics, Inc. (&#x201c;Elicio&#x201d; or the &#x201c;Company&#x201d;) is a clinical-stage biotechnology company pioneering the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. Elicio and its wholly-owned subsidiaries, Elicio Securities Corporation (&#x201c;ESC&#x201d;), an investment company, Elicio Operating Company, Inc. (&#x201c;Former Elicio&#x201d;), and Elicio Australia Pty Ltd. (&#x201c;Elicio Pty&#x201d;), an Australian subsidiary established for the purposes of qualifying for research credits for studies conducted in Australia, are collectively referred to as &#x201c;Elicio&#x201d; throughout these condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Liquidity and Going Concern&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has experienced net losses and negative cash flows from operating activities since inception. As of September&#160;30, 2025, the Company had an accumulated deficit of $226.0 million. The Company expects that its operating losses and negative operating cash flows will continue for the foreseeable future as the Company continues to develop its product candidates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of September&#160;30, 2025, the Company had $20.6 million in cash and cash equivalents. The Company&#x2019;s losses from operations, negative operating cash flows and accumulated deficit, as well as the additional capital needed to fund operations for at least twelve months following the issuance of the condensed consolidated financial statements, raise substantial doubt about the Company&#x2019;s ability to continue as a going concern. The Company expects to incur substantial expenditures in the foreseeable future for the development of its product candidates and will require additional financing to continue this development. The Company plans to address this condition through the sale of Company common stock or other securities in public offerings and/or private placements, debt financings, or through other capital sources, including licensing arrangements, partnerships and collaborations with other companies or other strategic transactions, but there is no assurance these plans will be completed successfully or at all.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;If the Company is unable to obtain additional capital when and as needed to continue as a going concern, it might have to further reduce or scale back its operations and/or liquidate its assets, and the values it receives for its assets in liquidation or dissolution could be significantly lower than the values reflected in its financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated financial statements have been prepared on a basis that assumes that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-5" id="f-433" unitRef="usd">-226000000.0</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-5" id="f-434" unitRef="usd">20600000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-435">Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Grant Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Not-for-Profit Entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and that the grants are not within the scope of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant. Employees also track hours worked by using the project code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Please refer to Note 2 &#x2013; &#x201c;Summary of Significant Accounting Policies" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's significant accounting policies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) promulgated by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2023-09&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;This ASU requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#x2019;s consolidated financial statements, once adopted. The Company is currently evaluating the effect that adoption of ASU 2023-09 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;(&#x201c;ASU 2024-04&#x201d;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is currently evaluating the effect that adoption of ASU 2024-04 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <angn:GrantRevenuePolicyTextBlock contextRef="c-1" id="f-436">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Grant Income&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant funding for research and development received under grant agreements, where there is no obligation to repay and where the funding received is in excess of the costs incurred is recognized as grant income in the period during which the related qualifying expenses are incurred, based on the applicable reimbursement percentage, provided that the grants are fully approved by the granting agencies and the conditions under which the grants were provided have been met. The Company concluded that payments received under these grants represent conditional, nonreciprocal contributions, as described in ASC 958, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Not-for-Profit Entities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, and that the grants are not within the scope of ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, as the organizations providing the grants do not meet the definition of a customer. Expenses for grants are tracked by using a project code specific to the grant. Employees also track hours worked by using the project code.&lt;/span&gt;&lt;/div&gt;</angn:GrantRevenuePolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-437">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The accompanying condensed consolidated interim financial statements have been prepared in accordance with U.S. generally accepted accounting principles (&#x201c;U.S. GAAP&#x201d;). Any references in these notes to applicable guidance are meant to refer to U.S. GAAP as found in Accounting Standards Codification (&#x201c;ASC&#x201d;) and Accounting Standards Update (&#x201c;ASU&#x201d;) promulgated by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The consolidated interim financial statements include the accounts of the Company and its wholly-owned subsidiaries, Elicio Pty, ESC, and Former Elicio.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;All significant intercompany balances and transactions have been eliminated. These interim financial statements are unaudited and reflect all normal recurring adjustments that are, in the opinion of management, necessary for the fair statement of such interim financial statements. The December 31, 2024 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by U.S. GAAP for complete financial statements. The accompanying financial information should be read in conjunction with the consolidated financial statements and notes thereto contained in the Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-438">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Recently Issued Accounting Standards Not Yet Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. Except as noted below, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its condensed consolidated financial statements and disclosures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In December 2023, the FASB issued ASU No. 2023-09, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2023-09&#x201d;)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;This ASU requires disaggregated information about a reporting entity&#x2019;s effective tax rate reconciliation as well as additional information on income taxes paid. The standard requires entities to disclose federal, state, and foreign income taxes in their rate reconciliation tables and elaborate on reconciling items that exceed a quantitative threshold. Additionally, it requires an annual disclosure of income taxes paid, net of refunds, categorized by jurisdiction based on a quantitative threshold. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is permitted. This ASU will result in the required additional disclosures being included in the Company&#x2019;s consolidated financial statements, once adopted. The Company is currently evaluating the effect that adoption of ASU 2023-09 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASU 2024-03&#x201d;). This ASU requires enhanced disclosures of disaggregated income statement expenses. Disclosure within the notes to the financial statements for each annual and interim period should include: employee compensation, depreciation, and intangible asset amortization, included in each relevant expense caption; certain amounts that are already required to be disclosed under current U.S. GAAP in the same disclosure as the other disaggregation requirement; a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively; and the total amount of selling expenses and, in annual reporting periods, an entity&#x2019;s definition of selling expenses. For public entities, the provisions within ASU 2024-03 (as further clarified through ASU No. 2025-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (Subtopic 220-40)) are effective for the first annual reporting period beginning after December 15, 2026 and for interim reporting periods after December 15, 2027. The provisions within ASU 2024-03 are required to be applied prospectively; however, such provisions may be applied retrospectively for all comparative periods following the effective date. The Company is currently evaluating the effect that adoption of ASU 2024-03 will have on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2024, the FASB issued ASU No. 2024-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Debt &#x2013; Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments &lt;/span&gt;(&#x201c;ASU 2024-04&#x201d;). This new guidance clarifies the accounting treatment of whether the settlement of convertible debt should be accounted for as an induced conversion or extinguishment of convertible debt. This guidance is effective for annual reporting periods beginning after December 15, 2025. The Company is currently evaluating the effect that adoption of ASU 2024-04 will have on its consolidated financial statements</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-440">Fair Value Measurements&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;&#160;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash equivalents at September&#160;30, 2025 and December&#160;31, 2024 were held in U.S. Treasury securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;There were no transfers made among the three levels in the fair value hierarchy during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the warrants assumed in the merger (the &#x201c;Merger&#x201d;) with Angion Biomedica Corp. (&#x201c;Angion&#x201d; and the warrants, the &#x201c;Angion Warrants&#x201d;) were classified as Level 3 with key Level 3 inputs of exercise price, term, and volatility. The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liability (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;For the nine months ended, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;For the year ended,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Both observable and unobservable inputs were used to determine the fair value of positions that the Company has classified within the Level 3 category. Unrealized gains and losses associated with assets and liabilities within the Level 3 category include changes in fair value that were attributable to both observable (e.g., changes in market interest rates) and unobservable (e.g., changes in unobservable long-dated volatilities) inputs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the Angion Warrants issued by the Company has been estimated using the Black-Scholes option pricing model. The underlying equity included in Black-Scholes was valued based on the equity value implied from sales of preferred and common stock at each measurement date, as applicable. The fair value of the Angion Warrants was impacted by the model selected as well as assumptions surrounding unobservable inputs including the underlying equity value, expected volatility of the underlying equity, risk-free interest rate, and the expected term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the assumed Angion Warrant liability was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed an underwritten public offering (the &#x201c;Public Offering&#x201d;), consisting of (i) 500,000 shares of the Company&#x2019;s common stock (the &#x201c;July 2024 Shares&#x201d;), (ii) pre-funded warrants exercisable for 1,800,000 shares of common stock (the &#x201c;July 2024 Pre-Funded Warrants&#x201d;), and (iii) common warrants to purchase up to 2,300,000 shares of common stock (the &#x201c;July 2024 Common Warrants&#x201d;). Each July 2024 Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. As of the current reporting period end, the outstanding July 2024 Pre-Funded Warrants are equity classified. The Company identified the July 2024 Common Warrants as liabilities and measured them at fair value on July 1, 2024, and subsequently remeasures the fair value of these warrant liabilities at each reporting period end. The Company is able to calculate the fair value measurement based on directly observable inputs from active markets, therefore these warrants are classified as Level 2. Refer to Note 6 and 8 for further discussion. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. At the Company&#x2019;s annual stockholder&#x2019;s meeting in November 2024, the Company obtained stockholder approval for GKCC, LLC (&#x201c;GKCC&#x201d;), together with its affiliates, to exceed the 19.99% beneficial ownership limitation pursuant to the rules and regulations of the Nasdaq Stock Market LLC (&#x201c;Nasdaq&#x201d;) (&#x201c;Stockholder Approval&#x201d;). As a result of obtaining Stockholder Approval, certain July 2024 Common Warrants are equity classified while the remainder of the outstanding July 2024 Common Warrants are liability classified and are subsequently remeasured at each reporting period end. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;For the three and nine months ended September 30, 2025, the Company recognized a change in fair value of $1.8 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;and $3.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company records the fair value remeasurement of the outstanding liability-classified warrants in change in fair value of warrant liabilities in the condensed consolidated statements of operations and comprehensive loss included in this Quarterly Report on Form 10-Q.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-441">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables present the Company's financial assets and liabilities measured at fair value on a recurring basis and their assigned levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;&#160;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Money market funds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;12,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Warrant liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Total liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Included in cash, cash equivalents, and restricted cash on the condensed consolidated balance sheets. This balance includes cash requirements settled on a nightly basis.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-442" unitRef="usd">6189000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-443" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-444" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-445" unitRef="usd">6189000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-446" unitRef="usd">6189000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-447" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-448" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-449" unitRef="usd">6189000</us-gaap:AssetsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-100" decimals="-3" id="f-450" unitRef="usd">0</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-101" decimals="-3" id="f-451" unitRef="usd">3872000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-102" decimals="-3" id="f-452" unitRef="usd">5000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-103" decimals="-3" id="f-453" unitRef="usd">3877000</angn:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-100" decimals="-3" id="f-454" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-101" decimals="-3" id="f-455" unitRef="usd">3872000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-102" decimals="-3" id="f-456" unitRef="usd">5000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-103" decimals="-3" id="f-457" unitRef="usd">3877000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-458" unitRef="usd">12100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-459" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-460" unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-461" unitRef="usd">12100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-462" unitRef="usd">12100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-463" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-464" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-465" unitRef="usd">12100000</us-gaap:AssetsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-104" decimals="-3" id="f-466" unitRef="usd">0</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-105" decimals="-3" id="f-467" unitRef="usd">2827000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-106" decimals="-3" id="f-468" unitRef="usd">1000</angn:WarrantsFairValueDisclosure>
    <angn:WarrantsFairValueDisclosure contextRef="c-107" decimals="-3" id="f-469" unitRef="usd">2828000</angn:WarrantsFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-104" decimals="-3" id="f-470" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-105" decimals="-3" id="f-471" unitRef="usd">2827000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-106" decimals="-3" id="f-472" unitRef="usd">1000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-107" decimals="-3" id="f-473" unitRef="usd">2828000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock contextRef="c-1" id="f-474">The following table presents a summary of changes in Level 3 in the fair value of the Company&#x2019;s common stock warrant liability (in thousands):&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.388%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;For the nine months ended, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;For the year ended,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Balance, end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-108" decimals="-3" id="f-475" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-109" decimals="-3" id="f-476" unitRef="usd">11000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-110" decimals="-3" id="f-477" unitRef="usd">4000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings contextRef="c-111" decimals="-3" id="f-478" unitRef="usd">-10000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-112" decimals="-3" id="f-479" unitRef="usd">5000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue contextRef="c-108" decimals="-3" id="f-480" unitRef="usd">1000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-481">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of the assumed Angion Warrant liability was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:2.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average strike price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;76.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Contractual term (years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Volatility (annual)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Risk-free rate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Dividend yield (per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-113"
      decimals="2"
      id="f-482"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="c-114"
      decimals="2"
      id="f-483"
      unitRef="usdPerShare">76.00</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-115" id="f-484">P2Y10M24D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-116" id="f-485">P3Y8M12D</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-117" decimals="3" id="f-486" unitRef="number">0.803</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-117" decimals="3" id="f-487" unitRef="number">0.803</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-118" decimals="3" id="f-488" unitRef="number">0.749</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-119" decimals="3" id="f-489" unitRef="number">0.038</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-119" decimals="3" id="f-490" unitRef="number">0.038</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-120" decimals="3" id="f-491" unitRef="number">0.044</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-121" decimals="3" id="f-492" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput contextRef="c-122" decimals="3" id="f-493" unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-123" decimals="0" id="f-494" unitRef="shares">500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-124" decimals="0" id="f-495" unitRef="shares">1800000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-125" decimals="0" id="f-496" unitRef="shares">2300000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-126"
      decimals="2"
      id="f-497"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-125"
      decimals="2"
      id="f-498"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:SaleOfStockBeneficialOwnershipLimitationPercentage contextRef="c-3" decimals="INF" id="f-499" unitRef="number">0.1999</angn:SaleOfStockBeneficialOwnershipLimitationPercentage>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-127" decimals="-5" id="f-500" unitRef="usd">-1800000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-128" decimals="-5" id="f-501" unitRef="usd">-3200000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-502">Balance Sheet Components&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prepaid and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Depreciation expense for the three and nine months ended September 30, 2025 was $0.1 million and $0.2 million, respectively. For the three and nine months ended September 30, 2024, depreciation expense was immaterial and $0.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Other long-term prepaid assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $0.8 million and $0.6 million for September&#160;30, 2025 and December&#160;31, 2024, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Accrued Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock contextRef="c-1" id="f-503">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Prepaid and other current assets consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid research and development contract services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Advanced professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Prepaid insurance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;854&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <angn:PrepaidResearchAndDevelopmentExpenses contextRef="c-3" decimals="-3" id="f-504" unitRef="usd">107000</angn:PrepaidResearchAndDevelopmentExpenses>
    <angn:PrepaidResearchAndDevelopmentExpenses contextRef="c-4" decimals="-3" id="f-505" unitRef="usd">1206000</angn:PrepaidResearchAndDevelopmentExpenses>
    <angn:AdvancedProfessionalFees contextRef="c-3" decimals="-3" id="f-506" unitRef="usd">238000</angn:AdvancedProfessionalFees>
    <angn:AdvancedProfessionalFees contextRef="c-4" decimals="-3" id="f-507" unitRef="usd">243000</angn:AdvancedProfessionalFees>
    <us-gaap:PrepaidInsurance contextRef="c-3" decimals="-3" id="f-508" unitRef="usd">444000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance contextRef="c-4" decimals="-3" id="f-509" unitRef="usd">347000</us-gaap:PrepaidInsurance>
    <angn:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-510" unitRef="usd">65000</angn:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <angn:OtherPrepaidExpensesAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-511" unitRef="usd">101000</angn:OtherPrepaidExpensesAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-512" unitRef="usd">854000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-513" unitRef="usd">1897000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-514">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Leasehold improvements&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total property and equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,552)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Property and equipment, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-129" decimals="-3" id="f-515" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-130" decimals="-3" id="f-516" unitRef="usd">1661000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-131" decimals="-3" id="f-517" unitRef="usd">242000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-132" decimals="-3" id="f-518" unitRef="usd">242000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-133" decimals="-3" id="f-519" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-134" decimals="-3" id="f-520" unitRef="usd">132000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-521" unitRef="usd">2035000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-522" unitRef="usd">2035000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-523" unitRef="usd">1707000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-524" unitRef="usd">1552000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-525" unitRef="usd">328000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-526" unitRef="usd">483000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-5" decimals="-5" id="f-527" unitRef="usd">100000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-528" unitRef="usd">200000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-5" id="f-529" unitRef="usd">0</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-7" decimals="-5" id="f-530" unitRef="usd">200000</us-gaap:Depreciation>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-3" decimals="-5" id="f-531" unitRef="usd">800000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent contextRef="c-4" decimals="-5" id="f-532" unitRef="usd">600000</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-533">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Accrued expenses consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.876%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Accrued research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total accrued expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-3" decimals="-3" id="f-534" unitRef="usd">761000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="c-4" decimals="-3" id="f-535" unitRef="usd">1167000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-536" unitRef="usd">1688000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-537" unitRef="usd">2312000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <angn:AccruedResearchAndDevelopmentCurrent contextRef="c-3" decimals="-3" id="f-538" unitRef="usd">2714000</angn:AccruedResearchAndDevelopmentCurrent>
    <angn:AccruedResearchAndDevelopmentCurrent contextRef="c-4" decimals="-3" id="f-539" unitRef="usd">4910000</angn:AccruedResearchAndDevelopmentCurrent>
    <angn:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-540" unitRef="usd">50000</angn:AccruedOtherOperatingLiabilitiesCurrent>
    <angn:AccruedOtherOperatingLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-541" unitRef="usd">26000</angn:AccruedOtherOperatingLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-542" unitRef="usd">5213000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-543" unitRef="usd">8415000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock contextRef="c-1" id="f-544">Research Grants&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In September 2022, Former Elicio entered into a grant agreement with the Gastro-Intestinal (&#x201c;GI&#x201d;) Research Foundation, a not-for-profit organization focused on supporting research to treat, cure, and prevent digestive diseases. Of the $2.8 million award, $2.3 million was received in September 2022 and the remaining $0.5 million was received in June 2023 with the completion of the development efforts as defined in the grant agreement. The final $0.5 million payment was applied as a credit to the second grant agreement described below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In September 2023, the Company entered into a second grant agreement with the GI Research Foundation for $3.1 million, with such amount received net of the $0.5 million credit described above.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;three and nine months ended September 30, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, the Company incurred &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$0 and $2.2 million in research and development expenses related to this project, respectively. As of September&#160;30, 2024, the grant funds available for the second grant agreement were&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$0&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and the deferred research obligation was &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$0, as the second grant agreement activities were completed in the third quarter of 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into a third grant agreement with the GI Research Foundation for $1.5 million. For each of the three and nine months ended September 30, 2024, the Company incurred $0.2 million in research and development expenses related to this project, all of which was reimbursed from available grant funds. For the three and nine months ended September 30, 2025, the Company incurred $0 and $0.8 million in research and development expenses related to this project, respectively, of which $0 and $0.8 million was reimbursed from available grant funds, respectively. The third grant agreement activities were completed in the second quarter of 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The award money for the three grant agreements was recorded as contra-expense to offset the research and development costs incurred. Following completion of the third grant agreement with GI Research Foundation, during 2025, the remaining $0.4 million of the grant funds were recognized as grant income, as there were no further conditions to be met.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-135" decimals="-5" id="f-545" unitRef="usd">2800000</angn:ResearchAndDevelopmentArrangementGrant>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-135" decimals="-5" id="f-546" unitRef="usd">2300000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-136" decimals="-5" id="f-547" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-136" decimals="-5" id="f-548" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-137" decimals="-5" id="f-549" unitRef="usd">3100000</angn:ResearchAndDevelopmentArrangementGrant>
    <angn:ResearchAndDevelopmentArrangementCredit contextRef="c-137" decimals="-5" id="f-550" unitRef="usd">500000</angn:ResearchAndDevelopmentArrangementCredit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-138" decimals="-5" id="f-551" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-139" decimals="-5" id="f-552" unitRef="usd">2200000</us-gaap:ResearchAndDevelopmentExpense>
    <angn:ResearchAndDevelopmentArrangementGrantReceived contextRef="c-140" decimals="-5" id="f-553" unitRef="usd">0</angn:ResearchAndDevelopmentArrangementGrantReceived>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-140" decimals="-5" id="f-554" unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <angn:ResearchAndDevelopmentArrangementGrant contextRef="c-141" decimals="-5" id="f-555" unitRef="usd">1500000</angn:ResearchAndDevelopmentArrangementGrant>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-142" decimals="-5" id="f-556" unitRef="usd">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-143" decimals="-5" id="f-557" unitRef="usd">200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-144" decimals="-5" id="f-558" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-145" decimals="-5" id="f-559" unitRef="usd">800000</us-gaap:ResearchAndDevelopmentExpense>
    <angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds contextRef="c-144" decimals="-5" id="f-560" unitRef="usd">0</angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds>
    <angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds contextRef="c-145" decimals="-5" id="f-561" unitRef="usd">800000</angn:ResearchAndDevelopmentArrangementReimbursementFromGrantFunds>
    <angn:NumberOfResearchGrantAgreements
      contextRef="c-3"
      decimals="INF"
      id="f-562"
      unitRef="agreement">3</angn:NumberOfResearchGrantAgreements>
    <angn:GrantRevenueNonoperating contextRef="c-1" decimals="-5" id="f-563" unitRef="usd">400000</angn:GrantRevenueNonoperating>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-564">Common Stock and Stockholders' Equity&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Authorized Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company's current Amended and Restated Certificate of Incorporation, as amended, authorizes 300,000,000 shares of common stock, par value $0.01 per share, and 10,000,000 shares of preferred stock, par value $0.01 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;At-The-Market Equity Programs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In May 2022, the Company filed a registration statement on Form S-3 (the &#x201c;Prior Shelf Registration St&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;atement&#x201d;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, and warrants to purchase common stock, preferred stock and/or debt securities, not to exceed an aggregate initial offering price of $100&#160;million. Simultaneously, the Company entered into an At-the-Market Equity Offering Sales Agreement with Stifel, Nicolaus &amp;amp; Company, Incorporated and Virtu Americas LLC, as sales agents, that provided for the issuance and sale of up to $21 million of shares of common stock from time to time in &#x201c;at-the-market&#x201d; offerings under the Prior Shelf Registration Statement and related prospectus filed with the Prior Shelf Registration Statement (the &#x201c;2022 ATM Program"). During the nine months ended September 30, 2024, the Company issued and sold a total of 650,179 shares of common stock at a weighted average price of $8.42 per share under the 2022 ATM Program for aggregate net sale proceeds of approximately $5.4 million after deducting sales commissions. In May 2024, the 2022 ATM Program was terminated by the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2024, the Company filed a registration statement on Form S-3 (the &#x201c;2024 Registration Statement&#x201d;) with the SEC that registered the offering, issuance, and sale of an amount of common stock, preferred stock, debt securities, warrants to purchase common stock, preferred stock and/or debt securities, and/or units consisting of any combination of such securities, not to exceed an aggregate initial offering price of $200&#160;million. Simultaneously, the Company entered into the Capital on Demand&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline"&gt;TM&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; Sales Agreement with JonesTrading Institutional Services LLC, as agent, to provide for the issuance and sale of up to $40&#160;million of shares of common stock from time to time in &#x201c;at-the-market&#x201d; offerings under the 2024 Registration Statement and related prospectus filed with the 2024 Registration Statement (the &#x201c;2024 ATM Program&#x201d;). During the nine months ended September 30, 2025, the Company issued and sold 1,176,449 shares of common stock at a weighted average price of $9.68 per share under the 2024 ATM Program for aggregate net sale proceeds of approximately $11.4 million after deducting sales commissions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Private Placement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2024, the Company entered into a subscription agreement (the &#x201c;March Subscription Agreement&#x201d;) with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors, providing for the issuance and sale by the Company to GKCC of pre-funded warrants (the &#x201c;March 2024 Pre-Funded Warrants&#x201d;) (the &#x201c;March 2024 Offering&#x201d;). Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. The net proceeds to the Company from the March 2024 Offering were approximately $6.0 million. Refer to Note 8 for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Public Offerings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In July 2024, the Company closed the Public Offering, which resulted in net proceeds of $10.9&#160;million to the Company, after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company. The Public Offering consisted of the July 2024 Shares or in lieu thereof, the July 2024 Pre-Funded Warrants, and accompanying July 2024 Common Warrants. Each July 2024 Share and accompanying July 2024 Common Warrant were sold together at a combined offering price of $5.00 per July Share and accompanying July 2024 Common Warrant, and each July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant were sold together at a combined offering price of $4.99 per July 2024 Pre-Funded Warrant and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;accompanying July 2024 Common Warrant, which represented the combined purchase price per July 2024 Pre-Funded Warrant and accompanying July 2024 Common Warrant less the $0.01 per share exercise price for each such July 2024 Pre-Funded Warrant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The July 2024 Common Warrants have an exercise price of $5.00 per share, are immediately exercisable and will expire five years from the issuance date. Refer to Note 3 and 8 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2025, the Company entered into a securities purchase agreement with certain institutional investors (each an &#x201c;Investor&#x201d; and, collectively, the &#x201c;Investors&#x201d;), pursuant to which the Company agreed to issue and sell, in a registered direct offering by the Company directly to the Investors (the &#x201c;January 2025 Offering&#x201d;): (i) an aggregate of 1,261,830 shares of the Company&#x2019;s common stock (the &#x201c;January 2025 Shares&#x201d;) and (ii) common warrants to purchase up to an aggregate of 1,261,830 shares of common stock (the &#x201c;January 2025 Common Warrants&#x201d;). Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. The January 2025 Offering resulted in net proceeds of $9.2&#160;million to the Company after deducting the placement agent&#x2019;s fees and related offering expenses. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company entered into a note purchase agreement (the &#x201c;June 2025 Promissory Note Financing&#x201d;) with GKCC pursuant to which the Company issued a Senior Secured Promissory Note due June 3, 2028 (the &#x201c;June 2025 Promissory Note&#x201d;) in the principal amount of $10.0&#160;million. In connection with the June 2025 Promissory Note Financing, the Company issued to GKCC a warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock (the &#x201c;June 2025 Warrant&#x201d;). The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable, and expires five years from the date of issuance. Refer to Note 11 for further detail.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-565" unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-566"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-567" unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-568"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-146" decimals="-6" id="f-569" unitRef="usd">100000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-147" decimals="-6" id="f-570" unitRef="usd">21000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-148" decimals="0" id="f-571" unitRef="shares">650179</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-149"
      decimals="INF"
      id="f-572"
      unitRef="usdPerShare">8.42</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-148" decimals="-5" id="f-573" unitRef="usd">5400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-150" decimals="-6" id="f-574" unitRef="usd">200000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <angn:SaleOfStockAggregateInitialOfferingPrice contextRef="c-151" decimals="-6" id="f-575" unitRef="usd">40000000</angn:SaleOfStockAggregateInitialOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-152" decimals="0" id="f-576" unitRef="shares">1176449</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-153"
      decimals="INF"
      id="f-577"
      unitRef="usdPerShare">9.68</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-152" decimals="-5" id="f-578" unitRef="usd">11400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-154"
      decimals="2"
      id="f-579"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-155" decimals="-5" id="f-580" unitRef="usd">6000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-123" decimals="-5" id="f-581" unitRef="usd">10900000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-156"
      decimals="2"
      id="f-582"
      unitRef="usdPerShare">5.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c-157"
      decimals="2"
      id="f-583"
      unitRef="usdPerShare">4.99</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-124"
      decimals="2"
      id="f-584"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-125"
      decimals="INF"
      id="f-585"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-125" id="f-586">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-158" decimals="0" id="f-587" unitRef="shares">1261830</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-159"
      decimals="INF"
      id="f-588"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-160"
      decimals="3"
      id="f-589"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-160"
      decimals="1"
      id="f-590"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-161" id="f-591">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-162" decimals="-5" id="f-592" unitRef="usd">9200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-163" decimals="INF" id="f-593" unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-163"
      decimals="INF"
      id="f-594"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-163"
      decimals="2"
      id="f-595"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-163" id="f-596">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-597">Stock-Based Compensation&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of September&#160;30, 2025, there was an aggregate of 806,700 shares of common stock available for issuance under the Company&#x2019;s equity incentive plans, including 462,097 shares available for future grants under the Company&#x2019;s 2021 Incentive Award Plan, 177,295 shares available for future grants under the Company&#x2019;s 2022 Equity Incentive Plan, as amended, and 167,308 shares available for future grants issuance under the Company&#x2019;s 2024 Inducement Incentive Award Plan. Refer to Note 8 &#x2013; &#x201c;Stock-Based Compensation" to the Company's consolidated financial statements from the Form 10-K for the discussion of the Company's equity incentive plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,890,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;15.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;656,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(31,918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(51,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,464,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,345,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;19.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The aggregate intrinsic value in the above table is calculated as the difference between the estimated fair value of the Company's common stock and the exercise price of the stock options. 656,099 stock options were granted during the nine months ended September 30, 2025. The weighted average grant date fair value per share for the stock option grants during the nine months ended September 30, 2025 was $7.40. As of September&#160;30, 2025, the total unrecognized compensation expense related to unvested stock option awards granted was $5.1 million, which the Company expects to recognize over a weighted-average period of approximately 2.7 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Stock-based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each option is estimated on the date of grant using a Black-Scholes option pricing model with the assumptions noted in the table below. The fair value of an award with only a service condition is amortized as compensation expense on a straight-line basis over the requisite service period of the award, which is generally the vesting period. Compensation cost of awards that contain a performance condition are recognized when success is considered probable during the performance period. The Company has elected to account for forfeitures as they occur, rather than estimating the number of awards that are expected to vest. The risk-free interest rate is estimated using the weighted average rate of return on U.S. Treasury notes with a life that approximates the expected life of the option. The expected term of options granted to employees was calculated using the simplified method, which represents the average of the contractual term of the option and the weighted average vesting period of the option. The Company uses the simplified method because it does not have sufficient historical option exercise data to provide a reasonable basis upon which to estimate expected term. The contractual life of the option was used for the expected life of options granted to non-employees. Expected volatility is based on the weighted average of the historical volatility of a peer group of publicly traded companies, using the daily closing prices during the equivalent period of the calculated expected term of stock-based awards. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of the Company&#x2019;s common stock price becomes available, or until circumstances change, such that the identified entities are no longer comparable companies. The assumed dividend yield is based upon the Company's expectation of not paying dividends in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.277%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.4% - 3.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7% - 4.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.4% - 4.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected term in years (for employees)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.8 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.0 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;110.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;104.6% - 104.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;106.9% - 110.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;79.5% - 104.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2021 and June 2022, certain employees of the Company early exercised stock options. The shares had not fully vested at the time of exercise and were recorded as an unvested option exercise liability. As the shares vested, the Company recognized the shares and related expense as issuance of common stock upon settlement of restricted stock in the condensed consolidated financial statements for the period ended September&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2021, the board of directors of Angion approved the Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;). The ESPP was effective on the date immediately prior to the effectiveness of Angion's registration statement relating to Angion&#x2019;s initial public offering. The offering period and purchase period was determined by Angion&#x2019;s board of directors. No offering periods or purchasing periods were active as of September&#160;30, 2025. As of September&#160;30, 2025, 275,309 shares remained available for purchase under the ESPP and no offerings have been authorized.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="c-3" decimals="INF" id="f-598" unitRef="shares">806700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-164"
      decimals="INF"
      id="f-599"
      unitRef="shares">462097</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-165"
      decimals="INF"
      id="f-600"
      unitRef="shares">177295</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-166"
      decimals="INF"
      id="f-601"
      unitRef="shares">167308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-602">&lt;div style="margin-top:6pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes information and activity related to the Company&#x2019;s stock options:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Number of &lt;br/&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average &lt;br/&gt;Remaining Contractual Life &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Total &lt;br/&gt;Intrinsic Value &lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,890,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;15.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.78&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;656,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options exercised &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(31,918)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited (unvested)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(51,106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding as of September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,464,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;13.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;10,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Options vested and exercisable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,345,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;19.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="INF" id="f-603" unitRef="shares">1890932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-604"
      unitRef="usdPerShare">15.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-167" id="f-605">P6Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-606" unitRef="usd">920000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-607" unitRef="shares">656099</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-608"
      unitRef="usdPerShare">7.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="INF" id="f-609" unitRef="shares">31918</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-610"
      unitRef="usdPerShare">4.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="INF" id="f-611" unitRef="shares">51106</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-612"
      unitRef="usdPerShare">6.80</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-3" decimals="INF" id="f-613" unitRef="shares">2464007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-614"
      unitRef="usdPerShare">13.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-615">P6Y11M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-3" decimals="-3" id="f-616" unitRef="usd">10525000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-3" decimals="INF" id="f-617" unitRef="shares">1345848</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-3"
      decimals="2"
      id="f-618"
      unitRef="usdPerShare">19.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-619">P5Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-3" decimals="-3" id="f-620" unitRef="usd">5509000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="INF" id="f-621" unitRef="shares">656099</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-622"
      unitRef="usdPerShare">7.40</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-3" decimals="-5" id="f-623" unitRef="usd">5100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-1" id="f-624">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-625">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes total stock-based compensation expense recorded in the condensed consolidated statements of operations (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-168" decimals="-3" id="f-626" unitRef="usd">264000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-169" decimals="-3" id="f-627" unitRef="usd">138000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-170" decimals="-3" id="f-628" unitRef="usd">755000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-171" decimals="-3" id="f-629" unitRef="usd">414000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-172" decimals="-3" id="f-630" unitRef="usd">434000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-173" decimals="-3" id="f-631" unitRef="usd">176000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-174" decimals="-3" id="f-632" unitRef="usd">1170000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-175" decimals="-3" id="f-633" unitRef="usd">574000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-634" unitRef="usd">698000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-635" unitRef="usd">314000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-636" unitRef="usd">1925000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-637" unitRef="usd">988000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-638">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The fair value of each employee and non-employee stock option grant was estimated on the date of grant using Black-Scholes based on the following weighted average assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.649%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.273%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.277%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.4% - 3.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3.7% - 4.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;3.4% - 4.2%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected term in years (for employees)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.8 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5.5 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;5.0 - 6.1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;110.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;104.6% - 104.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;106.9% - 110.4%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;79.5% - 104.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-176" decimals="3" id="f-639" unitRef="number">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-177" decimals="3" id="f-640" unitRef="number">0.034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-177" decimals="3" id="f-641" unitRef="number">0.036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-178" decimals="3" id="f-642" unitRef="number">0.037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-178" decimals="3" id="f-643" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="c-179" decimals="3" id="f-644" unitRef="number">0.034</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="c-179" decimals="3" id="f-645" unitRef="number">0.042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-176" decimals="3" id="f-646" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-177" decimals="3" id="f-647" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-178" decimals="3" id="f-648" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-179" decimals="3" id="f-649" unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-176" id="f-650">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-180" id="f-651">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-181" id="f-652">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-182" id="f-653">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-183" id="f-654">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-184" id="f-655">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-185" id="f-656">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-176" decimals="3" id="f-657" unitRef="number">1.104</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-177" decimals="3" id="f-658" unitRef="number">1.046</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-177" decimals="3" id="f-659" unitRef="number">1.048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-178" decimals="3" id="f-660" unitRef="number">1.069</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-178" decimals="3" id="f-661" unitRef="number">1.104</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="c-179" decimals="3" id="f-662" unitRef="number">0.795</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="c-179" decimals="3" id="f-663" unitRef="number">1.048</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-186"
      decimals="INF"
      id="f-664"
      unitRef="shares">275309</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-186"
      decimals="INF"
      id="f-665"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <angn:WarrantsAndRightsOutstandingTextBlock contextRef="c-1" id="f-666">Warrants&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In accordance with FASB ASC Topic 815, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; (&#x201c;ASC 815&#x201d;), certain of the Company&#x2019;s outstanding warrants are classified as liabilities and are recorded at fair value at the issuance date, with subsequent changes in the fair value recognized in the condensed consolidated statements of operations and comprehensive loss in each reporting period. Refer to Note 3 for changes in the fair value recognized during the periods reported. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Note 6, in March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon issuance, the March 2024 Pre-Funded Warrants were liability-classified, with a fair value of $6.6&#160;million, as determined by the Black-Scholes option pricing model as of the grant date. The Company recorded the $0.6 million difference between the proceeds and grant date fair value as a loss on issuance of warrants in the statements of operations and comprehensive loss during the three months ended March 31, 2024 and nine months ended September 30, 2024. As of September 30, 2025, the March 2024 Pre-Funded Warrants were classified as equity due to the receipt of Stockholder Approval in November 2024, as discussed in Note 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Notes 3 and 6, in July 2024, the Company closed its Public Offering consisting of (i) the July 2024 Shares, (ii) the July 2024 Pre-Funded Warrants, and (iii) the July 2024 Common Warrants. Each July 2024 Pre-Funded Warrant issued and sold in the Public Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Pre-Funded Warrants. Each July 2024 Common Warrant is exercisable at an exercise price equal to $5.00 per share, subject to certain adjustments and limitations as provided under the terms of the July 2024 Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Upon issuance, the July 2024 Pre-Funded Warrants and July 2024 Common Warrants were liability-classified, with a fair value of $6.8 million and $6.5 million, respectively, measured using the Black-Scholes option pricing model as of the grant date. The Company recorded the $2.9 million difference between the proceeds and the grant date fair value as a loss on the issuance of warrants in the statements of operations and comprehensive loss during the third quarter of 2024. As of September&#160;30, 2025, certain July 2024 Pre-Funded Warrants are classified as equity, following Stockholder Approval in November 2024. For the three and nine months ended September 30, 2025, the Company recognized a loss of $1.8 million and $3.2 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;in fair value remeasurement, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Following receipt of Stockholder Approval in November 2024, the Company remeasured the March 2024 Pre-Funded Warrants and the July 2024 Pre-Funded Warrants, held by GKCC, at fair value and recognized the loss from change in fair value on the consolidated financial statements during the year ended December 31, 2024. As a result of obtaining Stockholder Approval, the March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants held by GKCC and its affiliates met the equity classification requirements under ASC 815. During the quarter ended December 31, 2024, the Company reclassified the July 2024 Common Warrants held by GKCC and its affiliates from liability to equity classification. The Company will re-assess the equity classification for the remaining March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants at each reporting period end. During the nine months ended September 30, 2025, there were no changes to the equity classification.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As disclosed in Note 6, in January 2025, the Company closed the January 2025 Offering pursuant to which the Company agreed to issue and sell: (i) the January 2025 Shares and (ii) the January 2025 Common Warrants. Each January 2025 Share and accompanying January 2025 Common Warrant were sold together at a combined offering price of $7.925. The January 2025 Common Warrants have an exercise price of $7.80 per share, are immediately exercisable and will expire five years from the initial exercise date. The fair value of the January 2025 Common Warrants, as determined by the Black-Scholes option pricing model, was $9.7 million on the closing date of the January 2025 Offering. The net proceeds were allocated using the relative fair value of the January 2025 Shares and January 2025 Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. The fair value of the June 2025 Warrant, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance. See Note 11 for further detail regarding the June 2025 Promissory Note Financing.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables summarize information regarding the warrants outstanding and warrant activity at September&#160;30, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Warrants Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Elicio Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Angion Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,041,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Warrants Outstanding at September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of September 30, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.279%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.645%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.685%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,081,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,365,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(258,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at September&#160;30, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</angn:WarrantsAndRightsOutstandingTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-187"
      decimals="2"
      id="f-667"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:WarrantExercisedFairValue contextRef="c-188" decimals="-5" id="f-668" unitRef="usd">6600000</angn:WarrantExercisedFairValue>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-189" decimals="-5" id="f-669" unitRef="usd">-600000</angn:GainLossOnIssuanceOfWarrants>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-190" decimals="-5" id="f-670" unitRef="usd">-600000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-126"
      decimals="2"
      id="f-671"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-125"
      decimals="2"
      id="f-672"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:WarrantExercisedFairValue contextRef="c-191" decimals="-5" id="f-673" unitRef="usd">6800000</angn:WarrantExercisedFairValue>
    <angn:WarrantExercisedFairValue contextRef="c-192" decimals="-5" id="f-674" unitRef="usd">6500000</angn:WarrantExercisedFairValue>
    <angn:GainLossOnIssuanceOfWarrants contextRef="c-193" decimals="-5" id="f-675" unitRef="usd">-2900000</angn:GainLossOnIssuanceOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-127" decimals="-5" id="f-676" unitRef="usd">-1800000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-128" decimals="-5" id="f-677" unitRef="usd">-3200000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-194"
      decimals="3"
      id="f-678"
      unitRef="usdPerShare">7.925</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-194"
      decimals="1"
      id="f-679"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-195" id="f-680">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-196" decimals="-5" id="f-681" unitRef="usd">9700000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-163"
      decimals="INF"
      id="f-682"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-163"
      decimals="2"
      id="f-683"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-163" id="f-684">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-197" decimals="-5" id="f-685" unitRef="usd">600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c-1" id="f-686">&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following tables summarize information regarding the warrants outstanding and warrant activity at September&#160;30, 2025:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.982%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.315%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.296%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.409%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.870%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Warrants Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average Remaining Contractual Life (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Elicio Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;144,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Angion Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2024 Pre-Funded Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,600,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Perpetual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2024 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,041,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2025 Common Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity-classified &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Warrants Outstanding at September 30, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.69&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The March 2024 Pre-Funded Warrants and July 2024 Pre-Funded Warrants outstanding as of September 30, 2025 have a perpetual term and are therefore excluded from the calculation of the weighted-average remaining contractual life.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.137%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.279%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.151%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.645%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.679%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.685%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted &lt;br/&gt;Average &lt;br/&gt;Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Weighted Average Life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,081,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,365,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(258,500)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at September&#160;30, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,188,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-198"
      decimals="INF"
      id="f-687"
      unitRef="shares">144814</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-199"
      decimals="2"
      id="f-688"
      unitRef="usdPerShare">53.59</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-200" id="f-689">P3Y8M12D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-201"
      decimals="INF"
      id="f-690"
      unitRef="shares">3950</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-202"
      decimals="2"
      id="f-691"
      unitRef="usdPerShare">76.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-203" id="f-692">P2Y10M24D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-204"
      decimals="INF"
      id="f-693"
      unitRef="shares">1032702</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-205"
      decimals="2"
      id="f-694"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-206"
      decimals="INF"
      id="f-695"
      unitRef="shares">1600000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-207"
      decimals="2"
      id="f-696"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-208"
      decimals="INF"
      id="f-697"
      unitRef="shares">2041500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-209"
      decimals="2"
      id="f-698"
      unitRef="usdPerShare">5.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-210" id="f-699">P3Y9M18D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-211"
      decimals="INF"
      id="f-700"
      unitRef="shares">1261830</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-212"
      decimals="2"
      id="f-701"
      unitRef="usdPerShare">7.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-213" id="f-702">P4Y3M18D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="c-214"
      decimals="INF"
      id="f-703"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-215"
      decimals="2"
      id="f-704"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-216" id="f-705">P4Y8M12D</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-3" decimals="INF" id="f-706" unitRef="shares">6188021</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-217"
      decimals="2"
      id="f-707"
      unitRef="usdPerShare">4.69</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms contextRef="c-1" id="f-708">P4Y</angn:ClassOfWarrantOrRightWeightedAverageRemainingContractualTerms>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-4" decimals="INF" id="f-709" unitRef="shares">5081466</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-4"
      decimals="INF"
      id="f-710"
      unitRef="usdPerShare">3.85</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageLife contextRef="c-4" id="f-711">P4Y6M</angn:ClassOfWarrantOrRightWeightedAverageLife>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-1" decimals="INF" id="f-712" unitRef="shares">1365055</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-713"
      unitRef="usdPerShare">7.80</angn:ClassOfWarrantOrRightWeightedAverageExercisePriceIssuedInPeriod>
    <angn:ClassOfWarrantOrRightExercisedInPeriod contextRef="c-1" decimals="INF" id="f-714" unitRef="shares">258500</angn:ClassOfWarrantOrRightExercisedInPeriod>
    <angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod
      contextRef="c-1"
      decimals="INF"
      id="f-715"
      unitRef="usdPerShare">5.00</angn:ClassOfWarrantOrRightWeightedAverageExercisePriceExercisesInPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-3" decimals="INF" id="f-716" unitRef="shares">6188021</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-3"
      decimals="INF"
      id="f-717"
      unitRef="usdPerShare">4.69</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <angn:ClassOfWarrantOrRightWeightedAverageLife contextRef="c-3" id="f-718">P4Y</angn:ClassOfWarrantOrRightWeightedAverageLife>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-719">Commitments and Contingencies&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Legal Proceedings &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;From time to time, the Company may be involved in legal proceedings, or may be subject to various demands, claims and threatened litigation, which arise in the normal course of its business or otherwise. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The outcome of any future litigation is uncertain. Such litigation, if not resolved, could result in substantial costs to the Company, including any costs associated with the indemnification of directors and officers, and could lead to a diversion of management resources among other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company may be exposed to litigation in connection with its products under development and operations. The Company&#x2019;s policy is to assess the likelihood of any adverse judgments or outcomes related to legal matters, as well as ranges of probable losses. As of the time of this report, the Company does not believe it is a party to any claim, proceeding or litigation, the outcome of which, if determined adversely to the Company, would individually or in the aggregate be reasonably expected to have a material adverse effect on its business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;License Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In January 2016, Former Elicio entered into a license agreement to license certain intellectual property from a university, which agreement has been amended from time to time to license additional intellectual property and to adjust fees and milestone and diligence requirements. The Company is required to pay certain contractual maintenance and milestone payments related to clinical trials and product sales and royalties on product sales over the term of the contract, with royalty payments commencing in the calendar year of commercialization. Royalty rates range from 0.25%-2.00%, depending on whether commercial sales relate to a licensed product or an identified product, and the country the products were sold in. The license term for the license agreement extends until terminated by either party under certain provisions. During the nine months ended September 30, 2024, in accordance with the terms of the license agreement, the Company achieved a milestone related to the ongoing clinical trials and recorded license expense of $0.4&#160;million. No such expenses were recorded in the nine months ended September 30, 2025. No commercialization royalties have been achieved to date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is required to pay a total of up to $20.9&#160;million upon achievement of certain late-stage developmental and commercial milestones. The developmental milestone payments will be recorded when each milestone is achieved, and the commercial milestone payments and royalties will be recorded when the sales occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Future minimum annual maintenance payments are $0.1&#160;million for the year ended December&#160;31, 2025 and for each year thereafter. Future minimum annual payments are due until the termination of the agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <angn:RoyaltyRatePercent contextRef="c-218" decimals="4" id="f-720" unitRef="number">0.0025</angn:RoyaltyRatePercent>
    <angn:RoyaltyRatePercent contextRef="c-219" decimals="4" id="f-721" unitRef="number">0.0200</angn:RoyaltyRatePercent>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-220" decimals="-5" id="f-722" unitRef="usd">400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-221" decimals="-5" id="f-723" unitRef="usd">0</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RoyaltyExpense contextRef="c-222" decimals="-3" id="f-724" unitRef="usd">0</us-gaap:RoyaltyExpense>
    <angn:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct contextRef="c-223" decimals="-5" id="f-725" unitRef="usd">20900000</angn:CollaborativeArrangementRightsAndObligationsMaximumAggregateMilestonePaymentsPerProduct>
    <angn:CollaborativeArrangementFutureMinimumMaintenancePayments contextRef="c-224" decimals="-5" id="f-726" unitRef="usd">100000</angn:CollaborativeArrangementFutureMinimumMaintenancePayments>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-727">Leases&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has an operating lease for office and laboratory space in Boston, Massachusetts (the &#x201c;Boston Lease&#x201d;).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Boston Lease commenced in February 2022 with the term set to expire in February 2030. The Boston Lease has rent payments escalating annually, which total $11.1&#160;million in the aggregate. As a result, at the commencement of the Boston Lease the Company recognized a right-of-use (&#x201c;ROU&#x201d;) lease asset of $8.0&#160;million with a corresponding lease liability of $8.0&#160;million based on the present value of the minimum rental payments. In addition, the Company will make payments for operating expenses and real estate taxes. In June 2023, the Company secured a letter of credit for the $0.7&#160;million deposit on the Boston Lease, which was reported as restricted cash, noncurrent on the condensed consolidated balance sheets as of September&#160;30, 2025 and December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company also assumed a lease for clinical and regulatory space in Newton, Massachusetts, comprising approximately 6,157 square feet for approximately $0.2&#160;million per year, under a non-cancelable operating lease that expired on June 30, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Lease expense for all leases for the three and nine months ended September 30, 2025 was $0.3 million and $1.0 million, respectively. Lease expense for all leases for the three and nine months ended September 30, 2024 was $0.3 million and $1.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2025, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2025 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseExpense contextRef="c-225" decimals="-5" id="f-728" unitRef="usd">11100000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-226" decimals="-5" id="f-729" unitRef="usd">8000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-226" decimals="-5" id="f-730" unitRef="usd">8000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ProceedsFromSecuredLinesOfCredit contextRef="c-227" decimals="-5" id="f-731" unitRef="usd">700000</us-gaap:ProceedsFromSecuredLinesOfCredit>
    <us-gaap:AreaOfRealEstateProperty contextRef="c-228" decimals="0" id="f-732" unitRef="sqft">6157</us-gaap:AreaOfRealEstateProperty>
    <angn:LesseeOperatingLeaseAnnualRentExpense contextRef="c-229" decimals="-5" id="f-733" unitRef="usd">200000</angn:LesseeOperatingLeaseAnnualRentExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-5" decimals="-5" id="f-734" unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-1" decimals="-5" id="f-735" unitRef="usd">1000000.0</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-6" decimals="-5" id="f-736" unitRef="usd">300000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-7" decimals="-5" id="f-737" unitRef="usd">1100000</us-gaap:OperatingLeaseExpense>
    <angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock contextRef="c-1" id="f-738">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The following table summarizes quantitative information about the Company's operating leases (dollars in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.229%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average remaining lease term&#x2014;operating leases (in years)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 13pt 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted-average discount rate&#x2014;operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</angn:ScheduleOfQuantitativeInformationOnOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-739" unitRef="usd">1012000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-7" decimals="-3" id="f-740" unitRef="usd">1096000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-741">P4Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-98" id="f-742">P5Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-743" unitRef="number">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-98" decimals="3" id="f-744" unitRef="number">0.080</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-745">&lt;div style="margin-top:9pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2025, maturities of lease liabilities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.673%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Amounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2025 (remaining three months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;338&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less present value discount&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Less: operating lease liability, current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Operating lease liability, noncurrent portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;4,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-746" unitRef="usd">338000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-747" unitRef="usd">1383000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-748" unitRef="usd">1425000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-749" unitRef="usd">1467000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-750" unitRef="usd">1512000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <angn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour contextRef="c-3" decimals="-3" id="f-751" unitRef="usd">253000</angn:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-752" unitRef="usd">6378000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-753" unitRef="usd">1041000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-754" unitRef="usd">5337000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-755" unitRef="usd">981000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-756" unitRef="usd">4356000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-757">Debt&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into a securities purchase agreement (the &#x201c;Securities Purchase Agreement&#x201d;) with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors, pursuant to which the Company issued a 3% Senior Secured Convertible Promissory Note due February 15, 2026 (the &#x201c;Convertible Note&#x201d;) in the principal amount of $20.0 million (the &#x201c;Convertible Note Financing&#x201d;). Unless earlier converted in accordance with the terms of the Convertible Note, the Convertible Note would mature on February 15, 2026. Interest on the Convertible Note accrued and was payable quarterly in cash on the principal amount equal to 3% per annum, with an initial interest payment date of June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Convertible Note included multiple conversion features. The Company evaluated all conversion features included within the Convertible Note, under ASC 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and determined that the default interest feature met the definition of a derivative, but the value was de minimis. During the nine months ended September 30, 2025, the Company recorded an immaterial amount in other expense related to the accretion of the discount of Convertible Note debt issuance costs. During the nine months ended September 30, 2025, the Company recorded accrued interest expense of $0.1 million related to the interest due on the Convertible Note but not yet payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. In March 2025, the Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company issued the June 2025 Promissory Note in the principal amount of $10.0&#160;million to GKCC, an entity controlled by a member of the board of directors of the Company. The June 2025 Promissory Note will mature on June 3, 2028, or such earlier date as the June 2025 Promissory Note is required or permitted to be repaid in accordance with the terms of the June 2025 Promissory Note and is a senior, secured obligation of the Company and its subsidiaries. Interest will accrue and be payable in cash on the principal amount at the rate of the sum of the Prime Rate (as defined in the June 2025 Promissory Note) plus 5.00%, provided that the maximum interest rate shall not exceed 12.5% per annum, with an initial interest payment date of July 1, 2026. The June 2025 Promissory Note is secured by a (i) first priority lien on substantially all assets of the Company and its subsidiaries, pursuant to a security agreement and (ii) first priority lien on intellectual property of the Company, pursuant to an intellectual property security agreement. The June 2025 Promissory Note contains customary terms and covenants and customary events of default.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock. The June 2025 Warrant has an exercise price of $7.75 per share, is immediately exercisable and expires five years from the date of issuance. GKCC will not have the right to exercise any portion of the June 2025 Warrant if GKCC (together with its affiliates) would beneficially own in excess of 49.99% of the number of shares of the Company&#x2019;s common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the June 2025 Warrant. The fair value of the June 2025 Warrants, as determined by the Black-Scholes option pricing model, was $0.6 million at the date of issuance, and recorded as a debt discount to the June 2025 Promissory Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company received net proceeds of $9.9 million from the sale of the June 2025 Promissory Note, after deducting debt issuance costs. The June 2025 Promissory Note included multiple conversion features. The Company evaluated all conversion features included within the June 2025 Promissory Note, under ASC 815&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; and determined that the default interest feature met the definition of a derivative, but the value was immaterial. The net proceeds were allocated with the June 2025 Warrant using the relative fair value. As of September 30, the net carrying value of the June 2025 Promissory Note was $9.7 million and the debt discount for the June 2025 Promissory Note was $0.3 million. Accretion of the discount on the June 2025 Promissory Note was $0.4 million and $0.5 million for the three and nine months ended September 30, 2025, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-230" decimals="2" id="f-758" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-230" decimals="-5" id="f-759" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-230" decimals="2" id="f-760" unitRef="number">0.03</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-231" decimals="-5" id="f-761" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-232" decimals="-5" id="f-762" unitRef="usd">100000</us-gaap:InterestExpenseDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-233"
      decimals="INF"
      id="f-763"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-230" decimals="-5" id="f-764" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-234" decimals="-5" id="f-765" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-235" decimals="-5" id="f-766" unitRef="usd">10000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 contextRef="c-236" decimals="4" id="f-767" unitRef="number">0.0500</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-237" decimals="3" id="f-768" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-163"
      decimals="INF"
      id="f-769"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-163"
      decimals="2"
      id="f-770"
      unitRef="usdPerShare">7.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="c-163" id="f-771">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <angn:ClassOfWarrantOrRightOwnershipPercentMaximum contextRef="c-238" decimals="4" id="f-772" unitRef="number">0.4999</angn:ClassOfWarrantOrRightOwnershipPercentMaximum>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-197" decimals="-5" id="f-773" unitRef="usd">600000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-236" decimals="-5" id="f-774" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-235" decimals="-5" id="f-775" unitRef="usd">9700000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="c-235" decimals="-5" id="f-776" unitRef="usd">300000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-239" decimals="-5" id="f-777" unitRef="usd">400000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-240" decimals="-5" id="f-778" unitRef="usd">500000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-779">Income Taxes&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company did not record a provision or benefit for income taxes during the three and nine months ended September&#160;30, 2025 or 2024. As of September&#160;30, 2025 and December&#160;31, 2024, the Company continues to maintain a full valuation allowance against all of its deferred tax assets in light of its history of cumulative net losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On July 4, 2025, H.R. 1 (the &#x201c;Act&#x201d;), formerly known as the One Big Beautiful Bill Act, was signed into law in the United States, introducing changes to U.S. federal tax provisions affecting businesses. The Act includes modifications to the capitalization of research and development expenses and to the depreciation of fixed assets. The legislation has multiple effective dates, with certain provisions effective in 2025 and others implemented through 2027. The Company is currently evaluating the full impact of the Act on its financial position, results of operations, and cash flows. However, the Company does not expect the Act to have a material effect on its financial statements. The impact to the Company&#x2019;s income tax expense and effective tax rate for the three and nine months ended September 30, 2025 associated with this legislation is not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="INF" id="f-780" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="INF" id="f-781" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="INF" id="f-782" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="INF" id="f-783" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-784">Net Loss Per Share&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has reported losses since inception and has computed basic net loss per share attributable to common stockholders by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock and pre-funded warrants outstanding for the period, without consideration for potentially dilutive securities. The Company computes diluted net loss per share of common stock after giving consideration to all potentially dilutive shares of common stock, including options to purchase common stock and preferred stock outstanding during the period determined using the treasury-stock and if-converted methods, except where the effect of including such securities would be anti-dilutive. Because the Company has reported net losses since inception, these potential shares of common stock and preferred stock have been anti-dilutive and basic and diluted loss per share were the same for all periods presented. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the three and nine months ended September&#160;30, 2025 and 2024 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(10,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(18,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(31,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(37,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average of common shares and pre-funded warrants outstanding, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,692,476&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,582,345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,247,864&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,720,527&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(3.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.904%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.906%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,007&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819,302&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of warrants (excluding pre-funded warrants)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555,319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,448,769&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,019,326&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,268,071&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-785">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated for the three and nine months ended September&#160;30, 2025 and 2024 as follows (in thousands, except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.268%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Numerator&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(10,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(18,838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(31,853)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(37,894)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Weighted average of common shares and pre-funded warrants outstanding, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,692,476&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,582,345&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,247,864&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,720,527&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Net loss per share, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(0.60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1.39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(2.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(3.23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-786" unitRef="usd">-10083000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-787" unitRef="usd">-18838000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-788" unitRef="usd">-31853000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-789" unitRef="usd">-37894000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-790" unitRef="shares">16692476</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-791" unitRef="shares">16692476</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-792" unitRef="shares">13582345</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-793" unitRef="shares">13582345</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-794" unitRef="shares">15247864</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-795" unitRef="shares">15247864</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-796" unitRef="shares">11720527</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-797" unitRef="shares">11720527</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-798"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-799"
      unitRef="usdPerShare">-0.60</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-800"
      unitRef="usdPerShare">-1.39</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-801"
      unitRef="usdPerShare">-1.39</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-802"
      unitRef="usdPerShare">-2.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-803"
      unitRef="usdPerShare">-2.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-804"
      unitRef="usdPerShare">-3.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-805"
      unitRef="usdPerShare">-3.23</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-806">The table below provides potentially dilutive securities not included in the calculation of the diluted net loss per share because to do so would be anti-dilutive:&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.807%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:72.293%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.904%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.906%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,007&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;819,302&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Shares issuable upon the exercise of warrants (excluding pre-funded warrants)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,555,319&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,448,769&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;6,019,326&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;3,268,071&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-241" decimals="0" id="f-807" unitRef="shares">2464007</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-242" decimals="0" id="f-808" unitRef="shares">819302</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-243" decimals="0" id="f-809" unitRef="shares">3555319</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-244" decimals="0" id="f-810" unitRef="shares">2448769</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="0" id="f-811" unitRef="shares">6019326</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-7" decimals="0" id="f-812" unitRef="shares">3268071</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c-1" id="f-813">Related Party Transactions&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Private Placement and Subscription Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2024, the Company entered into the March Subscription Agreement with GKCC, an entity controlled by a member of the Company&#x2019;s board of directors. Each March 2024 Pre-Funded Warrant issued and sold in the March 2024 Offering is exercisable at an exercise price equal to $0.01 per share, subject to certain adjustments and limitations as provided under the terms of the March 2024 Pre-Funded Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The net proceeds to the Company from the March 2024 Offering were approximately $6.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As part of the Public Offering described in Note 6, Yekaterina Chudnovsky, a member of the Company&#x2019;s board of directors,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;and Jay Venkatesan, a member of the Company&#x2019;s board of directors, and trusts affiliated with Jay Venkatesan, purchased 1,600,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants and 200,000 July 2024 Pre-Funded Warrants and accompanying July 2024 Common Warrants, respectively, with such July 2024 Pre-Funded Warrants and July 2024 Common Warrants subject to the terms and conditions of the July 2024 Pre-Funded Warrants and July 2024 Common Warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The net proceeds to the Company from the Public Offering were approximately $10.9 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Convertible Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In August 2024, the Company entered into the Securities Purchase Agreement with GKCC, pursuant to which the Company issued the Convertible Note in the principal amount of $20.0 million. The Company received net proceeds of approximately $19.7 million from the Convertible Note Financing, after deducting debt issuance costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In March 2025, the Company exercised its right under the Convertible Note to require GKCC to convert the full amount of the Convertible Note, including all accrued and unpaid interest, into shares of the Company&#x2019;s common stock. The Company issued 3,500,573 shares of its common stock to GKCC in exchange for the principal balance of $20.0 million plus $0.3&#160;million in accrued interest, in satisfaction in full of the Convertible Note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Senior Secured Promissory Note Financing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In June 2025, the Company entered into the June 2025 Promissory Note Financing with GKCC, pursuant to which the Company issued the June 2025 Promissory Note in the principal amount of $10.0 million. The Company received net proceeds of approximately $9.9 million from the June 2025 Promissory Note Financing, after deducting debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Additionally, in connection with the June 2025 Promissory Note Financing, the Company issued to GKCC the June 2025 Warrant to purchase an aggregate of 103,225 shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-154"
      decimals="2"
      id="f-814"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-155" decimals="-5" id="f-815" unitRef="usd">6000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-245" decimals="0" id="f-816" unitRef="shares">1600000</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <angn:ClassOfWarrantOrRightIssuedInPeriod contextRef="c-246" decimals="0" id="f-817" unitRef="shares">200000</angn:ClassOfWarrantOrRightIssuedInPeriod>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-247" decimals="-5" id="f-818" unitRef="usd">10900000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-230" decimals="-5" id="f-819" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-231" decimals="-5" id="f-820" unitRef="usd">19700000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-233"
      decimals="INF"
      id="f-821"
      unitRef="shares">3500573</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-230" decimals="-5" id="f-822" unitRef="usd">20000000.0</us-gaap:DebtInstrumentFaceAmount>
    <angn:AccruedInterestPremiumForConvertiblePreferredStock contextRef="c-234" decimals="-5" id="f-823" unitRef="usd">300000</angn:AccruedInterestPremiumForConvertiblePreferredStock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-163" decimals="INF" id="f-824" unitRef="usd">10000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-236" decimals="-5" id="f-825" unitRef="usd">9900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="c-163"
      decimals="INF"
      id="f-826"
      unitRef="shares">103225</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-827">Segment Reporting&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company has one reportable segment relating to the development of immunotherapies for patients with limited treatment options and poor outcomes suffering from cancer. The Company&#x2019;s Chief Operating Decision Maker (&#x201c;CODM&#x201d;), its Chief Executive Officer, manages the Company&#x2019;s operations on a consolidated basis, assesses performance for the operating segment and decides how to allocate resources based on consolidated net loss, which is reported on the condensed consolidated statements of operations and comprehensive loss. Depreciation expense, amortization expense, stock-based compensation expense, and the change in fair value of warrants are significant noncash items included in consolidated net loss reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. Other segment items include interest income, interest expense, grant income, and change in the fair value of liability-classified warrants. Expenditures for additions to long-lived assets, which include purchases of property and equipment, are included in total consolidated assets reviewed by the CODM and are reported on the condensed consolidated statements of cash flows. All long-lived assets are located in the United States. The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.465%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,984&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments contextRef="c-1" decimals="INF" id="f-828" unitRef="entity">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-829">The following table presents certain financial data for the Company&#x2019;s reportable segment (in thousands):&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.465%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.411%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.202%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;Nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Clinical trial expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Chemistry, manufacturing and controls expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and grant reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(544)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(754)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee related general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional fees and other general and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,984&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.848%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.121%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.407%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.124%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;September 30,&lt;br/&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:115%"&gt;December 31,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-248" decimals="-3" id="f-830" unitRef="usd">1054000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-249" decimals="-3" id="f-831" unitRef="usd">3757000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-250" decimals="-3" id="f-832" unitRef="usd">8491000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-251" decimals="-3" id="f-833" unitRef="usd">9304000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-252" decimals="-3" id="f-834" unitRef="usd">2073000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-253" decimals="-3" id="f-835" unitRef="usd">1995000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-254" decimals="-3" id="f-836" unitRef="usd">6696000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-255" decimals="-3" id="f-837" unitRef="usd">6147000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-256" decimals="-3" id="f-838" unitRef="usd">456000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-257" decimals="-3" id="f-839" unitRef="usd">476000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-258" decimals="-3" id="f-840" unitRef="usd">1486000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-259" decimals="-3" id="f-841" unitRef="usd">3534000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-260" decimals="-3" id="f-842" unitRef="usd">1458000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-261" decimals="-3" id="f-843" unitRef="usd">1523000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-262" decimals="-3" id="f-844" unitRef="usd">3909000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-263" decimals="-3" id="f-845" unitRef="usd">4849000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-264" decimals="-3" id="f-846" unitRef="usd">0</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-265" decimals="-3" id="f-847" unitRef="usd">-544000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-266" decimals="-3" id="f-848" unitRef="usd">-754000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:RecoveryOfDirectCosts contextRef="c-267" decimals="-3" id="f-849" unitRef="usd">-888000</us-gaap:RecoveryOfDirectCosts>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-264" decimals="-3" id="f-850" unitRef="usd">1333000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-265" decimals="-3" id="f-851" unitRef="usd">846000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-266" decimals="-3" id="f-852" unitRef="usd">3782000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-267" decimals="-3" id="f-853" unitRef="usd">2724000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-264" decimals="-3" id="f-854" unitRef="usd">1670000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-265" decimals="-3" id="f-855" unitRef="usd">2289000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-266" decimals="-3" id="f-856" unitRef="usd">5259000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:OtherGeneralAndAdministrativeExpense contextRef="c-267" decimals="-3" id="f-857" unitRef="usd">5837000</us-gaap:OtherGeneralAndAdministrativeExpense>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-264" decimals="-3" id="f-858" unitRef="usd">2039000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-265" decimals="-3" id="f-859" unitRef="usd">8496000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-266" decimals="-3" id="f-860" unitRef="usd">2984000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-267" decimals="-3" id="f-861" unitRef="usd">6387000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:NetIncomeLoss contextRef="c-264" decimals="-3" id="f-862" unitRef="usd">10083000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-265" decimals="-3" id="f-863" unitRef="usd">18838000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-266" decimals="-3" id="f-864" unitRef="usd">31853000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-267" decimals="-3" id="f-865" unitRef="usd">37894000</us-gaap:NetIncomeLoss>
    <us-gaap:Assets contextRef="c-268" decimals="-3" id="f-866" unitRef="usd">28284000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-269" decimals="-3" id="f-867" unitRef="usd">28178000</us-gaap:Assets>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-868">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-5" id="f-869">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-5" id="f-870">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-871">false</ecd:NonRule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
